Citrus Sinensis ID: 008121
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 577 | 2.2.26 [Sep-21-2011] | |||||||
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | yes | no | 0.941 | 0.772 | 0.699 | 0.0 | |
| Q9C8M9 | 719 | Protein STRUBBELIG-RECEPT | no | no | 0.942 | 0.756 | 0.459 | 1e-128 | |
| Q9LUL4 | 717 | Protein STRUBBELIG-RECEPT | no | no | 0.951 | 0.765 | 0.444 | 1e-124 | |
| Q6R2K1 | 699 | Protein STRUBBELIG-RECEPT | no | no | 0.941 | 0.776 | 0.405 | 1e-121 | |
| Q6R2K2 | 687 | Protein STRUBBELIG-RECEPT | no | no | 0.937 | 0.787 | 0.411 | 1e-111 | |
| Q9FG24 | 735 | Protein STRUBBELIG-RECEPT | no | no | 0.927 | 0.727 | 0.393 | 1e-104 | |
| Q06BH3 | 775 | Protein STRUBBELIG-RECEPT | no | no | 0.927 | 0.690 | 0.410 | 1e-101 | |
| Q6R2K3 | 776 | Protein STRUBBELIG-RECEPT | no | no | 0.317 | 0.235 | 0.586 | 2e-57 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.805 | 0.390 | 0.306 | 4e-50 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.696 | 0.321 | 0.326 | 4e-50 |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 768 bits (1984), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/562 (69%), Positives = 448/562 (79%), Gaps = 19/562 (3%)
Query: 21 AFVLILSIFLT----LSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWK 76
A +L +F+ S+V+C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWK
Sbjct: 7 AMFTVLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWK 66
Query: 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
G+ CEGSAVV+IDIS LG+SGT+GYLLSDL SLRK D+SGNSIHDT+PYQLPPNLTSLNL
Sbjct: 67 GITCEGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPPNLTSLNL 126
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
A NN SGNLPYSI++M SLSY+NVS NSLT SIGDIF + LATLDLS NNFSGDLP+S
Sbjct: 127 ARNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSS 186
Query: 197 FISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
++S +S LY+QNNQ+TGS++V SGLPL TLNVANNHF+G IP+EL SI+T IYDGNSF
Sbjct: 187 LSTVSTLSVLYVQNNQLTGSIDVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSF 246
Query: 257 DNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS-GSQSSSSD--KELPAGAIVGIVLGAV 313
DN PA P P + GS P GS+ SSD K L G + GIV G++
Sbjct: 247 DNVPASPQPERPG--------KKETPSGSKKPKIGSEEKSSDSGKGLSGGVVTGIVFGSL 298
Query: 314 FLVALALLALYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPP 372
F+ + L LY C+ K +RKV G+ R+S S P+S E+ EQRVKSVA+V DL
Sbjct: 299 FVAGIIALVLYLCLHKKKRKVRGSTRASQRSLPLSGT---PEVQEQRVKSVASVADLKSS 355
Query: 373 PAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA 432
PAEK+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF
Sbjct: 356 PAEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFP 415
Query: 433 NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492
NGKIMA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGN
Sbjct: 416 NGKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGN 475
Query: 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552
GNL D LH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+EL
Sbjct: 476 GNLDDTLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEEL 535
Query: 553 NPHLSDCGLAALTPNTERQVIT 574
NPHLSD GLAALTPNTERQV T
Sbjct: 536 NPHLSDSGLAALTPNTERQVST 557
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C8M9|SRF6_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 6 OS=Arabidopsis thaliana GN=SRF6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 460 bits (1184), Expect = e-128, Method: Compositional matrix adjust.
Identities = 259/564 (45%), Positives = 350/564 (62%), Gaps = 20/564 (3%)
Query: 21 AFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC 80
A + + L + TD+SD AL L++ ++SP+ LT W GDPCG++W+GV C
Sbjct: 9 ALFTLCIVGFELRFIHGATDASDTSALNTLFSGMHSPAQLTQWTAAAGDPCGQNWRGVTC 68
Query: 81 EGSAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN 139
GS V I +SGL LSGT+G Y+L L SL + DLS N++ +PYQ PPNL LNLA+N
Sbjct: 69 SGSRVTQIKLSGLELSGTLGGYMLDKLTSLTELDLSSNNLGGDLPYQFPPNLQRLNLANN 128
Query: 140 NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS 199
F+G YS++ + L YLN+ N I F L L TLD SFN+F+ LP +F S
Sbjct: 129 QFTGAASYSLSQITPLKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSFTNSLPATFSS 188
Query: 200 LSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNG 259
L+++ SLYLQNNQ +G+++V +GLPL TLN+ANN F+GWIP L I T I DGNSF+ G
Sbjct: 189 LTSLKSLYLQNNQFSGTVDVLAGLPLETLNIANNDFTGWIPSSLKGI-TLIKDGNSFNTG 247
Query: 260 PAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVFLVALA 319
PAPPPPP T P G R+ S +++ S K + ++ ++ LV A
Sbjct: 248 PAPPPPPGTPPIRGSPSRKSGGRESRSSDESTRNGDSKKSGIGAGAIAGIIISL-LVVTA 306
Query: 320 LLALYFCIRKNRRKVSG----ARSSAGSFPVSTNNMNTEMHEQRVKSVAAVT-------D 368
LL +F R+ + K S ++ F +++N+ + Q SV +
Sbjct: 307 LLVAFFLFRRKKSKRSSPMDIEKTDNQPFTLASNDFHENNSIQSSSSVETKKLDTSLSIN 366
Query: 369 LTPPPAEKLVI----ERVAKSGSLKK--IKSPITATSYTVASLQTATNSFSQEFLIGEGS 422
L PPP ++ + K ++KK + P Y+VA LQ AT SFS + L+GEG+
Sbjct: 367 LRPPPIDRNKSFDDEDSTRKPIAVKKSTVVVPSNVRLYSVADLQIATGSFSVDNLLGEGT 426
Query: 423 LGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482
GRVYRAEF +GK++AVKKID++AL D+F+E VS ++ L HPN+ L GYCAEHGQ
Sbjct: 427 FGRVYRAEFDDGKVLAVKKIDSSALPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAEHGQ 486
Query: 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542
L+VYE+ NG+LHD LH +++ SK L WN+RV++ALGTARALEYLHEVC PS+V +N K
Sbjct: 487 HLVVYEFHKNGSLHDFLHLSEEESKALVWNSRVKIALGTARALEYLHEVCSPSIVDKNIK 546
Query: 543 SANILLDDELNPHLSDCGLAALTP 566
SANILLD ELNPHLSD GLA+ P
Sbjct: 547 SANILLDSELNPHLSDSGLASFLP 570
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LUL4|SRF7_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 7 OS=Arabidopsis thaliana GN=SRF7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 257/578 (44%), Positives = 361/578 (62%), Gaps = 29/578 (5%)
Query: 13 FSTSRLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCG 72
+ +R++ A +++ + S + TDSSD AL ++++S+NSP L+ W + GDPCG
Sbjct: 1 MTENRVVLALLILCIVGFEPSFIHGATDSSDTSALNIMFSSMNSPGQLSQWTASGGDPCG 60
Query: 73 ESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLT 132
++WKG+ C GS V I + LGLSG++G++L L S+ +FD+S N++ +PYQLPPNL
Sbjct: 61 QNWKGITCSGSRVTQIKLPSLGLSGSLGFMLDKLTSVTEFDMSNNNLGGDLPYQLPPNLE 120
Query: 133 SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD 192
LNLA+N F+G+ YSI+ M L YLN++ N L Q D F L L+ LDLS N F G
Sbjct: 121 RLNLANNQFTGSAQYSISMMAPLKYLNLAHNQLKQLAID-FTKLTSLSILDLSSNAFIGS 179
Query: 193 LPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYD 252
LPN+ SL++ S+YLQNNQ +G++++ + LPL LN+ANN F+GWIP L I D
Sbjct: 180 LPNTCSSLTSAKSIYLQNNQFSGTIDILATLPLENLNIANNRFTGWIPDSLKGI-NLQKD 238
Query: 253 GNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKE--LPAGAIVGIVL 310
GN ++GPAPPPPP T P S S +S +G+ S S +S + L AG + GIV+
Sbjct: 239 GNLLNSGPAPPPPPGTPPISKSSPTPKSGNRGNRSNGDSSNSKDSSKSGLGAGGVAGIVI 298
Query: 311 GAVFLVALALLALYFCIRKNRRKVSGARSSAGSF--PV--STNNMNTE--------MHEQ 358
+ + A+ L R R + + + P+ ++N+ + E + E
Sbjct: 299 SLIVVTAVIAFFLIKRKRSKRSSSTDIEKTDNNINQPIILASNDFHQENKSVQNPPLVET 358
Query: 359 RVKSVAAVTDLTPPPAEK----------LVIERVAKSGSLKKIKSPITATSYTVASLQTA 408
+ + +L PPP+E+ + VAK + + P +YTV+ LQ A
Sbjct: 359 KKLDTSLSMNLRPPPSERHKSFDDDDSTMRKPIVAKKAA---VVVPSNVNTYTVSDLQVA 415
Query: 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
TNSFS + L+GEG+ GRVYRA+F +GK++AVKKID++AL D+F E VS ++ L H
Sbjct: 416 TNSFSVDNLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADDFTEIVSKIAHLDHE 475
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N+ L GYC+EHGQ L+VYE+ NG+LHD LH A++ SK L WN RV++ALGTARALEYL
Sbjct: 476 NVTKLDGYCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPRVKIALGTARALEYL 535
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
HEVC PS+VH+N KSANILLD ELNPHLSD GLA+ P
Sbjct: 536 HEVCSPSIVHKNIKSANILLDSELNPHLSDSGLASFLP 573
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K1|SRF5_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 5 OS=Arabidopsis thaliana GN=SRF5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1120), Expect = e-121, Method: Compositional matrix adjust.
Identities = 231/570 (40%), Positives = 340/570 (59%), Gaps = 27/570 (4%)
Query: 23 VLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEG 82
++I+S+ +T++L+Q TD+ +V AL V++TSLNSPS L WK N GDPC +SW+GV C+G
Sbjct: 8 LVIVSLAITVTLLQAKTDNQEVSALNVMFTSLNSPSKLKGWKANGGDPCEDSWEGVKCKG 67
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142
S+V + +SG L G+ GYLLS+L SL FDLS N++ IPYQLPPN+ +L+ + N
Sbjct: 68 SSVTELQLSGFELGGSRGYLLSNLKSLTTFDLSKNNLKGNIPYQLPPNIANLDFSENELD 127
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
GN+PYS++ M +L +N+ +N L + D+F L+ L TLD S N SG LP SF +L++
Sbjct: 128 GNVPYSLSQMKNLQSINLGQNKLNGELPDMFQKLSKLETLDFSLNKLSGKLPQSFANLTS 187
Query: 203 ISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAP 262
+ L+LQ+N+ TG +NV L + LNV +N F GWIP EL I + + GN + AP
Sbjct: 188 LKKLHLQDNRFTGDINVLRNLAIDDLNVEDNQFEGWIPNELKDIDSLLTGGNDWSTETAP 247
Query: 263 PPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVFLVAL---- 318
PPPP + R+ S S G ++ + AGA +G+++ + L+AL
Sbjct: 248 PPPPGV----------KYGRKSSGSKDGGGITAGTGMVIAGACLGVLVLIIVLIALVSKK 297
Query: 319 -ALLALYFCIRKNRRKVSGARS-----SAGSFPVSTNN-----MNTEMHEQRVKSVAA-- 365
+ L+ +F N +S SA V N + + ++ + + +
Sbjct: 298 KSSLSPHFIDEDNSHHTPKFKSLTSHGSAQELRVDFGNDYKDGKSGDSGDENIHRIGSKG 357
Query: 366 VTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGR 425
+ A + K+ S +A + ++ LQ+AT +FS L+GEGS+GR
Sbjct: 358 LKHYVSSRVMSFTDTEFANKLNAKRTTSTRSAVEFELSDLQSATANFSPGNLLGEGSIGR 417
Query: 426 VYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485
VYRA++++G+ +AVKKID+ + + V ++S++RH NI L GYC+E G +L
Sbjct: 418 VYRAKYSDGRTLAVKKIDSTLFDSGKSEGITPIVMSLSKIRHQNIAELVGYCSEQGHNML 477
Query: 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545
VYEY NG+LH+ LH +D SK LTWN RVR+ALGTARA+EYLHE C PSV+H+N KS+N
Sbjct: 478 VYEYFRNGSLHEFLHLSDCFSKPLTWNTRVRIALGTARAVEYLHEACSPSVMHKNIKSSN 537
Query: 546 ILLDDELNPHLSDCGLAALTPNTERQVITG 575
ILLD +LNP LSD GL+ T + + G
Sbjct: 538 ILLDADLNPRLSDYGLSKFYLRTSQNLGEG 567
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K2|SRF4_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 4 OS=Arabidopsis thaliana GN=SRF4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 401 bits (1030), Expect = e-111, Method: Compositional matrix adjust.
Identities = 243/590 (41%), Positives = 338/590 (57%), Gaps = 49/590 (8%)
Query: 17 RLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWK 76
R++ F+ IF S+V TDS DV AL Y S+NSPS L W + GDPCG+SW
Sbjct: 7 RIVLVFIACFGIFT--SVVLAKTDSQDVSALNDAYKSMNSPSKLKGWSSSGGDPCGDSWD 64
Query: 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
G+ C+GS+V I +SG GLSG++GY L +L SL D+S N+++ +PYQLP LT L+
Sbjct: 65 GITCKGSSVTEIKVSGRGLSGSLGYQLGNLKSLTYLDVSKNNLNGNLPYQLPDKLTYLDG 124
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
+ N+F+GN+PYS++ M LSYLN+ RN+L + D+F L L T+DLS N +G LP S
Sbjct: 125 SENDFNGNVPYSVSLMNDLSYLNLGRNNLNGELSDMFQKLPKLETIDLSSNQLTGKLPQS 184
Query: 197 FISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNS 255
F +L+ + +L+LQ NQ GS+N LP + +NVANN F+GWIP EL +I GN
Sbjct: 185 FANLTGLKTLHLQENQFKGSINALRDLPQIDDVNVANNQFTGWIPNELKNIGNLETGGNK 244
Query: 256 FDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGI-VLGAVF 314
+ +G AP PPP G H +R+ S K L G I+ + +G +
Sbjct: 245 WSSGRAPSPPP------GTRHIDRNSS--------GGGGGSSKALTLGVIIAVSSIGGLI 290
Query: 315 LVALALLALYFCIRKNRRKVS-------GARSSAGSF-PVSTNNMNTEMHEQ--RVKSVA 364
L A L+AL RKN S G S F P S+ + + E+ K+V
Sbjct: 291 LFA-GLIAL-ISRRKNSNDSSHFFDDEKGTNRSKPLFTPQSSQMLQFDNMEEFKNQKTVD 348
Query: 365 AVTDLTPPPAEKLVIERVAKSG-----------------SLKKIKSPIT--ATSYTVASL 405
+ T L P+ K K+ S SP T ++++A L
Sbjct: 349 SNTSLETKPSVKRTSSVSFKNSPTFHLIPSTQVAATPDRSSTSQDSPDTRGVKAFSLADL 408
Query: 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL 465
Q + FS L+GEG++GRVY+A+F +G+ AVK+ID++ L + F VS++S +
Sbjct: 409 QNTASCFSPNRLLGEGTIGRVYKAKFQDGRKFAVKEIDSSLLGKGNPEEFSHIVSSISSI 468
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
H N+ L GYC+E G+ +LVYEY +G+LH LH +DD SK LTWN R+R+ALGTA+A+
Sbjct: 469 HHKNMAELVGYCSEQGRNMLVYEYFTSGSLHRFLHLSDDFSKPLTWNTRIRIALGTAKAI 528
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITG 575
EYLHE C P +VH+N KS+NILLD+ELNP LSD GLA T + + G
Sbjct: 529 EYLHETCSPPLVHKNIKSSNILLDNELNPRLSDYGLANFHHRTSQNLGVG 578
|
Acts as a direct positive regulator of leaf size but not leaf shape. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FG24|SRF2_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 2 OS=Arabidopsis thaliana GN=SRF2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 378 bits (970), Expect = e-104, Method: Compositional matrix adjust.
Identities = 228/580 (39%), Positives = 327/580 (56%), Gaps = 45/580 (7%)
Query: 21 AFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC 80
A +L+ +I L+ + TD +V ALQ LY SL +P L W+ GDPCGE+W G++C
Sbjct: 11 ATILLTTILFVLA--KTDTDPLEVLALQDLYKSLRNPEQLRGWRLEGGDPCGEAWLGISC 68
Query: 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNN 140
GS++V + + L L G++G L L +L+ D+S N++ IP+ LPPN T +N+A NN
Sbjct: 69 SGSSIVDLQLRELKLLGSLGNQLQHLHNLKILDVSFNNLEGEIPFGLPPNATHINMAYNN 128
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
+ ++P+S+ M SL LN+S NSL+ +G++F L + +DLSFNN +GDLP+SF +L
Sbjct: 129 LTQSIPFSLPLMTSLQSLNLSHNSLSGPLGNVFSGLQ-IKEMDLSFNNLTGDLPSSFGTL 187
Query: 201 SNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGP 260
N++SLYLQNN++TGS+ + LPL LN+ +N FSG IP SI GN F P
Sbjct: 188 MNLTSLYLQNNRLTGSVIYLADLPLADLNIEDNQFSGIIPSHFQSIPHLWIWGNKFHVEP 247
Query: 261 APPP---PPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVF--- 314
P P P N + + S + + + GI G+ F
Sbjct: 248 NYKPWKFPLDVRP----LIQNDTGYPTTESSAIMNFPRPETQKVKKKKKGIGAGSTFLLV 303
Query: 315 ---LVALALLALYFCIRKNRRKVSGA-------RSSAGSFPVSTNN---MNTEMHEQRVK 361
+ AL F +R N R+ S A S PVST + TE + Q
Sbjct: 304 GGLALLGTFFAL-FAVRMNHRRAQNLAAIHRSNNSIAYSLPVSTGREYPVATEDNPQ--- 359
Query: 362 SVAAVTDLTPPPAEKL--------VIERVAKSGSLK-KIKSPITATSYTVASLQTATNSF 412
+ PPPA +L I++ A+ S + P A ++ A LQ ATN F
Sbjct: 360 ----IKRFQPPPAPQLRHLPSPPVRIDKSARRKSFSATCQYPSFAKLFSAAELQLATNCF 415
Query: 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
S+E L+GEG LG VYRA+ +G+ V+ I ++LSL EE+ F E + S+LRHPNIVT
Sbjct: 416 SEENLLGEGPLGSVYRAKLPDGQFAVVRNIPMSSLSLHEEEQFTEVLQTASKLRHPNIVT 475
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G+C E+G+ LLVYEYVG+ +L++ +H D+ K L+W R+R+A+G ARAL+YLH
Sbjct: 476 LLGFCIENGEHLLVYEYVGHLSLYNAMH--DEVYKPLSWGLRLRIAIGVARALDYLHSSF 533
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
P + H + K+ NILLD+EL P ++DCGLA+L P T V
Sbjct: 534 CPPIAHSDLKATNILLDEELTPRIADCGLASLRPLTSNSV 573
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q06BH3|SRF1_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 1 OS=Arabidopsis thaliana GN=SRF1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 370 bits (949), Expect = e-101, Method: Compositional matrix adjust.
Identities = 255/621 (41%), Positives = 342/621 (55%), Gaps = 86/621 (13%)
Query: 21 AFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC 80
+F LI L+L+L T+ DV A+ L+ +L SP +L W + GDPCGESW+GV C
Sbjct: 19 SFALISLPSLSLAL----TNPDDVAAINSLFLALESP-LLPGWVASGGDPCGESWQGVLC 73
Query: 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNN 140
S V +I + L G +G L+ SL+ D S N I +IP LP +L +L L+ NN
Sbjct: 74 NASQVETIILISANLGGELGVGLNMFTSLKAMDFSNNHIGGSIPSTLPVSLQNLFLSGNN 133
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
F+G +P S++S+ SLS ++++ N L+ I D+F +L + +DLS NN SG LP S +L
Sbjct: 134 FTGTIPESLSSLKSLSVMSLNNNLLSGKIPDVFQDLGLMINIDLSSNNLSGPLPPSMQNL 193
Query: 201 SNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGP 260
S ++SL LQNN ++G L+V LPL LNV NN F+G IP +L+SI FI GN F+
Sbjct: 194 STLTSLLLQNNHLSGELDVLQDLPLKDLNVENNLFNGPIPEKLLSIPNFIKGGNLFNVTI 253
Query: 261 AP-------------------PPPPSTAPPSGRSHNN---RSHRQGSHSPSGSQSSSSDK 298
AP PP P+ + G++H H +P G + S + K
Sbjct: 254 APSPSPETPPSPTSPKRPFFGPPSPNASAGHGQAHVRSPPSDHHPSRPTPQGKEDSFTSK 313
Query: 299 ELPAGAIVGIVLGAVFLVALALLALYF---CIRKNR---------------RKVSGARSS 340
+ I +LGA V LAL+ L C+RK R G+RS+
Sbjct: 314 RI----IWISILGAFSFVVLALVCLLCGRKCLRKREDSEQLSKPHLTSEYGRAREGSRSN 369
Query: 341 AGSFPVS-TNNMNTE------------MHEQRVKSVAA--------------VTDLTPP- 372
A P S T N + E +H +SV + DL P
Sbjct: 370 ASMLPPSNTFNKDKEARPKERVGGASKLHGGAERSVGSESKQESHEIDMNGNAMDLMHPS 429
Query: 373 --PAEKLVIERVAK--SGSLKKIKS----PITATS-YTVASLQTATNSFSQEFLIGEGSL 423
P K VI + + SLK+ S P+TA +TVASLQ TNSFS E LIG G L
Sbjct: 430 SIPPIKRVIAKATEPAEASLKRTTSKSHGPLTAVKHFTVASLQQHTNSFSHENLIGTGML 489
Query: 424 GRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483
G VYRAE GK+ AV+K+D + + +EE FLE V+N+ R+RH NIV L G+C+EH QR
Sbjct: 490 GSVYRAELPGGKLFAVRKLDKKSPNHEEEGKFLELVNNIDRIRHANIVQLVGFCSEHSQR 549
Query: 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543
LL++EY NG LHD+LH D L+WN RVR+AL A+ALEYLHE+C P +HRNFKS
Sbjct: 550 LLIHEYCRNGTLHDLLHIDDRLKIELSWNVRVRIALEAAKALEYLHEICDPPSIHRNFKS 609
Query: 544 ANILLDDELNPHLSDCGLAAL 564
ANILLDD++ H+SDCGLA L
Sbjct: 610 ANILLDDDIRVHVSDCGLAPL 630
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K3|SRF3_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 3 OS=Arabidopsis thaliana GN=SRF3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (569), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 109/186 (58%), Positives = 133/186 (71%), Gaps = 3/186 (1%)
Query: 380 ERVAKSGSLKKIKSPITATS-YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMA 438
ER K S K++ P+T+ Y++ASLQ T SF+QE LIG G LG VYRA NGK+ A
Sbjct: 454 ERPVKKTSPKRL--PLTSVKHYSIASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFA 511
Query: 439 VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDM 498
VKK+D A Q++ F+E V+N+ +RH NIV L GYCAEH QRLLVYEY NG L D
Sbjct: 512 VKKLDKRASEQQQDHEFIELVNNIDMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDG 571
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
LH D+ K L+WN RV +ALG ARALEYLHEVC P ++HRNFKSAN+LLDD+L+ +SD
Sbjct: 572 LHSDDEFKKKLSWNTRVSMALGAARALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSD 631
Query: 559 CGLAAL 564
CGLA L
Sbjct: 632 CGLAPL 637
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 4e-50, Method: Compositional matrix adjust.
Identities = 155/505 (30%), Positives = 248/505 (49%), Gaps = 40/505 (7%)
Query: 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLAS 138
E +V I +S LSG + LS L +L DLSGN++ +IP ++ L LNLA+
Sbjct: 602 ECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLAN 661
Query: 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N +G++P S + SL LN+++N L + GNL L +DLSFNN SG+L +
Sbjct: 662 NQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELS 721
Query: 199 SLSNISSLYLQNNQVTGSLNVFSG--LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
++ + LY++ N+ TG + G L L+V+ N SG IP ++ + + +
Sbjct: 722 TMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAK 781
Query: 257 DN--GPAPP----PPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKEL-PAGAIVGIV 309
+N G P PS A SG +++ GS +L A I G++
Sbjct: 782 NNLRGEVPSDGVCQDPSKALLSG-------NKELCGRVVGSDCKIEGTKLRSAWGIAGLM 834
Query: 310 LGAVFLVALALLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDL 369
LG +V + + +L RR R V + M E R+K +L
Sbjct: 835 LGFTIIVFVFVFSL-------RRWAMTKR-------VKQRDDPERMEESRLKGFVD-QNL 879
Query: 370 TPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA 429
+ R S ++ + P+ + + AT+ FS++ +IG+G G VY+A
Sbjct: 880 YFLSGSR---SREPLSINIAMFEQPLLKVR--LGDIVEATDHFSKKNIIGDGGFGTVYKA 934
Query: 430 EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489
K +AVKK+ A Q F+ + + +++HPN+V+L GYC+ ++LLVYEY
Sbjct: 935 CLPGEKTVAVKKLSEA--KTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEY 992
Query: 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549
+ NG+L L + L W+ R+++A+G AR L +LH +P ++HR+ K++NILLD
Sbjct: 993 MVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLD 1052
Query: 550 DELNPHLSDCGLAALTPNTERQVIT 574
+ P ++D GLA L E V T
Sbjct: 1053 GDFEPKVADFGLARLISACESHVST 1077
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 4e-50, Method: Compositional matrix adjust.
Identities = 154/471 (32%), Positives = 237/471 (50%), Gaps = 69/471 (14%)
Query: 112 FDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
L GNS++ +IP ++ L LNL N FSG+LP ++ + L L +SRNSLT I
Sbjct: 700 LSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEI 759
Query: 170 GDIFGNLAGL-ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLPLT 226
G L L + LDLS+NNF+GD+P++ +LS + +L L +NQ+TG + +V L
Sbjct: 760 PVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLG 819
Query: 227 TLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSH 286
LNV+ N+ G + ++ + GN+ G P R + RS+ +
Sbjct: 820 YLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGS----------PLSRCNRVRSNNK--- 866
Query: 287 SPSGSQSSSSDKELPAGAIVGIV-LGAVFLVALALLALYFCIRKNRRKVSGARSSAGSFP 345
Q S+ + AI + +G + LV +AL+F R + K G S+A +
Sbjct: 867 ----QQGLSARSVVIISAISALTAIGLMILV----IALFFKQRHDFFKKVGHGSTAYTSS 918
Query: 346 VSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASL 405
S++ H+ ++ A+ +D+ +
Sbjct: 919 SSSSQAT---HKPLFRNGASKSDIR-------------------------------WEDI 944
Query: 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL 465
AT++ S+EF+IG G G+VY+AE NG+ +AVKKI L +F V + R+
Sbjct: 945 MEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKD-DLMSNKSFSREVKTLGRI 1003
Query: 466 RHPNIVTLAGYCAE--HGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVAL 519
RH ++V L GYC+ G LL+YEY+ NG++ D LH + K L W AR+R+A+
Sbjct: 1004 RHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAV 1063
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTE 569
G A+ +EYLH C+P +VHR+ KS+N+LLD + HL D GLA LT N +
Sbjct: 1064 GLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCD 1114
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 577 | ||||||
| 356555690 | 705 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.946 | 0.774 | 0.717 | 0.0 | |
| 356532229 | 706 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.935 | 0.764 | 0.723 | 0.0 | |
| 359494846 | 729 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.982 | 0.777 | 0.718 | 0.0 | |
| 297803912 | 703 | kinase [Arabidopsis lyrata subsp. lyrata | 0.946 | 0.776 | 0.704 | 0.0 | |
| 79481791 | 703 | STRUBBELIG-receptor family 8 protein [Ar | 0.941 | 0.772 | 0.699 | 0.0 | |
| 224117956 | 672 | predicted protein [Populus trichocarpa] | 0.902 | 0.775 | 0.752 | 0.0 | |
| 449455383 | 711 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.941 | 0.763 | 0.7 | 0.0 | |
| 255554777 | 640 | Serine/threonine-protein kinase PBS1, pu | 0.811 | 0.731 | 0.750 | 0.0 | |
| 449513527 | 647 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.857 | 0.765 | 0.661 | 0.0 | |
| 357138966 | 715 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.922 | 0.744 | 0.633 | 1e-178 |
| >gi|356555690|ref|XP_003546163.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/556 (71%), Positives = 461/556 (82%), Gaps = 10/556 (1%)
Query: 23 VLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEG 82
+L+ +F+ L L TD SDVQAL+V+Y +LNSP+ LT WK GDPCGESWKGV CEG
Sbjct: 10 ILLSLVFVALPLSLANTDPSDVQALEVMYNALNSPTQLTGWKIGGGDPCGESWKGVTCEG 69
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142
SAVVSI +SGLGL GT+GYLLSDL+SLR+ DLS N IHDTIPYQLPPNLTSLN A NN S
Sbjct: 70 SAVVSIKLSGLGLDGTLGYLLSDLMSLRELDLSDNKIHDTIPYQLPPNLTSLNFARNNLS 129
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
GNLPYSI++MVSL+YLN+S N+L+ ++GDIF +L L TLDLSFNNFSGDLP SF++L+N
Sbjct: 130 GNLPYSISAMVSLNYLNLSNNALSMTVGDIFASLQDLGTLDLSFNNFSGDLPPSFVALAN 189
Query: 203 ISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAP 262
+SSL+LQ NQ+TGSL V GLPL TLNVANN+FSGWIP EL SIR FIYDGNSF+N PAP
Sbjct: 190 LSSLFLQKNQLTGSLGVLVGLPLDTLNVANNNFSGWIPHELSSIRNFIYDGNSFENSPAP 249
Query: 263 PPPPSTAPPSGRSHNNRSHRQGSHSP---SGSQSSSSDKELPAGAIVGIVLGAVFLVALA 319
PP T+PP H GSH+ S ++ S K L GA+VGIVLG+V + A+
Sbjct: 250 LPPAFTSPPPNGPHGRHHSGSGSHNKTQVSDNEKSDGHKGLTVGAVVGIVLGSVLVAAIV 309
Query: 320 LLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVI 379
LLAL FCIRK + K GAR+ +GS P++ +M EQRVKS A VTDL P PAE + +
Sbjct: 310 LLALVFCIRKQKGK-KGARNFSGSLPLT-----PQMQEQRVKSAAVVTDLKPRPAENVTV 363
Query: 380 ERVA-KSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMA 438
ERVA KSGS+K++KSPIT+T YTVASLQ+ATNSFSQEF+IGEGSLGRVY+A+F NGK+MA
Sbjct: 364 ERVAVKSGSVKQMKSPITSTLYTVASLQSATNSFSQEFIIGEGSLGRVYKADFPNGKVMA 423
Query: 439 VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDM 498
+KKIDN+ALSLQEEDNFLEAVSNMSRLRHP+IVTLAGYCAEHGQRLLVYEY+ NGNLHDM
Sbjct: 424 IKKIDNSALSLQEEDNFLEAVSNMSRLRHPSIVTLAGYCAEHGQRLLVYEYIANGNLHDM 483
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
LHFA+DSSK L+WNARVR+ALGTARALEYLHEVCLPSVVHRNFKSANILLD+ELNPHLSD
Sbjct: 484 LHFAEDSSKALSWNARVRIALGTARALEYLHEVCLPSVVHRNFKSANILLDEELNPHLSD 543
Query: 559 CGLAALTPNTERQVIT 574
CGLAALTPNTERQV T
Sbjct: 544 CGLAALTPNTERQVST 559
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532229|ref|XP_003534676.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 792 bits (2045), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/553 (72%), Positives = 459/553 (83%), Gaps = 13/553 (2%)
Query: 28 IFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVS 87
IF+ L L TTD SDVQAL+V+Y LNSP+ LT WK GDPCGESWKGV CEGSAVVS
Sbjct: 15 IFVALPLSLATTDPSDVQALEVMYNVLNSPTQLTGWKIGGGDPCGESWKGVTCEGSAVVS 74
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY 147
I +SGLGL GT+GYLLSDL+SLR DLS N IHDTIPYQLPPNLTSLN A NN SGNLPY
Sbjct: 75 IKLSGLGLDGTLGYLLSDLMSLRDLDLSDNKIHDTIPYQLPPNLTSLNFARNNLSGNLPY 134
Query: 148 SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY 207
SI++M SL+YLN+S N+L+ ++GDIF +L L TLDLSFNNFSGDLP S +L+N+SSL+
Sbjct: 135 SISAMGSLNYLNLSNNALSMTVGDIFASLQDLGTLDLSFNNFSGDLPPSVGALANLSSLF 194
Query: 208 LQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPS 267
LQ NQ+TGSL+ GLPL TLNVANN+FSGWIP EL SI FIYDGNSF+N PAP PP
Sbjct: 195 LQKNQLTGSLSALVGLPLDTLNVANNNFSGWIPHELSSIHNFIYDGNSFENRPAPLPPTV 254
Query: 268 TAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKE-----LPAGAIVGIVLGAVFLVALALLA 322
T+PP SH R H GS S + +Q+S ++K L GA++GIVLG+V + A+ LA
Sbjct: 255 TSPPPSGSH--RRHHSGSGSHNKTQASDNEKSNGHKGLTVGAVIGIVLGSVLVAAIVFLA 312
Query: 323 LYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV 382
L FCIRK + K GAR+ +GS P++ +M EQRVKS A VTDL P PAE + +ERV
Sbjct: 313 LVFCIRKQKGKKKGARNFSGSLPLT-----PQMQEQRVKSAAVVTDLKPRPAENVTVERV 367
Query: 383 A-KSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKK 441
A KSGS+K++KSPIT+TSYTVASLQ+ATNSFSQEF+IGEGSLGRVYRA+F NGK+MA+KK
Sbjct: 368 AVKSGSVKQMKSPITSTSYTVASLQSATNSFSQEFIIGEGSLGRVYRADFPNGKVMAIKK 427
Query: 442 IDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF 501
IDN+ALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY+ NGNLHDMLHF
Sbjct: 428 IDNSALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYIANGNLHDMLHF 487
Query: 502 ADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
A+DSSK+L+WNARVR+ALGTARALEYLHEVCLPSVVHRNFKSANILLD+ELNPHLSDCGL
Sbjct: 488 AEDSSKDLSWNARVRIALGTARALEYLHEVCLPSVVHRNFKSANILLDEELNPHLSDCGL 547
Query: 562 AALTPNTERQVIT 574
AALTPNTERQV T
Sbjct: 548 AALTPNTERQVST 560
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359494846|ref|XP_002267170.2| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Vitis vinifera] gi|297741762|emb|CBI32991.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2037), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/590 (71%), Positives = 475/590 (80%), Gaps = 23/590 (3%)
Query: 1 MAVQYTAVFPLPFSTSRLIDAFVLILS---IFLTLSLVQCTTDSSDVQALQVLYTSLNSP 57
MAV F S SR A +++ S I LS V TD SDVQ LQV+Y SLN P
Sbjct: 1 MAVNGALSFSCSHSHSRFFFALLVLFSFSAILPPLS-VYGATDPSDVQGLQVIYNSLNGP 59
Query: 58 SVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN 117
S LT W + GDPCGESWKGV CEGSAVVSI ISGLGL+GTMGYLLS+ LSLR D+S N
Sbjct: 60 SQLTGWTNSSGDPCGESWKGVTCEGSAVVSIQISGLGLNGTMGYLLSNFLSLRTLDMSDN 119
Query: 118 SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
+IHDTIPYQLPPNLT+LNLASNN +G+ PYSI++MVSL+YLNVS NS++QSIGDIF LA
Sbjct: 120 NIHDTIPYQLPPNLTNLNLASNNLTGSFPYSISTMVSLNYLNVSHNSISQSIGDIFAKLA 179
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSG 237
GL LDLS NNF+GDLPNSF SLSN+S+LYLQNNQ+TG L+V +GLPLT LNVANN+FSG
Sbjct: 180 GLTILDLSVNNFTGDLPNSFTSLSNLSTLYLQNNQLTGPLSVLTGLPLTDLNVANNNFSG 239
Query: 238 WIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQS---- 293
WIP EL SIR FIYDGNSFDNGPAPPPPP T PP RS +NR +HSP +++
Sbjct: 240 WIPSELRSIRKFIYDGNSFDNGPAPPPPPYTPPPPSRSRSNR-----THSPPEARTPSSS 294
Query: 294 -------SSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGSFPV 346
+ +K L G I+GIVLG++ LV +AL+AL FC+RK ++K +GAR S GS PV
Sbjct: 295 DGQSSNSDNGNKGLAIGPIIGIVLGSL-LVLVALIALVFCVRKAKKKGTGARPSVGSVPV 353
Query: 347 STNNMNTE-MHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKSPITATSYTVAS 404
T +NTE M EQR K A VTDL PPPAE L++ERV K+GS K++KSPITATSYTVAS
Sbjct: 354 VTEKVNTETMQEQRTKFTATVTDLKPPPAENLMVERVQGKNGSGKRVKSPITATSYTVAS 413
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
LQTATNSFSQEFLIGEGSLGRVYRA+F NGK MA+KKIDNAALSLQEEDNFLEAVSNMSR
Sbjct: 414 LQTATNSFSQEFLIGEGSLGRVYRADFPNGKTMAIKKIDNAALSLQEEDNFLEAVSNMSR 473
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
LRH NIVTL GYCAEHGQRLLVYEY+GNG+LHDMLHF DDS K LTWNARVRVALGTARA
Sbjct: 474 LRHQNIVTLVGYCAEHGQRLLVYEYIGNGSLHDMLHFTDDSGKTLTWNARVRVALGTARA 533
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
LEYLHEVCLPS VHRNFKSANILLD+ELNPHLSDCGLAALTPNTERQV T
Sbjct: 534 LEYLHEVCLPSTVHRNFKSANILLDEELNPHLSDCGLAALTPNTERQVST 583
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297803912|ref|XP_002869840.1| kinase [Arabidopsis lyrata subsp. lyrata] gi|297315676|gb|EFH46099.1| kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2035), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/561 (70%), Positives = 450/561 (80%), Gaps = 15/561 (2%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
+ +L +++ S+V C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWKG
Sbjct: 8 MFTVLLLFIALISGFSIVSCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWKG 67
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
+ CEGSAVVSIDIS LG+SGT+GYLLSDL+SLRK D+SGNSIHDT+PYQLPPNLTSLNLA
Sbjct: 68 ITCEGSAVVSIDISDLGVSGTLGYLLSDLMSLRKLDVSGNSIHDTLPYQLPPNLTSLNLA 127
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
NN SGNLPYSI++M SLSYLNVS NSLT SIGDIF + L+TLDLS NNFSGDLP+S
Sbjct: 128 RNNLSGNLPYSISAMGSLSYLNVSGNSLTMSIGDIFADHKSLSTLDLSHNNFSGDLPSSL 187
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
++S +S LY+QNNQ+TGS++V SGLPLTTLNVANNHF+G IP+EL SI+T IYDGNSFD
Sbjct: 188 STVSALSVLYVQNNQLTGSIDVLSGLPLTTLNVANNHFNGSIPKELSSIQTLIYDGNSFD 247
Query: 258 NGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS-GSQSSSSD--KELPAGAIVGIVLGAVF 314
N PA P P + GS P GS+ SSD K L G + GIV G++F
Sbjct: 248 NVPATPQPERPG--------KKGEPSGSKKPKIGSEKKSSDSGKGLSGGVVTGIVFGSLF 299
Query: 315 LVALALLALYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPP 373
+ + L LY C+ K +RKV G+ R+S S P+S EM EQRVKSVA+V DL P
Sbjct: 300 VAGIIALVLYLCLHKKKRKVGGSTRASQRSLPLSGT---PEMQEQRVKSVASVADLKSSP 356
Query: 374 AEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFAN 433
AEK+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF N
Sbjct: 357 AEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPN 416
Query: 434 GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493
GKIMA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGNG
Sbjct: 417 GKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNG 476
Query: 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553
NL DMLH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+ELN
Sbjct: 477 NLDDMLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELN 536
Query: 554 PHLSDCGLAALTPNTERQVIT 574
PHLSD GLAALTPNTERQV T
Sbjct: 537 PHLSDSGLAALTPNTERQVST 557
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79481791|ref|NP_193944.2| STRUBBELIG-receptor family 8 protein [Arabidopsis thaliana] gi|75127758|sp|Q6R2J8.1|SRF8_ARATH RecName: Full=Protein STRUBBELIG-RECEPTOR FAMILY 8; AltName: Full=Leucine-rich repeat receptor kinase-like protein SRF8; Flags: Precursor gi|41323415|gb|AAR99876.1| strubbelig receptor family 8 [Arabidopsis thaliana] gi|224589624|gb|ACN59345.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332659160|gb|AEE84560.1| STRUBBELIG-receptor family 8 protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1984), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/562 (69%), Positives = 448/562 (79%), Gaps = 19/562 (3%)
Query: 21 AFVLILSIFLT----LSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWK 76
A +L +F+ S+V+C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWK
Sbjct: 7 AMFTVLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWK 66
Query: 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
G+ CEGSAVV+IDIS LG+SGT+GYLLSDL SLRK D+SGNSIHDT+PYQLPPNLTSLNL
Sbjct: 67 GITCEGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPPNLTSLNL 126
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
A NN SGNLPYSI++M SLSY+NVS NSLT SIGDIF + LATLDLS NNFSGDLP+S
Sbjct: 127 ARNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSS 186
Query: 197 FISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
++S +S LY+QNNQ+TGS++V SGLPL TLNVANNHF+G IP+EL SI+T IYDGNSF
Sbjct: 187 LSTVSTLSVLYVQNNQLTGSIDVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSF 246
Query: 257 DNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS-GSQSSSSD--KELPAGAIVGIVLGAV 313
DN PA P P + GS P GS+ SSD K L G + GIV G++
Sbjct: 247 DNVPASPQPERPG--------KKETPSGSKKPKIGSEEKSSDSGKGLSGGVVTGIVFGSL 298
Query: 314 FLVALALLALYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPP 372
F+ + L LY C+ K +RKV G+ R+S S P+S E+ EQRVKSVA+V DL
Sbjct: 299 FVAGIIALVLYLCLHKKKRKVRGSTRASQRSLPLSGT---PEVQEQRVKSVASVADLKSS 355
Query: 373 PAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA 432
PAEK+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF
Sbjct: 356 PAEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFP 415
Query: 433 NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492
NGKIMA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGN
Sbjct: 416 NGKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGN 475
Query: 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552
GNL D LH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+EL
Sbjct: 476 GNLDDTLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEEL 535
Query: 553 NPHLSDCGLAALTPNTERQVIT 574
NPHLSD GLAALTPNTERQV T
Sbjct: 536 NPHLSDSGLAALTPNTERQVST 557
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224117956|ref|XP_002331522.1| predicted protein [Populus trichocarpa] gi|222873746|gb|EEF10877.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/530 (75%), Positives = 454/530 (85%), Gaps = 9/530 (1%)
Query: 50 LYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSL 109
+YTSLNSPS LT WK N GDPC ESWKG+ CEGSAVVSI ISGLGL GTMGYLL++L+SL
Sbjct: 1 MYTSLNSPSQLTTWKSNGGDPCAESWKGITCEGSAVVSIQISGLGLDGTMGYLLANLMSL 60
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
R DLS N +HD+ PYQLPPNLTSLNLA NN SGN+PYS++SMVSLSYLN+SRNSL QSI
Sbjct: 61 RTLDLSDNHLHDSFPYQLPPNLTSLNLAKNNLSGNIPYSMSSMVSLSYLNISRNSLAQSI 120
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLN 229
GD+F NL+ LAT+DLSFN+FSGDLP+SF SLSN+S+L +QNNQ+TGSLNV +GLPLTTLN
Sbjct: 121 GDVFLNLSLLATMDLSFNSFSGDLPSSFNSLSNLSTLNVQNNQLTGSLNVLTGLPLTTLN 180
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSP- 288
VANN+FSGWIP+EL SI FIYDGNSFDNGP+PPPPP T PP G+SH NR+H GS +P
Sbjct: 181 VANNNFSGWIPQELSSIPNFIYDGNSFDNGPSPPPPPYTPPPPGKSHRNRTH-PGSGAPV 239
Query: 289 ---SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGSFP 345
S Q S SDK + GAIVG+ LG++ LV + LLAL FCI+K++ K G ++ GS P
Sbjct: 240 TPSSDGQPSQSDKGISVGAIVGVALGSLVLVLIVLLALVFCIKKHKSKEIGPLATRGSRP 299
Query: 346 VSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKSPITATSYTVAS 404
T++ M E RVK++AAVTDL PPPAEKLV+ER+ SGS+K++KSPITATSY+VAS
Sbjct: 300 ADTDD---NMQESRVKNMAAVTDLKPPPAEKLVVERLQGNSGSIKRMKSPITATSYSVAS 356
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
LQTATNSFSQEFLIGEGSLGRVYR EF NGK+MAVKKIDNAALSLQEEDNFLEAVSNMS
Sbjct: 357 LQTATNSFSQEFLIGEGSLGRVYRGEFPNGKMMAVKKIDNAALSLQEEDNFLEAVSNMSH 416
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
LRHPNIV+L GYC EHGQRLLVYEY+ NG++HD+LHFADD SK L+WNARVRVALGTARA
Sbjct: 417 LRHPNIVSLVGYCVEHGQRLLVYEYIANGSVHDILHFADDGSKTLSWNARVRVALGTARA 476
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
LEYLHEVCLPSVVHRN KSANILLD+ELNPHLSDCGLAALTPNTERQV T
Sbjct: 477 LEYLHEVCLPSVVHRNLKSANILLDEELNPHLSDCGLAALTPNTERQVST 526
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455383|ref|XP_004145432.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/550 (70%), Positives = 455/550 (82%), Gaps = 7/550 (1%)
Query: 31 TLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDI 90
++ ++ TD+SDVQALQV+YTSL+SP LT W + GDPC ESWKGV CEGSAVVSI+I
Sbjct: 17 SIPFLRAHTDASDVQALQVMYTSLDSPPQLTGWIVSGGDPCAESWKGVTCEGSAVVSIEI 76
Query: 91 SGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
SGLGL+GTMGY LS LSL+K D+S NSIHD +PYQLPPNLTSLN+A N+ GNLPYS++
Sbjct: 77 SGLGLNGTMGYALSSFLSLKKLDMSDNSIHDAVPYQLPPNLTSLNMAKNSLIGNLPYSLS 136
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
+M SL+YLN+S N L+Q IGD+F NL L TLDLSFNNF+GDLP S +LSN+SSL+ QN
Sbjct: 137 TMASLNYLNMSHNLLSQVIGDVFTNLTTLETLDLSFNNFTGDLPKSLGTLSNVSSLFFQN 196
Query: 211 NQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAP 270
N++TGSLN+ LPLTTLNVANN+FSGWIP+EL S+ +FIYDGNSFDN PAPPPPP T P
Sbjct: 197 NRLTGSLNILIDLPLTTLNVANNNFSGWIPQELKSVESFIYDGNSFDNSPAPPPPPFTPP 256
Query: 271 PSGRSHNNRSH---RQGSHSP--SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYF 325
P GRS N+ H G+H+ S SS S+K LP AIVGIVLGA+ V + L+A
Sbjct: 257 PPGRSRNSPKHPGSSGGTHTAPSSEGSSSHSNKGLPVLAIVGIVLGAIIFVLIVLVAFAV 316
Query: 326 CIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AK 384
C +K +RK G R+S+G + T ++N E+ E RVKSVAAV D+ P PAEK+ ER+ AK
Sbjct: 317 CFQKRKRKNIGLRASSGRLSIGT-SVNAEVQEHRVKSVAAVADIKPLPAEKMNPERLQAK 375
Query: 385 SGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDN 444
+GS+K+IK+PITATSYTVASLQ ATNSFSQE ++GEGSLGRVY+AEF NGK MA+KKIDN
Sbjct: 376 NGSVKRIKAPITATSYTVASLQAATNSFSQECIVGEGSLGRVYKAEFPNGKTMAIKKIDN 435
Query: 445 AALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD 504
+ALSLQEEDNFLEAVSNMSRLRH NIVTL GYCAEHGQRLLVYE++G+G+LHDMLHFA++
Sbjct: 436 SALSLQEEDNFLEAVSNMSRLRHTNIVTLNGYCAEHGQRLLVYEFIGHGSLHDMLHFAEE 495
Query: 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
SSK LTWNARVRVALGTARALEYLHEVCLPSVVHRN K+ANILLD++LNPHLSDCGLAAL
Sbjct: 496 SSKTLTWNARVRVALGTARALEYLHEVCLPSVVHRNLKTANILLDEDLNPHLSDCGLAAL 555
Query: 565 TPNTERQVIT 574
TPNTERQ+ T
Sbjct: 556 TPNTERQIST 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255554777|ref|XP_002518426.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223542271|gb|EEF43813.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 674 bits (1739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/481 (75%), Positives = 411/481 (85%), Gaps = 13/481 (2%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
L + DLS N+IHDTIPYQLPPNLTSLNLA NN SGNLPYSI++MVSL+YLN+S NS++
Sbjct: 14 LRFKGIDLSDNNIHDTIPYQLPPNLTSLNLARNNLSGNLPYSISTMVSLTYLNMSHNSIS 73
Query: 167 QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLT 226
QS+GD+F NLA L TLDLSFNNFSG+LP+SF SLSN+S+ Y+QNNQ+TGSL+V +GLPLT
Sbjct: 74 QSVGDVFANLALLTTLDLSFNNFSGNLPSSFSSLSNLSTFYIQNNQLTGSLDVLAGLPLT 133
Query: 227 TLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHR-QGS 285
TLNVANNH +GWIPREL S+ FIYDGNSFDNGPAPPPPP T PP GRS NN SH G+
Sbjct: 134 TLNVANNHLTGWIPRELNSVPNFIYDGNSFDNGPAPPPPPYTPPPPGRSRNNHSHSGSGT 193
Query: 286 HSP--SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGS 343
+P S QSS SDK + GAIVGIVLG+V L+ +ALLA+ FC RK ++K GA S GS
Sbjct: 194 RTPPSSDDQSSESDKGMSVGAIVGIVLGSVLLIFIALLAVLFCTRKKKQKDGGAIVSQGS 253
Query: 344 FPVSTNNM---------NTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKS 393
T + +TEM EQRVKS+AAV DL PPPAEKLV++++ SGS+K++KS
Sbjct: 254 RSAGTTDSAKFSSVIAGDTEMQEQRVKSIAAVADLKPPPAEKLVVDKLQGHSGSVKRMKS 313
Query: 394 PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED 453
PITATSYTVASLQTATNSFSQEF+IGEGSLGRVYR EF+NGKIMA+KKIDNAALSLQEED
Sbjct: 314 PITATSYTVASLQTATNSFSQEFIIGEGSLGRVYRGEFSNGKIMAIKKIDNAALSLQEED 373
Query: 454 NFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
NFLEAVSNMSRLRHPNIV+LAGYCAEHGQRLLVYE++GNG+LHDMLHFA+D SK L+WNA
Sbjct: 374 NFLEAVSNMSRLRHPNIVSLAGYCAEHGQRLLVYEHIGNGSLHDMLHFAEDGSKTLSWNA 433
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVI 573
RVRVALGTARALEYLHEVCLPS+VHRNFKSANILLD+ELNPHLSDCGLAALTPNTERQV
Sbjct: 434 RVRVALGTARALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDCGLAALTPNTERQVS 493
Query: 574 T 574
T
Sbjct: 494 T 494
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449513527|ref|XP_004164349.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1695), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/531 (66%), Positives = 412/531 (77%), Gaps = 36/531 (6%)
Query: 50 LYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSL 109
+YTSL+SP LT W + GDPC ESWKGV CEGSAVVSI+ISGLGL+GTMGY LS LSL
Sbjct: 1 MYTSLDSPPQLTGWIVSGGDPCAESWKGVTCEGSAVVSIEISGLGLNGTMGYALSSFLSL 60
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
+K D+S NSIHD +PYQLPPNLTSLN+A N+ GNLPYS+++M SL+YLN+S N L+Q I
Sbjct: 61 KKLDMSDNSIHDAVPYQLPPNLTSLNMAKNSLIGNLPYSLSTMASLNYLNMSHNLLSQVI 120
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLN 229
GD+F NL L TLDLSFNNF+GDLP S +LSN+SSL+ QNN++TGSLN+ LPLTTLN
Sbjct: 121 GDVFTNLTTLETLDLSFNNFTGDLPKSLGTLSNVSSLFFQNNRLTGSLNILIDLPLTTLN 180
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSH---RQGSH 286
VANN+FSGWIP+EL S+ +FIYDGNSFDN PAPPPPP T PP GRS N+ H G+H
Sbjct: 181 VANNNFSGWIPQELKSVESFIYDGNSFDNSPAPPPPPFTPPPPGRSRNSPKHPGSSGGTH 240
Query: 287 SP--SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGSF 344
+ S SS S+K LP AIVGIVLGA+ V + L+A C +K +RK G R+S+G
Sbjct: 241 TAPSSEGSSSHSNKGLPVLAIVGIVLGAIIFVLIVLVAFAVCFQKRKRKNIGLRASSGRL 300
Query: 345 PVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKSPITATSYTVA 403
+ T+ +N E+ E RVKSVAAV D+ P PAEK+ ER+ AK+GS+K+IK+PITATSYTVA
Sbjct: 301 SIGTS-VNAEVQEHRVKSVAAVADIKPLPAEKMNPERLQAKNGSVKRIKAPITATSYTVA 359
Query: 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS 463
SLQ ATNSFSQE ++GEGSLGRVY+AEF NGK MA+KKIDN+ALSLQEEDNFLEAVSNMS
Sbjct: 360 SLQAATNSFSQECIVGEGSLGRVYKAEFPNGKTMAIKKIDNSALSLQEEDNFLEAVSNMS 419
Query: 464 RLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
RLRH NIVTL ++SSK LTWNARVRVALGTAR
Sbjct: 420 RLRHTNIVTL-----------------------------NESSKTLTWNARVRVALGTAR 450
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
ALEYLHEVCLPSVVHRN K+ANILLD++LNPHLSDCGLAALTPNTERQ+ T
Sbjct: 451 ALEYLHEVCLPSVVHRNLKTANILLDEDLNPHLSDCGLAALTPNTERQIST 501
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357138966|ref|XP_003571057.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1626), Expect = e-178, Method: Compositional matrix adjust.
Identities = 347/548 (63%), Positives = 414/548 (75%), Gaps = 16/548 (2%)
Query: 40 DSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTM 99
+SSD AL LYTS NSPS L W + GDPCG W+GV+C GS V I ++G GL+G++
Sbjct: 23 ESSDAAALGNLYTSWNSPSQLAGWSASGGDPCGAGWQGVSCNGSGVTEIKLAGTGLNGSL 82
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
GY LS+L SL+ DLS N+IH +IPYQLPPNLT LNLA+NNFSGNLPYSI++M S+ YLN
Sbjct: 83 GYELSNLYSLKTLDLSNNNIHGSIPYQLPPNLTYLNLATNNFSGNLPYSISNMASIEYLN 142
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+S NSL+Q IGD+F NL L+ LD+SFN +GDLPNS SLSNISSLY+QNNQ+TG +NV
Sbjct: 143 ISHNSLSQQIGDLFRNLNSLSELDISFNKLTGDLPNSIGSLSNISSLYMQNNQLTGPVNV 202
Query: 220 FSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNR 279
SGL LTTLN+ANN+FSGWIP+E SI I GNSF NGPAPPPPP PP R N
Sbjct: 203 LSGLGLTTLNIANNNFSGWIPKEFSSIPDVILGGNSFANGPAPPPPPFMPPPPRRPRNRP 262
Query: 280 SHRQGS-HSPSGSQSSS--SDKE--LPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKV 334
++ GS ++P GS+SS+ DK+ L GA+VGI++G++ LL L CIR R++
Sbjct: 263 NNSGGSGNAPKGSESSTGQGDKKQGLQTGALVGIIVGSILAALCVLLVLVLCIRNARKRK 322
Query: 335 SGARSSAGSF--PVSTN-----NMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSG 386
+ S + F P+S N + H SVAA+ L PAEK+ ERV +G
Sbjct: 323 DDSSSESKDFVGPLSVNIQEASDREIAEHGHENTSVAAMKVL---PAEKMTPERVYGING 379
Query: 387 SLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAA 446
S++K K PITAT YTVASLQ ATNSF Q+ L+GEGSLGRVY+A+F NGK++AVKKID+AA
Sbjct: 380 SMRKAKVPITATPYTVASLQVATNSFCQDSLLGEGSLGRVYKADFPNGKVLAVKKIDSAA 439
Query: 447 LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSS 506
LSLQEEDNFLE VS+MSRLRHPNIV L GYC EH QRLLVYEY+GNG LHDMLHF+D+ S
Sbjct: 440 LSLQEEDNFLEVVSSMSRLRHPNIVPLTGYCVEHAQRLLVYEYIGNGTLHDMLHFSDEMS 499
Query: 507 KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
+ LTWN RVR+ALGTARALEYLHEVCLPSVVHRNFKS+NILLD+E N HLSDCGLAALTP
Sbjct: 500 RKLTWNIRVRIALGTARALEYLHEVCLPSVVHRNFKSSNILLDEEHNAHLSDCGLAALTP 559
Query: 567 NTERQVIT 574
NTERQV T
Sbjct: 560 NTERQVST 567
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 577 | ||||||
| TAIR|locus:2120683 | 703 | SRF8 "STRUBBELIG-receptor fami | 0.951 | 0.780 | 0.650 | 2.2e-183 | |
| TAIR|locus:2091015 | 717 | SRF7 "STRUBBELIG-receptor fami | 0.372 | 0.299 | 0.531 | 1e-109 | |
| TAIR|locus:2024837 | 720 | SRF6 "STRUBBELIG-receptor fami | 0.961 | 0.770 | 0.410 | 4.3e-109 | |
| TAIR|locus:2207280 | 699 | SRF5 "STRUBBELIG-receptor fami | 0.415 | 0.343 | 0.425 | 1.5e-102 | |
| TAIR|locus:2089210 | 687 | SRF4 "STRUBBELIG-receptor fami | 0.417 | 0.350 | 0.430 | 1.1e-99 | |
| TAIR|locus:2125566 | 776 | SRF3 "STRUBBELIG-receptor fami | 0.351 | 0.261 | 0.539 | 2e-96 | |
| TAIR|locus:2051404 | 775 | SRF1 "STRUBBELIG-receptor fami | 0.386 | 0.287 | 0.502 | 9.9e-95 | |
| TAIR|locus:2170219 | 735 | SRF2 "STRUBBELIG-receptor fami | 0.419 | 0.329 | 0.424 | 1.6e-89 | |
| TAIR|locus:2202084 | 768 | SUB "STRUBBELIG" [Arabidopsis | 0.305 | 0.229 | 0.522 | 1.7e-84 | |
| TAIR|locus:2154709 | 1036 | PSKR2 "phytosylfokine-alpha re | 0.298 | 0.166 | 0.425 | 7.9e-49 |
| TAIR|locus:2120683 SRF8 "STRUBBELIG-receptor family 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1779 (631.3 bits), Expect = 2.2e-183, P = 2.2e-183
Identities = 363/558 (65%), Positives = 408/558 (73%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
+ +L ++ S+V+C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWKG
Sbjct: 8 MFTVLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWKG 67
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
+ CEGSAVV+IDIS LG+SGT+GYLLSDL SLRK D+SGNSIHDT+PYQLPPNLTSLNLA
Sbjct: 68 ITCEGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPPNLTSLNLA 127
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDXXXXX 197
NN SGNLPYSI++M SLSY+NVS NSLT SIGDIF + LATLDLS NNFSGD
Sbjct: 128 RNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSSL 187
Query: 198 XXXXXXXXXXXXXXQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
Q+TGS++V SGLPL TLNVANNHF+G IP+EL SI+T IYDGNSFD
Sbjct: 188 STVSTLSVLYVQNNQLTGSIDVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSFD 247
Query: 258 NGXXXXXXXXXXXXXGRSHNNXXXXXXXXXXXXXXXXXXDKELPAGAXXXXXXXXXXXXX 317
N G+ K L G
Sbjct: 248 N----VPASPQPERPGKKETPSGSKKPKIGSEEKSSDSG-KGLSGGVVTGIVFGSLFVAG 302
Query: 318 XXXXXXYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEK 376
Y C+ K +RKV G+ R+S S P+S E+ EQRVKSVA+V DL PAEK
Sbjct: 303 IIALVLYLCLHKKKRKVRGSTRASQRSLPLSGT---PEVQEQRVKSVASVADLKSSPAEK 359
Query: 377 LVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKI 436
+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF NGKI
Sbjct: 360 VTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKI 419
Query: 437 MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLH 496
MA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGNGNL
Sbjct: 420 MAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLD 479
Query: 497 DMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556
D LH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+ELNPHL
Sbjct: 480 DTLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHL 539
Query: 557 SDCGLAALTPNTERQVIT 574
SD GLAALTPNTERQV T
Sbjct: 540 SDSGLAALTPNTERQVST 557
|
|
| TAIR|locus:2091015 SRF7 "STRUBBELIG-receptor family 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 589 (212.4 bits), Expect = 1.0e-109, Sum P(2) = 1.0e-109
Identities = 118/222 (53%), Positives = 152/222 (68%)
Query: 352 NTEMHEQRVKSVAAVTDLTPPPAEKLVI-----ERVAKSGSLKK--IKSPITATSYTVAS 404
N + E + + +L PPP+E+ + K KK + P +YTV+
Sbjct: 352 NPPLVETKKLDTSLSMNLRPPPSERHKSFDDDDSTMRKPIVAKKAAVVVPSNVNTYTVSD 411
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
LQ ATNSFS + L+GEG+ GRVYRA+F +GK++AVKKID++AL D+F E VS ++
Sbjct: 412 LQVATNSFSVDNLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADDFTEIVSKIAH 471
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
L H N+ L GYC+EHGQ L+VYE+ NG+LHD LH A++ SK L WN RV++ALGTARA
Sbjct: 472 LDHENVTKLDGYCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPRVKIALGTARA 531
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
LEYLHEVC PS+VH+N KSANILLD ELNPHLSD GLA+ P
Sbjct: 532 LEYLHEVCSPSIVHKNIKSANILLDSELNPHLSDSGLASFLP 573
|
|
| TAIR|locus:2024837 SRF6 "STRUBBELIG-receptor family 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
Identities = 237/577 (41%), Positives = 322/577 (55%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
++ F L + F L + TD+SD AL L++ ++SP+ LT W GDPCG++W+G
Sbjct: 7 VVALFTLCIVGF-ELRFIHGATDASDTSALNTLFSGMHSPAQLTQWTAAAGDPCGQNWRG 65
Query: 78 VACEGSAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
V C GS V I +SGL LSGT+G Y+L L SL + DLS N++ +PYQ PPNL LNL
Sbjct: 66 VTCSGSRVTQIKLSGLELSGTLGGYMLDKLTSLTELDLSSNNLGGDLPYQFPPNLQRLNL 125
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDXXXX 196
A+N F+G YS++ + L YLN+ N I F L L TLD SFN+F+
Sbjct: 126 ANNQFTGAASYSLSQITPLKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSFTNSLPAT 185
Query: 197 XXXXXXXXXXXXXXXQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
Q +G+++V +GLPL TLN+ANN F+GWIP L I T I DGNSF
Sbjct: 186 FSSLTSLKSLYLQNNQFSGTVDVLAGLPLETLNIANNDFTGWIPSSLKGI-TLIKDGNSF 244
Query: 257 DNGXXXXXXXXXXXXXGRSHNNXXXXXXXXXXXXXXXXXXDKELPAGAXXXXXXXXXXXX 316
+ G G S + K+ GA
Sbjct: 245 NTGPAPPPPPGTPPIRG-SPSRKSGGRESRSSDESTRNGDSKKSGIGAGAIAGIIISLLV 303
Query: 317 XXXXXXXYFCIRKNRRKVSGA----RSSAGSFPVSTNNMNTEMHEQRVKSV-------AA 365
+F R+ + K S ++ F +++N+ + Q SV +
Sbjct: 304 VTALLVAFFLFRRKKSKRSSPMDIEKTDNQPFTLASNDFHENNSIQSSSSVETKKLDTSL 363
Query: 366 VTDLTPPPAEKLVI----ERVAKSGSLKK--IKSPITATSYTVASLQTATNSFSQEFLIG 419
+L PPP ++ + K ++KK + P Y+VA LQ AT SFS + L+G
Sbjct: 364 SINLRPPPIDRNKSFDDEDSTRKPIAVKKSTVVVPSNVRLYSVADLQIATGSFSVDNLLG 423
Query: 420 EGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479
EG+ GRVYRAEF +GK++AVKKID++AL D+F+E VS ++ L HPN+ L GYCAE
Sbjct: 424 EGTFGRVYRAEFDDGKVLAVKKIDSSALPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAE 483
Query: 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHR 539
HGQ L+VYE+ NG+LHD LH +++ SK L WN+RV++ALGTARALEYLHEVC PS+V +
Sbjct: 484 HGQHLVVYEFHKNGSLHDFLHLSEEESKALVWNSRVKIALGTARALEYLHEVCSPSIVDK 543
Query: 540 NFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
N KSANILLD ELNPHLSD GLA+ P T +++ T
Sbjct: 544 NIKSANILLDSELNPHLSDSGLASFLP-TANELLNQT 579
|
|
| TAIR|locus:2207280 SRF5 "STRUBBELIG-receptor family 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 534 (193.0 bits), Expect = 1.5e-102, Sum P(2) = 1.5e-102
Identities = 103/242 (42%), Positives = 148/242 (61%)
Query: 15 TSRLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGES 74
T +L+ ++I+S+ +T++L+Q TD+ +V AL V++TSLNSPS L WK N GDPC +S
Sbjct: 2 TQKLVR--LVIVSLAITVTLLQAKTDNQEVSALNVMFTSLNSPSKLKGWKANGGDPCEDS 59
Query: 75 WKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSL 134
W+GV C+GS+V + +SG L G+ GYLLS+L SL FDLS N++ IPYQLPPN+ +L
Sbjct: 60 WEGVKCKGSSVTELQLSGFELGGSRGYLLSNLKSLTTFDLSKNNLKGNIPYQLPPNIANL 119
Query: 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDXX 194
+ + N GN+PYS++ M +L +N+ +N L + D+F L+ L TLD S N SG
Sbjct: 120 DFSENELDGNVPYSLSQMKNLQSINLGQNKLNGELPDMFQKLSKLETLDFSLNKLSGKLP 179
Query: 195 XXXXXXXXXXXXXXXXXQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGN 254
+ TG +NV L + LNV +N F GWIP EL I + + GN
Sbjct: 180 QSFANLTSLKKLHLQDNRFTGDINVLRNLAIDDLNVEDNQFEGWIPNELKDIDSLLTGGN 239
Query: 255 SF 256
+
Sbjct: 240 DW 241
|
|
| TAIR|locus:2089210 SRF4 "STRUBBELIG-receptor family 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 1.1e-99, Sum P(2) = 1.1e-99
Identities = 105/244 (43%), Positives = 144/244 (59%)
Query: 17 RLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWK 76
R++ F+ IF S+V TDS DV AL Y S+NSPS L W + GDPCG+SW
Sbjct: 7 RIVLVFIACFGIFT--SVVLAKTDSQDVSALNDAYKSMNSPSKLKGWSSSGGDPCGDSWD 64
Query: 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
G+ C+GS+V I +SG GLSG++GY L +L SL D+S N+++ +PYQLP LT L+
Sbjct: 65 GITCKGSSVTEIKVSGRGLSGSLGYQLGNLKSLTYLDVSKNNLNGNLPYQLPDKLTYLDG 124
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDXXXX 196
+ N+F+GN+PYS++ M LSYLN+ RN+L + D+F L L T+DLS N +G
Sbjct: 125 SENDFNGNVPYSVSLMNDLSYLNLGRNNLNGELSDMFQKLPKLETIDLSSNQLTGKLPQS 184
Query: 197 XXXXXXXXXXXXXXXQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNS 255
Q GS+N LP + +NVANN F+GWIP EL +I GN
Sbjct: 185 FANLTGLKTLHLQENQFKGSINALRDLPQIDDVNVANNQFTGWIPNELKNIGNLETGGNK 244
Query: 256 FDNG 259
+ +G
Sbjct: 245 WSSG 248
|
|
| TAIR|locus:2125566 SRF3 "STRUBBELIG-receptor family 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 559 (201.8 bits), Expect = 2.0e-96, Sum P(2) = 2.0e-96
Identities = 115/213 (53%), Positives = 144/213 (67%)
Query: 371 PPPA-EKLVI------ERVAKSGSLKKIKSPITATS-YTVASLQTATNSFSQEFLIGEGS 422
PPP EK+ + ER K S K++ P+T+ Y++ASLQ T SF+QE LIG G
Sbjct: 438 PPPLDEKVTVMPIISPERPVKKTSPKRL--PLTSVKHYSIASLQQYTESFAQENLIGSGM 495
Query: 423 LGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482
LG VYRA NGK+ AVKK+D A Q++ F+E V+N+ +RH NIV L GYCAEH Q
Sbjct: 496 LGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNIDMIRHSNIVELVGYCAEHDQ 555
Query: 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542
RLLVYEY NG L D LH D+ K L+WN RV +ALG ARALEYLHEVC P ++HRNFK
Sbjct: 556 RLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAARALEYLHEVCEPPIIHRNFK 615
Query: 543 SANILLDDELNPHLSDCGLAALTPNTERQVITG 575
SAN+LLDD+L+ +SDCGLA L + ++G
Sbjct: 616 SANVLLDDDLSVLVSDCGLAPLISSGSVSQLSG 648
|
|
| TAIR|locus:2051404 SRF1 "STRUBBELIG-receptor family 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 9.9e-95, Sum P(2) = 9.9e-95
Identities = 116/231 (50%), Positives = 146/231 (63%)
Query: 336 GARSSAGSFPVSTN-NMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSP 394
G+ S S + N N MH + + V PAE + +KS P
Sbjct: 406 GSESKQESHEIDMNGNAMDLMHPSSIPPIKRVIAKATEPAEASLKRTTSKS------HGP 459
Query: 395 ITATS-YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED 453
+TA +TVASLQ TNSFS E LIG G LG VYRAE GK+ AV+K+D + + +EE
Sbjct: 460 LTAVKHFTVASLQQHTNSFSHENLIGTGMLGSVYRAELPGGKLFAVRKLDKKSPNHEEEG 519
Query: 454 NFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
FLE V+N+ R+RH NIV L G+C+EH QRLL++EY NG LHD+LH D L+WN
Sbjct: 520 KFLELVNNIDRIRHANIVQLVGFCSEHSQRLLIHEYCRNGTLHDLLHIDDRLKIELSWNV 579
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
RVR+AL A+ALEYLHE+C P +HRNFKSANILLDD++ H+SDCGLA L
Sbjct: 580 RVRIALEAAKALEYLHEICDPPSIHRNFKSANILLDDDIRVHVSDCGLAPL 630
|
|
| TAIR|locus:2170219 SRF2 "STRUBBELIG-receptor family 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 1.6e-89, Sum P(2) = 1.6e-89
Identities = 112/264 (42%), Positives = 154/264 (58%)
Query: 325 FCIRKNRRKVSGA----RSS---AGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKL 377
F +R N R+ RS+ A S PVST E + + PPPA +L
Sbjct: 316 FAVRMNHRRAQNLAAIHRSNNSIAYSLPVSTGREYPVATEDNPQ----IKRFQPPPAPQL 371
Query: 378 -----VIERVAKSGSLKKIKS----PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYR 428
R+ KS K + P A ++ A LQ ATN FS+E L+GEG LG VYR
Sbjct: 372 RHLPSPPVRIDKSARRKSFSATCQYPSFAKLFSAAELQLATNCFSEENLLGEGPLGSVYR 431
Query: 429 AEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488
A+ +G+ V+ I ++LSL EE+ F E + S+LRHPNIVTL G+C E+G+ LLVYE
Sbjct: 432 AKLPDGQFAVVRNIPMSSLSLHEEEQFTEVLQTASKLRHPNIVTLLGFCIENGEHLLVYE 491
Query: 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548
YVG+ +L++ +H D+ K L+W R+R+A+G ARAL+YLH P + H + K+ NILL
Sbjct: 492 YVGHLSLYNAMH--DEVYKPLSWGLRLRIAIGVARALDYLHSSFCPPIAHSDLKATNILL 549
Query: 549 DDELNPHLSDCGLAALTPNTERQV 572
D+EL P ++DCGLA+L P T V
Sbjct: 550 DEELTPRIADCGLASLRPLTSNSV 573
|
|
| TAIR|locus:2202084 SUB "STRUBBELIG" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 1.7e-84, Sum P(2) = 1.7e-84
Identities = 92/176 (52%), Positives = 124/176 (70%)
Query: 391 IKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ 450
+ S +AT +T+ASLQ TN+FS+E +IGEGS+G VYRAE +GK +AVKK+ N Q
Sbjct: 476 LNSSSSATVFTIASLQQYTNNFSEENIIGEGSIGNVYRAELRHGKFLAVKKLSNTINRTQ 535
Query: 451 EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT 510
+ FL VSN+ +L+ +I+ L GYC E GQRLLVYEY NG+L D LH K LT
Sbjct: 536 SDGEFLNLVSNVLKLKRGHILELLGYCNEFGQRLLVYEYCPNGSLQDALHLDRKLHKKLT 595
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
WN R+ +ALG ++AL++LHEVC P VVH+NFKS+ +LLD +L+ ++D GLA + P
Sbjct: 596 WNVRINIALGASKALQFLHEVCQPPVVHQNFKSSKVLLDGKLSVRVADSGLAYMLP 651
|
|
| TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 361 (132.1 bits), Expect = 7.9e-49, Sum P(2) = 7.9e-49
Identities = 74/174 (42%), Positives = 105/174 (60%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVS 460
+V L +TN+FSQ +IG G G VY+A F +G AVK++ ++ E F V
Sbjct: 743 SVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQMERE--FQAEVE 800
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
+SR H N+V+L GYC RLL+Y ++ NG+L LH D + L W+ R+++A G
Sbjct: 801 ALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMTLIWDVRLKIAQG 860
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
AR L YLH+VC P+V+HR+ KS+NILLD++ HL+D GLA L + V T
Sbjct: 861 AARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDTHVTT 914
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6R2J8 | SRF8_ARATH | No assigned EC number | 0.6992 | 0.9410 | 0.7724 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | scaffold_702155.1 | annotation not avaliable (703 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 577 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-33 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-30 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-21 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-10 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 8e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.002 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.002 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.003 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.003 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.003 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 52/163 (31%), Positives = 77/163 (47%), Gaps = 10/163 (6%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G GS G VY+A+ GKI+AVK + + +++ + + RL HPNIV L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ LV EY G+L D L L+ + ++AL R LEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN---GI 119
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVITGTS 577
+HR+ K NILLD+ ++D GLA ++ GT
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTP 162
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 56/163 (34%), Positives = 80/163 (49%), Gaps = 11/163 (6%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+GEG G VY A GK +A+K I S E+ E + + +L HPNIV L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLRE-IEILKKLNHPNIVKLYGV 59
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ LV EY G+L D+L ++ L+ + +R+ L LEYLH +
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 537 VHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQVIT--GT 576
+HR+ K NILLD D L+D GL+ L + + + T GT
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 121/477 (25%), Positives = 206/477 (43%), Gaps = 81/477 (16%)
Query: 94 GLSGTMGYLLSDLLSLRKFDLSGNSIH---DTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
SG + + L + D+S N++ ++ + +P +L L+LA N F G LP S
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP-SLQMLSLARNKFFGGLPDSFG 473
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
S L L++SRN + ++ G+L+ L L LS N SG++P+ S + SL L +
Sbjct: 474 SK-RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 211 NQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFD--NGPAPPPPP 266
NQ++G + FS +P L+ L+++ N SG IP+ L ++ + + S + +G P
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 267 STAPPSGRSHNNRSHRQGSHSPSGSQSSSS-------DKELPAGAIVGIVLGAVFLVALA 319
A N S G+ G ++S K + LGA ++AL
Sbjct: 593 FLAI-------NASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALV 645
Query: 320 LLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVI 379
F +N ++ + G++ + +
Sbjct: 646 AFGFVFIRGRNNLELKRVENEDGTWELQFFD----------------------------- 676
Query: 380 ERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAV 439
+V+KS ++ I S S +E +I G G Y+ + + V
Sbjct: 677 SKVSKSITINDILS-----------------SLKEENVISRGKKGASYKGKSIKNGMQFV 719
Query: 440 KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML 499
K N S+ + +++M +L+HPNIV L G C L++EY+ NL ++L
Sbjct: 720 VKEINDVNSIPSSE-----IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 500 HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556
+NL+W R ++A+G A+AL +LH C P+VV N I++D + PHL
Sbjct: 775 -------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 8e-29
Identities = 55/162 (33%), Positives = 79/162 (48%), Gaps = 10/162 (6%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEGS G+VY A + GK++A+K I + E E + + +L+HPNIV L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILRE-IKILKKLKHPNIVRLYD 64
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + LV EY G+L D+L L+ + ALEYLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYLHSKG--- 117
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVITGT 576
+VHR+ K NILLD++ + L+D GLA L P + GT
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 50/150 (33%), Positives = 76/150 (50%), Gaps = 12/150 (8%)
Query: 418 IGEGSLGRVYRA----EFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG+ G VY+ + + AVK + A + E+ FLE S M +L HPNIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNIVR 65
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C + +V EY+ G+L D L + LT +++AL A+ +EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ VHR+ + N L+ + L +SD GL+
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 14/151 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G VY+ + GK AVK + A Q E+ FL M +L HPN+V
Sbjct: 7 LGEGAFGEVYKGK-LKGKGGKKKVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNVV 64
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C E +V EY+ G+L L + L+ + + AL AR +EYL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + N L+ + L +SD GL+
Sbjct: 122 N---FIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 52/151 (34%), Positives = 73/151 (48%), Gaps = 13/151 (8%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G VY+ GK AVK + A Q E+ FL M +L HPNIV
Sbjct: 7 LGEGAFGEVYKGT-LKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNIV 64
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C E ++V EY+ G+L D L K L+ + + AL AR +EYL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK 122
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + N L+ + L +SD GL+
Sbjct: 123 N---FIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 15/155 (9%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVT 472
+GEG+ G VY+ + AVK + A + +D FL EA M +L HPN+V
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARV-MKKLGHPNVVR 60
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEY 527
L G C E LV EY+ G+L D L F L+ + A+ A+ +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L VHR+ + N L+ ++L +SD GL+
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 9/146 (6%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G G V ++ K+ AVK + + + + Q FL S M+ LRHPN+V L G
Sbjct: 13 TIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQA---FLAEASVMTTLRHPNLVQLLGV 68
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ +V EY+ G+L D L + +T ++ AL +EYL E +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEE---KNF 123
Query: 537 VHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N+L+ ++L +SD GLA
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 50/150 (33%), Positives = 70/150 (46%), Gaps = 12/150 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLA 474
L+G GS G VY A + G++MAVK ++ + +EE LE + +S L+HPNIV
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 475 GYC--AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G E + EYV G+L +L L + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK----KFGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+VHR+ K ANIL+D + L+D G A
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCA 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
LIG G+ G VY+ G +A+K+I + + + ++ + + L+HPNIV G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
++ EY NG+L ++ ++L +V G L YLHE
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG----LAYLHE---QG 119
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLA 562
V+HR+ K+ANIL + L+D G+A
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAG 475
IG+G G VY+A GK +A+K I L +E+ + + + + +HPNIV
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHPNIVKY-- 62
Query: 476 YCA--EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
Y + + + +V E+ G+L D+L + + + A V + LEYLH
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL-TESQIA--YVCKELLKGLEYLHSN-- 117
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVITGT 576
++HR+ K+ANILL + L D GL+A L+ R + GT
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 47/170 (27%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
F IG+GS G V++ A+ ++ A+K+ID + ++ +E + ++ +++L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDS--SKNLTWNARVRVALGTARALEYL 528
+ + G+ +V EY NG+LH +L ++ W +++ LG L +L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTE-RQVITGT 576
H ++HR+ KS N+ LD N + D G+A L+ NT I GT
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 54/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLE---AVSNMSRLRHPNIVTL 473
IG G+ G VY+A + A G+++A+K I L+ D+F +S + RHPNIV
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI-----KLEPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + +V EY G G+L D+ L R L + L YLHE
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHET-- 120
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
+HR+ K ANILL ++ + L+D G++A T +R+ GT
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGT 164
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 26/170 (15%)
Query: 412 FSQEFLIGEGSLGRVYRAEFA--NGKIM----AVKKI-DNAALSLQEEDNFLEAVSNMSR 464
F +E +GEG+ G+VY+ E N ++ A+K + +NA +Q+E F + MS
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE--FRQEAELMSD 64
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWN 512
L+HPNIV L G C + +++EY+ +G+LH+ L + +L +
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ +A+ A +EYL VHR+ + N L+ + L +SD GL+
Sbjct: 125 DFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 53/174 (30%), Positives = 79/174 (45%), Gaps = 30/174 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNIV 471
IG G+ G+VY A G++MAVK+I +Q+ D + + + L+HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEI-----RIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 472 TLAGYCAE-HGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYL 528
Y E H +++ ++ EY G L ++L +++ +RV L L YL
Sbjct: 63 KY--YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-----IRVYTLQLLEGLAYL 115
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA------ALTPNTERQVITGT 576
H +VHR+ K ANI LD L D G A T E Q + GT
Sbjct: 116 HS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 418 IGEGSLGRVYRAEFANGK------IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ E + + ++AVK + A + +D F ++ +H NIV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELLTNFQHENIV 71
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML-----HFA-----DDSSKNLTWNARVRVALGT 521
G C E ++V+EY+ +G+L+ L A D LT + +++A+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A + YL VHR+ + N L+ +L + D G++
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 55/163 (33%), Positives = 81/163 (49%), Gaps = 14/163 (8%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEG+ G VY+A + A GK +A+KK+ L Q ++ + + M +HPNIV
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 477 CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G L +V EY+ G+L D++ + + V + LEYLH +
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQ---NFVRMNEPQIAYVCREVLQGLEYLH---SQN 136
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTE-RQVITGT 576
V+HR+ KS NILL + + L+D G AA LT R + GT
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 3e-16
Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 14/152 (9%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+GS G+VY ++GK+ +K+ID + +S +E ++ L V + +L HPNI+
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 476 YCAEHGQRLL-VYEYVGNGNLHDMLHFADDSSKNLT----WNARVRVALGTARALEYLHE 530
E +L V EY G+L + K + V++ L AL+YLH
Sbjct: 67 -SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLHS 121
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++HR+ K NI L L D G++
Sbjct: 122 ---RKILHRDIKPQNIFLTSNGLVKLGDFGIS 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-16
Identities = 80/274 (29%), Positives = 128/274 (46%), Gaps = 40/274 (14%)
Query: 24 LILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPS-VLTNWKGNEGDPCGESWKGVACEG 82
++ + L L + +++ L +S+N P L+NW + D C W+G+ C
Sbjct: 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWN-SSADVC--LWQGITCNN 67
Query: 83 SA-VVSIDISGLGLSGTM---------------------GYLLSDLL----SLRKFDLSG 116
S+ VVSID+SG +SG + G + D+ SLR +LS
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 117 NSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176
N+ +IP PNL +L+L++N SG +P I S SL L++ N L I + NL
Sbjct: 128 NNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 177 AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLN---VANN 233
L L L+ N G +P + ++ +YL N ++G + G LT+LN + N
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYN 246
Query: 234 HFSGWIPRELISIRT----FIYDGNSFDNGPAPP 263
+ +G IP L +++ F+Y N +GP PP
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQ-NKL-SGPIPP 278
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-16
Identities = 57/163 (34%), Positives = 86/163 (52%), Gaps = 4/163 (2%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNL 145
+D+ G L G + L++L SL L+ N + IP +L +L + L NN SG +
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205
PY I + SL++L++ N+LT I GNL L L L N SG +P S SL + S
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 206 LYLQNNQVTGSLN--VFSGLPLTTLNVANNHFSGWIPRELISI 246
L L +N ++G + V L L++ +N+F+G IP L S+
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
|
Length = 968 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKK--IDNAALSLQEEDNFLEAVSNMSRLR 466
F +GEGS G VY+A G+++A+K ++ + +E +S + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE------ISILKQCD 56
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
P IV G ++ +V EY G G++ D++ ++K LT + T + LE
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLE 113
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
YLH +HR+ K+ NILL++E L+D G++ +T +R + GT
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 8/160 (5%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
S E +G G G V+ + +AVK + +S + FL+ M +LRH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---FLQEAQIMKKLRHDK 62
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V L C+E +V EY+ G+L D L K L V +A A + YL
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+ +HR+ + NIL+ + L ++D GLA L + E
Sbjct: 121 SR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 56/173 (32%), Positives = 77/173 (44%), Gaps = 20/173 (11%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAA---LSLQEEDNFLEAVSNMSRLRHPNIVT 472
+IGEG+ G+VY+A G+++A+K +D ++EE N L SN HPNI T
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN-----HPNIAT 67
Query: 473 LAG------YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
G Q LV E G G++ D++ K L + T R L
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQVITGTS 577
YLHE V+HR+ K NILL L D G++A +T R GT
Sbjct: 128 YLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTP 177
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-15
Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 5/167 (2%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNL 145
+D+S L+G + L +L K L NS+ IP L +L + L N+FSG L
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205
P + + +L++S N+L I ++ L L L+ N F G LP+SF S + +
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLEN 479
Query: 206 LYLQNNQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPRELISIRTFI 250
L L NQ +G++ L L L ++ N SG IP EL S + +
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
|
Length = 968 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 11/152 (7%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+F +E +G G G V+ ++ +A+K I A+S ED+F+E M +L HPN+
Sbjct: 7 TFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNL 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G C + +V EY+ NG L L++ + L + + A+EYL
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCL---LNYLRERKGKLGTEWLLDMCSDVCEAMEYLES 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + N L+ ++ +SD GLA
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 76.3 bits (186), Expect = 6e-15
Identities = 54/155 (34%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDN-FLEAVSNMSRLRHP-NIVTLA 474
+GEGS G VY A + K++A+K + S +E FL + ++ L HP NIV L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ + G LV EYV G+L D+L L+ + + + ALEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHSKG-- 121
Query: 535 SVVHRNFKSANILLDDELN-PHLSDCGLAALTPNT 568
++HR+ K NILLD + L D GLA L P+
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 29/158 (18%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNA-ALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+GS G+V + GK+ A+K + + +E ++ L + +SR+ HP IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 476 YCAEHGQ-RL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------AL 525
+ A + +L LV EY G L L + R + AR AL
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL------------SKEGRFSEERARFYAAEIVLAL 106
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563
EYLH + +++R+ K NILLD + + L+D GLA
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK 141
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
IGEG+ G+VY+A G+++A+KKI E++ F + + + +LRHPNIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME----NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 473 LAGYCAEH--GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
L G +V+EY+ HD+ D T + L+YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA------ALTPNTERQVIT 574
++HR+ K +NIL++++ L+D GLA T R VIT
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR-VIT 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (179), Expect = 4e-14
Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 32/158 (20%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEG+ G VY+A + G+I+A+KKI EE+ L +S + L+HPNIV
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD----NEEEGIPSTALREISLLKELKHPNIVK 62
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA--------RA 524
L + LV+EY +L L ++ R
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLD-----------KRPGPLSPNLIKSIMYQLLRG 110
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L Y H ++HR+ K NIL++ + L+D GLA
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-14
Identities = 54/164 (32%), Positives = 76/164 (46%), Gaps = 29/164 (17%)
Query: 39 TDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCG---ESWKGVACEGSAVVSI-DISGLG 94
T +V ALQ L +SL P G GDPC W G C+ + I GLG
Sbjct: 369 TLLEEVSALQTLKSSLGLPLRF----GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLG 424
Query: 95 LS--GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
L G G++ +D+ LR L S+NL+ N+ GN+P S+ S+
Sbjct: 425 LDNQGLRGFIPNDISKLRH-------------------LQSINLSGNSIRGNIPPSLGSI 465
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
SL L++S NS SI + G L L L+L+ N+ SG +P +
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 40/153 (26%), Positives = 75/153 (49%), Gaps = 7/153 (4%)
Query: 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
F+ E +G G G V+ + N +A+K + + L Q++ F + V + RLRH +++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+L C+ ++ E + G+L L + L + + +A A + YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE- 122
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
+ +HR+ + NIL+ ++L ++D GLA L
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 15/160 (9%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKID----NAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
IG G+ VY A N + +A+K+ID ++ D + V MS+ HPN+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-----DELRKEVQAMSQCNHPNVVK 63
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ LV Y+ G+L D++ + L V + LEYLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQ 571
+HR+ K+ NILL ++ + ++D G++A L +R
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 13/151 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVK--KIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G GS G VY +G AVK + + + QE LE ++ +S+L+HPNIV
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 473 LAGYCAEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G L ++ E V G+L +L + + ++ LG LEYLH+
Sbjct: 67 YLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHD- 120
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ VHR+ K ANIL+D L+D G+A
Sbjct: 121 --RNTVHRDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEG+ G VY+A G+I+A+KKI S L + + L HPNI+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCLPS 535
G LV+E++ D+ D + L + ++ L + L + H
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHS---HG 118
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLA 562
++HR+ K N+L++ E L+D GLA
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 418 IGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG G+V + G+ +AVK + N + Q +F + + L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTARALEYL 528
G C + G R L+ EY+ +G+L D L D + K L + + + ++YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMDYL 125
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
+HR+ + NIL++ E +SD GLA + P
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 24/176 (13%)
Query: 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALS-----LQEEDNFLEAVSNMS 463
F+ IG+GS G VY+A + +++A+K ID +Q+E FL S
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFL------S 54
Query: 464 RLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
+ R P I G G +L ++ EY G G+ D+L L +
Sbjct: 55 QCRSPYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVL 108
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPN-TERQVITGT 576
LEYLHE +HR+ K+ANILL +E + L+D G++ LT ++R GT
Sbjct: 109 LGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGT 161
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 11/153 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+GS G V + ++GKI+ K+ID ++ +E+ + V+ + L+HPNIV Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 477 CAE----HGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-- 529
Q L +V EY G+L ++ K + R+ AL H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+V+HR+ K ANI LD N L D GLA
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G VY A + +++A+KK+ + E+ + ++ V + +LRHPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 476 -YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y EH LV EY G+ D+L + K L + G + L YLH
Sbjct: 83 CYLREH-TAWLVMEYC-LGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAAL 564
+HR+ K+ NILL + L+D G A+L
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 31/169 (18%)
Query: 417 LIGEGSLGRVYRAEF------ANGKIMAVKKI-DNAALSLQEEDNFLEAVSNMSRL---- 465
+GEG+ G+V +AE +AVK + D+A E + + VS M +
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-----EKDLSDLVSEMEMMKMIG 73
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----------FADD--SSKNLTWNA 513
+H NI+ L G C + G +V EY +GNL D L D + LT
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V A AR +E+L +HR+ + N+L+ ++ ++D GLA
Sbjct: 134 LVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 11/166 (6%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+ QE IG G G V+ + + +A+K I A+S E++F+E M +L HP +
Sbjct: 7 TLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKL 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G C E LV+E++ +G L D L + + + L + YL
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLES 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
V+HR+ + N L+ + +SD G+ + + TGT
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-13
Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 4/159 (2%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS 142
++S+D+S LSG + L+ L +L L N+ IP L P L L L SN FS
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
G +P ++ +L+ L++S N+LT I + + L L L N+ G++P S + +
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405
Query: 203 ISSLYLQNNQVTGSLNV-FSGLPLTT-LNVANNHFSGWI 239
+ + LQ+N +G L F+ LPL L+++NN+ G I
Sbjct: 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 24/155 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
IGEG+ G VYRA + +G+I+A+KK+ E D L ++ + LRHPNIV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMD----NERDGIPISSLREITLLLNLRHPNIVE 70
Query: 473 LAGYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEY 527
L G+ L LV EY D+ D+ + ++V+ + L R L+Y
Sbjct: 71 LKEVVV--GKHLDSIFLVMEYCE----QDLASLLDNMPTPFS-ESQVKCLMLQLLRGLQY 123
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
LHE ++HR+ K +N+LL D+ ++D GLA
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 56/155 (36%), Positives = 81/155 (52%), Gaps = 4/155 (2%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASM 152
LSG + Y + L SL DL N++ IP L NL L L N SG +P SI S+
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L L++S NSL+ I ++ L L L L NNF+G +P + SL + L L +N+
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 213 VTGSL--NVFSGLPLTTLNVANNHFSGWIPRELIS 245
+G + N+ LT L+++ N+ +G IP L S
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G VY + +AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLGV 70
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C ++ E++ GNL D L + + + +A + A+EYL + +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNF 125
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAAL 564
+HR+ + N L+ + ++D GL+ L
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL 153
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 55/155 (35%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIAS 151
LSG + + L L DLS NS+ IP QL NL L+L SNNF+G +P ++ S
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ-NLEILHLFSNNFTGKIPVALTS 330
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ L L + N + I G L LDLS NN +G++P S N+ L L +N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 212 QVTG----SLNVFSGLPLTTLNVANNHFSGWIPRE 242
+ G SL L L +N FSG +P E
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQ--DNSFSGELPSE 423
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 3/139 (2%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNL 145
+D+S SG + L L L + LS N + IP +L L SL+L+ N SG +
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205
P S + M LS L++S+N L+ I GN+ L +++S N+ G LP++ L+ +S
Sbjct: 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS 599
Query: 206 LYLQNNQVTGSLNVFSGLP 224
N + G + SGLP
Sbjct: 600 AVAGNIDLCGG-DTTSGLP 617
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 418 IGEGSLGRVYRAEFA-NGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG G G V R GK +A+K + + S ++ +FL S M + HPNI+ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + +++ EY+ NG+L L D T V + G A ++YL E+
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
VHR+ + NIL++ L +SD GL+ ++E
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 31/167 (18%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN------FLEAVSNMSRLRHPN 469
++GEG+ G V + A G+I+A+KK + ED+ L V + +LRH N
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF------KESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH-----FADDSSKNLTWNARVRVALGTARA 524
IV L G+ LV+EYV L ++L D+ ++ W +A
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQ--------LLQA 112
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTER 570
+ Y H +++HR+ K NIL+ + L D G A AL
Sbjct: 113 IAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 37/138 (26%), Positives = 66/138 (47%), Gaps = 12/138 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA----VSNMSRLRHPNIV 471
+G G+ Y+A + G +MAVK++ + E++ +EA + M+RL HP+I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ G E L E++ G++ +L + + + R L YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSYLHE- 121
Query: 532 CLPSVVHRNFKSANILLD 549
++HR+ K AN+L+D
Sbjct: 122 --NQIIHRDVKGANLLID 137
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 15/154 (9%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED---NFLEA----VSNMSRLRHP 468
LIG GS G VY A +G++MAVK+++ ++S +D + L+A ++ + L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
NIV G + + EYV G++ +L+ + L N VR L + L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF-VRQIL---KGLNYL 122
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
H ++HR+ K ANIL+D++ +SD G++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + +A+K + ++S + FL + M +L+HP +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG+L D L LT N + +A A + ++ + +
Sbjct: 71 TQE-PIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIER---KNYI 124
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
HR+ ++ANIL+ + L ++D GLA L + E
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 48/160 (30%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRL-RHPNI 470
+IGEGS V A E K A+K +D L +++ + V ++RL HP I
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY---VKIEKEVLTRLNGHPGI 64
Query: 471 VTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+ L Y + + L V EY NG L + S + R A ALEYLH
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKC-TRFYAAE-ILLALEYLH 119
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
++HR+ K NILLD +++ ++D G A +
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 43/161 (26%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV-TLAG 475
IGEG+ G V++A + G+ +A+KK+ L + L + + +HP +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYLHEVCL 533
+ HG LV EY+ + L ++L D + L A+V+ + + Y+H
Sbjct: 68 F--PHGSGFVLVMEYMPSD-LSEVLR---DEERPLP-EAQVKSYMRMLLKGVAYMHAN-- 118
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
++HR+ K AN+L+ + ++D GLA L E ++ +
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI--DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEG G V + E+ G+ +AVK I D A + FLE + M++L H N+V L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA------FLEETAVMTKLHHKNLVRLLG 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+G + V E + GNL + L + ++ ++ +L A +EYL
Sbjct: 67 VILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLES---KK 120
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTP 566
+VHR+ + NIL+ ++ +SD GLA +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 45/152 (29%), Positives = 66/152 (43%), Gaps = 14/152 (9%)
Query: 418 IGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG G G+V E G K V K A+ + E+ FL+ V L HPN++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 476 YCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
C E LLV E+ G+L + L A + K++ R+A A L +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV----LQRMACEVASGLLWLHQ 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+H + N L +L+ + D GLA
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 417 LIGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+IG+G G VY ++G+ + AVK + N L+E + FL+ M HPN+++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 473 LAGYC-AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C G L+V Y+ +G D+ +F + N T + L A+ +EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHG---DLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS- 116
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N +LD+ ++D GLA
Sbjct: 117 --KKFVHRDLAARNCMLDESFTVKVADFGLA 145
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 21/169 (12%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED-NF--LEAVSNMSRLRHPNIVT 472
+GEG+ VY+A G+I+A+KKI ++ NF L + + L+HPNI+
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 473 L-AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYLH 529
L + H + LV+E++ D+ D S LT A ++ L T R LEYLH
Sbjct: 67 LLDVFG--HKSNINLVFEFMET----DLEKVIKDKSIVLT-PADIKSYMLMTLRGLEYLH 119
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER----QVIT 574
++HR+ K N+L+ + L+D GLA + R QV+T
Sbjct: 120 SN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + +AVK + +S ++FLE M +LRH +V L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+E +V EY+ G+L D L D + L V +A A + Y+ + + +
Sbjct: 71 SEE-PIYIVTEYMSKGSLLDFLK--DGEGRALKLPNLVDMAAQVAAGMAYIERM---NYI 124
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
HR+ +SANIL+ D L ++D GLA L + E
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 7/146 (4%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G+ G VY+ +AVK + L + FL+ + + HPNIV L G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G+L L F LT ++++L A +EYL
Sbjct: 61 CVQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 537 VHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + N L+ + +SD G++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 48/185 (25%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEED---NFLEAVSNMSRLR---HPN 469
IGEG+ G VY+A + G+ +A+KK+ + L EE + L ++ + +L HPN
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 470 IVTLAGYCAEHGQRL-------LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR 516
IV L C HG R LV+E+V + +L L ++ K+L
Sbjct: 63 IVRLLDVC--HGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ---- 115
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-------ALTPNTE 569
R +++LH +VHR+ K NIL+ + ++D GLA ALT
Sbjct: 116 ----LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS--- 165
Query: 570 RQVIT 574
V+T
Sbjct: 166 -VVVT 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 10/164 (6%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+GS G VY+ + ++ + A+K++D ++S +E ++ + + ++ + HPNI+
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---S 63
Query: 476 YCAEH--GQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
Y G +L +V EY G+L + K + R+ + R L+ LHE
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
++HR+ KSANILL + D G++ + + GT
Sbjct: 123 --KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 412 FSQEFL-----IGEGSLGRV--YRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSN 461
F + +L +GEG G+V Y + AN G+++AVK + Q + + ++
Sbjct: 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINI 59
Query: 462 MSRLRHPNIVTLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
+ L H NIV G C+E G + L+ EYV G+L D L L + A
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQ 114
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+ YLH +HR+ + N+LLD++ + D GLA P
Sbjct: 115 QICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 46/159 (28%), Positives = 89/159 (55%), Gaps = 19/159 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEGS G++Y A+ ++ + +K+ID + ++E++ + V +++++HPNIVT
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLH------FADDSSKNLTWNARVRVALGTARALEYLHE 530
E+G+ +V EY G+L ++ F++D + L+W V+++LG L+++H+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSW--FVQISLG----LKHIHD 119
Query: 531 VCLPSVVHRNFKSANILLDDE-LNPHLSDCGLAALTPNT 568
++HR+ KS NI L + L D G+A ++
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A + + G+ +AVKK+D L Q+ L V M +HPNIV +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V E++ G L D++ + + V L +AL +LH
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA---QG 135
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAA 563
V+HR+ KS +ILL + LSD G A
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 41/163 (25%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAV--------SNMSRLRHP 468
IGEG+ G VY+A + G+I+A+KKI L+ ED E V S + L HP
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-----RLETED---EGVPSTAIREISLLKELNHP 58
Query: 469 NIVTLAGYCAEH-GQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
NIV L H +L LV+E++ D+ + D S L
Sbjct: 59 NIVRL--LDVVHSENKLYLVFEFLD----LDLKKYMDSSPL---------TGLDPPLIKS 103
Query: 527 YLHEVCLP-------SVVHRNFKSANILLDDELNPHLSDCGLA 562
YL+++ V+HR+ K N+L+D E L+D GLA
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 18/161 (11%)
Query: 417 LIGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTL 473
+IGEG+ G+V +A ++ A K S + +F + + +L HPNI+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLH----------FADDSSKNLTWNAR--VRVALGT 521
G C G L EY +GNL D L FA +S T +++ + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
AR ++YL + +HR+ + NIL+ + ++D GL+
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 55/179 (30%), Positives = 81/179 (45%), Gaps = 27/179 (15%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNLPYSIASM 152
+G + L+ L L+ L N IP L NLT L+L++NN +G +P + S
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L L + NSL I G L + L N+FSG+LP+ F L + L + NN
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 213 VTGSLN------------------VFSGLP-------LTTLNVANNHFSGWIPRELISI 246
+ G +N F GLP L L+++ N FSG +PR+L S+
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498
|
Length = 968 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 37/162 (22%)
Query: 417 LIGEGSLGRVYRA------EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ GRV+ + K+MA+ ++ + L++E + + + HP I
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEV----IRLKQEQHVHNEKRVLKEVSHPFI 63
Query: 471 VTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
+ L + EH QR L + EYV G L L R + T
Sbjct: 64 IRL--FWTEHDQRFLYMLMEYVPGGELFSYLR------------NSGRFSNSTGLFYASE 109
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
ALEYLH +V+R+ K NILLD E + L+D G A
Sbjct: 110 IVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFA 148
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 415 EFLIGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIV 471
E +IGEG+ G+V RA K+ A K+ S + +F + + +L HPNI+
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLH----------FADD--SSKNLTWNARVRVAL 519
L G C G + EY GNL D L FA + ++ LT ++ A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A ++YL E +HR+ + N+L+ + L ++D GL+
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS 166
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 43/161 (26%), Positives = 62/161 (38%), Gaps = 22/161 (13%)
Query: 418 IGEGSLGRV----YRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G G+ G V Y + +AVK + + FL S M++L HP IV L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLH 529
G C +LV E G L L K L A A + YL
Sbjct: 62 IGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--------AHQVAMGMAYLE 112
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTE 569
VHR+ + N+LL + +SD G++ AL ++
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 38/156 (24%), Positives = 70/156 (44%), Gaps = 14/156 (8%)
Query: 417 LIGEGSLGRVYRA-----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
L+ EG+ GR++ + + + VK + + A S + L+ + L H NI+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNIL 71
Query: 472 TLAGYCAE-HGQRLLVYEYVGNGNLHDMLHFADDSSKN----LTWNARVRVALGTARALE 526
+ C E ++Y Y+ GNL L N L+ V +A+ A +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
YLH+ V+H++ + N ++D+EL ++D L+
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALS 164
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 9e-11
Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
S + +G+G G V+ + +A+K + + + FL+ M +LRH +
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKL 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L +E +V E++G G+L D L D K L V +A A + Y+
Sbjct: 64 VPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER 120
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+ + +HR+ ++ANIL+ D L ++D GLA L + E
Sbjct: 121 M---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
S E +G+G G V+ + +A+K + +S + FL+ M +LRH +
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKL 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L +E +V EY+ G+L D L + K L V +A A + Y+
Sbjct: 64 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+ + VHR+ ++ANIL+ + L ++D GLA L + E
Sbjct: 121 M---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 11/152 (7%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+F +E +G G G V+ ++ +A+K I+ A+S E++F+E M +L HP +
Sbjct: 7 TFMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKL 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G C + +V E++ NG L L++ L+ + + + +EYL
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
S +HR+ + N L+ +SD G+
Sbjct: 119 ---NSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 36/159 (22%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 417 LIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
++GEG G V + + K+ AVK + + E + FL + M HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 472 TLAGYCAEHGQR------LLVYEYVGNGNLHDMLHFA--DDSSKNLTWNARVRVALGTAR 523
L G C E +++ ++ +G+LH L ++ + L ++ + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+EYL + +HR+ + N +L +++ ++D GL+
Sbjct: 125 GMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 14/164 (8%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G V ++ G +AVK I N A + FL S M++LRH N+V L G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 478 AE-HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
E G +V EY+ G+L D L S L + ++ +L A+EYL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEA---NNF 123
Query: 537 VHRNFKSANILLDDELNPHLSDCGL---AALTPNTERQVITGTS 577
VHR+ + N+L+ ++ +SD GL A+ T +T + + T+
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 167
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 39/145 (26%), Positives = 66/145 (45%), Gaps = 9/145 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +A+K I ++S ED F+E M +L H +V L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ +V EY+ NG L L++ + K + + + + YL +
Sbjct: 69 TKQRPIYIVTEYMSNGCL---LNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFI 122
Query: 538 HRNFKSANILLDDELNPHLSDCGLA 562
HR+ + N L+DD+ +SD GL+
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 418 IGEGSLGRVYRAEFANG-------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IG+G+ GRV++A A G ++AVK + A S + +F + M+ HPNI
Sbjct: 13 IGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNI 70
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL----TWNARVRVALGTARALE 526
V L G CA L++EY+ G+L++ L S + + R L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 527 YLHEVCLPS-------------VVHRNFKSANILLDDELNPHLSDCGLA 562
++C+ VHR+ + N L+ + + ++D GL+
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 37/159 (23%), Positives = 68/159 (42%), Gaps = 8/159 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + N +AVK + ++ +D FL M +LRHP ++ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK--PGTMDPKD-FLAEAQIMKKLRHPKLIQLYAVC 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+V E + G+L + L + + L + +A A + YL + +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEA---QNYI 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
HR+ + N+L+ + ++D GLA + + G
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA 164
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNA-ALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+G+ G+V + K+ A+K ++ + N L + L HP +V L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW- 66
Query: 476 YCAEHGQRL-LVYEYVGNGNL--H--DMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
Y + + + LV + + G+L H + F+++ K W + ALEYLH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVK--FWICEI------VLALEYLHS 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVITGT 576
++HR+ K NILLD++ + H++D +A +TP+T +GT
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGT 162
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+GS G VY+ GKI A+KKI + + L + + P +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV--RVALGTARALEYLHEVCLP 534
+ G+ +V EY+ G+L D+L K V +A + L+YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTK--R 119
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568
++HR+ K +N+L++ + ++D G++ + NT
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRL 465
+ +++ +IG G G V+R G+ +A+K + Q +D FL S M +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQF 63
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
H NI+ L G + +++ EY+ NG L L D + +R G A +
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGM 120
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+YL ++ + VHR+ + NIL++ L +SD GL+
Sbjct: 121 KYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNF---LEAVSNMSRLRHPNIVTL 473
IG G+ G VY+A N G++ A+K I L+ ++F + + M +H NIV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-----KLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + + E+ G G+L D+ H S++ V+ T + L YLH
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQI----AYVSRETLQGLYYLHS--- 124
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
+HR+ K ANILL D + L+D G++A T +R+ GT
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGT 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 30/175 (17%)
Query: 408 ATNSFSQEFLIGEGSLGRVYRAEF---ANG---KIMAVKKI-DNAALSLQEEDNFLEAVS 460
+T F +E +GE G+VY+ A G + +A+K + D A L+EE F
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE--FKHEAM 60
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA----------DDSSKNLT 510
SRL+HPNIV L G + +++ Y + +LH+ L DD + T
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 511 WNAR--VRVALGTARALEYL--HEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
V + A +E+L H V H++ + N+L+ D+LN +SD GL
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 41/163 (25%), Positives = 78/163 (47%), Gaps = 22/163 (13%)
Query: 418 IGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GE + G++Y+ + +++A+K + + + Q+ F + S M+ L HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVC 71
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSS-------------KNLTWNARVRVAL 519
L G + +++EY+ G+LH+ L S +L + +A+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A +EYL VH++ + NIL+ ++L+ +SD GL+
Sbjct: 132 QIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 24/164 (14%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA--------VSNMSRLRH 467
LIG+G+ GRVY A G++MAVK+++ A D+ + + + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTAR 523
NIV G+ + EYV G++ L F + + T
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567
L YLH ++HR+ K+ N+L+D + +SD G++ + +
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDD 160
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G VY A ++ +++AVKK+ + E+ + ++ V + +L+HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 476 -YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y EH LV EY G+ D+L + + A + G + L YLH +
Sbjct: 89 CYLKEH-TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHNM- 142
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALT 565
+HR+ K+ NILL + L+D G A+ +
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSASKS 171
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLR 466
+F E IG+G VY+A +G+++A+KK+ + + + L+ + + +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-HFADDSS---KNLTWNARVRVALGTA 522
HPN++ E+ + +V E G+L M+ HF + W V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
ALE++H ++HR+ K AN+ + L D GL
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G+G+ GRVY + G+ +AVK++ D + ++E N LE + + L+H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 473 LAGYCAEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G C + L ++ EY+ G++ D L ++ +T ++ G +EYLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG----VEYLHS- 122
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+VHR+ K ANIL D N L D G +
Sbjct: 123 --NMIVHRDIKGANILRDSAGNVKLGDFGAS 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 415 EFLIGEGSLGRVYRAEF-ANGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
E +IG G G V R GK +A+K + + Q D FL S M + HPNI
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ L G + +++ E++ NG L L D T V + G A ++YL E
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSE 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ + VHR+ + NIL++ L +SD GL+
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G+ G+VY+A+ + A KI + ED +E + +S +HPNIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-IDILSECKHPNIVGLYEAY 71
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ E+ G L ++ + + LT V AL +LH V+
Sbjct: 72 FYENKLWILIEFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHS---HKVI 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
HR+ K+ NILL + + L+D G++A +T +R GT
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGT 166
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + N +AVK + +S+Q FLE + M L+H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ G+L D L +D+ K + + + A + Y+ + +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLK-SDEGGK-VLLPKLIDFSAQIAEGMAYIER---KNYI 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
HR+ ++AN+L+ + L ++D GLA + + E
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 418 IGEGSLGR-VYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEGS G+ + +GK +K+I+ + +S +E + + V+ +S ++HPNIV
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP-- 534
E+G +V +Y G+L+ + NA+ V + L++ ++CL
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKI------------NAQRGVLFPEDQILDWFVQICLALK 115
Query: 535 -----SVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568
++HR+ KS NI L + L D G+A + +T
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 20/166 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF---LEAVSNMSRLRHPNIVTL 473
+G G+ G VY+A G++ AVK I L+ D+F + + + +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII-----KLEPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSK-NLTWNARVRVALGTARALEYLHEVC 532
G + + EY G G+L D+ H S+ + + R T + L YLH
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHS-- 124
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
+HR+ K ANILL D + L+D G+AA T +R+ GT
Sbjct: 125 -KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGT 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 45/176 (25%), Positives = 82/176 (46%), Gaps = 34/176 (19%)
Query: 418 IGEGSLGRVYRAEFANGK----------------IMAVKKIDNAALSLQEEDNFLEAVSN 461
+GEG G V+ E N + ++ KI + ++FL+ V
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 462 MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDSSKN----------- 508
+SRL+ PNI+ L G C + ++ EY+ NG+L+ L H DD +N
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 509 --LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+++++ + VAL A ++YL + + VHR+ + N L+ + L ++D G++
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVT 472
+IGEG+ G+V +A +G M A+K++ A S + +F + + +L HPNI+
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLH------------FADDSSKNLTWNARVRVALG 520
L G C G L EY +GNL D L A+ ++ L+ + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
AR ++YL + +HR+ + NIL+ + ++D GL+
Sbjct: 133 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
EFL GEG+ EF ++ K+ A ++ ++FL+ + MSRL++PNI+ L
Sbjct: 30 AEFL-GEGA------PEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSK--------NLTWNARVRVALGTARAL 525
G C ++ EY+ NG+L+ L + S +++ + +A+ A +
Sbjct: 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGM 142
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+YL + + VHR+ + N L+ + ++D G++
Sbjct: 143 KYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 21/169 (12%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEED--NFLEAVSNMSRLRH---PNI 470
LIG G+ G VYR G+++A+K I+ L ++D + V+ +S+LR PNI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 471 VTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
G G RL ++ EY G++ ++ + K ++ R AL+Y+H
Sbjct: 65 TKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIH 118
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVITGT 576
+V V+HR+ K+ANIL+ + N L D G+AAL +++R GT
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 48/150 (32%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G VY A + N +++A+KK+ + E+ + ++ V + +LRHPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 476 -YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y EH LV EY G+ D+L + + A V G + L YLH
Sbjct: 83 CYLREH-TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS---H 134
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAAL 564
+++HR+ K+ NILL + L D G A++
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 35/150 (23%), Positives = 67/150 (44%), Gaps = 14/150 (9%)
Query: 418 IGEGSLGR--VYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+G+ G +YR + ++ K+++ LS +E + L + +S L+HPNI+
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVC 532
+ + L+ EY G L+D + + + W A+ Y+H+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHKA- 120
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++HR+ K+ NI L L D G++
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGIS 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 39/156 (25%), Positives = 72/156 (46%), Gaps = 14/156 (8%)
Query: 418 IGEGSLGRVYRAEFANGKIM---AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+GEG G V + + AVK + A + E ++FL M HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 475 GYCAEHGQR------LLVYEYVGNGNLHDMLHFA--DDSSKNLTWNARVRVALGTARALE 526
G C + + +++ ++ +G+LH L ++ D + L V+ A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
YL S +HR+ + N +L++ +N ++D GL+
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 35/171 (20%)
Query: 418 IGEGSLGRVYRAEFANG---------KIMAVKKI-DNAALSLQEEDNFLEAVSNMSRL-- 465
+GEG G+V RAE A G +AVK + DNA + + + +S M +
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNAT-----DKDLADLISEMELMKL 73
Query: 466 --RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH--------FADDSSK----NLTW 511
+H NI+ L G C + G ++ EY GNL + L + D +K L++
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 512 NARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V A AR +EYL +HR+ + N+L+ ++ ++D GLA
Sbjct: 134 KDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 47/167 (28%), Positives = 68/167 (40%), Gaps = 33/167 (19%)
Query: 418 IGEGSLGRVYRA---EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIV 471
IG G+ GRVY+A +GK A+KK Q A ++ LR H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFK--GDKEQYTGISQSACREIALLRELKHENVV 65
Query: 472 TLAGYCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL---- 525
+L EH + L+++Y HD+ + RV + ++L
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQ----AKRVSIPPSMVKSLLWQI 117
Query: 526 ----EYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAAL 564
YLH V+HR+ K ANIL+ E + D GLA L
Sbjct: 118 LNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 11/163 (6%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G+ G V + GKIMAVK I ++ + L + + + P IV G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV--RVALGTARALEYLHEVCLP 534
+G + EY+ G+L +L R+ ++A+ + L YLHE
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQG-----RIPERILGKIAVAVLKGLTYLHEKH-- 120
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
++HR+ K +NIL++ L D G++ N+ + GTS
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTS 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 31/157 (19%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-------SLQEEDNFLEAVSNMSRLRHPN 469
I +G+ GRV+ A+ + G I A+K I A + + E + L S+ + P
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDIL------SQAQSPY 54
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARA 524
+V L Y + + L LV EY+ G+L +L +D ++ + L A
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI----AEIVL----A 105
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
LEYLH ++HR+ K NIL+D + L+D GL
Sbjct: 106 LEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGL 139
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 52/182 (28%), Positives = 91/182 (50%), Gaps = 19/182 (10%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN---FL 456
T+ S+ +++ IG+G+ G V+ A + A G+ +A+K+I+ LQ++ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-----LQKQPKKELII 64
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M L++PNIV + +V EY+ G+L D++ + A R
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCR 122
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-NTERQVIT 574
L +ALE+LH V+HR+ KS N+LL + + L+D G A +TP ++R +
Sbjct: 123 ECL---QALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 575 GT 576
GT
Sbjct: 177 GT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 46/169 (27%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEG+ G VY+A + G+++A+KKI L E+D F L + + +L+HPN+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALREIKILKKLKHPNVVP 71
Query: 473 LAGYCAEHG-----QRLLVY---EYVGNGNLHD---MLHFADDSSKNLTWNARVRVALGT 521
L E +R VY Y+ HD +L N V++
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMD----HDLSGLLE-----------NPSVKLTESQ 116
Query: 522 AR--------ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ + YLHE ++HR+ K+ANIL+D++ ++D GLA
Sbjct: 117 IKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 18/143 (12%)
Query: 418 IGEGSLGRVYRA---------EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
+G+G+ ++++ E +++ +K +D + + E +F EA S MS+L H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVL-LKVLDKSHRNYSE--SFFEAASMMSQLSHK 59
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
++V G C + ++V EYV G+L D + + N++W ++ VA A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISW--KLEVAKQLAWALHFL 116
Query: 529 HEVCLPSVVHRNFKSANILLDDE 551
+ + H N + N+LL E
Sbjct: 117 ED---KGLTHGNVCAKNVLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 6e-09
Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 19/139 (13%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS GRV +GK A+K + A + L++ ++ L + +RHP +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ L LV EYV G L L F + ++ +V L ALEYLH
Sbjct: 69 -SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYA----AQVVL----ALEYLHS 119
Query: 531 VCLPSVVHRNFKSANILLD 549
+ +V+R+ K N+LLD
Sbjct: 120 L---DIVYRDLKPENLLLD 135
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 57/182 (31%), Positives = 94/182 (51%), Gaps = 19/182 (10%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQ-EEDNFLEA 458
T+ S+ +++ IG+G+ G VY A + A G+ +A+K+++ L Q +++ +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINE 66
Query: 459 VSNMSRLRHPNIVT-LAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M +HPNIV L Y G L +V EY+ G+L D++ + A R
Sbjct: 67 ILVMRENKHPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCR 122
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-NTERQVIT 574
L +ALE+LH V+HR+ KS NILL + + L+D G A +TP ++R +
Sbjct: 123 ECL---QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 575 GT 576
GT
Sbjct: 177 GT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 40/166 (24%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
IG+G+ G V++A +I+A+KK+ L E++ F L + + L+H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 473 LAGYC-----AEHGQR---LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
L C + + LV+E+ HD+ L N V+ L +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCE----HDL--------AGLLSNKNVKFTLSEIKK 123
Query: 525 --------LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L Y+H ++HR+ K+ANIL+ + L+D GLA
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 49/159 (30%), Positives = 69/159 (43%), Gaps = 31/159 (19%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQE-------EDNFLEAVSNMSRLRHPN 469
+G+G G V + GK+ A KK+D L ++ E LE VS+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS------RF 54
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-----VALGTAR 523
IV+LA Y E L LV + G+L H + AR + G
Sbjct: 55 IVSLA-YAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFP-EARAIFYAAQIICG--- 107
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
LE+LH+ +V+R+ K N+LLDD N +SD GLA
Sbjct: 108 -LEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 20/152 (13%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTLA 474
IG+GS G+V A+ A+GK AVK + A+ ++E + A N + ++HP +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLH 529
Y + +L V +YV G L L F + ++ + A + ALG YLH
Sbjct: 63 -YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--FYAAEIASALG------YLH 113
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
+ ++++R+ K NILLD + + L+D GL
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 45/172 (26%), Positives = 68/172 (39%), Gaps = 25/172 (14%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKI---DNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+GEG+ G V + G I A+K I N L Q L + + P IV
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSCKSPYIVKY 64
Query: 474 AG-YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARV------RVALGTARAL 525
G + E + + EY G+L + K R+ ++A + L
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
YLH ++HR+ K +NILL + L D G++ N+ TGTS
Sbjct: 119 SYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTS 167
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 40/146 (27%), Positives = 64/146 (43%), Gaps = 7/146 (4%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
L+G+G+ G V++ + +AVK L + + FL + + HPNIV L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G D L F L V+ AL A + YL +
Sbjct: 61 CTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNC 114
Query: 537 VHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + N L+ + +SD G++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 9/161 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G+ G+VY+A+ ++A K+ + S +E ++++ + ++ HPNIV L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
++ E+ G + ++ + + LT V T AL YLHE ++
Sbjct: 72 YYENNLWILIEFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
HR+ K+ NIL + + L+D G++A T R GT
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 166
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDN------FLEAVSNMSRLRHPN 469
L+GEGS G V + + G+I+A+KK L+ ED+ + + + +LRH N
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF------LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V L + LV+E+V + L D+ + + L + + R +E+ H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCH 117
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+++HR+ K NIL+ L D G A
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G G+ G VY A+ G+ +AVK++ D + +E N LE + + LRH IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 473 LAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + ++ L EY+ G++ D L + LT N R + + YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCG 560
+VHR+ K ANIL D N L D G
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 8/146 (5%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V+ A+ +AVK L + FL+ + + HPNIV L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G D L F L +++ A +EYL
Sbjct: 62 CTQKQPIYIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 537 VHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + N L+ ++ +SD G++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 44/149 (29%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 417 LIGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+GS G V R E+ + GK++ AVK + + LS +D FL+ + M L H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-FLKEAAIMHSLDHENLIR 60
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G H ++V E G+L D L D+ + + A+ A + YL
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGL 561
+HR+ + NILL + + D GL
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGL 143
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLR----HPN 469
+GEG G+V AE K A+ + ++D + + VS M ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH--------FADDSSK----NLTWNARVRV 517
I+ L G C + G ++ EY GNL + L ++ D+ K LT+ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A AR +EYL +HR+ + N+L+ ++ ++D GLA
Sbjct: 140 AYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 22/144 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAG 475
IGEG+ V +A GK A+K + SL E+ N L + + RL HPNI+ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIE 65
Query: 476 --YCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEYL 528
+ + G+ LV+E + + NL++++ + K+ + ++L+++
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQ--------LLKSLDHM 116
Query: 529 HEVCLPSVVHRNFKSANILLDDEL 552
H + HR+ K NIL+ D++
Sbjct: 117 HR---NGIFHRDIKPENILIKDDI 137
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 30/158 (18%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED-----NFLEAVSNMSRLRHPNIV 471
IGEG+ G VY+ G+I+A+KKI L+ E+ + +S + L+HPNIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-----RLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L + + L++E++ D+ + D K + YL+++
Sbjct: 63 CLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQY--------MDAELVKSYLYQI 110
Query: 532 CLP-------SVVHRNFKSANILLDDELNPHLSDCGLA 562
V+HR+ K N+L+D++ L+D GLA
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPN 469
F+ IG GS G VY A +++A+KK+ + E+ + ++ V + R++HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 470 IVTLAG-YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+ G Y EH LV EY G+ D+L + + A + G + L YL
Sbjct: 87 SIEYKGCYLREH-TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYL 141
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
H +++HR+ K+ NILL + L+D G A++
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 47/152 (30%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 415 EFLIGEGSLGRVYRAEFA-NGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
E +IG G G V GK +A+K + Q D FL S M + HPNI
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ L G + ++V EY+ NG+L L D T V + G A ++YL +
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSD 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ VHR+ + NIL++ L +SD GL+
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 417 LIGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++GEGS GR + N A+K+I S ED+ EAV +++++HPNIV
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL-LAKMKHPNIVAFKE 65
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G +V EY G+L M K + ++ + ++++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDL--MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KR 120
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPN 567
V+HR+ KS NI L L D G A L +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 48/164 (29%), Positives = 65/164 (39%), Gaps = 33/164 (20%)
Query: 423 LGRVYRAEFANGKIMAVKKIDNAALSLQEEDN------------------FLEAVSNMSR 464
LGR R + G + K D+ E F E S M +
Sbjct: 3 LGRGTRTQIYAGILN--YKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
+ H +IV L G C + ++V E+V G L +H S LT + +VA A A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASA 117
Query: 525 LEYLHEVCLPSVVHRNFKSANILL-----DDELNP--HLSDCGL 561
L YL + +VH N + NILL D E P LSD G+
Sbjct: 118 LSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 44/152 (28%), Positives = 67/152 (44%), Gaps = 16/152 (10%)
Query: 417 LIGEGSLGRVYRAEF---ANGKI-MAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IGEG G VY+ + N KI +AVK K + S++E FL+ M + HP+I
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVRE--KFLQEAYIMRQFDHPHI 69
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G E+ +V E G L + + +L + + + + AL YL
Sbjct: 70 VKLIGVITEN-PVWIVMELAPLGELR---SYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N+L+ L D GL+
Sbjct: 126 K---RFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 17/151 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS GRV A+ G+ A+K + L +++ + + S + L HP IV +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ + + E+V G L L F +D +K ++A + +A EYLH
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK--FYHAELVLAF------EYLHSK 137
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+++R+ K N+LLD++ + ++D G A
Sbjct: 138 ---DIIYRDLKPENLLLDNKGHVKVTDFGFA 165
|
Length = 329 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 22/162 (13%)
Query: 418 IGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N ++AVK + A+ S +++ F ++ L+H +IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIV 70
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML--HFAD----DSSKN-----LTWNARVRVALG 520
G C E L+V+EY+ +G+L+ L H D ++ LT + +A
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A + YL + VHR+ + N L+ L + D G++
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 418 IGEGSLGRVYR-AEFANGKIMAVKKID---NAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG+G+ G+VY+ +G + AVK +D + ++ E N L+++ N HPN+V
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN-----HPNVVKF 84
Query: 474 AG--YCAEH---GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
G Y A+ GQ LV E G++ +++ + L + G L++L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
H ++HR+ K NILL E L D G++A +T R GT
Sbjct: 145 HN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKID---NAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
L+G G+ G+VY+ G++ A+K +D + +++E N L+ S+ H NI T
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-----HRNIAT 67
Query: 473 LAGYCAEHG------QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV-RVALGTARAL 525
G + Q LV E+ G G++ D++ ++ W A + R L R L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGL 124
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
+LH+ V+HR+ K N+LL + L D G++A T R GT
Sbjct: 125 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 44/160 (27%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 418 IGEGSLGRVYRAEFAN-----GKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N KI+ AVK + +A+ + +++ F ++ L+H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--FHREAELLTNLQHEHIV 70
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML--HFAD-------DSSKNLTWNARVRVALGTA 522
G C E ++V+EY+ +G+L+ L H D + LT + + +A A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ YL VHR+ + N L+ + L + D G++
Sbjct: 131 AGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 27/156 (17%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEE---DNFLEAVSNMSRLRHPNIVTL 473
IGEG+ G VY+A G+++A+KKI L + E + +S + L HPNIV L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV-- 531
+ LV+E++ D+ F D S + + YL ++
Sbjct: 65 LDVIHTENKLYLVFEFLH----QDLKKFMDASPLS---------GIPLPLIKSYLFQLLQ 111
Query: 532 ----CLP-SVVHRNFKSANILLDDELNPHLSDCGLA 562
C V+HR+ K N+L++ E L+D GLA
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G+G+ GRVY + G+ +A K++ D + +E + LE + + L+H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 473 LAGYCAEHGQRLLV--YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + ++ L EY+ G++ D L ++++T ++ G + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEG----MSYLHS 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCG 560
+VHR+ K ANIL D N L D G
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 29/164 (17%)
Query: 417 LIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G+G+ G V + G+++AVKK+ ++ + F + + L+H NIV
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD--FEREIEILKSLQHDNIV 68
Query: 472 TLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
G C G+R LV EY+ G+L D L K+ R L + L Y
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYL------QKH-------RERLDHRKLLLYAS 115
Query: 530 EVC-----LPS--VVHRNFKSANILLDDELNPHLSDCGLAALTP 566
++C L S VHR+ + NIL++ E + D GL + P
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 50/155 (32%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 418 IGEGSLGRVYRAEFANGK----IMAVKKID----NAALSLQEEDNFLEAVSNMSRLRHPN 469
+G G G+V AE+ I A+KK D + SL E E + RHP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERHPF 63
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTARALE 526
+V L C + + V EY G+L M+H D S + A V LG L+
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYA-ACVVLG----LQ 115
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
YLHE +V+R+ K N+LLD E ++D GL
Sbjct: 116 YLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 29/176 (16%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRL 465
F + L+G+G +GRV+ GK+ A+K +D + + N ++ V ++ L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM---IKRNKVKRVLTEQEILATL 58
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH------FADDSSKNLTWNARVRVAL 519
HP + TL LV +Y G L +L +++ AR A
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEV-------ARFYAAE 111
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVI 573
ALEYLH L +V+R+ K NILL + + H LSD L+ + V
Sbjct: 112 VLL-ALEYLH---LLGIVYRDLKPENILLHE--SGHIMLSDFDLSKQSDVEPPPVS 161
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 57/188 (30%), Positives = 92/188 (48%), Gaps = 53/188 (28%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF-LEAVSNMSRLR---HPNI 470
IGEG+ G+VY+A + G+++A+KK+ DN E++ F + A+ + LR H NI
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDN------EKEGFPITAIREIKILRQLNHRNI 68
Query: 471 VTL----------AGYCAEHGQRLLVYEYVGNGNLHD--------MLHFADDSSKNLTWN 512
V L + + G LV+EY+ HD ++HF++D K+
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFSEDHIKSF--- 121
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL------TP 566
++ L L Y H+ + +HR+ K +NILL+++ L+D GLA L P
Sbjct: 122 --MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 567 NTERQVIT 574
T + VIT
Sbjct: 174 YTNK-VIT 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 7/147 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMA---VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G G+V +E +A VK++ A S +E++ FL+ L+HPNI+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKEL-KANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G C E LLV+EY G+L L +N R+A A + ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--- 118
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGL 561
+ +H + N L +L + D G+
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 20/172 (11%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLR 466
F++ IG+GS G VY+ + +++A+K ID L+E ++ +E + +S+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
P I G + + ++ EY+G G+ D+L L + + L+
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLD 115
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQVITGT 576
YLH +HR+ K+AN+LL ++ + L+D G+A +T+ R GT
Sbjct: 116 YLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 7/152 (4%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL-AG 475
+G+GS G V +GK +KK++ S +E + +S+L+HPNIV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ E G +V + G+L+ L + K L N V + A AL+YLHE
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLK--EQKGKLLPENQVVEWFVQIAMALQYLHE---KH 122
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPN 567
++HR+ K+ N+ L + D G+A + N
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 22/154 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
I EG+ G VYRA + G+I+A+KK+ +E++ F L ++ + +L+HPNIVT
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKME----KEKEGFPITSLREINILLKLQHPNIVT 68
Query: 473 LA----GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+ G + + +V EYV HD+ + + + + L + +L
Sbjct: 69 VKEVVVG--SNLDKIYMVMEYVE----HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
H+ ++HR+ K++N+LL++ + D GLA
Sbjct: 123 HD---NWILHRDLKTSNLLLNNRGILKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 17/158 (10%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSR 464
+S+ + +GEGS VY+ + NGK++A+K I LQEE+ + S +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-----RLQEEEGTPFTAIREASLLKG 59
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
L+H NIV L LV+EYV D+ + D L R
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRG 115
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L Y+H+ ++HR+ K N+L+ D L+D GLA
Sbjct: 116 LSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 19/152 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G+ G VY A G+++A+KK+ S +E N E S HPNIV L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 477 CAEHGQRLLVYEYVGNGNLHDML------HFADDSSKNLTWNARVRVALGTARALEYLHE 530
E+ + V+EY+ GNL+ ++ F++ +++ + + L ++H+
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQ--------ILQGLAHIHK 117
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
HR+ K N+L+ ++D GLA
Sbjct: 118 HGF---FHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 31/169 (18%)
Query: 418 IGEGSLGRVYRAEF--------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---- 465
+GEG G+V AE +AVK + + A E + + VS M +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIG 78
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--------HFADD----SSKNLTWNA 513
+H NI+ L G C + G ++ EY GNL + L ++ D + +T+
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V AR +EYL +HR+ + N+L+ + ++D GLA
Sbjct: 139 LVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLA 184
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-08
Identities = 16/43 (37%), Positives = 21/43 (48%), Gaps = 4/43 (9%)
Query: 40 DSSDVQALQVLYTSLNSPS--VLTNWKGNEGDPCGESWKGVAC 80
+ D AL +SLN L++W + DPC SW GV C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 23/165 (13%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLR----HPN 469
+GEG G+V AE ++ A+ + + D + + +S M ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF------------ADDSSKNLTWNARVRV 517
I+ L G C + G ++ EY GNL + L + L++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A AR +EYL +HR+ + N+L+ ++ ++D GLA
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLA 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 46/154 (29%), Positives = 72/154 (46%), Gaps = 22/154 (14%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRL-----RHP 468
++G+GS G+V AE ++ AVK K D + LQ++D +E R+ +HP
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKD---VILQDDD--VECTMTEKRVLALAGKHP 56
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+ L C + RL V EYV G+L M H S A L++
Sbjct: 57 FLTQLHS-CFQTKDRLFFVMEYVNGGDL--MFHI--QRSGRFDEPRARFYAAEIVLGLQF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
LHE +++R+ K N+LLD E + ++D G+
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDSEGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 53/163 (32%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A E GK +AVKK+D L Q+ L V M H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V E++ G L D++ + + + V L RAL YLH
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN---QG 138
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
V+HR+ KS +ILL + LSD G A +R+ + GT
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGT 181
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 24/162 (14%)
Query: 418 IGEGSLGRVYRAEFANG---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G VY+A+ +G + A+K+I+ +S+ ++ + L+HPN+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISLQ 64
Query: 475 GYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY----- 527
H R L+++Y HD+ H + V++ G ++L Y
Sbjct: 65 KVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPH-----LSDCGLAAL 564
+H + V+HR+ K ANIL+ E P ++D G A L
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 417 LIGEGSLGRVYRAEFANG--KIMAVKKID--NAAL--SLQEED-NFLEAVSNMS----RL 465
+G G+ G VY+ N ++A+K+I+ N A +E D + + VS ++ +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT----WNARVRVALGT 521
RHPNIV E+ + +V + + L + + + + T WN V++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
AL YLH+ +VHR+ NI+L ++ ++D GLA
Sbjct: 125 --ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 18/168 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+G+ G VY A + + +A+K+I + E ++ S L+H NIV G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLH--FADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
+E+G + E V G+L +L + T + L L+YLH+
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL---EGLKYLHDN-- 127
Query: 534 PSVVHRNFKSANILLDDELNP-HLSDCG----LAALTPNTERQVITGT 576
+VHR+ K N+L++ +SD G LA + P TE TGT
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE--TFTGT 172
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 24/188 (12%)
Query: 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKID---NAALSLQEEDNFLE 457
+++L+ F ++G G+ G+VY+ G++ A+K +D + ++ E N L+
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 458 AVSNMSRLRHPNIVTLAGYCAEHG------QRLLVYEYVGNGNLHDMLHFADDSSKNLTW 511
S+ H NI T G + Q LV E+ G G++ D++ ++ W
Sbjct: 68 KYSH-----HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122
Query: 512 NARV-RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT-- 568
A + R L R L +LH V+HR+ K N+LL + L D G++A T
Sbjct: 123 IAYICREIL---RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 569 ERQVITGT 576
R GT
Sbjct: 177 RRNTFIGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 29/161 (18%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN------FLEAVSNMSRLRHPNI 470
IGEGS G V++ G+I+A+KK ++ ED+ L + + +L+HPN+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF------VESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALE 526
V L + LV+EY + L+++ + K + W T +A+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQAVN 114
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTP 566
+ H+ + +HR+ K NIL+ + L D G A LT
Sbjct: 115 FCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 40/143 (27%), Positives = 61/143 (42%), Gaps = 19/143 (13%)
Query: 418 IGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G G+ G VY + A +AVK + + S Q+E +FL MS+ H NIV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIV 72
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARAL 525
L G E R ++ E + G D+ F ++ LT + A A+
Sbjct: 73 RLIGVSFERLPRFILLELMAGG---DLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 526 EYLHEVCLPSVVHRNFKSANILL 548
+YL E +HR+ + N LL
Sbjct: 130 KYLEE---NHFIHRDIAARNCLL 149
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEED-----NFLEAVSNMSRLRHPNIV 471
IGEG+ G VY+A + + +A+KKI L++ED + +S + ++H NIV
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-----RLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR-VRVAL-GTARALEYLH 529
L + LV+EY+ +L H DSS + N R ++ L R + Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYL---DLDLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 530 EVCLPSVVHRNFKSANILLDDELNP-HLSDCGLA 562
V+HR+ K N+L+D N L+D GLA
Sbjct: 120 S---HRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
|
Length = 294 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 39/182 (21%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA--------ALSLQEEDNFLEAVSN 461
+F Q ++G+G G V + A GK+ A KK++ +++L E+ LE V+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEK-QILEKVN- 58
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
SR +V+LA Y E L LV + G+L ++ ++
Sbjct: 59 -SRF----VVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGEA------------GFE 100
Query: 521 TARALEYLHEVCL-------PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVI 573
RA+ Y E+C +V+R+ K NILLDD + +SD GLA P E Q I
Sbjct: 101 EGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTI 158
Query: 574 TG 575
G
Sbjct: 159 KG 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G+G+ GRVY A+ G+ +AVK++ D + +E N LE + + L H IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 473 LAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + +R L E++ G++ D L S LT N + + YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCG 560
+VHR+ K ANIL D N L D G
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 20/145 (13%)
Query: 417 LIGEGSLGRVYRAEF------ANGKI-MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
+G G+ G VY +G I +AVK + A + QE+ FL+ MS HPN
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPN 60
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTAR 523
IV L G C + + ++ E + G D+L + D+ LT + + L A+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 524 ALEYLHEVCLPSVVHRNFKSANILL 548
YL ++ +HR+ + N L+
Sbjct: 118 GCVYLEQM---HFIHRDLAARNCLV 139
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 40/151 (26%), Positives = 62/151 (41%), Gaps = 11/151 (7%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG G+ G V + G IMAVK+I + L+ V M P IV
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCPYIVKF 68
Query: 474 AGYCAEHGQRLLVYEYVGNG--NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G G + E + + ++ + + ++A+ T +AL YL E
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVY--EVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++HR+ K +NILLD N L D G++
Sbjct: 127 L--KIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 2e-07
Identities = 22/59 (37%), Positives = 29/59 (49%)
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L L++S N LT F L L LDLS NN + P +F L ++ SL L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMA---VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G G+V E +G A VK++ +A S+QE+ FLE L+H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV--RVALGTARALEYLHEVC 532
G C E LLV E+ G+L L + ++ +T + R+A A L +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLR-SCRKAELMTPDPTTLQRMACEIALGLLHLHK-- 118
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ +H + N LL +L + D GL+
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 21/159 (13%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQE-------EDNFLEAVSNMSRLRHPN 469
+G+G G V + N GK+ A KK+D L + E LE V++ P
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS------PF 54
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
IV LA Y E L LV + G+L H + + L + + + +L
Sbjct: 55 IVNLA-YAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHL 111
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567
H + +V+R+ K N+LLDD+ N LSD GLA +
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLR 466
F++ IG+GS G V++ + K++A+K ID L+E ++ +E + +S+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFAD-DSSKNLTWNARVRVALGTARAL 525
P + G + + ++ EY+G G+ D+L D ++ T + + L
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQVITGT 576
+YLH +HR+ K+AN+LL + L+D G+A +T+ R GT
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 47/137 (34%), Positives = 69/137 (50%), Gaps = 6/137 (4%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L +LL L DL+ N + I L NLTSL+L +NN + P +L L+
Sbjct: 87 ENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELD 146
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+S N + + NL L LDLSFN+ S DLP +LSN+++L L N+++ L
Sbjct: 147 LSDNKIESLPSPL-RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 220 FSGLP--LTTLNVANNH 234
L L L+++NN
Sbjct: 204 EIELLSALEELDLSNNS 220
|
Length = 394 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 35/162 (21%)
Query: 417 LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEED--------NFLEAVSNMSR 464
++G+G G+V++ GKI A+K + A + ++D N LEAV
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV----- 57
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVAL 519
+HP IV L Y + G +L L+ EY+ G L L F +D++ + + + +AL
Sbjct: 58 -KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTAC--FYLSEISLAL 113
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
E+LH+ +++R+ K NILLD + + L+D GL
Sbjct: 114 ------EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGL 146
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 22/153 (14%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED-----NFLEAVSNMSRLRHPNIV 471
IGEG+ G V++A+ +I+A+K++ L ++D + L + + L+H NIV
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 472 TLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
L Y H + LV+EY D+ + D + ++ + L + H
Sbjct: 63 RL--YDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+V+HR+ K N+L++ L+D GLA
Sbjct: 117 S---HNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 23/153 (15%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEGS VY+ G+++A+K+I L+ E+ + S + L+H NIVT
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-----RLEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 473 LAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
L H ++ L V+EY+ D+ + DD L+ + VR+ L R L Y H
Sbjct: 68 LHDII--HTKKTLTLVFEYLDT----DLKQYMDDCGGGLSMH-NVRLFLFQLLRGLAYCH 120
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ V+HR+ K N+L+ + L+D GLA
Sbjct: 121 Q---RRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 23/166 (13%)
Query: 418 IGEGSLGRVYRA----EFANGKI-MAVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G G+ G VY+ E KI +A+K + + + +E L+ M+ + HP++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE--ILDEAYVMASVDHPHVV 72
Query: 472 TLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEY 527
L G C ++ L+ + + G L D + D S L W ++ A+ + Y
Sbjct: 73 RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSY 124
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVI 573
L E L VHR+ + N+L+ + ++D GLA L E++
Sbjct: 125 LEEKRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH 167
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 32/172 (18%)
Query: 418 IGEGSLGRVYRAE------FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG G+V +A A +AVK + A S + D L + + ++ HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD-LLSEFNLLKQVNHPHVI 66
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLH---------------------FADDSSKNLT 510
L G C++ G LL+ EY G+L L D + LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD-ERALT 125
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ A +R ++YL E+ +VHR+ + N+L+ + +SD GL+
Sbjct: 126 MGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLS 174
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 30/168 (17%)
Query: 418 IGEGSLGRVYRAE----------------FANGKIM-AVKKI-DNAALSLQEEDNFLEAV 459
+GEG G V+ E A+ ++ AVK + +A+ + +E+ FL+ V
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED--FLKEV 70
Query: 460 SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDS-----SKNLTWN 512
+SRL PNI L G C ++ EY+ NG+L+ L H A+ S SK+L+++
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560
+ +A A + YL + VHR+ + N L+ ++D G
Sbjct: 131 TLLYMATQIASGMRYLESLNF---VHRDLATRNCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 23/163 (14%)
Query: 418 IGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N ++AVK + + L+ +++ F ++ L+H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIV 70
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML--HFAD----------DSSKNLTWNARVRVAL 519
G C + ++V+EY+ +G+L+ L H D + L + + +A
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A + YL VHR+ + N L+ L + D G++
Sbjct: 131 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 15/153 (9%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-------HPN 469
+G G+ G+V A + K AV K+ A L+ + E + MS L+ H N
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKV--AVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
IV L G C G L++ EY G+L + L LT + + A+ + +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ +HR+ + N+LL + D GLA
Sbjct: 159 S---KNCIHRDLAARNVLLTHGKIVKICDFGLA 188
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 44/173 (25%), Positives = 84/173 (48%), Gaps = 22/173 (12%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLR 466
F++ IG+GS G V++ + +++A+K ID L+E ++ +E + +S+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFAD-DSSKNLTWNARVRVALGTARAL 525
P + G + + ++ EY+G G+ D+L D + T + + L
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEI------LKGL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQVITGT 576
+YLH +HR+ K+AN+LL ++ + L+D G+A +T+ R GT
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G+ G+VY+A+ +A K+ S +E ++++ + ++ HP IV L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
G+ ++ E+ G + ++ D R L AL+YLH + ++
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML---EALQYLHSM---KII 132
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
HR+ K+ N+LL + + L+D G++A T R GT
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGT 173
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 417 LIGEGSLGRVYRA----EFANGKI-MAVKKIDNAA--LSLQEEDNFLEAVSNMSRLRHPN 469
L+G G G V++ E + KI +A+K I + + + QE + + A M L H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA---MGSLDHAY 70
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDS-SKNLTWNARVRVALGTARALEY 527
IV L G C G L LV + G+L D + DS N V++A G + Y
Sbjct: 71 IVRLLGICP--GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG----MYY 124
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVI 573
L E + VHRN + NILL + ++D G+A L +++
Sbjct: 125 LEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 13/160 (8%)
Query: 417 LIGEGSLGRVYRA----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G G+ G VY+ E KI KI N + F++ M+ + HP++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLH-FADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C +L V + + +G L D +H D+ L N V++A G + YL E
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG----MMYLEER 128
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571
L VHR+ + N+L+ + ++D GLA L E++
Sbjct: 129 RL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 32/170 (18%)
Query: 418 IGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQE---------EDNFLEAVSNMSR 464
+G G+ G+V+ GK+ A+K + A + +Q+ E LEAV
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVR---- 62
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TA 522
R P +VTL Y + +L L+ +YV G L L+ ++ T + VRV +
Sbjct: 63 -RCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLY----QREHFT-ESEVRVYIAEIV 115
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTER 570
AL++LH++ +++R+ K NILLD E + L+D GL+ L ER
Sbjct: 116 LALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 418 IGEGSLGRVYRAEFANGKI---MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G VY+A+ +GK A+K+I+ +S+ ++ + L+HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIALQ 64
Query: 475 GYCAEHGQR--LLVYEYVGNGNLHDM-LHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
H R L+++Y + H + H A ++K R V + L+ +H +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 532 CLPSVVHRNFKSANILLDDELNPH-----LSDCGLAAL 564
V+HR+ K ANIL+ E P ++D G A L
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 8e-07
Identities = 48/182 (26%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN---FL 456
++ S+ +++ IG+G+ G VY A + A G+ +A+K+ ++LQ++ +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQ-----MNLQQQPKKELII 64
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M ++PNIV + +V EY+ G+L D++ + +
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA 119
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-NTERQVIT 574
V +AL++LH V+HR+ KS NILL + + L+D G A +TP ++R +
Sbjct: 120 VCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 575 GT 576
GT
Sbjct: 177 GT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 31/174 (17%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA--------ALSLQEEDNFLEAVSN 461
+F ++G+G G V + A GK+ A KK++ A++L E+ LE V++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-QILEKVNS 59
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNL----HDMLHFADDSSKNLTWNARVR 516
+V+LA Y E L LV + G+L ++M + D + + + A +
Sbjct: 60 ------RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI- 111
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
G LE LH +V+R+ K NILLDD + +SD GLA P E
Sbjct: 112 -TCG----LEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHP 468
+F E IG G VYRA +G +A+KK+ L + + ++ + + +L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-HFADDSS---KNLTWNARVRVALGTARA 524
N++ E + +V E G+L M+ HF + W V++ A
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL----CSA 118
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
LE++H V+HR+ K AN+ + L D GL
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLG 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
+IG+GS G+V A A K AVK + A+ ++E+ + + N + ++HP +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYLHEV 531
+ + +L V +Y+ G L F + R R A A AL YLH +
Sbjct: 62 H-FSFQTADKLYFVLDYINGGEL-----FYHLQRERCFLEPRARFYAAEIASALGYLHSL 115
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTERQVITGT 576
++V+R+ K NILLD + + L+D GL + N GT
Sbjct: 116 ---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 14/150 (9%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
+IG+GS G+V A+ ++G AVK + + ++E N + A N + L+HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYLHEV 531
Y + ++L V +YV G L H + R R A A A+ YLH +
Sbjct: 62 H-YSFQTAEKLYFVLDYVNGGEL--FFHL---QRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGL 561
++++R+ K NILLD + + L+D GL
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 38/158 (24%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 417 LIGEGSLGRVYRA----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G+G G V A E + + +AVK + S + + FL + M HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 473 LAGYC--AEHGQRL----LVYEYVGNGNLHDMLHFA--DDSSKNLTWNARVRVALGTARA 524
L G + RL ++ ++ +G+LH L + + L VR + A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+EYL + +HR+ + N +L++ + ++D GL+
Sbjct: 126 MEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V A + +GK +A+KKI +A L + + +H NI+ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 477 C---AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA-RALEYLHEVC 532
+ + V + +LH ++H S + LT +R L R L+Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIH----SDQPLT-EEHIRYFLYQLLRGLKYIHSAN 127
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V+HR+ K +N+L++++ + D G+A
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMA 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 417 LIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH----P 468
++G G+ G+V+ G K+ A+K + AAL +Q+ + + L H P
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSP 65
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALE 526
+VTL Y + +L L+ +YV G + L+ D+ S+ VR G ALE
Sbjct: 66 FLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGEIILALE 119
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTER 570
+LH++ +V+R+ K NILLD E + L+D GL+ L+ ER
Sbjct: 120 HLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 418 IGEGSLGRVYRAEF---ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G V + + + K +AVK + N +D L + M +L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G C E +LV E G L+ L +K++T + + ++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE---T 114
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLA-ALT 565
+ VHR+ + N+LL + +SD GL+ AL
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 42/125 (33%), Positives = 57/125 (45%), Gaps = 15/125 (12%)
Query: 455 FLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR 514
F E S MS+L H ++V L G C ++V EYV G L LH ++ +L W +
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHRE-KNNVSLHW--K 103
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNP---HLSDCGLA-ALTP 566
+ VA A AL YL + L VH N NIL+ +E LSD G+ +
Sbjct: 104 LDVAKQLASALHYLEDKKL---VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160
Query: 567 NTERQ 571
ER
Sbjct: 161 REERV 165
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNI 470
++G+GS G+V A +G++ AVK + + LQ++D +E R+ HP +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDD--VECTMTEKRILSLARNHPFL 58
Query: 471 VTLAGYCAEHGQRLL-VYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYL 528
L C + RL V E+V G+L M H S+ AR R A AL +L
Sbjct: 59 TQLY-CCFQTPDRLFFVMEFVNGGDL--MFHI--QKSRRFD-EARARFYAAEITSALMFL 112
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
H+ +++R+ K N+LLD E + L+D G+
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 48/182 (26%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN---FL 456
++ S+ +++ IG+G+ G VY A + A G+ +A+++ ++LQ++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQ-----MNLQQQPKKELII 65
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M ++PNIV + +V EY+ G+L D++ + +
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA 120
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-NTERQVIT 574
V +ALE+LH V+HR+ KS NILL + + L+D G A +TP ++R +
Sbjct: 121 VCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 575 GT 576
GT
Sbjct: 178 GT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A ++GK++AVKK+D L Q+ L V M +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V E++ G L D++ + + + V L +AL LH
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QG 136
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
V+HR+ KS +ILL + LSD G A R+ + GT
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKI----DNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G+G+ G VY G+++AVK++ N + +E + E V + L+H NIV
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G C + + E+V G++ +L+ + + ++ G A YLH C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNNC 122
Query: 533 LPSVVHRNFKSANILL 548
VVHR+ K N++L
Sbjct: 123 ---VVHRDIKGNNVML 135
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 37/166 (22%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED----------NF--LEAVSNMSR 464
+GEG+ G+V +A GKI+A+KK+ +S +F L + M+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA------ 518
++H NI+ L E LV + + A D K + + ++R+
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-----------ASDLKKVV--DRKIRLTESQVKC 123
Query: 519 --LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L L LH+ +HR+ ANI ++ + ++D GLA
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA 166
|
Length = 335 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 28/169 (16%)
Query: 418 IGEGSLGRVYRAEFANG------KIMAVKKIDN-----AALSLQEEDN------FLEAVS 460
+GEG G V+ E A G K ++ N A L+E+ N FL+ +
Sbjct: 13 LGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-------HFADDSSKNLTWNA 513
MSRL+ PNI+ L C ++ EY+ NG+L+ L ++++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ +A A ++YL + + VHR+ + N L+ ++D G++
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 14/152 (9%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+IG+GS G V A + G+ +A+KKI++ + + L + + LRHP+IV +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 476 YCAEHGQR-----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+R +V+E + + +LH ++ DD LT RAL+Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELMES-DLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHT 121
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+V HR+ K NIL + + + D GLA
Sbjct: 122 A---NVFHRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 41/166 (24%), Positives = 70/166 (42%), Gaps = 20/166 (12%)
Query: 418 IGEGSLGRVYRAEFANGKI-------MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G+GS G VY A G + +A+K + N S++E FL S M ++
Sbjct: 14 LGQGSFGMVYEG-LAKGVVKGEPETRVAIKTV-NENASMRERIEFLNEASVMKEFNCHHV 71
Query: 471 VTLAGYCAEHGQR-LLVYEYVGNGNLHDML--HFADDSSKNL----TWNARVRVALGTAR 523
V L G + GQ L+V E + G+L L + + T +++A A
Sbjct: 72 VRLLGVVST-GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+ YL VHR+ + N ++ ++L + D G+ T+
Sbjct: 131 GMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 46/155 (29%), Positives = 83/155 (53%), Gaps = 25/155 (16%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQE------EDNFLEAVSNMSRLRHPNI 470
+G+G+ G V++A + +++A+KKI +A + + E FL+ + + HPNI
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD-----HPNI 69
Query: 471 VTL-AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEY 527
V L AE+ + + LV+EY+ +LH ++ N+ + R + +AL+Y
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-ETDLHAVIR------ANILEDVHKRYIMYQLLKALKY 122
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+H +V+HR+ K +NILL+ + L+D GLA
Sbjct: 123 IHS---GNVIHRDLKPSNILLNSDCRVKLADFGLA 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 6/147 (4%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
+G G+ G V + G IMAVK+I A ++ QE+ L + +M + P VT G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G + E V + +L D + + ++A+ +ALEYLH S
Sbjct: 68 ALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--S 124
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLA 562
V+HR+ K +N+L++ L D G++
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 17/150 (11%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIVT 472
+GEG+ VY+ ++A+K+I L+ E+ + VS + L+H NIVT
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L LV+EY+ D+ + DD ++ + R L Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR-- 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V+HR+ K N+L+++ L+D GLA
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 48/154 (31%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLRHP 468
+IG GS +V E +I A+K I ++ +Q E + E SN HP
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN-----HP 56
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+V L C + RL V E+V G+L M H K +AR A + AL +
Sbjct: 57 FLVGLHS-CFQTESRLFFVIEFVSGGDL--MFHM-QRQRKLPEEHARFYSA-EISLALNF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
LHE +++R+ K N+LLD E + L+D G+
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 41/155 (26%), Positives = 61/155 (39%), Gaps = 25/155 (16%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSL--QEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G GRV + + A+K + + Q+E F E + HP IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKL- 58
Query: 475 GYCA----EHGQRLLVY---EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
Y ++ +Y EY G L +L + + AR +A A EY
Sbjct: 59 -YRTFKDKKY-----IYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEY 108
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
LH +++R+ K N+LLD L D G A
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFA 140
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 24/159 (15%)
Query: 418 IGEGSLGRVYRA-EFANG-KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR------HPN 469
IGEG+ G+V++A + NG + +A+K++ + EE L + ++ LR HPN
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 470 IVTLAGYCA-----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTAR 523
+V L C + LV+E+V D+ + D + ++ + R
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L++LH VVHR+ K NIL+ L+D GLA
Sbjct: 122 GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIVT 472
+GEG+ V++ ++A+K+I L+ E+ + VS + L+H NIVT
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI-----RLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEV 531
L LV+EY+ + D+ + D+ NL V++ + R L Y H+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS----DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK- 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++HR+ K N+L++++ L+D GLA
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 11/162 (6%)
Query: 418 IGEGSLGRVYRAEFANGKI--MAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
+G GS GRV A + N +A+K+ + + + Q++ D+ ++ + HP V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G + LV E+V G L +K + A EYL +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL--- 150
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
++V+R+ K N+LLD + ++D G A + +T + GT
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DTRTYTLCGT 191
|
Length = 340 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 48/168 (28%), Positives = 73/168 (43%), Gaps = 21/168 (12%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQE-------EDNFLEAVSNM 462
+F Q ++G+G G V + A GK+ A K+++ + ++ E LE V+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-- 58
Query: 463 SRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGT 521
S+ +V LA Y E L LV + G+L H + + + A
Sbjct: 59 SQF----VVNLA-YAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFYAAEI 111
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
LE LH + V+R+ K NILLDD + +SD GLA P E
Sbjct: 112 LCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 50/163 (30%), Positives = 73/163 (44%), Gaps = 15/163 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A E +G+ +AVK +D L Q+ L V M +H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ ++ E++ G L D++ S L V +AL YLH
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHS---QG 137
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ERQVITGT 576
V+HR+ KS +ILL + LSD G A +R+ + GT
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 54/174 (31%), Positives = 78/174 (44%), Gaps = 40/174 (22%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI------DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IG G+ G VY+A + +G +A+K + D LS E L+ + HPNI
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLK---RLEAFDHPNI 64
Query: 471 VTLAGYCA-----EHGQRLLVYEYVGNGNLHDMLHFAD------DSSKNLTWNARVRVAL 519
V L CA + LV+E+V + +L L ++ K+L +R L
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDL-----MRQFL 118
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-------ALTP 566
R L++LH C +VHR+ K NIL+ L+D GLA ALTP
Sbjct: 119 ---RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP 166
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 27/198 (13%)
Query: 394 PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKID---NAALSL 449
P++ + S ++++ IG+G+ G+V++ NG AVK +D + +
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI 61
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYC----AEHGQRL-LVYEYVGNGNLHD----MLH 500
+ E N L+A+S+ HPN+V G ++G +L LV E G++ D L
Sbjct: 62 EAEYNILKALSD-----HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK 116
Query: 501 FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560
+ + + +G L++LH +HR+ K NILL E L D G
Sbjct: 117 RGERMEEPIIAYILHEALMG----LQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFG 169
Query: 561 LAALTPNT--ERQVITGT 576
++A +T R GT
Sbjct: 170 VSAQLTSTRLRRNTSVGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 9/159 (5%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
S E +G G G V+ A + +AVK + ++S++ FL + M L+H +
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKL 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L + ++ E++ G+L D L + S + L + + A + ++ +
Sbjct: 64 VKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ 120
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+ +HR+ ++ANIL+ L ++D GLA + + E
Sbjct: 121 ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 9/149 (6%)
Query: 418 IGEGSLGRVYRAEFANG-KIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+GS G+V + + +I A+K I A + S E + L + ++++ P IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ LV ++ G L H + AR A ALE LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTA-ELLCALENLHKF---N 113
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAAL 564
V++R+ K NILLD + + L D GL L
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL 142
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 48/150 (32%), Positives = 76/150 (50%), Gaps = 14/150 (9%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
+IG+GS G+V A+ +GK AVK + + ++E + A N + ++HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYLHEV 531
Y + ++L V ++V G L H + S R R A A AL YLH +
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLHSI 115
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGL 561
++V+R+ K NILLD + + L+D GL
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 19/152 (12%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A+GK A+K + + ++E + L + RHP + +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLH 529
Y + RL V EYV G L L F++D ++ + A + AL+YLH
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR--FYGAEI------VSALDYLH 112
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
+V+R+ K N++LD + + ++D GL
Sbjct: 113 S---GKIVYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 46/135 (34%), Positives = 67/135 (49%), Gaps = 3/135 (2%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
LLS+L +L DLSGN I D P + SNN L S++++ +LS L +S
Sbjct: 181 LLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELS 240
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N L + GNL+ L TLDLS NN + S SL+N+ L L N ++ +L + +
Sbjct: 241 NNKLEDLP-ESIGNLSNLETLDLS-NNQISSIS-SLGSLTNLRELDLSGNSLSNALPLIA 297
Query: 222 GLPLTTLNVANNHFS 236
L L + N +
Sbjct: 298 LLLLLLELLLNLLLT 312
|
Length = 394 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEE---DNFLEAVSNMSRLR 466
+F Q +GEG+ VY+ G+I+A+K+I A EE + +S M L+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA----EEGTPSTAIREISLMKELK 56
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFAD----------DSSKNLTWNARVR 516
H NIV L + +LV+EY+ D+ + D ++ K+ T+
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQ---- 108
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ + + HE V+HR+ K N+L++ L+D GLA
Sbjct: 109 ----LLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 17/150 (11%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIVT 472
+GEG+ V++ ++A+K+I L+ E+ + VS + L+H NIVT
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI-----RLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L LV+EY+ D+ + DD ++ + R L Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK----DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR-- 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V+HR+ K N+L+++ L+D GLA
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 12/158 (7%)
Query: 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN-MSRLRH 467
F + L+G G G V E A G I A+K + + L QE +F E + +S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 468 PNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDS-SKNLTWNARVRVALGTARAL 525
P I L Y + L LV EY G+L +L+ +D +++ + L A +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-----AQFYL--AELV 112
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563
+H V VHR+ K N+L+D + L+D G AA
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA 150
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 33/169 (19%)
Query: 412 FSQEFL-----IGEGSLGRV----YRAEFAN-GKIMAVKKIDNAALSLQEED------NF 455
F + FL +GEG G+V Y E N G+ +AVK SL+ E +
Sbjct: 1 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-------SLKPESGGNHIADL 53
Query: 456 LEAVSNMSRLRHPNIVTLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKN-LTWN 512
+ + + L H NIV G C E G L+ E++ +G+L + L +KN +
Sbjct: 54 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKNKINLK 109
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
+++ A+ + ++YL VHR+ + N+L++ E + D GL
Sbjct: 110 QQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 22/156 (14%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL-- 473
IG G+ G V A G+ +A+KKI N L + L + + LRH NI+ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD 66
Query: 474 ---AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV----ALGTARALE 526
+ +V E + +LH ++ S + LT + ++ L R L+
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET-DLHKVIK----SPQPLT-DDHIQYFLYQIL---RGLK 117
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
YLH +V+HR+ K +NIL++ + + D GLA
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 36/154 (23%), Positives = 67/154 (43%), Gaps = 5/154 (3%)
Query: 411 SFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHP 468
+F E IG G VYRA + K +A+KK+ + + + ++ + + +L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N++ E + +V E G+L M+ + + + + + A+E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
H V+HR+ K AN+ + L D GL
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLG 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNA--ALSLQEE----DNFLEAVSNMSRLRHPNIV 471
+G G+ G V + + M K+ID A L + E D + M +L +P IV
Sbjct: 3 LGSGNFGCVKKGVYK----MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ G C E +LV E G L+ L D +T + V + + ++YL
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEG- 113
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ VHR+ + N+LL ++ +SD GL+
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN---MSRLRHPNIVTL 473
+G+G G V + A GK+ A KK++ L++ + A+ ++++ IV+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKK--RLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
A Y + L LV + G+L ++ D+ + LE+LH+
Sbjct: 59 A-YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-- 115
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+++R+ K N+LLD++ N +SD GLA
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIV 471
+IG G G VY A+ GK+ A+K +D + +++ + N +S +S P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYL 528
+ + + + + G+LH H + S K + + A + LG LE++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRFYA-TEIILG----LEHM 113
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
H VV+R+ K ANILLD+ + +SD GLA
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 49/170 (28%), Positives = 71/170 (41%), Gaps = 22/170 (12%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLRHP 468
+IG GS +V +I A+K + ++ +Q E + E SN HP
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-----HP 56
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+V L + V EYV G+L M H K +AR A + AL YL
Sbjct: 57 FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHM-QRQRKLPEEHARFYSA-EISLALNYL 112
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVITGT 576
HE +++R+ K N+LLD E + L+D G+ L P GT
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 21/60 (35%), Positives = 33/60 (55%)
Query: 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189
NL SL+L++N + + + +L L++S N+LT + F L L +LDLS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE---DNFLEAVSNMSRLRH-PNIVT 472
IGEG+ G+VY+A + GK++A+KK L + EE L +S + L IV
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK---TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 473 LAGYCAEH-------GQRLLVYEYVGNGNLHDMLHFADD----SSKNLTWNARVRVALGT 521
L EH LV+EY+ + D+ F D + L
Sbjct: 66 L--LDVEHVEEKNGKPSLYLVFEYLDS----DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNP-HLSDCGL 561
+ + + H+ V+HR+ K N+L+D + ++D GL
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 17/151 (11%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A GK A+K + + ++E + L + RHP + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHE 530
H + V EY G L L F++D ++ + A + AL YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--FYGAEI------VSALGYLHS 113
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
VV+R+ K N++LD + + ++D GL
Sbjct: 114 C---DVVYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 47/181 (25%), Positives = 71/181 (39%), Gaps = 53/181 (29%)
Query: 406 QTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNF-----LEAV 459
N IG G+ G+VY+ F G +MAVK++ + +E+N L+ V
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVV 67
Query: 460 SNMSRLRH--PNIVTLAGY----------------CAEHGQRLLVYEYVGNGNLHDMLHF 501
S H P IV GY C + +LL + + D+L
Sbjct: 68 L-KS---HDCPYIVKCYGYFITDSDVFICMELMSTCLD---KLL--KRIQGPIPEDILG- 117
Query: 502 ADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
++ + +AL YL E V+HR+ K +NILLD N L D G+
Sbjct: 118 --------------KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGI 161
Query: 562 A 562
+
Sbjct: 162 S 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 17/151 (11%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A G+ A+K + + ++E + + + RHP + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHE 530
H + V EY G L L F ++ ++ + A + ALEYLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR--FYGAEI------VSALEYLHS 113
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
VV+R+ K N++LD + + ++D GL
Sbjct: 114 ---RDVVYRDIKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 50/177 (28%), Positives = 76/177 (42%), Gaps = 37/177 (20%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA--------ALSLQEEDNFLEAVSN 461
+F ++G+G G V + A GK+ A KK++ A++L E+ LE V+
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-RILEKVN- 58
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
SR +V+LA Y E L LV + G+L ++ +
Sbjct: 59 -SRF----VVSLA-YAYETKDALCLVLTIMNGGDLKFHIYNMGNP------------GFD 100
Query: 521 TARALEYLHEVCL-------PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
RA+ Y E+C +V+R+ K NILLDD + +SD GLA P E
Sbjct: 101 EQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 36/122 (29%), Positives = 51/122 (41%), Gaps = 16/122 (13%)
Query: 463 SRLRHPNIVTL--AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
+RL HPNIV L +G G V+EYV L ++L A D + L R+ L
Sbjct: 33 ARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL--AADGA--LPAGETGRLMLQ 87
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTE---RQVIT 574
AL H +VHR+ K NI++ + + D G+ L P +T
Sbjct: 88 VLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 575 GT 576
T
Sbjct: 145 RT 146
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 33/153 (21%), Positives = 63/153 (41%), Gaps = 26/153 (16%)
Query: 417 LIGEGSLGR----VYRAEFANGKIMAVKKIDNAALSLQEEDNFLE---AVSNMSRLRHPN 469
LIG+ + + + ++AVKKI+ L +++ + +L+HPN
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKIN---LDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVAL---GTARA 524
I+ + +V + G+ D+L HF + + +A A
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA-------IAFILKDVLNA 113
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557
L+Y+H +HR+ K+++ILL + LS
Sbjct: 114 LDYIHSK---GFIHRSVKASHILLSGDGKVVLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 24/171 (14%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNI 470
++G+GS G+V AE ++ A+K + + LQ++D ++ R+ +HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDD--VDCTMTEKRILALAAKHPFL 58
Query: 471 VTLAGYCAEHGQRLL-VYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEY 527
L C + RL V EYV G+L + + D ++ + A V +AL +
Sbjct: 59 TALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVITGT 576
LH V++R+ K NILLD E + L+D G+ + GT
Sbjct: 112 LHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 20/155 (12%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIV 471
+IG G G VY A+ GK+ A+K +D + +++ + N +S +S P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 472 TLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEY 527
++ Y +L + + + G+LH H + S + + A + LG LE+
Sbjct: 61 CMS-YAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEAEMRFYA-AEIILG----LEH 112
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+H VV+R+ K ANILLD+ + +SD GLA
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 34/141 (24%), Positives = 56/141 (39%), Gaps = 20/141 (14%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G+ G V+ A+ K++ +K+I ++ E + L HPNI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY-------L 528
E ++V EY G L + + R L L + L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYI------------QKRCNSLLDEDTILHFFVQILLAL 114
Query: 529 HEVCLPSVVHRNFKSANILLD 549
H V ++HR+ K+ NILLD
Sbjct: 115 HHVHTKLILHRDLKTQNILLD 135
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 108 SLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
+L+ DLS N + PNL L+L+ NN + P + + + SL L++S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 17/167 (10%)
Query: 412 FSQEFLIGEGSLGRVYRA----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
F + ++G G+ G VY+ E KI K A S + L+ M+ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARA 524
P++ L G C +L + + + G L D + D S L W ++ A+
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571
+ YL E L VHR+ + N+L+ + ++D GLA L E++
Sbjct: 122 MNYLEERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 29/164 (17%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-------SLQEEDNFLEAVSNMSRLRHPN 469
I G+ G+VY N K+ AVK + A + +Q E + L A+S + P
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALS-----KSPF 65
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARAL 525
IV L LV EY+ G++ +LH F ++ + V+ A AL
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA--------VKYISEVALAL 117
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+YLH ++HR+ K N+L+ +E + L+D GL+ +T N E
Sbjct: 118 DYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 455 FLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR 514
F E S MS++ H ++ + G C + ++V E+V +G L D+ + + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--K 119
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548
+ VA A AL YL + ++VH N + NILL
Sbjct: 120 ITVAQQLASALSYLED---KNLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 2e-04
Identities = 22/60 (36%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHF 235
L +LDLS N + +F L N+ L L N +T S FSGLP L +L+++ N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 27/158 (17%)
Query: 417 LIGEGSLGRVY--RAEFA--NGKIMAVKKIDNAALSLQE------EDNFLEAVSNMSRLR 466
++G+GS G+V+ R G++ A+K + A L +++ E + L V+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------ 56
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR-VRVALGT-ARA 524
HP IV L G+ L+ +++ G+L L SK + + V+ L A A
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALA 110
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L++LH + +++R+ K NILLD+E + L+D GL+
Sbjct: 111 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 16/151 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A G+ A+K + + ++E + L + RHP + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHE 530
H + V EY G L L F++D ++ + A + AL+YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--FYGAEI------VSALDYLHS 113
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
+VV+R+ K N++LD + + ++D GL
Sbjct: 114 E--KNVVYRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 42/182 (23%), Positives = 72/182 (39%), Gaps = 30/182 (16%)
Query: 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFANG------KIMAVKKIDNAALSLQEEDN-- 454
++LQ T +G G G V+ A+ ++ VK AL +++N
Sbjct: 5 SNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVK-----ALQKTKDENLQ 52
Query: 455 --FLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF---ADDSSK-- 507
F + +L H N+V L G C E ++ EY G+L L D+ K
Sbjct: 53 SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP 112
Query: 508 NLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567
L+ +V + A +++L VHR+ + N L+ + +S L+ N
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169
Query: 568 TE 569
+E
Sbjct: 170 SE 171
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 28/157 (17%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNI 470
++G+GS G+V+ AE + A+K + + + D+ +E R+ HP +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFL 58
Query: 471 VTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFAD----DSSKNLTWNARVRVALGTARA 524
L YC + L V EY+ G+L M H D + + A + L
Sbjct: 59 THL--YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGL----- 109
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
++LH +V+R+ K NILLD + + ++D G+
Sbjct: 110 -QFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 38/154 (24%), Positives = 67/154 (43%), Gaps = 8/154 (5%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANGK-IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
N F ++GEG+ G V + K I+A+KK ++ + + ++ L + + L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
NIV L G+ LV+EYV +ML ++ + +A+ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEK----NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
H+ +VHR+ K N+L+ L D G A
Sbjct: 117 HK---NDIVHRDIKPENLLISHNDVLKLCDFGFA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 20/153 (13%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-SLQEEDNF-LEAVSNMSRLRHPNIVTLA 474
I +G+ G VY A+ + G A+K + + + + + N E M + P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLH 529
Y + L LV EY+ G+ ++ +D +K V LG +E LH
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYI----AEVVLG----VEDLH 114
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ ++HR+ K N+L+D + L+D GL+
Sbjct: 115 Q---RGIIHRDIKPENLLIDQTGHLKLTDFGLS 144
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 27/157 (17%)
Query: 417 LIGEGSLGRVY-------RAEFANGKIMAVKKIDNAALSL--QEEDNFLEAVSNMSRLRH 467
LI G+ G VY R FA +KKI+ L L Q + F+E ++ +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFA------MKKINKQNLILRNQIQQVFVER-DILTFAEN 60
Query: 468 PNIVTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
P +V++ +C+ +R L V EYV G+ +L ++ AR+ A T AL
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM---ARMYFA-ETVLAL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
EYLH +VHR+ K N+L+ + L+D GL+
Sbjct: 115 EYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 418 IGEGSLGRVYRA---EFANGKI---MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G+GS G VY + G+ +AVK ++ +A SL+E FL S M ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 72
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARAL 525
L G ++ L+V E + +G+L L ++N T +++A A +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
YL+ VHR+ + N ++ + + D G+
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM 165
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 10/91 (10%)
Query: 418 IGEGSLGRVYRAEFANG-------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPN 469
+G G+ GRV A A+G +AVK + + A S E+ + + MS L H N
Sbjct: 45 LGSGAFGRVVEAT-AHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLN 102
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH 500
IV L G C + G ++ EY G+L D LH
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 9e-04
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 25/163 (15%)
Query: 410 NSFSQEFLIGEGSLGRVYRAE-FANGKIMAVK--------KIDNAALSLQEEDNFLEAVS 460
F +IG+G+ G V + GKI A+K K D A E D E+ S
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
P +V+L Y + Q L L+ E++ G+L ML D S+++T R +A
Sbjct: 61 -------PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---RFYMA- 108
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A+E +H++ +HR+ K NIL+D + LSD GL+
Sbjct: 109 ECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 22/166 (13%)
Query: 417 LIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH----P 468
++G G+ G+V+ +G K+ A+K + A + +Q+ + L H P
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSP 65
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALE 526
+VTL Y + +L L+ +Y+ G L L + + V++ G ALE
Sbjct: 66 FLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EVQIYSGEIVLALE 119
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTER 570
+LH++ +++R+ K NILLD + L+D GL+ ER
Sbjct: 120 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER 162
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 17/155 (10%)
Query: 417 LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G G+ G VY+ + N KI K+ S + L+ M+ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLH 529
L G C +L V + + G L D + D S L W ++ A+ + YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
EV L VHR+ + N+L+ + ++D GLA L
Sbjct: 127 EVRL---VHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 33/145 (22%), Positives = 57/145 (39%), Gaps = 9/145 (6%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF---ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
S E ++G G G + R + ++ A S ++ FL + + H
Sbjct: 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
NIV L G ++V EY+ NG L L L + + G A ++Y
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKY 122
Query: 528 LHEVCLPSVVHRNFKSANILLDDEL 552
L E+ VH+ + +L++ +L
Sbjct: 123 LSEM---GYVHKGLAAHKVLVNSDL 144
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 50/171 (29%), Positives = 74/171 (43%), Gaps = 24/171 (14%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLRHP 468
+IG GS +V N +I A+K + + +Q E + E S+ +P
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-----NP 56
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+V L C + RL LV EYV G+L M H K +AR A AL +
Sbjct: 57 FLVGLHS-CFQTTSRLFLVIEYVNGGDL--MFHM-QRQRKLPEEHARFYAA-EICIALNF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVITGT 576
LHE +++R+ K N+LLD + + L+D G+ L P GT
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 37/157 (23%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 418 IGEGSLGRVYRAEFANGKI-------MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G+GS G VY A G + +A+K ++ AA S++E FL S M ++
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHV 71
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARA 524
V L G ++ L++ E + G+L L +N + +++A A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
+ YL+ VHR+ + N ++ ++ + D G+
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 165
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 19/157 (12%)
Query: 415 EFL--IGEGSLGRVYRA-EFANGKIMAVKKI----DNAALS--LQEEDNFLEAVSNMSRL 465
E L +G+G+ G VY+ G MA+K+I D + + + E D +AVS
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS----- 58
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
P IV G G + EY+ G+L D L+ +++ + + R+ + L
Sbjct: 59 --PYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++L E +++HR+ K N+L++ L D G++
Sbjct: 116 KFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 11/156 (7%)
Query: 409 TNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
TN + +G G+ G V A + G+ +A+KKI + + + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 468 PNIVTLAG-YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
NI++L+ + + V E +G +LH +L +S+ L R L+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGT-DLHRLL-----TSRPLEKQFIQYFLYQILRGLK 122
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
Y+H VVHR+ K +NIL+++ + + D GLA
Sbjct: 123 YVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V A + +A+KKI NA + + L + + L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 477 CAEHGQR-----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHE 530
+ +VYE + + +LH ++ SS+ L+ + + L R L+Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM-DTDLHQIIR----SSQTLS-DDHCQYFLYQLLRGLKYIHS 126
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
+V+HR+ K +N+LL+ + + D GLA T + + +T
Sbjct: 127 A---NVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMT 166
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 577 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.98 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.95 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.95 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.95 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.94 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.94 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.94 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.93 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.93 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.93 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.93 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.93 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.93 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.93 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.93 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.93 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.93 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.93 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.92 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.92 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.92 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.92 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.92 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.92 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.92 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.92 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.92 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.92 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.92 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.92 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.92 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.92 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.92 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.92 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.92 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.92 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.92 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.92 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.91 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.91 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.91 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.91 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.91 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.91 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.91 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.91 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.91 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.91 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.91 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.91 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.91 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.9 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.9 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.9 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.9 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.9 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.9 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.9 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.9 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.9 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.9 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.9 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.9 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.9 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.9 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.9 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.9 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.9 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.9 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.9 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.89 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.89 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.89 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.89 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.89 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.89 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.89 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.89 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.89 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.89 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.89 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.89 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.89 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.89 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.89 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.89 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.89 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.89 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.89 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.89 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.89 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.89 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.89 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.89 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.89 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.89 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.89 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.89 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.89 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.89 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.88 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.88 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.88 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.88 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.88 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.88 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.88 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.88 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.88 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.88 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.88 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.88 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.88 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.88 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.88 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.88 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.88 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.88 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.88 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.88 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.88 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.88 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.88 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.87 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.87 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.87 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.87 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.87 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.87 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.87 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.87 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.87 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.87 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.87 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.87 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.87 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.87 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.87 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.87 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.87 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.87 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.87 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.87 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.87 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.87 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.86 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.86 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.86 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.86 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.86 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.86 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.86 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.86 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.86 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.86 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.86 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.86 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.86 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.86 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.86 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.85 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.85 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.85 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.85 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.85 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.85 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.85 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.85 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.85 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.84 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.84 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.84 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.84 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.84 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.84 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.84 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.84 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.84 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.83 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.83 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.83 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.83 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.83 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.83 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.82 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.82 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.82 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.81 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.81 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.81 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.8 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.75 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.71 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.68 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.68 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.64 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.64 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.61 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.6 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.59 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.58 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.52 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.52 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.5 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.47 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.46 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.38 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.37 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.32 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.32 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.3 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.23 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.21 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.2 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.16 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.09 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.09 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.08 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.05 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.05 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.0 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.99 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.99 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.86 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.71 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.7 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.66 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.51 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.49 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.42 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.36 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.33 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.22 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.21 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.21 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.18 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.14 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.13 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=443.26 Aligned_cols=417 Identities=28% Similarity=0.442 Sum_probs=288.5
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
..++.|+|++|+++|.+|..+..++.|+.|+|++|++++.+|..+. ++|+.|+|++|++.+.+|..++ +++|+.|+|
T Consensus 404 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~l 482 (968)
T PLN00113 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDL 482 (968)
T ss_pred CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEEC
Confidence 5788999999999999999999999999999999999988886543 8899999999999988887664 588999999
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccc
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGW 238 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~ 238 (577)
++|++++.+|..|.++++|+.|+|++|+++|.+|..+..+++|++|+|++|.+++.++ .+..++ |+.|+|++|+++|.
T Consensus 483 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 562 (968)
T PLN00113 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGE 562 (968)
T ss_pred cCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccccc
Confidence 9999999999888889999999999999998899888889999999999999988765 455555 88999999999998
Q ss_pred cCcccc---cccceeecCCcCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCceeehhHHHH
Q 008121 239 IPRELI---SIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQ---GSHSPSGSQSSSSDKELPAGAIVGIVLGA 312 (577)
Q Consensus 239 ~p~~l~---~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~s~~s~s~~~~~~~~iv~iv~~~ 312 (577)
+|..+. ++..+++++|++.+..+...............+...... .+..++. ...+......++++++++
T Consensus 563 ~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~----~~~~~~~~~~~~~~~~~~ 638 (968)
T PLN00113 563 IPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK----RVRKTPSWWFYITCTLGA 638 (968)
T ss_pred CChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCc----cccccceeeeehhHHHHH
Confidence 887655 456778888887643221111000000000000000000 0000110 001111112233333333
Q ss_pred HHHHHHHHHHHHHHHhhcccccCCCCCCCCCCCcccCCCCcchhhccccccccccCCCCCChhhhhhhhhcccCCccccc
Q 008121 313 VFLVALALLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIK 392 (577)
Q Consensus 313 ~~lv~~~~~~~~~~~~rrr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (577)
++++++++++++++++|++.+.... .... .. + .. .....
T Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---------~~-~----------~~-----------~~~~~------- 677 (968)
T PLN00113 639 FLVLALVAFGFVFIRGRNNLELKRV---ENED---------GT-W----------EL-----------QFFDS------- 677 (968)
T ss_pred HHHHHHHHHHHHHHHhhhccccccc---cccc---------cc-c----------cc-----------ccccc-------
Confidence 3333333333332222221111000 0000 00 0 00 00000
Q ss_pred CCCcceeecHHHHHHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCcee
Q 008121 393 SPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (577)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv 471 (577)
.....++++++ ...|...+.||+|+||.||+|.. .+++.||||+++.... ...+|++.+++++|||||
T Consensus 678 --~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv 746 (968)
T PLN00113 678 --KVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIV 746 (968)
T ss_pred --ccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcc
Confidence 00011233332 23567788999999999999987 5789999999864321 113458889999999999
Q ss_pred eEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
+++|+|.+.+..|+||||+++|+|.++++ .++|.++.+|+.|+++||+|||+.+.++|+||||||+||+++.+
T Consensus 747 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~ 819 (968)
T PLN00113 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819 (968)
T ss_pred eEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC
Confidence 99999999999999999999999999995 27999999999999999999997766799999999999999999
Q ss_pred CCeEEeccccCcc
Q 008121 552 LNPHLSDCGLAAL 564 (577)
Q Consensus 552 ~~~kl~DFGla~~ 564 (577)
+.+++. ||.+..
T Consensus 820 ~~~~~~-~~~~~~ 831 (968)
T PLN00113 820 DEPHLR-LSLPGL 831 (968)
T ss_pred CceEEE-eccccc
Confidence 988876 666543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.23 Aligned_cols=168 Identities=49% Similarity=0.875 Sum_probs=153.1
Q ss_pred cceeecHHHHHHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEee
Q 008121 396 TATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475 (577)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~ 475 (577)
....|++.++..+|++|...+.||+|+||.||+|.+.+|..||||++....... ..+|..|++++++++|||+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 456799999999999999999999999999999999999999999886543211 455999999999999999999999
Q ss_pred EEEeCC-eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 008121 476 YCAEHG-QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (577)
Q Consensus 476 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 554 (577)
||.+.+ +.+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+.+.|+||||||||+|||||+++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 999998 599999999999999999843322 89999999999999999999999998899999999999999999999
Q ss_pred EEeccccCcccCC
Q 008121 555 HLSDCGLAALTPN 567 (577)
Q Consensus 555 kl~DFGla~~~~~ 567 (577)
||+|||+|+..+.
T Consensus 217 KlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 217 KLSDFGLAKLGPE 229 (361)
T ss_pred EccCccCcccCCc
Confidence 9999999988765
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=279.54 Aligned_cols=161 Identities=27% Similarity=0.439 Sum_probs=144.9
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.+|...+.||+|+||+||+|+++ ++..||||.+.+........+-+..|+.+++.++|||||++++++..++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46777788999999999999875 58999999998776666677788999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC------CCeEEeccccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE------LNPHLSDCGLA 562 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~------~~~kl~DFGla 562 (577)
||.+|||.++++ ..+.+++.....++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999997 455899999999999999999999999 99999999999999764 46899999999
Q ss_pred cccCCCcc-ccccCCC
Q 008121 563 ALTPNTER-QVITGTS 577 (577)
Q Consensus 563 ~~~~~~~~-~~~~Gt~ 577 (577)
+.+.+... .+.||+|
T Consensus 163 R~L~~~~~a~tlcGSp 178 (429)
T KOG0595|consen 163 RFLQPGSMAETLCGSP 178 (429)
T ss_pred hhCCchhHHHHhhCCc
Confidence 98876554 6788986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=267.39 Aligned_cols=162 Identities=27% Similarity=0.409 Sum_probs=139.7
Q ss_pred hcCCCccceeccCccceEEEE-EEcCCcEEEEEEccccccchH-----HHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQ-----EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
.+.|...+.||+|+||.|-+| +..+|+.||||++++...... ......+|+++|++++|||||+++++|...++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 345677889999999999999 456799999999976543321 12335699999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCeEEecc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDC 559 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl~DF 559 (577)
.|+|||||+||+|.+.+- ..+.+.+.....+++|++.|+.|||++ +|+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999986 456677788889999999999999999 99999999999999755 78999999
Q ss_pred ccCcccCCC-ccccccCCC
Q 008121 560 GLAALTPNT-ERQVITGTS 577 (577)
Q Consensus 560 Gla~~~~~~-~~~~~~Gt~ 577 (577)
|+||...+. -..+.||||
T Consensus 324 GlAK~~g~~sfm~TlCGTp 342 (475)
T KOG0615|consen 324 GLAKVSGEGSFMKTLCGTP 342 (475)
T ss_pred chhhccccceehhhhcCCc
Confidence 999987543 347899997
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=273.55 Aligned_cols=161 Identities=25% Similarity=0.487 Sum_probs=146.7
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
..|...+.||+|+|+.||.++. ..|+.||+|++.+... +....+...+||++.+.++|||||+++++|.+.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999987 8899999999976432 3345677889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+|++|+|.++++ .++++++.++..+++||+.||.|||+. +|||||||-.|++|++++++||+|||||..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999996 678999999999999999999999999 999999999999999999999999999998864
Q ss_pred --CccccccCCC
Q 008121 568 --TERQVITGTS 577 (577)
Q Consensus 568 --~~~~~~~Gt~ 577 (577)
+...+.||||
T Consensus 171 ~~Erk~TlCGTP 182 (592)
T KOG0575|consen 171 DGERKKTLCGTP 182 (592)
T ss_pred cccccceecCCC
Confidence 3446899998
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=258.48 Aligned_cols=158 Identities=26% Similarity=0.427 Sum_probs=141.3
Q ss_pred CccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-eEEEEEEec
Q 008121 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-QRLLVYEYV 490 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~ 490 (577)
+....||+|..|+||++.++ +++.+|+|.+... ......+++.+|++++.+++||+||++||.|...+ +..++||||
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 33567999999999999875 5889999999543 34556778999999999999999999999999988 599999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCcc
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 570 (577)
++|+|.++++ ..+.+++...-+|+.+|++||.|||+.. +||||||||+|||++..|++||||||.++.+.++..
T Consensus 161 DgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 161 DGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred CCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhhhc
Confidence 9999999996 3477999999999999999999999732 899999999999999999999999999999988888
Q ss_pred ccccCCC
Q 008121 571 QVITGTS 577 (577)
Q Consensus 571 ~~~~Gt~ 577 (577)
.+++||.
T Consensus 235 ~tfvGT~ 241 (364)
T KOG0581|consen 235 NTFVGTS 241 (364)
T ss_pred ccccccc
Confidence 8999984
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=268.98 Aligned_cols=158 Identities=35% Similarity=0.578 Sum_probs=138.8
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-eEEEEEEecCCC
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-QRLLVYEYVGNG 493 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~g 493 (577)
.+.+|+|+||+||+|.+.....||||++.....+....++|.+|+.+|++++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4459999999999999986666999999876555555779999999999999999999999999887 799999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCCeeeCCCC-CeEEeccccCcccCCC--c
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS-VVHRNFKSANILLDDEL-NPHLSDCGLAALTPNT--E 569 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~-ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~--~ 569 (577)
+|.++++.. ....+++..+++|+.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++..... .
T Consensus 126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 999999743 467899999999999999999999999 6 99999999999999997 9999999999977653 2
Q ss_pred cccccCCC
Q 008121 570 RQVITGTS 577 (577)
Q Consensus 570 ~~~~~Gt~ 577 (577)
....+||+
T Consensus 201 ~~~~~GT~ 208 (362)
T KOG0192|consen 201 MTSVAGTY 208 (362)
T ss_pred ccCCCCCc
Confidence 23356773
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=254.88 Aligned_cols=162 Identities=27% Similarity=0.397 Sum_probs=143.6
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch-HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
-++|+..++||+|+||+||+++.. +++.+|+|.+++..... .+.+....|..++.+++||+||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 356888999999999999999664 58899999997664333 3566778899999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+||+.||+|..+|. +.+.+++..+.-++.+|+.||.|||+. +||||||||+|||||++|+++|+||||++...
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999996 456789998889999999999999999 99999999999999999999999999999654
Q ss_pred C--CccccccCCC
Q 008121 567 N--TERQVITGTS 577 (577)
Q Consensus 567 ~--~~~~~~~Gt~ 577 (577)
. ..++++|||+
T Consensus 177 ~~~~~t~tfcGT~ 189 (357)
T KOG0598|consen 177 KDGDATRTFCGTP 189 (357)
T ss_pred cCCCccccccCCc
Confidence 3 3567889996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=266.91 Aligned_cols=154 Identities=29% Similarity=0.478 Sum_probs=139.3
Q ss_pred ccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 414 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
..+.||+|.||+||.|.+.....||+|.++... ...++|.+|+.+|.+++|+|||+++|+|..++..|||||||+.|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 356799999999999999988899999997653 34567999999999999999999999999988999999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCccccc
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVI 573 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 573 (577)
+|.++|+. ..+..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+||||||...+++....
T Consensus 287 sLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 287 SLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred cHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 99999984 3567788999999999999999999999 999999999999999999999999999997777766655
Q ss_pred cC
Q 008121 574 TG 575 (577)
Q Consensus 574 ~G 575 (577)
.|
T Consensus 362 ~~ 363 (468)
T KOG0197|consen 362 EG 363 (468)
T ss_pred CC
Confidence 54
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=253.29 Aligned_cols=166 Identities=27% Similarity=0.422 Sum_probs=147.9
Q ss_pred CCCccceeccCccceEEEE-EEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEee-EEEeCCe-EEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG-YCAEHGQ-RLLVY 487 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~lv~ 487 (577)
+|.+.+.||+|+||+||++ ...+|+.||.|.++-...+.+..++...|+.+|+.++|||||++++ -+.++.+ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 4666788999999999999 5578999999999866667778889999999999999999999998 4555555 78999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||..|||.++++..+...+.+++..+++++.|+++||.++|+.. |+ |+||||||.||+|+.+|.+||+||||++++
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999988888889999999999999999999999942 35 999999999999999999999999999998
Q ss_pred CCCcc--ccccCCC
Q 008121 566 PNTER--QVITGTS 577 (577)
Q Consensus 566 ~~~~~--~~~~Gt~ 577 (577)
..... ++..|||
T Consensus 179 ~s~~tfA~S~VGTP 192 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTP 192 (375)
T ss_pred cchhHHHHhhcCCC
Confidence 77665 6677987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=260.77 Aligned_cols=156 Identities=30% Similarity=0.456 Sum_probs=137.3
Q ss_pred hcCCCccceeccCccceEEEEE-EcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 485 (577)
.+.|+..+.||+|.||.||+|+ ..+|+.||+|+++.............+||.+|++++||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4567778899999999999995 57799999999976654455566678999999999999999999998876 68999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|||+. ||.-++. ...-.+++.++..+++|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999976 8888874 3456799999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCccc
Q 008121 566 PNTERQ 571 (577)
Q Consensus 566 ~~~~~~ 571 (577)
......
T Consensus 269 ~~~~~~ 274 (560)
T KOG0600|consen 269 TPSGSA 274 (560)
T ss_pred cCCCCc
Confidence 766654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=244.53 Aligned_cols=149 Identities=23% Similarity=0.354 Sum_probs=131.2
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
.|+..-++|+|+||.||+|+.+ +|+.||||++.....+....+--++||++++.++|+|+|.+++.|......++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4666778999999999999875 499999999977655555566678999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+.. + |++.+.....++.....+++.|+++|+.|+|++ +||||||||+|||+..++.+||||||+|+.+.
T Consensus 83 ~dhT-v---L~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 83 CDHT-V---LHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred cchH-H---HHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 9863 3 333334567789999999999999999999999 99999999999999999999999999999876
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=251.30 Aligned_cols=161 Identities=27% Similarity=0.420 Sum_probs=145.1
Q ss_pred cCCCccceeccCccceEEEEE-EcCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
-+|++.+.||+|.||+|-++. +..|+.||||.+++... +.++.-.+++||++|+.++||||+.+|++|...+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 356777889999999999994 46799999999976543 3445667889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||..+|+|+|++. ..+.|++.++.++++||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++.++..
T Consensus 133 EYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999996 567899999999999999999999999 999999999999999999999999999999877
Q ss_pred Ccc-ccccCCC
Q 008121 568 TER-QVITGTS 577 (577)
Q Consensus 568 ~~~-~~~~Gt~ 577 (577)
.+. +++||.|
T Consensus 206 ~kfLqTFCGSP 216 (668)
T KOG0611|consen 206 KKFLQTFCGSP 216 (668)
T ss_pred ccHHHHhcCCc
Confidence 665 7888875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=237.84 Aligned_cols=160 Identities=27% Similarity=0.411 Sum_probs=144.1
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||.|+||.|.+++.+ +|..+|+|++++... .....+...+|..+++.+.||+++++++.|.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777889999999999999764 588999999975432 2334566778999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||++||.|..+++ ..+++++..+.-++.||+.||+|||+. .|++||+||+|||||.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999997 456799999999999999999999999 999999999999999999999999999999876
Q ss_pred CccccccCCC
Q 008121 568 TERQVITGTS 577 (577)
Q Consensus 568 ~~~~~~~Gt~ 577 (577)
. +.+.||||
T Consensus 197 r-T~TlCGTP 205 (355)
T KOG0616|consen 197 R-TWTLCGTP 205 (355)
T ss_pred c-EEEecCCc
Confidence 6 88999997
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=236.19 Aligned_cols=154 Identities=27% Similarity=0.414 Sum_probs=137.3
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.+|...+.+|+|.||.||+|+. .+|+.||||+++.......-.....+||..++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999965 679999999998765444445567899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
||+. ||+..++ +....++..+...++.++.+|++|||++ .|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 9999996 4567899999999999999999999999 8999999999999999999999999999987654
Q ss_pred cc
Q 008121 569 ER 570 (577)
Q Consensus 569 ~~ 570 (577)
..
T Consensus 155 ~~ 156 (318)
T KOG0659|consen 155 NR 156 (318)
T ss_pred Cc
Confidence 43
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=253.22 Aligned_cols=163 Identities=27% Similarity=0.450 Sum_probs=141.8
Q ss_pred HhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.+.+.....++||+|.||+|.+|+...+..||||+++... ......+|.+|+++|.+++|||||+++|.|..++..++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 4445667788999999999999999988999999998764 344568899999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+|||++|||.+++...+ .....-...++|+.||+.||+||.+. ++||||+.++|||+|.++++||+|||+++-+.
T Consensus 614 ~EYmEnGDLnqFl~ahe--apt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHE--LPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhcc--CcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999997432 22245566788999999999999998 99999999999999999999999999999776
Q ss_pred CCccccccC
Q 008121 567 NTERQVITG 575 (577)
Q Consensus 567 ~~~~~~~~G 575 (577)
..+.+...|
T Consensus 689 sg~yy~vqg 697 (807)
T KOG1094|consen 689 SGDYYRVQG 697 (807)
T ss_pred cCCceeeec
Confidence 666655544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=236.21 Aligned_cols=163 Identities=29% Similarity=0.415 Sum_probs=146.8
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
-++|.+++.||+|.||.||.|+. +++-.||+|++.+.+. ..+.+.++.+|+++-+.++||||+++|+||.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 45788899999999999999966 4578899999865443 233467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+||.++|+++..|+. .....+++.....++.|+|.||.|+|.. +||||||||+|+|++..+..||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999973 3456788888999999999999999999 99999999999999999999999999999999
Q ss_pred CCccccccCC
Q 008121 567 NTERQVITGT 576 (577)
Q Consensus 567 ~~~~~~~~Gt 576 (577)
..++.++|||
T Consensus 176 ~~kR~tlcgt 185 (281)
T KOG0580|consen 176 SNKRKTLCGT 185 (281)
T ss_pred CCCceeeecc
Confidence 9999999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=258.47 Aligned_cols=160 Identities=29% Similarity=0.489 Sum_probs=138.9
Q ss_pred CCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
+....+.||+|+||+||+|+.. +...||||.+++.. +.+...+|++|+++++.++|||||+|+|.|.+++.+|
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 3344567999999999999753 34679999998764 4557889999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccC------C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 008121 485 LVYEYVGNGNLHDMLHFADD------S----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 554 (577)
+|+|||..|||.++|+.... . ..+|+..+.+.||.|||.||+||-++ .+|||||.++|+|+.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 99999999999999975321 1 23488999999999999999999999 89999999999999999999
Q ss_pred EEeccccCcccCCCcccccc
Q 008121 555 HLSDCGLAALTPNTERQVIT 574 (577)
Q Consensus 555 kl~DFGla~~~~~~~~~~~~ 574 (577)
||+||||+|.....+.+.+-
T Consensus 643 KIsDfGLsRdiYssDYYk~~ 662 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVR 662 (774)
T ss_pred Eecccccchhhhhhhhhccc
Confidence 99999999987777665544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=249.36 Aligned_cols=163 Identities=31% Similarity=0.470 Sum_probs=142.3
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc---hHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCe
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~ 482 (577)
....|...+.||+|+||+|+.|.. .+++.||+|.+...... ....+...+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456788899999999999999965 56899999977654221 123445668999999999 9999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEecccc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGL 561 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGl 561 (577)
.|+||||+.+|+|.+++. ..+++.+.++.++++|++.|++|+|+. +|+||||||+|||+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999997 357788899999999999999999999 99999999999999999 9999999999
Q ss_pred CcccC--CCccccccCCC
Q 008121 562 AALTP--NTERQVITGTS 577 (577)
Q Consensus 562 a~~~~--~~~~~~~~Gt~ 577 (577)
+.... ....++.||||
T Consensus 168 s~~~~~~~~~l~t~cGsp 185 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSP 185 (370)
T ss_pred ccccCCCCCcccCCCCCc
Confidence 99883 44557889986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=246.22 Aligned_cols=154 Identities=29% Similarity=0.404 Sum_probs=135.5
Q ss_pred HhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccch-HHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeE
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 483 (577)
...++|..++.||+|+|++||+|+. +.++.||||++.+..... ...+...+|-++|.+| .||.|++|+..|+++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3446788889999999999999954 568999999987653322 2345566788889999 899999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
|+|+||+++|+|.++|+ .-+.+++.....++.+|+.||+|||+. +||||||||+|||||.+|++||+|||-|+
T Consensus 150 YFvLe~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999997 446789999999999999999999999 99999999999999999999999999999
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
.+.+
T Consensus 223 ~l~~ 226 (604)
T KOG0592|consen 223 ILSP 226 (604)
T ss_pred cCCh
Confidence 8754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=246.62 Aligned_cols=160 Identities=31% Similarity=0.447 Sum_probs=143.4
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||||+.+ +.+.||+|.+.+......+.+...+|++++++++|||||.++++|....+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45777788999999999999654 57899999998777677778889999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+.| +|+.+|. ..+.+++..+..|+.+++.||.|||+. +|+|||+||.|||++..|.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9976 9999996 567899999999999999999999999 9999999999999999999999999999987654
Q ss_pred cc--ccccCCC
Q 008121 569 ER--QVITGTS 577 (577)
Q Consensus 569 ~~--~~~~Gt~ 577 (577)
.. ....|||
T Consensus 154 t~vltsikGtP 164 (808)
T KOG0597|consen 154 TSVLTSIKGTP 164 (808)
T ss_pred ceeeeeccCcc
Confidence 33 3455776
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-29 Score=246.04 Aligned_cols=153 Identities=24% Similarity=0.419 Sum_probs=134.2
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCC-eEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG-QRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~l 485 (577)
.++|...+.||.|+||.||+|.- .+|+.||||+++++-.+.++ -.=.||+..+++++ |||||++.+.+.+.+ ..|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 35677788999999999999954 56899999999876544333 23468999999999 999999999999888 9999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||||+. +|+++++ ++++.+++..+..|+.||++||+|+|.+ ++.|||+||+|||+.....+||+|||+||.+
T Consensus 88 VfE~Md~-NLYqLmK---~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMK---DRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHh---hcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999965 9999997 4578999999999999999999999999 9999999999999998889999999999977
Q ss_pred CCCc
Q 008121 566 PNTE 569 (577)
Q Consensus 566 ~~~~ 569 (577)
....
T Consensus 161 ~Skp 164 (538)
T KOG0661|consen 161 RSKP 164 (538)
T ss_pred ccCC
Confidence 5543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=231.58 Aligned_cols=153 Identities=25% Similarity=0.350 Sum_probs=131.6
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCeEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~l 485 (577)
.+.|...+.|++|+||.||+|+. ++++.||+|+++...-...-.-.-.+||.++.+++|||||.+..+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 34577788999999999999976 468899999998654222223345899999999999999999998764 357999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||||+. ||..+++. ...++...+...++.|+++|++|||++ -|+|||||++|+|+.+.|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999976 99999973 346888999999999999999999999 8999999999999999999999999999988
Q ss_pred CCC
Q 008121 566 PNT 568 (577)
Q Consensus 566 ~~~ 568 (577)
.+.
T Consensus 228 gsp 230 (419)
T KOG0663|consen 228 GSP 230 (419)
T ss_pred cCC
Confidence 766
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=234.24 Aligned_cols=160 Identities=31% Similarity=0.463 Sum_probs=135.2
Q ss_pred cCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC--eEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLLV 486 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv 486 (577)
.+|...+.||+|+||.||++...+ |+.+|||.+.... ....+.+.+|+.+|.+++|||||+++|.....+ .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 346667899999999999997754 8999999986542 122566899999999999999999999865554 68899
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeccccCccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALT 565 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~~ 565 (577)
|||+++|+|.+++... +..+++..+.++.+||++||+|||++ +||||||||+|||++. ++.+||+|||+++..
T Consensus 95 mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999999732 22799999999999999999999999 9999999999999999 799999999999977
Q ss_pred CC-----CccccccCCC
Q 008121 566 PN-----TERQVITGTS 577 (577)
Q Consensus 566 ~~-----~~~~~~~Gt~ 577 (577)
.. .....+.|||
T Consensus 169 ~~~~~~~~~~~~~~Gtp 185 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTP 185 (313)
T ss_pred ccccccccccccccCCc
Confidence 63 2234566775
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=276.29 Aligned_cols=217 Identities=31% Similarity=0.570 Sum_probs=141.6
Q ss_pred cCCChHHHHHHHHHHHhcCCC-CCCCCCCCCCCCCCCCCCccEEee-CCcEEEEEcCCCCCcccccccccCCCCCCEEEc
Q 008121 37 CTTDSSDVQALQVLYTSLNSP-SVLTNWKGNEGDPCGESWKGVACE-GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDL 114 (577)
Q Consensus 37 ~~~~~~~~~~l~~~~~~~~~~-~~l~~w~~~~~~~c~~~w~gv~C~-~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~L 114 (577)
+..+++|.+||++||+++.++ ..+.+|+. ..|+| .|.||+|+ .++|+.|+|++|+++|.++..|..+++|+.|+|
T Consensus 24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c--~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L 100 (968)
T PLN00113 24 SMLHAEELELLLSFKSSINDPLKYLSNWNS-SADVC--LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINL 100 (968)
T ss_pred cCCCHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCC--cCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence 444678999999999999876 46789974 45778 89999997 468999999999999998888888888888888
Q ss_pred cCCCcCCcCCCCCC---CCccEEEccCCcCCCcC----------------------CCCccCCCCccEEEeccCCCcccc
Q 008121 115 SGNSIHDTIPYQLP---PNLTSLNLASNNFSGNL----------------------PYSIASMVSLSYLNVSRNSLTQSI 169 (577)
Q Consensus 115 s~N~l~~~~p~~~~---~~L~~L~l~~N~l~~~~----------------------p~~~~~l~~L~~L~L~~N~l~~~~ 169 (577)
++|+++|.+|..+. ++|++|+|++|+++|.+ |..++++++|++|+|++|.+.+.+
T Consensus 101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180 (968)
T ss_pred CCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccC
Confidence 88888887775432 55666666666655544 444455555555555555555555
Q ss_pred cccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCcccc---
Q 008121 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPRELI--- 244 (577)
Q Consensus 170 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~~l~--- 244 (577)
|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.++ .+..++ |+.|++++|+++|.+|..+.
T Consensus 181 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 260 (968)
T PLN00113 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK 260 (968)
T ss_pred ChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCC
Confidence 5555555555555555555555555555555555555555555554333 233333 56666666666666665443
Q ss_pred cccceeecCCcC
Q 008121 245 SIRTFIYDGNSF 256 (577)
Q Consensus 245 ~l~~l~~~~n~~ 256 (577)
+++.|.+++|.+
T Consensus 261 ~L~~L~L~~n~l 272 (968)
T PLN00113 261 NLQYLFLYQNKL 272 (968)
T ss_pred CCCEEECcCCee
Confidence 334455555554
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=236.80 Aligned_cols=152 Identities=26% Similarity=0.394 Sum_probs=129.7
Q ss_pred HHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchH------------HHHHHHHHHHHhhcCCCCceee
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQ------------EEDNFLEAVSNMSRLRHPNIVT 472 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~H~niv~ 472 (577)
...-++|++.+.||+|.||.|-+|+. .+++.||||++.+.....+ ..+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34457899999999999999999976 4689999999975432211 1357889999999999999999
Q ss_pred EeeEEEeC--CeEEEEEEecCCCCHHHhhhhccCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 008121 473 LAGYCAEH--GQRLLVYEYVGNGNLHDMLHFADDSSKN-LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (577)
Q Consensus 473 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~ 549 (577)
|+++..+. +..|||+|||..|.+...- ..++ +++.++.+|++++..||+|||.+ +||||||||+|+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence 99998764 5799999999998765432 3344 99999999999999999999999 999999999999999
Q ss_pred CCCCeEEeccccCccc
Q 008121 550 DELNPHLSDCGLAALT 565 (577)
Q Consensus 550 ~~~~~kl~DFGla~~~ 565 (577)
++|++||+|||.+-.+
T Consensus 245 ~~g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEF 260 (576)
T ss_pred CCCcEEeeccceeeec
Confidence 9999999999999866
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=244.57 Aligned_cols=152 Identities=28% Similarity=0.479 Sum_probs=133.2
Q ss_pred hcCCCccceeccCccceEEEEEEcC--C--cE-EEEEEccc-cccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN--G--KI-MAVKKIDN-AALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~--~--~~-vavK~~~~-~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
.++....++||+|+||.||+|.+.. + .. ||||..+. .........+|+.|.++|+.++|||||++||++..+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3444555899999999999997743 2 23 89999875 23456678899999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++|||+|.||+|.++|+. ....++..++++++.+.|+||+|||++ ++|||||.++|||++.++.+||+|||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence 9999999999999999973 233699999999999999999999999 9999999999999999999999999998
Q ss_pred cccC
Q 008121 563 ALTP 566 (577)
Q Consensus 563 ~~~~ 566 (577)
+.-.
T Consensus 310 ~~~~ 313 (474)
T KOG0194|consen 310 RAGS 313 (474)
T ss_pred cCCc
Confidence 8643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=237.64 Aligned_cols=154 Identities=23% Similarity=0.341 Sum_probs=136.8
Q ss_pred HhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
...++|....+||+|+||.||+|+- .+|+.+|+|++++... ...+....+.|-.+|...++|+||+|+..|++.++.|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3567899999999999999999965 4599999999976532 2334556778889999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
|||||++|||+..+|. ....|++..+..++.+++.|++-||+. ++|||||||+|+|||..|++||+||||++-
T Consensus 218 LiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999996 567899999999999999999999999 999999999999999999999999999975
Q ss_pred cCC
Q 008121 565 TPN 567 (577)
Q Consensus 565 ~~~ 567 (577)
+..
T Consensus 291 l~~ 293 (550)
T KOG0605|consen 291 LDK 293 (550)
T ss_pred hhh
Confidence 443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=230.32 Aligned_cols=147 Identities=32% Similarity=0.506 Sum_probs=126.7
Q ss_pred CccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhh--cCCCCceeeEeeEEEeCC----eEEEE
Q 008121 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS--RLRHPNIVTLAGYCAEHG----QRLLV 486 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~~----~~~lv 486 (577)
...++||+|+||.||+|.+. ++.||||++. .++.+.|..|-++.+ .++|+||++++++-.... +++||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34567999999999999986 4999999986 345666777766654 578999999998865544 89999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV------CLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~------~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
+||.+.|+|.++|+ ...++|....+|+..+++||+|||+. ..|+|+|||||++|||+..|+++.|+|||
T Consensus 287 t~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999995 67899999999999999999999974 46899999999999999999999999999
Q ss_pred cCcccCCCcc
Q 008121 561 LAALTPNTER 570 (577)
Q Consensus 561 la~~~~~~~~ 570 (577)
||..+...+.
T Consensus 362 LAl~~~p~~~ 371 (534)
T KOG3653|consen 362 LALRLEPGKP 371 (534)
T ss_pred eeEEecCCCC
Confidence 9998765443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=227.20 Aligned_cols=152 Identities=26% Similarity=0.384 Sum_probs=129.1
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCc-eeeEeeEEEeCC------e
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN-IVTLAGYCAEHG------Q 482 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~------~ 482 (577)
.|...++||+|+||+||+|+. .+|+.||+|+++-..........-.+|+.++.+++|+| ||.+++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455567899999999999965 56899999999754322223445689999999999999 999999998877 7
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++|+||++. ||.+++.........++...+..+++|+++||+|||++ +|+||||||.|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999965 99999975432224677788999999999999999999 9999999999999999999999999999
Q ss_pred cccC
Q 008121 563 ALTP 566 (577)
Q Consensus 563 ~~~~ 566 (577)
+...
T Consensus 168 ra~~ 171 (323)
T KOG0594|consen 168 RAFS 171 (323)
T ss_pred HHhc
Confidence 9655
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=228.25 Aligned_cols=152 Identities=26% Similarity=0.400 Sum_probs=136.2
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
+.|+..+.||.|..++||+|+. ..++.||||++.-..... ..+.+.+|+..|+.++||||++++..|..+.+.|+||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4677889999999999999954 668999999997665443 36889999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||.+|++.++++.. ....+++..+..|.+++++||.|||++ +.||||||+.|||||.+|.+||+|||.+..+.+
T Consensus 105 fMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999843 345589999999999999999999999 999999999999999999999999998775543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=232.36 Aligned_cols=150 Identities=27% Similarity=0.381 Sum_probs=124.8
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-----eEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----QRL 484 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 484 (577)
.|...+++|.|+||.||+|... +++.||||++-... +.--+|+++|++++|||||++..+|.... +..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4566789999999999999764 47899999985332 12246899999999999999998885432 235
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeccccCc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGLAA 563 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGla~ 563 (577)
+||||||. +|.+.++.....+..++...+.-+..|+.+||+|||+. +|+||||||.|+|+|.+ |.+||||||-|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999987 99999975444567788888889999999999999998 99999999999999976 999999999999
Q ss_pred ccCCCcc
Q 008121 564 LTPNTER 570 (577)
Q Consensus 564 ~~~~~~~ 570 (577)
.+...+.
T Consensus 175 ~L~~~ep 181 (364)
T KOG0658|consen 175 VLVKGEP 181 (364)
T ss_pred eeccCCC
Confidence 8765554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=242.90 Aligned_cols=152 Identities=27% Similarity=0.466 Sum_probs=136.7
Q ss_pred CCCccceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
...++++||.|.||+|++|+++- ...||||.++... ......+|+.|..+|.+++||||++|.|........+||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45678899999999999998753 4579999998654 455677899999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
.|||+||+|..+|+.. .+.+++.+...+.++||.||.||.+. ++|||||.++|||++.+..+|++|||+++.++
T Consensus 709 TEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999743 45699999999999999999999999 99999999999999999999999999999876
Q ss_pred CCc
Q 008121 567 NTE 569 (577)
Q Consensus 567 ~~~ 569 (577)
++.
T Consensus 783 dd~ 785 (996)
T KOG0196|consen 783 DDP 785 (996)
T ss_pred cCC
Confidence 544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=241.23 Aligned_cols=160 Identities=26% Similarity=0.386 Sum_probs=142.2
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEcccc-ccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA-ALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
-|+.++.||.|+.|.|..|++ .+|+.+|||++.+. ..+........+||.+|+-+.||||+++|+.+.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 467788999999999999965 67999999999765 3333345567899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|.|++++. ..+++++.++.++++||+.|+.|+|.. +|+|||+||+|+|||..+++||+|||+|.+..+.
T Consensus 93 yv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999997 567899999999999999999999999 9999999999999999999999999999976544
Q ss_pred c-cccccCCC
Q 008121 569 E-RQVITGTS 577 (577)
Q Consensus 569 ~-~~~~~Gt~ 577 (577)
+ -++.||.|
T Consensus 166 klLeTSCGSP 175 (786)
T KOG0588|consen 166 KLLETSCGSP 175 (786)
T ss_pred ccccccCCCc
Confidence 4 37888875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=239.95 Aligned_cols=151 Identities=26% Similarity=0.483 Sum_probs=135.9
Q ss_pred HHHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 405 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
....-+.+...+.||+|.||+||+|+|.. .||||+++......+..+.|..|+.++++-+|.||+=+.|||..++. .
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 33344455667889999999999999973 69999999887778889999999999999999999999999998877 9
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
||..+|+|-+|+.+||.. ...++..+.+.|++|||+||.|||.+ +|||||||..||++.+++.+||+||||+..
T Consensus 464 IiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 999999999999999843 35688899999999999999999999 999999999999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=237.69 Aligned_cols=159 Identities=27% Similarity=0.448 Sum_probs=140.6
Q ss_pred hcCCCccceeccCccceEEEEE-EcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
...|...+.||+|+.|.||.+. ..+++.||||++.... ....+-..+|+.+|+..+|+|||++++.|...++.|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 3457777899999999999995 4668999999997543 334555789999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|||++|+|.|.+. ...+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..
T Consensus 350 Eym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 350 EYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999999984 45589999999999999999999999 999999999999999999999999999997755
Q ss_pred C--ccccccCCC
Q 008121 568 T--ERQVITGTS 577 (577)
Q Consensus 568 ~--~~~~~~Gt~ 577 (577)
. ++.++.|||
T Consensus 422 ~~~KR~TmVGTP 433 (550)
T KOG0578|consen 422 EQSKRSTMVGTP 433 (550)
T ss_pred ccCccccccCCC
Confidence 4 457788997
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=235.36 Aligned_cols=156 Identities=24% Similarity=0.419 Sum_probs=130.9
Q ss_pred hhcCCCccceeccCccceEEEEEE------cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 480 (577)
..++|...+.||+|+||.||+|.+ .+++.||||+++... .......+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 346788899999999999999964 235689999987532 234456789999999999 899999999988764
Q ss_pred C-eEEEEEEecCCCCHHHhhhhccCC------------------------------------------------------
Q 008121 481 G-QRLLVYEYVGNGNLHDMLHFADDS------------------------------------------------------ 505 (577)
Q Consensus 481 ~-~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------ 505 (577)
+ ..++||||+++|+|.++++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 588999999999999998642210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 506 ----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 506 ----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
...+++.++.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 23578889999999999999999998 999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=224.15 Aligned_cols=150 Identities=29% Similarity=0.447 Sum_probs=128.7
Q ss_pred hhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhc--CCCCceeeEeeEEEeCC----
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAEHG---- 481 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~---- 481 (577)
...+....+.||+|.||+||+|+|+ |+.||||++.. .+++.+.+|.++.+. ++|+||+.+++.-..+.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 3455677889999999999999997 89999999853 345667777777765 59999999988764433
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeeecCCCCCCeeeCCCCCeEE
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-----VCLPSVVHRNFKSANILLDDELNPHL 556 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-----~~~~~ivHrDlk~~NILl~~~~~~kl 556 (577)
+.|||.||.+.|+|+|+|. ...++....++++..+|.||+|||. +..|.|.|||||+.|||+..++.+.|
T Consensus 283 QLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 6899999999999999995 4789999999999999999999995 45789999999999999999999999
Q ss_pred eccccCcccCCC
Q 008121 557 SDCGLAALTPNT 568 (577)
Q Consensus 557 ~DFGla~~~~~~ 568 (577)
+|+|||......
T Consensus 358 ADLGLAv~h~~~ 369 (513)
T KOG2052|consen 358 ADLGLAVRHDSD 369 (513)
T ss_pred eeceeeEEeccc
Confidence 999999876544
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=228.93 Aligned_cols=156 Identities=28% Similarity=0.485 Sum_probs=132.8
Q ss_pred cCCCccceeccCccceEEEEEEcC-----------------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceee
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-----------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~ 472 (577)
++|...+.||+|+||.||+|.+.+ +..||+|.+.... ......+|.+|++++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 567788999999999999997532 3469999986542 3344667999999999999999999
Q ss_pred EeeEEEeCCeEEEEEEecCCCCHHHhhhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 008121 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537 (577)
Q Consensus 473 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iv 537 (577)
+++++...+..++||||+++|+|.+++..... ....++|..+.+++.|++.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999864211 123578899999999999999999999 999
Q ss_pred ecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 538 HrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
||||||+|||+++++.+||+|||+++......
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~ 192 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGD 192 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCc
Confidence 99999999999999999999999998764443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=236.16 Aligned_cols=150 Identities=21% Similarity=0.313 Sum_probs=132.6
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|+..+.||+|+||+||++... +++.||+|+++.... .......+.+|+.++.+++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888899999999999999764 588999999865321 2233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999996 345789999999999999999999999 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=236.37 Aligned_cols=154 Identities=21% Similarity=0.314 Sum_probs=134.4
Q ss_pred HHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
....++|...+.||+|+||.||+++.. +++.||+|.+..... .......+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344567999999999999999999875 578999999864321 223345678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
|+||||+++|+|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+
T Consensus 119 ~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 119 YMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 99999999999999985 23578899999999999999999999 99999999999999999999999999998
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
....
T Consensus 191 ~~~~ 194 (370)
T cd05621 191 KMDE 194 (370)
T ss_pred eccc
Confidence 7643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=237.67 Aligned_cols=164 Identities=24% Similarity=0.375 Sum_probs=140.7
Q ss_pred HHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCe
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 482 (577)
....++|...++||+|.||+|++++.+ +++.+|||.+++.. ...++.+..+.|-+++.-. +||.+++++.+|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344568889999999999999999875 47899999998654 3344566677777776655 59999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.|.||||+.|||+..+. ..+.+++..+.-++..|+.||.|||++ +|||||||-+|||||.+|.+||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 99999999999955444 356799999999999999999999999 9999999999999999999999999999
Q ss_pred ccc--CCCccccccCCC
Q 008121 563 ALT--PNTERQVITGTS 577 (577)
Q Consensus 563 ~~~--~~~~~~~~~Gt~ 577 (577)
|.. ....+.++||||
T Consensus 516 Ke~m~~g~~TsTfCGTp 532 (694)
T KOG0694|consen 516 KEGMGQGDRTSTFCGTP 532 (694)
T ss_pred cccCCCCCccccccCCh
Confidence 954 455678899997
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=231.95 Aligned_cols=159 Identities=25% Similarity=0.407 Sum_probs=136.8
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46778899999999999999875 588999999865422 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...+
T Consensus 98 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999996 345688999999999999999999999 999999999999999999999999999987644
Q ss_pred CccccccCC
Q 008121 568 TERQVITGT 576 (577)
Q Consensus 568 ~~~~~~~Gt 576 (577)
.. ...+||
T Consensus 171 ~~-~~~~gt 178 (329)
T PTZ00263 171 RT-FTLCGT 178 (329)
T ss_pred Cc-ceecCC
Confidence 32 234455
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=235.06 Aligned_cols=149 Identities=23% Similarity=0.324 Sum_probs=131.6
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||++.. .+++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3678889999999999999976 4689999999864321 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999986 345688999999999999999999999 9999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=228.55 Aligned_cols=159 Identities=26% Similarity=0.361 Sum_probs=136.2
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999775 688999999864322 1234566889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999996 345689999999999999999999999 999999999999999999999999999987643
Q ss_pred CccccccCC
Q 008121 568 TERQVITGT 576 (577)
Q Consensus 568 ~~~~~~~Gt 576 (577)
. ....+||
T Consensus 154 ~-~~~~~gt 161 (291)
T cd05612 154 R-TWTLCGT 161 (291)
T ss_pred C-cccccCC
Confidence 2 2233454
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=230.85 Aligned_cols=151 Identities=25% Similarity=0.353 Sum_probs=133.8
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|... +++.||+|+++..... ......+.+|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999875 4889999998754321 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++ ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999996 345688999999999999999999999 999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=234.24 Aligned_cols=150 Identities=23% Similarity=0.354 Sum_probs=132.9
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|+..+.||+|+||.||+|+.. +++.||||++..... .......+.+|++++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999775 589999999965321 1233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999986 345689999999999999999999999 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=231.31 Aligned_cols=159 Identities=25% Similarity=0.399 Sum_probs=135.8
Q ss_pred cCCCccceeccCccceEEEEEEcC--CcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN--GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
++|...+.||+|+||.||+|.+.+ +..||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 467888999999999999997643 36899999864322 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999996 345689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCccccccCC
Q 008121 567 NTERQVITGT 576 (577)
Q Consensus 567 ~~~~~~~~Gt 576 (577)
.. ....+||
T Consensus 183 ~~-~~~~~gt 191 (340)
T PTZ00426 183 TR-TYTLCGT 191 (340)
T ss_pred CC-cceecCC
Confidence 32 2344555
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=234.19 Aligned_cols=148 Identities=19% Similarity=0.242 Sum_probs=131.1
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.|...+.||+|+||+||+|.. .+++.||+|++..... .......+.+|++++.+++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999966 4588999999965432 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 999999999986 345688999999999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=228.64 Aligned_cols=143 Identities=27% Similarity=0.380 Sum_probs=127.0
Q ss_pred ceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 416 FLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
+.||+|+||.||++.. .+|+.||+|+++.... .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 4689999999875422 2234456788999999999999999999999999999999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9999986 345789999999999999999999999 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=250.36 Aligned_cols=157 Identities=31% Similarity=0.543 Sum_probs=137.3
Q ss_pred cCCCccceeccCccceEEEEEEcC--Cc----EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN--GK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.+....+.||+|+||.||.|...+ +. .||||.+++. .+.++..+|.+|..+|++++|||||+++|.|.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 445567789999999999997654 33 4899999765 3577888999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 484 LLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
+|++|||++|||..+|++.+. ....++..+.+.|+.|||+|+.||+++ ++|||||.++|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999985422 256788999999999999999999999 89999999999999999999999999
Q ss_pred cCcccCCCcc
Q 008121 561 LAALTPNTER 570 (577)
Q Consensus 561 la~~~~~~~~ 570 (577)
+|+.....+.
T Consensus 848 lArDiy~~~y 857 (1025)
T KOG1095|consen 848 LARDIYDKDY 857 (1025)
T ss_pred hhHhhhhchh
Confidence 9995544443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=222.68 Aligned_cols=151 Identities=26% Similarity=0.342 Sum_probs=131.6
Q ss_pred CCccceeccCccceEEEEEE-cCCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
|...+.||+|+||.||++.. .+++.||+|.+...... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999976 56899999998654322 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999999888532 234689999999999999999999999 999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=231.09 Aligned_cols=163 Identities=27% Similarity=0.437 Sum_probs=145.7
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe-EEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ-RLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lv~ 487 (577)
++|...+.+|+|+||.++..++ .+++.+++|++.....+...++....|+.++++++|||||.+++.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4677789999999999999865 457889999998776666667788899999999999999999999999888 99999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+|++||++.+.+...+ +..+++...++++.|++.|+.|||++ +|+|||||+.||++..+..+||+|||+||.+.+
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998543 56789999999999999999999988 999999999999999999999999999999887
Q ss_pred Cc--cccccCCC
Q 008121 568 TE--RQVITGTS 577 (577)
Q Consensus 568 ~~--~~~~~Gt~ 577 (577)
+. ..+..|||
T Consensus 159 ~~~~a~tvvGTp 170 (426)
T KOG0589|consen 159 EDSLASTVVGTP 170 (426)
T ss_pred chhhhheecCCC
Confidence 75 35677886
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=230.57 Aligned_cols=164 Identities=28% Similarity=0.407 Sum_probs=146.0
Q ss_pred HhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
.....|.+...||+|.|+.|..+.+ .++..||||.+.+..........+.+|+++|..++|||||+++.+...+...|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3456788899999999999999976 458999999998887777776779999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+.+|.+++++. ......+..+..++.|+.+|++|||++ .|||||||++|||||.++++||+|||++..+
T Consensus 133 V~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence 999999999999997 344555688889999999999999999 8999999999999999999999999999987
Q ss_pred CCCc-cccccCCC
Q 008121 566 PNTE-RQVITGTS 577 (577)
Q Consensus 566 ~~~~-~~~~~Gt~ 577 (577)
.... -++.||+|
T Consensus 206 ~~~~~lqt~cgsp 218 (596)
T KOG0586|consen 206 DYGLMLQTFCGSP 218 (596)
T ss_pred cccccccccCCCC
Confidence 6544 37888875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=231.91 Aligned_cols=156 Identities=28% Similarity=0.429 Sum_probs=132.9
Q ss_pred hcCCCccceeccCccceEEEEEE------cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 481 (577)
.++|...+.||+|+||.||+|.+ .++..||||+++... .....+.+.+|+.++..+ +||||++++++|...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 44677889999999999999964 235689999986443 234456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccC---------------------------------------------------------
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADD--------------------------------------------------------- 504 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 504 (577)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999864211
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 505 --------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 505 --------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
....+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 112578999999999999999999998 9999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=212.25 Aligned_cols=162 Identities=30% Similarity=0.453 Sum_probs=140.1
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc------hHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 480 (577)
-+.|...+.+|.|..+.|.+|.. .+|+..|+|++...... ....++-.+|+.+++++ .||+|+++.++|..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 34566778899999999999855 56889999998543211 12234556799999987 699999999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
...++|+|.|+.|.|.|+|. ..-.++++...+|++|+.+|++|||.. .||||||||+|||+|++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 99999999999999999996 566799999999999999999999999 99999999999999999999999999
Q ss_pred cCcccCCCcc-ccccCCC
Q 008121 561 LAALTPNTER-QVITGTS 577 (577)
Q Consensus 561 la~~~~~~~~-~~~~Gt~ 577 (577)
+|..++..+. ...||||
T Consensus 169 Fa~~l~~GekLrelCGTP 186 (411)
T KOG0599|consen 169 FACQLEPGEKLRELCGTP 186 (411)
T ss_pred eeeccCCchhHHHhcCCC
Confidence 9998877665 6899997
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=225.95 Aligned_cols=146 Identities=26% Similarity=0.393 Sum_probs=128.7
Q ss_pred ceeccCccceEEEEEE----cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecC
Q 008121 416 FLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
+.||+|+||.||+++. .+|+.||+|+++...........+.+|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 357899999997544333345567889999999999999999999999999999999999
Q ss_pred CCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 492 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+|+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 999999986 345689999999999999999999999 9999999999999999999999999999875444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=226.49 Aligned_cols=143 Identities=26% Similarity=0.378 Sum_probs=127.0
Q ss_pred ceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 416 FLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
+.||+|+||.||++.. .+++.||+|++..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 4589999999865422 2334567889999999999999999999999999999999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 9998885 345689999999999999999999999 9999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=224.53 Aligned_cols=141 Identities=29% Similarity=0.383 Sum_probs=125.7
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 418 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
||+|+||.||++... +++.||+|+++... ........+.+|++++.+++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999775 57899999986432 1233456788999999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~ 143 (312)
T cd05585 81 FHHLQ----REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLN 143 (312)
T ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence 99996 345689999999999999999999999 9999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=226.21 Aligned_cols=143 Identities=27% Similarity=0.374 Sum_probs=126.6
Q ss_pred ceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 416 FLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
+.||+|+||.||++.. .+|+.||+|+++.... .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999976 4689999999865421 2234556788999999999999999999999999999999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 9998886 345689999999999999999999999 9999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=230.11 Aligned_cols=153 Identities=22% Similarity=0.327 Sum_probs=135.3
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch-HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|... +++.||||+++...... .....+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999775 68999999987543222 34567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999962 36789999999999999999999998 999999999999999999999999999987654
Q ss_pred Cc
Q 008121 568 TE 569 (577)
Q Consensus 568 ~~ 569 (577)
..
T Consensus 154 ~~ 155 (350)
T cd05573 154 AK 155 (350)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=230.57 Aligned_cols=156 Identities=21% Similarity=0.306 Sum_probs=135.4
Q ss_pred HHHHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC
Q 008121 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (577)
Q Consensus 404 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 481 (577)
++....++|...+.||+|+||.||++... +++.||+|.+..... .......+.+|+.+++.++||||+++++++...+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455678999999999999999999775 578999999864321 2233456788999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..|+||||+++|+|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999985 23578888999999999999999999 999999999999999999999999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
++....
T Consensus 189 a~~~~~ 194 (371)
T cd05622 189 CMKMNK 194 (371)
T ss_pred eeEcCc
Confidence 987643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=231.84 Aligned_cols=152 Identities=21% Similarity=0.298 Sum_probs=132.7
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
..++|...+.||+|+||.||++... +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999999999999764 588999999864321 12334557889999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 121 v~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999985 23578888999999999999999999 9999999999999999999999999999876
Q ss_pred CC
Q 008121 566 PN 567 (577)
Q Consensus 566 ~~ 567 (577)
..
T Consensus 193 ~~ 194 (370)
T cd05596 193 DA 194 (370)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-25 Score=224.27 Aligned_cols=161 Identities=24% Similarity=0.364 Sum_probs=138.8
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|+..+.||+|+||.||++... ++..||+|.+.... .....+++.+|++++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 467888999999999999999775 57889999986532 2344567999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++ ....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 83 EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999996 3356889999999999999999999862 699999999999999999999999999987655
Q ss_pred CccccccCC
Q 008121 568 TERQVITGT 576 (577)
Q Consensus 568 ~~~~~~~Gt 576 (577)
.......||
T Consensus 157 ~~~~~~~g~ 165 (331)
T cd06649 157 SMANSFVGT 165 (331)
T ss_pred cccccCCCC
Confidence 544444555
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=224.05 Aligned_cols=143 Identities=26% Similarity=0.381 Sum_probs=125.9
Q ss_pred ceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 416 FLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
+.||+|+||.||++.. .+++.||+|.++.... .......+.+|++++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 4689999999875422 2234556788999999999999999999999999999999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 9999885 34568999999999999999999997 6 8999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=230.57 Aligned_cols=147 Identities=20% Similarity=0.272 Sum_probs=130.1
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
+|+..+.||+|+||.||+++.. +++.||||++...... ......+.+|++++++++||||+++++.+.+.+..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888899999999999999764 5889999998653221 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
|+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|..
T Consensus 82 ~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 82 YIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 999999999996 345688889999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=225.13 Aligned_cols=152 Identities=24% Similarity=0.269 Sum_probs=132.8
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+++.. +++.||+|.+.... ........+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999775 57889999986432 12233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999963 235688999999999999999999999 999999999999999999999999999986644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=231.19 Aligned_cols=147 Identities=19% Similarity=0.259 Sum_probs=130.2
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.|...+.||+|+||.||+|.. .+++.||+|++..... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 577889999999999999976 4588999999865322 22345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 999999999986 235688899999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=227.77 Aligned_cols=150 Identities=22% Similarity=0.329 Sum_probs=132.2
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|+..+.||+|+||.||++... +++.||+|+++.... .......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35778899999999999999765 588999999864321 2234566888999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999986 345689999999999999999999999 99999999999999999999999999988553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=225.12 Aligned_cols=152 Identities=23% Similarity=0.287 Sum_probs=132.9
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||++... +++.||+|++.... ......+.|.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888899999999999999765 58899999986422 12234556889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999963 245688999999999999999999999 999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=224.73 Aligned_cols=153 Identities=25% Similarity=0.313 Sum_probs=134.4
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||++... +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999764 688999999975432 2234566889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999963 235689999999999999999999999 999999999999999999999999999987654
Q ss_pred C
Q 008121 568 T 568 (577)
Q Consensus 568 ~ 568 (577)
.
T Consensus 155 ~ 155 (330)
T cd05601 155 N 155 (330)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=229.21 Aligned_cols=156 Identities=28% Similarity=0.434 Sum_probs=132.5
Q ss_pred hcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 481 (577)
.++|...+.||+|+||.||+|... +++.||+|+++... .....+.+.+|+++++.+ +|+|||+++++|...+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 456888899999999999998642 24579999997543 234456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccC---------------------------------------------------------
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADD--------------------------------------------------------- 504 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 504 (577)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999864210
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 505 ---------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 505 ---------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
....+++.++.+|+.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 123578899999999999999999998 9999999999999999999999999999865443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=221.52 Aligned_cols=157 Identities=26% Similarity=0.410 Sum_probs=139.3
Q ss_pred cceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 415 EFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
.++||+|.||+||-|.+ ++|+.||||.+.+..+....+++++.|+.+++.+.||.||.+.-.|...+..++|||-+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 57899999999999966 56999999999988888888899999999999999999999999999999999999999 56
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeccccCcccCCCcc
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFGla~~~~~~~~ 570 (577)
|+.+.+-.. ..+++++....-++.||+.||.|||.+ +|+|+||||+|||+.. .-++||||||+|+...+...
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 888877533 456788888888999999999999999 9999999999999964 34899999999999876654
Q ss_pred -ccccCCC
Q 008121 571 -QVITGTS 577 (577)
Q Consensus 571 -~~~~Gt~ 577 (577)
..+.|||
T Consensus 723 RrsVVGTP 730 (888)
T KOG4236|consen 723 RRSVVGTP 730 (888)
T ss_pred hhhhcCCc
Confidence 6788997
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=223.82 Aligned_cols=143 Identities=27% Similarity=0.407 Sum_probs=125.2
Q ss_pred ceeccCccceEEEEEE----cCCcEEEEEEcccccc--chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 416 FLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+.||+|+||.||+++. .+++.||+|.++.... .......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 3578999999865322 122345678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+++|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 99999999986 345678888999999999999999999 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-26 Score=217.82 Aligned_cols=157 Identities=29% Similarity=0.491 Sum_probs=141.0
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
-|.+.++||+|+||.||++.+ +.|+.||||++... ...+++..||.+|+.++.|+||++||.|......|+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 355677899999999999955 56999999998653 3567789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC-
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT- 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~- 568 (577)
|..|+..|.++ .+++++++.++..|.+..++||+|||.. .-||||||+.|||++.+|.+||+|||.|..+.+.
T Consensus 110 CGAGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 110 CGAGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred cCCCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999996 4678999999999999999999999998 8899999999999999999999999999987664
Q ss_pred -ccccccCCC
Q 008121 569 -ERQVITGTS 577 (577)
Q Consensus 569 -~~~~~~Gt~ 577 (577)
++.++.|||
T Consensus 184 AKRNTVIGTP 193 (502)
T KOG0574|consen 184 AKRNTVIGTP 193 (502)
T ss_pred HhhCccccCc
Confidence 456788987
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=234.30 Aligned_cols=152 Identities=18% Similarity=0.179 Sum_probs=132.0
Q ss_pred CCccceeccCccceEEEEEEc-C-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-N-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
|...+.||+|+||.||+|... + ++.||+|.+... .......+.+|+++++.++|||||++++++...+..|+||||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 777889999999999999653 3 578888876433 234455678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+++|+|.++++........+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999998864333455789999999999999999999999 9999999999999999999999999999976543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=224.19 Aligned_cols=161 Identities=28% Similarity=0.403 Sum_probs=140.5
Q ss_pred hcCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccch-HHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 485 (577)
...|...+.||+|.||.||+|.... |+.+|+|.+.+..... ...+...+|+.+|+++. |||||.+++.|.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3457777899999999999997765 9999999997654322 23567899999999998 9999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC----CCeEEecccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE----LNPHLSDCGL 561 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~----~~~kl~DFGl 561 (577)
|||++.||.|.+.+... .+++.++..+++|++.|+.|||+. +|+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999633 399999999999999999999998 99999999999999643 5799999999
Q ss_pred CcccCCC-ccccccCCC
Q 008121 562 AALTPNT-ERQVITGTS 577 (577)
Q Consensus 562 a~~~~~~-~~~~~~Gt~ 577 (577)
|+..... ..+..+|||
T Consensus 186 a~~~~~~~~~~~~~Gtp 202 (382)
T KOG0032|consen 186 AKFIKPGERLHTIVGTP 202 (382)
T ss_pred ceEccCCceEeeecCCc
Confidence 9998764 347788986
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=223.61 Aligned_cols=149 Identities=27% Similarity=0.359 Sum_probs=129.6
Q ss_pred CCCccceeccCccceEEEEEE----cCCcEEEEEEcccccc--chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 483 (577)
+|+..+.||+|+||.||+++. .+++.||+|++..... .....+.+..|++++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477789999999999999865 3578999999864321 122345678899999999 499999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++||||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999986 345689999999999999999999999 99999999999999999999999999998
Q ss_pred ccC
Q 008121 564 LTP 566 (577)
Q Consensus 564 ~~~ 566 (577)
.+.
T Consensus 154 ~~~ 156 (332)
T cd05614 154 EFL 156 (332)
T ss_pred ccc
Confidence 653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=232.40 Aligned_cols=161 Identities=27% Similarity=0.456 Sum_probs=135.1
Q ss_pred CCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC------CeEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------GQRL 484 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~ 484 (577)
|...+.||+|+||.||+|+. .+|+.||||.++... .....+...+|+++|++++|+|||++++.-.+. ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34457899999999999984 679999999997644 455677889999999999999999999875443 3568
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCC--CeEEeccc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DEL--NPHLSDCG 560 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~--~~~--~~kl~DFG 560 (577)
+|||||.+|||+..|...+ ....|++.+.+.+..+++.||.|||++ +||||||||.||++- .+| .-||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 9999999999999997543 456799999999999999999999999 999999999999994 334 47999999
Q ss_pred cCcccCCCcc-ccccCCC
Q 008121 561 LAALTPNTER-QVITGTS 577 (577)
Q Consensus 561 la~~~~~~~~-~~~~Gt~ 577 (577)
.||-+++... .++.||+
T Consensus 170 ~Arel~d~s~~~S~vGT~ 187 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTE 187 (732)
T ss_pred ccccCCCCCeeeeecCch
Confidence 9998765553 5666874
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=222.38 Aligned_cols=142 Identities=25% Similarity=0.361 Sum_probs=125.4
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||++... +++.||+|+++..... ....+.+.+|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999764 5889999999754322 23345678899999888 799999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 99998885 345789999999999999999999999 999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=222.31 Aligned_cols=151 Identities=24% Similarity=0.282 Sum_probs=131.5
Q ss_pred cCCCccceeccCccceEEEEEEcC-CcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||++.... ++.||+|.+.+... .......|.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 367888999999999999998754 77899999864321 2223455888999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 99999999999963 234689999999999999999999999 99999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=236.35 Aligned_cols=151 Identities=26% Similarity=0.381 Sum_probs=129.6
Q ss_pred hcCCCccceeccCccceEEEEEEcCC-cEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEee-EEEe------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANG-KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAG-YCAE------ 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~-~~~~------ 479 (577)
..++++++.|.+|||+.||.+....+ ..||+|++-.. +........+||++|+.|+ |+|||.+++ ....
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34566788999999999999988766 99999998644 4667788999999999997 999999999 3321
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
.-+.+|.||||++|.|-|++... ....|++.++++|+.|+++|+++||.. .|+|||||||.|||||+.++..|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~R--lq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTR--LQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHH--HhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 12678999999999999999743 234499999999999999999999987 678999999999999999999999999
Q ss_pred ccCcc
Q 008121 560 GLAAL 564 (577)
Q Consensus 560 Gla~~ 564 (577)
|-|.-
T Consensus 191 GSatt 195 (738)
T KOG1989|consen 191 GSATT 195 (738)
T ss_pred ccccc
Confidence 98874
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=216.50 Aligned_cols=147 Identities=24% Similarity=0.340 Sum_probs=127.7
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 418 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
||+|+||+||++... +++.||+|++...... ....+.+..|++++++++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999764 6889999998654322 12345678899999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
.+.+.........+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 988864434456789999999999999999999999 999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=226.58 Aligned_cols=155 Identities=28% Similarity=0.410 Sum_probs=132.2
Q ss_pred hcCCCccceeccCccceEEEEEEcC------CcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~ 481 (577)
.++|.+.+.||+|+||.||+|.... +..||||+++... .....+.|.+|+++++++. |||||+++++|.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4578888999999999999997531 3479999996543 2344567999999999996 999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccC---------------------------------------------------------
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADD--------------------------------------------------------- 504 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 504 (577)
..|+||||+++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999864211
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 008121 505 -----------------------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (577)
Q Consensus 505 -----------------------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~ 549 (577)
....+++.++.+++.|+++||+|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 113578889999999999999999998 999999999999999
Q ss_pred CCCCeEEeccccCcccCC
Q 008121 550 DELNPHLSDCGLAALTPN 567 (577)
Q Consensus 550 ~~~~~kl~DFGla~~~~~ 567 (577)
+++.+||+|||+++....
T Consensus 272 ~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 272 QGKIVKICDFGLARDIMH 289 (400)
T ss_pred CCCEEEEEeCCcceeccc
Confidence 999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=221.29 Aligned_cols=148 Identities=22% Similarity=0.324 Sum_probs=127.9
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCC-ceeeEeeEEEeCCeEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHP-NIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~ 487 (577)
+|...+.||+|+||.||+|... +++.||+|+++.... .....+.+..|.+++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677889999999999999765 478899999865322 223456688899999999765 5888999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999999986 345688999999999999999999999 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=221.23 Aligned_cols=143 Identities=25% Similarity=0.364 Sum_probs=125.0
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||++... +++.||+|+++.... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 578999999875432 223445677888888776 899999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 99998885 345689999999999999999999999 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-26 Score=211.96 Aligned_cols=162 Identities=26% Similarity=0.370 Sum_probs=139.1
Q ss_pred hcCCCccceeccCccceEEEEE-EcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
+++|+..+.||+|.|+.||++. -.+|+.+|+|++.....+....+++.+|+++.+.++|||||++.+.+.+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4567777899999999999994 467999999999876666667788999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DFGla~~ 564 (577)
|+|.||+|..-+- .+..+++..+-..++||++||.|+|.+ +|||||+||+|+|+. ..--+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999977664 235678889999999999999999999 999999999999995 344689999999998
Q ss_pred cCCCcc-ccccCCC
Q 008121 565 TPNTER-QVITGTS 577 (577)
Q Consensus 565 ~~~~~~-~~~~Gt~ 577 (577)
+.+... ..+.|||
T Consensus 163 l~~g~~~~G~~GtP 176 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTP 176 (355)
T ss_pred eCCccccccccCCC
Confidence 873322 4566776
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=214.00 Aligned_cols=150 Identities=28% Similarity=0.428 Sum_probs=130.7
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe-----CCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-----HGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~~ 483 (577)
..|...+.||+|+||.|..+.. .+|+.||||++...-...-..++-.+|+.+++.++|+||+.+++.+.. -...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4455568899999999999965 568999999997544445556778899999999999999999999865 3468
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
|+|+|+| .-||.+.++ ..+.++......++.|+++||.|+|+. +|+|||+||+|+|++.+...||+|||+|+
T Consensus 102 YiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred EEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 9999999 559999996 455699999999999999999999999 99999999999999999999999999999
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
....
T Consensus 174 ~~~~ 177 (359)
T KOG0660|consen 174 YLDK 177 (359)
T ss_pred eccc
Confidence 8754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=220.95 Aligned_cols=161 Identities=22% Similarity=0.362 Sum_probs=137.5
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|+..+.||+|+||.||++... +++.+|+|.++... .......+.+|++++++++||||++++++|.+.++.++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 467888999999999999999775 57889999886532 2344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++ ....+++.....++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||+++....
T Consensus 83 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999996 3356889999999999999999999752 699999999999999999999999999987654
Q ss_pred CccccccCC
Q 008121 568 TERQVITGT 576 (577)
Q Consensus 568 ~~~~~~~Gt 576 (577)
.......||
T Consensus 157 ~~~~~~~~~ 165 (333)
T cd06650 157 SMANSFVGT 165 (333)
T ss_pred hccccCCCC
Confidence 433334444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=217.93 Aligned_cols=151 Identities=24% Similarity=0.365 Sum_probs=131.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||+|+++.........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999875 57899999987544334445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|++++.+..+.+ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999877665442 345689999999999999999999998 999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=212.48 Aligned_cols=148 Identities=25% Similarity=0.428 Sum_probs=131.9
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|+..+.||+|+||.||++++.++..+|+|.+.... ...++|.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 3467778899999999999999888899999886442 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 81 MENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 9999999998632 24589999999999999999999999 99999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=214.19 Aligned_cols=150 Identities=23% Similarity=0.384 Sum_probs=131.9
Q ss_pred hcCCCccceeccCccceEEEEEEc----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.++|...+.||+|+||.||+|.+. .+..||+|.++... +......|.+|+.++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 346778899999999999999753 35689999987543 3344567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999999863 234689999999999999999999999 999999999999999999999999998765
Q ss_pred c
Q 008121 565 T 565 (577)
Q Consensus 565 ~ 565 (577)
.
T Consensus 157 ~ 157 (266)
T cd05064 157 D 157 (266)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=233.77 Aligned_cols=157 Identities=22% Similarity=0.290 Sum_probs=136.0
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-----
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----- 481 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----- 481 (577)
..++|...+.||+|+||.||+|.. .+++.||||++.....+......+.+|+..+..++|+||+++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 446888999999999999999965 56899999999765555566677899999999999999999988775432
Q ss_pred ---eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEec
Q 008121 482 ---QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (577)
Q Consensus 482 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D 558 (577)
..++||||+++|+|.++++........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 36799999999999999975444456789999999999999999999999 999999999999999999999999
Q ss_pred cccCcccCC
Q 008121 559 CGLAALTPN 567 (577)
Q Consensus 559 FGla~~~~~ 567 (577)
||+++.+..
T Consensus 187 FGls~~~~~ 195 (496)
T PTZ00283 187 FGFSKMYAA 195 (496)
T ss_pred cccCeeccc
Confidence 999987543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=218.39 Aligned_cols=149 Identities=28% Similarity=0.390 Sum_probs=129.7
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||||+++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 357888999999999999999875 688999999864321 223345778999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||++ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 83 EYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAK 153 (303)
T ss_pred ECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence 9995 688888752 345688999999999999999999999 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=222.47 Aligned_cols=147 Identities=28% Similarity=0.464 Sum_probs=127.0
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-----eEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----QRL 484 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 484 (577)
+|...+.||+|+||.||+|... +++.||||++...........++.+|++++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777889999999999999764 6899999998653323344567889999999999999999999885432 479
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||++ ++|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 69999886 345689999999999999999999999 999999999999999999999999999986
Q ss_pred c
Q 008121 565 T 565 (577)
Q Consensus 565 ~ 565 (577)
.
T Consensus 153 ~ 153 (338)
T cd07859 153 A 153 (338)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=215.76 Aligned_cols=152 Identities=26% Similarity=0.342 Sum_probs=131.7
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.|+..+.||+|+||.||++... +++.||+|++...... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999764 6889999998653322 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999888632 235689999999999999999999999 999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=224.57 Aligned_cols=145 Identities=22% Similarity=0.381 Sum_probs=125.7
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++|+||+++++++...+..++||||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3455678999999999999764 68999999986432 234456789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++|+|.+.. ..++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999986532 346677889999999999999999 999999999999999999999999999987643
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=219.29 Aligned_cols=154 Identities=22% Similarity=0.345 Sum_probs=126.2
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhc-CCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||+|... +++.||+|.++.... .....+.+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999774 578999999865321 12234445666666654 4899999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC--cc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ER 570 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~--~~ 570 (577)
|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 81 GDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 99999986 335689999999999999999999998 9999999999999999999999999999864322 22
Q ss_pred ccccCC
Q 008121 571 QVITGT 576 (577)
Q Consensus 571 ~~~~Gt 576 (577)
...+||
T Consensus 154 ~~~~gt 159 (316)
T cd05592 154 STFCGT 159 (316)
T ss_pred ccccCC
Confidence 334555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=219.89 Aligned_cols=143 Identities=26% Similarity=0.377 Sum_probs=124.5
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||+|+.. +++.||+|+++.... .....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999775 478999999865322 223345677888888765 799999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 99999886 345689999999999999999999999 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=216.81 Aligned_cols=149 Identities=24% Similarity=0.385 Sum_probs=129.2
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||+|.++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 45888899999999999999764 58899999986432 12234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|++ |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 84 YLD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 997 499998852 234578999999999999999999999 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=219.39 Aligned_cols=159 Identities=21% Similarity=0.316 Sum_probs=131.3
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 487 (577)
+|...+.||+|+||.||+|... +++.||+|.++.... .......+..|.+++..+ +|++|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677889999999999999765 478999999875422 122344567777887777 5899999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+.+. ....+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999886 335689999999999999999999999 999999999999999999999999999986432
Q ss_pred C--ccccccCC
Q 008121 568 T--ERQVITGT 576 (577)
Q Consensus 568 ~--~~~~~~Gt 576 (577)
. .....+||
T Consensus 154 ~~~~~~~~~gt 164 (323)
T cd05616 154 DGVTTKTFCGT 164 (323)
T ss_pred CCCccccCCCC
Confidence 2 22344565
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=220.19 Aligned_cols=146 Identities=27% Similarity=0.416 Sum_probs=125.0
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHH---hhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSN---MSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~---l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
|...+.||+|+||.||+|... +++.||||+++.... .....+.+.+|+++ ++.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999764 589999999865421 12234456666554 4677899999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||+++|+|...++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999998885 34689999999999999999999999 9999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=219.99 Aligned_cols=143 Identities=24% Similarity=0.374 Sum_probs=124.3
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||+|... +++.||+|+++.... .....+.+..|.+++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999775 588999999865321 123345677888888776 699999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 99999886 345689999999999999999999999 9999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=219.20 Aligned_cols=143 Identities=28% Similarity=0.415 Sum_probs=121.8
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHH-HHhhcCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAV-SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||+|+.. +++.||+|++..... .......+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999774 588999999864322 122334455554 467889999999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+.+. ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 99998885 345688888999999999999999998 9999999999999999999999999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=219.10 Aligned_cols=143 Identities=29% Similarity=0.436 Sum_probs=122.2
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHH-HhhcCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVS-NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||+||+|... +|+.||+|++...... .....++..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999774 6899999998653221 222334555544 56789999999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 99999886 345688999999999999999999999 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=218.32 Aligned_cols=150 Identities=24% Similarity=0.445 Sum_probs=129.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCc----EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.+|+..+.||+|+||.||+|.+. +++ .||+|.++... .....++|.+|+.+++.++||||++++|+|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46888899999999999999763 333 48999986432 334566789999999999999999999999765 578
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+++||+++|+|.++++. ....+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999963 234688999999999999999999999 999999999999999999999999999997
Q ss_pred cCC
Q 008121 565 TPN 567 (577)
Q Consensus 565 ~~~ 567 (577)
...
T Consensus 159 ~~~ 161 (316)
T cd05108 159 LGA 161 (316)
T ss_pred ccC
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=218.73 Aligned_cols=143 Identities=25% Similarity=0.351 Sum_probs=125.5
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||++... +++.||+|+++..... ....+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 5789999999754322 23455678899998888 699999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99998885 345689999999999999999999999 9999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=218.05 Aligned_cols=143 Identities=23% Similarity=0.372 Sum_probs=122.9
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhc-CCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||+|... +++.||||+++.... .......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 478999999865421 12234456667777765 5899999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 99999986 335688999999999999999999999 9999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=219.02 Aligned_cols=143 Identities=29% Similarity=0.416 Sum_probs=122.5
Q ss_pred ceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHH-HhhcCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVS-NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||+||+|.. .+|+.||+|++..... .......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999976 4689999999865422 1223344555554 56789999999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99998885 345789999999999999999999999 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=218.50 Aligned_cols=143 Identities=29% Similarity=0.408 Sum_probs=120.7
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHH-HHhhcCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAV-SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||+|... +++.||+|++...... ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999775 5788999998653221 12233444444 456789999999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+++. ....+++.....++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 99999986 345678888889999999999999999 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=210.91 Aligned_cols=152 Identities=24% Similarity=0.417 Sum_probs=134.9
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||+|...+++.||+|.++... ...++|.+|++++++++||||+++++++...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 45678889999999999999988788899999986542 235668999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++++|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999632 245689999999999999999999998 9999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=212.36 Aligned_cols=150 Identities=29% Similarity=0.370 Sum_probs=132.9
Q ss_pred CCCccceeccCccceEEEEEEcC-CcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.|+..+.||.|.-|.||++++.+ +..+|+|++.+.... .....+...|-++|+.++||.++.||+.+..++..|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45567789999999999999876 588999999765433 3345566778889999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||+||||..+.+ +...+.+++..+.-++.+|+-||+|||.. +||+|||||+||||-++|++-|+||.|+...
T Consensus 158 yCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 158 YCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred cCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999987 34567899999999999999999999999 9999999999999999999999999998754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=225.65 Aligned_cols=157 Identities=25% Similarity=0.451 Sum_probs=139.9
Q ss_pred CCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+....++||-|.||.||.|.|+. .-.||||.++.. ....++|+.|..+|+.++|||+|+|+|+|..+...|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 34456789999999999999976 678999999865 45678899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
|.+|+|.++|+++ .+..++....+.++.||+.||+||..+ .+|||||.++|+|+.++..+||+||||++++..+.
T Consensus 345 M~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 345 MCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999999999855 455677888899999999999999999 89999999999999999999999999999987766
Q ss_pred cccccC
Q 008121 570 RQVITG 575 (577)
Q Consensus 570 ~~~~~G 575 (577)
.....|
T Consensus 420 YTAHAG 425 (1157)
T KOG4278|consen 420 YTAHAG 425 (1157)
T ss_pred eecccC
Confidence 655554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-25 Score=193.49 Aligned_cols=151 Identities=25% Similarity=0.363 Sum_probs=132.2
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...++||+|.||+||+|+. ++++.||+|+++....+........+||-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455678899999999999965 5689999999976554555566778999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|.. +|..+.. .-++.++......++.|+++||.|+|++ .+.|||+||.|.||+.+|+.|++|||+|+-+.-.
T Consensus 83 cdq-dlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CDQ-DLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hhH-HHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 964 8888775 3467789999999999999999999999 9999999999999999999999999999976433
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=224.10 Aligned_cols=141 Identities=21% Similarity=0.293 Sum_probs=125.9
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++|||||++++++......++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 35799999999999999999976 458899999753 234678999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||+. ++|.+++. ....+++.+++.|+.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+..
T Consensus 163 e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 163 PRYK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred ecCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 9995 78988885 345689999999999999999999999 9999999999999999999999999999754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=209.59 Aligned_cols=149 Identities=26% Similarity=0.424 Sum_probs=131.9
Q ss_pred CCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
+|...+.||+|+||.||++++.++..+|+|.++.... ..++|.+|+.++.+++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 4667788999999999999888777899999875432 3456899999999999999999999999888999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
++|+|.++++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999998632 23689999999999999999999999 9999999999999999999999999999865443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=217.04 Aligned_cols=143 Identities=20% Similarity=0.334 Sum_probs=122.7
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhc-CCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||+|+.. +++.||+|.++..... ......+..|.+++.. .+||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999775 5889999998653211 1234456667777765 4899999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+++. ....+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 99999886 345688999999999999999999999 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-25 Score=223.00 Aligned_cols=145 Identities=27% Similarity=0.480 Sum_probs=129.0
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCC
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGN 494 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 494 (577)
.+.||.|+-|.||+|+++ ++.||||+++.. -..+|.-|++++||||+.+.|+|.....+|||||||+.|-
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 567999999999999997 688999998532 1346888999999999999999999999999999999999
Q ss_pred HHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCccc-cc
Q 008121 495 LHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ-VI 573 (577)
Q Consensus 495 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~ 573 (577)
|+++|+ ....++......+..+||.||.|||.+ .|||||||.-||||..+-.+||+|||-++...+..++ .+
T Consensus 199 L~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 199 LYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred HHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence 999997 567788888999999999999999999 9999999999999999999999999999987665443 56
Q ss_pred cCC
Q 008121 574 TGT 576 (577)
Q Consensus 574 ~Gt 576 (577)
+||
T Consensus 272 aGT 274 (904)
T KOG4721|consen 272 AGT 274 (904)
T ss_pred hhh
Confidence 676
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-25 Score=229.45 Aligned_cols=152 Identities=26% Similarity=0.442 Sum_probs=132.5
Q ss_pred CCccceeccCccceEEEEEE-cCC----cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEF-ANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
+...++||+|+||+||+|.| .+| -+||||++.... +.+..++|++|+.+|++++|||+++++|+|.... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34467899999999999976 334 468999986543 4555778999999999999999999999998775 7899
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
++||+.|+|.|+++. .+..+-.+..+.|..|||+||.|||.+ ++|||||.++|||+..-..+||.|||+|+++.
T Consensus 776 tq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999985 345677888999999999999999999 99999999999999999999999999999987
Q ss_pred CCccc
Q 008121 567 NTERQ 571 (577)
Q Consensus 567 ~~~~~ 571 (577)
..+..
T Consensus 850 ~d~~e 854 (1177)
T KOG1025|consen 850 PDEKE 854 (1177)
T ss_pred ccccc
Confidence 66654
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=209.69 Aligned_cols=148 Identities=28% Similarity=0.442 Sum_probs=131.3
Q ss_pred CCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
+|+..+.||+|+||.||++.+.++..+|+|.+.... ...++|.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 466778999999999999988877889999986432 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
++++|.++++.. ...+++..++.|+.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...+
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999998632 34689999999999999999999999 999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=217.62 Aligned_cols=147 Identities=21% Similarity=0.320 Sum_probs=127.0
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 488 (577)
|...+.||+|+||.||+|... +++.||+|+++.... .....+.+..|.+++..+. |++|+++++++...+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 666789999999999999764 588999999865322 2233456778888888886 5678889999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+++|+|.+++. ....+++.++..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 82 y~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 82 YVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecccccccc
Confidence 999999999986 345689999999999999999999999 9999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=209.70 Aligned_cols=151 Identities=23% Similarity=0.415 Sum_probs=134.7
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|+..+.||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++++...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 3567888999999999999999888889999998643 2245678999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++|+|.++++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 82 YMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999632 345688999999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=213.42 Aligned_cols=152 Identities=27% Similarity=0.407 Sum_probs=124.5
Q ss_pred CCCccceeccCccceEEEEEEc--CCcEEEEEEccccccchHHHHHHHHHHHHhhcC---CCCceeeEeeEEEe-----C
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVTLAGYCAE-----H 480 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~ 480 (577)
+|...+.||+|+||.||+|+.. +++.||+|+++...........+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999763 468899999865433333334566677666655 79999999999852 3
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
...++||||++ ++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 46899999996 6999998632 234589999999999999999999999 99999999999999999999999999
Q ss_pred cCcccCCC
Q 008121 561 LAALTPNT 568 (577)
Q Consensus 561 la~~~~~~ 568 (577)
+++.....
T Consensus 156 ~~~~~~~~ 163 (290)
T cd07862 156 LARIYSFQ 163 (290)
T ss_pred ceEeccCC
Confidence 99876443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=211.66 Aligned_cols=145 Identities=20% Similarity=0.352 Sum_probs=125.7
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccch-HHHHHHHHHHHHhhcCCCCceeeEeeEEEe----CCeEEEEEEec
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLVYEYV 490 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~ 490 (577)
..||+|++|.||+|.+ +|+.||||+++...... ...+.|.+|+++|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 68999999997543222 224678899999999999999999999876 34689999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
++|+|.++++ ....+++....+++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++....
T Consensus 105 ~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 9999999996 3456899999999999999999999742 688999999999999999999999999986543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=221.87 Aligned_cols=149 Identities=23% Similarity=0.368 Sum_probs=130.0
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-----eEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----QRL 484 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 484 (577)
+|+..+.||+|+||.||++.. .+++.||||++..........+++.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467788999999999999976 46899999998654333445567889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 58888875 345789999999999999999999999 999999999999999999999999999986
Q ss_pred cCC
Q 008121 565 TPN 567 (577)
Q Consensus 565 ~~~ 567 (577)
...
T Consensus 153 ~~~ 155 (372)
T cd07853 153 EEP 155 (372)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=234.41 Aligned_cols=153 Identities=25% Similarity=0.341 Sum_probs=132.8
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|... +++.||+|+++..... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999765 5899999998653222 234567999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 488 EYVGNGNLHDMLHFAD-------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~-------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
||+++|+|.++++... .....+++..+++++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 1123467788899999999999999999 99999999999999999999999999
Q ss_pred cCccc
Q 008121 561 LAALT 565 (577)
Q Consensus 561 la~~~ 565 (577)
+++..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99876
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-25 Score=225.54 Aligned_cols=158 Identities=23% Similarity=0.389 Sum_probs=135.9
Q ss_pred cceeccCccceEEEEEE-cCCcEEEEEEcc--ccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe--EEEEEEe
Q 008121 415 EFLIGEGSLGRVYRAEF-ANGKIMAVKKID--NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ--RLLVYEY 489 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e~ 489 (577)
.++||+|+|-+||+|.+ .+|..||--.++ +...+....++|..|+.+|+.|+|||||++|.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 45799999999999965 457777754332 222334556899999999999999999999999987655 7789999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~~~~~~ 568 (577)
+..|+|+.+++ +.+.+..+....|++||++||.|||++ .|+|||||||-+||+|+ ..|.+||+|+|||++...+
T Consensus 125 ~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999997 446678889999999999999999998 68999999999999997 5799999999999999888
Q ss_pred ccccccCCC
Q 008121 569 ERQVITGTS 577 (577)
Q Consensus 569 ~~~~~~Gt~ 577 (577)
....+.|||
T Consensus 200 ~aksvIGTP 208 (632)
T KOG0584|consen 200 HAKSVIGTP 208 (632)
T ss_pred ccceeccCc
Confidence 888899998
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=221.10 Aligned_cols=154 Identities=29% Similarity=0.427 Sum_probs=131.0
Q ss_pred hcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~ 481 (577)
.++|...+.||+|+||.||+|.+. .++.||+|+++... .....+.+.+|++++.++. |||||+++++|...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 345777889999999999999764 24689999997543 2333457899999999997 999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccC---------------------------------------------------------
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADD--------------------------------------------------------- 504 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 504 (577)
..++||||+++|+|.++++..+.
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999974321
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 505 -------------------------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 505 -------------------------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
....+++....+|+.|++.||+|||+. +|+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 112467888999999999999999998 9999999999999
Q ss_pred eCCCCCeEEeccccCcccC
Q 008121 548 LDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~ 566 (577)
+++++.+||+|||+++...
T Consensus 272 l~~~~~~kL~DfGla~~~~ 290 (401)
T cd05107 272 ICEGKLVKICDFGLARDIM 290 (401)
T ss_pred EeCCCEEEEEecCcceecc
Confidence 9999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=210.08 Aligned_cols=150 Identities=27% Similarity=0.470 Sum_probs=130.1
Q ss_pred cCCCccceeccCccceEEEEEE-----cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQ 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~ 482 (577)
.+|...+.||+|+||.||++.. .+++.||+|++... .....+.|.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4677788999999999999974 35789999998643 23446678999999999999999999998754 346
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred eEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 8999999999999999962 234689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCC
Q 008121 563 ALTPN 567 (577)
Q Consensus 563 ~~~~~ 567 (577)
+....
T Consensus 156 ~~~~~ 160 (284)
T cd05081 156 KVLPQ 160 (284)
T ss_pred ccccC
Confidence 97654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=220.07 Aligned_cols=160 Identities=31% Similarity=0.462 Sum_probs=140.7
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
..|...+.||+|.||.||+|.. ..++.||+|++.... ...+.++..+|+.+++.++++||.++||.+..+...|++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3466678999999999999965 568999999997654 34566788999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
||.+|++.+.++ ....+++....-|++++..||.|||.+ +.+|||||+.|||+..+|.+|++|||.+..+.+.
T Consensus 92 y~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 999999999996 445558888888999999999999999 9999999999999999999999999999977654
Q ss_pred c--cccccCCC
Q 008121 569 E--RQVITGTS 577 (577)
Q Consensus 569 ~--~~~~~Gt~ 577 (577)
. +.++.|||
T Consensus 165 ~~rr~tfvGTP 175 (467)
T KOG0201|consen 165 VKRRKTFVGTP 175 (467)
T ss_pred hhccccccccc
Confidence 4 36788997
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=224.49 Aligned_cols=159 Identities=31% Similarity=0.453 Sum_probs=135.7
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccc-ccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA-ALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
..|...+.||.|+||.||-++. .+.+.||||++.-. ..+...-.+++.|+..+.+++|||+|.+.|+|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3456677899999999999965 56889999998522 223444567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|||- |+..|++.- -.+++.+.++..|..|.+.||+|||+. +.||||||+.|||+.+.|.+||+|||-|....+
T Consensus 106 EYCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 106 EYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 9995 577777742 346788999999999999999999999 899999999999999999999999999998654
Q ss_pred CccccccCCC
Q 008121 568 TERQVITGTS 577 (577)
Q Consensus 568 ~~~~~~~Gt~ 577 (577)
.+++.|||
T Consensus 179 --AnsFvGTP 186 (948)
T KOG0577|consen 179 --ANSFVGTP 186 (948)
T ss_pred --hhcccCCc
Confidence 46677886
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=211.83 Aligned_cols=155 Identities=25% Similarity=0.449 Sum_probs=132.3
Q ss_pred hcCCCccceeccCccceEEEEEEc-----------------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCcee
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-----------------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv 471 (577)
.++|+..+.||+|+||.||+++.. ++..||+|+++... ......+|.+|++++++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 356888899999999999998543 23468999986542 334567899999999999999999
Q ss_pred eEeeEEEeCCeEEEEEEecCCCCHHHhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 008121 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD-------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (577)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~ 544 (577)
++++++...+..+++|||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 999999999999999999999999999864321 123578889999999999999999999 9999999999
Q ss_pred CeeeCCCCCeEEeccccCcccCC
Q 008121 545 NILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 545 NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|||+++++.+||+|||+++.+..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eEEEcCCCCEEeccCcccccccC
Confidence 99999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=209.27 Aligned_cols=145 Identities=41% Similarity=0.653 Sum_probs=126.5
Q ss_pred cceeccCccceEEEEEEc-----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 415 EFLIGEGSLGRVYRAEFA-----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
.+.||+|.||.||+|.+. .+..|+||.++.. ......+.|.+|++.+++++||||++++|++...+..++||||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccccc
Confidence 568999999999999887 2578999999653 2344578899999999999999999999999988889999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+++|+|.++|+.. ....+++.++..|+.|+++||.|||+. +|+|+||+++||++++++.+||+|||+++..
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 9999999999743 346789999999999999999999999 8999999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=212.48 Aligned_cols=160 Identities=23% Similarity=0.347 Sum_probs=136.1
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||++... ++..+|+|.++... ......++.+|++++.+++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36888899999999999999764 57889999886432 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.++++ ....+++..+..++.|+++||+|||+.. +++||||||+|||+++++.+||+|||+++.....
T Consensus 80 y~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 80 HMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred ccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999996 2356899999999999999999999742 8999999999999999999999999999876544
Q ss_pred ccccccCC
Q 008121 569 ERQVITGT 576 (577)
Q Consensus 569 ~~~~~~Gt 576 (577)
.....+|+
T Consensus 154 ~~~~~~~~ 161 (308)
T cd06615 154 MANSFVGT 161 (308)
T ss_pred ccccCCCC
Confidence 33333443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=208.58 Aligned_cols=152 Identities=26% Similarity=0.493 Sum_probs=127.9
Q ss_pred CccceeccCccceEEEEEEcCC-c--EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC------CeE
Q 008121 413 SQEFLIGEGSLGRVYRAEFANG-K--IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------GQR 483 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~ 483 (577)
...+.||+|+||.||+|.+.+. . .||+|.++....+....+.|.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999987543 2 689999876544455677899999999999999999999987532 246
Q ss_pred EEEEEecCCCCHHHhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 484 LLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
+++|||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999875322 2335689999999999999999999998 999999999999999999999999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
++....
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 987643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=207.74 Aligned_cols=150 Identities=29% Similarity=0.469 Sum_probs=132.9
Q ss_pred cCCCccceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
++|+..+.||+|+||.||+|.+.. ...||||.++... ......+|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 568888999999999999998743 4579999986543 34445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+|||+++|+|.+++.. ....+++..+.+++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999963 234789999999999999999999998 9999999999999999999999999999977
Q ss_pred C
Q 008121 566 P 566 (577)
Q Consensus 566 ~ 566 (577)
.
T Consensus 157 ~ 157 (266)
T cd05033 157 E 157 (266)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=215.18 Aligned_cols=143 Identities=24% Similarity=0.374 Sum_probs=124.9
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||+++.. +++.||||.++.... .......+..|++++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999775 478999999875421 223455677888888877 699999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 99999886 345689999999999999999999999 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=208.16 Aligned_cols=145 Identities=28% Similarity=0.408 Sum_probs=123.9
Q ss_pred eeccCccceEEEEEEcC---CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 417 LIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
.||+|+||.||+|...+ ...+|+|.+.... .......|.+|++.++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 3568888875432 3344567889999999999999999999999999999999999999
Q ss_pred CHHHhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 494 NLHDMLHFADDS-SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 494 ~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+|.++++..... ....++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccc
Confidence 999999743221 23456888899999999999999999 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=207.72 Aligned_cols=155 Identities=23% Similarity=0.391 Sum_probs=135.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|... +++.||||.++... ........|.+|++++++++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999764 68999999875422 23344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.........+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999865444456688999999999999999999999 999999999999999999999999999887643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=207.75 Aligned_cols=152 Identities=28% Similarity=0.470 Sum_probs=132.3
Q ss_pred cCCCccceeccCccceEEEEEEc----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
.+|...+.||+|+||.||+|... .+..+|+|.++... .....+.|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 45777899999999999999763 23479999986543 23446678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.+++.. ....+++.+++.|+.|++.||+|||+. +++||||||+|||++.++.+|++|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999963 234689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCC
Q 008121 566 PNT 568 (577)
Q Consensus 566 ~~~ 568 (577)
...
T Consensus 157 ~~~ 159 (267)
T cd05066 157 EDD 159 (267)
T ss_pred ccc
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=205.14 Aligned_cols=144 Identities=24% Similarity=0.432 Sum_probs=127.6
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGN 494 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 494 (577)
+.||+|+||.||+|... +++.||+|.+.... .......|.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36999999999999764 68899999886432 34456679999999999999999999999999999999999999999
Q ss_pred HHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 495 LHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 495 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|.++++. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 80 L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 80 FLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccc
Confidence 9999862 234689999999999999999999999 99999999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=211.66 Aligned_cols=155 Identities=25% Similarity=0.445 Sum_probs=131.9
Q ss_pred hcCCCccceeccCccceEEEEEEcC---------------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN---------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l 473 (577)
.++|...+.||+|+||.||++...+ ...||+|.++... .......|.+|++++++++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 3578888999999999999986542 2358999987542 34455679999999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCCHHHhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 008121 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADD--------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (577)
Q Consensus 474 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~N 545 (577)
++++...+..++||||+++++|.+++..... ....+++..+++++.|++.||+|||+. +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999864211 112478999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeccccCcccCC
Q 008121 546 ILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 546 ILl~~~~~~kl~DFGla~~~~~ 567 (577)
|++++++.+||+|||+++....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~ 181 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYS 181 (295)
T ss_pred EEEcCCCcEEeccccccccccc
Confidence 9999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=209.30 Aligned_cols=153 Identities=26% Similarity=0.493 Sum_probs=131.1
Q ss_pred cCCCccceeccCccceEEEEEE-----cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
++|+..+.||+|+||.||+|.+ .+++.||+|.+.... ......+|.+|++++++++||||+++++++...+..|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 3566778999999999999974 346789999987532 2344567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 485 LVYEYVGNGNLHDMLHFAD-------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
+||||+++|+|.+++.... .....+++.+.+.++.|++.||+|||+. +|+||||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 9999999999999985321 0123578999999999999999999999 99999999999999999
Q ss_pred CCeEEeccccCcccC
Q 008121 552 LNPHLSDCGLAALTP 566 (577)
Q Consensus 552 ~~~kl~DFGla~~~~ 566 (577)
+.+||+|||+++...
T Consensus 161 ~~~kl~dfg~~~~~~ 175 (283)
T cd05090 161 LHVKISDLGLSREIY 175 (283)
T ss_pred CcEEecccccccccc
Confidence 999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-23 Score=207.25 Aligned_cols=153 Identities=23% Similarity=0.481 Sum_probs=130.8
Q ss_pred CCccceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe-----
Q 008121 412 FSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ----- 482 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 482 (577)
|...+.||+|+||.||+|.+.. +..||+|+++.........+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999997642 3679999987654445556789999999999999999999999866554
Q ss_pred -EEEEEEecCCCCHHHhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 483 -RLLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 483 -~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
.++++||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999985432 2234689999999999999999999998 9999999999999999999999999
Q ss_pred ccCcccCC
Q 008121 560 GLAALTPN 567 (577)
Q Consensus 560 Gla~~~~~ 567 (577)
|+++....
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=208.09 Aligned_cols=155 Identities=23% Similarity=0.373 Sum_probs=132.4
Q ss_pred hhcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 481 (577)
..++|+..+.||+|+||.||+|.+. .+..||||++.... ......+|.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4567888999999999999998653 24679999986432 2344567899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeE
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDS------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 555 (577)
..++||||+++|+|.++++..... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998643211 23467889999999999999999998 999999999999999999999
Q ss_pred EeccccCcccC
Q 008121 556 LSDCGLAALTP 566 (577)
Q Consensus 556 l~DFGla~~~~ 566 (577)
|+|||+++...
T Consensus 160 l~dfg~~~~~~ 170 (277)
T cd05062 160 IGDFGMTRDIY 170 (277)
T ss_pred ECCCCCccccC
Confidence 99999987543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=233.51 Aligned_cols=151 Identities=28% Similarity=0.401 Sum_probs=133.7
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|.+.+.||+|+||.||+|... +++.||||+++.... .......+.+|+.++..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56788899999999999999775 688999999865322 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++. ...+++..++.|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 99999999999962 34688899999999999999999998 999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=215.21 Aligned_cols=141 Identities=27% Similarity=0.353 Sum_probs=120.5
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcC---CCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL---RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 418 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
||+|+||.||+|+.. +++.||||++...... ......+..|..++... +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999764 5899999998643221 12233455666666655 699999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 99999886 345689999999999999999999999 9999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=207.84 Aligned_cols=146 Identities=27% Similarity=0.374 Sum_probs=125.5
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEccccccch-HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 418 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
||+|+||.||+++.. +|+.||+|++....... .....+..|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999764 58999999986433221 2234566799999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9888632 334588999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=209.24 Aligned_cols=150 Identities=27% Similarity=0.340 Sum_probs=130.2
Q ss_pred CCccceeccCccceEEEEEE-cCCcEEEEEEccccccch-HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
|+..+.||+|+||+||++.. .+++.||+|.+....... .....+.+|++++++++|+||+.+.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999976 468899999986543222 2345578899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 9999999888632 234699999999999999999999998 99999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=216.57 Aligned_cols=154 Identities=25% Similarity=0.422 Sum_probs=129.2
Q ss_pred hcCCCccceeccCccceEEEEEE------cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC-
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH- 480 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~- 480 (577)
.++|...+.||+|+||.||+|.+ .+++.||||+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35788899999999999999963 346889999997543 233456788999999999 689999999988654
Q ss_pred CeEEEEEEecCCCCHHHhhhhccC--------------------------------------------------------
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADD-------------------------------------------------------- 504 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 504 (577)
...+++|||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999999864211
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 505 -------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 505 -------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
....+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 012478889999999999999999999 99999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=209.93 Aligned_cols=157 Identities=27% Similarity=0.480 Sum_probs=134.7
Q ss_pred hhcCCCccceeccCccceEEEEEEcC------CcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 480 (577)
..++|+..+.||+|+||.||++...+ ...+|+|.+.... ......++.+|++++.++ +|+||+++++++...
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34567788899999999999997642 3678999987543 234456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFAD------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl 548 (577)
+..+++|||+++|+|.++++... .....+++..+++++.|++.||+|||+. +|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 99999999999999999986421 2345789999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeccccCcccCCC
Q 008121 549 DDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 549 ~~~~~~kl~DFGla~~~~~~ 568 (577)
++++.+||+|||+++.+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~ 185 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHI 185 (293)
T ss_pred cCCCeEEeCccccccccccc
Confidence 99999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=205.50 Aligned_cols=155 Identities=23% Similarity=0.402 Sum_probs=136.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56888899999999999999776 789999998864322 2334667899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.........+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999875444456689999999999999999999999 999999999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=208.79 Aligned_cols=156 Identities=28% Similarity=0.447 Sum_probs=133.8
Q ss_pred hcCCCccceeccCccceEEEEEEcC-----------------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCcee
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-----------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv 471 (577)
..+|...+.||+|+||.||++...+ +..||+|.+.... .....++|.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4578888999999999999986542 2468999987543 234567799999999999999999
Q ss_pred eEeeEEEeCCeEEEEEEecCCCCHHHhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 008121 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD-------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (577)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~ 544 (577)
++++++..++..+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999974321 123689999999999999999999998 9999999999
Q ss_pred CeeeCCCCCeEEeccccCcccCCC
Q 008121 545 NILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 545 NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
||++++++.+||+|||+++.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~ 183 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSS 183 (296)
T ss_pred ceeecCCCceEEccccceeecccC
Confidence 999999999999999999865433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=208.15 Aligned_cols=151 Identities=27% Similarity=0.363 Sum_probs=130.6
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
|+..+.||+|+||.||++... +++.||+|.+...... ......+..|+.++++++|+||+.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 666788999999999999764 5889999998654322 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 9999999988632 234689999999999999999999998 999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=205.93 Aligned_cols=161 Identities=24% Similarity=0.360 Sum_probs=139.3
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...++||+|.||+|.+++- .+++.+|+|++++... ..++...-..|-++++..+||.+..+...|+..+..|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 5677788999999999999954 5689999999976543 2334445577899999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc--
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT-- 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~-- 565 (577)
||..||.|.-+|. ..+.+++....-+...|+.||.|||++ +||.||+|.+|.|+|.+|++||+|||+++--
T Consensus 248 eyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999998885 356678888888899999999999999 9999999999999999999999999999953
Q ss_pred CCCccccccCCC
Q 008121 566 PNTERQVITGTS 577 (577)
Q Consensus 566 ~~~~~~~~~Gt~ 577 (577)
.....+++||||
T Consensus 321 ~g~t~kTFCGTP 332 (516)
T KOG0690|consen 321 YGDTTKTFCGTP 332 (516)
T ss_pred ccceeccccCCh
Confidence 344558899997
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=215.41 Aligned_cols=155 Identities=25% Similarity=0.430 Sum_probs=130.0
Q ss_pred hcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC-
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH- 480 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~- 480 (577)
.++|.+.+.||+|+||.||+|... +++.||+|+++... .....+.+..|++++.++ +|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 456888999999999999999542 24789999987542 234456788899999999 899999999988654
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCC-------------------------------------------------------
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDS------------------------------------------------------- 505 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------- 505 (577)
...+++|||+++|+|.++++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5688999999999999998632110
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 506 --SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 506 --~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
...++|..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 13689999999999999999999999 999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=205.92 Aligned_cols=149 Identities=26% Similarity=0.468 Sum_probs=131.9
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||+|.+. .++.||+|++... .....++.+|++++++++||||+++++++..++..+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 4667788999999999999765 4889999998643 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++|+|.+++... ....+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 84 MTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999998632 345689999999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=205.44 Aligned_cols=146 Identities=29% Similarity=0.382 Sum_probs=125.5
Q ss_pred eeccCccceEEEEEEcC---CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 417 LIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
.||+|+||.||+|.+.+ +..+|+|.++... .......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999997643 4578999886543 2344567899999999999999999999999999999999999999
Q ss_pred CHHHhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 494 NLHDMLHFADD-SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 494 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+|.++++.... .....++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999974322 234567888889999999999999999 99999999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=207.07 Aligned_cols=152 Identities=26% Similarity=0.462 Sum_probs=135.5
Q ss_pred hhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
+..+|...+.||+|+||.||+|...+++.+|+|.+.... .....++.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 345677888999999999999998889999999987542 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.++++.. ....+++..+.+++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 82 ELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred eecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 999999999999732 345689999999999999999999998 89999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=208.31 Aligned_cols=155 Identities=24% Similarity=0.377 Sum_probs=131.5
Q ss_pred hhcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 481 (577)
..++|...+.||+|+||.||+|... .+..||+|.+.... ......++.+|+..+++++||||+++++++...+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567888999999999999999653 24579999886443 2334556889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeE
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADD------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 555 (577)
..++||||+++|+|.++++.... .....++..+..++.|++.||.|||+. +|+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999974321 123456788899999999999999998 999999999999999999999
Q ss_pred EeccccCcccC
Q 008121 556 LSDCGLAALTP 566 (577)
Q Consensus 556 l~DFGla~~~~ 566 (577)
|+|||+++...
T Consensus 160 L~Dfg~~~~~~ 170 (288)
T cd05061 160 IGDFGMTRDIY 170 (288)
T ss_pred ECcCCcccccc
Confidence 99999998543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=206.14 Aligned_cols=150 Identities=28% Similarity=0.475 Sum_probs=130.3
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|...+.||+|+||.||+|.+.++..||+|+++... ...++|.+|++++++++||||+++++++. .+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 4578889999999999999988777789999987532 23456899999999999999999999874 4568999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+++|+|.++++.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999632 334679999999999999999999998 9999999999999999999999999999866433
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=203.57 Aligned_cols=153 Identities=26% Similarity=0.430 Sum_probs=135.7
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||++... +++.|++|.+..........+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999764 589999999865444456677899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+++++|.++++.. ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999732 345789999999999999999999998 9999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=207.71 Aligned_cols=147 Identities=33% Similarity=0.534 Sum_probs=130.1
Q ss_pred CCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|+..+.||+|+||.||++.... ++.||+|.+..............+|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567889999999999998755 678999999766443444444567999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
++++|.+++. ....+++.++..++.|+++||+|||+. +|+||||||+||++++++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 9999999996 356789999999999999999999999 9999999999999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=207.61 Aligned_cols=153 Identities=26% Similarity=0.469 Sum_probs=132.3
Q ss_pred cCCCccceeccCccceEEEEEE------cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.+|...+.||+|+||.||++.. .++..+|+|.+... .......+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4677889999999999999964 23456899988643 234566799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 008121 484 LLVYEYVGNGNLHDMLHFAD---------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 554 (577)
++||||+++|+|.++++... .....+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999986432 1234589999999999999999999998 99999999999999999999
Q ss_pred EEeccccCcccCC
Q 008121 555 HLSDCGLAALTPN 567 (577)
Q Consensus 555 kl~DFGla~~~~~ 567 (577)
||+|||+++....
T Consensus 160 kl~dfg~~~~~~~ 172 (288)
T cd05093 160 KIGDFGMSRDVYS 172 (288)
T ss_pred EeccCCccccccC
Confidence 9999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=208.34 Aligned_cols=152 Identities=30% Similarity=0.450 Sum_probs=134.2
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||++... +++.||+|.++.... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36778899999999999999765 589999999864322 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999996 336789999999999999999999998 999999999999999999999999999987654
Q ss_pred C
Q 008121 568 T 568 (577)
Q Consensus 568 ~ 568 (577)
.
T Consensus 154 ~ 154 (290)
T cd05580 154 R 154 (290)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=202.97 Aligned_cols=153 Identities=21% Similarity=0.347 Sum_probs=135.1
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|+..+.||+|+||.||.++. .+++.+++|++.....+.....++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477789999999999999865 4588999999865544455667789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+++|+|.+++... ....+++.++..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999632 245689999999999999999999998 9999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=204.88 Aligned_cols=149 Identities=30% Similarity=0.415 Sum_probs=132.1
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35688889999999999999976 568899999986432 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 86 EYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 9999999999986 335689999999999999999999998 99999999999999999999999999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=204.97 Aligned_cols=149 Identities=26% Similarity=0.465 Sum_probs=131.6
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...++||+|+||.||+|...+++.||+|.+.... ...++|.+|++++++++|+||+++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45678889999999999999998889999999987543 23457899999999999999999999864 457899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+++|+|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++...
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999998632 345789999999999999999999998 99999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=205.94 Aligned_cols=154 Identities=21% Similarity=0.371 Sum_probs=131.6
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||+|.. .+++.||+|.+.... ......+|.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 566778999999999999975 568899999986432 234456789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
+++|+|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986542 367888999999999999999999 99999999999999999999999999998765444
Q ss_pred cccccCC
Q 008121 570 RQVITGT 576 (577)
Q Consensus 570 ~~~~~Gt 576 (577)
.....||
T Consensus 150 ~~~~~~~ 156 (279)
T cd06619 150 AKTYVGT 156 (279)
T ss_pred ccCCCCC
Confidence 4434444
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=205.70 Aligned_cols=144 Identities=28% Similarity=0.418 Sum_probs=122.7
Q ss_pred eeccCccceEEEEEEcCC---cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 417 LIGEGSLGRVYRAEFANG---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
.||+|+||.||+++..++ ..+++|.+.... .....+.|.+|+.+++.++||||++++++|......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999976543 345667665432 2345678999999999999999999999999999999999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+|.++++.........++.....++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccc
Confidence 99999975433344567778889999999999999998 999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=222.33 Aligned_cols=149 Identities=26% Similarity=0.339 Sum_probs=123.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC-------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------- 480 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------- 480 (577)
..+|...+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 457888999999999999999764 58899999885321 2235699999999999999999887432
Q ss_pred -CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEec
Q 008121 481 -GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSD 558 (577)
Q Consensus 481 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~D 558 (577)
...++||||+++ +|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 246799999975 78887764444556799999999999999999999999 999999999999999654 799999
Q ss_pred cccCcccCC
Q 008121 559 CGLAALTPN 567 (577)
Q Consensus 559 FGla~~~~~ 567 (577)
||+|+.+..
T Consensus 215 FGla~~~~~ 223 (440)
T PTZ00036 215 FGSAKNLLA 223 (440)
T ss_pred cccchhccC
Confidence 999987644
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=209.36 Aligned_cols=152 Identities=29% Similarity=0.518 Sum_probs=129.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCc--EEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 484 (577)
.++|+..+.||+|+||.||+|.+. ++. .+|+|.++.. ........|.+|++++.++ +||||+++++++...+..|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 356778889999999999999864 344 4577776542 2344566789999999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008121 485 LVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~ 552 (577)
+||||+++|+|.++++.... ....+++.+++.++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 99999999999999974321 124688999999999999999999998 999999999999999999
Q ss_pred CeEEeccccCcc
Q 008121 553 NPHLSDCGLAAL 564 (577)
Q Consensus 553 ~~kl~DFGla~~ 564 (577)
.+||+|||+++.
T Consensus 162 ~~kl~dfg~~~~ 173 (303)
T cd05088 162 VAKIADFGLSRG 173 (303)
T ss_pred cEEeCccccCcc
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=204.40 Aligned_cols=149 Identities=29% Similarity=0.489 Sum_probs=130.8
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|...+.||+|+||.||+|...++..+|+|.++.... ..+.|.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 46777889999999999999888888999999875432 2456899999999999999999999875 4568999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++++|.++++.. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999999632 345689999999999999999999999 999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=205.85 Aligned_cols=153 Identities=29% Similarity=0.516 Sum_probs=131.5
Q ss_pred cCCCccceeccCccceEEEEEEcC------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
++|+..+.||+|+||.||+|.... ...||+|.++... ......+|.+|++.+++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 357778899999999999997643 2579999986442 334456789999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 484 LLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
+++|||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999964311 115688999999999999999999999 99999999999999999
Q ss_pred CCeEEeccccCcccC
Q 008121 552 LNPHLSDCGLAALTP 566 (577)
Q Consensus 552 ~~~kl~DFGla~~~~ 566 (577)
+.+||+|||+++...
T Consensus 161 ~~~~L~dfg~~~~~~ 175 (283)
T cd05048 161 LTVKISDFGLSRDIY 175 (283)
T ss_pred CcEEECCCcceeecc
Confidence 999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=206.67 Aligned_cols=153 Identities=25% Similarity=0.471 Sum_probs=132.5
Q ss_pred cCCCccceeccCccceEEEEEEcC------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
++|...+.||+|+||.||+|...+ ++.||||.++... .....+.|.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 456777899999999999997643 4789999986543 233467899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhcc----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008121 484 LLVYEYVGNGNLHDMLHFAD----------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~ 553 (577)
++||||+++|+|.++++... .....+++.++..++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999997432 1234578999999999999999999999 9999999999999999999
Q ss_pred eEEeccccCcccC
Q 008121 554 PHLSDCGLAALTP 566 (577)
Q Consensus 554 ~kl~DFGla~~~~ 566 (577)
+||+|||+++...
T Consensus 161 ~kl~d~g~~~~~~ 173 (280)
T cd05049 161 VKIGDFGMSRDVY 173 (280)
T ss_pred EEECCcccceecc
Confidence 9999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=210.87 Aligned_cols=148 Identities=24% Similarity=0.374 Sum_probs=128.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||+|.++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 45788899999999999999765 578899999864422 2234457889999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 85 YLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred CCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceec
Confidence 9975 88888752 234578999999999999999999999 9999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-23 Score=202.89 Aligned_cols=144 Identities=27% Similarity=0.442 Sum_probs=125.6
Q ss_pred eeccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 417 LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
.||+|+||.||+|.++ +++.+|+|+++.........+++.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999653 57889999987554444556789999999999999999999998864 4678999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999996 234689999999999999999999998 9999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=196.24 Aligned_cols=157 Identities=28% Similarity=0.403 Sum_probs=138.7
Q ss_pred HhhcCCCccceeccCccceEEEEE-EcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC-----
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH----- 480 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----- 480 (577)
...++|.+.+.||+|||..||.++ ..++..+|+|++.... .++.+..++|++..++++||||+++++++..+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 345688899999999999999996 5678999999996543 56677889999999999999999999987533
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
.+.|++++|...|+|.+.+...+..+..+++.+.++|+.+|++||++||+. .|+++||||||.|||+.+.+.+++.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 358999999999999999987777777899999999999999999999998 3569999999999999999999999999
Q ss_pred cCcccC
Q 008121 561 LAALTP 566 (577)
Q Consensus 561 la~~~~ 566 (577)
-+...+
T Consensus 175 S~~~a~ 180 (302)
T KOG2345|consen 175 SATQAP 180 (302)
T ss_pred Cccccc
Confidence 988653
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=204.12 Aligned_cols=151 Identities=29% Similarity=0.494 Sum_probs=134.7
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||++...+++.||||.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45788889999999999999998888899999987543 234668999999999999999999999998889999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++++|.+++... ....+++..+..++.|++.|+.|||+. +|+|+||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999632 335689999999999999999999999 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=205.53 Aligned_cols=150 Identities=27% Similarity=0.388 Sum_probs=126.4
Q ss_pred cCCCccceeccCccceEEEEEEc-CCc----EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
++|...+.||+|+||.||+|.+. +++ .+++|.+.... ......++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 45677889999999999999764 344 47888875332 23344678888889999999999999998864 4578
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+++||+++|+|.++++. ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 85 ~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 89999999999999963 245689999999999999999999998 899999999999999999999999999987
Q ss_pred cCC
Q 008121 565 TPN 567 (577)
Q Consensus 565 ~~~ 567 (577)
...
T Consensus 159 ~~~ 161 (279)
T cd05111 159 LYP 161 (279)
T ss_pred ccC
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-23 Score=201.75 Aligned_cols=142 Identities=25% Similarity=0.418 Sum_probs=123.3
Q ss_pred eccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCC
Q 008121 418 IGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGN 494 (577)
Q Consensus 418 lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 494 (577)
||+|+||.||+|.+. ++..||+|.+.... .....+.|.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 899999999999764 35579999986542 33445679999999999999999999998864 57899999999999
Q ss_pred HHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 495 LHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 495 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|.+++.. ....+++..+++++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 9999862 345789999999999999999999998 999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=203.64 Aligned_cols=155 Identities=26% Similarity=0.393 Sum_probs=130.1
Q ss_pred cCCCccceeccCccceEEEEEEcC-----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe-CCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~ 483 (577)
..|+....||+|.||.||+|...+ .+.+|+|+++...........-.+|+.+++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 457778899999999999995432 3478999997653222334456789999999999999999999877 7789
Q ss_pred EEEEEecCCCCHHHhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC----CCeEEec
Q 008121 484 LLVYEYVGNGNLHDMLHFADD-SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE----LNPHLSD 558 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~----~~~kl~D 558 (577)
|+++||.+. ||.+.|+..+. ..+.++......|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 99999987543 346789999999999999999999999 69999999999999766 8999999
Q ss_pred cccCcccCCC
Q 008121 559 CGLAALTPNT 568 (577)
Q Consensus 559 FGla~~~~~~ 568 (577)
||+|+++.+.
T Consensus 180 lGlaR~~~~p 189 (438)
T KOG0666|consen 180 LGLARLFNNP 189 (438)
T ss_pred ccHHHHhhcc
Confidence 9999987654
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=214.25 Aligned_cols=148 Identities=23% Similarity=0.305 Sum_probs=127.0
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 481 (577)
.++|...+.||+|+||.||++.. .+++.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46788899999999999999976 45899999998754434445667889999999999999999999986543
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..|+||||+++ +|.+.++ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 47999999965 6766664 2478888999999999999999999 999999999999999999999999999
Q ss_pred CcccC
Q 008121 562 AALTP 566 (577)
Q Consensus 562 a~~~~ 566 (577)
++...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-23 Score=202.83 Aligned_cols=149 Identities=28% Similarity=0.494 Sum_probs=129.3
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|...+.||+|+||.||++...++..+|+|.+.... ...+.|.+|++++++++|+|++++++++. .+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4577788999999999999988877789999886432 23456889999999999999999998875 4568999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++|+|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 82 MGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 9999999999632 334589999999999999999999998 999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=205.27 Aligned_cols=155 Identities=23% Similarity=0.362 Sum_probs=132.9
Q ss_pred hcCCCccceeccCccceEEEEEEcC------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
.++|...+.||+|+||.||+|...+ +..||+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4567788999999999999997642 3689999986443 23445678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 008121 483 RLLVYEYVGNGNLHDMLHFADD------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl 556 (577)
.++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 9999999999999999964321 123578999999999999999999998 9999999999999999999999
Q ss_pred eccccCcccCC
Q 008121 557 SDCGLAALTPN 567 (577)
Q Consensus 557 ~DFGla~~~~~ 567 (577)
+|||+++....
T Consensus 161 ~dfg~~~~~~~ 171 (277)
T cd05032 161 GDFGMTRDIYE 171 (277)
T ss_pred CCcccchhhcc
Confidence 99999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=208.31 Aligned_cols=155 Identities=26% Similarity=0.477 Sum_probs=132.1
Q ss_pred hcCCCccceeccCccceEEEEEEc--------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 479 (577)
..+|.+.+.||+|+||.||++... ++..||+|.+.... .....+++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 456777889999999999999642 24579999886432 234556789999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
.+..+++|||+++|+|.+++..... ....+++.+++.++.|+++||+|||+. +|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999974321 124578899999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccCcccCC
Q 008121 548 LDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~~ 567 (577)
+++++.+||+|||+++....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 170 VTENNVMKIADFGLARDVNN 189 (304)
T ss_pred EcCCCcEEECCCccceeccc
Confidence 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-23 Score=200.95 Aligned_cols=143 Identities=26% Similarity=0.459 Sum_probs=127.6
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
++||+|+||.||+|...+++.+|+|.++... .......|.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3699999999999998889999999986543 233455789999999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
.+++.. ....+++..+..++.|++.||.|+|+. +++||||||+||++++++.+||+|||++...
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 143 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQE 143 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceec
Confidence 998852 234578999999999999999999998 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=206.06 Aligned_cols=152 Identities=24% Similarity=0.411 Sum_probs=132.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35778889999999999999875 58999999986443223334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|++++.|..+++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988887764 344689999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=206.95 Aligned_cols=162 Identities=24% Similarity=0.328 Sum_probs=136.3
Q ss_pred ecHHHHHHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEE
Q 008121 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (577)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~ 477 (577)
+.+.++..+.++|...+.||+|+||.||++... +++.+|+|.+... .....++..|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 444556677889999999999999999999764 5789999987542 22345678899999999 699999999988
Q ss_pred E-----eCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008121 478 A-----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (577)
Q Consensus 478 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~ 552 (577)
. .++..++||||+++|+|.++++........+++..+..++.|+++||.|||+. +|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 4 34568999999999999998864333445788999999999999999999998 999999999999999999
Q ss_pred CeEEeccccCcccCC
Q 008121 553 NPHLSDCGLAALTPN 567 (577)
Q Consensus 553 ~~kl~DFGla~~~~~ 567 (577)
.+||+|||+++....
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (286)
T cd06638 162 GVKLVDFGVSAQLTS 176 (286)
T ss_pred CEEEccCCceeeccc
Confidence 999999999986543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=202.13 Aligned_cols=149 Identities=31% Similarity=0.526 Sum_probs=132.8
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||+|... ++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 346777889999999999999875 7889999997542 246779999999999999999999999998889999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+++++|.++++.. ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 81 YMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999999632 223689999999999999999999999 99999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=230.00 Aligned_cols=169 Identities=22% Similarity=0.313 Sum_probs=136.8
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCeEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRL 484 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~ 484 (577)
..++|.+.+.||+|+||.||++... +++.||+|.+............|..|+.+++.++|||||+++++|.. ....|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3467888999999999999999764 47788999987554445566789999999999999999999998854 35689
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeeecCCCCCCeeeCC----------
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL----PSVVHRNFKSANILLDD---------- 550 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~----~~ivHrDlk~~NILl~~---------- 550 (577)
+||||+++|+|.++|.........+++..++.|+.||+.||+|||+... .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999997543344679999999999999999999998521 25999999999999964
Q ss_pred -------CCCeEEeccccCcccCCCcc-ccccCC
Q 008121 551 -------ELNPHLSDCGLAALTPNTER-QVITGT 576 (577)
Q Consensus 551 -------~~~~kl~DFGla~~~~~~~~-~~~~Gt 576 (577)
.+.+||+|||+++....... ....||
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGT 204 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGT 204 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccccccCCC
Confidence 23589999999987643322 233455
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=213.72 Aligned_cols=151 Identities=20% Similarity=0.346 Sum_probs=129.0
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC------
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 480 (577)
..++|...+.||+|+||.||+|.. .+++.||||++..........+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 346788899999999999999976 4678999999875433334456678999999999999999999887533
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
...|+++|++ +++|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3578999988 789988874 34689999999999999999999999 99999999999999999999999999
Q ss_pred cCcccCC
Q 008121 561 LAALTPN 567 (577)
Q Consensus 561 la~~~~~ 567 (577)
+++....
T Consensus 164 ~~~~~~~ 170 (343)
T cd07878 164 LARQADD 170 (343)
T ss_pred cceecCC
Confidence 9987644
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-23 Score=205.40 Aligned_cols=152 Identities=28% Similarity=0.472 Sum_probs=129.7
Q ss_pred CCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
+|...+.||+|+||.||+|... ....+++|.+.... .....+++.+|+.++++++||||+++++++...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 3667789999999999999653 23578888886543 2344567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhcc--------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 008121 485 LVYEYVGNGNLHDMLHFAD--------------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~ 544 (577)
+++||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 9999999999999986421 1124588999999999999999999998 9999999999
Q ss_pred CeeeCCCCCeEEeccccCcccC
Q 008121 545 NILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 545 NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++++.+||+|||+++...
T Consensus 157 nill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred eEEEcCCCcEEecccccccccc
Confidence 9999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-23 Score=206.88 Aligned_cols=152 Identities=30% Similarity=0.514 Sum_probs=129.3
Q ss_pred cCCCccceeccCccceEEEEEEcC-Cc--EEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 485 (577)
++|...+.||+|+||.||+|...+ +. .+++|.++... .....+.|.+|+++++++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 467888999999999999997754 33 47888876422 234456789999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008121 486 VYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~ 553 (577)
++||+++|+|.++++.... ....+++..+..|+.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 9999999999999964221 123588999999999999999999998 9999999999999999999
Q ss_pred eEEeccccCccc
Q 008121 554 PHLSDCGLAALT 565 (577)
Q Consensus 554 ~kl~DFGla~~~ 565 (577)
+||+|||++...
T Consensus 158 ~kl~dfg~~~~~ 169 (297)
T cd05089 158 SKIADFGLSRGE 169 (297)
T ss_pred EEECCcCCCccc
Confidence 999999998743
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=206.59 Aligned_cols=152 Identities=26% Similarity=0.419 Sum_probs=129.4
Q ss_pred CCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
|...+.||+|+||.||+|... +++.||+|+++... .....+.|.+|+.++..++||||+++++++...+..++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 555678999999999999763 25789999997543 23345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008121 486 VYEYVGNGNLHDMLHFAD------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~ 553 (577)
++||+++++|.+++.... .....+++..+.+++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985211 1124588899999999999999999999 9999999999999999999
Q ss_pred eEEeccccCcccCC
Q 008121 554 PHLSDCGLAALTPN 567 (577)
Q Consensus 554 ~kl~DFGla~~~~~ 567 (577)
+||+|||+++....
T Consensus 163 ~kl~Dfg~~~~~~~ 176 (283)
T cd05091 163 VKISDLGLFREVYA 176 (283)
T ss_pred eEeccccccccccc
Confidence 99999999886543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=206.81 Aligned_cols=156 Identities=20% Similarity=0.334 Sum_probs=133.5
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|+..+.||+|+||.||++... +++.||+|.++... .......+.+|++++.+++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 5677889999999999999875 68999999886432 333456789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
+++++|.++++... ....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999886321 1347899999999999999999999642 89999999999999999999999999998664433
Q ss_pred c
Q 008121 570 R 570 (577)
Q Consensus 570 ~ 570 (577)
.
T Consensus 158 ~ 158 (286)
T cd06622 158 A 158 (286)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-23 Score=207.65 Aligned_cols=153 Identities=28% Similarity=0.405 Sum_probs=132.0
Q ss_pred hcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 481 (577)
.++|...+.||+|+||.||++... .+..||+|+++... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 356888899999999999999642 24579999986542 233456789999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..+++|||+++|+|.++++.. ....+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+|++|||+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999632 233489999999999999999999998 999999999999999999999999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
++....
T Consensus 188 ~~~~~~ 193 (302)
T cd05055 188 ARDIMN 193 (302)
T ss_pred cccccC
Confidence 986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-23 Score=205.12 Aligned_cols=150 Identities=23% Similarity=0.435 Sum_probs=129.9
Q ss_pred CCCccceeccCccceEEEEEE-----cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQR 483 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 483 (577)
.|...+.||+|+||.||++.+ .+++.||+|.++... .......+.+|++++++++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 457788999999999999974 347889999986442 234456799999999999999999999998775 568
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 999999999999999852 234689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
....
T Consensus 158 ~~~~ 161 (284)
T cd05079 158 AIET 161 (284)
T ss_pred cccc
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=218.28 Aligned_cols=144 Identities=22% Similarity=0.282 Sum_probs=126.8
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
...|...+.||+|+||.||++.+. .++.||||.... ..+.+|++++++++|+|||++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 457889999999999999999775 478899996421 23568999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+. |+|.+++.. ....++|.+++.|+.|+++||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 240 e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 240 PKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 9995 799988852 234799999999999999999999999 999999999999999999999999999987643
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-23 Score=204.18 Aligned_cols=151 Identities=23% Similarity=0.419 Sum_probs=129.3
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCc----EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.++|...+.||+|+||.||+|.+. +++ .||+|.++... ......++.+|+.++..++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 346777889999999999999753 444 48999986542 344566788999999999999999999998754 57
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++++||+++|+|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 84 ~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 899999999999999863 235689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
....
T Consensus 158 ~~~~ 161 (279)
T cd05109 158 LLDI 161 (279)
T ss_pred eccc
Confidence 7643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=204.55 Aligned_cols=141 Identities=26% Similarity=0.359 Sum_probs=119.7
Q ss_pred eeccCccceEEEEEEcC-------------------------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCcee
Q 008121 417 LIGEGSLGRVYRAEFAN-------------------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv 471 (577)
.||+|+||.||+|.+.. ...||+|.+.... .....+|.+|+++++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999996421 1358899886432 23456788999999999999999
Q ss_pred eEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
+++++|.+....++||||+++|+|.++++. ....+++..+++++.|+++||+|||+. +|+||||||+|||+++.
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999999999999999999999999998862 245688999999999999999999998 99999999999999865
Q ss_pred C-------CeEEeccccCccc
Q 008121 552 L-------NPHLSDCGLAALT 565 (577)
Q Consensus 552 ~-------~~kl~DFGla~~~ 565 (577)
+ .+|++|||++...
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred CcccCccceeeecCCcccccc
Confidence 4 3799999988643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=208.12 Aligned_cols=153 Identities=27% Similarity=0.466 Sum_probs=131.3
Q ss_pred cCCCccceeccCccceEEEEEEc--------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 480 (577)
++|...+.||+|+||.||++... +...+|+|.++... ......++.+|++++.++ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 46788899999999999999652 23579999987542 234456788899999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl 548 (577)
+..|+||||+++|+|.+++..... ....+++.++++++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999974321 123589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeccccCcccC
Q 008121 549 DDELNPHLSDCGLAALTP 566 (577)
Q Consensus 549 ~~~~~~kl~DFGla~~~~ 566 (577)
++++.+||+|||+++...
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=204.44 Aligned_cols=155 Identities=24% Similarity=0.385 Sum_probs=135.2
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||++.. .+++.+|||.+.... .......+|.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999975 578999999876432 22334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++++|.++++........+++..+..++.|+++||+|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875444456789999999999999999999999 999999999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=201.55 Aligned_cols=150 Identities=23% Similarity=0.413 Sum_probs=132.0
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||++.+.++..+|+|.+... ....+.|.+|++++++++|+||+++++++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3567788999999999999998888888999988643 2345678999999999999999999999877 77899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++|+|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999632 345678999999999999999999998 999999999999999999999999999986644
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=202.16 Aligned_cols=151 Identities=26% Similarity=0.498 Sum_probs=132.0
Q ss_pred cCCCccceeccCccceEEEEEEc-CC---cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NG---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
++|+..+.||+|+||.||+|... ++ ..+|+|+++... .....+++..|++++++++||||+++.+++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 46777889999999999999764 23 378999986542 23446678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++++|.++++. ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999863 235689999999999999999999999 9999999999999999999999999999866
Q ss_pred CC
Q 008121 566 PN 567 (577)
Q Consensus 566 ~~ 567 (577)
..
T Consensus 158 ~~ 159 (268)
T cd05063 158 ED 159 (268)
T ss_pred cc
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-23 Score=204.60 Aligned_cols=154 Identities=27% Similarity=0.396 Sum_probs=128.6
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHH-hhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSN-MSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||++... +|+.||+|+++..... ....++..|++. ++..+||||+++++++..++..|++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 36778899999999999999775 5899999998754322 233445556654 66678999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||++ |+|.++++........+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 6898888654334567899999999999999999999863 799999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=201.69 Aligned_cols=150 Identities=28% Similarity=0.398 Sum_probs=131.9
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc---hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
++|...+.||+|+||.||++.. .+++.||+|.+...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999976 46899999988643221 2234578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+||+++++|.+++. ....+++..+.+++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999986 335688999999999999999999999 9999999999999999999999999999865
Q ss_pred C
Q 008121 566 P 566 (577)
Q Consensus 566 ~ 566 (577)
.
T Consensus 155 ~ 155 (263)
T cd06625 155 Q 155 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=200.44 Aligned_cols=150 Identities=29% Similarity=0.423 Sum_probs=132.1
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccc---cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA---LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
+|...+.||+|+||.||+|... +++.|++|.+.... ...+..+.+.+|++++++++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999876 78999999885432 1233556789999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++++|.++++ ....+++..+..++.|+++||+|||+. +|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999996 234688999999999999999999999 99999999999999999999999999988654
Q ss_pred C
Q 008121 567 N 567 (577)
Q Consensus 567 ~ 567 (577)
.
T Consensus 154 ~ 154 (258)
T cd06632 154 E 154 (258)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=203.00 Aligned_cols=154 Identities=28% Similarity=0.402 Sum_probs=131.8
Q ss_pred hcCCCccceeccCccceEEEEEEcC------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
+++|...+.||+|+||.||+|.+.+ +..||+|.+.... .......|.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4668888999999999999997753 5678999886432 23445679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEE
Q 008121 483 RLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHL 556 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl 556 (577)
.++||||+++|+|.++++.... ....+++..+++++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999975321 123589999999999999999999999 899999999999998654 6999
Q ss_pred eccccCcccC
Q 008121 557 SDCGLAALTP 566 (577)
Q Consensus 557 ~DFGla~~~~ 566 (577)
+|||+++...
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=202.31 Aligned_cols=148 Identities=26% Similarity=0.404 Sum_probs=130.9
Q ss_pred CCCccceeccCccceEEEEEEcCCcEEEEEEccccccc----hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS----LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
+|...+.||+|+||.||+|...+++.+|+|.+...... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778899999999999998888999999988643211 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999996 234688999999999999999999998 8999999999999999999999999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=204.65 Aligned_cols=150 Identities=25% Similarity=0.393 Sum_probs=130.1
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|+..+.||+|+||.||+|... +++.||+|+++...........+.+|+.++.+++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999774 689999999865432333346688899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
++ ++|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 97 68988886322 235789999999999999999999999 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-24 Score=231.52 Aligned_cols=169 Identities=25% Similarity=0.282 Sum_probs=144.0
Q ss_pred HHHHHHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEe
Q 008121 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (577)
Q Consensus 402 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 479 (577)
+..++...++|.+.++||+|+||.|..++++ +++.||.|++.+-... .....-|.+|-.+|...+.+-||++...|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3456666788999999999999999999875 4788999999753222 2345568889999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
+.+.|+|||||+||||..++. .-..+++..+.-++..|+-||.-||+. ++|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999995 223799999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccCCCcc---ccccCCC
Q 008121 560 GLAALTPNTER---QVITGTS 577 (577)
Q Consensus 560 Gla~~~~~~~~---~~~~Gt~ 577 (577)
|-+-.+..... .+..|||
T Consensus 220 GsClkm~~dG~V~s~~aVGTP 240 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTP 240 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCC
Confidence 98776654433 4455887
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=202.49 Aligned_cols=150 Identities=29% Similarity=0.501 Sum_probs=131.1
Q ss_pred CCCccceeccCccceEEEEEEcC-C---cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFAN-G---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.|...+.||+|+||.||+|.+.. + ..||||.+.... ......+|..|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46678899999999999997753 3 369999986542 344567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.++++. ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999863 234689999999999999999999998 99999999999999999999999999988654
Q ss_pred C
Q 008121 567 N 567 (577)
Q Consensus 567 ~ 567 (577)
.
T Consensus 158 ~ 158 (269)
T cd05065 158 D 158 (269)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=204.21 Aligned_cols=146 Identities=29% Similarity=0.504 Sum_probs=126.7
Q ss_pred CccceeccCccceEEEEEE-----cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeEEE
Q 008121 413 SQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLL 485 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 485 (577)
...+.||+|+||+||++.. .+++.||+|.++... .......|.+|++++++++||||+++++++... ...++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 7778999999999988643 357889999986542 233456788999999999999999999988654 35789
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+|||+++|+|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999985 23589999999999999999999999 9999999999999999999999999999876
Q ss_pred CC
Q 008121 566 PN 567 (577)
Q Consensus 566 ~~ 567 (577)
..
T Consensus 158 ~~ 159 (283)
T cd05080 158 PE 159 (283)
T ss_pred CC
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=203.79 Aligned_cols=156 Identities=23% Similarity=0.381 Sum_probs=134.0
Q ss_pred hhcCCCccceeccCccceEEEEEEcC-----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe-CC
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HG 481 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~ 481 (577)
..++|...+.||+|+||.||+|.+.+ +..|++|++... ........+.+|+.++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34678888999999999999998765 688999988643 234456778999999999999999999998876 46
Q ss_pred eEEEEEEecCCCCHHHhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDS----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~ 557 (577)
..++++||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998643222 25689999999999999999999998 99999999999999999999999
Q ss_pred ccccCcccCC
Q 008121 558 DCGLAALTPN 567 (577)
Q Consensus 558 DFGla~~~~~ 567 (577)
|||+++.+..
T Consensus 160 d~g~~~~~~~ 169 (280)
T cd05043 160 DNALSRDLFP 169 (280)
T ss_pred CCCCcccccC
Confidence 9999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=203.78 Aligned_cols=153 Identities=24% Similarity=0.454 Sum_probs=131.0
Q ss_pred cCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.+|...+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|++.+++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 34667789999999999999642 34568999886432 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 484 LLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999964221 124589999999999999999999999 99999999999999999
Q ss_pred CCeEEeccccCcccCC
Q 008121 552 LNPHLSDCGLAALTPN 567 (577)
Q Consensus 552 ~~~kl~DFGla~~~~~ 567 (577)
+.+||+|||+++....
T Consensus 160 ~~~~l~dfg~a~~~~~ 175 (291)
T cd05094 160 LLVKIGDFGMSRDVYS 175 (291)
T ss_pred CcEEECCCCcccccCC
Confidence 9999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=212.98 Aligned_cols=150 Identities=21% Similarity=0.297 Sum_probs=128.1
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC------
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 480 (577)
..++|...+.||+|+||.||++... .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3467888999999999999999764 588999999875443444566788999999999999999999988643
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
...++||||+++ ++.+.+. ..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999965 6777664 2478899999999999999999999 99999999999999999999999999
Q ss_pred cCcccCC
Q 008121 561 LAALTPN 567 (577)
Q Consensus 561 la~~~~~ 567 (577)
+++....
T Consensus 165 ~~~~~~~ 171 (355)
T cd07874 165 LARTAGT 171 (355)
T ss_pred ccccCCC
Confidence 9987544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=213.78 Aligned_cols=152 Identities=28% Similarity=0.490 Sum_probs=132.9
Q ss_pred CCccceeccCccceEEEEEEcC---Cc--EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEFAN---GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
....+.||+|.||.||+|.+.+ |+ .||||..+... ..+..+.|+.|..+|+.++|||||+++|.|.+. ..|+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 4456789999999999997643 33 58999887643 455578899999999999999999999999875 68999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||.++-|.|..+|+. ....++......++.||+.||+|||+. ++|||||.++|||+...--+|++|||+++.++
T Consensus 469 mEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 469 MELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 999999999999973 456788889999999999999999999 99999999999999999999999999999987
Q ss_pred CCccc
Q 008121 567 NTERQ 571 (577)
Q Consensus 567 ~~~~~ 571 (577)
++...
T Consensus 543 d~~yY 547 (974)
T KOG4257|consen 543 DDAYY 547 (974)
T ss_pred ccchh
Confidence 76654
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-23 Score=206.04 Aligned_cols=150 Identities=29% Similarity=0.400 Sum_probs=130.9
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc---hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
+|...+.||+|+||.||+|... +++.||||+++..... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999764 5899999999754332 22345577899999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+ +|+|.++++.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 99999999621 23689999999999999999999999 99999999999999999999999999998764
Q ss_pred C
Q 008121 567 N 567 (577)
Q Consensus 567 ~ 567 (577)
.
T Consensus 154 ~ 154 (298)
T cd07841 154 S 154 (298)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=203.89 Aligned_cols=152 Identities=27% Similarity=0.457 Sum_probs=130.3
Q ss_pred HhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC----
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH---- 480 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~---- 480 (577)
.+++.|...+.||+|+||.||+|... +++.||+|++... ......+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 35567888889999999999999764 5788999998643 23345688899999998 699999999998753
Q ss_pred --CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEec
Q 008121 481 --GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (577)
Q Consensus 481 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D 558 (577)
...|++|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 4689999999999999998632 235688999999999999999999999 999999999999999999999999
Q ss_pred cccCcccC
Q 008121 559 CGLAALTP 566 (577)
Q Consensus 559 FGla~~~~ 566 (577)
||+++...
T Consensus 155 fg~~~~~~ 162 (272)
T cd06637 155 FGVSAQLD 162 (272)
T ss_pred CCCceecc
Confidence 99998654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=206.79 Aligned_cols=154 Identities=27% Similarity=0.482 Sum_probs=131.8
Q ss_pred hcCCCccceeccCccceEEEEEEc--------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 479 (577)
..+|...+.||+|+||.||++... ....+|+|.++... ......++..|++++.++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 356778899999999999999642 24578999987532 234466788999999999 69999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
.+..+++|||+++|+|.+++..... ....+++.++++++.|++.||+|||+. +|+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 9999999999999999999964321 224689999999999999999999998 9999999999999
Q ss_pred eCCCCCeEEeccccCcccC
Q 008121 548 LDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~ 566 (577)
+++++.+||+|||+++...
T Consensus 167 l~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 167 VTEDNVMKIADFGLARGVH 185 (314)
T ss_pred EcCCCcEEEcccccccccc
Confidence 9999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=201.24 Aligned_cols=142 Identities=29% Similarity=0.426 Sum_probs=121.9
Q ss_pred ceeccCccceEEEEEEcCCc-----------EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 416 FLIGEGSLGRVYRAEFANGK-----------IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
+.||+|+||.||+|.+.+.. .|++|.+.... .....|.+|+.++++++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46999999999999876433 57778765432 126778999999999999999999999988 7789
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-------CeEEe
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-------NPHLS 557 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-------~~kl~ 557 (577)
+||||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 77 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999999632 23689999999999999999999998 999999999999999887 79999
Q ss_pred ccccCcccCC
Q 008121 558 DCGLAALTPN 567 (577)
Q Consensus 558 DFGla~~~~~ 567 (577)
|||+++....
T Consensus 151 Dfg~a~~~~~ 160 (259)
T cd05037 151 DPGIPITVLS 160 (259)
T ss_pred CCCccccccc
Confidence 9999987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=200.42 Aligned_cols=145 Identities=30% Similarity=0.545 Sum_probs=124.0
Q ss_pred ceeccCccceEEEEEEcC-Cc--EEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEEEecC
Q 008121 416 FLIGEGSLGRVYRAEFAN-GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
+.||+|+||.||+|.+.+ +. .+++|.++... .....+.+.+|++++.++ +||||+++++++...+..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998754 43 46888876432 234556789999999999 79999999999999999999999999
Q ss_pred CCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 492 NGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 492 ~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
+|+|.++++.... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 9999999964321 123588999999999999999999998 9999999999999999999999999
Q ss_pred ccCcc
Q 008121 560 GLAAL 564 (577)
Q Consensus 560 Gla~~ 564 (577)
|+++.
T Consensus 157 gl~~~ 161 (270)
T cd05047 157 GLSRG 161 (270)
T ss_pred CCccc
Confidence 99863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=204.05 Aligned_cols=153 Identities=29% Similarity=0.476 Sum_probs=132.7
Q ss_pred hcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
.++|...+.||+|+||.||++... ++..||+|.+.... ......+|.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 467888899999999999999763 46789999987542 33445679999999999999999999999999889
Q ss_pred EEEEEEecCCCCHHHhhhhcc------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 008121 483 RLLVYEYVGNGNLHDMLHFAD------------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~ 544 (577)
.+++|||+++|+|.+++.... .....+++.+++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999996421 1123578899999999999999999998 9999999999
Q ss_pred CeeeCCCCCeEEeccccCccc
Q 008121 545 NILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 545 NILl~~~~~~kl~DFGla~~~ 565 (577)
||++++++.+||+|||+++..
T Consensus 160 nil~~~~~~~~l~dfg~~~~~ 180 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNI 180 (288)
T ss_pred heEecCCCceEECccccceec
Confidence 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=204.75 Aligned_cols=149 Identities=27% Similarity=0.405 Sum_probs=132.5
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
..+|...+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 35788889999999999999976 568999999986543 234566889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++++|.+++. ...+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 96 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 96 EYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred cccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999999985 24578999999999999999999998 999999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=207.13 Aligned_cols=145 Identities=22% Similarity=0.302 Sum_probs=126.2
Q ss_pred cceeccC--ccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecC
Q 008121 415 EFLIGEG--SLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 415 ~~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
.++||+| +|++||++.. .+|+.||+|+++.........+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7889999966 568999999997554334455667889999999999999999999999999999999999
Q ss_pred CCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 492 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++|||.+..
T Consensus 83 ~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 83 YGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred CCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhc
Confidence 99999998632 234589999999999999999999998 999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=207.80 Aligned_cols=160 Identities=24% Similarity=0.334 Sum_probs=139.7
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
-|..++.||+|.|..|-++++ =+|+.||||++.+...+......+.+|++-|+-++|||||++|++....-..|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 366678899999999999954 4799999999988777666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~~~~~~ 568 (577)
-++|||+|+|-. ....+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- +-|-+||+|||++..+.+.
T Consensus 99 GD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999953 345688999999999999999999999 899999999999875 5689999999999866544
Q ss_pred c-cccccCC
Q 008121 569 E-RQVITGT 576 (577)
Q Consensus 569 ~-~~~~~Gt 576 (577)
+ -.++||.
T Consensus 173 ~kL~TsCGS 181 (864)
T KOG4717|consen 173 KKLTTSCGS 181 (864)
T ss_pred chhhcccch
Confidence 4 4677774
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=213.98 Aligned_cols=148 Identities=26% Similarity=0.382 Sum_probs=128.0
Q ss_pred CCCccceeccCccceEEEEE-EcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-C-----CceeeEeeEEEeCCeE
Q 008121 411 SFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-H-----PNIVTLAGYCAEHGQR 483 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~~~~~~~~~~ 483 (577)
+|.+.+.||+|+||+|.+|. ..+++.||||+++.. .....+-..|+.+|..++ | -|+|++++||..+++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 78889999999999999995 466999999999765 344555677899998887 4 3799999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC--CCeEEecccc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE--LNPHLSDCGL 561 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~--~~~kl~DFGl 561 (577)
|||+|.++. +|+++|+.. .-..++......|+.||+.||.+||+. +|||+||||+||||.+. ..+||+|||.
T Consensus 264 ciVfELL~~-NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhhhh-hHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999955 999999844 445689999999999999999999999 99999999999999753 4799999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
|.....
T Consensus 338 Sc~~~q 343 (586)
T KOG0667|consen 338 SCFESQ 343 (586)
T ss_pred ccccCC
Confidence 987543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-23 Score=211.60 Aligned_cols=144 Identities=20% Similarity=0.288 Sum_probs=125.8
Q ss_pred HhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
....+|...+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++...+..++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 34457999999999999999999775 4678999975432 13468899999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+. |+|.+++.. ....+++..+..|+.||+.||.|||+. +||||||||+|||++.++.+||+|||+++..
T Consensus 135 v~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 135 VLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 999995 689888852 345789999999999999999999999 9999999999999999999999999999853
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=198.44 Aligned_cols=149 Identities=32% Similarity=0.530 Sum_probs=131.1
Q ss_pred ceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecC
Q 008121 416 FLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
+.||+|+||.||+|.... +..|++|.++...... ..+++.+|++.+..++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999997754 7889999997653322 46788999999999999999999999999999999999999
Q ss_pred CCCHHHhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 492 NGNLHDMLHFADDS-----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 492 ~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+|+|.++++..... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999743111 46789999999999999999999998 99999999999999999999999999999776
Q ss_pred CC
Q 008121 567 NT 568 (577)
Q Consensus 567 ~~ 568 (577)
..
T Consensus 157 ~~ 158 (262)
T cd00192 157 DD 158 (262)
T ss_pred cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=201.70 Aligned_cols=150 Identities=25% Similarity=0.446 Sum_probs=129.6
Q ss_pred cCCCccceeccCccceEEEEEEcC-Cc----EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-GK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.+|...+.||+|+||.||+|.+.+ |+ .+|+|.+.... ......++.+|++++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 456777899999999999997643 32 58999886543 24456678999999999999999999999987 7889
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999863 234589999999999999999999998 999999999999999999999999999987
Q ss_pred cCC
Q 008121 565 TPN 567 (577)
Q Consensus 565 ~~~ 567 (577)
...
T Consensus 159 ~~~ 161 (279)
T cd05057 159 LDV 161 (279)
T ss_pred ccC
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=199.93 Aligned_cols=156 Identities=29% Similarity=0.428 Sum_probs=134.7
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCeEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLVY 487 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 487 (577)
+|...+.||+|+||.||++.. .+++.||+|.+..........+++..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366778999999999999965 467899999987554455566788999999999999999999998764 34679999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-----EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-----~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
||+++++|.+++.........+++..++.++.|++.||+||| +. +|+|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999754444567999999999999999999999 65 8999999999999999999999999999
Q ss_pred cccCCCc
Q 008121 563 ALTPNTE 569 (577)
Q Consensus 563 ~~~~~~~ 569 (577)
+......
T Consensus 158 ~~~~~~~ 164 (265)
T cd08217 158 KILGHDS 164 (265)
T ss_pred ccccCCc
Confidence 9765433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=201.25 Aligned_cols=147 Identities=28% Similarity=0.429 Sum_probs=129.3
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|+..+.||+|+||.||++... ++..+++|.+... .....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 455678999999999999775 4778899988643 2345667899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
++|+|.+++.. ....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 85 ~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 85 AGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccc
Confidence 99999988752 245789999999999999999999999 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=200.98 Aligned_cols=152 Identities=21% Similarity=0.379 Sum_probs=130.7
Q ss_pred cCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
++|...+.||+|+||.||+|... +.+.|++|.+.... .....++|.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 46778889999999999999764 24678999886432 122456799999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEec
Q 008121 484 LLVYEYVGNGNLHDMLHFADDS-----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D 558 (577)
++||||+++|+|.++++..... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999743211 12689999999999999999999999 999999999999999999999999
Q ss_pred cccCccc
Q 008121 559 CGLAALT 565 (577)
Q Consensus 559 FGla~~~ 565 (577)
||+++..
T Consensus 161 ~~~~~~~ 167 (275)
T cd05046 161 LSLSKDV 167 (275)
T ss_pred ccccccc
Confidence 9998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=201.76 Aligned_cols=148 Identities=30% Similarity=0.436 Sum_probs=130.6
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 45667788999999999999764 58899999986442 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+++|+|.++++ ....+++.+...++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 87 FCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred ccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999999986 345689999999999999999999999 99999999999999999999999999987543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=210.99 Aligned_cols=149 Identities=21% Similarity=0.289 Sum_probs=127.5
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC------C
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------G 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 481 (577)
.++|...+.||+|+||.||++... .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467888999999999999999764 588999999975443344556788999999999999999999987543 3
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..|+||||+++ +|.+.+. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999965 7877774 2478889999999999999999999 999999999999999999999999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
++....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=198.72 Aligned_cols=148 Identities=26% Similarity=0.508 Sum_probs=130.9
Q ss_pred CCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
+|+..+.||+|+||.||++.+.++..+|+|.+..... ...+|.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4666788999999999999887788999999865432 3456899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
++|+|.++++. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++...+
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999999862 234678999999999999999999999 899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=198.93 Aligned_cols=145 Identities=29% Similarity=0.424 Sum_probs=127.2
Q ss_pred ceeccCccceEEEEEEcC--C--cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecC
Q 008121 416 FLIGEGSLGRVYRAEFAN--G--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...++|.+|++++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999997743 3 36899999765433 556789999999999999999999999988 88999999999
Q ss_pred CCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 492 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+|+|.+++.... ...+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 79 LGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999997322 15789999999999999999999999 999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=206.43 Aligned_cols=141 Identities=20% Similarity=0.225 Sum_probs=113.8
Q ss_pred hcCCCccceeccCccceEEEEEEc--CCcEEEEEEcccccc---chHHHHHHHHHHHHhhcCCCCceee-EeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVT-LAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~~ 482 (577)
..+|...+.||+|+||+||+|.+. +++.||||++..... .....+.|.+|++++++++|+|++. ++++ +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 456888999999999999999764 577889998753211 2234567999999999999999985 4432 46
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeeCCCCCeEEecccc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF-KSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl-k~~NILl~~~~~~kl~DFGl 561 (577)
.|+||||+++++|.. +. ... ...++.|+++||+|||+. +|+|||| ||+|||++.++.+||+|||+
T Consensus 93 ~~LVmE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cEEEEEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 799999999999963 21 111 146788999999999999 9999999 99999999999999999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
|+.+..
T Consensus 159 A~~~~~ 164 (365)
T PRK09188 159 ASVFRR 164 (365)
T ss_pred ceeccc
Confidence 997654
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=204.35 Aligned_cols=148 Identities=26% Similarity=0.371 Sum_probs=130.6
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||++... +++.||+|.+...... ....+.+.+|++++..++||||+++++.+..+++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36778899999999999999765 4789999998654321 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 9999999999996 235689999999999999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=203.52 Aligned_cols=151 Identities=29% Similarity=0.411 Sum_probs=122.8
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcC---CCCceeeEeeEEEe-----CC
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVTLAGYCAE-----HG 481 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~ 481 (577)
+|...+.||+|+||.||+|... +++.||+|.++...........+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999765 588999999865432222233455666666554 79999999998864 24
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..+++|||++ ++|.++++.. ....+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 5898888632 234589999999999999999999999 999999999999999999999999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
++....
T Consensus 155 ~~~~~~ 160 (288)
T cd07863 155 ARIYSC 160 (288)
T ss_pred cccccC
Confidence 987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=202.21 Aligned_cols=151 Identities=25% Similarity=0.360 Sum_probs=133.8
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999764 689999999876543344466789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+ +++|.++++. ....+++.++..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 9999999863 236689999999999999999999999 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=196.78 Aligned_cols=144 Identities=27% Similarity=0.457 Sum_probs=128.7
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
+.||+|+||.||++...+++.||+|++...... .....|.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999998877999999998754332 3566799999999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
.++++. ....+++..++.++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 999863 234678999999999999999999999 99999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=206.87 Aligned_cols=154 Identities=28% Similarity=0.475 Sum_probs=131.1
Q ss_pred cCCCccceeccCccceEEEEEEcC--------CcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 480 (577)
.+|...+.||+|+||.||++.... +..||+|.++... .....+++.+|++++.++ +||||++++++|...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 457788999999999999996421 2368999886432 334567789999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl 548 (577)
+..+++|||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 999999999999999999964221 234588999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeccccCcccCC
Q 008121 549 DDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 549 ~~~~~~kl~DFGla~~~~~ 567 (577)
++++.+||+|||+++....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 168 TEDNVMKIADFGLARDVHN 186 (334)
T ss_pred cCCCcEEECCcccceeccc
Confidence 9999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=205.24 Aligned_cols=151 Identities=25% Similarity=0.392 Sum_probs=132.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35777899999999999999875 48999999986544333345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++++|.++.. ....+++.++..++.|+++||+|||+. +|+||||+|+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999998888764 234589999999999999999999998 999999999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=203.85 Aligned_cols=153 Identities=22% Similarity=0.348 Sum_probs=132.3
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|+..+.||+|+||+||++... +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 45667788999999999999765 58899999876432 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.++++ ..+.+++..+..++.|++.||.|||+.. +|+||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999886 2356899999999999999999999742 7999999999999999999999999998765443
Q ss_pred c
Q 008121 569 E 569 (577)
Q Consensus 569 ~ 569 (577)
.
T Consensus 158 ~ 158 (284)
T cd06620 158 I 158 (284)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=198.80 Aligned_cols=149 Identities=28% Similarity=0.371 Sum_probs=127.9
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc---chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 483 (577)
.+|...+.||+|+||.||++... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 36788899999999999999764 589999998753211 123456788999999999999999999988763 467
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
+++|||+++|+|.+++. ....+++....+++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999986 234578888999999999999999999 99999999999999999999999999998
Q ss_pred cc
Q 008121 564 LT 565 (577)
Q Consensus 564 ~~ 565 (577)
..
T Consensus 155 ~~ 156 (265)
T cd06652 155 RL 156 (265)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=196.85 Aligned_cols=151 Identities=26% Similarity=0.386 Sum_probs=131.7
Q ss_pred HHHHHHhhcCCCccceeccCccceEEEE-EEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEe
Q 008121 402 VASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAE 479 (577)
Q Consensus 402 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~ 479 (577)
+.+....+ .+.||+|+|+.|--| ...+|..+|||++.+.. ...+.+..+|++++..++ |+||+++++||.+
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 45555555 368999999999998 46789999999997663 455677889999999995 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCeEE
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHL 556 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl 556 (577)
+...|||||-|.||.|...|+ ..+.+++.++.++.++|+.||.|||.+ +|.|||+||+|||-.+. .-+||
T Consensus 148 d~~FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred cceEEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 999999999999999999997 467789999999999999999999999 99999999999999654 35899
Q ss_pred eccccCcccC
Q 008121 557 SDCGLAALTP 566 (577)
Q Consensus 557 ~DFGla~~~~ 566 (577)
|||.++.-..
T Consensus 221 CDfDLgSg~k 230 (463)
T KOG0607|consen 221 CDFDLGSGIK 230 (463)
T ss_pred eccccccccc
Confidence 9999877543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=201.58 Aligned_cols=153 Identities=23% Similarity=0.350 Sum_probs=131.9
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLVY 487 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 487 (577)
+|...+.||.|++|.||++... +++.+|+|.+.... ......++.+|++++++++||||++++++|... +..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 5777889999999999999874 57899999986442 234567789999999999999999999998654 4689999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++++|.+++.........+++.....|+.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998865444456789999999999999999999998 999999999999999999999999999876443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=197.57 Aligned_cols=152 Identities=28% Similarity=0.398 Sum_probs=131.5
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe-CCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e 488 (577)
+|+..+.||+|++|.||++... +++.||+|++..........+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4777899999999999999764 57889999987554444556678999999999999999999988764 446789999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++++|.++++.. ....+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999999632 345689999999999999999999999 999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=203.79 Aligned_cols=147 Identities=27% Similarity=0.414 Sum_probs=130.9
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.+|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++......|+|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 4677888999999999999975 468899999986543 2335668899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+++|+|.++++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 98 YLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred ccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 999999999985 23578999999999999999999999 99999999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-24 Score=218.40 Aligned_cols=158 Identities=27% Similarity=0.416 Sum_probs=135.7
Q ss_pred CCccceeccCccceEEEEEEcCCc-EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEFANGK-IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|.+...||.|+||.||++..++.. ..|.|.+.-. +..+.++|+-||++|+.++||+||+|++.|..++..|++.|||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 445567999999999999776544 4466777533 4567788999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC--CC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP--NT 568 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~--~~ 568 (577)
.||-...++-+ -...|++.++..+++|++.||.|||++ .|||||||+.|||+.-+|.++|+|||.+.... -.
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 99999888753 467899999999999999999999999 99999999999999999999999999876543 34
Q ss_pred ccccccCCC
Q 008121 569 ERQVITGTS 577 (577)
Q Consensus 569 ~~~~~~Gt~ 577 (577)
++..+.|||
T Consensus 186 kRDsFIGTP 194 (1187)
T KOG0579|consen 186 KRDSFIGTP 194 (1187)
T ss_pred hhccccCCc
Confidence 457888987
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=202.29 Aligned_cols=150 Identities=28% Similarity=0.415 Sum_probs=133.0
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|.+.+.||+|+||.||++... +++.||+|.+... .....+.|.+|++++++++||||+++++++..++..|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 346778889999999999999774 5889999998643 3445667999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 82 e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 82 EFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999999863 235689999999999999999999999 99999999999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=196.97 Aligned_cols=151 Identities=25% Similarity=0.392 Sum_probs=132.1
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||++... +++.+|+|.++... .....+.+.+|+.++++++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4677889999999999999764 58899999986432 233456788899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++|+|.+++... ....+++.....++.|++.||.|||+. +|+|+||||+||++++++.++++|||+++....
T Consensus 80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 80 CDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 9999999988632 345678999999999999999999999 999999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=201.15 Aligned_cols=153 Identities=28% Similarity=0.347 Sum_probs=122.9
Q ss_pred eeccCccceEEEEEEc-CCcEEEEEEccccccchH-HHHHHHHHHHH---hhcCCCCceeeEeeEEEeCCeEEEEEEecC
Q 008121 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ-EEDNFLEAVSN---MSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~---l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
.||+|+||.||++... +++.+|+|.+........ ....+.+|..+ +...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 588999998865432222 22334444433 334579999999999999999999999999
Q ss_pred CCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCccc
Q 008121 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (577)
Q Consensus 492 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 571 (577)
+|+|.+++. ....+++..+..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (279)
T cd05633 81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (279)
T ss_pred CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence 999999886 345689999999999999999999999 9999999999999999999999999999765443333
Q ss_pred cccCC
Q 008121 572 VITGT 576 (577)
Q Consensus 572 ~~~Gt 576 (577)
...||
T Consensus 154 ~~~~~ 158 (279)
T cd05633 154 ASVGT 158 (279)
T ss_pred CcCCC
Confidence 33343
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=200.90 Aligned_cols=152 Identities=27% Similarity=0.470 Sum_probs=130.8
Q ss_pred cCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.+|...+.||+|+||.||++... ++..+|+|.+... .......|.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 45667789999999999999642 3568899988643 344566899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008121 484 LLVYEYVGNGNLHDMLHFADD-----------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~ 552 (577)
+++|||+++|+|.++++.... ....+++..++.++.|++.|++|||+. +|+||||||+|||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 999999999999999874321 113588999999999999999999998 999999999999999999
Q ss_pred CeEEeccccCcccC
Q 008121 553 NPHLSDCGLAALTP 566 (577)
Q Consensus 553 ~~kl~DFGla~~~~ 566 (577)
.+||+|||+++...
T Consensus 160 ~~kL~dfg~~~~~~ 173 (280)
T cd05092 160 VVKIGDFGMSRDIY 173 (280)
T ss_pred CEEECCCCceeEcC
Confidence 99999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=200.69 Aligned_cols=149 Identities=26% Similarity=0.466 Sum_probs=130.3
Q ss_pred CCCccceeccCccceEEEEEEc-----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCeE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQR 483 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~ 483 (577)
.|...+.||+|+||.||++.+. +++.||||.++..... ...++|.+|++++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 4566788999999999999764 3688999998755332 346789999999999999999999999877 5578
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
+++|||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999963 233589999999999999999999998 99999999999999999999999999998
Q ss_pred ccC
Q 008121 564 LTP 566 (577)
Q Consensus 564 ~~~ 566 (577)
...
T Consensus 158 ~~~ 160 (284)
T cd05038 158 VLP 160 (284)
T ss_pred ccc
Confidence 765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=197.79 Aligned_cols=152 Identities=26% Similarity=0.410 Sum_probs=133.7
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|+..+.||+|+||.||++.. .+++.||+|++...........++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999966 4688999999865443445566789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++++|.+++... ....+++.++.+++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999998632 234678999999999999999999998 999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=198.68 Aligned_cols=149 Identities=28% Similarity=0.446 Sum_probs=130.0
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc-------hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
+|.....||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999976 45789999988643221 1123568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.+++|||+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999996 335688999999999999999999998 9999999999999999999999999998
Q ss_pred cccC
Q 008121 563 ALTP 566 (577)
Q Consensus 563 ~~~~ 566 (577)
+...
T Consensus 154 ~~~~ 157 (267)
T cd06628 154 KKLE 157 (267)
T ss_pred cccc
Confidence 8765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=203.03 Aligned_cols=161 Identities=27% Similarity=0.402 Sum_probs=136.8
Q ss_pred ecHHHHHHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEE
Q 008121 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (577)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~ 477 (577)
+++.++..++++|...+.||+|+||.||++.. .+++.+|+|.+.... ....++.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 44455666788999999999999999999976 468899999986431 2345677889999988 899999999998
Q ss_pred EeC-----CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008121 478 AEH-----GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (577)
Q Consensus 478 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~ 552 (577)
... +..++||||+++|+|.++++........+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 754 358999999999999999864333456789999999999999999999998 999999999999999999
Q ss_pred CeEEeccccCcccC
Q 008121 553 NPHLSDCGLAALTP 566 (577)
Q Consensus 553 ~~kl~DFGla~~~~ 566 (577)
.+||+|||+++...
T Consensus 166 ~~kl~dfg~~~~~~ 179 (291)
T cd06639 166 GVKLVDFGVSAQLT 179 (291)
T ss_pred CEEEeecccchhcc
Confidence 99999999988654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=197.29 Aligned_cols=143 Identities=27% Similarity=0.423 Sum_probs=124.2
Q ss_pred ceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecC
Q 008121 416 FLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
+.||+|+||.||+|.+.. +..+|+|.+...... ...+++.+|+.++++++||||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999996532 268999998765432 45677999999999999999999999876 446899999999
Q ss_pred CCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 492 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+|+|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 79 ~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 79 LGPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeec
Confidence 999999996 234789999999999999999999998 999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=205.27 Aligned_cols=165 Identities=28% Similarity=0.340 Sum_probs=142.7
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchH-HHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQ-EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
..+.|..-++||+|+||.||-|.. .+|+.+|.|++.++..... .+.--+.|-.++.+++.+.||.+-..|.+.+..|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 346788889999999999999966 4599999999876544333 34455788999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+..|.||||.-+|... ....+++..++-++.+|+.||++||+. +||.||+||+|||||++|+++|+|.|||..+
T Consensus 263 VLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999888633 336799999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCccccc-cCCC
Q 008121 566 PNTERQVI-TGTS 577 (577)
Q Consensus 566 ~~~~~~~~-~Gt~ 577 (577)
++.+.... .||.
T Consensus 338 ~~g~~~~~rvGT~ 350 (591)
T KOG0986|consen 338 PEGKPIRGRVGTV 350 (591)
T ss_pred CCCCccccccCcc
Confidence 88777554 7773
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=200.99 Aligned_cols=151 Identities=25% Similarity=0.342 Sum_probs=133.8
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
+|...+.||+|+||.||++... +++.||+|.+...... ....+.+.+|++++++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777889999999999999775 5899999998654322 2456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++++|.+++. ....+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999996 235789999999999999999999998 9999999999999999999999999998865443
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=197.68 Aligned_cols=147 Identities=31% Similarity=0.503 Sum_probs=127.7
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEE-eCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA-EHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e 488 (577)
++|...+.||+|+||.||++... +..||+|.++.. ...+.|.+|+.++++++|+|++++++++. ..+..+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46777889999999999999765 778999988643 23457899999999999999999999765 4567899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+++|+|.++++.. ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 81 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecc
Confidence 99999999998632 234588999999999999999999998 99999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=200.66 Aligned_cols=148 Identities=26% Similarity=0.438 Sum_probs=131.6
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
+.|+..+.||+|+||.||+|... +++.|++|.+... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 56778889999999999999775 4889999998643 34456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|+++++|..++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 90 FCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred cCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999888752 234689999999999999999999998 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=203.90 Aligned_cols=149 Identities=26% Similarity=0.387 Sum_probs=129.0
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||+|.++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46778899999999999999764 578999999864321 2234457789999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|++ ++|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 85 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 85 YLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 997 599888853 244688999999999999999999999 99999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=198.25 Aligned_cols=143 Identities=30% Similarity=0.373 Sum_probs=121.4
Q ss_pred ceeccCccceEEEEEEcC-------------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 416 FLIGEGSLGRVYRAEFAN-------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
+.||+|+||.||+|.+.+ ...|++|.+.... ......|.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999997532 2358888876432 3345578889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-------eE
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-------PH 555 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~-------~k 555 (577)
.++||||+++|+|..+++. ....+++..+.+++.|+++||+|||+. +|+||||||+|||++.++. +|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999888852 235689999999999999999999999 9999999999999987664 89
Q ss_pred EeccccCcccC
Q 008121 556 LSDCGLAALTP 566 (577)
Q Consensus 556 l~DFGla~~~~ 566 (577)
++|||++....
T Consensus 153 l~d~g~~~~~~ 163 (262)
T cd05077 153 LSDPGIPITVL 163 (262)
T ss_pred eCCCCCCcccc
Confidence 99999987553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=198.19 Aligned_cols=150 Identities=29% Similarity=0.436 Sum_probs=133.9
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||+|... +++.||+|.++.........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999764 688999999876544344677899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++++|.++++ ....+++..+..|+.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 99999999986 334578999999999999999999999 999999999999999999999999999887643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=199.00 Aligned_cols=152 Identities=25% Similarity=0.321 Sum_probs=130.3
Q ss_pred HhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
.+++++.....||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 44566666778999999999999764 57789999886542 3455678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeccccC
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNL--TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLA 562 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla 562 (577)
|+||+++++|.++++.. ...+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999999632 2334 7888899999999999999998 9999999999999986 679999999998
Q ss_pred cccC
Q 008121 563 ALTP 566 (577)
Q Consensus 563 ~~~~ 566 (577)
....
T Consensus 157 ~~~~ 160 (268)
T cd06624 157 KRLA 160 (268)
T ss_pred eecc
Confidence 7653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=203.38 Aligned_cols=151 Identities=29% Similarity=0.412 Sum_probs=133.4
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch-HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
+|...+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|+++++.++|+||+++++.+......|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5778889999999999999775 48999999987543322 345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+++++|.+++.. .....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 82 YCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred ecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 9999999999862 2346789999999999999999999999 99999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=212.05 Aligned_cols=144 Identities=22% Similarity=0.269 Sum_probs=126.3
Q ss_pred hcCCCccceeccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
..+|...+.||+|+||.||+|... .++.||+|.+... ..+.+|++++++++|||||++++++...+..++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 357888999999999999999653 3578999987532 234679999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+|||+. ++|.+++. ....+++.+++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 68988884 346789999999999999999999999 9999999999999999999999999999865
Q ss_pred CC
Q 008121 566 PN 567 (577)
Q Consensus 566 ~~ 567 (577)
..
T Consensus 236 ~~ 237 (392)
T PHA03207 236 DA 237 (392)
T ss_pred Cc
Confidence 44
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=204.70 Aligned_cols=145 Identities=23% Similarity=0.427 Sum_probs=119.7
Q ss_pred cceeccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCeEEEEEEe
Q 008121 415 EFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLVYEY 489 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 489 (577)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 457999999999999764 46789999986432 23346789999999999999999998854 4568899999
Q ss_pred cCCCCHHHhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCeEEeccc
Q 008121 490 VGNGNLHDMLHFAD-----DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCG 560 (577)
Q Consensus 490 ~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl----~~~~~~kl~DFG 560 (577)
++ ++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 95 58888875321 1223588999999999999999999999 99999999999999 456799999999
Q ss_pred cCcccCC
Q 008121 561 LAALTPN 567 (577)
Q Consensus 561 la~~~~~ 567 (577)
+|+....
T Consensus 158 ~a~~~~~ 164 (317)
T cd07868 158 FARLFNS 164 (317)
T ss_pred ceeccCC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=197.40 Aligned_cols=152 Identities=24% Similarity=0.470 Sum_probs=128.0
Q ss_pred CCccceeccCccceEEEEEEc----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC------
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 481 (577)
|...+.||+|+||.||+|.+. +++.||||.+..........+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999753 3688999998765544556777899999999999999999999886532
Q ss_pred eEEEEEEecCCCCHHHhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
..++++||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875321 2233578999999999999999999998 9999999999999999999999999
Q ss_pred ccCcccC
Q 008121 560 GLAALTP 566 (577)
Q Consensus 560 Gla~~~~ 566 (577)
|+++...
T Consensus 158 g~~~~~~ 164 (273)
T cd05074 158 GLSKKIY 164 (273)
T ss_pred ccccccc
Confidence 9998654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=197.34 Aligned_cols=149 Identities=26% Similarity=0.384 Sum_probs=128.7
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc---chHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~ 483 (577)
.+|...+.||+|+||.||++.. .++..||+|++..... .......+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688889999999999999976 4588999998864321 12345578899999999999999999998865 3577
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++++||+++++|.+++. ....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999996 334588999999999999999999998 99999999999999999999999999988
Q ss_pred cc
Q 008121 564 LT 565 (577)
Q Consensus 564 ~~ 565 (577)
..
T Consensus 155 ~~ 156 (266)
T cd06651 155 RL 156 (266)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=202.47 Aligned_cols=148 Identities=26% Similarity=0.393 Sum_probs=128.6
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 56788899999999999999775 688999999864321 1223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|++ ++|.+++.. ....+++.....++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 84 ~~~-~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 84 YLD-TDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred cCC-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccccccc
Confidence 997 499998863 234688999999999999999999999 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-23 Score=191.79 Aligned_cols=144 Identities=19% Similarity=0.229 Sum_probs=110.5
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccchHH------------------------HHHHHHHHHHhhcCCCCce
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE------------------------EDNFLEAVSNMSRLRHPNI 470 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~H~ni 470 (577)
...||+|+||.||+|...+|+.||||+++....+... ......|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999998888999999998654221111 1122348999999988876
Q ss_pred eeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCCeeeC
Q 008121 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL-HEVCLPSVVHRNFKSANILLD 549 (577)
Q Consensus 471 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivHrDlk~~NILl~ 549 (577)
.....+.. ...++||||++++++..... ....+++.+...++.|++.+|+|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333322 23489999999887765432 234688999999999999999999 677 899999999999998
Q ss_pred CCCCeEEeccccCcccCCC
Q 008121 550 DELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 550 ~~~~~kl~DFGla~~~~~~ 568 (577)
++.++|+|||+|......
T Consensus 153 -~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred -CCcEEEEEccccccCCCc
Confidence 478999999999866544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=196.40 Aligned_cols=144 Identities=30% Similarity=0.536 Sum_probs=122.0
Q ss_pred ceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEE-eCCeEEEEEEec
Q 008121 416 FLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA-EHGQRLLVYEYV 490 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~ 490 (577)
+.||+|+||.||+|.+.+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999997632 3579999985432 2345677889999999999999999999876 455688999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
++|+|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 80 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 80 KHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999962 234567888899999999999999998 99999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=199.02 Aligned_cols=149 Identities=26% Similarity=0.390 Sum_probs=129.2
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc--------hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS--------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 481 (577)
+|...+.||+|+||.||+|.. .+++.||+|.++..... ....+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778999999999999965 46889999987532111 112346788999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..++||||+++|+|.++++. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999962 35689999999999999999999998 999999999999999999999999999
Q ss_pred CcccC
Q 008121 562 AALTP 566 (577)
Q Consensus 562 a~~~~ 566 (577)
++...
T Consensus 155 ~~~~~ 159 (272)
T cd06629 155 SKKSD 159 (272)
T ss_pred ccccc
Confidence 98654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=203.06 Aligned_cols=149 Identities=23% Similarity=0.361 Sum_probs=129.4
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999774 689999999865433333345678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
++ ++|.+++.. ....+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 97 588888752 245689999999999999999999999 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=201.13 Aligned_cols=150 Identities=26% Similarity=0.329 Sum_probs=128.5
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
++++|...+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+++++.++|+||+++++++...+..|+|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 346788899999999999999976 4688999999865432 22334577899999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||++ +++.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 82 FEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred Eeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 99995 688777642 234578888999999999999999999 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=198.24 Aligned_cols=153 Identities=29% Similarity=0.348 Sum_probs=124.0
Q ss_pred eeccCccceEEEEEE-cCCcEEEEEEccccccch-HHHHHHHHHH---HHhhcCCCCceeeEeeEEEeCCeEEEEEEecC
Q 008121 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL-QEEDNFLEAV---SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~---~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
.||+|+||.||++.. .+++.||+|.+....... .....+..|. ..++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999976 458899999986543221 1222233443 34555689999999999999999999999999
Q ss_pred CCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCccc
Q 008121 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (577)
Q Consensus 492 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 571 (577)
+|+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 153 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence 999999885 345799999999999999999999998 8999999999999999999999999999866544444
Q ss_pred cccCC
Q 008121 572 VITGT 576 (577)
Q Consensus 572 ~~~Gt 576 (577)
..+||
T Consensus 154 ~~~~~ 158 (278)
T cd05606 154 ASVGT 158 (278)
T ss_pred CcCCC
Confidence 44444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=197.92 Aligned_cols=150 Identities=27% Similarity=0.417 Sum_probs=128.4
Q ss_pred cCCCccceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
++|...+.||+|+||.||+|.+.+ ...||||...... .....+.|.+|+.++++++||||+++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 457778899999999999997643 2468999886442 23456679999999999999999999998875 46789
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999963 234589999999999999999999998 9999999999999999999999999999865
Q ss_pred CC
Q 008121 566 PN 567 (577)
Q Consensus 566 ~~ 567 (577)
..
T Consensus 158 ~~ 159 (270)
T cd05056 158 ED 159 (270)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=195.74 Aligned_cols=150 Identities=29% Similarity=0.501 Sum_probs=134.3
Q ss_pred hcCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|...+ ++.+++|.+.... ..+++.+|++++++++||||+++++++......|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 3578888999999999999998765 7899999986432 2677999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++++|.+++.. ....+++..+..++.|+++||.|||+. +|+||||+|+||++++++.+||+|||++.....
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999852 346789999999999999999999999 999999999999999999999999999987654
Q ss_pred C
Q 008121 568 T 568 (577)
Q Consensus 568 ~ 568 (577)
.
T Consensus 152 ~ 152 (256)
T cd06612 152 T 152 (256)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-23 Score=213.79 Aligned_cols=154 Identities=30% Similarity=0.453 Sum_probs=134.1
Q ss_pred CCccceeccCccceEEEEEEc--CCc--EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA--NGK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
....++||+|.||.|++|.|. .|+ .||||.++...... ..++|++|+.+|.+|+|+|+++|||...+ ....+|+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 344678999999999999885 354 57999998765433 67889999999999999999999999987 5788999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|.++.|+|.+.|+. .....+.......++.|||.||.||.++ ++|||||.++|+|+...-.+||+||||.+-+..
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999985 3456788888999999999999999999 999999999999999999999999999998766
Q ss_pred Ccccc
Q 008121 568 TERQV 572 (577)
Q Consensus 568 ~~~~~ 572 (577)
.+...
T Consensus 265 ned~Y 269 (1039)
T KOG0199|consen 265 NEDMY 269 (1039)
T ss_pred CCcce
Confidence 55543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=196.43 Aligned_cols=146 Identities=30% Similarity=0.495 Sum_probs=127.1
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|...+.||+|+||.||++.. +++.||+|.++.. ...+.+.+|+.++++++||||+++++++... ..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4577889999999999999975 5788999998643 2345788999999999999999999998654 57999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+++|+|.++++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 80 MSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 9999999999632 234688999999999999999999998 99999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=200.93 Aligned_cols=151 Identities=28% Similarity=0.383 Sum_probs=132.4
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|+..+.||+|+||.||+|... +++.||+|+++.........+.+.+|++++++++|+||+++++++...+..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778899999999999999775 588999999875443444467789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
++++.+..+.. ....+++.++..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 82 VERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99877766553 345589999999999999999999999 9999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=200.32 Aligned_cols=150 Identities=23% Similarity=0.347 Sum_probs=129.7
Q ss_pred CCCccceeccCccceEEEEEE----cCCcEEEEEEcccccc--chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 483 (577)
+|+..+.||+|+||.||++.. .+|+.||+|+++.... .....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999976 3688999999864321 122346678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++||||+++++|.+++. ....+++.....++.|+++||.|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999986 235688999999999999999999998 99999999999999999999999999998
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
....
T Consensus 154 ~~~~ 157 (290)
T cd05613 154 EFHE 157 (290)
T ss_pred eccc
Confidence 7544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=195.77 Aligned_cols=151 Identities=30% Similarity=0.474 Sum_probs=133.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++...+..|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 357888899999999999999764 57889999986542 234677899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++++|.++++. ....+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 80 EYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred eCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999999863 235689999999999999999999998 999999999999999999999999999886543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=200.71 Aligned_cols=150 Identities=27% Similarity=0.410 Sum_probs=131.0
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|+..+.||+|+||.||+|... +++.||||+++...........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777889999999999999764 688999999865433333446788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+. ++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 95 6899888632 345689999999999999999999998 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=192.87 Aligned_cols=152 Identities=26% Similarity=0.444 Sum_probs=135.3
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|++|.||++... +++.|++|.+..........+.+.+|++++++++|||++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999765 578999999976654445667899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999986 236789999999999999999999999 99999999999999999999999999998765433
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=196.92 Aligned_cols=155 Identities=25% Similarity=0.415 Sum_probs=136.5
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|+..+.||+|+||.||++.. .+++.+|+|++...........++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 467788999999999999965 4678999999875444445567788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+++++|.+++.........+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999875443456789999999999999999999999 9999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=201.09 Aligned_cols=152 Identities=26% Similarity=0.359 Sum_probs=130.6
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLV 486 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 486 (577)
++|...+.||+|+||.||+|... +++.+|+|.++...........+.+|+.++++++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999875 588999999875433333344577899999999999999999998877 889999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||++ ++|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 599998863 233689999999999999999999999 99999999999999999999999999998765
Q ss_pred CC
Q 008121 567 NT 568 (577)
Q Consensus 567 ~~ 568 (577)
..
T Consensus 158 ~~ 159 (293)
T cd07843 158 SP 159 (293)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=201.29 Aligned_cols=151 Identities=25% Similarity=0.463 Sum_probs=127.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCc----EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.++|...+.||+|+||.||+|.+. +++ .||+|.+.... ......++.+|+.++++++||||++++++|... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 346777889999999999999763 343 57888886432 233445688999999999999999999998754 46
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++++||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence 799999999999999862 234688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
....
T Consensus 158 ~~~~ 161 (303)
T cd05110 158 LLEG 161 (303)
T ss_pred cccC
Confidence 7643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=197.78 Aligned_cols=150 Identities=25% Similarity=0.419 Sum_probs=130.4
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc----hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS----LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
+|+..+.||+|+||.||++.. .+++.||+|.+...... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999965 56899999998643211 1235678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeccccCcc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAAL 564 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~ 564 (577)
||||+++++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999996 234688999999999999999999999 999999999999998775 599999999886
Q ss_pred cCC
Q 008121 565 TPN 567 (577)
Q Consensus 565 ~~~ 567 (577)
...
T Consensus 154 ~~~ 156 (268)
T cd06630 154 LAA 156 (268)
T ss_pred ccc
Confidence 643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=206.11 Aligned_cols=160 Identities=21% Similarity=0.283 Sum_probs=137.5
Q ss_pred cCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHH------HHHHHHHHHHhhcCC---CCceeeEeeEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQE------EDNFLEAVSNMSRLR---HPNIVTLAGYCAE 479 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~---H~niv~l~~~~~~ 479 (577)
.+|+....+|+|+||.|+.|.++. ...|+||.+.+...-.+. .-..-.||.+|+.++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 357888999999999999997754 678999998654321110 111235999999998 9999999999999
Q ss_pred CCeEEEEEEec-CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEec
Q 008121 480 HGQRLLVYEYV-GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (577)
Q Consensus 480 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D 558 (577)
++++||+||-. ++-||++++. ....+++.++..|++||+.|+++||++ +|||||||-+||.+|.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999976 5669999996 567799999999999999999999999 999999999999999999999999
Q ss_pred cccCcccCCCccccccCC
Q 008121 559 CGLAALTPNTERQVITGT 576 (577)
Q Consensus 559 FGla~~~~~~~~~~~~Gt 576 (577)
||-|.+..+....++.||
T Consensus 714 fgsaa~~ksgpfd~f~gt 731 (772)
T KOG1152|consen 714 FGSAAYTKSGPFDVFVGT 731 (772)
T ss_pred ccchhhhcCCCcceeeee
Confidence 999999988888888887
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-22 Score=194.69 Aligned_cols=150 Identities=25% Similarity=0.453 Sum_probs=134.4
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|++|.||++... +++.|++|++...... ...+.+.+|++.+.+++|+||+++++++...+..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 35778899999999999999776 4899999998754322 456779999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++++|.+++.. ...+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999962 3678999999999999999999999 8 999999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-22 Score=195.65 Aligned_cols=156 Identities=23% Similarity=0.372 Sum_probs=131.4
Q ss_pred CCCccceeccCccceEEEEEEcC--CcEEEEEEccccc--------cchHHHHHHHHHHHHhhc-CCCCceeeEeeEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFAN--GKIMAVKKIDNAA--------LSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAE 479 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~ 479 (577)
.|+..+.||+|+||.||++.+.. ++.+|+|.+.... .......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777889999999999998765 6889999875321 122345567888888865 799999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
.+..+++|||+++++|.+++.........+++..+++++.|++.||.|||+.. +++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999998654444567899999999999999999999631 7999999999999999999999999
Q ss_pred ccCcccCCC
Q 008121 560 GLAALTPNT 568 (577)
Q Consensus 560 Gla~~~~~~ 568 (577)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999875544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=200.03 Aligned_cols=152 Identities=24% Similarity=0.325 Sum_probs=128.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCe-----
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQ----- 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~----- 482 (577)
++|+..+.||+|+||.||+|... +++.||+|.++...........+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788899999999999999765 5899999988654322233456888999999995 6999999999877665
Q ss_pred EEEEEEecCCCCHHHhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeccc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDS-SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCG 560 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFG 560 (577)
.|+||||+++ +|.+++...... ...+++..+..++.||++||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 899888643322 45689999999999999999999999 9999999999999998 8999999999
Q ss_pred cCccc
Q 008121 561 LAALT 565 (577)
Q Consensus 561 la~~~ 565 (577)
+++..
T Consensus 157 ~~~~~ 161 (295)
T cd07837 157 LGRAF 161 (295)
T ss_pred cceec
Confidence 98854
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=198.07 Aligned_cols=149 Identities=26% Similarity=0.385 Sum_probs=132.1
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|+..+.||+|+||.||++... +++.||+|++.... ......++.+|++++++++||||+++++++...+..++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 4667788999999999999775 58899999986543 234567789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+++++|.+++... ...+++....+++.|++.||+|||+ . +++||||||+||++++++.+||+|||.+....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999999632 2678899999999999999999999 7 99999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=194.51 Aligned_cols=152 Identities=22% Similarity=0.361 Sum_probs=133.0
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||++.. .+++.+|+|.+............+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477788999999999999976 4688999999876544555677899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGla~~~~~ 567 (577)
+++++|.+++... ....+++..+.+++.|+++||+|||++ +|+||||||+||+++++ +.+||+|||+++....
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999632 245689999999999999999999999 99999999999999855 4689999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=193.18 Aligned_cols=155 Identities=28% Similarity=0.461 Sum_probs=137.2
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||++... +++.||+|++..........+++.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999775 588999999876544445667789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+++++|.++++........+++.++..++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999975433357899999999999999999999999 9999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-22 Score=193.91 Aligned_cols=150 Identities=33% Similarity=0.538 Sum_probs=130.4
Q ss_pred CccceeccCccceEEEEEEcC-----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 413 SQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
...+.||+|+||.||++...+ +..||+|++.... .....+.+..|++++..++|+||+++++++...+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999997754 3889999996543 2225678999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++++|.++++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999996321 12289999999999999999999999 999999999999999999999999999986654
Q ss_pred C
Q 008121 568 T 568 (577)
Q Consensus 568 ~ 568 (577)
.
T Consensus 156 ~ 156 (258)
T smart00219 156 D 156 (258)
T ss_pred c
Confidence 3
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=199.74 Aligned_cols=147 Identities=27% Similarity=0.440 Sum_probs=129.4
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 445677999999999999764 57889999886443 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
++++|.+++. ...+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999885 35688999999999999999999998 999999999999999999999999999986544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=195.67 Aligned_cols=147 Identities=26% Similarity=0.435 Sum_probs=130.1
Q ss_pred CCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|+..+.||+|+||.||+|.. .+++.||+|.+..... ......|.+|++.+++++||||+++++++..++..++||||+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 56678899999999999976 4688999998764332 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
++|+|.+++. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999999985 34689999999999999999999998 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=195.67 Aligned_cols=148 Identities=24% Similarity=0.417 Sum_probs=131.1
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
.|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4666788999999999999764 58899999886442 234567789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++|+|.+++. ...+++.+...++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 84 LGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999985 24588999999999999999999998 999999999999999999999999999976544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=199.63 Aligned_cols=147 Identities=28% Similarity=0.436 Sum_probs=131.3
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.+|...+.||.|+||.||+|.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4578888999999999999965 568999999986432 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+++|+|.+++. ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 97 ~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 97 YLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred ecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 999999999885 34589999999999999999999999 99999999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=197.16 Aligned_cols=147 Identities=29% Similarity=0.454 Sum_probs=125.3
Q ss_pred ceeccCccceEEEEEEcC-------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 416 FLIGEGSLGRVYRAEFAN-------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
+.||+|+||.||+|...+ ++.+|+|.+.... ......+|.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999997643 2578999886432 22345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-----CeEEeccc
Q 008121 489 YVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-----NPHLSDCG 560 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-----~~kl~DFG 560 (577)
|+++|+|.++++.... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.+. .+|++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999964321 234578999999999999999999998 899999999999999877 89999999
Q ss_pred cCcccC
Q 008121 561 LAALTP 566 (577)
Q Consensus 561 la~~~~ 566 (577)
+++...
T Consensus 157 ~~~~~~ 162 (269)
T cd05044 157 LARDIY 162 (269)
T ss_pred cccccc
Confidence 998653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=195.35 Aligned_cols=149 Identities=30% Similarity=0.442 Sum_probs=132.5
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||.|+||.||+|... +++.||+|.+.... .......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 5777889999999999999765 58899999986442 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+++++|.++++ ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLK-----PGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 99999999986 23789999999999999999999998 9999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=200.20 Aligned_cols=153 Identities=27% Similarity=0.412 Sum_probs=128.4
Q ss_pred CCCccceeccCccceEEEEEEc---CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 484 (577)
+|...+.||+|+||.||+|... +++.||+|.+.... ......+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3667788999999999999774 47899999987532 1122245678899999999999999999999888 7899
Q ss_pred EEEEecCCCCHHHhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----CCCeEEecc
Q 008121 485 LVYEYVGNGNLHDMLHFADDS-SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD----ELNPHLSDC 559 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~----~~~~kl~DF 559 (577)
+||||+++ +|.+++...... ...+++..+..|+.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 787777543322 23789999999999999999999999 8999999999999999 999999999
Q ss_pred ccCcccCC
Q 008121 560 GLAALTPN 567 (577)
Q Consensus 560 Gla~~~~~ 567 (577)
|+++....
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-22 Score=200.74 Aligned_cols=142 Identities=33% Similarity=0.440 Sum_probs=126.2
Q ss_pred cceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 415 EFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
...||+|+||.||++.. .+++.||||++.... ....+.+.+|+..+++++|+||+++++.+...+..++||||++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 45699999999999976 458899999986432 344567889999999999999999999999999999999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 105 ~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 105 ALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred cHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 9999884 23588999999999999999999999 99999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=214.80 Aligned_cols=157 Identities=15% Similarity=0.190 Sum_probs=121.4
Q ss_pred hhcCCCccceeccCccceEEEEEEcC--CcEEEEEEc--------------c-ccccchHHHHHHHHHHHHhhcCCCCce
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFAN--GKIMAVKKI--------------D-NAALSLQEEDNFLEAVSNMSRLRHPNI 470 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~--------------~-~~~~~~~~~~~~~~e~~~l~~l~H~ni 470 (577)
..++|.+.+.||+|+||+||+|.++. +...++|.+ . ...........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45689999999999999999986532 222222211 0 001112335568899999999999999
Q ss_pred eeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 008121 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD-SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (577)
Q Consensus 471 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~ 549 (577)
|++++++...+..|+|+|++. ++|.+++..... ........+...|+.|++.||+|||+. +||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999995 578877753211 112234566788999999999999999 999999999999999
Q ss_pred CCCCeEEeccccCcccCCC
Q 008121 550 DELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 550 ~~~~~kl~DFGla~~~~~~ 568 (577)
.++.+||+|||+++.+...
T Consensus 302 ~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCEEEEeCCCceecCcc
Confidence 9999999999999876543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=221.92 Aligned_cols=151 Identities=28% Similarity=0.393 Sum_probs=124.9
Q ss_pred HHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC----
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH---- 480 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~---- 480 (577)
.+..++|+..+.||+||||.||+++. -||+.||||+|.... +...-....+|+..+++++|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 34556788889999999999999976 479999999998765 455566788999999999999999998743210
Q ss_pred --------------------------------------------------------------------------------
Q 008121 481 -------------------------------------------------------------------------------- 480 (577)
Q Consensus 481 -------------------------------------------------------------------------------- 480 (577)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEEecCCCCHHHhhhhccCCCCCC-CHHHHHHHHHHHHHH
Q 008121 481 -----------------------------------GQRLLVYEYVGNGNLHDMLHFADDSSKNL-TWNARVRVALGTARA 524 (577)
Q Consensus 481 -----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l-~~~~~~~i~~~i~~~ 524 (577)
...||=||||+.-.+.++++. +... .....++++++|++|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHH
Confidence 014677888888777777752 2222 466789999999999
Q ss_pred HHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 525 L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
|.|+|+. +||||||||.||++|++..+||+|||+|+.
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchh
Confidence 9999999 999999999999999999999999999997
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=199.83 Aligned_cols=145 Identities=24% Similarity=0.428 Sum_probs=119.6
Q ss_pred cceeccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCeEEEEEEe
Q 008121 415 EFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLVYEY 489 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 489 (577)
...||+|+||.||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 357999999999999865 35789999986432 23457789999999999999999998854 4578999999
Q ss_pred cCCCCHHHhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCeEEeccc
Q 008121 490 VGNGNLHDMLHFAD-----DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCG 560 (577)
Q Consensus 490 ~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl----~~~~~~kl~DFG 560 (577)
++ ++|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ ++++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 86 48888875321 1234588999999999999999999999 99999999999999 567899999999
Q ss_pred cCcccCC
Q 008121 561 LAALTPN 567 (577)
Q Consensus 561 la~~~~~ 567 (577)
+++....
T Consensus 158 ~a~~~~~ 164 (317)
T cd07867 158 FARLFNS 164 (317)
T ss_pred ceeccCC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=192.80 Aligned_cols=153 Identities=27% Similarity=0.394 Sum_probs=134.1
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|+..+.||+|+||.||+|... ++..+|+|++....... ..+.+.+|++.++.++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 36788899999999999999764 57899999986543323 56778999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++++|.++++... ....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999999996321 125689999999999999999999998 999999999999999999999999999886554
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=195.97 Aligned_cols=153 Identities=33% Similarity=0.503 Sum_probs=133.2
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCC----
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG---- 481 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~---- 481 (577)
++++|...+.||+|+||.||+|... +++.+++|.+.... ...++|.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4678999999999999999999875 57889999986432 3456789999999999 6999999999997644
Q ss_pred --eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 482 --QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 482 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
..++||||+++++|.++++........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999999875433356789999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccC
Q 008121 560 GLAALTP 566 (577)
Q Consensus 560 Gla~~~~ 566 (577)
|++....
T Consensus 158 ~~~~~~~ 164 (275)
T cd06608 158 GVSAQLD 164 (275)
T ss_pred ccceecc
Confidence 9987643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=197.03 Aligned_cols=143 Identities=27% Similarity=0.388 Sum_probs=121.4
Q ss_pred ceeccCccceEEEEEEcC--------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 416 FLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
+.||+|+||.||+|.... ...||+|.+.... ....+.|.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 369999999999997632 2348888875432 334567889999999999999999999999989999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--------eEEecc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--------PHLSDC 559 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~--------~kl~DF 559 (577)
||+++|+|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +|++||
T Consensus 79 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999963 234689999999999999999999999 9999999999999987765 599999
Q ss_pred ccCcccC
Q 008121 560 GLAALTP 566 (577)
Q Consensus 560 Gla~~~~ 566 (577)
|++....
T Consensus 153 g~~~~~~ 159 (258)
T cd05078 153 GISITVL 159 (258)
T ss_pred ccccccC
Confidence 9987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=193.60 Aligned_cols=149 Identities=28% Similarity=0.391 Sum_probs=128.4
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccc---cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA---LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 483 (577)
.+|...+.||+|+||.||+|.. .+++.||+|.+.... ........+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3678889999999999999976 458999999874321 1233456788999999999999999999998664 457
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++++||+++++|.+++. ....+++....+++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999986 234588999999999999999999999 99999999999999999999999999998
Q ss_pred cc
Q 008121 564 LT 565 (577)
Q Consensus 564 ~~ 565 (577)
..
T Consensus 155 ~~ 156 (264)
T cd06653 155 RI 156 (264)
T ss_pred cc
Confidence 65
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=202.06 Aligned_cols=158 Identities=20% Similarity=0.332 Sum_probs=133.8
Q ss_pred ecHHHHHHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEE
Q 008121 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (577)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 478 (577)
...+++....++|...+.||+|+||.||++.. .+++.||+|++..........+.+.+|++++.+++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34456677788999999999999999999965 56899999998754333344567889999999999999999999885
Q ss_pred eC------CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008121 479 EH------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (577)
Q Consensus 479 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~ 552 (577)
.. ...+++++++ +++|.++++ ...+++..+..++.|+++||+|||+. +|+||||||+||++++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 43 3467888887 789988874 24589999999999999999999999 999999999999999999
Q ss_pred CeEEeccccCcccC
Q 008121 553 NPHLSDCGLAALTP 566 (577)
Q Consensus 553 ~~kl~DFGla~~~~ 566 (577)
.+||+|||+++...
T Consensus 158 ~~kl~dfg~~~~~~ 171 (345)
T cd07877 158 ELKILDFGLARHTD 171 (345)
T ss_pred CEEEeccccccccc
Confidence 99999999998653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=195.48 Aligned_cols=144 Identities=28% Similarity=0.360 Sum_probs=125.2
Q ss_pred eccCccceEEEEEE-cCCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 418 lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
||+|+||.||++.. .+|+.||+|.+...... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999965 46889999998653222 22345678899999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
.+++... ....+++.++..++.|++.||.|||+. +++||||||+||++++++.+||+|||++....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 9998632 224689999999999999999999999 99999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=192.94 Aligned_cols=144 Identities=22% Similarity=0.325 Sum_probs=127.6
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 418 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
||.|+||.||++... +++.||+|.+...... ....+.+.+|+.++++++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 4889999998654322 23456789999999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
.+++. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILR----DRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 99996 234589999999999999999999998 9999999999999999999999999999976554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=198.40 Aligned_cols=154 Identities=27% Similarity=0.389 Sum_probs=130.5
Q ss_pred HhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC----
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG---- 481 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---- 481 (577)
...++|+..+.||+|+||.||+|... +++.||+|+++...........+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567888999999999999999875 5889999998654322333456788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeE
Q 008121 482 ------QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (577)
Q Consensus 482 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 555 (577)
..++|+||+++ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 77777642 244689999999999999999999999 999999999999999999999
Q ss_pred EeccccCcccCC
Q 008121 556 LSDCGLAALTPN 567 (577)
Q Consensus 556 l~DFGla~~~~~ 567 (577)
|+|||+++....
T Consensus 157 l~dfg~~~~~~~ 168 (302)
T cd07864 157 LADFGLARLYNS 168 (302)
T ss_pred eCcccccccccC
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=194.80 Aligned_cols=149 Identities=29% Similarity=0.475 Sum_probs=130.6
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC---CCceeeEeeEEEeCCeEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv 486 (577)
.|+..+.||+|+||.||+|.+ .+++.||+|.++... ......++.+|+.++++++ |||++++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 466778899999999999976 568999999986432 2334566888999999986 99999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++++|.++++ ...+++.....++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 81 MEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999985 23689999999999999999999999 99999999999999999999999999998764
Q ss_pred CC
Q 008121 567 NT 568 (577)
Q Consensus 567 ~~ 568 (577)
..
T Consensus 153 ~~ 154 (277)
T cd06917 153 QN 154 (277)
T ss_pred CC
Confidence 43
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=196.19 Aligned_cols=150 Identities=25% Similarity=0.348 Sum_probs=127.4
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|++|.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46788899999999999999775 68899999986543333345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeccccCccc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALT 565 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~~ 565 (577)
|++ ++|.+++... ....+++.....++.|++.||+|||+. +|+||||||+||++++ ++.+||+|||+++..
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 996 5888887522 233467888889999999999999999 9999999999999985 567999999999764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=190.65 Aligned_cols=152 Identities=32% Similarity=0.436 Sum_probs=135.5
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLVY 487 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 487 (577)
+|...+.||+|++|.||+|... +++.|++|.+..........+.+.+|++++++++||||+++++++... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677889999999999999876 688999999876544445677899999999999999999999999988 8899999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++++|.+++.. ...+++.++..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999862 33789999999999999999999998 999999999999999999999999999987755
Q ss_pred Cc
Q 008121 568 TE 569 (577)
Q Consensus 568 ~~ 569 (577)
..
T Consensus 154 ~~ 155 (260)
T cd06606 154 IE 155 (260)
T ss_pred cc
Confidence 43
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=180.74 Aligned_cols=158 Identities=23% Similarity=0.366 Sum_probs=132.8
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhc-CCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
+.......||+|++|.|-+-++ .+|+.+|+|++.... ..+...+...|+.+..+ ...|.+|++||.+......|+.|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3444456799999999988866 579999999997653 35566677888887655 47999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|.|.- +|..+-++.-..+..+++...-+|+..|.+||.|||++. .+||||+||+|||++.+|++|+||||++..+.+
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99954 887776655557788999999999999999999999985 899999999999999999999999999998766
Q ss_pred Cccc
Q 008121 568 TERQ 571 (577)
Q Consensus 568 ~~~~ 571 (577)
+-..
T Consensus 202 SiAk 205 (282)
T KOG0984|consen 202 SIAK 205 (282)
T ss_pred hhHH
Confidence 5443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=194.74 Aligned_cols=142 Identities=30% Similarity=0.436 Sum_probs=126.1
Q ss_pred eccCccceEEEEEEcC-CcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 418 lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
||+|+||.||+++..+ ++.+++|.+..... .....+.+.+|++++++++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998864 89999999865432 123456788999999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
.++++. ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||++....
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 999963 23789999999999999999999998 99999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=193.65 Aligned_cols=152 Identities=26% Similarity=0.429 Sum_probs=132.1
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|...+.||+|+||.||++... +|..||+|.+..........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999775 588999999865443344566788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~~ 567 (577)
+++++|.+++... ....+++..+..++.|+++||.|||+. +++|+||||+||++++++ .+||+|||.+....+
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999998632 234579999999999999999999998 999999999999999875 569999999986644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=195.02 Aligned_cols=157 Identities=26% Similarity=0.446 Sum_probs=132.2
Q ss_pred HHHHHHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEe
Q 008121 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (577)
Q Consensus 402 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 479 (577)
+.++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 344445667888889999999999999977 45789999987543 23445688899999998 69999999999853
Q ss_pred ------CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008121 480 ------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (577)
Q Consensus 480 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~ 553 (577)
.+..|++|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 45789999999999999998632 234578888999999999999999999 9999999999999999999
Q ss_pred eEEeccccCcccC
Q 008121 554 PHLSDCGLAALTP 566 (577)
Q Consensus 554 ~kl~DFGla~~~~ 566 (577)
+||+|||+++...
T Consensus 160 ~~l~dfg~~~~~~ 172 (282)
T cd06636 160 VKLVDFGVSAQLD 172 (282)
T ss_pred EEEeeCcchhhhh
Confidence 9999999987543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=195.43 Aligned_cols=150 Identities=27% Similarity=0.411 Sum_probs=129.7
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|+..+.||+|++|.||+|... +|+.||||+++.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4777899999999999999875 588999999865432 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+++ +|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 80 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 80 MDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred CCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 985 8988886322 235689999999999999999999998 99999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=184.34 Aligned_cols=143 Identities=20% Similarity=0.240 Sum_probs=112.8
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccch----------------------H--HHHHHHHHHHHhhcCCCCce
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL----------------------Q--EEDNFLEAVSNMSRLRHPNI 470 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------------~--~~~~~~~e~~~l~~l~H~ni 470 (577)
...||+|+||+||+|...+|+.||||+++...... . ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999988789999999987542110 0 02234678999999999987
Q ss_pred eeEeeEEEeCCeEEEEEEecCCCCHHHh-hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeee
Q 008121 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDM-LHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILL 548 (577)
Q Consensus 471 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NILl 548 (577)
.....+... ..++||||++++++... +. ...++..+..+++.|++.++.|+|+ . +|+||||||+|||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 654444333 24899999998855433 32 2456788899999999999999999 7 99999999999999
Q ss_pred CCCCCeEEeccccCcccCCC
Q 008121 549 DDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 549 ~~~~~~kl~DFGla~~~~~~ 568 (577)
+ ++.++|+|||+|+..+..
T Consensus 152 ~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred E-CCCEEEEEcccceecCCC
Confidence 9 789999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=201.38 Aligned_cols=150 Identities=19% Similarity=0.328 Sum_probs=129.2
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-----
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----- 481 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----- 481 (577)
..++|...+.||+|+||.||++.. .+++.||||++............+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456788899999999999999965 46899999998644333334566889999999999999999999986543
Q ss_pred -eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 482 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
..++||||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 779988874 34689999999999999999999998 99999999999999999999999999
Q ss_pred cCcccC
Q 008121 561 LAALTP 566 (577)
Q Consensus 561 la~~~~ 566 (577)
+++...
T Consensus 164 ~~~~~~ 169 (343)
T cd07880 164 LARQTD 169 (343)
T ss_pred cccccc
Confidence 998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=207.87 Aligned_cols=161 Identities=22% Similarity=0.318 Sum_probs=123.7
Q ss_pred HHHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC------CCceeeEeeEE
Q 008121 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR------HPNIVTLAGYC 477 (577)
Q Consensus 405 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~~~~ 477 (577)
+....++|...+.||+|+||.||+|... .++.||||+++... ....++..|++++..++ |.+++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3445678999999999999999999764 57889999986421 22333455666666554 45689999988
Q ss_pred EeC-CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----
Q 008121 478 AEH-GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---- 552 (577)
Q Consensus 478 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~---- 552 (577)
... ++.|+|||++ +++|.+++. ....+++..+..|+.||+.||+|||++. +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccc
Confidence 754 4788999988 778999886 2357899999999999999999999732 899999999999998765
Q ss_pred ------------CeEEeccccCcccCCCccccccCC
Q 008121 553 ------------NPHLSDCGLAALTPNTERQVITGT 576 (577)
Q Consensus 553 ------------~~kl~DFGla~~~~~~~~~~~~Gt 576 (577)
.+||+|||.+..... .....+||
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt 308 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH-SRTAIVST 308 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc-ccccccCC
Confidence 499999998865322 22334455
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=198.01 Aligned_cols=160 Identities=23% Similarity=0.356 Sum_probs=131.9
Q ss_pred cCCCccceeccCccceEEEE-EEcCCcEEEEEEccccccchH-----HHHHHHHHHHHhhcCCCCceeeEeeEEE-eCCe
Q 008121 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQ-----EEDNFLEAVSNMSRLRHPNIVTLAGYCA-EHGQ 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~ 482 (577)
++|-...+||+|+|++||++ ++...+.||||+-.......+ ..+...+|.++-+.+.||.||++|+|+. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 45666778999999999999 556678899997543221111 1234568999999999999999999985 5667
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEecc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDC 559 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DF 559 (577)
.|-|+|||+|.||.-+|+ ..+.++++++..|+.||+.||.||.+. .|+|||-||||.|||+- .-|.+||+||
T Consensus 543 FCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 899999999999999997 566789999999999999999999987 57899999999999995 4578999999
Q ss_pred ccCcccCCCcccccc
Q 008121 560 GLAALTPNTERQVIT 574 (577)
Q Consensus 560 Gla~~~~~~~~~~~~ 574 (577)
||++.++++......
T Consensus 618 GLSKIMdddSy~~vd 632 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVD 632 (775)
T ss_pred chhhhccCCccCccc
Confidence 999999877665443
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=196.19 Aligned_cols=150 Identities=31% Similarity=0.463 Sum_probs=129.6
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
..|...+.||+|+||.||+|... +++.||+|++.... ......+++.+|++++++++||||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777889999999999999764 58999999885332 22344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||++ |++.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||+++...
T Consensus 95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9997 578777742 234689999999999999999999998 99999999999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-24 Score=195.50 Aligned_cols=153 Identities=25% Similarity=0.422 Sum_probs=125.2
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--------CC
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--------HG 481 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~~ 481 (577)
.|....+||+|.||+||+|+.. +|+.||+|++-...-.......-.+|+.++..++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445667999999999999765 47788988764322122233456789999999999999999998853 23
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..|+|+++|+. ||.-+|. +....++..++.+++.++..||.|+|+. .|+|||+||+|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 58999999976 8888884 4556889999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCcc
Q 008121 562 AALTPNTER 570 (577)
Q Consensus 562 a~~~~~~~~ 570 (577)
|+.+...+.
T Consensus 171 ar~fs~~~n 179 (376)
T KOG0669|consen 171 ARAFSTSKN 179 (376)
T ss_pred ccceecccc
Confidence 987654443
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=196.22 Aligned_cols=148 Identities=28% Similarity=0.420 Sum_probs=130.8
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 5788889999999999999965 467899999985432 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++|+|.+++. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999999985 23578999999999999999999999 999999999999999999999999998875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=198.70 Aligned_cols=143 Identities=30% Similarity=0.386 Sum_probs=126.3
Q ss_pred cceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 415 EFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
...||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++..++||||+++++++..++..++||||++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 44699999999999976 468999999986432 234566889999999999999999999999999999999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 104 ALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 9999874 34589999999999999999999999 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-23 Score=225.41 Aligned_cols=165 Identities=28% Similarity=0.385 Sum_probs=140.5
Q ss_pred HHhhcCCCccceeccCccceEEEEE-EcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
..-+-+|.....||.|.||.||-|. ..+|+..|+|-++-............+|+.++..++|||+|++||+-..++..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3444577888899999999999995 567999999988655433444556788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
|.||||++|+|.+++. .+...++.....+..|++.|++|||+. +||||||||+||+||.+|.+|++|||.|+.
T Consensus 1311 IFMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence 9999999999999996 345567777788899999999999999 999999999999999999999999999997
Q ss_pred cCCCc------cccccCCC
Q 008121 565 TPNTE------RQVITGTS 577 (577)
Q Consensus 565 ~~~~~------~~~~~Gt~ 577 (577)
+.+.. -+.+.|||
T Consensus 1384 i~~~~~~~~~el~~~~GT~ 1402 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTP 1402 (1509)
T ss_pred ecCchhcCCHHHHhhcCCc
Confidence 75543 24566775
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=197.55 Aligned_cols=150 Identities=26% Similarity=0.393 Sum_probs=126.8
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-------
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------- 481 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------- 481 (577)
++|...+.||+|+||.||+|... +++.||||++............+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999764 5899999988643322333445678999999999999999999987654
Q ss_pred -eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 482 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
..++||||+. ++|.+.+.. ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 3599999996 588888752 334689999999999999999999999 99999999999999999999999999
Q ss_pred cCcccC
Q 008121 561 LAALTP 566 (577)
Q Consensus 561 la~~~~ 566 (577)
++....
T Consensus 165 ~~~~~~ 170 (310)
T cd07865 165 LARAFS 170 (310)
T ss_pred Cccccc
Confidence 998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=193.68 Aligned_cols=150 Identities=29% Similarity=0.451 Sum_probs=130.1
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeEEEEEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLVYE 488 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 488 (577)
|...+.||+|+||.||+|... +++.+|+|++............+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999875 488999999975532233456688999999999999999999999887 88999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++ +|.+++.. ....+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9974 89888852 235789999999999999999999998 9999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=195.28 Aligned_cols=151 Identities=29% Similarity=0.403 Sum_probs=133.4
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 486 (577)
++|...+.||+|+||.||++... +++.||+|.+..... .....+.+.+|.+++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778889999999999999764 689999999865322 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++++|.+++. ....+++..+..|+.|++.||.|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999996 334799999999999999999999999 99999999999999999999999999998764
Q ss_pred C
Q 008121 567 N 567 (577)
Q Consensus 567 ~ 567 (577)
.
T Consensus 154 ~ 154 (280)
T cd05581 154 P 154 (280)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=197.45 Aligned_cols=152 Identities=32% Similarity=0.417 Sum_probs=129.1
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 485 (577)
.++|...+.||+|+||.||+|... +|+.||+|+++...........+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457888899999999999999774 589999999864432222234567899999999999999999998755 46899
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||++ ++|.+++.. ....+++.++..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 589888863 235689999999999999999999999 9999999999999999999999999999876
Q ss_pred CC
Q 008121 566 PN 567 (577)
Q Consensus 566 ~~ 567 (577)
..
T Consensus 159 ~~ 160 (309)
T cd07845 159 GL 160 (309)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=193.88 Aligned_cols=149 Identities=28% Similarity=0.392 Sum_probs=129.1
Q ss_pred CCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|+..+.||+|++|.||+|.. .+|+.||+|++............+.+|++++++++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678899999999999976 46899999998654333333456888999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+ ++|.+++... ....+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||+++...
T Consensus 81 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 6999988632 224689999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-22 Score=204.21 Aligned_cols=152 Identities=30% Similarity=0.385 Sum_probs=131.0
Q ss_pred eeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
+||+|.||+||-|+..+ ...+|||.+.... ....+-+.+||.+-+.++|.|||+++|.+.+++..-|.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 69999999999997755 4578999997543 34455678999999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeccccCcccC--CCcc
Q 008121 496 HDMLHFADDSSKNL--TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTP--NTER 570 (577)
Q Consensus 496 ~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~~~~--~~~~ 570 (577)
.++|+. .=+++ .+.+.--+.+||++||.|||++ .|||||||-+|||++ -.|.+||+|||-+|.+. +..+
T Consensus 660 SsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 660 SSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred HHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 999963 23445 5677788999999999999999 999999999999997 57999999999999764 4556
Q ss_pred ccccCC
Q 008121 571 QVITGT 576 (577)
Q Consensus 571 ~~~~Gt 576 (577)
.++|||
T Consensus 734 ETFTGT 739 (1226)
T KOG4279|consen 734 ETFTGT 739 (1226)
T ss_pred cccccc
Confidence 788888
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=206.16 Aligned_cols=168 Identities=28% Similarity=0.461 Sum_probs=141.5
Q ss_pred HHHHHHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEe
Q 008121 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (577)
Q Consensus 402 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 479 (577)
++.+...++-|.+.+.||+|.+|.||++.. ++++.+|||+.... ....++...|.++++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344445667788899999999999999954 66889999987643 33445566778887766 69999999999853
Q ss_pred -----CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 008121 480 -----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (577)
Q Consensus 480 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 554 (577)
+++.|||||||.+|+..|+++... +..+.|..+..|++.+++|+.+||.. .++|||||=.|||++.++.+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 468999999999999999998543 67899999999999999999999999 89999999999999999999
Q ss_pred EEeccccCcccCCCc--cccccCCC
Q 008121 555 HLSDCGLAALTPNTE--RQVITGTS 577 (577)
Q Consensus 555 kl~DFGla~~~~~~~--~~~~~Gt~ 577 (577)
|++|||++..+.... +.+.+|||
T Consensus 163 KLvDFGvSaQldsT~grRnT~iGtP 187 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNTFIGTP 187 (953)
T ss_pred EEeeeeeeeeeecccccccCcCCCc
Confidence 999999999876554 45677886
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=201.51 Aligned_cols=149 Identities=25% Similarity=0.382 Sum_probs=128.3
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe----CCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~ 484 (577)
++|...+.||+|+||.||+|... +++.||+|++............+.+|+.++.+++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999764 58999999987543333345667889999999999999999998753 34689
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+. |+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 68999885 345589999999999999999999998 999999999999999999999999999976
Q ss_pred cC
Q 008121 565 TP 566 (577)
Q Consensus 565 ~~ 566 (577)
..
T Consensus 157 ~~ 158 (334)
T cd07855 157 LS 158 (334)
T ss_pred ec
Confidence 53
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=199.66 Aligned_cols=150 Identities=21% Similarity=0.318 Sum_probs=128.2
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC------
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 480 (577)
..++|...+.||+|+||.||+|.. .+++.||+|++...........++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 346788899999999999999976 4689999999865433344456678899999999999999999988643
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
...|+||||++ ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999996 58888875 1288899999999999999999999 99999999999999999999999999
Q ss_pred cCcccCC
Q 008121 561 LAALTPN 567 (577)
Q Consensus 561 la~~~~~ 567 (577)
+++....
T Consensus 164 ~~~~~~~ 170 (353)
T cd07850 164 LARTAGT 170 (353)
T ss_pred cceeCCC
Confidence 9987644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-21 Score=185.91 Aligned_cols=149 Identities=32% Similarity=0.520 Sum_probs=133.1
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|...+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++...+..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 667789999999999999875 688999999865432 35677899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||.+......
T Consensus 80 ~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 80 SGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999863 225789999999999999999999998 9999999999999999999999999999876554
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=197.67 Aligned_cols=153 Identities=27% Similarity=0.386 Sum_probs=130.8
Q ss_pred HHHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe-CCe
Q 008121 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQ 482 (577)
Q Consensus 405 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~ 482 (577)
+...+++|...+.||+|+||.||++... +++.||+|++..........+.+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446788999999999999999999654 78999999886543333445668899999999999999999999865 557
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++++||+ +++|.++++ ...+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 89999999 568988885 34578888899999999999999999 9999999999999999999999999998
Q ss_pred cccC
Q 008121 563 ALTP 566 (577)
Q Consensus 563 ~~~~ 566 (577)
+...
T Consensus 156 ~~~~ 159 (328)
T cd07856 156 RIQD 159 (328)
T ss_pred cccC
Confidence 8543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=197.71 Aligned_cols=143 Identities=23% Similarity=0.317 Sum_probs=124.3
Q ss_pred ceeccC--ccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEG--SLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
..||+| +||+||++.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346766 9999999976 4689999999875443444567889999999999999999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
|+|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+.
T Consensus 84 ~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 84 GSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred CCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 9999998742 234588999999999999999999998 99999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.6e-22 Score=201.39 Aligned_cols=150 Identities=19% Similarity=0.256 Sum_probs=128.2
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.-|...+.||-|+||+|.+++- ++...||.|.+++...- .........|-.+|+.-+.+-||+||..|.+.+..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3477788999999999999854 45677899998754321 222334567888999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||++|||+-.+|. +.+.+++..+.-++.++..|+++.|.. ++|||||||+|||||.+|.+||+||||+.-+.
T Consensus 709 dYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999986 456678888888888999999999999 99999999999999999999999999988543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=198.87 Aligned_cols=150 Identities=27% Similarity=0.429 Sum_probs=127.8
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC--CeEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH--GQRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~~ 484 (577)
.++|...+.||+|+||.||+|... +++.+|+|++............+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456778889999999999999765 588999998854322333445677899999999 999999999998654 3689
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||++ ++|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIR-----ANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 59999885 22788999999999999999999998 999999999999999999999999999986
Q ss_pred cCC
Q 008121 565 TPN 567 (577)
Q Consensus 565 ~~~ 567 (577)
...
T Consensus 157 ~~~ 159 (337)
T cd07852 157 LSE 159 (337)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.6e-21 Score=188.17 Aligned_cols=144 Identities=22% Similarity=0.311 Sum_probs=120.4
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHH-hhcCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSN-MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||+|... +++.||+|.++..... ......+..|..+ ....+|+||+++++++...+..|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999764 5889999998653221 1222334445444 4456899999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+|.++++ ....+++..+.+++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999996 335688999999999999999999998 99999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=191.49 Aligned_cols=150 Identities=30% Similarity=0.421 Sum_probs=133.0
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++.|...+.||+|+||.||++.+. +++.|++|.+..... ..+.+.+|++++++++|+||+++++++...+..|++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4556777889999999999999876 688999999864321 456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 94 MEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999999732 14799999999999999999999998 99999999999999999999999999887543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=205.06 Aligned_cols=154 Identities=18% Similarity=0.284 Sum_probs=121.2
Q ss_pred hhcCCCccceeccCccceEEEEEE-----------------cCCcEEEEEEccccccchHHH--------------HHHH
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-----------------ANGKIMAVKKIDNAALSLQEE--------------DNFL 456 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~~ 456 (577)
..++|++.++||+|+||.||+|.+ .+++.||||++.... .... +.+.
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~--~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR--QGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc--hhhHHHHHhhhhhhhcccchhH
Confidence 467899999999999999999954 235679999986432 1112 2334
Q ss_pred HHHHHhhcCCCCce-----eeEeeEEEe--------CCeEEEEEEecCCCCHHHhhhhccC-------------------
Q 008121 457 EAVSNMSRLRHPNI-----VTLAGYCAE--------HGQRLLVYEYVGNGNLHDMLHFADD------------------- 504 (577)
Q Consensus 457 ~e~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~------------------- 504 (577)
.|+.++.+++|.++ +++++||.. .+..|+||||+++|+|.++++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777888877655 677777753 3568999999999999999874211
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 505 -SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 505 -~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
....++|..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 112356788999999999999999998 89999999999999999999999999997653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-23 Score=191.37 Aligned_cols=152 Identities=25% Similarity=0.394 Sum_probs=129.6
Q ss_pred ccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-----eEEEEE
Q 008121 414 QEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----QRLLVY 487 (577)
Q Consensus 414 ~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~ 487 (577)
-.+.||-|+||.||-... ++|+.||.|++..........+++.+|+.++..++|.|++..++...-.. +.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 357899999999999865 67999999998765444556678899999999999999999998876543 568899
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|.|. .||...+- +...++.....-+..||++||.|||+. +|.||||||.|.|++.+...||||||+|+..+.
T Consensus 137 ELmQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 9985 48888775 677888888899999999999999999 999999999999999999999999999998766
Q ss_pred Cccccc
Q 008121 568 TERQVI 573 (577)
Q Consensus 568 ~~~~~~ 573 (577)
.+...+
T Consensus 209 d~~~hM 214 (449)
T KOG0664|consen 209 RDRLNM 214 (449)
T ss_pred hhhhhh
Confidence 555433
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-21 Score=192.85 Aligned_cols=142 Identities=32% Similarity=0.453 Sum_probs=126.3
Q ss_pred ceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCC
Q 008121 416 FLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGN 494 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~ 494 (577)
..||+|+||.||++.. .+++.||||++... .......+.+|+.+++.++|+||+++++++...+..++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 5699999999999977 46899999988543 23456678999999999999999999999999999999999999999
Q ss_pred HHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 495 LHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 495 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|.+++. ...+++.....++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 104 L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 104 LTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 999874 33578999999999999999999999 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=193.20 Aligned_cols=150 Identities=25% Similarity=0.349 Sum_probs=128.8
Q ss_pred CCCccceeccCccceEEEEEE----cCCcEEEEEEccccccc--hHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAALS--LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 483 (577)
+|...+.||+|+||.||++.. .+++.||||.++..... ....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999864 35788999998643211 22345688999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++||||+++|+|.+++. ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999986 235688999999999999999999998 99999999999999999999999999988
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
....
T Consensus 154 ~~~~ 157 (288)
T cd05583 154 EFLA 157 (288)
T ss_pred cccc
Confidence 6543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=192.64 Aligned_cols=148 Identities=30% Similarity=0.479 Sum_probs=127.7
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
|...+.||+|+||.||++... ++..||+|++.... .......++.+|++++++++|||++++++++...+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999764 58899999986432 1233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
++ |+|.+.+.. ....+++.++..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++....
T Consensus 107 ~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 107 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 96 588887752 245689999999999999999999999 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=198.60 Aligned_cols=150 Identities=29% Similarity=0.408 Sum_probs=131.1
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-----eEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----QRL 484 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 484 (577)
+|...+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999875 4899999998754333445667899999999999999999999988765 789
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
++|||++ ++|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 58988886 334799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
....
T Consensus 153 ~~~~ 156 (330)
T cd07834 153 VDPD 156 (330)
T ss_pred eccc
Confidence 6554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-21 Score=190.02 Aligned_cols=147 Identities=28% Similarity=0.376 Sum_probs=123.9
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeC--CeEEEEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEH--GQRLLVY 487 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~ 487 (577)
|...+.||+|+||.||+|... +++.||+|+++....+. ......+|+.++.++. |+||+++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 456778999999999999764 68899999986543222 2234457888898885 99999999999887 8899999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||++ |+|.+.+.. ....+++.++..++.|++.||+|||+. +|+||||||+||++++ +.+||+|||+++....
T Consensus 80 e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 80 ELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred ecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 9997 588888852 235789999999999999999999999 9999999999999999 9999999999986543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=195.32 Aligned_cols=144 Identities=20% Similarity=0.243 Sum_probs=122.6
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
+.+|.|+++.||++.. +++.||||++..........+.+.+|+++++.++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445555555555544 689999999876533455667899999999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
.++++.. ....+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 87 ~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 87 EDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred HHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceee
Confidence 9999732 234688999999999999999999999 9999999999999999999999999988754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=211.45 Aligned_cols=162 Identities=28% Similarity=0.446 Sum_probs=138.0
Q ss_pred hcCCCccceeccCccceEEEEEEc--------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 479 (577)
.++....+.+|+|.||.|++|... ....||||.++....+ .+.+.+..|+++|..+ +|+||+.++|+|..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 334455568999999999999643 1457999999876654 6778899999999998 59999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhcc---C-------CC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFAD---D-------SS--KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
++..++|+||++.|+|.++++..+ . .. ..++..+.+.++.|||.||+||++. ++|||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence 999999999999999999998654 0 01 2388999999999999999999999 8999999999999
Q ss_pred eCCCCCeEEeccccCcccCCCcccccc
Q 008121 548 LDDELNPHLSDCGLAALTPNTERQVIT 574 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~~~~~~~~~ 574 (577)
+.++..+||+|||+|+...+.+.....
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~ 477 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTK 477 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEec
Confidence 999999999999999977666655433
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=190.37 Aligned_cols=145 Identities=32% Similarity=0.451 Sum_probs=127.9
Q ss_pred CCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|...+.||+|++|.||++.. .+++.+++|++... .....+.+.+|+.+++.++||||+++++++...++.++++||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 44457899999999999976 46889999988543 2334566889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 99999999862 4689999999999999999999999 99999999999999999999999999887543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=197.69 Aligned_cols=148 Identities=24% Similarity=0.397 Sum_probs=127.0
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-----e
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----Q 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~ 482 (577)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ......++.+|+.++++++||||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 36788899999999999999975 468999999986422 2234566888999999999999999999876443 5
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++++||++ ++|.++++ ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 799999996 48888774 35689999999999999999999999 9999999999999999999999999999
Q ss_pred cccC
Q 008121 563 ALTP 566 (577)
Q Consensus 563 ~~~~ 566 (577)
+...
T Consensus 154 ~~~~ 157 (336)
T cd07849 154 RIAD 157 (336)
T ss_pred eecc
Confidence 8654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=197.84 Aligned_cols=152 Identities=26% Similarity=0.419 Sum_probs=129.4
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC-----Ce
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 482 (577)
.++|...+.||+|+||.||++.. .+++.||||.++...........+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688889999999999999976 4689999999865432333455677899999999999999999988644 34
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 68988885 345689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC
Q 008121 563 ALTPNT 568 (577)
Q Consensus 563 ~~~~~~ 568 (577)
+.....
T Consensus 156 ~~~~~~ 161 (337)
T cd07858 156 RTTSEK 161 (337)
T ss_pred cccCCC
Confidence 876443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=188.96 Aligned_cols=150 Identities=29% Similarity=0.418 Sum_probs=125.2
Q ss_pred CCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcC---CCCceeeEeeEEEeCCe-----
Q 008121 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVTLAGYCAEHGQ----- 482 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~----- 482 (577)
|+..+.||+|+||.||+|.... ++.||+|+++...........+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5567889999999999998864 89999999975432233344566777766555 69999999999988776
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.+++|||+. ++|.+++... ....+++..+..++.|+++||.|||+. +++|+||||+||++++++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 5899988632 223689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCC
Q 008121 563 ALTPN 567 (577)
Q Consensus 563 ~~~~~ 567 (577)
.....
T Consensus 155 ~~~~~ 159 (287)
T cd07838 155 RIYSF 159 (287)
T ss_pred eeccC
Confidence 87643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=194.20 Aligned_cols=148 Identities=24% Similarity=0.316 Sum_probs=124.1
Q ss_pred CCCccceeccCccceEEEEEEc-C--CcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC----Ce
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-N--GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH----GQ 482 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~~ 482 (577)
+|...+.||+|+||.||++... + ++.||+|++..........+.+.+|++++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667789999999999999764 3 67899999864332233456688899999999 599999999875432 45
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++++||+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899986 68999885 345789999999999999999999999 9999999999999999999999999999
Q ss_pred cccC
Q 008121 563 ALTP 566 (577)
Q Consensus 563 ~~~~ 566 (577)
+...
T Consensus 153 ~~~~ 156 (332)
T cd07857 153 RGFS 156 (332)
T ss_pred eecc
Confidence 8654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=194.25 Aligned_cols=148 Identities=26% Similarity=0.339 Sum_probs=126.1
Q ss_pred CCC-ccceeccCccceEEEEEEc-CCcEEEEEEccccccchH------------HHHHHHHHHHHhhcCCCCceeeEeeE
Q 008121 411 SFS-QEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ------------EEDNFLEAVSNMSRLRHPNIVTLAGY 476 (577)
Q Consensus 411 ~~~-~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~H~niv~l~~~ 476 (577)
+|. ..+.||+|+||.||+|... +++.||||++........ ....+.+|++++++++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 443 3567999999999999764 689999999864322110 01247789999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 008121 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (577)
Q Consensus 477 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl 556 (577)
+...+..++||||++ |+|.+++. ....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 999999999999996 69999885 345689999999999999999999998 9999999999999999999999
Q ss_pred eccccCcccC
Q 008121 557 SDCGLAALTP 566 (577)
Q Consensus 557 ~DFGla~~~~ 566 (577)
+|||+++...
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-21 Score=190.57 Aligned_cols=153 Identities=27% Similarity=0.395 Sum_probs=125.3
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 488 (577)
+|...+.||+|+||.||++... +++.||+|++..... ......+.+|+.++.++. |+||+++++++..++..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 3445678999999999999764 589999999865432 244567889999999996 9999999999999899999999
Q ss_pred ecCCCCHHHhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFA-DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|++. ++.++.... ......+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 665543221 112467899999999999999999999742 899999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-21 Score=181.38 Aligned_cols=152 Identities=24% Similarity=0.395 Sum_probs=128.0
Q ss_pred ccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEEEecC
Q 008121 414 QEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 414 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
....||.|+.|.|++++.. +|..+|||...... ...+.++++..++++.+.. .|.||+.+|||..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 3456999999999999775 48899999997654 3556677777888777664 8999999999999999999999995
Q ss_pred CCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCccc
Q 008121 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (577)
Q Consensus 492 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 571 (577)
. .+..+++. ..+++++..+-++...+.+||.||.+++ +|||||+||+|||+|+.|++|+||||++..+-+++.+
T Consensus 175 ~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 175 T-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred H-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 3 66666653 3466888888999999999999999986 8999999999999999999999999999987766654
Q ss_pred c
Q 008121 572 V 572 (577)
Q Consensus 572 ~ 572 (577)
+
T Consensus 249 t 249 (391)
T KOG0983|consen 249 T 249 (391)
T ss_pred c
Confidence 3
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=206.65 Aligned_cols=138 Identities=36% Similarity=0.587 Sum_probs=97.2
Q ss_pred ccCCChHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCC---CCCccEEeeCC------cEEEEEcCCCCCcccccccccCC
Q 008121 36 QCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCG---ESWKGVACEGS------AVVSIDISGLGLSGTMGYLLSDL 106 (577)
Q Consensus 36 ~~~~~~~~~~~l~~~~~~~~~~~~l~~w~~~~~~~c~---~~w~gv~C~~~------~v~~l~l~~~~l~g~~~~~~~~l 106 (577)
...+.++|++||+.+|+++..+.. .+|.. |||. +.|.||.|... .|+.|+|++|+|+|.+|..++.|
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~-~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLR-FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCccc-CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 345677899999999999976532 37963 5663 47999999621 36677777777777777666666
Q ss_pred CCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcC
Q 008121 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF 186 (577)
Q Consensus 107 ~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 186 (577)
++|+.|+|++|+|+| .+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|++
T Consensus 442 ~~L~~L~Ls~N~l~g----------------------~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 442 RHLQSINLSGNSIRG----------------------NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred CCCCEEECCCCcccC----------------------cCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 666666665555554 4555566677777777777777777777777777777777777
Q ss_pred CcccCCCCCCccC
Q 008121 187 NNFSGDLPNSFIS 199 (577)
Q Consensus 187 N~l~g~~p~~~~~ 199 (577)
|+|+|.+|..++.
T Consensus 500 N~l~g~iP~~l~~ 512 (623)
T PLN03150 500 NSLSGRVPAALGG 512 (623)
T ss_pred CcccccCChHHhh
Confidence 7777777766643
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=189.43 Aligned_cols=149 Identities=28% Similarity=0.438 Sum_probs=128.3
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEEEe
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
|...+.||+|+||.||+|... +++.|+||++...... .......+|+..+++++ |+||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 456788999999999999875 4788999998654322 23334567899999999 99999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+ +|+|.+.++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++....
T Consensus 80 ~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 80 M-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred C-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 9 88999988632 235789999999999999999999998 999999999999999999999999999986654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=194.66 Aligned_cols=148 Identities=20% Similarity=0.340 Sum_probs=125.6
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 481 (577)
.++|...+.||+|+||.||+|.. .+++.||||++............+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788889999999999999976 46899999998654323333456889999999999999999999986542
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..++|+||+.. +|.++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 776654 23588999999999999999999999 999999999999999999999999999
Q ss_pred CcccC
Q 008121 562 AALTP 566 (577)
Q Consensus 562 a~~~~ 566 (577)
++...
T Consensus 164 ~~~~~ 168 (342)
T cd07879 164 ARHAD 168 (342)
T ss_pred CcCCC
Confidence 98653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=184.03 Aligned_cols=143 Identities=31% Similarity=0.433 Sum_probs=126.8
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 418 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
||+|+||.||++... +++.+|+|.+...... ....+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999775 4889999998654322 23456789999999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
.+++. ....+++.....++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLS----KEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 99996 334689999999999999999999998 999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=184.45 Aligned_cols=149 Identities=20% Similarity=0.280 Sum_probs=120.8
Q ss_pred HHHHhhcCCCcccee--ccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhc-CCCCceeeEeeEEEe
Q 008121 404 SLQTATNSFSQEFLI--GEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAE 479 (577)
Q Consensus 404 ~~~~~~~~~~~~~~l--g~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~ 479 (577)
+.....++|...+.+ |+|+||.||++.. .+++.+|+|.+........ |+..... .+||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEec
Confidence 334444566666665 9999999999976 4578899999864322111 1211111 279999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEec
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSD 558 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~D 558 (577)
.+..++||||+++|+|.++++ ....+++.++..++.|+++||.|||+. +++||||||+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 999999999999999999996 234789999999999999999999999 899999999999999988 999999
Q ss_pred cccCcccC
Q 008121 559 CGLAALTP 566 (577)
Q Consensus 559 FGla~~~~ 566 (577)
||+++...
T Consensus 154 fg~~~~~~ 161 (267)
T PHA03390 154 YGLCKIIG 161 (267)
T ss_pred CccceecC
Confidence 99988654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.9e-21 Score=192.37 Aligned_cols=151 Identities=29% Similarity=0.412 Sum_probs=126.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 481 (577)
.++|...+.||+|+||.||+|... +++.+|+|++............+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999764 5889999998654322223445778999999999999999999875433
Q ss_pred --eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 482 --QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 482 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
..++|+||+++ ++.+.+.. ....+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999965 77777652 345799999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccC
Q 008121 560 GLAALTP 566 (577)
Q Consensus 560 Gla~~~~ 566 (577)
|+++...
T Consensus 160 g~~~~~~ 166 (311)
T cd07866 160 GLARPYD 166 (311)
T ss_pred ccchhcc
Confidence 9998654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=188.44 Aligned_cols=150 Identities=27% Similarity=0.404 Sum_probs=130.8
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|...+.||+|++|.||++... +++.+++|+++...........+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455678999999999999764 6889999998765444345667889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
++ +|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||.+......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 88888863 235789999999999999999999999 9999999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=187.06 Aligned_cols=153 Identities=22% Similarity=0.316 Sum_probs=126.7
Q ss_pred CCCccceeccCccceEEEEEEcC-CcEEEEEEccc---cccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDN---AALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
+|...+.||+|+||.||++.... +..+++|.++. .........++.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999997643 34455554432 222233455677899999999999999999999988899999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++++|.+++.........+++.+++.++.|+++||.|||+. +++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875444556799999999999999999999998 9999999999999986 569999999998654
Q ss_pred C
Q 008121 567 N 567 (577)
Q Consensus 567 ~ 567 (577)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=188.36 Aligned_cols=149 Identities=30% Similarity=0.405 Sum_probs=129.7
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|+..+.||+|+||.||+|... +++.||+|.+..........+.+..|++++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999775 4899999998764322334566788999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+ ++|.+++... ...+++..+.+++.|+++||+|||+. +|+||||+|+||++++++.+||+|||+++....
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 7 5999999632 24689999999999999999999999 999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=195.19 Aligned_cols=150 Identities=21% Similarity=0.366 Sum_probs=129.5
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe----
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ---- 482 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~---- 482 (577)
..++|...+.||+|+||.||+|... +++.||||++............+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888899999999999999875 57899999986543333345667889999999999999999988766554
Q ss_pred --EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 483 --RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 483 --~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
.++|+||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 679999885 35689999999999999999999999 99999999999999999999999999
Q ss_pred cCcccC
Q 008121 561 LAALTP 566 (577)
Q Consensus 561 la~~~~ 566 (577)
++....
T Consensus 164 ~~~~~~ 169 (343)
T cd07851 164 LARHTD 169 (343)
T ss_pred cccccc
Confidence 998754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.4e-20 Score=186.49 Aligned_cols=147 Identities=30% Similarity=0.468 Sum_probs=126.4
Q ss_pred CCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
|...+.||+|+||.||+|.. .+++.|++|++..... .......+.+|+++++.++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 45567799999999999976 4588999999864322 233445788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+. |++.+++.. ....+++.++..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 95 588887752 345689999999999999999999999 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=186.71 Aligned_cols=150 Identities=20% Similarity=0.263 Sum_probs=111.6
Q ss_pred hcCCCccceeccCccceEEEEEEcCC----cEEEEEEccccccchHH---------HHHHHHHHHHhhcCCCCceeeEee
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQE---------EDNFLEAVSNMSRLRHPNIVTLAG 475 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~H~niv~l~~ 475 (577)
.++|.+.+.||+|+||.||+|...++ ..+|+|........... ......+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788899999999999999987543 45666653221111000 112233445566789999999999
Q ss_pred EEEeCC----eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 476 YCAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 476 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
++.... ..++++|++.. ++.+.+.. ....++..+..|+.|+++||+|||+. +|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 765543 44678887743 66666642 23457888899999999999999999 99999999999999999
Q ss_pred CCeEEeccccCcccC
Q 008121 552 LNPHLSDCGLAALTP 566 (577)
Q Consensus 552 ~~~kl~DFGla~~~~ 566 (577)
+.+||+|||+|+.+.
T Consensus 163 ~~~~l~DFGla~~~~ 177 (294)
T PHA02882 163 NRGYIIDYGIASHFI 177 (294)
T ss_pred CcEEEEEcCCceeec
Confidence 999999999998653
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=188.15 Aligned_cols=149 Identities=32% Similarity=0.472 Sum_probs=127.4
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.|...+.||+|+||.||+|... +++.+|+|.+.... .......++.+|+++++.++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3555678999999999999764 57889999885321 123345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+. |++.+.+.. ....+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 96 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 96 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred ccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 996 688887752 235688999999999999999999998 99999999999999999999999999988654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-22 Score=199.43 Aligned_cols=161 Identities=21% Similarity=0.276 Sum_probs=139.0
Q ss_pred cCCCccceeccCccceEEEEEEcCCc-EEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGK-IMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~-~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++.+...||-|+||.|-+......+ .+|+|++++.. .+....+....|-.+|..++.|.||++|..|.+..+.|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555667999999999998776543 47888886543 34455666788999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|-|-||.|...|+ .++.++.....-++..+.+|++|||++ +||+|||||+|+++|.+|-+||.|||+||.+..
T Consensus 500 EaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999997 566788888888999999999999999 999999999999999999999999999998765
Q ss_pred Cc-cccccCCC
Q 008121 568 TE-RQVITGTS 577 (577)
Q Consensus 568 ~~-~~~~~Gt~ 577 (577)
.. +-++||||
T Consensus 573 g~KTwTFcGTp 583 (732)
T KOG0614|consen 573 GRKTWTFCGTP 583 (732)
T ss_pred CCceeeecCCc
Confidence 54 46899997
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-22 Score=184.76 Aligned_cols=150 Identities=27% Similarity=0.397 Sum_probs=123.5
Q ss_pred cceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHh-hcCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 415 EFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNM-SRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
...||.|+||+|++..+ +.|+.+|||+++.... ..+..+++.|.+.. +.-+.||||++||.+..++..|+-||.|+
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 44699999999999966 5699999999986543 45567788887764 55579999999999999999999999995
Q ss_pred CCHHHhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 493 GNLHDMLHFA-DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 493 g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
-+|..+.+.. .-....+++...-+|...+++||+||-... .|||||+||+|||+|..|.+||||||++..+.++
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 4665554321 123456888888899999999999999875 8999999999999999999999999998876543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=186.32 Aligned_cols=150 Identities=27% Similarity=0.427 Sum_probs=125.8
Q ss_pred cCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|.+.+ ++.||||.++.... .....++.+|+.++.+.. ||||+++++++......|++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 567778899999999999998865 89999999865432 233455667777776665 999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||++ +++.+++.. ....+++..+..++.|+++||+|||+.. +|+||||+|+||++++++.+||+|||++....
T Consensus 94 e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9985 577777653 2347899999999999999999999732 89999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-21 Score=189.25 Aligned_cols=161 Identities=22% Similarity=0.332 Sum_probs=132.8
Q ss_pred cCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchH-HHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQ-EEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 486 (577)
.+|....+||+|+||.|.+++.+. .+.+|||++++....+. ..+--+.|-++|+-- +-|.++++..+|+..+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 457777899999999999997764 57789999976543222 122224455666554 578999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc--
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL-- 564 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~-- 564 (577)
|||+.||||--.++ .-+.+.+..+.-++.+||-||-|||++ +||.||||.+|||+|.+|.+||+|||+++.
T Consensus 429 MEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999988886 345567778889999999999999999 999999999999999999999999999994
Q ss_pred cCCCccccccCCC
Q 008121 565 TPNTERQVITGTS 577 (577)
Q Consensus 565 ~~~~~~~~~~Gt~ 577 (577)
++...+.++||||
T Consensus 502 ~~~~TTkTFCGTP 514 (683)
T KOG0696|consen 502 FDGVTTKTFCGTP 514 (683)
T ss_pred cCCcceeeecCCC
Confidence 4556668899997
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.3e-21 Score=179.60 Aligned_cols=139 Identities=22% Similarity=0.316 Sum_probs=116.5
Q ss_pred ceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEE----eCCeEEEEEEe
Q 008121 416 FLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA----EHGQRLLVYEY 489 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~----~~~~~~lv~e~ 489 (577)
++||-|-.|.|..|.. .+++.+|+|++... ..-++|+++--.. .|||||+++++|. ......+|||.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 5799999999999966 46889999998542 2245677754333 6999999999874 34567899999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DFGla~~~~ 566 (577)
|+||+|++.+.. .....+++.++-.|++||+.|+.|||+. .|.||||||+|+|.. .+...||+|||+||.-.
T Consensus 141 meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 141 MEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccC
Confidence 999999999973 3456799999999999999999999999 999999999999996 45679999999999754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=180.29 Aligned_cols=163 Identities=23% Similarity=0.344 Sum_probs=138.0
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchH-HHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ-EEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 484 (577)
..++|...++||+|+|.+|..+++. +.+.+|+|++++.....+ ..+....|-.+...- +||.+|.+..+|+.+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3467888999999999999999875 478899999987654433 234445565555444 7999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+|.||+++|||--.++ ..+.+++..+.-+...|+-||.|||++ +||.||||.+|||+|..|.+|++|+|+++.
T Consensus 328 fvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999987776 556799999999999999999999999 999999999999999999999999999994
Q ss_pred --cCCCccccccCCC
Q 008121 565 --TPNTERQVITGTS 577 (577)
Q Consensus 565 --~~~~~~~~~~Gt~ 577 (577)
-+..-+.++||||
T Consensus 401 ~l~~gd~tstfcgtp 415 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTP 415 (593)
T ss_pred CCCCCcccccccCCC
Confidence 3445567899997
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.1e-20 Score=173.02 Aligned_cols=139 Identities=16% Similarity=0.218 Sum_probs=106.9
Q ss_pred CCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-----CCCceeeEeeEEEeCC---eE
Q 008121 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNIVTLAGYCAEHG---QR 483 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~~ 483 (577)
+...+.||+|+||.||. .-.++.. +||++.... ....+.+.+|+.++..+ .||||++++|++.++. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34567899999999996 3233444 688876432 23456789999999999 6799999999998763 43
Q ss_pred E-EEEEe--cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCCeeeCC----CCCeE
Q 008121 484 L-LVYEY--VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL-EYLHEVCLPSVVHRNFKSANILLDD----ELNPH 555 (577)
Q Consensus 484 ~-lv~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L-~yLH~~~~~~ivHrDlk~~NILl~~----~~~~k 555 (577)
+ +|+|| +++|+|.++++. ..+++. ..++.|++.++ +|||++ +||||||||+|||++. ++.++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence 4 78999 668999999962 235544 35678888888 999999 9999999999999974 34899
Q ss_pred Eec-cccCcc
Q 008121 556 LSD-CGLAAL 564 (577)
Q Consensus 556 l~D-FGla~~ 564 (577)
|+| ||.+.+
T Consensus 150 LiDg~G~~~~ 159 (210)
T PRK10345 150 VCDNIGESTF 159 (210)
T ss_pred EEECCCCcce
Confidence 999 555554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-21 Score=172.75 Aligned_cols=147 Identities=22% Similarity=0.399 Sum_probs=125.6
Q ss_pred hcCCCccceeccCccceEEEEE-EcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCC--eEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG--QRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~ 484 (577)
.++|++.+.+|+|.|++||.|. ..+.++++||.++.. ..+.+.+|+.++..++ ||||+++++...+.. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4578888999999999999995 466888999998643 3456889999999997 999999999987654 567
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeccccCc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGLAA 563 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGla~ 563 (577)
+|+||+.+.|...+. ..++..++..++.++++||.|+|+. +|+|||+||.|+++|.. -..+|+|+|+|.
T Consensus 112 LiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 999999998887665 3567778889999999999999999 99999999999999964 579999999999
Q ss_pred ccCCCcc
Q 008121 564 LTPNTER 570 (577)
Q Consensus 564 ~~~~~~~ 570 (577)
++.....
T Consensus 182 FYHp~~e 188 (338)
T KOG0668|consen 182 FYHPGKE 188 (338)
T ss_pred hcCCCce
Confidence 8865543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-20 Score=189.94 Aligned_cols=146 Identities=28% Similarity=0.387 Sum_probs=123.9
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--------
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-------- 480 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------- 480 (577)
.+|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 5788889999999999999976 458899999986442 23456688999999999999999999776543
Q ss_pred ------CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCC
Q 008121 481 ------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELN 553 (577)
Q Consensus 481 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-~~~~ 553 (577)
...++||||++ ++|.+++. ...+++..+..++.|+++||.|||+. +|+||||||+||+++ +++.
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 35789999997 58988874 34688999999999999999999999 999999999999998 4567
Q ss_pred eEEeccccCcccC
Q 008121 554 PHLSDCGLAALTP 566 (577)
Q Consensus 554 ~kl~DFGla~~~~ 566 (577)
+|++|||+++...
T Consensus 154 ~kl~dfg~~~~~~ 166 (342)
T cd07854 154 LKIGDFGLARIVD 166 (342)
T ss_pred EEECCcccceecC
Confidence 8999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-20 Score=185.97 Aligned_cols=161 Identities=23% Similarity=0.299 Sum_probs=138.2
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 487 (577)
...|++.+.||+||.+.||++...+.+.||+|++.....+.+..+-|..||..|.+++ |.+||+|++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4568888999999999999999888899999999877778888999999999999995 999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||= ..||..+|+.. ......| .+..+..|++.|+.++|.+ +|||.||||.|.|+-+ |.+||+|||+|+.+.+
T Consensus 440 E~G-d~DL~kiL~k~--~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKK--KSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecc-cccHHHHHHhc--cCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 987 56999999732 2223335 6778999999999999999 9999999999999865 6899999999998876
Q ss_pred Ccc----ccccCCC
Q 008121 568 TER----QVITGTS 577 (577)
Q Consensus 568 ~~~----~~~~Gt~ 577 (577)
+.+ ..-+||+
T Consensus 512 DTTsI~kdsQvGT~ 525 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTV 525 (677)
T ss_pred cccceeeccccCcc
Confidence 655 3345663
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=177.70 Aligned_cols=132 Identities=21% Similarity=0.239 Sum_probs=113.9
Q ss_pred CccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHhh
Q 008121 421 GSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML 499 (577)
Q Consensus 421 G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l 499 (577)
|.||.||++.. .+++.||+|+++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999966 468899999986431 2334555556667999999999999999999999999999999998
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 500 HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 500 ~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+....
T Consensus 77 ~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 77 SK----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred HH----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 62 34589999999999999999999998 99999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-20 Score=172.38 Aligned_cols=146 Identities=21% Similarity=0.351 Sum_probs=122.1
Q ss_pred hcCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeE-EEeCCeEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGY-CAEHGQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~-~~~~~~~~l 485 (577)
.+.|.+.+.+|+|.||.+-+++++. .+.+++|.++... ....+|.+|...--.+ .|.||+.-|+. |+..+.+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 4567888999999999999998865 6788999987643 3467799998765555 58999987765 677788889
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCCeEEeccccCc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLAA 563 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~--~~~~~kl~DFGla~ 563 (577)
++||+|.|||.+-+. ...+-+....+++.|++.|++|||++ .+||||||.+||||- +..++||||||+.+
T Consensus 100 ~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence 999999999998773 45577888899999999999999999 999999999999993 34589999999987
Q ss_pred cc
Q 008121 564 LT 565 (577)
Q Consensus 564 ~~ 565 (577)
..
T Consensus 172 k~ 173 (378)
T KOG1345|consen 172 KV 173 (378)
T ss_pred cc
Confidence 54
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.4e-21 Score=197.55 Aligned_cols=161 Identities=30% Similarity=0.466 Sum_probs=140.2
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
..++|.....+|.|.||.|||++. ..++..|+|.++.... +...-...|+-+++.++|||||.++|.|...+..|+.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 456788889999999999999965 5688999999976542 2334456789999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||||.+|+|.+.-+ ...++++.++..+.+...+|++|||+. +-+|||||-.|||+.+.|.+|++|||.+..+.
T Consensus 91 MEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 99999999999876 567899999999999999999999999 88999999999999999999999999988654
Q ss_pred --CCccccccCCC
Q 008121 567 --NTERQVITGTS 577 (577)
Q Consensus 567 --~~~~~~~~Gt~ 577 (577)
-.+++.+.|||
T Consensus 164 ati~KrksfiGtp 176 (829)
T KOG0576|consen 164 ATIAKRKSFIGTP 176 (829)
T ss_pred hhhhhhhcccCCc
Confidence 34567788886
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-19 Score=169.74 Aligned_cols=149 Identities=33% Similarity=0.513 Sum_probs=131.6
Q ss_pred CCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
|...+.||+|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.+.+++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4556789999999999998865 889999999754322 24677899999999999999999999999989999999999
Q ss_pred CCCCHHHhhhhccCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 491 GNGNLHDMLHFADDSSKN-LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
++++|.+++... .. +++.....++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 80 EGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 999999999632 23 88999999999999999999999 9999999999999999999999999999977554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.8e-19 Score=193.02 Aligned_cols=150 Identities=21% Similarity=0.289 Sum_probs=105.8
Q ss_pred hhcCCCccceeccCccceEEEEEEcC-----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeE------
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY------ 476 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------ 476 (577)
..++|...+.||+|+||.||+|.+.+ +..||||++.... ..+.+..| .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 45678899999999999999998754 6899999875421 11112211 1222222222222211
Q ss_pred EEeCCeEEEEEEecCCCCHHHhhhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecC
Q 008121 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDS----------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRN 540 (577)
Q Consensus 477 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrD 540 (577)
+....+.++||||+++++|.++++..... ........+..|+.|++.||+|||+. +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 24556899999999999999998632100 00112334567999999999999998 999999
Q ss_pred CCCCCeeeCC-CCCeEEeccccCcccC
Q 008121 541 FKSANILLDD-ELNPHLSDCGLAALTP 566 (577)
Q Consensus 541 lk~~NILl~~-~~~~kl~DFGla~~~~ 566 (577)
|||+|||+++ ++.+||+|||+|+.+.
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccc
Confidence 9999999985 6899999999998653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-21 Score=170.24 Aligned_cols=161 Identities=27% Similarity=0.403 Sum_probs=147.5
Q ss_pred eCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEE
Q 008121 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158 (577)
Q Consensus 81 ~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 158 (577)
+...++.|.|++|+|+ .+|+.++.|.+|+.|++++|+|. .+|.++. ++|+.|+++-|++. .+|..|++++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3467899999999998 77889999999999999999999 7888886 89999999999998 899999999999999
Q ss_pred EeccCCCc-ccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccc
Q 008121 159 NVSRNSLT-QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS 236 (577)
Q Consensus 159 ~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~ 236 (577)
||.+|+++ ..+|+.|..++.|+.|+|++|.|. .+|..++++++|+.|.+.+|.|-..+..+..+. |+.|++.+|+++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee
Confidence 99999998 568999999999999999999999 899999999999999999999988777666665 999999999999
Q ss_pred cccCcccccc
Q 008121 237 GWIPRELISI 246 (577)
Q Consensus 237 g~~p~~l~~l 246 (577)
.+|++++++
T Consensus 187 -vlppel~~l 195 (264)
T KOG0617|consen 187 -VLPPELANL 195 (264)
T ss_pred -ecChhhhhh
Confidence 788887765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.9e-19 Score=170.75 Aligned_cols=147 Identities=18% Similarity=0.150 Sum_probs=113.1
Q ss_pred CCCccceeccCccceEEEEE--EcCCcEEEEEEccccccch----------------------HHHHHHHHHHHHhhcCC
Q 008121 411 SFSQEFLIGEGSLGRVYRAE--FANGKIMAVKKIDNAALSL----------------------QEEDNFLEAVSNMSRLR 466 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~ 466 (577)
-|.+.+.||+|+||.||+|. ..+|+.||+|+++...... .....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36677899999999999997 5679999999986432100 01234568999999997
Q ss_pred CCc--eeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCC
Q 008121 467 HPN--IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS-VVHRNFKS 543 (577)
Q Consensus 467 H~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~-ivHrDlk~ 543 (577)
+.. +.+++++ ...++||||+++++|..... ....+...+...++.|++.++.|||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 633 3344443 23589999999988876542 123455666789999999999999999 8 99999999
Q ss_pred CCeeeCCCCCeEEeccccCcccCCCc
Q 008121 544 ANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 544 ~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
+||+++ ++.++|+|||.|.......
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCCcc
Confidence 999999 8899999999999765544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.7e-18 Score=161.10 Aligned_cols=144 Identities=35% Similarity=0.563 Sum_probs=126.8
Q ss_pred eccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCHH
Q 008121 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLH 496 (577)
Q Consensus 418 lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 496 (577)
||+|.+|.||++...+ ++.+++|++....... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998764 8999999987543211 3567999999999999999999999999989999999999999999
Q ss_pred HhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeccccCcccCCC
Q 008121 497 DMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 497 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~ 568 (577)
+++... ...+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+......
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 80 DLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 998622 14689999999999999999999999 9999999999999999 899999999999876543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.9e-18 Score=158.60 Aligned_cols=135 Identities=18% Similarity=0.192 Sum_probs=107.0
Q ss_pred ccceeccCccceEEEEEEcCCcEEEEEEccccccchH--HHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEEEec
Q 008121 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ--EEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 414 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
....|++|+||+||.+.. .+.+++.+.+.....-.. ....|.+|+++|+++. |++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999998766 577888777765432111 1225789999999995 5789999886 3469999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeeCCCCCeEEeccccCcccCC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF-KSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl-k~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+|.+|.+.+. .. ...++.|++++|+|+|+. +|+|||| ||+|||++.++.++|+|||+|+....
T Consensus 81 ~G~~L~~~~~-----~~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPP-----RG------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhh-----hh------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9998875442 11 135778999999999999 9999999 79999999999999999999996543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=164.21 Aligned_cols=149 Identities=17% Similarity=0.116 Sum_probs=113.7
Q ss_pred HHHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccch--------------------HHHHHHHHHHHHhhc
Q 008121 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL--------------------QEEDNFLEAVSNMSR 464 (577)
Q Consensus 405 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~~ 464 (577)
+......|...+.||+|+||.||++...+|+.||||+++...... .....+..|+..+.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 333333467788999999999999988889999999875422110 012236778888999
Q ss_pred CCCCc--eeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 008121 465 LRHPN--IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542 (577)
Q Consensus 465 l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 542 (577)
+.|++ +...++ ....++||||+++++|.+... . .....++.+++.++.++|+. +|+|||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----L------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc----c------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 88874 444443 245689999999999876542 0 23467889999999999998 99999999
Q ss_pred CCCeeeCCCCCeEEeccccCcccCCCcc
Q 008121 543 SANILLDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 543 ~~NILl~~~~~~kl~DFGla~~~~~~~~ 570 (577)
|+||++++++.++|+|||++.....+..
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~~~ 180 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHPNA 180 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCccH
Confidence 9999999999999999999976655433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=163.98 Aligned_cols=138 Identities=21% Similarity=0.307 Sum_probs=114.9
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccch------HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL------QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+.||+|++|.||+|.+ +|..|++|+........ ....++.+|++++..++|++|+....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5699999999999987 57788899765332111 1234678899999999999998877777777888999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+++++|.+++... .+ .+..++.+++.+|.++|+. +++|||++|+|||++ ++.++|+|||.++...
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999998521 12 7889999999999999999 999999999999999 7899999999998643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=168.54 Aligned_cols=165 Identities=25% Similarity=0.376 Sum_probs=137.6
Q ss_pred ecHHHHHHhhcCCCccceeccCccceEEEEEEcC------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeE
Q 008121 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473 (577)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l 473 (577)
..+.++.....++....++-+|.||.||+|.|.+ .+.|-+|.++... +.-....|..|--++..+.|||+..+
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccce
Confidence 3455666777788888899999999999996643 4567788886543 45566778999999999999999999
Q ss_pred eeEEEeC-CeEEEEEEecCCCCHHHhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008121 474 AGYCAEH-GQRLLVYEYVGNGNLHDMLHFADD----SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (577)
Q Consensus 474 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl 548 (577)
.+.+.++ ...+.+|.++..|+|..+|..++. ..+.++..+...++.|++.|++|||.+ +|||.||.++|++|
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVI 429 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhccee
Confidence 9998654 467899999999999999985542 234677788999999999999999999 99999999999999
Q ss_pred CCCCCeEEeccccCcccCCC
Q 008121 549 DDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 549 ~~~~~~kl~DFGla~~~~~~ 568 (577)
|+..++||+|=.+++.+-+.
T Consensus 430 dd~LqVkltDsaLSRDLFP~ 449 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPG 449 (563)
T ss_pred hhheeEEeccchhccccCcc
Confidence 99999999999999965443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=163.09 Aligned_cols=144 Identities=13% Similarity=0.139 Sum_probs=116.3
Q ss_pred HhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHH-H------HHHHHHHHHhhcCCCCceeeEeeEEEe
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE-E------DNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~-~------~~~~~e~~~l~~l~H~niv~l~~~~~~ 479 (577)
...++|...+++|+|+||.||..+. ++..+|+|.++......+. . +.|.+|++.+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3467899999999999999999766 5778999999754322221 1 226789999999999999999888654
Q ss_pred C--------CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 480 H--------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 480 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
. +..+++|||++|.+|.++.. ++. ....+++.++..+|+. +++|||+||+||+++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 35789999999999988742 222 2456999999999999 99999999999999998
Q ss_pred CCeEEeccccCcccCC
Q 008121 552 LNPHLSDCGLAALTPN 567 (577)
Q Consensus 552 ~~~kl~DFGla~~~~~ 567 (577)
+ ++|+|||..+....
T Consensus 172 g-i~liDfg~~~~~~e 186 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQ 186 (232)
T ss_pred C-EEEEECCCcccccc
Confidence 8 99999999886643
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=186.53 Aligned_cols=143 Identities=17% Similarity=0.304 Sum_probs=114.7
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEcccccc-----chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL-----SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
...|...+.||+|+||.||+|.+.+...++.+++.+... .....+++.+|++++..++|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 344566789999999999999876554433333322111 112245688999999999999999888888777788
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++||||+++++|.+++. ....++.|++++|.|||+. +|+||||||+|||+ +++.++|+|||+++
T Consensus 412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999999884 3567899999999999999 99999999999999 57799999999999
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
....
T Consensus 476 ~~~~ 479 (535)
T PRK09605 476 YSDL 479 (535)
T ss_pred cCCc
Confidence 7543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.5e-18 Score=164.85 Aligned_cols=139 Identities=35% Similarity=0.533 Sum_probs=122.7
Q ss_pred ccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHhhh
Q 008121 422 SLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH 500 (577)
Q Consensus 422 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 500 (577)
+||.||+|...+ ++.+|+|++........ .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999998864 89999999875432211 5789999999999999999999999999999999999999999999986
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 501 FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 501 ~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
. ...+++..+..++.++++++.|||+. +|+|+||+|+||++++++.++|+|||.+......
T Consensus 80 ~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 80 K----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred h----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 3 22389999999999999999999999 9999999999999999999999999999876553
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-18 Score=163.62 Aligned_cols=149 Identities=20% Similarity=0.313 Sum_probs=124.8
Q ss_pred CCCccceeccCccceEEEE-EEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.|.+.++||+|+||+++.| .+-+++.||||.-... .+..++..|.+..+.+ ..++|..+|.|..+..+-.||+|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 5788899999999999999 4678999999975433 2334466677766666 47899999988888888899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-----CCeEEeccccCc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-----LNPHLSDCGLAA 563 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-----~~~kl~DFGla~ 563 (577)
.+ |-+|+|+..-+ ++.++.++.+.||.|+..-++|+|++ .+|.|||||+|.||... ..+.|+|||+||
T Consensus 105 LL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 98 77999998644 46789999999999999999999999 89999999999999753 358899999999
Q ss_pred ccCCCcc
Q 008121 564 LTPNTER 570 (577)
Q Consensus 564 ~~~~~~~ 570 (577)
.+.+.++
T Consensus 178 ~YrDp~T 184 (449)
T KOG1165|consen 178 EYRDPKT 184 (449)
T ss_pred hhcCccc
Confidence 8876655
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-18 Score=160.11 Aligned_cols=134 Identities=21% Similarity=0.332 Sum_probs=108.5
Q ss_pred eeccCccceEEEEEEcCCcEEEEEEccccccc------hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
.||+|+||.||+|.+ ++..|++|........ .....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 5678889986432211 112356788999999999988766555666667789999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
++++|.+++... .. .++.+++.+|.++|+. +++|||++|+||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999999987521 10 7899999999999999 999999999999999 7899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.4e-18 Score=157.04 Aligned_cols=150 Identities=24% Similarity=0.349 Sum_probs=124.8
Q ss_pred cCCCccceeccCccceEEEEE-EcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCC-CceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 487 (577)
..|...+.||.|+||.+|.|. ..+|+.||||.-+... ...++..|..+...++| ..|..++.|..+..+-.+||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 568889999999999999995 4679999999865432 23346678888888875 56888888888899999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl~DFGla~~ 564 (577)
|.+ |.+|++++..+ .+.++..+.+-.+-|++.-++|+|.+ .+|||||||+|.|..-+ ..+.++|||+|+.
T Consensus 91 dLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 998 78999999765 35688899999999999999999999 89999999999999743 4688999999998
Q ss_pred cCCCcc
Q 008121 565 TPNTER 570 (577)
Q Consensus 565 ~~~~~~ 570 (577)
+.+..+
T Consensus 164 y~d~~t 169 (341)
T KOG1163|consen 164 YRDIRT 169 (341)
T ss_pred hccccc
Confidence 765443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.6e-18 Score=182.33 Aligned_cols=150 Identities=24% Similarity=0.334 Sum_probs=118.2
Q ss_pred CCCccceeccCccc-eEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLG-RVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 488 (577)
-|...+++|.|+-| .||+|..+ |+.||||++-.. ..+...+|+..++.- +|||||++++.-.++...||..|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 35556789999887 67999886 789999998532 233456899988877 59999999988888899999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---C--CCeEEeccccCc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---E--LNPHLSDCGLAA 563 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---~--~~~kl~DFGla~ 563 (577)
.|. .+|.+++...........-...+.+..|++.||++||+. +||||||||.||||+. + ..++|+|||++|
T Consensus 584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 995 599999974211111111134577889999999999997 9999999999999975 3 579999999999
Q ss_pred ccCCCcc
Q 008121 564 LTPNTER 570 (577)
Q Consensus 564 ~~~~~~~ 570 (577)
.+.....
T Consensus 660 kl~~~~s 666 (903)
T KOG1027|consen 660 KLAGGKS 666 (903)
T ss_pred ccCCCcc
Confidence 8866554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.4e-18 Score=165.61 Aligned_cols=153 Identities=20% Similarity=0.338 Sum_probs=127.0
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCC--Cc----eeeEeeEEEeC
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PN----IVTLAGYCAEH 480 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~n----iv~l~~~~~~~ 480 (577)
.+++|.+...+|+|.||.|-.+.. ..+..||||+++.. ....+.-+-|++++.++.+ |+ +|.+.+||...
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 377899999999999999999954 44789999998743 2334556779999999942 22 88899999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----------
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---------- 550 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---------- 550 (577)
++.|+|+|.+ |-+++++|+ .+.-.+++...+..|+.|++++++|||+. +++|-||||+|||+-+
T Consensus 164 ghiCivfell-G~S~~dFlk--~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLK--ENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhc--cCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 9999999998 569999997 33456788999999999999999999999 9999999999999921
Q ss_pred ----------CCCeEEeccccCcccCCCc
Q 008121 551 ----------ELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 551 ----------~~~~kl~DFGla~~~~~~~ 569 (577)
...+||+|||-|+......
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc
Confidence 2358999999999865554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-18 Score=176.13 Aligned_cols=146 Identities=27% Similarity=0.303 Sum_probs=121.5
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 486 (577)
+..|.....+|.|+|+.|-++.+ .+++..+||++.+... +-.+|+.++... +||||+++.+.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 45677777899999999999966 5578899999976522 223466555554 799999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-CCCCCeEEeccccCccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL-DDELNPHLSDCGLAALT 565 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl-~~~~~~kl~DFGla~~~ 565 (577)
||++.+|-+.+.+.. .+ ....++..|+.+++.|+.|||++ +|||||+||+|||+ ++.++++|+|||.++..
T Consensus 395 ~e~l~g~ell~ri~~----~~-~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 395 MELLDGGELLRRIRS----KP-EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ehhccccHHHHHHHh----cc-hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999988888752 22 22377788999999999999998 99999999999999 68999999999999987
Q ss_pred CCC
Q 008121 566 PNT 568 (577)
Q Consensus 566 ~~~ 568 (577)
...
T Consensus 467 ~~~ 469 (612)
T KOG0603|consen 467 ERS 469 (612)
T ss_pred chh
Confidence 655
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.2e-17 Score=164.41 Aligned_cols=135 Identities=21% Similarity=0.394 Sum_probs=113.6
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-----CC---ceeeEeeEEEe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----HP---NIVTLAGYCAE 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----H~---niv~l~~~~~~ 479 (577)
..+|...++||-|.|++||+|.. .+.+.||+|+.+.. ....+.-+.||.+|++++ |+ .||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 36788899999999999999954 56788999998754 344566788999999874 33 59999999965
Q ss_pred C----CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 480 H----GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 480 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
. .+.|+|+|++ |-+|..+|+.. .-+.++...+.+|++||+.||.|||++| +|||-||||+|||+...
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 3 4899999999 67999999854 4567899999999999999999999998 99999999999999543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.4e-18 Score=160.36 Aligned_cols=148 Identities=21% Similarity=0.319 Sum_probs=120.4
Q ss_pred cCCCccceeccCccceEEEE-EEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC------e
Q 008121 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------Q 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~ 482 (577)
.+|.....+|.|.- .|-.+ +.-.++.||+|++..........++-.+|...+..++|+||++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35566677888876 44444 3345889999998655444445566788999999999999999999986443 5
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.|+|||||. ++|.+.++ ..++-.....|..|++.|+.|||+. +|+||||||+||++..++.+||.|||+|
T Consensus 96 ~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 799999995 58988885 3467778899999999999999999 9999999999999999999999999999
Q ss_pred cccCCC
Q 008121 563 ALTPNT 568 (577)
Q Consensus 563 ~~~~~~ 568 (577)
+.....
T Consensus 166 r~e~~~ 171 (369)
T KOG0665|consen 166 RTEDTD 171 (369)
T ss_pred cccCcc
Confidence 965443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=149.49 Aligned_cols=140 Identities=21% Similarity=0.251 Sum_probs=99.5
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHH----------------------HHHHHHhhcCCCCc--e
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNF----------------------LEAVSNMSRLRHPN--I 470 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~H~n--i 470 (577)
.+.||+|+||+||+|...+++.||||+++...........+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999988889999999886432211111111 34555565554443 3
Q ss_pred eeEeeEEEeCCeEEEEEEecCCCCHHHh-hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeee
Q 008121 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDM-LHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILL 548 (577)
Q Consensus 471 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NILl 548 (577)
.+.+++ ...++||||++++.+... +... ... .+...++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444433 245899999999644321 1100 001 5678899999999999999 6 99999999999999
Q ss_pred CCCCCeEEeccccCcccCCC
Q 008121 549 DDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 549 ~~~~~~kl~DFGla~~~~~~ 568 (577)
+ ++.++++|||.+.....+
T Consensus 149 ~-~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred E-CCcEEEEECcccccccCc
Confidence 9 889999999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.2e-17 Score=161.57 Aligned_cols=145 Identities=27% Similarity=0.383 Sum_probs=125.5
Q ss_pred HHhhcCCCccceeccCccceEEEEEEc----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeC
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEH 480 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~ 480 (577)
....+.|..+++||+|.|+.||++.+. ..+.||+|.+... ....+...|+++|..+. +.||+++.+++..+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 344567888999999999999999553 4678999998643 23455889999999985 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEecc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDC 559 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DF 559 (577)
+...+|+||++.-+..++.. .++..++..+++.+..||+|+|.+ +||||||||+|+|.+. .+.-.|.||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 99999999999988888874 366888999999999999999999 9999999999999985 467899999
Q ss_pred ccCcc
Q 008121 560 GLAAL 564 (577)
Q Consensus 560 Gla~~ 564 (577)
|+|..
T Consensus 178 gLA~~ 182 (418)
T KOG1167|consen 178 GLAQR 182 (418)
T ss_pred hhHHH
Confidence 99984
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.2e-18 Score=174.64 Aligned_cols=182 Identities=26% Similarity=0.331 Sum_probs=153.1
Q ss_pred cEEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCC--CCCCCCccEEEccCCcCCCcCCCCccCCCC
Q 008121 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP--YQLPPNLTSLNLASNNFSGNLPYSIASMVS 154 (577)
Q Consensus 77 gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~ 154 (577)
|+.-....+..|+|..|+++..-..++.+|+.|+.||||+|.|...-+ +++.++|++|+|++|+|+..-+++|..|..
T Consensus 263 G~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~ 342 (873)
T KOG4194|consen 263 GAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQ 342 (873)
T ss_pred cceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHH
Confidence 333334578899999999998888899999999999999999986555 455699999999999999888889999999
Q ss_pred ccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCC---CccCCCCCCeEEccCcccccccc-cCCCCC-ccEEE
Q 008121 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN---SFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLN 229 (577)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~ 229 (577)
|+.|+|++|+++..-...|..+++|++|||++|.|++.|-+ .|.+|++|+.|.|.+|+|..++. +|.+++ |+.||
T Consensus 343 Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld 422 (873)
T KOG4194|consen 343 LEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD 422 (873)
T ss_pred hhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence 99999999999988888999999999999999999988764 47789999999999999998764 688887 99999
Q ss_pred eecCccccccCcccc--cccceeecCCcCCC
Q 008121 230 VANNHFSGWIPRELI--SIRTFIYDGNSFDN 258 (577)
Q Consensus 230 l~~N~l~g~~p~~l~--~l~~l~~~~n~~~~ 258 (577)
|.+|.|...-|+.|. .++.|.+...++.|
T Consensus 423 L~~NaiaSIq~nAFe~m~Lk~Lv~nSssflC 453 (873)
T KOG4194|consen 423 LGDNAIASIQPNAFEPMELKELVMNSSSFLC 453 (873)
T ss_pred CCCCcceeecccccccchhhhhhhcccceEE
Confidence 999999877777665 44555555555443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=161.13 Aligned_cols=145 Identities=22% Similarity=0.288 Sum_probs=118.4
Q ss_pred CCCccceeccCccceEEEEEEcCC--cEEEEEEccccccchHHHHHHHHHHHHhhcCCC----CceeeEeeEE-EeCCeE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH----PNIVTLAGYC-AEHGQR 483 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~ 483 (577)
+|.+.+.||+|+||.||.+..... +.+|+|........ . ...+..|+.++..+.. +++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~-~-~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS-K-PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC-C-CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 788899999999999999976553 47888876543211 1 1156778888887763 5888898888 477789
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-----CCeEEec
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-----LNPHLSD 558 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-----~~~kl~D 558 (577)
|+||+.+ |.+|.++.+.. ..+.++..+.++|+.|++.+|++||+. +++||||||+|++++.. ..+.|.|
T Consensus 97 ~iVM~l~-G~sL~dl~~~~--~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRN--PPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEEEecc-CccHHHHHHhC--CCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 9999988 77999987532 257899999999999999999999999 99999999999999865 4689999
Q ss_pred cccCc
Q 008121 559 CGLAA 563 (577)
Q Consensus 559 FGla~ 563 (577)
||+|+
T Consensus 171 fGlar 175 (322)
T KOG1164|consen 171 FGLAR 175 (322)
T ss_pred cCCCc
Confidence 99999
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.8e-16 Score=140.52 Aligned_cols=136 Identities=20% Similarity=0.217 Sum_probs=114.4
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCC--CceeeEeeEEEeCCeEEEEEEecCC
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..+++|||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4679999999999998765 7889999865421 4568899999999977 5899999888888889999999988
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++..+
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 766432 556677889999999999998744579999999999999998999999999998654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.6e-18 Score=174.44 Aligned_cols=170 Identities=27% Similarity=0.349 Sum_probs=134.5
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC---CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
..++.|||++|+|. ..|..+..-+++-+|+||+|+|. +||..+. +-|-+||||+|+|. .+|+.+..|..|++|+
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK 179 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence 46788888888887 66778888888888888888887 6776665 56677888888887 6677778888888888
Q ss_pred eccCCCc-------------------------ccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccc
Q 008121 160 VSRNSLT-------------------------QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (577)
Q Consensus 160 L~~N~l~-------------------------~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (577)
|++|.|. ..+|.++..|.+|..+|||.|+|. .+|+.+.++.+|+.|+|++|+|+
T Consensus 180 Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 180 LSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred cCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 8888542 246778888999999999999999 89999999999999999999998
Q ss_pred cccccCCCC-CccEEEeecCccccccCccccccc---ceeecCCcCC
Q 008121 215 GSLNVFSGL-PLTTLNVANNHFSGWIPRELISIR---TFIYDGNSFD 257 (577)
Q Consensus 215 ~~~~~~~~~-~L~~L~l~~N~l~g~~p~~l~~l~---~l~~~~n~~~ 257 (577)
..--..... .|++|++|.|+|+ .+|+.++.++ .|...+|.+.
T Consensus 259 eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 259 ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence 754333333 3899999999999 8888777554 4556666654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=148.57 Aligned_cols=139 Identities=15% Similarity=0.181 Sum_probs=107.6
Q ss_pred cceec-cCccceEEEEEEcCCcEEEEEEcccccc-----------chHHHHHHHHHHHHhhcCCCCce--eeEeeEEEeC
Q 008121 415 EFLIG-EGSLGRVYRAEFANGKIMAVKKIDNAAL-----------SLQEEDNFLEAVSNMSRLRHPNI--VTLAGYCAEH 480 (577)
Q Consensus 415 ~~~lg-~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~ 480 (577)
...|| .|+.|+||.++.. +..++||.+..... +.....++.+|++++.+++|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999775 67788988753211 11234567889999999998885 6677765432
Q ss_pred C----eEEEEEEecCC-CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeE
Q 008121 481 G----QRLLVYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (577)
Q Consensus 481 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 555 (577)
. ..++||||+++ .+|.+++.. ..++.. .+.+++.++.+||+. +|+||||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 699988852 234433 357899999999999 999999999999999988999
Q ss_pred EeccccCcccC
Q 008121 556 LSDCGLAALTP 566 (577)
Q Consensus 556 l~DFGla~~~~ 566 (577)
|+|||.++...
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999998765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-17 Score=169.67 Aligned_cols=157 Identities=25% Similarity=0.288 Sum_probs=79.9
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC---CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
.+++.|+|..|.|.-.---.|.+|.+|+.|.|..|.|+. +..+.. .++++|+|+.|+++..-.+++.+|++|+.|+
T Consensus 221 ~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k-L~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~ 299 (873)
T KOG4194|consen 221 PKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK-LDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLD 299 (873)
T ss_pred chhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc-ccCcceeeecccceeecccchhhhhhcccccccchhhhhc
Confidence 356677777777653333455566666666666665552 221111 4555555555555544444555555555555
Q ss_pred eccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCcccc
Q 008121 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSG 237 (577)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g 237 (577)
||+|.|..+-++.+.-.++|++|+|++|+|+..-+.+|..|..|++|+|++|.+...-. .|.+++ |+.|||++|.|++
T Consensus 300 lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~ 379 (873)
T KOG4194|consen 300 LSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSW 379 (873)
T ss_pred cchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEE
Confidence 55555555555555555555555555555553334444455555555555555444322 233333 4455555555544
Q ss_pred ccC
Q 008121 238 WIP 240 (577)
Q Consensus 238 ~~p 240 (577)
.|-
T Consensus 380 ~IE 382 (873)
T KOG4194|consen 380 CIE 382 (873)
T ss_pred EEe
Confidence 443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.6e-15 Score=150.36 Aligned_cols=151 Identities=36% Similarity=0.537 Sum_probs=128.4
Q ss_pred CCccceeccCccceEEEEEEcCCcEEEEEEccccccchH-HHHHHHHHHHHhhcCCCC-ceeeEeeEEEeCCeEEEEEEe
Q 008121 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ-EEDNFLEAVSNMSRLRHP-NIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 489 (577)
|...+.||.|+||.||++... ..+++|.+........ ....|.+|+..++.+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999877 7889999876544332 467899999999999988 799999999777778999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~ 568 (577)
+.++++.+++...... ..++......++.|++.++.|+|+. +++|||+||+||+++... .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777522111 3688899999999999999999999 899999999999999988 7999999999865543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.2e-15 Score=164.19 Aligned_cols=168 Identities=20% Similarity=0.295 Sum_probs=116.3
Q ss_pred ccCCChHHHHHHHHHHHhcCCCCCCCC----CCCCCCCCCCCC--------------CccEEeeCCc-------------
Q 008121 36 QCTTDSSDVQALQVLYTSLNSPSVLTN----WKGNEGDPCGES--------------WKGVACEGSA------------- 84 (577)
Q Consensus 36 ~~~~~~~~~~~l~~~~~~~~~~~~l~~----w~~~~~~~c~~~--------------w~gv~C~~~~------------- 84 (577)
...+.++|.+.++.+.+.+..|+++.+ |+. ..|+|.-. -.-|.|.++.
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~-~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~ 135 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGG-ADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQAS 135 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCchhhccccccCC-CCcccccCCcchhhheeeecCCceEEecCCCcccccccccccccc
Confidence 455678999999999999999988888 985 46888521 1237775432
Q ss_pred --------------------------------------------EEEEEcCCCCCcccccccccCCCCCCEEEccCCCcC
Q 008121 85 --------------------------------------------VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIH 120 (577)
Q Consensus 85 --------------------------------------------v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~ 120 (577)
.+.|+|++++|+. +|..+. ++|+.|+|++|+|+
T Consensus 136 ~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt 212 (754)
T PRK15370 136 SASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK 212 (754)
T ss_pred cCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC
Confidence 3456777777763 454443 46788888888887
Q ss_pred CcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCC
Q 008121 121 DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200 (577)
Q Consensus 121 ~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 200 (577)
.+|..+.++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. .+|+.|+|++|+|+ .+|..+.
T Consensus 213 -sLP~~l~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~-- 282 (754)
T PRK15370 213 -SLPENLQGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP-- 282 (754)
T ss_pred -cCChhhccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--
Confidence 577666677888888888877 4565443 36777777777777 4555543 46777777777777 4666553
Q ss_pred CCCCeEEccCccccccc
Q 008121 201 SNISSLYLQNNQVTGSL 217 (577)
Q Consensus 201 ~~L~~L~l~~N~l~~~~ 217 (577)
.+|+.|+|++|+|++.+
T Consensus 283 ~sL~~L~Ls~N~Lt~LP 299 (754)
T PRK15370 283 EELRYLSVYDNSIRTLP 299 (754)
T ss_pred CCCcEEECCCCccccCc
Confidence 46777777777776543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-16 Score=156.80 Aligned_cols=193 Identities=25% Similarity=0.318 Sum_probs=143.3
Q ss_pred CCCCCCCC---ccEEeeCC-----------cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCc
Q 008121 68 GDPCGESW---KGVACEGS-----------AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNL 131 (577)
Q Consensus 68 ~~~c~~~w---~gv~C~~~-----------~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L 131 (577)
+.||.|+= .-|.|+.. ..+.|+|..|+|+.+.|.+|+.+++|+.||||+|+|+..-|..|. ++|
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 35777654 44999853 467899999999999999999999999999999999976675553 343
Q ss_pred -cEEEccCCcCCCcCCCCccCCCCccEEEec------------------------cCCCcc-------------------
Q 008121 132 -TSLNLASNNFSGNLPYSIASMVSLSYLNVS------------------------RNSLTQ------------------- 167 (577)
Q Consensus 132 -~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~------------------------~N~l~~------------------- 167 (577)
+-+++++|+|+....+.|++|.+|+.|.+. +|.+..
T Consensus 118 ~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~ 197 (498)
T KOG4237|consen 118 LSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQ 197 (498)
T ss_pred hHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhc
Confidence 334455577775555556555444433332 222110
Q ss_pred ------------------------------------------------------------------ccc-ccccCCCCCc
Q 008121 168 ------------------------------------------------------------------SIG-DIFGNLAGLA 180 (577)
Q Consensus 168 ------------------------------------------------------------------~~p-~~~~~l~~L~ 180 (577)
.-| ..|..|++|+
T Consensus 198 np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~ 277 (498)
T KOG4237|consen 198 NPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLR 277 (498)
T ss_pred CccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccce
Confidence 000 2467789999
Q ss_pred EEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCcccc---cccceeecCCc
Q 008121 181 TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPRELI---SIRTFIYDGNS 255 (577)
Q Consensus 181 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~ 255 (577)
.|+|++|+|+++-+.+|.++..+++|+|..|+|...-. .|.++. |+.|+|.+|+|+..-|..|. .+.++.+-+|+
T Consensus 278 ~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np 357 (498)
T KOG4237|consen 278 KLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNP 357 (498)
T ss_pred EeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCc
Confidence 99999999998888999999999999999999887543 466665 99999999999988886665 56778899999
Q ss_pred CCCCC
Q 008121 256 FDNGP 260 (577)
Q Consensus 256 ~~~~~ 260 (577)
|+|..
T Consensus 358 ~~CnC 362 (498)
T KOG4237|consen 358 FNCNC 362 (498)
T ss_pred ccCcc
Confidence 98754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.2e-17 Score=142.50 Aligned_cols=153 Identities=30% Similarity=0.501 Sum_probs=136.1
Q ss_pred cccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCC
Q 008121 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (577)
Q Consensus 102 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (577)
.+.++.+.+.|.||+|+++ .+|..+. .+|+.|++++|++. .+|.+++++++|+.|+++-|++. .+|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4567888899999999999 6777776 89999999999999 78999999999999999999998 889999999999
Q ss_pred cEEeCcCCccc-CCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccCcccc---cccceeecCC
Q 008121 180 ATLDLSFNNFS-GDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRELI---SIRTFIYDGN 254 (577)
Q Consensus 180 ~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n 254 (577)
+.|||++|+|+ ..+|..|..++.|+.|+|++|.|.-.++....+. |+.|.+..|.+- .+|.+++ .++.|...||
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 99999999997 4589999999999999999999998888888776 999999999998 7897766 4567778888
Q ss_pred cCCC
Q 008121 255 SFDN 258 (577)
Q Consensus 255 ~~~~ 258 (577)
.+.-
T Consensus 184 rl~v 187 (264)
T KOG0617|consen 184 RLTV 187 (264)
T ss_pred eeee
Confidence 8753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-16 Score=164.19 Aligned_cols=173 Identities=24% Similarity=0.286 Sum_probs=124.0
Q ss_pred CCcEEEEEcCCCCCc-ccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEE
Q 008121 82 GSAVVSIDISGLGLS-GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~-g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 158 (577)
-+++.++++.+|+|. .-+|+++..|..|+.||||+|++. +.|..+- +++..|+||+|+|..+....|.+|+.|-+|
T Consensus 77 Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfL 155 (1255)
T KOG0444|consen 77 LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFL 155 (1255)
T ss_pred chhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhh
Confidence 345677788888884 346788888999999999999988 6787665 788889999999884433455688888899
Q ss_pred EeccCCCcccccccccCCCCCcEEeCcCCccc-------------------------CCCCCCccCCCCCCeEEccCccc
Q 008121 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS-------------------------GDLPNSFISLSNISSLYLQNNQV 213 (577)
Q Consensus 159 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-------------------------g~~p~~~~~l~~L~~L~l~~N~l 213 (577)
|||+|+|. .+|+.+..|..|++|+|++|-|. ..+|.++-.+.+|..+||+.|+|
T Consensus 156 DLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L 234 (1255)
T KOG0444|consen 156 DLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL 234 (1255)
T ss_pred ccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC
Confidence 99999987 56666777777888888877542 23566666667777777777777
Q ss_pred ccccccCCCCC-ccEEEeecCccccccC---cccccccceeecCCcCC
Q 008121 214 TGSLNVFSGLP-LTTLNVANNHFSGWIP---RELISIRTFIYDGNSFD 257 (577)
Q Consensus 214 ~~~~~~~~~~~-L~~L~l~~N~l~g~~p---~~l~~l~~l~~~~n~~~ 257 (577)
.-.+..+..++ |+.|+||+|+|+ .+. ..+.++.+|+++.|.+.
T Consensus 235 p~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt 281 (1255)
T KOG0444|consen 235 PIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT 281 (1255)
T ss_pred CcchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc
Confidence 76666555544 777777777776 222 34456667777777664
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.8e-15 Score=150.48 Aligned_cols=155 Identities=24% Similarity=0.280 Sum_probs=128.0
Q ss_pred HhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC------CCceeeEeeEEEe
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR------HPNIVTLAGYCAE 479 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~~~~~~ 479 (577)
....+|...-..|+|-|+.|.+|.. ..|+.||||+|..... ..+.=+.|+++|.+++ --|+++++..|..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3445777778899999999999965 4588999999976532 2333467899999985 3478999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEec
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSD 558 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~D 558 (577)
.++.|||+|-+. -+|.++|+..+ ....|....+..++.|+.-||..|-.. +|+|.||||.|||+++. ...||||
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeecc
Confidence 999999999884 49999997543 455688888999999999999999988 99999999999999975 5789999
Q ss_pred cccCcccCCCc
Q 008121 559 CGLAALTPNTE 569 (577)
Q Consensus 559 FGla~~~~~~~ 569 (577)
||-|....+.+
T Consensus 581 fGSA~~~~ene 591 (752)
T KOG0670|consen 581 FGSASFASENE 591 (752)
T ss_pred Ccccccccccc
Confidence 99998776544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.8e-14 Score=149.73 Aligned_cols=145 Identities=21% Similarity=0.266 Sum_probs=102.9
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccch--------------------------------------HHHHHHH
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL--------------------------------------QEEDNFL 456 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------------------~~~~~~~ 456 (577)
.+.||.|++|+||+|++.+|+.||||+.+...... ..+-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46899999999999999999999999986431000 0011355
Q ss_pred HHHHHhhcC----CCCceeeEeeEE-EeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHhc
Q 008121 457 EAVSNMSRL----RHPNIVTLAGYC-AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR-ALEYLHE 530 (577)
Q Consensus 457 ~e~~~l~~l----~H~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~L~yLH~ 530 (577)
+|.+.+.++ +|.+-+.+-..+ ......++||||++|++|.++..... ... .+.+++.++++ .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 566655555 233333333333 23445799999999999988764211 112 23456666666 4678898
Q ss_pred CCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 531 ~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
. +++|+|+||.||++++++.++++|||+++.+.+.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 8 9999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.7e-17 Score=157.39 Aligned_cols=168 Identities=24% Similarity=0.353 Sum_probs=144.2
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC-CCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
.+..++..+|+++ ++|++++++.+|..|++.+|++....|..+. +.|+.||.-.|-+. .+|+.++.|.+|+-|||..
T Consensus 138 ~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~ 215 (565)
T KOG0472|consen 138 DLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRR 215 (565)
T ss_pred hhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhh
Confidence 4666788889988 6788999999999999999999954443333 88999999999987 8899999999999999999
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCcc-CCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p 240 (577)
|+|. .+| +|.++..|++|+++.|+|. .+|.+.. .+.+|..|||.+|+|+..+..+..+. |+.||+|+|.|+ .+|
T Consensus 216 Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp 291 (565)
T KOG0472|consen 216 NKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLP 291 (565)
T ss_pred cccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCC
Confidence 9998 556 7999999999999999999 8898876 89999999999999999888777776 999999999999 677
Q ss_pred cccccc--cceeecCCcCC
Q 008121 241 RELISI--RTFIYDGNSFD 257 (577)
Q Consensus 241 ~~l~~l--~~l~~~~n~~~ 257 (577)
..++++ +.|.+.|||+.
T Consensus 292 ~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 292 YSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred cccccceeeehhhcCCchH
Confidence 777765 56778899875
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=161.80 Aligned_cols=147 Identities=29% Similarity=0.393 Sum_probs=115.7
Q ss_pred HHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC---CCceeeEeeEEEeCCe
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~ 482 (577)
......|.+.+.||+|+||.||+|...+|+.||+|.=+....- +|.--.+++.+++ -+-|..+...+...+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3445568888899999999999999888999999986433211 1222233344444 2345555566667778
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-------CCCCeE
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-------DELNPH 555 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-------~~~~~k 555 (577)
-++|+||.+.|+|.+++. ..+.++|...+.++.|+++-+++||.. +|||+||||+|.||. +...++
T Consensus 769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 899999999999999996 677899999999999999999999999 999999999999993 234689
Q ss_pred EeccccCcc
Q 008121 556 LSDCGLAAL 564 (577)
Q Consensus 556 l~DFGla~~ 564 (577)
|+|||-+-.
T Consensus 842 lIDfG~siD 850 (974)
T KOG1166|consen 842 LIDFGRSID 850 (974)
T ss_pred EEeccccee
Confidence 999999864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=4e-14 Score=157.18 Aligned_cols=162 Identities=20% Similarity=0.316 Sum_probs=102.1
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|+|++|+|+. +|..+. .+|+.|+|++|+|+ .+|..++++|+.|+|++|++. .+|..+. .+|+.|+|++
T Consensus 199 ~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~ 271 (754)
T PRK15370 199 EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSINRIT-ELPERLP--SALQSLDLFH 271 (754)
T ss_pred cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhhccccEEECcCCccC-cCChhHh--CCCCEEECcC
Confidence 468889999999884 555544 47888888888888 577777777888888888887 5666554 4678888888
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccC-------------------CCCCCeEEccCcccccccccCCCC
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS-------------------LSNISSLYLQNNQVTGSLNVFSGL 223 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~-------------------l~~L~~L~l~~N~l~~~~~~~~~~ 223 (577)
|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+.. .++|+.|++++|.|++.+..+. .
T Consensus 272 N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt~LP~~l~-~ 346 (754)
T PRK15370 272 NKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLPSGITHLNVQSNSLTALPETLPPGLKTLEAGENALTSLPASLP-P 346 (754)
T ss_pred CccC-ccccccC--CCCcEEECCCCccc-cCcccchhhHHHHHhcCCccccCCccccccceeccccCCccccCChhhc-C
Confidence 8887 3565543 46777777777777 35543321 1234444455554444322221 2
Q ss_pred CccEEEeecCccccccCccc-ccccceeecCCcCC
Q 008121 224 PLTTLNVANNHFSGWIPREL-ISIRTFIYDGNSFD 257 (577)
Q Consensus 224 ~L~~L~l~~N~l~g~~p~~l-~~l~~l~~~~n~~~ 257 (577)
.|+.|++++|+|+ .+|..+ .+++.|++++|.+.
T Consensus 347 sL~~L~Ls~N~L~-~LP~~lp~~L~~LdLs~N~Lt 380 (754)
T PRK15370 347 ELQVLDVSKNQIT-VLPETLPPTITTLDVSRNALT 380 (754)
T ss_pred cccEEECCCCCCC-cCChhhcCCcCEEECCCCcCC
Confidence 3666666666665 344332 24556666666554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-13 Score=151.38 Aligned_cols=53 Identities=28% Similarity=0.504 Sum_probs=36.5
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCC
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~ 142 (577)
.++.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|. ++++|+.|+|++|.|+
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~-lp~sL~~L~Ls~N~L~ 275 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV-LPPGLLELSIFSNPLT 275 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccC-cccccceeeccCCchh
Confidence 67888888888885 443 2578888999999888 4553 2355666655555554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.9e-16 Score=156.85 Aligned_cols=170 Identities=31% Similarity=0.433 Sum_probs=147.4
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+..||+.|.++ ++|..+..+..|+.|.|.+|.|. .+|..+. ..|++|||+.|+++ .+|..+..|+ |+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 3456788889887 78888999999999999999998 6777665 78999999999999 7788888886 9999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCCccEEEeecCccccccCc
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR 241 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~ 241 (577)
+|+++ .+|..++.+..|..||.+.|++. .+|..++++.+|+.|++..|++...++.+..++|..||+|.|+++ .||-
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv 228 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPV 228 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecch
Confidence 99998 77888888999999999999998 789999999999999999999999988888999999999999999 8998
Q ss_pred cccccc---ceeecCCcCCCCC
Q 008121 242 ELISIR---TFIYDGNSFDNGP 260 (577)
Q Consensus 242 ~l~~l~---~l~~~~n~~~~~~ 260 (577)
+|.+++ .|.+.+|++.+.|
T Consensus 229 ~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred hhhhhhhheeeeeccCCCCCCh
Confidence 877654 5668899887543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=1e-13 Score=153.13 Aligned_cols=155 Identities=26% Similarity=0.353 Sum_probs=106.7
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCC-------------------cCCCCCCCCccEEEccCCcCCCc
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD-------------------TIPYQLPPNLTSLNLASNNFSGN 144 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~-------------------~~p~~~~~~L~~L~l~~N~l~~~ 144 (577)
.++.|+|++|+|+. +|. .+++|+.|+|++|+|++ .+|. ++.+|++|+|++|+|++
T Consensus 283 ~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~-lp~~Lq~LdLS~N~Ls~- 356 (788)
T PRK15387 283 GLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPT-LPSGLQELSVSDNQLAS- 356 (788)
T ss_pred hcCEEECcCCcccc-ccc---cccccceeECCCCccccCCCCcccccccccccCccccccc-cccccceEecCCCccCC-
Confidence 34455666666553 232 13456666666666653 1221 23578888888888884
Q ss_pred CCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC
Q 008121 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP 224 (577)
Q Consensus 145 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~ 224 (577)
+|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|... ++|+.|++++|+|++.+... ..
T Consensus 357 LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~LssIP~l~--~~ 423 (788)
T PRK15387 357 LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTSLPMLP--SG 423 (788)
T ss_pred CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCCCCcch--hh
Confidence 5543 2467788888888885 5543 357899999999999 477543 57999999999998754322 24
Q ss_pred ccEEEeecCccccccCcccc---cccceeecCCcCCC
Q 008121 225 LTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 225 L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
|+.|++++|+|+ .+|..+. ++..+++++|++..
T Consensus 424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred hhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCc
Confidence 788999999998 7887655 55678899999874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-15 Score=148.98 Aligned_cols=147 Identities=24% Similarity=0.341 Sum_probs=133.9
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
+++.+++.+|.+....|..+. ++.|++||..+|-+. .+|.+++ .+|..|||..|++. .+| +|.++..|.+|+++
T Consensus 161 ~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g 236 (565)
T KOG0472|consen 161 KLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVG 236 (565)
T ss_pred HHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhc
Confidence 567789999999966665555 999999999999997 8998887 89999999999999 777 89999999999999
Q ss_pred cCCCccccccccc-CCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCCccEEEeecCccc
Q 008121 162 RNSLTQSIGDIFG-NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFS 236 (577)
Q Consensus 162 ~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~ 236 (577)
.|+|+ .+|.+.. ++++|.+|||.+|+++ ..|.++..+.+|.+||+++|.|++.++.++.+.|+.|-+.+|.+.
T Consensus 237 ~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 237 ENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred ccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchH
Confidence 99998 6666554 9999999999999999 899999999999999999999999999999999999999999987
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.8e-13 Score=144.74 Aligned_cols=149 Identities=16% Similarity=0.203 Sum_probs=97.7
Q ss_pred cCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccc---------------------------h-----H------
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS---------------------------L-----Q------ 450 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------~-----~------ 450 (577)
..|+. +.||.|++|+||+|.+++ |+.||||+++..... . +
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999987 999999998743100 0 0
Q ss_pred HHHHHHHHHHHhhcCC----CCceeeEeeEEEe-CCeEEEEEEecCCCCHHHhh--hhccCCCCCCCHHHHHHHHHHHHH
Q 008121 451 EEDNFLEAVSNMSRLR----HPNIVTLAGYCAE-HGQRLLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVALGTAR 523 (577)
Q Consensus 451 ~~~~~~~e~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~~i~~ 523 (577)
.+-+|.+|...+.+++ +.+.+.+-..+.+ ....++||||++|+.+.++- .........+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1123445555554442 4444444344332 45678999999999998742 2111011123333333333343
Q ss_pred HHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEeccccCcccCCCc
Q 008121 524 ALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDCGLAALTPNTE 569 (577)
Q Consensus 524 ~L~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DFGla~~~~~~~ 569 (577)
+.. +++|+|+||.||+++.++ ++++.|||++..++...
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~~ 318 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKED 318 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHHH
Confidence 345 899999999999999888 99999999999876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.8e-14 Score=129.86 Aligned_cols=138 Identities=22% Similarity=0.446 Sum_probs=118.2
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L 495 (577)
.+|.+...|+.|+|+|..+ .+++|++.....+....++|.+|...++-+.||||..++|.|.......++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 3588899999999999854 455688877666666778899999999999999999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 008121 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (577)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~ 557 (577)
+..|++ .....++..++.+++.++|+|++|||+.. |-|.---+.+..|++|++.+++|+
T Consensus 275 ynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 275 YNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee
Confidence 999984 34566788899999999999999999973 334444688999999999998875
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.5e-14 Score=153.89 Aligned_cols=170 Identities=26% Similarity=0.362 Sum_probs=135.9
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCC----------------------------CCCccEEE
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL----------------------------PPNLTSLN 135 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----------------------------~~~L~~L~ 135 (577)
.++.|.+..|.++ -+|+.+..+++|++|||..|+|. .+|..+ .+.|+.|+
T Consensus 288 ~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Ly 365 (1081)
T KOG0618|consen 288 SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELY 365 (1081)
T ss_pred hHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHH
Confidence 3455566666666 45566677777777777777776 333211 14688899
Q ss_pred ccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccc
Q 008121 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (577)
Q Consensus 136 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (577)
|.+|.|+...-+.|-++.+|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+.++..|++|...+|+|..
T Consensus 366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~ 444 (1081)
T KOG0618|consen 366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS 444 (1081)
T ss_pred HhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee
Confidence 9999999887778889999999999999999766677999999999999999999 899999999999999999999998
Q ss_pred ccccCCCCC-ccEEEeecCcccc-ccCccc--ccccceeecCCcCC
Q 008121 216 SLNVFSGLP-LTTLNVANNHFSG-WIPREL--ISIRTFIYDGNSFD 257 (577)
Q Consensus 216 ~~~~~~~~~-L~~L~l~~N~l~g-~~p~~l--~~l~~l~~~~n~~~ 257 (577)
.+ .+..++ |+.+|+|.|+|+- .+|..+ .+++.|+++||.+.
T Consensus 445 fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 445 FP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred ch-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 77 444454 9999999999974 455443 47899999999853
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.2e-13 Score=146.25 Aligned_cols=146 Identities=23% Similarity=0.263 Sum_probs=112.9
Q ss_pred CccceeccCccceEEEEEE-cCCcEEEEEEcc----ccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 413 SQEFLIGEGSLGRVYRAEF-ANGKIMAVKKID----NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
...+++|.|++|.|+.... ...+..+.|..+ ......+....+..|..+-.++.|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999998877743 334444444432 11111111222566777788899999998887777766666669
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++ ||..++. ....+...++..++.|+..|++|+|+. +|.|||+|++|+++..+|.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 9999985 334688888999999999999999999 99999999999999999999999999998653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.7e-12 Score=118.28 Aligned_cols=132 Identities=20% Similarity=0.142 Sum_probs=96.1
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCcee-eEeeEEEeCCeEEEEEEecCCC
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV-TLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~g 493 (577)
.+.++.|.++.||+++.. ++.|++|....... ....+..|++.+..+.+.+++ +++.+. ....++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 356899999999999875 77899998754321 123457788888888665554 454443 23458999999998
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC--LPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
++.+.- . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..-
T Consensus 77 ~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 77 ELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 765420 0 11345678999999999983 12369999999999999 668999999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.4e-13 Score=141.73 Aligned_cols=151 Identities=23% Similarity=0.335 Sum_probs=121.6
Q ss_pred eeccCccceEEEEE----EcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEEEecC
Q 008121 417 LIGEGSLGRVYRAE----FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
.+|+|.||.|+.++ .+.|..+|.|..++.............|..++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999873 234777888888665433222224455677788887 9999999999999999999999999
Q ss_pred CCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCccc
Q 008121 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (577)
Q Consensus 492 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 571 (577)
+|+|...+. .....++.....+...++-|++++|.. +|+|||+|++||+++.+|.+|+.|||+++..-+.+..
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999998875 344556666666777899999999999 9999999999999999999999999999977655554
Q ss_pred cccCC
Q 008121 572 VITGT 576 (577)
Q Consensus 572 ~~~Gt 576 (577)
|||
T Consensus 154 --cgt 156 (612)
T KOG0603|consen 154 --CGT 156 (612)
T ss_pred --ccc
Confidence 665
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-11 Score=146.47 Aligned_cols=79 Identities=18% Similarity=0.106 Sum_probs=37.2
Q ss_pred CCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcc-cccccccCCCCCccEEEeecCccccccCcccccccceeecCCcC
Q 008121 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ-VTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256 (577)
Q Consensus 178 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~l~~l~~l~~~~n~~ 256 (577)
+|+.|+|++|...+.+|.+++++++|+.|++++|. +...+.......|+.|++++|..-..+|....+++.|++++|.+
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~i 858 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGI 858 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCccccccccccccCEeECCCCCC
Confidence 44555555554444566666666666666666553 22222222111245555554433334444444444444444443
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-12 Score=149.06 Aligned_cols=94 Identities=13% Similarity=0.161 Sum_probs=74.5
Q ss_pred cCCC-CceeeEeeEE-------EeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 008121 464 RLRH-PNIVTLAGYC-------AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535 (577)
Q Consensus 464 ~l~H-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ 535 (577)
.++| +||++++++| ...+..+.++||+ +++|+++|+. ....+++.+++.|+.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4455 5788888887 2234567888988 5699999962 345699999999999999999999999 9
Q ss_pred eeecCCCCCCeeeCC-------------------CCCeEEeccccCcc
Q 008121 536 VVHRNFKSANILLDD-------------------ELNPHLSDCGLAAL 564 (577)
Q Consensus 536 ivHrDlk~~NILl~~-------------------~~~~kl~DFGla~~ 564 (577)
||||||||+||||+. ++.+|++|||+++.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~ 148 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR 148 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence 999999999999954 45566777777664
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.5e-13 Score=136.74 Aligned_cols=176 Identities=26% Similarity=0.403 Sum_probs=129.7
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCC---CCEEEccCCCcCCc----CC---CCCCCCccEEEccCCcCCCc----CCC
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLS---LRKFDLSGNSIHDT----IP---YQLPPNLTSLNLASNNFSGN----LPY 147 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~---L~~L~Ls~N~l~~~----~p---~~~~~~L~~L~l~~N~l~~~----~p~ 147 (577)
..+++.|+|++|.+.+..+..+..+.. |++|++++|++++. +. ....++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 358999999999998777777776666 99999999998831 11 12237899999999999843 344
Q ss_pred CccCCCCccEEEeccCCCccc----ccccccCCCCCcEEeCcCCcccCC----CCCCccCCCCCCeEEccCcccccc-cc
Q 008121 148 SIASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGS-LN 218 (577)
Q Consensus 148 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~-~~ 218 (577)
.+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|++|++++|.+++. +.
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 566778999999999999842 444566678999999999998743 334566788999999999998862 11
Q ss_pred ----cCC--CCCccEEEeecCcccc----ccCc---ccccccceeecCCcCC
Q 008121 219 ----VFS--GLPLTTLNVANNHFSG----WIPR---ELISIRTFIYDGNSFD 257 (577)
Q Consensus 219 ----~~~--~~~L~~L~l~~N~l~g----~~p~---~l~~l~~l~~~~n~~~ 257 (577)
.+. ...|+.|++++|.++. .+.. .+.++..+++++|.+.
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 111 1359999999999972 2222 2356778888888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.7e-11 Score=111.91 Aligned_cols=140 Identities=16% Similarity=0.183 Sum_probs=99.3
Q ss_pred ceeccCccceEEEEEEcC-------CcEEEEEEccccccc--------------------hHHHHHH----HHHHHHhhc
Q 008121 416 FLIGEGSLGRVYRAEFAN-------GKIMAVKKIDNAALS--------------------LQEEDNF----LEAVSNMSR 464 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~--------------------~~~~~~~----~~e~~~l~~ 464 (577)
..||.|.=+.||.|...+ +..+|||+.+....+ ......+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 478999987522100 0011222 378888888
Q ss_pred CCC--CceeeEeeEEEeCCeEEEEEEecCCCCHHH-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecC
Q 008121 465 LRH--PNIVTLAGYCAEHGQRLLVYEYVGNGNLHD-MLHFADDSSKNLTWNARVRVALGTARALEYL-HEVCLPSVVHRN 540 (577)
Q Consensus 465 l~H--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivHrD 540 (577)
+.. -++..++++ ...++||||+.++.+.. .++ ...++..+...+..+++.+|.+| |.. +|||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 854 456666654 45689999997654422 222 12344556677889999999999 777 999999
Q ss_pred CCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 541 FKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 541 lk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+++.|||+++ +.+.|+|||.|.....+
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~hp 177 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCCCC
Confidence 9999999974 68999999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.5e-13 Score=134.36 Aligned_cols=174 Identities=22% Similarity=0.242 Sum_probs=117.8
Q ss_pred CcEEEEEcCCCCCc------ccccccccCCCCCCEEEccCCCcCCcCCCCCC-----CCccEEEccCCcCCC----cCCC
Q 008121 83 SAVVSIDISGLGLS------GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASNNFSG----NLPY 147 (577)
Q Consensus 83 ~~v~~l~l~~~~l~------g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~~L~~L~l~~N~l~~----~~p~ 147 (577)
..++.|+++++.+. ..++..+..+++|+.|+|++|.+.+..+..+. ++|++|++++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 44777888877776 23445677788888888888888754443322 348888888888873 3334
Q ss_pred CccCC-CCccEEEeccCCCccc----ccccccCCCCCcEEeCcCCcccCC----CCCCccCCCCCCeEEccCccccccc-
Q 008121 148 SIASM-VSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL- 217 (577)
Q Consensus 148 ~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~- 217 (577)
.+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+++|++|+|++|.+++..
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 210 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence 45566 7888888888888843 344566777888888888888742 3334555678888888888887432
Q ss_pred ----ccCCCCC-ccEEEeecCccccccC----cc----cccccceeecCCcC
Q 008121 218 ----NVFSGLP-LTTLNVANNHFSGWIP----RE----LISIRTFIYDGNSF 256 (577)
Q Consensus 218 ----~~~~~~~-L~~L~l~~N~l~g~~p----~~----l~~l~~l~~~~n~~ 256 (577)
..+...+ |+.|++++|.+++... .. ..+++.+.+++|.+
T Consensus 211 ~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i 262 (319)
T cd00116 211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262 (319)
T ss_pred HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCC
Confidence 1233333 8888888888875222 12 24667777777765
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.5e-11 Score=113.99 Aligned_cols=144 Identities=22% Similarity=0.286 Sum_probs=110.7
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCC--ceeeEeeEEEeC---CeEEEEEEec
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP--NIVTLAGYCAEH---GQRLLVYEYV 490 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~~---~~~~lv~e~~ 490 (577)
+.|+.|.++.||+++..+|+.+++|........ ....++..|.+++..+++. ++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998877789999987543221 1345678899999998764 456777776653 2568999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-------------------------------------- 532 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-------------------------------------- 532 (577)
+++++.+.+. ...++..++..++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9988876542 135677778888889999999998531
Q ss_pred ---------------CCCeeecCCCCCCeeeCC--CCCeEEeccccCccc
Q 008121 533 ---------------LPSVVHRNFKSANILLDD--ELNPHLSDCGLAALT 565 (577)
Q Consensus 533 ---------------~~~ivHrDlk~~NILl~~--~~~~kl~DFGla~~~ 565 (577)
...++|+|+++.||+++. ++.+.|+||+.+..-
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.7e-13 Score=138.93 Aligned_cols=144 Identities=27% Similarity=0.380 Sum_probs=64.6
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC-CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCC
Q 008121 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165 (577)
Q Consensus 87 ~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 165 (577)
.+.|.+|.+. .+|..+++|..|++|||+.|+++ .+|..+. --|+.|-+++|+++ .+|+.++.+..|..||.+.|.+
T Consensus 102 ~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei 178 (722)
T KOG0532|consen 102 SLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI 178 (722)
T ss_pred HHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecCccc-cCCcccccchhHHHhhhhhhhh
Confidence 3444444444 44445555555555555555554 3443333 33455555555554 4444444444555555555554
Q ss_pred cccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccc
Q 008121 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS 236 (577)
Q Consensus 166 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~ 236 (577)
. .+|..++++.+|+.|++..|++. .+|.++..| .|..||++.|+++..+-.|..+. |++|-|.+|.|.
T Consensus 179 ~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 179 Q-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred h-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCC
Confidence 4 33334444444444444444444 344444322 24444444444444333333333 444444444443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=1e-11 Score=137.25 Aligned_cols=106 Identities=27% Similarity=0.382 Sum_probs=66.2
Q ss_pred ccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-ccEEEeec
Q 008121 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP-LTTLNVAN 232 (577)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~L~l~~ 232 (577)
++.|+|++|.|+|.+|..++++++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.++. +..++ |+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 55566666666666666666666666666666666666666666666666666666666655442 44443 66666666
Q ss_pred CccccccCccccc----ccceeecCCcCCCCC
Q 008121 233 NHFSGWIPRELIS----IRTFIYDGNSFDNGP 260 (577)
Q Consensus 233 N~l~g~~p~~l~~----l~~l~~~~n~~~~~~ 260 (577)
|+|+|.+|..+.. +..+.+.+|+..|+.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCC
Confidence 6677777765543 345677888877753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-10 Score=104.32 Aligned_cols=137 Identities=22% Similarity=0.307 Sum_probs=102.8
Q ss_pred eeccCccceEEEEEEcCCcEEEEEEccccccchH------HHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ------EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
.+++|+=+.+|.+.+.+.. +++|.-..+..... ..++-.+|.+++++++--.|...+=|..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999886444 55554322221111 2345678999999887666666555677778889999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
+|-.|.+.+... +..++..+-.-+.-||.. +|||+||.++||++..+. +.++||||+..-...+
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~E 145 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVE 145 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccccccHH
Confidence 999998888521 245677777888899999 999999999999998765 9999999999755443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.8e-11 Score=139.48 Aligned_cols=167 Identities=18% Similarity=0.201 Sum_probs=112.8
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC-CCccEEEcc---------------------CCcC
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLA---------------------SNNF 141 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~l~---------------------~N~l 141 (577)
.++.|+|+++..-..+|..+++|++|+.|+|++|..-+.+|..+. ++|+.|+|+ +|.+
T Consensus 658 ~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i 737 (1153)
T PLN03210 658 NLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI 737 (1153)
T ss_pred cccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc
Confidence 455666666555556677777777777777777544445554432 444444444 4443
Q ss_pred CCcCCCCc------------------------------cCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccC
Q 008121 142 SGNLPYSI------------------------------ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG 191 (577)
Q Consensus 142 ~~~~p~~~------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 191 (577)
. .+|..+ ...++|+.|+|++|...+.+|..++++++|+.|+|++|..-+
T Consensus 738 ~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~ 816 (1153)
T PLN03210 738 E-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLE 816 (1153)
T ss_pred c-cccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcC
Confidence 3 233221 012467888888888888899999999999999999975445
Q ss_pred CCCCCccCCCCCCeEEccCcccccccccCCCCCccEEEeecCccccccCcccc---cccceeecCC
Q 008121 192 DLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELI---SIRTFIYDGN 254 (577)
Q Consensus 192 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n 254 (577)
.+|..+ ++++|+.|+|++|.....++... ..|+.|+|++|.|+ .+|.++. ++..|++.++
T Consensus 817 ~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~-~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C 879 (1153)
T PLN03210 817 TLPTGI-NLESLESLDLSGCSRLRTFPDIS-TNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGC 879 (1153)
T ss_pred eeCCCC-CccccCEEECCCCCccccccccc-cccCEeECCCCCCc-cChHHHhcCCCCCEEECCCC
Confidence 788876 78999999999986444333221 24899999999998 6886654 5566677663
|
syringae 6; Provisional |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-11 Score=120.87 Aligned_cols=90 Identities=28% Similarity=0.405 Sum_probs=71.7
Q ss_pred CCCceeeEeeEEEeC---------------------------CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHH
Q 008121 466 RHPNIVTLAGYCAEH---------------------------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518 (577)
Q Consensus 466 ~H~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 518 (577)
+|||||++.++|.+. ...|+||.-.+. +|++++. ....+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence 699999999877431 247899987754 8999986 2344555667788
Q ss_pred HHHHHHHHHHhcCCCCCeeecCCCCCCeee--CCCC--CeEEeccccCcc
Q 008121 519 LGTARALEYLHEVCLPSVVHRNFKSANILL--DDEL--NPHLSDCGLAAL 564 (577)
Q Consensus 519 ~~i~~~L~yLH~~~~~~ivHrDlk~~NILl--~~~~--~~kl~DFGla~~ 564 (577)
.|+++|+.|||.+ +|.|||+|++|||+ |+|+ ...|+|||.+--
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA 394 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA 394 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence 8999999999999 99999999999999 4554 467999998653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.7e-12 Score=139.97 Aligned_cols=171 Identities=25% Similarity=0.374 Sum_probs=113.9
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC-------------------------CCccEEEccC
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-------------------------PNLTSLNLAS 138 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-------------------------~~L~~L~l~~ 138 (577)
.++.+++++|++++. |.+++.+.+|+.|+..+|+|+ .+|..+. +.|++|||..
T Consensus 242 nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~ 319 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQS 319 (1081)
T ss_pred cceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehh
Confidence 577788888888855 489999999999999999986 4553332 4566666666
Q ss_pred CcCCCcCCCCc-c-------------------------CCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCC
Q 008121 139 NNFSGNLPYSI-A-------------------------SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD 192 (577)
Q Consensus 139 N~l~~~~p~~~-~-------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 192 (577)
|+|. .+|+.+ . .+..|+.|+|.+|.|+...-+.+.+...|+.|+|++|+|. .
T Consensus 320 N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~ 397 (1081)
T KOG0618|consen 320 NNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-S 397 (1081)
T ss_pred cccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-c
Confidence 6665 223221 1 1123555666666666555555667777777777777777 5
Q ss_pred CCC-CccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccCc--ccccccceeecCCcCCCC
Q 008121 193 LPN-SFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPR--ELISIRTFIYDGNSFDNG 259 (577)
Q Consensus 193 ~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p~--~l~~l~~l~~~~n~~~~~ 259 (577)
+|+ .+.++..|++|+||+|+|+..+.....+. |++|...+|+|. ..|+ .+..++.++++.|.+...
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhhh
Confidence 554 35677777777777777777665544444 777777777777 6662 234566777888877644
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.9e-10 Score=99.33 Aligned_cols=148 Identities=19% Similarity=0.253 Sum_probs=104.2
Q ss_pred ccceeccCccceEEEEEEcCCcEEEEEEc-ccc----ccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKI-DNA----ALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 414 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~-~~~----~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
....+-+|+=+.|+++.+. |+...||.- .+. ..+ .-...+..+|++.+.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3567899999999999886 566555543 221 111 112456778999999987666655455566666678999
Q ss_pred EecCC-CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEEeccccCc
Q 008121 488 EYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHLSDCGLAA 563 (577)
Q Consensus 488 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl~DFGla~ 563 (577)
||+++ -++.+++...- ............++.|-+.+.-||.. .|||+||..+||++.+++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 37778776321 11122222367888889999999999 999999999999996554 45899999987
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
.-..
T Consensus 165 ~s~~ 168 (229)
T KOG3087|consen 165 VSRL 168 (229)
T ss_pred cccC
Confidence 5433
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.4e-11 Score=110.01 Aligned_cols=110 Identities=26% Similarity=0.347 Sum_probs=30.8
Q ss_pred ccCCCCCCEEEccCCCcCCcCCCCC-CCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcE
Q 008121 103 LSDLLSLRKFDLSGNSIHDTIPYQL-PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181 (577)
Q Consensus 103 ~~~l~~L~~L~Ls~N~l~~~~p~~~-~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 181 (577)
+.+...++.|+|++|+|+..-.... ..+|+.|||++|.|+.. + .+..+++|+.|+|++|+|+...+.....+++|++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE 92 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred cccccccccccccccccccccchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence 4445566777777777763211111 15677777777777633 2 3566677777777777777433222235677777
Q ss_pred EeCcCCcccCCCC--CCccCCCCCCeEEccCccccc
Q 008121 182 LDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTG 215 (577)
Q Consensus 182 L~Ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~ 215 (577)
|+|++|+|.. +- ..+..+++|+.|+|.+|.++.
T Consensus 93 L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 93 LYLSNNKISD-LNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp EE-TTS---S-CCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred EECcCCcCCC-hHHhHHHHcCCCcceeeccCCcccc
Confidence 7777777763 22 234456666666666666654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.6e-12 Score=118.98 Aligned_cols=125 Identities=30% Similarity=0.407 Sum_probs=54.3
Q ss_pred CCCCCEEEccCCCcCCcCCCCC--CCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEe
Q 008121 106 LLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLD 183 (577)
Q Consensus 106 l~~L~~L~Ls~N~l~~~~p~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 183 (577)
...|+.||||+|.|+ .+.++. .|+++.|++|+|.+... . .+..+++|+.||||+|.++. +.++=..|.+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee-h-hhhhcccceEeecccchhHh-hhhhHhhhcCEeeee
Confidence 344455555555554 232222 14555555555555421 1 14444555555555555542 222223344445555
Q ss_pred CcCCcccCCCCCCccCCCCCCeEEccCcccccc--cccCCCCC-ccEEEeecCccc
Q 008121 184 LSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS--LNVFSGLP-LTTLNVANNHFS 236 (577)
Q Consensus 184 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~-L~~L~l~~N~l~ 236 (577)
|+.|.|. .+ ..+.++-+|..||+++|+|... ...+..+| |+.|.|.+|.|.
T Consensus 359 La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 359 LAQNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 5555443 11 1234444455555555554431 22333333 444444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.6e-11 Score=109.79 Aligned_cols=121 Identities=23% Similarity=0.264 Sum_probs=52.2
Q ss_pred cEEEEEcCCCCCccccccccc-CCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCc-cCCCCccEEEec
Q 008121 84 AVVSIDISGLGLSGTMGYLLS-DLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVS 161 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~L~ 161 (577)
+++.|+|.+|+|+.+ +.++ .+.+|+.|||++|+|+........+.|++|++++|+|+. +++.+ ..+++|++|+|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLEGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S--TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-T
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCccccCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECc
Confidence 568899999999854 3566 689999999999999954333334999999999999995 44444 468999999999
Q ss_pred cCCCccccc-ccccCCCCCcEEeCcCCcccCCCCC----CccCCCCCCeEEc
Q 008121 162 RNSLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPN----SFISLSNISSLYL 208 (577)
Q Consensus 162 ~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~L~l 208 (577)
+|+|...-. ..+..+++|+.|+|.+|.++. .+. -+..+++|+.||-
T Consensus 97 ~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 97 NNKISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp TS---SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEETT
T ss_pred CCcCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeCC
Confidence 999985322 357789999999999999983 443 2557888888863
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.7e-11 Score=124.61 Aligned_cols=168 Identities=32% Similarity=0.488 Sum_probs=92.8
Q ss_pred cEEEEEcCCCCCcccccccccCCC-CCCEEEccCCCcCCcC--CCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDTI--PYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~-~L~~L~Ls~N~l~~~~--p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
.++.|++.+|.++ .+++..+.+. +|+.|++++|++. .+ |....++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 4556666666665 3444555553 6666666666665 33 2333366666666666666 44444445566666666
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCcccccc
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWI 239 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~ 239 (577)
++|+++ .+|.....+..|++|++++|++. .++..+.++.++..+.+.+|++...+.....++ +++|++++|+++ .+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i 270 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SI 270 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc-cc
Confidence 666665 33443344444666666666433 345555566666666666666655444344443 677777777776 33
Q ss_pred Cc--ccccccceeecCCcCC
Q 008121 240 PR--ELISIRTFIYDGNSFD 257 (577)
Q Consensus 240 p~--~l~~l~~l~~~~n~~~ 257 (577)
+. .+.++..+++++|.+.
T Consensus 271 ~~~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 271 SSLGSLTNLRELDLSGNSLS 290 (394)
T ss_pred ccccccCccCEEeccCcccc
Confidence 32 3334556666666553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.1e-10 Score=110.02 Aligned_cols=151 Identities=21% Similarity=0.298 Sum_probs=98.1
Q ss_pred CCccceeccCccceEEEEEEc-CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCC----------CceeeEeeEE--
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH----------PNIVTLAGYC-- 477 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H----------~niv~l~~~~-- 477 (577)
+...+.||.|+++.||.+.+. +++.+|+|.+.... ......+++.+|.-....+.+ -.++-.++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999775 58999999875332 223356677777655554332 1222222221
Q ss_pred -------EeCC--------eEEEEEEecCCCCHHHhhhhc---cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 008121 478 -------AEHG--------QRLLVYEYVGNGNLHDMLHFA---DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHR 539 (577)
Q Consensus 478 -------~~~~--------~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHr 539 (577)
.... ..+++|+-+ .+||.+++... ......+....++.+..|+++.+++||+. ++||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1111 235777777 56998886532 11223345566788889999999999999 99999
Q ss_pred CCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 540 NFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 540 Dlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||||+|++++.+|.++|+||+-.....
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g 196 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAG 196 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETT
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecC
Confidence 999999999999999999998766543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.7e-11 Score=134.54 Aligned_cols=143 Identities=24% Similarity=0.260 Sum_probs=114.8
Q ss_pred CCCccceeccCccceEEEEEEcCCcEEEEEEccccc--cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAA--LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++...+.||++.|=+|.+|++++|. |+||++-+.. .+.....+-.+|+. ...++|||.+.+.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4556778999999999999999888 7788874432 22222333344455 566799999998877666777788889
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
|... +|+|.|. .+..+...+..-|+.|++.||.-+|.. +|+|+|||.+|||+....=+.|+||.--|
T Consensus 102 yvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccC
Confidence 9855 9999984 556678888899999999999999999 99999999999999998889999997655
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.05 E-value=8.6e-11 Score=123.79 Aligned_cols=154 Identities=31% Similarity=0.449 Sum_probs=131.7
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCC--CCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ--LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
+++.|++++|++. .+|..++.+++|+.|++++|+++ .+|.. ..+.|+.|++++|+++ .+|..+..+..|++|+++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 7999999999998 45578999999999999999999 56665 4499999999999999 777776677779999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCC-CCccEEEeecCccccccC
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIP 240 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~~p 240 (577)
+|.+. .++..+.++.++..|.+.+|++. .++..++.+++|++|++++|+++.... +.. ..++.|++++|.++..+|
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccccc-ccccCccCEEeccCccccccch
Confidence 99654 45667889999999999999998 568889999999999999999998766 444 349999999999997777
Q ss_pred ccc
Q 008121 241 REL 243 (577)
Q Consensus 241 ~~l 243 (577)
...
T Consensus 295 ~~~ 297 (394)
T COG4886 295 LIA 297 (394)
T ss_pred hhh
Confidence 544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=2e-10 Score=86.39 Aligned_cols=61 Identities=43% Similarity=0.573 Sum_probs=40.8
Q ss_pred CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcc
Q 008121 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (577)
Q Consensus 129 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 189 (577)
++|++|+|++|+|+...++.|.++++|++|+|++|+++...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666655556666677777777777777666666666777777777776654
|
... |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.2e-11 Score=118.44 Aligned_cols=179 Identities=22% Similarity=0.245 Sum_probs=128.6
Q ss_pred EEeeCCcEEEEEcCCCCCccccc--ccccCCCCCCEEEccCCCcCCcCCC---CCCCCccEEEccCCcCCC-cCCCCccC
Q 008121 78 VACEGSAVVSIDISGLGLSGTMG--YLLSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSG-NLPYSIAS 151 (577)
Q Consensus 78 v~C~~~~v~~l~l~~~~l~g~~~--~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~~L~~L~l~~N~l~~-~~p~~~~~ 151 (577)
+.=....|+.|||++|-+..-.+ .....|++|+.|+|+.|++.-.... ...++|+.|.|+.|.|+- .+-..+..
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~ 220 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT 220 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence 33344689999999998875443 4567899999999999998733222 223899999999999982 23334457
Q ss_pred CCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCC--CCccCCCCCCeEEccCccccccc-ccC------CC
Q 008121 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGSL-NVF------SG 222 (577)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~-~~~------~~ 222 (577)
+|+|+.|+|+.|..-+.-......+..|++|||++|++- ..+ ...+.++.|..|+++.+.+...- +.. ..
T Consensus 221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~ 299 (505)
T KOG3207|consen 221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHT 299 (505)
T ss_pred CCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcc
Confidence 899999999999744444445566889999999999987 455 35678899999999999988742 211 11
Q ss_pred -CCccEEEeecCccccccC----cccccccceeecCCcCC
Q 008121 223 -LPLTTLNVANNHFSGWIP----RELISIRTFIYDGNSFD 257 (577)
Q Consensus 223 -~~L~~L~l~~N~l~g~~p----~~l~~l~~l~~~~n~~~ 257 (577)
.+|++|+++.|++..+-- ..+.+++.|.+.+|.++
T Consensus 300 f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 300 FPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 239999999999973321 23345566666666654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4e-11 Score=114.16 Aligned_cols=130 Identities=24% Similarity=0.296 Sum_probs=108.1
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccC
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (577)
.++.+||++|.|+ .+..+..-++.++.|++|+|+|...-...+.++|+.||||+|.++ .+.++-..+-+++.|.|+.|
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence 5789999999998 566788889999999999999984333444599999999999998 45555567889999999999
Q ss_pred CCcccccccccCCCCCcEEeCcCCcccCCCC--CCccCCCCCCeEEccCcccccccc
Q 008121 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGSLN 218 (577)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~~ 218 (577)
.|... ..+..|-+|..||+++|+|. .+- ..+++++-|+++.|.+|.|.+.+.
T Consensus 363 ~iE~L--SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 363 KIETL--SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hHhhh--hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccccch
Confidence 99743 23678889999999999997 333 468999999999999999998763
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.1e-10 Score=115.96 Aligned_cols=99 Identities=26% Similarity=0.478 Sum_probs=91.0
Q ss_pred hhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-eecC
Q 008121 462 MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV-VHRN 540 (577)
Q Consensus 462 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i-vHrD 540 (577)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+. .....++|.....+++++++||+|+|.- +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~---~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILS---NEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHh---ccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 456899999999999999999999999999999999996 3467789999999999999999999987 44 9999
Q ss_pred CCCCCeeeCCCCCeEEeccccCcccC
Q 008121 541 FKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 541 lk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
++++|+++|..+.+|++|||+..+..
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred eccccceeeeeEEEEechhhhccccc
Confidence 99999999999999999999988774
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.6e-10 Score=84.91 Aligned_cols=61 Identities=43% Similarity=0.557 Sum_probs=56.6
Q ss_pred CCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccc
Q 008121 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQV 213 (577)
Q Consensus 153 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l 213 (577)
++|++|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999988888999999999999999999987788999999999999999975
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-08 Score=100.80 Aligned_cols=143 Identities=15% Similarity=0.094 Sum_probs=99.9
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccch---------HHHHHHHHHHHHhhcCCCCce--eeEeeEEEe-----
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL---------QEEDNFLEAVSNMSRLRHPNI--VTLAGYCAE----- 479 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~----- 479 (577)
+.+-+.....|++.++ +|+.|.||+........ .....+.+|.+.+.++...+| +.++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445777766 47789999764322110 001137788888887754443 344555533
Q ss_pred CCeEEEEEEecCCC-CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-------C
Q 008121 480 HGQRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-------E 551 (577)
Q Consensus 480 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-------~ 551 (577)
....++|+|++++- +|.+++.... ....+...+..++.+++..+.-||.. +|+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999886 8998885221 23445667788999999999999999 9999999999999985 4
Q ss_pred CCeEEeccccCcc
Q 008121 552 LNPHLSDCGLAAL 564 (577)
Q Consensus 552 ~~~kl~DFGla~~ 564 (577)
..+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.2e-09 Score=96.71 Aligned_cols=130 Identities=22% Similarity=0.283 Sum_probs=84.2
Q ss_pred eEEEEEEcCCcEEEEEEcccccc------------------------chHHHHHHHHHHHHhhcCCCC--ceeeEeeEEE
Q 008121 425 RVYRAEFANGKIMAVKKIDNAAL------------------------SLQEEDNFLEAVSNMSRLRHP--NIVTLAGYCA 478 (577)
Q Consensus 425 ~Vy~~~~~~~~~vavK~~~~~~~------------------------~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~ 478 (577)
.||.|...+|..+|||..+.... .........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999999999999998753211 011134567899999999866 455666442
Q ss_pred eCCeEEEEEEecC--CCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCCeeeCCCCCeE
Q 008121 479 EHGQRLLVYEYVG--NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL-HEVCLPSVVHRNFKSANILLDDELNPH 555 (577)
Q Consensus 479 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivHrDlk~~NILl~~~~~~k 555 (577)
...+||||++ +..+..+.. . .++......++.+++..+..+ |.. +|||+|+.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-V-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-C-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHh-c-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 544433322 1 111334566777888866665 576 99999999999999988 999
Q ss_pred EeccccCcccCCC
Q 008121 556 LSDCGLAALTPNT 568 (577)
Q Consensus 556 l~DFGla~~~~~~ 568 (577)
|+|||.|....++
T Consensus 147 iIDf~qav~~~~p 159 (188)
T PF01163_consen 147 IIDFGQAVDSSHP 159 (188)
T ss_dssp E--GTTEEETTST
T ss_pred EEecCcceecCCc
Confidence 9999998876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.4e-11 Score=115.99 Aligned_cols=136 Identities=27% Similarity=0.382 Sum_probs=108.1
Q ss_pred cCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcC-CcccCCCCCCccCC
Q 008121 122 TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF-NNFSGDLPNSFISL 200 (577)
Q Consensus 122 ~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l 200 (577)
.+|..+++.-+.|+|..|+|+...|++|+.+++|+.||||+|+|+.+-|++|.++.+|..|-+.+ |+|+...-..|++|
T Consensus 60 eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL 139 (498)
T KOG4237|consen 60 EVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGL 139 (498)
T ss_pred cCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhH
Confidence 68888888889999999999988888999999999999999999999999999999987776655 99995444578899
Q ss_pred CCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCc----ccccccceeecCCcCCC
Q 008121 201 SNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFDN 258 (577)
Q Consensus 201 ~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~----~l~~l~~l~~~~n~~~~ 258 (577)
.+|+.|.+.-|++..... .|..++ +..|.+-+|.+. .++. .+..++++.+..|++-|
T Consensus 140 ~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic 202 (498)
T KOG4237|consen 140 SSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC 202 (498)
T ss_pred HHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc
Confidence 999999999999887654 466665 777888888887 4443 33455666677777654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.5e-10 Score=122.70 Aligned_cols=153 Identities=25% Similarity=0.295 Sum_probs=120.3
Q ss_pred cCCCccceeccCccceEEEEEEc--CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 486 (577)
..|...+.||+|+|+.|-..... ....+|+|.+.....+....+....|..+-..+. |+|++++++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34556677999999999988553 3456677777544322333344445676666676 99999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeecCCCCCCeeeCCCC-CeEEeccccCcc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-EVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAAL 564 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~ 564 (577)
+||..+|++.+.+.. ......+......+..|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988731 11224566677889999999999999 66 899999999999999999 999999999997
Q ss_pred cCC
Q 008121 565 TPN 567 (577)
Q Consensus 565 ~~~ 567 (577)
+..
T Consensus 175 ~~~ 177 (601)
T KOG0590|consen 175 YRN 177 (601)
T ss_pred ccc
Confidence 765
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.3e-10 Score=117.37 Aligned_cols=126 Identities=27% Similarity=0.370 Sum_probs=87.2
Q ss_pred CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCC-CccCCCCCCeEE
Q 008121 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN-SFISLSNISSLY 207 (577)
Q Consensus 129 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~ 207 (577)
-.|...+++.|.|. ....++.-++.|+.|||++|+++... .+..|+.|+.|||++|.|+ .+|. ...++. |+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 35777788888887 55667777788888888888887654 5777888888888888888 5554 344554 88888
Q ss_pred ccCcccccccccCCCCC-ccEEEeecCccccc---cC-cccccccceeecCCcCCCCC
Q 008121 208 LQNNQVTGSLNVFSGLP-LTTLNVANNHFSGW---IP-RELISIRTFIYDGNSFDNGP 260 (577)
Q Consensus 208 l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~---~p-~~l~~l~~l~~~~n~~~~~~ 260 (577)
|.+|.++.... +..+. |..|||++|-|++. .| ..+..+..|.+.|||+.|.+
T Consensus 239 lrnN~l~tL~g-ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 239 LRNNALTTLRG-IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ecccHHHhhhh-HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 88887775332 22232 77788888888763 22 23456677778888877643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.9e-09 Score=108.72 Aligned_cols=152 Identities=21% Similarity=0.230 Sum_probs=121.8
Q ss_pred HHhhcCCCccceeccCccceEEEEEE--cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCe
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEF--ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 482 (577)
...+.+|.....||.|.|+.||.... .++..|++|.+.+..........-..|+.+...+ .|.++++.+..+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34456788889999999999999854 4578899998876554433333345666666666 59999998877777777
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEecccc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGL 561 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGl 561 (577)
.|+--||++++++...+. ....++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.
T Consensus 341 ~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 889999999998876653 345677788899999999999999988 89999999999999886 7889999999
Q ss_pred Ccc
Q 008121 562 AAL 564 (577)
Q Consensus 562 a~~ 564 (577)
++.
T Consensus 414 ~t~ 416 (524)
T KOG0601|consen 414 WTR 416 (524)
T ss_pred ccc
Confidence 863
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4e-09 Score=111.63 Aligned_cols=168 Identities=23% Similarity=0.236 Sum_probs=80.0
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|+|.+|+|.+... .+..+++|++|+|++|.|+...+....+.|+.|++++|.++.. ..+..+++|+.+++++
T Consensus 95 ~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~ 171 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSY 171 (414)
T ss_pred cceeeeeccccchhhccc-chhhhhcchheeccccccccccchhhccchhhheeccCcchhc--cCCccchhhhcccCCc
Confidence 345555555555553321 2555555556666666555444433334455566666655522 1233355555556666
Q ss_pred CCCccccc-ccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCC--CccEEEeecCccccc-
Q 008121 163 NSLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL--PLTTLNVANNHFSGW- 238 (577)
Q Consensus 163 N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~--~L~~L~l~~N~l~g~- 238 (577)
|+++..-+ . ...+.+|+.+++.+|.+. ....+..+..+..+++..|.++..-+..... .|+.+++++|.+.-.
T Consensus 172 n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~~~ 248 (414)
T KOG0531|consen 172 NRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRISRSP 248 (414)
T ss_pred chhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCcccccc
Confidence 65554333 1 344555555555555554 1222333333444455555544322211111 155666666666521
Q ss_pred -cCcccccccceeecCCcC
Q 008121 239 -IPRELISIRTFIYDGNSF 256 (577)
Q Consensus 239 -~p~~l~~l~~l~~~~n~~ 256 (577)
....+..+..+++..|..
T Consensus 249 ~~~~~~~~l~~l~~~~n~~ 267 (414)
T KOG0531|consen 249 EGLENLKNLPVLDLSSNRI 267 (414)
T ss_pred ccccccccccccchhhccc
Confidence 123333444455444443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2e-08 Score=110.76 Aligned_cols=111 Identities=29% Similarity=0.466 Sum_probs=79.3
Q ss_pred hhcCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
...+|..++.|..|+||.||..+++. .+.+|. ++.++.. +.+. ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccch-------hhhc--cccccCCccee---------------
Confidence 34678889999999999999998764 567787 4433211 1111 22333344444
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
||-...++ ..+.++... +.+++|+|+. +|+|||+||+|.+|..-|.+|++|||+.+.
T Consensus 136 ------gDc~tllk----~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 ------GDCATLLK----NIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred ------chhhhhcc----cCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhh
Confidence 56666665 233444322 6799999999 999999999999999999999999999884
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.2e-08 Score=66.82 Aligned_cols=39 Identities=49% Similarity=1.026 Sum_probs=29.4
Q ss_pred hHHHHHHHHHHHhcCC-C-CCCCCCCCCC-CCCCCCCCccEEee
Q 008121 41 SSDVQALQVLYTSLNS-P-SVLTNWKGNE-GDPCGESWKGVACE 81 (577)
Q Consensus 41 ~~~~~~l~~~~~~~~~-~-~~l~~w~~~~-~~~c~~~w~gv~C~ 81 (577)
++|++||++||+++.+ + ..+.+|+.+. .+|| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C--~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC--SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC--CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe--eeccEEeC
Confidence 5799999999999984 5 5889999753 7899 89999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.8e-07 Score=99.28 Aligned_cols=122 Identities=24% Similarity=0.278 Sum_probs=97.8
Q ss_pred EEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCC
Q 008121 430 EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL 509 (577)
Q Consensus 430 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l 509 (577)
+..++.+|.|...+.... ...+...+.+..|+.+|||||++++..+..++..|+|+|-+. -|..+++. +
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------L 101 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------h
Confidence 345677888877754421 233445677888999999999999999999999999999885 46666652 2
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 510 TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 510 ~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
......-.+.||+.||.|||+.| +++|++|.-..|+++..|+.||++|-++..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~ 154 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSK 154 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence 24456667889999999999876 899999999999999999999999987753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.9e-07 Score=86.06 Aligned_cols=108 Identities=22% Similarity=0.301 Sum_probs=83.4
Q ss_pred HHHHHHHHHHhhcCCCCc--eeeEeeEEEeCC----eEEEEEEecCCC-CHHHhhhhccCCCCCCCHHHHHHHHHHHHHH
Q 008121 452 EDNFLEAVSNMSRLRHPN--IVTLAGYCAEHG----QRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARA 524 (577)
Q Consensus 452 ~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~ 524 (577)
.....+|...+..+.... +.+.+++..... ..++|+|++++- +|.+++... ...+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 345677877777765333 445666655422 458999999884 799988621 225666778899999999
Q ss_pred HHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEEeccccCcccC
Q 008121 525 LEYLHEVCLPSVVHRNFKSANILLDDEL---NPHLSDCGLAALTP 566 (577)
Q Consensus 525 L~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl~DFGla~~~~ 566 (577)
++-||+. +|+|+|+++.|||++.+. .+.++||+-++...
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999 999999999999999886 89999999888654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3e-07 Score=98.13 Aligned_cols=146 Identities=24% Similarity=0.290 Sum_probs=95.4
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcccccc---------------------------ch-----------HHHHHHHH
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL---------------------------SL-----------QEEDNFLE 457 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~---------------------------~~-----------~~~~~~~~ 457 (577)
+.|+.++-|+||+|++++|+.||||+.+.... +. ..+-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999999863211 00 01123445
Q ss_pred HHHHhhcCC-----CCceeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHH-HHHHhcC
Q 008121 458 AVSNMSRLR-----HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA-LEYLHEV 531 (577)
Q Consensus 458 e~~~l~~l~-----H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~-L~yLH~~ 531 (577)
|...+.+++ .++|.--.=|+.......|+|||++|-.+.+..... ....+.+. |+..++++ +.-+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 555555542 344332222333456789999999998888774211 13344222 33322222 2222223
Q ss_pred CCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCcc
Q 008121 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 532 ~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 570 (577)
+++|.|..|.||+++.++.+.+.|||+...+++..+
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~r 320 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKFR 320 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCHHHH
Confidence 789999999999999999999999999987765443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.1e-08 Score=108.32 Aligned_cols=169 Identities=23% Similarity=0.262 Sum_probs=118.4
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCC-CCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
.+..+++..|.+.. +-..+..+++|+.|+|.+|+|..... ....++|++|+|++|+|+...+ +..++.|+.|++++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSG 149 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccccc--hhhccchhhheecc
Confidence 34455577777764 33457888999999999999986555 4545899999999999986543 56677799999999
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCC-ccCCCCCCeEEccCcccccccccCCCCCccEEEeecCccccccCc
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR 241 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~ 241 (577)
|.|+.. ..+..+++|+.+++++|+++. +... ...+.+|+.+++.+|.+.-.-..-....+..+++..|.++-.-+-
T Consensus 150 N~i~~~--~~~~~l~~L~~l~l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~~~~~l 226 (414)
T KOG0531|consen 150 NLISDI--SGLESLKSLKLLDLSYNRIVD-IENDELSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKISKLEGL 226 (414)
T ss_pred Ccchhc--cCCccchhhhcccCCcchhhh-hhhhhhhhccchHHHhccCCchhcccchHHHHHHHHhhcccccceeccCc
Confidence 999843 235568889999999999984 4432 467788899999999877543322222355558888888743332
Q ss_pred c-ccc--ccceeecCCcCCC
Q 008121 242 E-LIS--IRTFIYDGNSFDN 258 (577)
Q Consensus 242 ~-l~~--l~~l~~~~n~~~~ 258 (577)
. ... ++.+.+.+|+...
T Consensus 227 ~~~~~~~L~~l~l~~n~i~~ 246 (414)
T KOG0531|consen 227 NELVMLHLRELYLSGNRISR 246 (414)
T ss_pred ccchhHHHHHHhcccCcccc
Confidence 1 222 6777788887654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.5e-07 Score=85.52 Aligned_cols=61 Identities=33% Similarity=0.292 Sum_probs=53.8
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+|.++++. ....+++.++..|+.|+++||+|||+. + ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc
Confidence 789999962 245699999999999999999999998 4 999999999999999 999987644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=9.7e-07 Score=84.57 Aligned_cols=139 Identities=18% Similarity=0.137 Sum_probs=94.7
Q ss_pred CCccceeccCccceEEEEEEcCCcEEEEEEcccccc------------------c--hHHHHHHHHHHHHhhcCCCC--c
Q 008121 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL------------------S--LQEEDNFLEAVSNMSRLRHP--N 469 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~--~~~~~~~~~e~~~l~~l~H~--n 469 (577)
..+...||.|.=+.||.|...+|.++|||.=+.... + .-......+|.+.|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345678999999999999999999999996432111 1 01123346788899988655 5
Q ss_pred eeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 008121 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (577)
Q Consensus 470 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~ 549 (577)
|.+.+++ +...+||||+++--|...- ++....-.|+..|++-+.-.-.. +|||+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 6666654 4568999999885554321 11222223333344444443455 899999999999999
Q ss_pred CCCCeEEeccccCcccC
Q 008121 550 DELNPHLSDCGLAALTP 566 (577)
Q Consensus 550 ~~~~~kl~DFGla~~~~ 566 (577)
++|.+.++||--+....
T Consensus 237 ~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 237 EDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cCCCEEEEeCcccccCC
Confidence 99999999997665543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3e-08 Score=99.55 Aligned_cols=173 Identities=22% Similarity=0.223 Sum_probs=117.4
Q ss_pred cEEEEEcCCCCCccccc-ccccCCCCCCEEEccCCCcCCcCC----CCCCCCccEEEccCCcCCCcCCCCc-cCCCCccE
Q 008121 84 AVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~-~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~ 157 (577)
.+..+.|.+....-... .....|++++.||||.|-|+...| .+-.++|+.|+|+.|+|.-...... ..++.|+.
T Consensus 122 kL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~ 201 (505)
T KOG3207|consen 122 KLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ 201 (505)
T ss_pred hhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence 34555555554431111 356789999999999999885443 1112899999999999974433222 25788999
Q ss_pred EEeccCCCccc-ccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccc--ccCCCCC-ccEEEeecC
Q 008121 158 LNVSRNSLTQS-IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANN 233 (577)
Q Consensus 158 L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~~-L~~L~l~~N 233 (577)
|.|+.+.|+-. +-..+..+++|+.|+|+.|..-+.--....-+..|++|+|++|++.... +....++ |+.|+++.+
T Consensus 202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~t 281 (505)
T KOG3207|consen 202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSST 281 (505)
T ss_pred EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcccc
Confidence 99999999832 3334567899999999999633333344556778999999999987654 3444455 888888888
Q ss_pred cccc-ccCc--------ccccccceeecCCcC
Q 008121 234 HFSG-WIPR--------ELISIRTFIYDGNSF 256 (577)
Q Consensus 234 ~l~g-~~p~--------~l~~l~~l~~~~n~~ 256 (577)
.++. .+|+ .+.+++.|....|+.
T Consensus 282 gi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 282 GIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred CcchhcCCCccchhhhcccccceeeecccCcc
Confidence 8864 2333 245667777777765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.3e-07 Score=99.21 Aligned_cols=152 Identities=23% Similarity=0.256 Sum_probs=117.1
Q ss_pred CCCccceecc--CccceEEEEEE---cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEE
Q 008121 411 SFSQEFLIGE--GSLGRVYRAEF---ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 411 ~~~~~~~lg~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~ 484 (577)
.|.....+|. |.+|.||.+.. +++..+|+|+-+...........=.+|+..-.+++ |+|.++.+..+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3445667899 99999999865 56888999884322211222223345666666664 999999888889999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEecc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----ALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDC 559 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~L~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DF 559 (577)
+-+|++. .+|.++.+ .....++......+..+..+ ||.++|+. .|+|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999985 68887775 23344677777888888888 99999999 99999999999999988 89999999
Q ss_pred ccCcccCCCc
Q 008121 560 GLAALTPNTE 569 (577)
Q Consensus 560 Gla~~~~~~~ 569 (577)
|+...+.+..
T Consensus 268 ~~v~~i~~~~ 277 (524)
T KOG0601|consen 268 GLVSKISDGN 277 (524)
T ss_pred ceeEEccCCc
Confidence 9988776554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.4e-07 Score=91.68 Aligned_cols=96 Identities=24% Similarity=0.424 Sum_probs=83.9
Q ss_pred HhhcCCCCceeeEeeEEEeCC-----eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 008121 461 NMSRLRHPNIVTLAGYCAEHG-----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535 (577)
Q Consensus 461 ~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ 535 (577)
-+-.+.|.|||++..|+.+.. ...++.|||+.|++.++|++.+.....+....-.++.-||..||.|||+. .|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 345567999999999986543 46789999999999999998777777888888889999999999999986 789
Q ss_pred eeecCCCCCCeeeCCCCCeEEe
Q 008121 536 VVHRNFKSANILLDDELNPHLS 557 (577)
Q Consensus 536 ivHrDlk~~NILl~~~~~~kl~ 557 (577)
|+|+++..+-|++..++-+|+.
T Consensus 199 iihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cccCCcchhheeecCCceEEec
Confidence 9999999999999999988875
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.6e-06 Score=81.19 Aligned_cols=141 Identities=15% Similarity=0.197 Sum_probs=84.6
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCce--eeEeeEEEeCCeEEEEEEecCC
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI--VTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~~~~~lv~e~~~~ 492 (577)
...||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.+++....+...+|||+++|
T Consensus 6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred heeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 357999999999984 24567788875422 22345778888888764443 5677777777778899999988
Q ss_pred CC-HHHh---------------------hhhccCCCCCCCHHHHHHHHH----------HHHH-HHHHHhcC-CCCCeee
Q 008121 493 GN-LHDM---------------------LHFADDSSKNLTWNARVRVAL----------GTAR-ALEYLHEV-CLPSVVH 538 (577)
Q Consensus 493 g~-L~~~---------------------l~~~~~~~~~l~~~~~~~i~~----------~i~~-~L~yLH~~-~~~~ivH 538 (577)
.+ +.+. +|...-....++.. ..++.. .+.+ ...+|... ..+.++|
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 63 2111 11100011111100 000000 0001 12222221 1246789
Q ss_pred cCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 539 RNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 539 rDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.1e-06 Score=88.59 Aligned_cols=141 Identities=17% Similarity=0.241 Sum_probs=106.7
Q ss_pred ceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEE----eCCeEEEEEEecCC-CCHHH
Q 008121 424 GRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA----EHGQRLLVYEYVGN-GNLHD 497 (577)
Q Consensus 424 g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~ 497 (577)
.+.|++.. .||..|++|+++.... +....-..-+++.+++.|+|||++.+.+. .+...++||+|.|+ ++|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 47788844 6799999999943221 11111223467789999999999999876 34468999999986 57766
Q ss_pred hhhhc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 498 MLHFA-----------DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 498 ~l~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+--.. -..+...++...+.++.|+..||.++|+. +..-+-|.+.+||++.+.+++|+.-|+...+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 53211 01234567889999999999999999999 88889999999999999999999888887765
Q ss_pred CCc
Q 008121 567 NTE 569 (577)
Q Consensus 567 ~~~ 569 (577)
++.
T Consensus 445 ~d~ 447 (655)
T KOG3741|consen 445 EDP 447 (655)
T ss_pred CCC
Confidence 554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.4e-06 Score=77.63 Aligned_cols=141 Identities=16% Similarity=0.098 Sum_probs=101.1
Q ss_pred eccCccceEEEEEEcCCcEEEEEEccccc-cc---hHHHHHHHHHHHHhhcCCCCc--eeeEeeEEEeC----CeEEEEE
Q 008121 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAA-LS---LQEEDNFLEAVSNMSRLRHPN--IVTLAGYCAEH----GQRLLVY 487 (577)
Q Consensus 418 lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~---~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~----~~~~lv~ 487 (577)
-|+||-+-|++-.+.+ +.+-+|+-.... .+ ......|.+|+..+.++..-+ +.++..+.... -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 4668888899987754 467788754111 11 235677999999988885433 44444222111 1357999
Q ss_pred EecCC-CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--eEEeccccCcc
Q 008121 488 EYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--PHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~--~kl~DFGla~~ 564 (577)
|-+++ -||.+++.. ....+.+...+..+..++++.+.-||+. ++.|+|+-+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97763 588888752 1234567778889999999999999999 9999999999999986666 99999976653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.9e-09 Score=110.78 Aligned_cols=123 Identities=24% Similarity=0.256 Sum_probs=90.6
Q ss_pred CCCEEEccCCCcCCcCCCC--CCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCc
Q 008121 108 SLRKFDLSGNSIHDTIPYQ--LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLS 185 (577)
Q Consensus 108 ~L~~L~Ls~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 185 (577)
.|.+.+.+.|++. .+... +.+.|+.|||++|+|+..- .+..|+.|++|||++|+|.-+.--....+. |+.|.|.
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4667777888876 23322 3388999999999998553 677889999999999999844333344444 9999999
Q ss_pred CCcccCCCCCCccCCCCCCeEEccCcccccccc--cCCCC-CccEEEeecCccc
Q 008121 186 FNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN--VFSGL-PLTTLNVANNHFS 236 (577)
Q Consensus 186 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~-~L~~L~l~~N~l~ 236 (577)
+|.++ .+ ..+.+|++|+.|||++|-|.+.-. .+..+ .|+.|+|.+|.+.
T Consensus 241 nN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99988 33 247788999999999999887432 22223 3888999999886
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.2e-08 Score=86.64 Aligned_cols=108 Identities=31% Similarity=0.426 Sum_probs=68.2
Q ss_pred cEEEEEcCCCCCccccc---ccccCCCCCCEEEccCCCcCCcCCCCCC---CCccEEEccCCcCCCcCCCCccCCCCccE
Q 008121 84 AVVSIDISGLGLSGTMG---YLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSY 157 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 157 (577)
....++|++++|- .++ ..+.....|+..+|++|.|. ..|..+. +.++.|+|++|.|+ .+|+++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3445566666553 222 34455566666777777777 4554443 46777777777777 56666777777777
Q ss_pred EEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCC
Q 008121 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196 (577)
Q Consensus 158 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 196 (577)
|+++.|.|. ..|..+..|.+|-.|+..+|.+. .+|..
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~d 141 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVD 141 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence 777777776 44555555777777777777666 55544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=5.1e-06 Score=88.49 Aligned_cols=144 Identities=22% Similarity=0.257 Sum_probs=91.3
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccc-----------------------------------hHHHHHHHHHH
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS-----------------------------------LQEEDNFLEAV 459 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------------------------~~~~~~~~~e~ 459 (577)
.+.||.-+.|+||+|++++|+.||||+-+..... ...+-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 4679999999999999999999999986532110 01122345555
Q ss_pred HHhhc----CCCCc------eeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 008121 460 SNMSR----LRHPN------IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529 (577)
Q Consensus 460 ~~l~~----l~H~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH 529 (577)
+-..+ ++|-+ |.+++. .......|+||||+|.-+.|.-.. ....++......-+.+...-+-+-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~- 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFK- 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHh-
Confidence 44333 34555 333332 223468999999999877665321 123344443333333322112222
Q ss_pred cCCCCCeeecCCCCCCeeeCC----CCCeEEeccccCcccCCC
Q 008121 530 EVCLPSVVHRNFKSANILLDD----ELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 530 ~~~~~~ivHrDlk~~NILl~~----~~~~kl~DFGla~~~~~~ 568 (577)
. +++|+|=.|-||+++. ++++.+-|||+.+.....
T Consensus 320 -~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 -T---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred -c---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2 7999999999999984 678999999998876543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.5e-07 Score=92.17 Aligned_cols=174 Identities=18% Similarity=0.240 Sum_probs=114.6
Q ss_pred CcEEEEEcCCCCCccccc----ccccCCCCCCEEEccCCCcCC---cC-C-----------CCCCCCccEEEccCCcCCC
Q 008121 83 SAVVSIDISGLGLSGTMG----YLLSDLLSLRKFDLSGNSIHD---TI-P-----------YQLPPNLTSLNLASNNFSG 143 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~----~~~~~l~~L~~L~Ls~N~l~~---~~-p-----------~~~~~~L~~L~l~~N~l~~ 143 (577)
++++.||||+|-+.-.-+ ..+..++.|++|+|.+|.+.- .. . ....++|+++..++|++..
T Consensus 92 ~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 92 PKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred CceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccccc
Confidence 478889999988754333 345678889999999988861 11 0 0112678888888888863
Q ss_pred c----CCCCccCCCCccEEEeccCCCc--cc--ccccccCCCCCcEEeCcCCcccCC----CCCCccCCCCCCeEEccCc
Q 008121 144 N----LPYSIASMVSLSYLNVSRNSLT--QS--IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNN 211 (577)
Q Consensus 144 ~----~p~~~~~l~~L~~L~L~~N~l~--~~--~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N 211 (577)
. +-..|...+.|+.+.++.|.|. |. +-..|..++.|+.|||.+|-|+-. +...+..+++|+.|+++++
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 2 2234556778888888888886 21 334577888888888888888622 2234566778888888888
Q ss_pred cccc--cc---ccCCC--CCccEEEeecCcccccc----C---cccccccceeecCCcC
Q 008121 212 QVTG--SL---NVFSG--LPLTTLNVANNHFSGWI----P---RELISIRTFIYDGNSF 256 (577)
Q Consensus 212 ~l~~--~~---~~~~~--~~L~~L~l~~N~l~g~~----p---~~l~~l~~l~~~~n~~ 256 (577)
.+.. .. ..+.. .+|++|.+.+|.++-.- - ..-..+..|.+++|.+
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 8863 22 22222 24888888888886311 1 1133455677777766
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.9e-07 Score=88.61 Aligned_cols=153 Identities=20% Similarity=0.281 Sum_probs=80.0
Q ss_pred CcEEEEEcCCCCCcc----cccccccCCCCCCEEEccCCCcCC----cCCCCC--------C-CCccEEEccCCcCCCcC
Q 008121 83 SAVVSIDISGLGLSG----TMGYLLSDLLSLRKFDLSGNSIHD----TIPYQL--------P-PNLTSLNLASNNFSGNL 145 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g----~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~--------~-~~L~~L~l~~N~l~~~~ 145 (577)
..++.|+|++|.+.- .+...+.+.++|+..++|+- ++| .+|..+ . ++|++||||.|-|.-.-
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g 108 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG 108 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence 467788888887643 23344556666666666542 222 233221 1 46777777777665433
Q ss_pred CCC----ccCCCCccEEEeccCCCcccc-------------cccccCCCCCcEEeCcCCcccCCCC----CCccCCCCCC
Q 008121 146 PYS----IASMVSLSYLNVSRNSLTQSI-------------GDIFGNLAGLATLDLSFNNFSGDLP----NSFISLSNIS 204 (577)
Q Consensus 146 p~~----~~~l~~L~~L~L~~N~l~~~~-------------p~~~~~l~~L~~L~Ls~N~l~g~~p----~~~~~l~~L~ 204 (577)
+.. +.++..|++|+|.+|-+.-.- ....++-+.|+++..++|++...-- ..|...+.|+
T Consensus 109 ~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~le 188 (382)
T KOG1909|consen 109 IRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLE 188 (382)
T ss_pred hHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccc
Confidence 332 335566777777766664111 1123344566666666666652111 1244455666
Q ss_pred eEEccCccccc--cc---ccC-CCCCccEEEeecCccc
Q 008121 205 SLYLQNNQVTG--SL---NVF-SGLPLTTLNVANNHFS 236 (577)
Q Consensus 205 ~L~l~~N~l~~--~~---~~~-~~~~L~~L~l~~N~l~ 236 (577)
.+.++.|.|.. .. ..+ ....|+.|||.+|-|+
T Consensus 189 evr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft 226 (382)
T KOG1909|consen 189 EVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFT 226 (382)
T ss_pred eEEEecccccCchhHHHHHHHHhCCcceeeecccchhh
Confidence 66666666542 10 112 2223666666666665
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.9e-08 Score=83.68 Aligned_cols=85 Identities=24% Similarity=0.303 Sum_probs=43.8
Q ss_pred CccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeec
Q 008121 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232 (577)
Q Consensus 154 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~ 232 (577)
.|...+|++|.|....+..-..++.++.|+|++|+|+ .+|.++..++.|+.|+++.|.|...+..+..+. +..||..+
T Consensus 54 el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds~~ 132 (177)
T KOG4579|consen 54 ELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDSPE 132 (177)
T ss_pred eEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhcCCC
Confidence 3444455555555433333333445555666666665 455556566666666666665555444333322 45555555
Q ss_pred CccccccC
Q 008121 233 NHFSGWIP 240 (577)
Q Consensus 233 N~l~g~~p 240 (577)
|.+. +||
T Consensus 133 na~~-eid 139 (177)
T KOG4579|consen 133 NARA-EID 139 (177)
T ss_pred Cccc-cCc
Confidence 5555 444
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.1e-05 Score=74.76 Aligned_cols=156 Identities=19% Similarity=0.219 Sum_probs=98.5
Q ss_pred cHHHHHHhhcCCCccce---eccCccceEEEEEEcCCcEEEEEEccccccchHH----------------------HHHH
Q 008121 401 TVASLQTATNSFSQEFL---IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE----------------------EDNF 455 (577)
Q Consensus 401 ~~~~~~~~~~~~~~~~~---lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~ 455 (577)
+...+....++..+.+. |++|.-+.||+|.-.++..+|||+++.....-.. ...-
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34444444444444444 5567777999998888999999998643211111 1122
Q ss_pred HHHHHHhhcCC--CCceeeEeeEEEeCCeEEEEEEecCCC-CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 008121 456 LEAVSNMSRLR--HPNIVTLAGYCAEHGQRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532 (577)
Q Consensus 456 ~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ 532 (577)
..|..-|.++. +-.+.+.+++.. -.|||||+... .-.-.|+ .-.+...+...+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 34665666553 333444444332 36999999653 1111111 112223356777778888888877733
Q ss_pred CCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 533 ~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
++||+||..=|||+. ++.+.|+|||-|.....+
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 899999999999999 789999999988866544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.8e-05 Score=76.14 Aligned_cols=143 Identities=15% Similarity=0.126 Sum_probs=84.7
Q ss_pred eeccCcc-ceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEEEecCCCC
Q 008121 417 LIGEGSL-GRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNGN 494 (577)
Q Consensus 417 ~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~ 494 (577)
.|..|.. ..||+.... +..+.+|+..... ..+..+|++++..+. +--+.+++++....+..++||||++|..
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 4555666 789998765 4678888875432 234566777777663 3335577777766667899999999877
Q ss_pred HHHhh-------------------hhccCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHhc---
Q 008121 495 LHDML-------------------HFADDSSKNLTW--NARVRVAL--------------------GTARALEYLHE--- 530 (577)
Q Consensus 495 L~~~l-------------------~~~~~~~~~l~~--~~~~~i~~--------------------~i~~~L~yLH~--- 530 (577)
+.+.. |.......+... ........ .+...+..|-.
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 76431 111000111110 00000000 01111222211
Q ss_pred -CCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 531 -VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 531 -~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
...+.++|+|+.|.|||++++....|+||+.|..-
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 12356999999999999999877899999988753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.13 E-value=2e-06 Score=59.36 Aligned_cols=36 Identities=39% Similarity=0.498 Sum_probs=15.8
Q ss_pred CccEEEeccCCCcccccccccCCCCCcEEeCcCCccc
Q 008121 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS 190 (577)
Q Consensus 154 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 190 (577)
+|++|+|++|+|+. +|+.+.+|++|++|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCC
Confidence 34444444444442 3333444555555555555444
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 577 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-06 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-05 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-06 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 4e-68
Identities = 69/184 (37%), Positives = 104/184 (56%), Gaps = 6/184 (3%)
Query: 397 ATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ-EEDNF 455
+++ LQ A+++FS + ++G G G+VY+ A+G ++AVK++ Q E F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGELQF 74
Query: 456 LEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV 515
V +S H N++ L G+C +RLLVY Y+ NG++ L +S L W R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT- 574
R+ALG+AR L YLH+ C P ++HR+ K+ANILLD+E + D GLA L + V T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 575 --GT 576
GT
Sbjct: 195 VRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 3e-63
Identities = 59/177 (33%), Positives = 102/177 (57%), Gaps = 5/177 (2%)
Query: 394 PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED 453
P + + L+ ATN+F +FLIG G G+VY+ +G +A+K+ S Q +
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIE 80
Query: 454 NFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
F + +S RHP++V+L G+C E + +L+Y+Y+ NGNL L+ +D + +++W
Sbjct: 81 EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
R+ + +G AR L YLH +++HR+ KS NILLD+ P ++D G++ ++
Sbjct: 141 RLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-58
Identities = 61/190 (32%), Positives = 99/190 (52%), Gaps = 17/190 (8%)
Query: 399 SYTVASLQTATNSFSQEF------LIGEGSLGRVYRAEFANGKIMAVKKIDNAAL--SLQ 450
S++ L+ TN+F + +GEG G VY+ + N +AVKK+ + +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEE 72
Query: 451 EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT 510
+ F + + M++ +H N+V L G+ ++ LVY Y+ NG+L D L D + L+
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLS 131
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
W+ R ++A G A + +LHE +HR+ KSANILLD+ +SD GLA + +
Sbjct: 132 WHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 571 QVIT----GT 576
V+T GT
Sbjct: 189 TVMTSRIVGT 198
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-43
Identities = 46/189 (24%), Positives = 78/189 (41%), Gaps = 28/189 (14%)
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL-EA-VSNM 462
L + + G G V++A+ + +AVK +Q++ ++ E V ++
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKI-----FPIQDKQSWQNEYEVYSL 72
Query: 463 SRLRHPNIVTLAGYCAE----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518
++H NI+ G L+ + G+L D L + ++WN +A
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIA 127
Query: 519 LGTARALEYLHE-------VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571
AR L YLHE P++ HR+ KS N+LL + L ++D GLA +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 572 VIT----GT 576
T GT
Sbjct: 188 GDTHGQVGT 196
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 57/161 (35%), Positives = 84/161 (52%), Gaps = 5/161 (3%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG GS G V+RAE+ +G +AVK + + + FL V+ M RLRHPNIV G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ +V EY+ G+L+ +LH + + L R+ +A A+ + YLH P +V
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQV--ITGT 576
HRN KS N+L+D + + D GL+ L +T GT
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT 202
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-39
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 16/234 (6%)
Query: 42 SDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGY 101
++ L L ++L +W N+ +PC ++ GV C V SID+S L+
Sbjct: 12 REIHQLISFKDVLPDKNLLPDWSSNK-NPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSA 68
Query: 102 L---LSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLP--YSIASMVSL 155
+ L L L LS + I+ ++ ++ +LTSL+L+ N+ SG + S+ S L
Sbjct: 69 VSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128
Query: 156 SYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL---YLQNN 211
+LNVS N+L L L LDLS N+ SG ++ L + N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 212 QVTGSLNVFSGLPLTTLNVANNHFSGWIP--RELISIRTFIYDGNSFDNGPAPP 263
+++G ++V + L L+V++N+FS IP + +++ GN +G
Sbjct: 189 KISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKL-SGDFSR 241
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-30
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNL 145
+DISG LSG +S L+ ++S N IP +L L+LA N F+G +
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEI 285
Query: 146 PYSIA-SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS-LSNI 203
P ++ + +L+ L++S N ++ FG+ + L +L LS NNFSG+LP + + +
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345
Query: 204 SSLYLQNNQVTGSL-NVFSGLP--LTTLNVANNHFSGWIPRELI-----SIRTFIYDGNS 255
L L N+ +G L + L L TL++++N+FSG I L +++ N
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405
Query: 256 FDNGPAPP 263
F G PP
Sbjct: 406 F-TGKIPP 412
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-30
Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 14/188 (7%)
Query: 86 VSIDISGLGLSGTMGY-LLSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASN 139
+++S L L SL DLS NSI L L ++ N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 140 NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS 199
SG++ ++ V+L +L+VS N+ + I + G+ + L LD+S N SGD + +
Sbjct: 189 KISGDVD--VSRCVNLEFLDVSSNNFSTGIPFL-GDCSALQHLDISGNKLSGDFSRAIST 245
Query: 200 LSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELI----SIRTFIYDGNS 255
+ + L + +NQ G + L L++A N F+G IP L ++ GN
Sbjct: 246 CTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH 305
Query: 256 FDNGPAPP 263
F G PP
Sbjct: 306 F-YGAVPP 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 6/164 (3%)
Query: 86 VSIDISGLGLSGTM--GYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNF 141
+++D+S SG + + +L++ L N IP L L SL+L+ N
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 142 SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
SG +P S+ S+ L L + N L I + L TL L FN+ +G++P+ + +
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490
Query: 202 NISSLYLQNNQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPREL 243
N++ + L NN++TG + L L L ++NN FSG IP EL
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-29
Identities = 51/212 (24%), Positives = 80/212 (37%), Gaps = 29/212 (13%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137
+ L G L+ L + +++ ++ L+++
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
N SG +P I SM L LN+ N ++ SI D G+L GL LDLS N G +P +
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTF---IYDGN 254
+L+ LT ++++NN+ SG IP TF + N
Sbjct: 701 SALTM----------------------LTEIDLSNNNLSGPIPEMGQ-FETFPPAKFLNN 737
Query: 255 SFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSH 286
G P P + G +H+ RSH H
Sbjct: 738 PGLCGY-PLPRCDPSNADGYAHHQRSHHHHHH 768
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 36/159 (22%), Positives = 62/159 (38%), Gaps = 2/159 (1%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASM 152
L G + L + +L L N + IP L NL ++L++N +G +P I +
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L+ L +S NS + +I G+ L LDL+ N F+G +P + S + +
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGK 573
Query: 213 VTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIY 251
+ F G +L + T
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-21
Identities = 32/186 (17%), Positives = 66/186 (35%), Gaps = 13/186 (6%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137
+ ++ + L+G + LS+ +L LS N + IP + NL L L+
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
+N+FSGN+P + SL +L+++ N +I + ++ N +G
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYI 578
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGL----PLTTLNVANNHFSGWIPRELISIRTFIY-- 251
+ + N + L N+ + + G + + ++
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 252 -DGNSF 256
N
Sbjct: 639 MSYNML 644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 16/169 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEE--DNFLEAVSNMSRLRHPNIVTLAG 475
IG G G+VYRA + G +AVK + + +N + + L+HPNI+ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
C + LV E+ G L+ +L K + + V A+ AR + YLH+ +
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 536 VVHRNFKSANILLDDELNPH--------LSDCGLAALTPNTERQVITGT 576
++HR+ KS+NIL+ ++ ++D GLA T + G
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA 177
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 29/147 (19%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+ E G +++ + G + VK + S ++ +F E + HPN++ + G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 478 AE--HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
L+ ++ G+L+++LH + ++ + + V+ AL AR + +LH P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLA 562
+ S ++++D+++ +S +
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVK 160
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 43/182 (23%), Positives = 67/182 (36%), Gaps = 24/182 (13%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLE--A 458
+ ++ LIG G G VY+ + + +AVK S NF+
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV-----FSFANRQNFINEKN 57
Query: 459 VSNMSRLRHPNIVTLAGYCAE-----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
+ + + H NI + LLV EY NG+L L W +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 514 RVRVALGTARALEYLHE------VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567
R+A R L YLH P++ HR+ S N+L+ ++ +SD GL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 568 TE 569
Sbjct: 173 NR 174
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 9/146 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G+ G V +A++ K +A+K+I++ E F+ + +SR+ HPNIV L G C
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
LV EY G+L+++LH + T + L ++ + YLH + +++
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 538 HRNFKSANILLDDELN-PHLSDCGLA 562
HR+ K N+LL + D G A
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTA 153
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKI-----DNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
IG+G G V++ + ++A+K + + +++ F V MS L HPNIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G +V E+V G+L+ L D + + W+ ++R+ L A +EY+
Sbjct: 87 KLYGLMHN--PPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQN- 140
Query: 532 CLPSVVHRNFKSANILLD-----DELNPHLSDCGLAALTPNT 568
P +VHR+ +S NI L + ++D GL+ + ++
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 36/237 (15%)
Query: 39 TDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC----EGSAVVSIDISGLG 94
+ D QAL + L +P+ L++W D C +W GV C + V ++D+SGL
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLAS-NNFSGNLPYSIAS 151
L IP L P L L + NN G +P +IA
Sbjct: 62 LPKPY----------------------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ L YL ++ +++ +I D + L TLD S+N SG LP S SL N+ + N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 212 QVTGSL-NVFSGLP--LTTLNVANNHFSGWIPREL--ISIRTFIYDGNSFDNGPAPP 263
+++G++ + + T++ ++ N +G IP +++ N G A
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML-EGDASV 215
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 35/142 (24%), Positives = 55/142 (38%), Gaps = 4/142 (2%)
Query: 95 LSGTMGYLLSDLLSLRKF-DLSGNSIHDTIPYQL-PPNLTSLNLASNNFSGNLPYSIASM 152
+SG + L +S N + IP NL ++L+ N G+ S
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ +++++NSL +G + G L LDL N G LP L + SL + N
Sbjct: 221 KNTQKIHLAKNSLAFDLGKV-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 213 VTGSLNVFSGLP-LTTLNVANN 233
+ G + L ANN
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 31/106 (29%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGN 144
+D+S L G L + +K L+ NS+ + L NL L+L +N G
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT 259
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDI--FGNLAGLATLDLSFNN 188
LP + + L LNVS N+L G+I GNL + N
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLC---GEIPQGGNLQRFDVSAYANNK 302
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 38/153 (24%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G G+ + G++M +K++ + + FL+ V M L HPN++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ + + EY+ G L ++ W+ RV A A + YLH + ++
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+HR+ S N L+ + N ++D GLA L + +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 22/172 (12%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLE--AVSNMSRLRHPNIVTLA 474
+G+G G V+R + G+ +AVK S ++E ++ + N LRH NI+
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 475 GYC----AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
Q L+ Y G+L+D L L + +R+ L A L +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 531 -----VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
P++ HR+ KS NIL+ ++D GLA + + Q+ G +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG GS G VY+ ++ +G + AVK ++ A + Q+ F V + + RH NI+ GY
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
Q +V ++ +L+ LH S + +A TAR ++YLH S++
Sbjct: 90 TAP-QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
HR+ KS NI L ++ + D GLA
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 22/167 (13%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL-EA-VSNMSRLRHPNIVTLA 474
IG+G G V+ ++ G+ +AVK EE ++ E + +RH NI+
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKV-----FFTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 475 GYC----AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
Q L+ +Y NG+L+D L S L + +++A + L +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 531 -----VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
P++ HR+ KS NIL+ ++D GLA + +V
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 22/157 (14%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL-EA-VSNMSRLRHPNIVTLA 474
IG+G G V+R ++ G+ +AVK S +EE ++ EA + LRH NI+
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILGFI 102
Query: 475 GYCAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ Q LV +Y +G+L D L+ +T +++AL TA L +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 531 -----VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
P++ HR+ KS NIL+ ++D GLA
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 9/152 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G+VY + +G++ A++ ID + + F V + RH N+V G C
Sbjct: 41 IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
++ L+ ++ D+ L N ++A + + YLH ++
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
H++ KS N+ D+ ++D GL +++ +
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQ 183
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 38/166 (22%), Positives = 67/166 (40%), Gaps = 11/166 (6%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG GS VY+ + +A ++ + L+ E F E + L+HPNIV
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 476 YC---AEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ + +++ E + +G L L K + + L++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 532 CLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPNTERQVITGT 576
P ++HR+ K NI + + + D GLA L + + + GT
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT 193
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 35/166 (21%), Positives = 63/166 (37%), Gaps = 11/166 (6%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNL-PYSIASMVSLSYL 158
+ L +L D+S +L L +A N+F N P + +L++L
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-L 217
++S+ L Q F +L+ L L++S NNF + L+++ L N + S
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
Query: 218 NVFSGLP--LTTLNVANNHFSG-----WIPRELISIRTFIYDGNSF 256
P L LN+ N F+ + + R + +
Sbjct: 536 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERM 581
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 10/165 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L L D +++ + + NL L+++ + + SL L
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL- 217
++ NS ++ DIF L L LDLS P +F SLS++ L + +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRELI----SIRTFIYDGNSFD 257
+ L L L+ + NH +EL S+ N F
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 38/195 (19%), Positives = 64/195 (32%), Gaps = 32/195 (16%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140
+ ++D+S L Y L+ DLS I +L++L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF-SGDLPNSFIS 199
+ + + SL L +L G+L L L+++ N S LP F +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 200 LSNISSLYLQNNQVTG-----------------------------SLNVFSGLPLTTLNV 230
L+N+ L L +N++ F + L L +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207
Query: 231 ANNHFSGWIPRELIS 245
NN S + + I
Sbjct: 208 RNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 32/129 (24%), Positives = 52/129 (40%), Gaps = 3/129 (2%)
Query: 111 KFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG 170
+ + + IP LP + +L+L+ N YS S L L++SR +
Sbjct: 11 TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTL 228
+ +L+ L+TL L+ N +F LS++ L + N L L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 229 NVANNHFSG 237
NVA+N
Sbjct: 130 NVAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-22
Identities = 34/159 (21%), Positives = 60/159 (37%), Gaps = 9/159 (5%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIH--DTIPYQL--PPNLTSLNLASNNFSGNLPYS 148
G + DL SL DLS N + +L L+L+ N + +
Sbjct: 333 TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 391
Query: 149 IASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY 207
+ L +L+ ++L Q +F +L L LD+S + F LS++ L
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 208 LQNNQVTGSL--NVFSGLP-LTTLNVANNHFSGWIPREL 243
+ N + ++F+ L LT L+++ P
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 32/136 (23%), Positives = 51/136 (37%), Gaps = 4/136 (2%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
+DIS + + L SL ++GNS + + NLT L+L+
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL-SN 202
P + S+ SL LN+S N+ + L L LD S N+ S+
Sbjct: 485 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544
Query: 203 ISSLYLQNNQVTGSLN 218
++ L L N +
Sbjct: 545 LAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 40/182 (21%), Positives = 66/182 (36%), Gaps = 28/182 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS------------------- 142
L + L ++ F L +I + L L + F
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336
Query: 143 GNLPYSIASMVSLSYLNVSRNSLT--QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
G +S + SL +L++SRN L+ L LDLSFN + ++F+ L
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 395
Query: 201 SNISSLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIPRE---LISIRTFIYDGN 254
+ L Q++ + +VF L L L++++ H L S+ GN
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 255 SF 256
SF
Sbjct: 456 SF 457
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 30/135 (22%), Positives = 60/135 (44%), Gaps = 6/135 (4%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
+ ++L +L DLS + P +L LN++ NNF + + SL L
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 523
Query: 159 NVSRNSLTQSIGDIFGNLAG-LATLDLSFNNFSGDLPNS-FIS-LSNISSLYLQNNQVTG 215
+ S N + S + LA L+L+ N+F+ + F+ + + L ++ ++
Sbjct: 524 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMEC 583
Query: 216 SL-NVFSGLPLTTLN 229
+ + G+P+ +LN
Sbjct: 584 ATPSDKQGMPVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 35/186 (18%), Positives = 60/186 (32%), Gaps = 15/186 (8%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKF----DLSGNSIHDTIPYQL-PPNLTSLNLASNNFS 142
+D+S + L L + DLS N ++ P L L L +N S
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDS 213
Query: 143 GNLPY-SIASMVSLSYLNVSRNSLTQSI---GDIFGNLAGLATLDLSFNNFS------GD 192
N+ I + L + L GL L + + D
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 193 LPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYD 252
+ + F L+N+SS L + + + L + N F + +L S++ +
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT 333
Query: 253 GNSFDN 258
N N
Sbjct: 334 SNKGGN 339
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 48/166 (28%), Positives = 71/166 (42%), Gaps = 17/166 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G G VY A E + I+A+K + A L E V S LRHPNI+ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
GY + + L+ EY G ++ L F + + A AL Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANALSYCHS 127
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
V+HR+ K N+LL ++D G + P++ R + GT
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGT 170
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 34/138 (24%), Positives = 58/138 (42%), Gaps = 3/138 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
S D S + +P LP N+T LNL N + L+ L+V N++++
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLP-L 225
++ L L L+L N S +F +N++ L+L +N + N F L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 226 TTLNVANNHFSGWIPREL 243
TL++++N S
Sbjct: 124 ITLDLSHNGLSSTKLGTQ 141
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 40/169 (23%), Positives = 69/169 (40%), Gaps = 6/169 (3%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS 142
+ ++++ L + L D+ N+I P P L LNL N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ A +L+ L++ NS+ + + F L TLDLS N S + + L N
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 203 ISSLYLQNNQVTG----SLNVFSGLPLTTLNVANNHFSGWIPRELISIR 247
+ L L NN++ L++F+ L L +++N + P +I
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 39/167 (23%), Positives = 60/167 (35%), Gaps = 6/167 (3%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNN 140
S + S+D+ +S L L L+ +L N + NLT L+L SN+
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
+L L++S N L+ + L L L LS N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
Query: 201 SNIS--SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
+N S L L +NQ+ S F + L L + N + +L
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 36/188 (19%), Positives = 66/188 (35%), Gaps = 18/188 (9%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSG 143
I +S + + SL++ L ++ + P NLT L+L++NN +
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQ--------SIGDIFGNLAGLATLDLSFNNFSGDLPN 195
+ + L L++ N+L + L+ L L+L N F
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 196 SFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIP----RELISIRTF 249
F L + + L N + +VF+ L +LN+ N + ++
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 250 IYDGNSFD 257
N FD
Sbjct: 615 DMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 42/169 (24%), Positives = 63/169 (37%), Gaps = 15/169 (8%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
++++ +S S L L DL N I + Q N+ + L+ N +
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 144 NLPYSIASMVSLSYLNVSRNSLT--QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
S A + SL L + R +L S F L L LDLS NN + + L
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 202 NISSLYLQNNQVT---------GSLNVFSGLP-LTTLNVANNHFSGWIP 240
+ L LQ+N + G + GL L LN+ +N F
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-22
Identities = 32/169 (18%), Positives = 64/169 (37%), Gaps = 18/169 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASNNF 141
+++S + + L L+ + ++ +L ++ +L+L+++
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234
Query: 142 SGNLPYSIASM--VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS 199
S + + +L+ L++S N+L D F L L L +NN +S
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294
Query: 200 LSNISSLYLQNNQVTGSL----------NVFSGLP-LTTLNVANNHFSG 237
L N+ L L+ + S+ F L L LN+ +N G
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-22
Identities = 40/149 (26%), Positives = 61/149 (40%), Gaps = 13/149 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS--------GNLPYSIAS 151
L +L DLS N+I + L L L+L NN + G Y +
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ L LN+ N + ++F +L L +DL NN + + F + ++ SL LQ N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 212 QVTG-SLNVFSGLP--LTTLNVANNHFSG 237
+T VF LT L++ N F
Sbjct: 595 LITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 34/172 (19%), Positives = 62/172 (36%), Gaps = 15/172 (8%)
Query: 87 SIDISGLGLSGTM-GYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSG 143
+D+ + + G L ++ + LS N P+L L L
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 144 --NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--------GDL 193
+ P + +L+ L++S N++ D+ L L LDL NN + G
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 194 PNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
LS++ L L++N + VF L L +++ N+ +
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-21
Identities = 34/168 (20%), Positives = 61/168 (36%), Gaps = 11/168 (6%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN 144
+ + + +L DLS N + T NL L L++N
Sbjct: 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160
Query: 145 LPYSIASM--VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF---IS 199
+ SL L +S N + + F + L L L+ L ++
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELA 220
Query: 200 LSNISSLYLQNNQVTGSLN-VFSGLP---LTTLNVANNHFSGWIPREL 243
++I +L L N+Q++ + N F GL LT L+++ N+ +
Sbjct: 221 NTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-20
Identities = 35/183 (19%), Positives = 69/183 (37%), Gaps = 17/183 (9%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-----------QLP 128
+ + + +D+S L+ + L L F L N+I + L
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304
Query: 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188
+ T +++ + +S + L +LN+ N + ++F L L L LS +
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 189 FSGD--LPNSFISLSNIS--SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRE 242
S +F+SL++ L L N+++ + FS L L L++ N + +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 243 LIS 245
Sbjct: 425 EWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 39/200 (19%), Positives = 77/200 (38%), Gaps = 21/200 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-QLP----------PNLTSLN 135
+ + + L L ++R +L + +I LP L LN
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335
Query: 136 LASNNFSGNLPYSIASMVSLSYLNVSRN--SLTQSIGDIFGNLA--GLATLDLSFNNFSG 191
+ N+ G +++L YL++S + SL + F +LA L L+L+ N S
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 192 DLPNSFISLSNISSLYLQNNQVTGSLN--VFSGLP-LTTLNVANNHFSGWIP---RELIS 245
++F L ++ L L N++ L + GL + + ++ N + + S
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455
Query: 246 IRTFIYDGNSFDNGPAPPPP 265
++ + + N + P P
Sbjct: 456 LQRLMLRRVALKNVDSSPSP 475
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 6/95 (6%)
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
VS + S LTQ D+ N + L+L+ N +F S ++SL + N
Sbjct: 4 VSHEVADCSHLKLTQVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 213 VTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELIS 245
++ + LP L LN+ +N S + + +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFA 94
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 36/198 (18%), Positives = 73/198 (36%), Gaps = 34/198 (17%)
Query: 45 QALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLS 104
+ L++L N+ + L WK KG+ S + +++ G +
Sbjct: 504 EKLEILDLQHNNLARL--WKHANPGGPIYFLKGL----SHLHILNLESNGFDEIPVEVFK 557
Query: 105 DLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164
DL L+ DL N+++ + VSL LN+ +N
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVF----------------------NNQVSLKSLNLQKNL 595
Query: 165 LTQSIGDIFG-NLAGLATLDLSFNNFSGDLPN-----SFISLSNISSLYLQNNQVTGSLN 218
+T +FG L LD+ FN F + ++I+ ++ + L ++ + +
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 219 VFSGLPLTTLNVANNHFS 236
+ G P+ + ++ S
Sbjct: 656 HYHGFPVRLFDTSSCKDS 673
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 17/166 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G G VY A E N IMA+K + + L E + S LRHPNI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
Y + + L+ E+ G L+ L F + S A AL Y HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCHE 132
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
V+HR+ K N+L+ + ++D G + P+ R+ + GT
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGT 175
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 49/167 (29%), Positives = 76/167 (45%), Gaps = 7/167 (4%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL-A 474
IG GS GR + ++GKI+ K++D +++ E+ + V+ + L+HPNIV
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
L +V EY G+L ++ + L +RV AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 534 PS--VVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTER-QVITGT 576
V+HR+ K AN+ LD + N L D GLA L +T + GT
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 10/181 (5%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSG 143
S+++S + L DL+ + Q L LNL+ +
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIG---DIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
+ + +L +LN+ N + + L L L LSF + S ++F SL
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 201 SNISSLYLQNNQVTG-SLNVFSGLPLTTLNVANNHFSGWIP---RELISIRTFIYDGNSF 256
++ + L +N++T S+ S L LN+A+NH S +P L RT N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
Query: 257 D 257
D
Sbjct: 560 D 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-22
Identities = 31/161 (19%), Positives = 49/161 (30%), Gaps = 7/161 (4%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN 144
+ + LGL+ G L + L + S N + NLT L+L
Sbjct: 16 TYNCENLGLNEIPGTLPNSTECL---EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
+ S L L ++ N L L L S + +
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
SLYL +N ++ L L L+ NN ++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 34/156 (21%), Positives = 59/156 (37%), Gaps = 8/156 (5%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSI- 149
+ S L +L L+ +LS N P L L+LA S
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421
Query: 150 ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG---DLPNSFISLSNISSL 206
++ L LN+S + L S +F L L L+L N+F NS +L + L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 207 YLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIP 240
L ++ + F+ L + +++++N +
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 22/130 (16%), Positives = 50/130 (38%), Gaps = 3/130 (2%)
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
+ ++ ++ IP LP + L + N + + +++L++L+++R +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTT 227
D F + L TL L+ N + + L+ ++ L +
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 228 LNVANNHFSG 237
L + +NH S
Sbjct: 134 LYLGSNHISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 8/168 (4%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS 142
V SI++ L++ DL+ + +P L L L L++N F
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE 314
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGD-IFGNLAGLATLDLSFNN--FSGDLPNSFIS 199
S ++ SL++L++ N+ +G NL L LDLS ++ S +
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
Query: 200 LSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELIS 245
LS++ SL L N+ F P L L++A +
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-20
Identities = 28/147 (19%), Positives = 51/147 (34%), Gaps = 9/147 (6%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+S+ +L + + L L+L + + S LP + + +L L +S N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDL-PNSFISLSNISSLYLQNNQVTGS---LNV 219
N L L + N +L +L N+ L L ++ + S
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 220 FSGLP-LTTLNVANNHFSGWIPRELIS 245
L L +LN++ N + E
Sbjct: 372 LRNLSHLQSLNLSYNEPLS-LKTEAFK 397
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 28/163 (17%), Positives = 54/163 (33%), Gaps = 10/163 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
S L++L DL+ I+ L +L L +N +++ +L +L
Sbjct: 53 FSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT----GS 216
+ ++ N L +L L N+ S + L QNN +
Sbjct: 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
Query: 217 LNVFSGLPLTTLNVANNHFSGWIPRE---LISIRTFIYDGNSF 256
++ +LN+ N +G I ++ + G
Sbjct: 173 MSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQN 214
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 31/143 (21%), Positives = 55/143 (38%), Gaps = 8/143 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN---LPYSIASMVSLS 156
+L L+ +LS + + + P L LNL N+F S+ ++ L
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L +S L+ F +L + +DLS N + + L I L L +N ++
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISII 538
Query: 216 SLNVFSGLP-LTTLNVANNHFSG 237
++ L T+N+ N
Sbjct: 539 LPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 25/141 (17%), Positives = 49/141 (34%), Gaps = 8/141 (5%)
Query: 104 SDLLSLRKFDLSGNSIHD----TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
S + SL D ++ S+NL + F + L L+
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-- 217
++ L++ + L+ L L LS N F S + +++ L ++ N L
Sbjct: 285 LTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
Query: 218 NVFSGLP-LTTLNVANNHFSG 237
L L L+++++
Sbjct: 344 GCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 25/143 (17%), Positives = 43/143 (30%), Gaps = 9/143 (6%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
LS +L+ I L L SL L SN+ S L L+
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLD 159
Query: 160 VSRNSLTQSIGDIFGNLAGLA--TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
N++ + +L +L+L+ N+ +G + + SL Q +
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVI 218
Query: 218 ---NVFSGLP-LTTLNVANNHFS 236
S + L +
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDE 241
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 24/164 (14%), Positives = 54/164 (32%), Gaps = 11/164 (6%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN 144
+ G+S L + +L L N I + L L+ +N
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 145 LPYSIASMVSLS--YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN--SFISL 200
++S+ + LN++ N + I + A +L+ + ++
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227
Query: 201 SNISSLYLQNNQVTG-SLNVFSGLP---LTTLNVANNHFSGWIP 240
++ ++ S VF GL + ++N+ ++F
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 36/146 (24%), Positives = 59/146 (40%), Gaps = 8/146 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V+ + AVK L + FL+ + + HPNIV L G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G+ L L +++ A +EYL
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 537 VHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + N L+ ++ +SD G++
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 45/192 (23%), Positives = 70/192 (36%), Gaps = 30/192 (15%)
Query: 411 SFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL 465
++ EF IG G G V++ + +G I A+K+ +E N L V + L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 466 -RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
+H ++V AE L+ EY G+L D + + L R
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPH-------------------LSDCGLAALT 565
L Y+H S+VH + K +NI + P+ + D G T
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV--T 182
Query: 566 PNTERQVITGTS 577
+ QV G S
Sbjct: 183 RISSPQVEEGDS 194
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 39/154 (25%), Positives = 63/154 (40%), Gaps = 26/154 (16%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS G V+R + G AVKK+ ++E + + L P IV L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE-------LVACAGLSSPRIVPLYG 117
Query: 476 YCAEHGQRLLVY-EYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + ++ E + G+L ++ +D + AL LEYLH
Sbjct: 118 -AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYL-----GQAL---EGLEYLHT 168
Query: 531 VCLPSVVHRNFKSANILLDDELNP-HLSDCGLAA 563
++H + K+ N+LL + + L D G A
Sbjct: 169 RR---ILHGDVKADNVLLSSDGSRAALCDFGHAL 199
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 35/180 (19%), Positives = 66/180 (36%), Gaps = 10/180 (5%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSG 143
+D+S G M L L+ D +++ + L L+++ N
Sbjct: 380 HLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ + SL+ L ++ NS + ++F N L LDLS F +L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 203 ISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSG---WIPRELISIRTFIYDGNSFD 257
+ L + +N + + ++ L L+TL+ + N + S+ F NS
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 37/167 (22%), Positives = 59/167 (35%), Gaps = 8/167 (4%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGN 144
+D+S + L L L+GN I P +L +L +
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 145 LPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNI 203
+ I +++L LNV+ N + + F NL L +DLS+N N L
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 204 S----SLYLQNNQVTG-SLNVFSGLPLTTLNVANNHFSGWIPRELIS 245
SL + N + F G+ L L + N S I + +
Sbjct: 180 PQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 27/133 (20%), Positives = 53/133 (39%), Gaps = 3/133 (2%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
+ + + +P +P + +++L+ N YS ++ L +L++SR +
Sbjct: 11 VPNITYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE 69
Query: 167 QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP- 224
+ L L+ L L+ N P SF L+++ +L ++ L
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 225 LTTLNVANNHFSG 237
L LNVA+N
Sbjct: 130 LKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 38/147 (25%), Positives = 57/147 (38%), Gaps = 6/147 (4%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS--GNLPYSIASMVSLSYLNVS 161
DL L+ L+ N + P+L+ L+L+ N S G YS SL +L++S
Sbjct: 325 LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL-NV 219
N + F L L LD + S F+SL + L + +
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 220 FSGLP-LTTLNVANNHFSGWIPRELIS 245
F GL L TL +A N F + +
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFA 470
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-19
Identities = 32/143 (22%), Positives = 53/143 (37%), Gaps = 9/143 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
S+ L+ DLS I +L++L L N P S + + SL L
Sbjct: 52 FSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTG-SLN 218
L G L L L+++ N LP F +L+N+ + L N + ++N
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171
Query: 219 VFSGLP-----LTTLNVANNHFS 236
L +L+++ N
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPID 194
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 41/203 (20%), Positives = 73/203 (35%), Gaps = 28/203 (13%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS---- 142
++ L ++ L+G SI SL++
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPT 324
Query: 143 ---------------GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAG--LATLDLS 185
G++ + ++ SLSYL++SRN+L+ S + +L L LDLS
Sbjct: 325 LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 186 FNNFSGDLPNSFISLSNISSLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIPRE 242
FN + +F+ L + L Q++ + + F L L L+++ +
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 243 ---LISIRTFIYDGNSFDNGPAP 262
L S+ T GNSF +
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 26/158 (16%), Positives = 57/158 (36%), Gaps = 16/158 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD-TIPYQLP--PNLTSLNLASNNFSG 143
++ L+ + + L++L+K +++ N IH +P NL ++L+ N
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
Query: 144 NLPYSIASMVSLS----YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFI 198
+ + L++S N + F + L L L N S ++
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQ 226
Query: 199 SLSNISSLYLQNNQVTG-------SLNVFSGLPLTTLN 229
+L+ + L + ++ GL T++
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 35/211 (16%), Positives = 62/211 (29%), Gaps = 44/211 (20%)
Query: 90 ISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY------QLPPNLTSLNLASNNFSG 143
I L S+L +L DLS N I + P SL+++ N
Sbjct: 140 IHSCKLPAY----FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID- 194
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLA---------------------- 180
+ + L L + N + +I NLAGL
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 181 ----------TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNV 230
L++ N D F L+N+S++ L + +V +L++
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314
Query: 231 ANNHFSGWIPRELISIRTFIYDGNSFDNGPA 261
+ +L +++ N
Sbjct: 315 IRCQLKQFPTLDLPFLKSLTLTMNKGSISFK 345
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 42/152 (27%), Positives = 58/152 (38%), Gaps = 10/152 (6%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEG V E +G A+K+I Q+ + HPNI+ L
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 476 YCAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
YC L+ + G L + + D LT + + + LG R LE +H
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563
HR+ K NILL DE P L D G
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 31/156 (19%), Positives = 60/156 (38%), Gaps = 15/156 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHD-TIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
++ + N++ + L L L N G LP + S + L+ LN
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTG-SL 217
++ N +T+ + G + L + N S+S +S++ N++
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 218 NVFSGLP--------LTTLNVANNHFSGWIPRELIS 245
F L ++++N++NN S P+EL S
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISK-FPKELFS 454
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-22
Identities = 27/169 (15%), Positives = 70/169 (41%), Gaps = 23/169 (13%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSG-------NLPYSIA 150
+ + N + IP +++++ + N L +
Sbjct: 372 FCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-------DLPNSFISLSNI 203
+++S +N+S N +++ ++F + L++++L N + D +F + +
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 204 SSLYLQNNQVTGSLN--VFSGLP-LTTLNVANNHFSGWIPRELISIRTF 249
+S+ L+ N++T + + LP L ++++ N FS P + ++ T
Sbjct: 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-21
Identities = 35/277 (12%), Positives = 73/277 (26%), Gaps = 43/277 (15%)
Query: 43 DVQALQVLYTSLNSPS---------VLTNWKGNEGDPCGESWKGVAC-EGSAVVSIDISG 92
D AL+ ++ +LN + NW N+ + GV+ V + + G
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEG 90
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSL------NLASNNFSGNLP 146
G SG + + L L L + P +++ ++
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 147 YSIA--SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
L ++ + +SI + NN + + + + L+ +
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209
Query: 205 SLYLQNNQVTGS-------------LNVFSGLP--------LTTLNVANNHFSGWIPRE- 242
Y+ N+ + LT + V N +P
Sbjct: 210 QFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 243 --LISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHN 277
L ++ N +G +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 23/178 (12%), Positives = 60/178 (33%), Gaps = 15/178 (8%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD--------TIPYQLP--PNLTSLNL 136
+++ + L L ++ +++ N P + + +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 137 ASNNF-SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN 195
NN + + S+ M L L N L + FG+ LA+L+L++N + N
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPAN 371
Query: 196 SFISLSNISSLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFI 250
+ +L +N++ ++ + ++ ++ + N + +
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-19
Identities = 29/169 (17%), Positives = 52/169 (30%), Gaps = 17/169 (10%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNF---- 141
+ T +L L ++ +P L P + +N+A N
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL-PEMQLINVACNRGISGE 289
Query: 142 ----SGNLPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
+ + + N+L + + L L+ +N G +
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPA 348
Query: 197 FISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
F S ++SL L NQ+T N + L+ A+N IP
Sbjct: 349 FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIF 396
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 30/182 (16%), Positives = 59/182 (32%), Gaps = 32/182 (17%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---------PNLTSLNLA 137
SI++S +S L S L +L GN + + L LTS++L
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 138 SNNFSGNLPYSIA--SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL------DLSFNNF 189
N + L ++ L +++S NS + N + L D N
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 190 SGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP------LTTLNVANNHFSGWIPREL 243
+ P +++ L + +N + ++ L++ +N +
Sbjct: 555 LREWPEGITLCPSLTQLQIGSND-------IRKVNEKITPNISVLDIKDNPNISIDLSYV 607
Query: 244 IS 245
Sbjct: 608 CP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 18/149 (12%), Positives = 38/149 (25%), Gaps = 14/149 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+ L LR+F + + + N ++ L+ + V
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENI---CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNF--------SGDLPNSFISLSNISSLYLQNNQ-V 213
+ L + ++++ N I +Y+ N
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 214 TGSL-NVFSGLP-LTTLNVANNHFSGWIP 240
T + + L L N G +P
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 23/118 (19%), Positives = 35/118 (29%), Gaps = 12/118 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSL------NLASNNFSGNLPYSIASMVS 154
+ L L DLS NS P Q L + N P I S
Sbjct: 509 ATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567
Query: 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L+ L + N + + I N ++ LD+ N + L ++
Sbjct: 568 LTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 10/78 (12%), Positives = 25/78 (32%), Gaps = 1/78 (1%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYS 148
D G ++ SL + + N I + ++ PN++ L++ N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNISIDLSY 606
Query: 149 IASMVSLSYLNVSRNSLT 166
+ + + +
Sbjct: 607 VCPYIEAGMYMLFYDKTQ 624
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 15/166 (9%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLA 474
IG G +V++ +I A+K ++ Q D++ ++ +++L+ + I+ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y +V E GN +L+ L K++ R A+ +H+
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAAL----TPNTERQVITGT 576
+VH + K AN L+ D L D G+A T + + GT
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 41/163 (25%), Positives = 76/163 (46%), Gaps = 8/163 (4%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEGS G+ + +G+ +K+I+ + +S +E + V+ ++ ++HPNIV
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
E+G +V +Y G+L ++ + + + AL+++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHVHD---RK 145
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTER-QVITGT 576
++HR+ KS NI L + L D G+A L E + GT
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGT 188
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 43/178 (24%), Positives = 64/178 (35%), Gaps = 24/178 (13%)
Query: 412 FSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL- 465
F Q F +G GS G V++ +G++ AVK+ + ++ L V + ++
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALG 520
+HP V L E G L E G +L + +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRD-------- 165
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVITGTS 577
T AL +LH +VH + K ANI L L D GL L +V G
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP 220
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 15/166 (9%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLA 474
IG G +V++ +I A+K ++ Q D++ ++ +++L+ + I+ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y +V E GN +L+ L K++ R A+ +H+
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAAL----TPNTERQVITGT 576
+VH + K AN L+ D L D G+A T + + GT
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 40/193 (20%), Positives = 74/193 (38%), Gaps = 33/193 (17%)
Query: 406 QTATNSFSQEF----LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVS 460
T F +F LIG G G+V++A+ +GK +K++ + E V
Sbjct: 3 HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE------VK 56
Query: 461 NMSRLRHPNIV---------------TLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD 504
+++L H NIV + + L + E+ G L +
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KR 114
Query: 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-A 563
+ L + + + ++Y+H +++R+ K +NI L D + D GL +
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 564 LTPNTERQVITGT 576
L + +R GT
Sbjct: 172 LKNDGKRTRSKGT 184
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 37/146 (25%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G VY + + AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLGV 77
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C ++ E++ GNL D L + + + ++ + +A + A+EYL + +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 537 VHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + N L+ + ++D GL+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 12/165 (7%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
L+G+GS VYRA G +A+K ID A+ V +L+HP+I+ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT-WNARVRVALGTARALEYLHEVCL 533
Y + LV E NG ++ L + K + AR + YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEAR-HFMHQIITGMLYLHSHG- 132
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVITGT 576
++HR+ +N+LL +N ++D GLA P+ + + GT
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGT 175
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 38/148 (25%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 418 IGEGSLGRVYRAEFANGKIM---AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G V + + K++ AVK + N A +D L + M +L +P IV +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G C +LV E G L+ L ++++ + + + ++YL E
Sbjct: 85 GICEAE-SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESNF- 138
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N+LL + +SD GL+
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 4e-21
Identities = 36/166 (21%), Positives = 67/166 (40%), Gaps = 15/166 (9%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLA 474
IG G +V++ +I A+K ++ Q D++ ++ +++L+ + I+ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y +V E GN +L+ L K++ R A+ +H+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAAL----TPNTERQVITGT 576
+VH + K AN L+ D L D G+A T + + G
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 30/182 (16%), Positives = 68/182 (37%), Gaps = 30/182 (16%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEA---------------VSNM 462
+ +G ++ E + K A+KK + + L + + + +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 463 SRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
+ +++ +T G + + ++YEY+ N ++ L N + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE----YFFVLDKNYTCFIPIQVI 153
Query: 523 R--------ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
+ + Y+H ++ HR+ K +NIL+D LSD G + + + +
Sbjct: 154 KCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR 211
Query: 575 GT 576
GT
Sbjct: 212 GT 213
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 15/168 (8%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G VYRA +G +A+KK+ L + + ++ + + +L HPN++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT----WNARVRVALGTARALEYLHE 530
E + +V E G+L M+ + + W V++ ALE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHMHS 154
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT--GT 576
V+HR+ K AN+ + L D GL + + GT
Sbjct: 155 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 199
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G VY + + AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLGV 284
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C ++ E++ GNL D L + + + ++ + +A + A+EYL + +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 537 VHRNFKSANILLDDELNPHLSDCGLA 562
+HRN + N L+ + ++D GL+
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLS 365
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-21
Identities = 27/152 (17%), Positives = 62/152 (40%), Gaps = 5/152 (3%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLP 146
I ++ + ++ G + +++ ++ + P NL L + + + +
Sbjct: 48 YITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKI 105
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
+++ + SL+ L++S ++ SI L + ++DLS+N D+ +L + SL
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSL 164
Query: 207 YLQNNQVTGSLNVFSGLP-LTTLNVANNHFSG 237
+Q + V P L L + G
Sbjct: 165 NIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 25/134 (18%), Positives = 52/134 (38%), Gaps = 3/134 (2%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+ + SL L+ ++ D + N+ L + + + + P I+ + +L L +
Sbjct: 41 AQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL 223
+T L L LD+S + + +L ++S+ L N + L
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTL 158
Query: 224 P-LTTLNVANNHFS 236
P L +LN+ +
Sbjct: 159 PELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 18/127 (14%), Positives = 46/127 (36%), Gaps = 22/127 (17%)
Query: 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ------------------SIG 170
+ S + A M SL+Y+ ++ ++T
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHAT 79
Query: 171 DI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-LNVFSGLP-LT 226
+ L+ L L + + + D + L++++ L + ++ S L + LP +
Sbjct: 80 NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139
Query: 227 TLNVANN 233
+++++ N
Sbjct: 140 SIDLSYN 146
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 33/172 (19%), Positives = 66/172 (38%), Gaps = 27/172 (15%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G + + + ++ A K + + L + + +S L H ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
G+ ++ +V E +L ++ R + AR +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH------------KRRKALTEPEARYYLRQIVLGCQ 155
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVITGT 576
YLH V+HR+ K N+ L+++L + D GLA ++V+ GT
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 204
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 47/146 (32%), Positives = 70/146 (47%), Gaps = 11/146 (7%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G V ++ G +AVK I N A FL S M++LRH N+V L G
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 478 AEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
E L +V EY+ G+L D L L + ++ +L A+EYL +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 537 VHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N+L+ ++ +SD GL
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 9/145 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG G G V+ + N +A+K I A E++F+E M +L HP +V L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
E LV E++ +G L D L + + L + YL E V+
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126
Query: 538 HRNFKSANILLDDELNPHLSDCGLA 562
HR+ + N L+ + +SD G+
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMT 151
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIM----AVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG G V AVK K+DN+ S +E + FL + M HPN++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVI 99
Query: 472 TLAGYCAEHGQR-----LLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVALGTARA 524
L G C E + +++ ++ G+LH L + K++ ++ + A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+EYL + +HR+ + N +L D++ ++D GL+
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 47/146 (32%), Positives = 69/146 (47%), Gaps = 11/146 (7%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G V + G +AVK I N A FL S M++LRH N+V L G
Sbjct: 29 IGKGEFGDVMLGD-YRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 478 AEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
E L +V EY+ G+L D L L + ++ +L A+EYL +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 537 VHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N+L+ ++ +SD GL
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 26/172 (15%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL----SLQEEDNFLEAVSNMSRLRHPNIV 471
++G+G+ G VY + +N +A+K+I L EE ++ L+H NIV
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE------IALHKHLKHKNIV 82
Query: 472 TLAGYCAEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA---RALEY 527
G + ++ E V G+L +L L N + + T L+Y
Sbjct: 83 QYLG-SFSENGFIKIFMEQVPGGSLSALLR---SKWGPLKDNEQT-IGFYTKQILEGLKY 137
Query: 528 LHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAA--LTPNTERQVITGT 576
LH+ +VHR+ K N+L++ +SD G + N + TGT
Sbjct: 138 LHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 33/172 (19%), Positives = 66/172 (38%), Gaps = 27/172 (15%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G + + + ++ A K + + L + + +S L H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
G+ ++ +V E +L ++ R + AR +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH------------KRRKALTEPEARYYLRQIVLGCQ 129
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVITGT 576
YLH V+HR+ K N+ L+++L + D GLA ++V+ GT
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 20/186 (10%)
Query: 402 VASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVS 460
+++L+ F L+G G+ G+VY+ G++ A+K +D ++ EE+ + ++
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEIN 72
Query: 461 NMSRL-RHPNIVT-----LAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
+ + H NI T + +L LV E+ G G++ D++ ++ W A
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 514 RV-RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT--ER 570
+ R L R L +LH+ V+HR+ K N+LL + L D G++A T R
Sbjct: 133 YICREIL---RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 571 QVITGT 576
GT
Sbjct: 187 NTFIGT 192
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 12/150 (8%)
Query: 418 IGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG G G VY +GK + AVK ++ + E FL M HPN+++L
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 474 AGYCAE-HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G C G L+V Y+ +G+L + + + + N T + L A+ ++YL
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK- 147
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N +LD++ ++D GLA
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 35/150 (23%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G G+ G VY+ + KI A+K++ A S + L+ M+ + +P++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C L+ + + G L D + + N+ + + A+ + YL +
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L VHR+ + N+L+ + ++D GLA
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 37/145 (25%), Positives = 62/145 (42%), Gaps = 9/145 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +AVK I + ED F + M +L HP +V G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
++ +V EY+ NG L + L K L + + + + +L +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 538 HRNFKSANILLDDELNPHLSDCGLA 562
HR+ + N L+D +L +SD G+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 17/164 (10%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG+G+ G VY A + A G+ +A+++++ L Q + + + + M ++PNIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G L +V EY+ G+L D++ + V +ALE+LH
Sbjct: 85 -SYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-NTERQVITGT 576
V+HR+ KS NILL + + L+D G A +TP ++R + GT
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 14/152 (9%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG G+V + N AVK + + D + + + L H NIV
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVK 87
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C E G L+ E++ +G+L + L + + +++ A+ + ++YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N+L++ E + D GL
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 34/157 (21%), Positives = 68/157 (43%), Gaps = 15/157 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIM----AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G+G G V A+ AVK + ++ + + FL + M HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 474 AGYCAEHGQR------LLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVALGTARAL 525
G + +++ ++ +G+LH L ++ NL VR + A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
EYL + +HR+ + N +L +++ ++D GL+
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 24/161 (14%)
Query: 418 IGEGSLGRVYRAEFANGKIM--------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
+G+G+ ++++ +K +D A + E F EA S MS+L H +
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASMMSKLSHKH 73
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V G C + +LV E+V G+L L + + ++ VA A A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 530 EVCLPSVVHRNFKSANILLDDELNPH--------LSDCGLA 562
E L +H N + NILL E + LSD G++
Sbjct: 131 ENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 38/163 (23%), Positives = 69/163 (42%), Gaps = 23/163 (14%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N AVK + + +L +F ++ L+H +IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIV 80
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARVRVAL 519
G C + ++V+EY+ +G+L+ L + L + + +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A + YL VHR+ + N L+ L + D G++
Sbjct: 141 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 37/145 (25%), Positives = 63/145 (43%), Gaps = 9/145 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +A+K I ++ ED F+E M L H +V L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG L + L + + + A+EYL +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142
Query: 538 HRNFKSANILLDDELNPHLSDCGLA 562
HR+ + N L++D+ +SD GL+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 6e-20
Identities = 29/211 (13%), Positives = 68/211 (32%), Gaps = 21/211 (9%)
Query: 90 ISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS----- 142
I G + + ++ LS N I ++++ L++N +
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 143 --GNLPYSIASMVSLSYLNVSRNSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPNSFIS 199
+ + L+ +++ N LT D L L+ +D+S+N FS P ++
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLN 774
Query: 200 LSNISSLYLQNNQVTGSLNVFSGLP--------LTTLNVANNHFSGWIPRELI-SIRTFI 250
S + + +++ + + P L L + +N + +L +
Sbjct: 775 SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYILD 833
Query: 251 YDGNSFDNGPAPPPPPSTAPPSGRSHNNRSH 281
N + P +++
Sbjct: 834 IADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 2e-19
Identities = 29/171 (16%), Positives = 50/171 (29%), Gaps = 17/171 (9%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSG- 143
+ S+L L +L +P L P L SLN+A N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 144 --------NLPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLP 194
L + + + N+L + + L LD N
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--L 588
Query: 195 NSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
+F + ++ L L NQ+ + + + L ++N IP
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIF 638
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 1e-18
Identities = 25/161 (15%), Positives = 61/161 (37%), Gaps = 21/161 (13%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGN-----LPYSIASM 152
+ + S N + IP + S++ + N
Sbjct: 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS-------GDLPNSFISLSNISS 205
++ S + +S N + + ++F + ++T+ LS N + ++ + +++
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 206 LYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
+ L+ N++T + LP L+ ++V+ N FS P +
Sbjct: 733 IDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQP 772
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 4e-17
Identities = 28/179 (15%), Positives = 60/179 (33%), Gaps = 19/179 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-----QLP------PNLTSLN 135
+++ + L DL L+ +++ N +L P +
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554
Query: 136 LASNNFSG-NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP 194
+ NN S+ MV L L+ N + + + FG L L L +N +P
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HL-EAFGTNVKLTDLKLDYNQIEE-IP 611
Query: 195 NS-FISLSNISSLYLQNNQVTGSLNVFS--GLP-LTTLNVANNHFSGWIPRELISIRTF 249
+ L +N++ N+F+ + + +++ + N S+ +
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDY 670
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 5e-17
Identities = 32/202 (15%), Positives = 62/202 (30%), Gaps = 37/202 (18%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN---SIHDTIPYQLP------PNLTSLNL 136
++ +S + L + + LS N SI + LT+++L
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735
Query: 137 ASNNFSGNLPYSIA--SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF------NN 188
N + L ++ LS ++VS N + S N + L + N
Sbjct: 736 RFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNR 793
Query: 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP------LTTLNVANNHF-----SG 237
P + ++ L + +N + L L++A+N +
Sbjct: 794 ILRQWPTGITTCPSLIQLQIGSND-------IRKVDEKLTPQLYILDIADNPNISIDVTS 846
Query: 238 WIPRELISIRTFIYDGNSFDNG 259
P + +YD G
Sbjct: 847 VCPYIEAGMYVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 22/144 (15%), Positives = 48/144 (33%), Gaps = 13/144 (9%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA------SNNFSGNLPYSIASMVSL 155
L L DL ++I+ + + ++L N + +I + L
Sbjct: 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKL 450
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
+ + + T + + + + S+ +L +++ + L N
Sbjct: 451 QIIYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505
Query: 216 SL-NVFSGLP-LTTLNVANNHFSG 237
L + LP L +LN+A N
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 25/189 (13%), Positives = 49/189 (25%), Gaps = 34/189 (17%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPN--LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
F+ + D L N +T L+LA G +P +I + L L+ +
Sbjct: 298 HSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTH 357
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-----------------------NSFISL 200
S T S + + +
Sbjct: 358 SETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417
Query: 201 SNISSLYLQNNQVTGSLNVFSGLP--------LTTLNVANNHFSGWIPRELISIRTFIYD 252
S + L++ Q+ N + + L + AN+ F+ +
Sbjct: 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDY 476
Query: 253 GNSFDNGPA 261
++N
Sbjct: 477 AKQYENEEL 485
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 18/158 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G+GS G VY A G + A+K + N A S++E FL S M ++
Sbjct: 33 LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML------HFADDSSKNLTWNARVRVALGTARA 524
V L G ++ L++ E + G+L L + + + +++A A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ YL+ VHR+ + N ++ ++ + D G+
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 39/176 (22%), Positives = 76/176 (43%), Gaps = 29/176 (16%)
Query: 412 FSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR 466
++ +F ++G+G+ G+V +A + + A+KKI + ++ L V ++ L
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLN 60
Query: 467 HPNIVTL------------AGYCAEHGQRL-LVYEYVGNGNLHDMLHFAD-DSSKNLTWN 512
H +V + L + EY NG L+D++H + + ++ W
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568
++ AL Y+H ++HR+ K NI +D+ N + D GLA +
Sbjct: 121 LFRQILE----ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 38/152 (25%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 418 IGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+G+ G V + G+++AVKK+ ++ + F + + L+H NIV
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 106
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C G+R L+ EY+ G+L D L + + ++ + +EYL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + NIL+++E + D GL
Sbjct: 164 KRY---IHRDLATRNILVENENRVKIGDFGLT 192
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 23/206 (11%)
Query: 382 VAKSGSLKKIKSPITATSYTVASLQTATNS------FSQEFLIGEGSLGRVYRA-EFANG 434
V +S + A+L+ + IGEGS G V A E +G
Sbjct: 11 VDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG 70
Query: 435 KIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGN 492
+ +AVK +D L Q+ L V M +H N+V + G+ L ++ E++
Sbjct: 71 RQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEFLQG 126
Query: 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552
G L D++ L V +AL YLH V+HR+ KS +ILL +
Sbjct: 127 GALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDG 178
Query: 553 NPHLSDCGLAA-LTP-NTERQVITGT 576
LSD G A ++ +R+ + GT
Sbjct: 179 RVKLSDFGFCAQISKDVPKRKSLVGT 204
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 13/168 (7%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
F +GEGS G VY+A G+I+A+K++ + ++ E +S M + P++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKE-ISIMQQCDSPHV 86
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V G ++ +V EY G G++ D++ +K LT + + T + LEYLH
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-NTERQVITGT 576
+ +HR+ K+ NILL+ E + L+D G+A LT +R + GT
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT 188
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 38/152 (25%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 418 IGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+G+ G V + G+++AVKK+ ++ + F + + L+H NIV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 75
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C G+R L+ EY+ G+L D L + + ++ + +EYL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + NIL+++E + D GL
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLT 161
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 48/189 (25%), Positives = 76/189 (40%), Gaps = 20/189 (10%)
Query: 387 SLKKIKSPITATSYTVASLQTATNSFSQEF---------LIGEGSLGRVYRAEF---ANG 434
K + A +T A SF++E +IG G G V
Sbjct: 17 QGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 435 KIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493
+ A+K + A + ++ +FL S M + HPNI+ L G ++V EY+ NG
Sbjct: 77 DVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG 135
Query: 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553
+L L T V + G + YL ++ VHR+ + N+L+D L
Sbjct: 136 SLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV 189
Query: 554 PHLSDCGLA 562
+SD GL+
Sbjct: 190 CKVSDFGLS 198
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 9/159 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ A + +AVK + ++S++ FL + M L+H +V L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKLHAVV 252
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ E++ G+L D L D + + A + ++ + + +
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
HR+ ++ANIL+ L ++D GLA + + E G
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 345
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 38/166 (22%), Positives = 57/166 (34%), Gaps = 8/166 (4%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNL 145
+D+S + L L L+GN I +L L N +
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 146 PYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
+ I + +L LNV+ N + + + F NL L LDLS N L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 205 ----SLYLQNNQVTG-SLNVFSGLPLTTLNVANNHFSGWIPRELIS 245
SL L N + F + L L + NN S + + I
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-19
Identities = 38/145 (26%), Positives = 64/145 (44%), Gaps = 6/145 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN--NFSGNLPYSIASMVSLSYLNVSRN 163
L SL++ + N + P+L L+L+ N +F G S SL YL++S N
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLN-VFS 221
+ ++ F L L LD +N + F+SL N+ L + + + N +F+
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 222 GLP-LTTLNVANNHFSGWIPRELIS 245
GL L L +A N F ++ +
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 37/156 (23%), Positives = 63/156 (40%), Gaps = 7/156 (4%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSG 143
+D+S G+ TM L L D +++ + NL L+++ +
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ SL L ++ NS ++ DIF L L LDLS P +F SLS+
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 203 ISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
+ L + +NQ+ +F L L + + N +
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 31/128 (24%), Positives = 51/128 (39%), Gaps = 3/128 (2%)
Query: 111 KFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG 170
+ + + IP LP + +L+L+ N YS S L L++SR +
Sbjct: 11 TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTL 228
+ +L+ L+TL L+ N +F LS++ L + L L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 229 NVANNHFS 236
NVA+N
Sbjct: 130 NVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 33/142 (23%), Positives = 59/142 (41%), Gaps = 9/142 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHD----TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
DL SL DLS N + + +L L+L+ N + + + L +L
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 159 NVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
+ ++L Q S +F +L L LD+S + F LS++ L + N +
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 218 --NVFSGLP-LTTLNVANNHFS 236
++F+ L LT L+++
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 27/113 (23%), Positives = 44/113 (38%), Gaps = 3/113 (2%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTS---LNLASNNFS 142
+ +DIS + + L SL ++GNS + + L + L+L+
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN 195
P + S+ SL LN++ N L IF L L + L N + P
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 29/178 (16%), Positives = 57/178 (32%), Gaps = 18/178 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD-TIPYQLP--PNLTSLNLASNNFSG 143
+ L+ + + L +L++ +++ N I +P NL L+L+SN
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 144 NLPYSIASMVSLSY----LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFI 198
+ + + L++S N + F + L L L N S ++
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQ 222
Query: 199 SLSNISSLYL-------QNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTF 249
L+ + L + N + G L L + + I F
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEG--LCNLTIEEFRLAYLDYYLDDIIDLF 278
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 38/206 (18%), Positives = 66/206 (32%), Gaps = 41/206 (19%)
Query: 96 SGTMGYLLSDLLSLRKFDLSGNSIHDTIP------YQLPPNLTSLNLASNNFSGNLPYSI 149
S + S+L +L DLS N I +Q+P SL+L+ N + +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA 196
Query: 150 ASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSG----------------- 191
+ L L + N + ++ LAGL L F
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 192 ----------------DLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHF 235
D+ + F L+N+SS L + + + L + N F
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
Query: 236 SGWIPRELISIRTFIYDGNSFDNGPA 261
+ +L S++ + N N +
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFS 342
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 9/145 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + +AVK + ++S FL + M +L+H +V L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 77
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG+L D L S LT N + +A A + ++ E + +
Sbjct: 78 TQEP-IYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 538 HRNFKSANILLDDELNPHLSDCGLA 562
HR+ ++ANIL+ D L+ ++D GLA
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLA 156
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 9/145 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G G V+ + +A+K + +S + FL+ M +LRH +V L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+E +V EY+ G+L D L ++ K L V +A A + Y+ + + V
Sbjct: 249 SEE-PIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 538 HRNFKSANILLDDELNPHLSDCGLA 562
HR+ ++ANIL+ + L ++D GLA
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLA 327
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 45/206 (21%), Positives = 78/206 (37%), Gaps = 31/206 (15%)
Query: 383 AKSGSLKKIKSPITATSYTVASLQTATNSFSQEF---------LIGEGSLGRVYRAEFAN 433
+ S + + + Q +++ +GEG+ G+V+ AE N
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHN 64
Query: 434 GKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487
AVK + A S +F ++ L+H +IV G C E L+V+
Sbjct: 65 LLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122
Query: 488 EYVGNGNLHDML-----------HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
EY+ +G+L+ L D + L + VA A + YL +
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HF 179
Query: 537 VHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N L+ L + D G++
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-19
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 9/178 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L DL+ N I + P LT L L +N S P +A + +L+ L ++
Sbjct: 239 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 296
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N L NL L L L FNN S P SL+ + L+ NN+V+ ++ +
Sbjct: 297 NQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS-DVSSLAN 351
Query: 223 LP-LTTLNVANNHFSGWIP-RELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNN 278
L + L+ +N S P L I + ++ N P + P + ++
Sbjct: 352 LTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 36/139 (25%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L + N I D P + NL L+L N ++ ++AS+ +L+ L+++
Sbjct: 195 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLAN 252
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ L L L L N S ++ L+ +++L L NQ+ ++ S
Sbjct: 253 NQISNLAP--LSGLTKLTELKLGANQIS-NISP-LAGLTALTNLELNENQLE-DISPISN 307
Query: 223 LP-LTTLNVANNHFSGWIP 240
L LT L + N+ S P
Sbjct: 308 LKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 30/136 (22%), Positives = 57/136 (41%), Gaps = 8/136 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+ L K L ++ DT+ +T+L ++ + + +L+ +N S
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 77
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N LT NL L + ++ N + +L+N++ L L NNQ+T ++
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQIT-DIDPLKN 132
Query: 223 LP-LTTLNVANNHFSG 237
L L L +++N S
Sbjct: 133 LTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 9/136 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L++L +L L N I D P + NL L L+SN S +++ + SL L+
Sbjct: 108 LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG- 164
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T NL L LD+S N S + L+N+ SL NNQ++ +
Sbjct: 165 NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS-DITPLGI 219
Query: 223 LP-LTTLNVANNHFSG 237
L L L++ N
Sbjct: 220 LTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 39/162 (24%), Positives = 61/162 (37%), Gaps = 7/162 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L +L+ N + D P NLT L L NN S P ++S+ L L
Sbjct: 283 LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ NL + L N S DL +L+ I+ L L + T + +
Sbjct: 341 NKVSDV--SSLANLTNINWLSAGHNQIS-DLTP-LANLTRITQLGLNDQAWTNAPVNYKA 396
Query: 223 LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPP 264
++ N N I IS + + N P+
Sbjct: 397 N-VSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTN 437
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 22/128 (17%), Positives = 43/128 (33%), Gaps = 8/128 (6%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
I+ L N + + + ++ L R + G
Sbjct: 9 TQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--V 64
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
L L ++ S N + D+ +L+ + + + NNQ+ + + L LT L + N
Sbjct: 65 EYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFN 121
Query: 233 NHFSGWIP 240
N + P
Sbjct: 122 NQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 10/120 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L++L ++ N I D P +T L L ++ N P + + VS+ +
Sbjct: 349 LANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNV 407
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
+ I + D+++N S + +S + Q + FSG
Sbjct: 408 TGALIAPATI-SDGGSYTEPDITWNLPS--------YTNEVSYTFSQPVTIGKGTTTFSG 458
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 9/90 (10%)
Query: 154 SLSYLNVSRNSLTQSIGDIFG--NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
L ++++ I IF LA L N + + L +++L
Sbjct: 2 PLGSATITQD---TPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL 56
Query: 212 QVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240
+ S++ L LT +N +NN + P
Sbjct: 57 GIK-SIDGVEYLNNLTQINFSNNQLTDITP 85
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 12/150 (8%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG+G G VY E+ A +I A+K + + +Q+ + FL M L HPN++ L
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 474 AGYC-AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G G ++ Y+ +G+L + +N T + L AR +EYL E
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N +LD+ ++D GLA
Sbjct: 145 F---VHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 35/150 (23%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 418 IGEGSLGRVYRAEFA----NGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G G+ G VY+ + KI A+K++ A S + L+ M+ + +P++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C L+ + + G L D + + N+ + + A+ + YL +
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L VHR+ + N+L+ + ++D GLA
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 16/152 (10%)
Query: 418 IGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG G+V + G+++AVK + A + + + + L H +I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG-WKQEIDILRTLYHEHIIK 97
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C + G LV EYV G+L D L ++ + A + YLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + N+LLD++ + D GLA
Sbjct: 153 QHY---IHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 56/244 (22%), Positives = 93/244 (38%), Gaps = 33/244 (13%)
Query: 345 PVSTNNMNTEMHEQRVKSVAAVTDLTPPPAE--------KLVIERVAKSGSLKKIKSPIT 396
P+ + H +R SVAA + +L K+GS
Sbjct: 3 PIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN 62
Query: 397 ATSYTVASLQTATNSFSQEFL-------------IGEGSLGRVYRAEF--ANGKIM--AV 439
+++L Q + IG G G VY +GK + AV
Sbjct: 63 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 440 KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-GQRLLVYEYVGNGNLHDM 498
K + N + E FL M HPN+++L G C G L+V Y+ +G+L +
Sbjct: 123 KSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
+ + + N T + L A+ +++L VHR+ + N +LD++ ++D
Sbjct: 182 IR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVAD 235
Query: 559 CGLA 562
GLA
Sbjct: 236 FGLA 239
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 35/164 (21%), Positives = 62/164 (37%), Gaps = 9/164 (5%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
LS L L L +I+ Y L L ++ + + + ++L+ L
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+++ +LT +L L L+LS+N S + L + + L Q+
Sbjct: 230 SITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSF 256
F GL L LNV+ N + + + ++ T I D N
Sbjct: 290 YAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 27/145 (18%), Positives = 57/145 (39%), Gaps = 7/145 (4%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
+ DL +L+ ++ N + I ++ +L L L N + +++ + L L
Sbjct: 123 MFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVL 181
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ ++ F L L L++S + + + + N++SL + + +T
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPR 241
L L LN++ N S I
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEG 265
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 32/146 (21%), Positives = 53/146 (36%), Gaps = 6/146 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
++L +LR L N + IP + NLT L+++ N L Y + +L L
Sbjct: 76 FNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLN 218
V N L F L L L L N + + L + L L++ +
Sbjct: 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 219 VFSGLP-LTTLNVANNHFSGWIPREL 243
F L L L +++ + +
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNC 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 42/185 (22%), Positives = 66/185 (35%), Gaps = 13/185 (7%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137
C ++ + ++ L DL N I + P+L L L
Sbjct: 9 CSAQDR-AVLCHRKRFVAVPEGIPTETRLL---DLGKNRIKTLNQDEFASFPHLEELELN 64
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
N S P + ++ +L L + N L +F L+ L LD+S N L F
Sbjct: 65 ENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMF 124
Query: 198 ISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIY 251
L N+ SL + +N + S FSGL L L + + + IP E L +
Sbjct: 125 QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRL 183
Query: 252 DGNSF 256
+
Sbjct: 184 RHLNI 188
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 28/129 (21%), Positives = 50/129 (38%), Gaps = 4/129 (3%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
++IS TM L+L ++ ++ +PY L LNL+ N S
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST 262
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNI 203
+ ++ L + + L F L L L++S N + + F S+ N+
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322
Query: 204 SSLYLQNNQ 212
+L L +N
Sbjct: 323 ETLILDSNP 331
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 31/115 (26%), Positives = 47/115 (40%), Gaps = 4/115 (3%)
Query: 79 ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLN 135
G + S+ I+ L+ + L+ LR +LS N I TI + L +
Sbjct: 220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQ 278
Query: 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS 190
L + PY+ + L LNVS N LT +F ++ L TL L N +
Sbjct: 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 37/151 (24%), Positives = 63/151 (41%), Gaps = 11/151 (7%)
Query: 415 EFLIGEGSLGRVYRAEF--ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+ +G G+ G V + + +I A+K + E+ + M +L +P IV
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIV 73
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C +LV E G G LH L + + + + + ++YL E
Sbjct: 74 RLIGVCQAE-ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N+LL + +SD GL+
Sbjct: 130 NF---VHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
+G+G+ G+VY+A G + A K I+ +EE ++++ + ++ HP IV L G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
H +L ++ E+ G + ++ D + LT V AL +LH
Sbjct: 84 -AYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-NTERQVITGT 576
++HR+ K+ N+L+ E + L+D G++A +R GT
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 13/150 (8%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G G G V++ + + KI +K I++ + + + + + L H +IV
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAIGSLDHAHIVR 79
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C LV +Y+ G+L D + L + + A+ + YL E
Sbjct: 80 LLGLCPGS-SLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ VHRN + N+LL ++D G+A
Sbjct: 136 M---VHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 22/167 (13%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
IG+GS G V++ + K++A+K ID L+E ++ +E + +S+ P +
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 473 LAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G +L ++ EY+G G+ D+L L + + L+YLH
Sbjct: 85 YYG-SYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE 138
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPN-TERQVITGT 576
+HR+ K+AN+LL + L+D G+A LT +R GT
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 182
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 24/164 (14%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+GE G+VY+ G A+K + + A + F +RL+HPN+
Sbjct: 17 LGEDRFGKVYKGH-LFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNV 74
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARVRVA 518
V L G + +++ Y +G+LH+ L L V +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 519 LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A +EYL VVH++ + N+L+ D+LN +SD GL
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 22/163 (13%)
Query: 417 LIGEGSLGRVYRAEFANGKIM---AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHPNIV 471
+IGEG+ G+V +A + A+K++ + A S + +F + + +L HPNI+
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNII 89
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARVRVAL 519
L G C G L EY +GNL D L A+ ++ L+ + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
AR ++YL + +HR+ + NIL+ + ++D GL+
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 8e-19
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 15/161 (9%)
Query: 418 IGEG--SLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG+G L V A G+ + V++I+ A S + + HPNIV
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY- 91
Query: 475 GYCA-EHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARV-RVALGTARALEYLHEV 531
L +V ++ G+ D++ N A + + L +AL+Y+H +
Sbjct: 92 -RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHM 147
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQ 571
VHR+ K+++IL+ + +LS + + +RQ
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ 185
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 9e-19
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 14/166 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLP-YSIASMVSLSY 157
L LR+ L N I +IP P+L L+L + + + +L Y
Sbjct: 142 AFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY 200
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
LN+ ++ + + L GL L++S N+F P SF LS++ L++ N+QV+
Sbjct: 201 LNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258
Query: 217 LNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
N F GL L LN+A+N+ S +P + L + N ++
Sbjct: 259 RNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 30/139 (21%), Positives = 46/139 (33%), Gaps = 7/139 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L L L NSI I +L +L L N + + + L L
Sbjct: 95 FRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLN 218
+ N + F + L LDL + +F L N+ L L + +
Sbjct: 154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP 212
Query: 219 VFSGLP-LTTLNVANNHFS 236
+ L L L ++ NHF
Sbjct: 213 NLTPLVGLEELEMSGNHFP 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 9/139 (6%)
Query: 101 YLLSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS 156
Y + + SL + DL I + L NL LNL N ++P ++ +V L
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLF-NLKYLNLGMCNIK-DMP-NLTPLVGLE 221
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L +S N + F L+ L L + + S N+F L+++ L L +N ++
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSL 281
Query: 216 SLNVFSGLP-LTTLNVANN 233
++F+ L L L++ +N
Sbjct: 282 PHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 34/128 (26%), Positives = 53/128 (41%), Gaps = 3/128 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
K + + +P +P N LNL NN + + L L + RNS+ Q
Sbjct: 55 QFSKVVCTRRGL-SEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ 113
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-L 225
F LA L TL+L N + +F LS + L+L+NN + F+ +P L
Sbjct: 114 IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSL 173
Query: 226 TTLNVANN 233
L++
Sbjct: 174 MRLDLGEL 181
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 32/142 (22%), Positives = 61/142 (42%), Gaps = 8/142 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+++L L L+ N I D P +L N + ++ +A+M L+ L +
Sbjct: 173 IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQIT-DIT-PVANMTRLNSLKIGN 230
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T NL+ L L++ N S N+ L+ + L + +NQ++ ++V +
Sbjct: 231 NKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS-DISVLNN 285
Query: 223 LP-LTTLNVANNHFSGWIPREL 243
L L +L + NN +
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVI 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 31/135 (22%), Positives = 61/135 (45%), Gaps = 6/135 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++++ L + N I D P LT L + +N S ++ ++ + L LNV
Sbjct: 217 VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGS 274
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ I + NL+ L +L L+ N + L+N+++L+L N +T + +
Sbjct: 275 NQIS-DI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DIRPLAS 331
Query: 223 LP-LTTLNVANNHFS 236
L + + + AN
Sbjct: 332 LSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 28/159 (17%), Positives = 63/159 (39%), Gaps = 25/159 (15%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS-----GNLPY---------- 147
+L S+ K ++G + + NL LNL N + NL
Sbjct: 40 QEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNK 99
Query: 148 -----SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
++ ++ +L L ++ ++++ NL + +L+L N+ DL +++
Sbjct: 100 ITDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTG 156
Query: 203 ISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240
++ L + ++V + + L L +L++ N P
Sbjct: 157 LNYLTVTESKVK-DVTPIANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L SL F N I D P L SL + +N + +L +A++ L++L +
Sbjct: 195 LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKIT-DLS-PLANLSQLTWLEIGT 252
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-LNVFS 221
N ++ I + +L L L++ N S D+ +LS ++SL+L NNQ+ + V
Sbjct: 253 NQIS-DI-NAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIG 308
Query: 222 GLP-LTTLNVANNHFSGWIP-RELISIRTFIYDGN 254
GL LTTL ++ NH + P L + + +
Sbjct: 309 GLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 30/139 (21%), Positives = 63/139 (45%), Gaps = 8/139 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+DL + L S+ D + + ++T L +A + ++ I + +L YLN++
Sbjct: 18 DADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNG 75
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T NL L L + N + ++ +L+N+ LYL + ++ ++ +
Sbjct: 76 NQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNIS-DISPLAN 130
Query: 223 LP-LTTLNVANNHFSGWIP 240
L + +LN+ NH +
Sbjct: 131 LTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 24/130 (18%), Positives = 49/130 (37%), Gaps = 8/130 (6%)
Query: 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
I+ P L + + + + S++ L V+ + S
Sbjct: 2 AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-S 58
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTT 227
I I L L L+L+ N + D+ +L +++LY+ N++T ++ L L
Sbjct: 59 IQGI-EYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKIT-DISALQNLTNLRE 114
Query: 228 LNVANNHFSG 237
L + ++ S
Sbjct: 115 LYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 4e-05
Identities = 14/67 (20%), Positives = 31/67 (46%), Gaps = 4/67 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
L++L L L+ N + + + NLT+L L+ N+ + P +AS+ + +
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
Query: 161 SRNSLTQ 167
+ + +
Sbjct: 341 ANQVIKK 347
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 36/166 (21%), Positives = 64/166 (38%), Gaps = 18/166 (10%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV---- 471
+G G G V+ A+ + A+K+I L E E V +++L HP IV
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE-VKALAKLEHPGIVRYFN 70
Query: 472 -----TLAGYCAEHGQRLLVY---EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
++ +Y + NL D ++ + + + + + L A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHIFLQIAE 129
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
A+E+LH ++HR+ K +NI + + D GL E
Sbjct: 130 AVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 1e-18
Identities = 51/243 (20%), Positives = 90/243 (37%), Gaps = 14/243 (5%)
Query: 326 CIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKS 385
C+++ S + +S + P + +T H QR TP PA ++
Sbjct: 249 CLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPM 308
Query: 386 GSLKKIKSPITATSYTVASLQTA---TNSFSQEFLIGEGSLGRVYRAEF--ANGKIM-AV 439
+ + + + N + +G G+ G V + + +I A+
Sbjct: 309 PMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 440 KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML 499
K + E+ + M +L +P IV L G C +LV E G G LH L
Sbjct: 369 KVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL 426
Query: 500 HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559
+ + + + + ++YL E VHRN + N+LL + +SD
Sbjct: 427 V---GKREEIPVSNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDF 480
Query: 560 GLA 562
GL+
Sbjct: 481 GLS 483
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 25/191 (13%), Positives = 43/191 (22%), Gaps = 36/191 (18%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+ G V+ + + A+K A S E + EA +RL +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 475 GYC--------------------------AEHGQRLLVYEYVGNGNLHDMLHFADDSSKN 508
LL+ +L + D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 509 ---LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565
A + R L +VH +F N+ + + L D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW-K 243
Query: 566 PNTERQVITGT 576
T +
Sbjct: 244 VGTRGPASSVP 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 40/158 (25%), Positives = 62/158 (39%), Gaps = 18/158 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ G VY + +G AVK + S Q+E +FL +S+ H NI
Sbjct: 38 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA---DDSSKNLTWNARVRVALGTARALEY 527
V G + R ++ E + G+L L +L + VA A +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHL---SDCGLA 562
L E +HR+ + N LL + D G+A
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 46/209 (22%)
Query: 389 KKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL 447
+ I Y + QE +IG G+ V A + +A+K+I+
Sbjct: 6 SALPWSINRDDYEL-----------QE-VIGSGATAVVQAAYCAPKKEKVAIKRIN---- 49
Query: 448 SLQEEDNFLEAVSN----MSRLRHPNIVTLAGYCA-EHGQRL-LVYEYVGNGNLHDMLHF 501
L++ ++ + MS+ HPNIV+ Y + L LV + + G++ D++
Sbjct: 50 -LEKCQTSMDELLKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSVLDIIKH 106
Query: 502 ADDSSKNLTWNAR-------VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554
++ + +R L LEYLH+ +HR+ K+ NILL ++ +
Sbjct: 107 IVAKGEHKSGVLDESTIATILREVL---EGLEYLHKN---GQIHRDVKAGNILLGEDGSV 160
Query: 555 HLSDCGLAA-------LTPNTERQVITGT 576
++D G++A +T N R+ GT
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGT 189
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 9/145 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G G V+ + +A+K + +S + FL+ M +LRH +V L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 331
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+E +V EY+ G+L D L ++ K L V +A A + Y+ + + V
Sbjct: 332 SEE-PIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 538 HRNFKSANILLDDELNPHLSDCGLA 562
HR+ ++ANIL+ + L ++D GLA
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLA 410
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 36/205 (17%), Positives = 72/205 (35%), Gaps = 6/205 (2%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
+S + L+ +++ + D S NSI + + + LT L L NN + + + +
Sbjct: 191 ANVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPVNVELTILKLQHNNLT-DTA-WLLNY 247
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L +++S N L + + F + L L +S N L + + L L +N
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 213 VTG-SLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPP 271
+ N L L + +N +++ N +D + A P
Sbjct: 307 LLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARP 366
Query: 272 SGRSHNNRSHRQGSHSPSGSQSSSS 296
+ ++ + G S
Sbjct: 367 AV-DDADQHCKIDYQLEHGLCCKES 390
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA----------- 150
SL+ LS N + + L P+L N++ N S L IA
Sbjct: 160 TFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSI 217
Query: 151 ------SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
V L+ L + N+LT + N GL +DLS+N + + F+ + +
Sbjct: 218 NVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 275
Query: 205 SLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPREL 243
LY+ NN++ +P L L++++NH + R
Sbjct: 276 RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 7/139 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
LL + +L+ I I + + L + N P+ ++ L+ L
Sbjct: 64 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ RN L+ IF N L TL +S NN ++F + +++ +L L +N++T L
Sbjct: 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL 182
Query: 218 NVFSGLPLTTLNVANNHFS 236
++ L NV+ N S
Sbjct: 183 SLIPS--LFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 27/154 (17%), Positives = 56/154 (36%), Gaps = 6/154 (3%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGN 144
+ I G+ L + + +++ +P L + LNL
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVELLNLNDLQIEEI 84
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
Y+ A ++ L + N++ +F N+ L L L N+ S F + ++
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
+L + NN + + F L L +++N +
Sbjct: 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 22/130 (16%), Positives = 50/130 (38%), Gaps = 6/130 (4%)
Query: 113 DLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
D+ + + + N + ++ + S + LN++ + +
Sbjct: 25 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI 84
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LT 226
F + L + FN P+ F ++ ++ L L+ N ++ +F P LT
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 227 TLNVANNHFS 236
TL+++NN+
Sbjct: 145 TLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 31/140 (22%), Positives = 60/140 (42%), Gaps = 14/140 (10%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+ +++K + N+I +P + P LT L L N+ S +LP I + L+
Sbjct: 88 AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT 145
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
L++S N+L + D F L L LS N + + S + ++ + N L
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNL----L 198
Query: 218 NVFSGLP-LTTLNVANNHFS 236
+ + + L+ ++N +
Sbjct: 199 STLAIPIAVEELDASHNSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 12/86 (13%), Positives = 24/86 (27%), Gaps = 4/86 (4%)
Query: 155 LSYLNVSRNSLTQSIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ +V + TQ + F L + + S + L L + Q
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80
Query: 213 VTG-SLNVFSGLP-LTTLNVANNHFS 236
+ F+ + L + N
Sbjct: 81 IEEIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 49/162 (30%), Positives = 72/162 (44%), Gaps = 13/162 (8%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAG 475
IG GS G VY A + N +++A+KK+ + E+ + V + +LRHPN + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
C LV EY G+ D+L K L V G + L YLH
Sbjct: 122 -CYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH--- 173
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
+++HR+ K+ NILL + L D G A++ GT
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--APANSFVGT 213
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-18
Identities = 28/154 (18%), Positives = 58/154 (37%), Gaps = 6/154 (3%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIH----DTIPYQLPPNLTSLNLASNNFSGN 144
+S + + L + ++I +T ++ L+L+
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL 281
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
++ L LN++ N + + + F L L L+LS+N ++F L ++
Sbjct: 282 NSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
+ LQ N + F L L TL++ +N +
Sbjct: 342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 9e-18
Identities = 37/155 (23%), Positives = 58/155 (37%), Gaps = 12/155 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L+ +L TI L PNL L+L S+ P + + L L
Sbjct: 44 FPFLEQLQLLELGSQYTPLTIDKEAFRNL-PNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102
Query: 159 NVSRNSLTQSI--GDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVT- 214
+ L+ ++ F NL L LDLS N L SF L+++ S+ +NQ+
Sbjct: 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162
Query: 215 ---GSLNVFSGLPLTTLNVANNHFSGWIPRELISI 246
L G L+ ++A N + +
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 31/156 (19%), Positives = 54/156 (34%), Gaps = 12/156 (7%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNL- 145
L+ + L + + LS N I P L L L S +
Sbjct: 10 FYRFCNLT----QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL--PNSFISLSNI 203
+ ++ +L L++ + + D F L L L L F S + F +L +
Sbjct: 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125
Query: 204 SSLYLQNNQVT--GSLNVFSGLP-LTTLNVANNHFS 236
+ L L NQ+ F L L +++ ++N
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 9e-17
Identities = 47/252 (18%), Positives = 79/252 (31%), Gaps = 22/252 (8%)
Query: 87 SIDISGLGLSG-TMGYLLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFS 142
I +S L + Y L + L+ L+ N P+L L L N
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 143 GNLPYSI-----ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
+ + L L ++ N L +F +L L L L+ N + N
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL 524
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
+N+ L + NQ+ + N + L+ L++ +N F + TFI + +
Sbjct: 525 --PANLEILDISRNQLL-APNPDVFVSLSVLDITHNKFI-----CECELSTFI-NWLNHT 575
Query: 258 NGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVFLVA 317
N PP S + S S S + + IV +
Sbjct: 576 NVTIAGPPADIYCVYPDSFSGVSLF----SLSTEGCDEEEVLKSLKFSLFIVCTVTLTLF 631
Query: 318 LALLALYFCIRK 329
L + R
Sbjct: 632 LMTILTVTKFRG 643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-16
Identities = 31/159 (19%), Positives = 59/159 (37%), Gaps = 17/159 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNL--PYSIASMVSLSY 157
+L +LR DL + I+ + +L L L S + ++ +L+
Sbjct: 69 FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
Query: 158 LNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS--SLYLQNNQVT 214
L++S+N + + FG L L ++D S N + L + L N +
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
Query: 215 --------GSLNVFSGLPLTTLNVANNHFSGWIPRELIS 245
+N F + L L+V+ N ++ I +
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 42/210 (20%), Positives = 73/210 (34%), Gaps = 24/210 (11%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140
S+V +D+S + + L L+ +L+ N I+ NL LNL+ N
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLP---- 194
+ + ++Y+++ +N + F L L TLDL N + +P
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPD 385
Query: 195 -----NSFISLSNIS----SLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSG----W 238
N ++L I+ ++L N++ L +P L L + N FS
Sbjct: 386 IFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQ 445
Query: 239 IPRELISIRTFIYDGNSFDNGPAPPPPPST 268
P E S+ N
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDV 475
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 34/179 (18%), Positives = 67/179 (37%), Gaps = 29/179 (16%)
Query: 87 SIDISGLGLSGTM--GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSL---NLASNNF 141
+ + GLS + +L +L + DLS N I + L SL + +SN
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 142 SGNLPYSIAS--MVSLSYLNVSRNSLTQSIGDIFGNLAG------LATLDLSFNNFSGDL 193
+ + +LS+ +++ NSL + +G L LD+S N ++ D+
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
Query: 194 PNSFIS------------LSNISSLYLQNNQVTG-SLNVFSGLP---LTTLNVANNHFS 236
+F + +I + + N F+GL + L++++
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 28/150 (18%), Positives = 48/150 (32%), Gaps = 18/150 (12%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSG-NLPYSIASMVSLS 156
L L + L + D + LT L+L+ N L S + SL
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151
Query: 157 YLNVSRNSLTQSIGDIFGNLAG--LATLDLSFNNFSGDLPNSFISLSN------ISSLYL 208
++ S N + L G L+ L+ N+ + + N + L +
Sbjct: 152 SIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV 211
Query: 209 QNNQVTG-----SLNVFSGLPLTTLNVANN 233
N T N S +L +A++
Sbjct: 212 SGNGWTVDITGNFSNAISKSQAFSLILAHH 241
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 19/87 (21%), Positives = 30/87 (34%), Gaps = 7/87 (8%)
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+LTQ + L L LSFN +SF L + L L +
Sbjct: 4 FDGRIAFYRFCNLTQ----VPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQY 59
Query: 213 VTGSL--NVFSGLP-LTTLNVANNHFS 236
++ F LP L L++ ++
Sbjct: 60 TPLTIDKEAFRNLPNLRILDLGSSKIY 86
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 42/149 (28%), Positives = 60/149 (40%), Gaps = 12/149 (8%)
Query: 418 IGEGSLGRVYRAEFANGKIM----AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+GEG G VY + N K AVK +L ++ F+ M L HP+IV L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G E ++ E G L L + +L V +L +A+ YL +
Sbjct: 79 IGIIEEE-PTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ NIL+ L D GL+
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 38/152 (25%), Positives = 66/152 (43%), Gaps = 15/152 (9%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+G+ G V + N + AVK++ ++ Q + F + + L IV
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD--FQREIQILKALHSDFIVK 88
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G G++ LV EY+ +G L D L L + + + + +EYL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + NIL++ E + ++D GLA
Sbjct: 146 RRC---VHRDLAARNILVESEAHVKIADFGLA 174
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 14/165 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLP-YSIASMVSLSYL 158
L L++ L N I +IP P+L L+L + + + +L YL
Sbjct: 132 FVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
N++ +L I + L L LDLS N+ S P SF L ++ L++ +Q+
Sbjct: 191 NLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER 248
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
N F L L +N+A+N+ + +P + L + N ++
Sbjct: 249 NAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 34/145 (23%), Positives = 50/145 (34%), Gaps = 8/145 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L L LS N I TI NL +L L N + + + L L
Sbjct: 84 FKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLN 218
+ N + F + L LDL + +F LSN+ L L + +
Sbjct: 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201
Query: 219 VFSGLP-LTTLNVANNHFSGWIPRE 242
+ L L L+++ NH S I
Sbjct: 202 NLTPLIKLDELDLSGNHLS-AIRPG 225
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 9/139 (6%)
Query: 101 YLLSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS 156
Y + + SLR+ DL I + L NL LNLA N +P ++ ++ L
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLS-NLRYLNLAMCNLR-EIP-NLTPLIKLD 210
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L++S N L+ F L L L + + N+F +L ++ + L +N +T
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL 270
Query: 216 SLNVFSGLP-LTTLNVANN 233
++F+ L L +++ +N
Sbjct: 271 PHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 32/128 (25%), Positives = 51/128 (39%), Gaps = 3/128 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
K ++ +P + N LNL N S + L L +SRN +
Sbjct: 44 QFSKVICVRKNL-REVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT 102
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-L 225
F LA L TL+L N + +F+ LS + L+L+NN + F+ +P L
Sbjct: 103 IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSL 162
Query: 226 TTLNVANN 233
L++
Sbjct: 163 RRLDLGEL 170
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 34/149 (22%), Positives = 55/149 (36%), Gaps = 10/149 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L +L +L N + TIP L L L +N Y+ + SL L+
Sbjct: 108 FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166
Query: 160 VSR-NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ L+ F L+ L L+L+ N ++P + L + L L N ++
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRP 224
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRELIS 245
F GL L L + + I R
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQ-VIERNAFD 252
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 23/92 (25%), Positives = 42/92 (45%), Gaps = 2/92 (2%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
L+ L+ L + DLSGN + P +L L + + + ++ SL +N+
Sbjct: 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD 192
+ N+LT D+F L L + L N ++ +
Sbjct: 263 AHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 39/149 (26%), Positives = 60/149 (40%), Gaps = 12/149 (8%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IGEG G V++ + N + A+K S + FL+ M + HP+IV L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G E+ ++ E G L L +L + + A + AL YL
Sbjct: 82 IGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N+L+ L D GL+
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 12/150 (8%)
Query: 418 IGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVT 472
+G+GS G V R E+ +GK + AVK + LS E D+F+ V+ M L H N++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G +V E G+L D L + R A+ A + YL
Sbjct: 86 LYGVVLTP-PMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+HR+ + N+LL + D GL
Sbjct: 142 F---IHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 47/201 (23%), Positives = 77/201 (38%), Gaps = 30/201 (14%)
Query: 387 SLKKIKSPITATSY---TVASLQTATNSFSQEF---------LIGEGSLGRVYRAEFANG 434
L K+++ T Y + +T++ S +E +G G+ G VY + +G
Sbjct: 36 KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQ-VSG 94
Query: 435 KIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487
AVK + S Q+E +FL +S+ H NIV G + R ++
Sbjct: 95 MPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 153
Query: 488 EYVGNGNLHDMLH---FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544
E + G+L L +L + VA A +YL E +HR+ +
Sbjct: 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAAR 210
Query: 545 NILLDDELNPHL---SDCGLA 562
N LL + D G+A
Sbjct: 211 NCLLTCPGPGRVAKIGDFGMA 231
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 11/149 (7%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G G G V + +I A+K + + ++ +FL S M + HPNI+ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + ++V EY+ NG+L L T V + G A ++YL ++
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + NIL++ L +SD GL
Sbjct: 167 -GYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 12/150 (8%)
Query: 418 IGEGSLGRVYRAEFANGKIM-----AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
IG G G VY+ A+K + A + ++ +FL M + H NI+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G +++ +++ EY+ NG L L + + V + G A ++YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + NIL++ L +SD GL+
Sbjct: 168 Y---VHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 27/201 (13%), Positives = 58/201 (28%), Gaps = 26/201 (12%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L S+ + N+I + ++ LA+N + + YL++
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 163 NSLTQ-SIGDIFGNLAGLATLDLSFNNFSG---------------------DLPNSFISL 200
N + + ++ + L L+L +N + F S
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSA 213
Query: 201 SNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIY--DGNSFD 257
+ ++ + L+NN++ L ++ N F R+ S + +
Sbjct: 214 AGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
Query: 258 NGPAPPPPPSTAPPSGRSHNN 278
T P G
Sbjct: 274 KLTGQNEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 31/143 (21%), Positives = 59/143 (41%), Gaps = 10/143 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L +LR DL+ N + + + P++ +L+ A+NN S + S + ++
Sbjct: 76 LESLSTLRTLDLNNNYVQ-ELL--VGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLAN 129
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N +T G + + LDL N + S + L LQ N + +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
Query: 222 GLP-LTTLNVANNHFSGWIPREL 243
L TL++++N + ++ E
Sbjct: 189 VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 31/147 (21%), Positives = 58/147 (39%), Gaps = 13/147 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ + + ++ +S+ + N+ L+L+ N S +A L LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLN 218
+S N L D +L+ L TLDL+ N +L +I +L+ NN ++ S +
Sbjct: 65 LSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNISRVSCS 117
Query: 219 VFSGLPLTTLNVANNHFSGWIPRELIS 245
G + +ANN + +
Sbjct: 118 RGQG--KKNIYLANNKITM-LRDLDEG 141
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 31/152 (20%), Positives = 58/152 (38%), Gaps = 14/152 (9%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146
++ L + L ++++ DLSGN + L L LNL+SN
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL 74
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
+ S+ +L L+++ N + + + TL + NN S + S ++
Sbjct: 75 -DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-RVSCS--RGQGKKNI 125
Query: 207 YLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
YL NN++T + L++ N
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 26/127 (20%), Positives = 49/127 (38%), Gaps = 4/127 (3%)
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L + +L +L N I+D + L +L+L+SN + + S +++++
Sbjct: 162 AELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD-LPNSFISLSNISSLYLQNNQ-VTGSL 217
+ N L I L DL N F L + F + ++ Q + +TG
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 218 NVFSGLP 224
+P
Sbjct: 280 EEECTVP 286
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 29/120 (24%), Positives = 47/120 (39%), Gaps = 9/120 (7%)
Query: 118 SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
+IH+ Q + ++ L S ++ L++S N L+Q
Sbjct: 1 AIHEIK--QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFT 58
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS 236
L L+LS N + SLS + +L L NN + P + TL+ ANN+ S
Sbjct: 59 KLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNIS 112
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 29/168 (17%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHP 468
+G G+ G+V A A G I AVK + +A L E + + + +S L H
Sbjct: 31 LGAGAFGKVVEAT-AYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHM 87
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--------------HFADDSSKNLTWNAR 514
NIV L G C G L++ EY G+L + L +D L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ + A+ + +L + +HR+ + NILL + D GLA
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 14/166 (8%)
Query: 103 LSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+ L L + DLS N S+ + L L +L+L L + + +L Y
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGL-GRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
L + N+L D F +L L L L N S +F L ++ L L N+V
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 217 LNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
+ F L L TL + N+ S +P E L +++ + N +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 30/128 (23%), Positives = 48/128 (37%), Gaps = 6/128 (4%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
+ +P +P + L N S S + +L+ L + N L +
Sbjct: 17 SCPQQGL-QAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 173 FGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTL 228
F LA L LDLS N + +F L + +L+L + L +F GL L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 229 NVANNHFS 236
+ +N
Sbjct: 135 YLQDNALQ 142
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 32/141 (22%), Positives = 54/141 (38%), Gaps = 9/141 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+L L N + I L L L+L+ N ++ + + L
Sbjct: 52 FRACRNLTILWLHSNVLA-RIDAAAFTGL-ALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
L++ R L + +F LA L L L N ++F L N++ L+L N+++
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169
Query: 217 LNVFSGLP-LTTLNVANNHFS 236
F GL L L + N +
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVA 190
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 30/113 (26%), Positives = 44/113 (38%), Gaps = 4/113 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L +L+ L N++ +P NLT L L N S + + SL L
Sbjct: 124 LFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ +N + F +L L TL L NN S + L + L L +N
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 8e-18
Identities = 37/210 (17%), Positives = 73/210 (34%), Gaps = 6/210 (2%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
+S + L+ +++ + D S NSI+ + + LT L L NN + + + +
Sbjct: 197 ANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLT-DTA-WLLNY 253
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L +++S N L + + F + L L +S N L + + L L +N
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 213 VTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPP 271
+ L L + +N +++ N +D + A P
Sbjct: 313 LLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARP 372
Query: 272 SGRSHNNRSHRQGSHSPSGSQSSSSDKELP 301
+ ++ + G SDK
Sbjct: 373 AV-DDADQHCKIDYQLEHGLCCKESDKPYL 401
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 5e-16
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA----------- 150
SL+ LS N + + L P+L N++ N S L IA
Sbjct: 166 TFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSI 223
Query: 151 ------SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
V L+ L + N+LT + N GL +DLS+N + + F+ + +
Sbjct: 224 NVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281
Query: 205 SLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPREL 243
LY+ NN++ +P L L++++NH + R
Sbjct: 282 RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 320
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 2e-15
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 7/139 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
LL + +L+ I I + + L + N P+ ++ L+ L
Sbjct: 70 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ RN L+ IF N L TL +S NN ++F + +++ +L L +N++T L
Sbjct: 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL 188
Query: 218 NVFSGLPLTTLNVANNHFS 236
++ L NV+ N S
Sbjct: 189 SLIPS--LFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 30/181 (16%), Positives = 61/181 (33%), Gaps = 6/181 (3%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGN 144
+ I G+ L + + +++ +P L + LNL
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
Y+ A ++ L + N++ +F N+ L L L N+ S F + ++
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAP 262
+L + NN + + F L L +++N + + S+ N P
Sbjct: 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIP 210
Query: 263 P 263
Sbjct: 211 I 211
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 22/130 (16%), Positives = 50/130 (38%), Gaps = 6/130 (4%)
Query: 113 DLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
D+ + + + N + ++ + S + LN++ + +
Sbjct: 31 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LT 226
F + L + FN P+ F ++ ++ L L+ N ++ +F P LT
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 227 TLNVANNHFS 236
TL+++NN+
Sbjct: 151 TLSMSNNNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 31/139 (22%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSI-ASMVSLSYL 158
+ +++K + N+I +P + P LT L L N+ S +LP I + L+ L
Sbjct: 95 FAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 152
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN 218
++S N+L + D F L L LS N + + S + ++ + N L+
Sbjct: 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNL----LS 205
Query: 219 VFSGLP-LTTLNVANNHFS 236
+ + L+ ++N +
Sbjct: 206 TLAIPIAVEELDASHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 28/197 (14%), Positives = 58/197 (29%), Gaps = 18/197 (9%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L + +S N + + P L L+L+ N+ ++ + L L
Sbjct: 273 PFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+ NS+ ++ L L LS N++ + + N++ + + +
Sbjct: 331 LDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA----DQHC 381
Query: 220 FSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNR 279
L ++ R L I S +A + S +
Sbjct: 382 KIDYQLEHGLCCKESDKPYLDRLLQYIAL-----TSVVEKVQRAQGRCSATDTINSVQSL 436
Query: 280 SHRQGSHSPSGSQSSSS 296
SH Q +
Sbjct: 437 SHYITQQGGVPLQGNEQ 453
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 14/110 (12%), Positives = 27/110 (24%), Gaps = 8/110 (7%)
Query: 135 NLASNNFSGNLPYSIASMVSLSYLNVSRN-SLTQSIGDIFG-----NLAGLATLDLSFNN 188
N P +L Y V + + D++ L + +
Sbjct: 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 189 FSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
S + L L + Q+ F+ + L + N
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 112
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 13/168 (7%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+G+ V+R G + A+K +N + + D + + +L H NIV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 476 YCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
E R L+ E+ G+L+ +L ++ L + + V + +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 534 PSVVHRNFKSANILLDDELNPH----LSDCGLAA-LTPNTERQVITGT 576
+VHRN K NI+ + L+D G A L + + + GT
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT 178
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 29/168 (17%)
Query: 418 IGEGSLGRVYRAEFANGKIM---------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-R 466
+GEG+ G+V AE A G AVK + D+A + ++ + + + M + +
Sbjct: 43 LGEGAFGQVVMAE-AVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGK 99
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNAR 514
H NI+ L G C + G ++ EY GNL + L + +T+
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V AR +EYL +HR+ + N+L+ + ++D GLA
Sbjct: 160 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 4/136 (2%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S +IP L + SL+L+ N + + + +L L + + + GD
Sbjct: 11 DGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLN 229
F +L L LDLS N+ S + F LS++ L L N G ++F L L TL
Sbjct: 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129
Query: 230 VANNHFSGWIPRELIS 245
+ N I R +
Sbjct: 130 IGNVETFSEIRRIDFA 145
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 11/165 (6%)
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135
++C+ S V D + L + + SL DLS N I L NL L
Sbjct: 2 LSCDASGVC--DGRSRSFTSIPSGLTAAMKSL---DLSFNKITYIGHGDLRACANLQVLI 56
Query: 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLP 194
L S+ + + S+ SL +L++S N L+ FG L+ L L+L N + +
Sbjct: 57 LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 195 NSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
+ F +L+N+ +L + N + + F+GL L L +
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 34/196 (17%), Positives = 66/196 (33%), Gaps = 13/196 (6%)
Query: 103 LSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L +L+ L + +I Y L +L L+L+ N+ S + SL YLN
Sbjct: 46 LRACANLQVLILKSSRINTIEGDAFYSL-GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104
Query: 160 VSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTG-S 216
+ N + +F NL L TL + ++ F L++++ L ++ +
Sbjct: 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164
Query: 217 LNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDNGPAPPPPPSTAPP 271
+ + L + + + ++ L S+R + P P
Sbjct: 165 SQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223
Query: 272 SGRSHNNRSHRQGSHS 287
+ R S
Sbjct: 224 PMKKLAFRGSVLTDES 239
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 14/141 (9%)
Query: 99 MGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLS 156
G +L L +L D+S N+ H +P P + LNL+S + I +L
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLE 434
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L+VS N+L L L L +S N LP++ + + + + NQ+
Sbjct: 435 VLDVSNNNLD----SFSLFLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSV 488
Query: 216 SLNVFSGLP-LTTLNVANNHF 235
+F L L + + N +
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 38/165 (23%), Positives = 63/165 (38%), Gaps = 19/165 (11%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSY 157
SL+ LS N + NLTSL+++ N F +P S + +
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
LN+S + I L LD+S NN + + L + LY+ N++ +L
Sbjct: 415 LNLSSTGIRVVKTCIPQT---LEVLDVSNNNLD----SFSLFLPRLQELYISRNKLK-TL 466
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
S P L + ++ N +P L S++ N +D
Sbjct: 467 PDASLFPVLLVMKISRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 25/139 (17%), Positives = 47/139 (33%), Gaps = 6/139 (4%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSL---NLASNNFSGNLPY-SIASMVSLSY 157
L SL+ +L GN L PNLT+L + + + A + SL+
Sbjct: 93 WFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
L + SL ++ + L L + + L LS++ L L++ +
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212
Query: 217 LNVFSGLP-LTTLNVANNH 234
+ + +
Sbjct: 213 FSPLPVDEVSSPMKKLAFR 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 23/138 (16%), Positives = 50/138 (36%), Gaps = 7/138 (5%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
L L F+ S + + + + L++ +L + + + + V + +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDL---PNSFISLSNISSLYLQNNQVT---GSLNV 219
+L L LDLS N + + ++ +L L N + + +
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 220 FSGLP-LTTLNVANNHFS 236
L LT+L+++ N F
Sbjct: 383 LLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 19/143 (13%), Positives = 44/143 (30%), Gaps = 7/143 (4%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L +L +L+ + I +L L + + + S+ S+ + +L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT---- 214
+ + + L+ + L+L N + + S + + +
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237
Query: 215 GSLNVFSGLPLTTLNVANNHFSG 237
S N L L ++ F
Sbjct: 238 ESFNELLKLLRYILELSEVEFDD 260
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 27/199 (13%), Positives = 62/199 (31%), Gaps = 28/199 (14%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGN--- 144
+ + + + L S+R +L ++ LP + S + F G+
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 145 ---------LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT--------LDLSFN 187
L I + + + + + N L ++ L L +
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 188 NFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRE--- 242
DL + L + + ++N++V + L L L+++ N +
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 243 ---LISIRTFIYDGNSFDN 258
S++T + N +
Sbjct: 357 KGAWPSLQTLVLSQNHLRS 375
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 23/87 (26%), Positives = 35/87 (40%), Gaps = 4/87 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
+L D+S N++ D+ LP L L ++ N LP + L + +SRN L
Sbjct: 430 PQTLEVLDVSNNNL-DSFSLFLP-RLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQL 485
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGD 192
IF L L + L N +
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 26/158 (16%), Positives = 49/158 (31%), Gaps = 8/158 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
+ L SL + ++ S+ + L ++ L L + + L + S+ YL +
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
+L + + + S SF L + L+ ++V F
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE-----F 258
Query: 221 SGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDN 258
L L N S + EL + T
Sbjct: 259 DDCTLNGLGDFNPSESDVVS-ELGKVETVTIRRLHIPQ 295
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 14/78 (17%), Positives = 26/78 (33%), Gaps = 4/78 (5%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY 147
+D+S L L L++ +S N + L P L + ++ N
Sbjct: 436 LDVSNNNLD----SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDG 491
Query: 148 SIASMVSLSYLNVSRNSL 165
+ SL + + N
Sbjct: 492 IFDRLTSLQKIWLHTNPW 509
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 28/181 (15%), Positives = 56/181 (30%), Gaps = 20/181 (11%)
Query: 385 SGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMA 438
L IK Q + L+GEG+ +VY A N +
Sbjct: 48 QCKLPAIK--------PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFV 99
Query: 439 VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDM 498
+K A + E + + + + +LV E G L +
Sbjct: 100 LKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNA 157
Query: 499 L-HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557
+ + + K + + A+ +E +H+ ++H + K N +L +
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214
Query: 558 D 558
+
Sbjct: 215 E 215
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 37/156 (23%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLA 474
++ EG VY A+ +G+ A+K++ + ++ ++ V M +L HPNIV
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 475 GYCAEHGQR-------LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+ + L+ + G L + L +S L+ + +++ T RA+++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563
+H P ++HR+ K N+LL ++ L D G A
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 26/138 (18%), Positives = 53/138 (38%), Gaps = 8/138 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+ L+ L + LS N + +P ++P L L + N + + + + +
Sbjct: 96 FAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154
Query: 163 NSLTQSI--GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNV 219
N L S F + L+ + ++ N + +++ L+L N++T
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAAS 211
Query: 220 FSGLP-LTTLNVANNHFS 236
GL L L ++ N S
Sbjct: 212 LKGLNNLAKLGLSFNSIS 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 32/165 (19%), Positives = 56/165 (33%), Gaps = 36/165 (21%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNF-------------------SG 143
+ L ++ +I TIP LPP+LT L+L N S
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 144 NLPYSI-----ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N ++ A+ L L+++ N L + + + + L NN S N F
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284
Query: 199 ------SLSNISSLYLQNNQVTGSL---NVFSGLP-LTTLNVANN 233
++ S + L +N V + F + + + N
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 29/144 (20%), Positives = 59/144 (40%), Gaps = 14/144 (9%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSIASMV 153
+ + L + +L N + + + L+ + +A N + +P +
Sbjct: 139 SVFNGLNQMIVVELGTNPLKSS---GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PP 192
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQV 213
SL+ L++ N +T+ L LA L LSFN+ S S + ++ L+L NN++
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 214 TGSLNVFSGLP-LTTLNVANNHFS 236
+ + + + NN+ S
Sbjct: 253 VKVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 32/136 (23%), Positives = 55/136 (40%), Gaps = 7/136 (5%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
LR S + +P LPP+ L+L +N + ++ +L L + N +++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-L 225
F L L L LS N +LP + L + N++T +VF+GL +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQM 147
Query: 226 TTLNVANNHF-SGWIP 240
+ + N S I
Sbjct: 148 IVVELGTNPLKSSGIE 163
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 32/172 (18%)
Query: 418 IGEGSLGRVYRAEFA-----NGKIM-AVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+GEG G+V +A G AVK + +NA S E + L + + ++ HP++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHV 88
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML--------------------HFADDSSKNLT 510
+ L G C++ G LL+ EY G+L L + LT
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ A ++ ++YL E+ +VHR+ + NIL+ + +SD GL+
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 32/172 (18%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IGEG+ GRV++A AVK + + A S + +F + M+ +PNI
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNI 112
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML--------------------HFADDSSKNLT 510
V L G CA L++EY+ G+L++ L + L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++ +A A + YL E VHR+ + N L+ + + ++D GL+
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 28/167 (16%)
Query: 418 IGEGSLGRVYRAEFANG-------KIMAVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHP 468
+G G+ G+V A+ A G + +AVK + + A + E + + + + H
Sbjct: 35 LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHL 91
Query: 469 NIVTLAGYCAEHGQ-RLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARV 515
N+V L G C + G +++ E+ GNL L D LT +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ A+ +E+L +HR+ + NILL ++ + D GLA
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 23/163 (14%)
Query: 418 IGEGSLGRVYRAEFA-----NGKIM-AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHPN 469
+G G+ G+V A + + AVK + A E++ + + MS L +H N
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHEN 111
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDML----------HFADDSSKNLTWNARVRVAL 519
IV L G C G L++ EY G+L + L ++ + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
A+ + +L + +HR+ + N+LL + + D GLA
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 5e-17
Identities = 40/149 (26%), Positives = 60/149 (40%), Gaps = 12/149 (8%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IGEG G V++ + N + A+K S + FL+ M + HP+IV L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G E+ ++ E G L L S L + + A + AL YL
Sbjct: 457 IGVITEN-PVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKRF 512
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ + N+L+ L D GL+
Sbjct: 513 ---VHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 29/168 (17%)
Query: 418 IGEGSLGRVYRAEFANGKIM---------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-R 466
+GEG G+V AE A G AVK + D+A + ++ + + + M + +
Sbjct: 89 LGEGCFGQVVMAE-AVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGK 145
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNAR 514
H NI+ L G C + G ++ EY GNL + L + +T+
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V AR +EYL +HR+ + N+L+ + ++D GLA
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 33/142 (23%), Positives = 58/142 (40%), Gaps = 8/142 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+ L +L D+S + +L L +A N+F N I + +L++
Sbjct: 121 VFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
L++S+ L Q F +L+ L L++S NNF + L+++ L N +
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 239
Query: 217 LNVFSGLP--LTTLNVANNHFS 236
P L LN+ N F+
Sbjct: 240 KQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 30/134 (22%), Positives = 56/134 (41%), Gaps = 7/134 (5%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT- 166
S + + + ++P +P + T L L SN + L+ L++S N L+
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 167 QSIGD-IFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGL 223
+ L LDLSFN + ++F+ L + L Q++ + +VF L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 224 P-LTTLNVANNHFS 236
L L++++ H
Sbjct: 126 RNLIYLDISHTHTR 139
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 31/142 (21%), Positives = 56/142 (39%), Gaps = 9/142 (6%)
Query: 103 LSDLLSLRKFDLSGNSIH--DTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L K LS N + +L L+L+ N + + + L +L
Sbjct: 48 FDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106
Query: 159 NVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
+ ++L Q S +F +L L LD+S + F LS++ L + N +
Sbjct: 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166
Query: 218 --NVFSGLP-LTTLNVANNHFS 236
++F+ L LT L+++
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 32/128 (25%), Positives = 49/128 (38%), Gaps = 4/128 (3%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNL 145
DIS + + L SL ++GNS + + NLT L+L+
Sbjct: 132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 191
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL-SNIS 204
P + S+ SL LN+S N+ + L L LD S N+ S+++
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 251
Query: 205 SLYLQNNQ 212
L L N
Sbjct: 252 FLNLTQND 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 418 IGEGSLGRVYRAEFANGKIM---------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-R 466
+GEG+ G+V AE A G AVK + +A + ++ + + + M + +
Sbjct: 77 LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGK 133
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNAR 514
H NI+ L G C + G ++ EY GNL + L + + + + L+
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V A AR +EYL +HR+ + N+L+ ++ ++D GLA
Sbjct: 194 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 34/173 (19%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHP 468
+G G+ G+V A A G AVK + + A E + + + M++L H
Sbjct: 53 LGSGAFGKVMNAT-AYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHE 109
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-------------------HFADDSSKNL 509
NIV L G C G L++EY G+L + L ++ L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 510 TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
T+ + A A+ +E+L S VHR+ + N+L+ + D GLA
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 37/174 (21%), Positives = 63/174 (36%), Gaps = 27/174 (15%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVSLS 156
L L+ + + +LP L +L LA N LP SIAS+ L
Sbjct: 100 AFRLSHLQHMTIDAAGLM-----ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153
Query: 157 YLNVSR-NSLTQ---SIG-----DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY 207
L++ LT+ + L L +L L + LP S +L N+ SL
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 208 LQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE---LISIRTF-IYDGNSF 256
++N+ ++ LP L L++ P ++ + D ++
Sbjct: 213 IRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 32/160 (20%), Positives = 57/160 (35%), Gaps = 27/160 (16%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP-----YQLPP------NLTSLNLASNNFSGNLPYSIAS 151
++ L LR+ + +P NL SL L +LP SIA+
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ +L L + + L+ ++G +L L LDL + P F + + L L++
Sbjct: 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
Query: 212 QVTGSLNVFSGLP--------LTTLNVANNHFSGWIPREL 243
+ LP L L++ +P +
Sbjct: 264 ------SNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 11/116 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVSLS 156
+++L +L+ + + + L P L L+L N P L
Sbjct: 202 IANLQNLKSLKIRNSPLS-----ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L + S ++ L L LDL LP+ L + + +
Sbjct: 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 26/155 (16%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+L + Q P +L + + + LP ++ L L
Sbjct: 80 QPGRVALELRSVPLP-----QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLT 133
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF---------ISLSNISSLYLQN 210
++RN L ++ +L L L + +LP L N+ SL L+
Sbjct: 134 LARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 211 NQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPREL 243
+ SL + L L +L + N+ S + +
Sbjct: 193 TGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAI 225
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 16/104 (15%), Positives = 30/104 (28%), Gaps = 7/104 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L L + DL G + P L L L + LP I + L L+
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKDCSNLLTLPLDIHRLTQLEKLD 283
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFN---NFSGDLPNSFISL 200
+ + + L + + + P + +
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 15/137 (10%), Positives = 33/137 (24%), Gaps = 26/137 (18%)
Query: 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI----------------- 172
+L + ++ + +R +
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATA 72
Query: 173 ----FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLP-LT 226
G L+L P+ LS++ + + + L + L
Sbjct: 73 DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLE 130
Query: 227 TLNVANNHFSGWIPREL 243
TL +A N +P +
Sbjct: 131 TLTLARNPLRA-LPASI 146
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 45/186 (24%), Positives = 74/186 (39%), Gaps = 41/186 (22%)
Query: 416 FLIGEGSLGRVYRA---EFANGKIMAVKKI--DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ G VY+A + + K A+K+I ++S E L L+HPN+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALL------RELKHPNV 80
Query: 471 VTLAGYCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA------ 522
++L H R L+++Y HD+ H + V++ G
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 523 --RALEYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLA--------ALTPNT 568
+ YLH V+HR+ K ANIL+ E ++D G A L +
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA-DL 192
Query: 569 ERQVIT 574
+ V+T
Sbjct: 193 DPVVVT 198
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 25/157 (15%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEG+ G V A + +AVK +D E+ E + L H N+V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHENVVKFYG 72
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALEY 527
+ E + L EY G L D + + + A+ + Y
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
LH + + HR+ K N+LLD+ N +SD GLA +
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 41/162 (25%), Positives = 65/162 (40%), Gaps = 15/162 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G G V R G+ +A+K+ LS + + + + M +L HPN+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 474 ---AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
A + LL EY G+L L+ ++ L + + AL YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 531 VCLPSVVHRNFKSANILLDDELNPH---LSDCGLAALTPNTE 569
++HR+ K NI+L + D G A E
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 38/160 (23%), Positives = 67/160 (41%), Gaps = 12/160 (7%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+G+ V+R G + A+K +N + + D + + +L H NIV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 476 YCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
E R L+ E+ G+L+ +L ++ L + + V + +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 534 PSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTE 569
+VHRN K NI+ + L+D G A + E
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 19/159 (11%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSR 464
++ + +GEG+ VY+ + ++A+K+I L+ E+ + VS +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKD 56
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TAR 523
L+H NIVTL LV+EY+ D+ + DD + V++ L R
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIIN-MHNVKLFLFQLLR 111
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L Y H V+HR+ K N+L+++ L+D GLA
Sbjct: 112 GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 25/157 (15%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEG+ G V A + +AVK +D E+ E + L H N+V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHENVVKFYG 72
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALEY 527
+ E + L EY G L D + + + A+ + Y
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
LH + + HR+ K N+LLD+ N +SD GLA +
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 39/168 (23%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+GS G V + + + AVK I+ A+ ++ L V + +L HPNI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ +V E G L D + F++ + + ++ + Y+H+
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS---GITYMHKH- 140
Query: 533 LPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTER-QVITGT 576
++VHR+ K NILL + + + + D GL+ + + GT
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 28/158 (17%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G+ +V A G+ +A+K ID L+ V M L HPNIV L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 477 -CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
E + L L+ EY G + D L A R+ AR A++
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLV------------AHGRMKEKEARSKFRQIVSAVQ 128
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
Y H+ +VHR+ K+ N+LLD ++N ++D G +
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE 163
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 31/143 (21%), Positives = 58/143 (40%), Gaps = 10/143 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L +LR DL+ N + + P++ +L+ A+NN S + S + ++
Sbjct: 76 LESLSTLRTLDLNNNYVQ-ELLV--GPSIETLHAANNNIS-RVSCSR--GQGKKNIYLAN 129
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N +T G + + LDL N + S + L LQ N + +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
Query: 222 GLP-LTTLNVANNHFSGWIPREL 243
L TL++++N + ++ E
Sbjct: 189 VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 33/161 (20%), Positives = 60/161 (37%), Gaps = 14/161 (8%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146
++ L + L ++++ DLSGN + L L LNL+SN
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL 74
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
+ S+ +L L+++ N + + + TL + NN S + N +
Sbjct: 75 -DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISRVSCSRGQGKKN---I 125
Query: 207 YLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELIS 245
YL NN++T + L++ N EL +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 30/154 (19%), Positives = 51/154 (33%), Gaps = 8/154 (5%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
+I ++ ++ ++ DL N I +L L LNL N
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNI 203
++ L L++S N L +G F + AG+ + L N + + N+
Sbjct: 183 DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 204 SSLYLQNNQ-VTGSLNVFSGLPLTTLNVANNHFS 236
L+ N G+L F VA
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 30/147 (20%), Positives = 57/147 (38%), Gaps = 13/147 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ + + ++ +S+ + N+ L+L+ N S +A L LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLN 218
+S N L D +L+ L TLDL+ N + +I +L+ NN ++ S +
Sbjct: 65 LSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCS 117
Query: 219 VFSGLPLTTLNVANNHFSGWIPRELIS 245
G + +ANN + +
Sbjct: 118 RGQG--KKNIYLANNKITM-LRDLDEG 141
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 25/138 (18%), Positives = 47/138 (34%), Gaps = 3/138 (2%)
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L + +L +L N I+D + L +L+L+SN + + S +++++
Sbjct: 162 AELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD-LPNSFISLSNISSLYLQNNQVTGSLN 218
+ N L I L DL N F L + F + ++ Q + N
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 219 VFSGLPLTTLNVANNHFS 236
T +
Sbjct: 280 EEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 29/120 (24%), Positives = 46/120 (38%), Gaps = 9/120 (7%)
Query: 118 SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
+IH+ Q + ++ L S ++ L++S N L+Q
Sbjct: 1 AIHEIK--QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFT 58
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS 236
L L+LS N SLS + +L L NN + P + TL+ ANN+ S
Sbjct: 59 KLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 10/131 (7%), Positives = 30/131 (22%), Gaps = 8/131 (6%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN-------NF 141
++ + G + + +P L +L + +
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCC-EDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 142 SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
+ L + ++ + I + TL+ + N + +
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384
Query: 202 NISSLYLQNNQ 212
+ Q
Sbjct: 385 ELDGTLQQAVG 395
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 18/151 (11%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-----VSNMSRLRHPNIV 471
IGEGS G V++ G+I+A+KK E+D ++ + + +L+HPN+V
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L + LV+EY H +LH D + + + + T +A+ + H+
Sbjct: 66 NLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ +HR+ K NIL+ L D G A
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 24/185 (12%)
Query: 405 LQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAV 459
+ + S+ + +G G+ G V A+K I ++S LE V
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 460 SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARV 515
+ + L HPNI+ L + + LV E G L D + F + + + +
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----I 142
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTER-Q 571
+ L + YLH+ ++VHR+ K N+LL + + + D GL+A+ N ++ +
Sbjct: 143 KQVLS---GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196
Query: 572 VITGT 576
GT
Sbjct: 197 ERLGT 201
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 51/253 (20%), Positives = 101/253 (39%), Gaps = 22/253 (8%)
Query: 335 SGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSP 394
SG + + + + + + A E++ ++ S I +P
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 395 ITATSYTVASLQTATNS----FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSL 449
+ + + + + S+ ++G G G+V++ E A G +A K I +
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GM 127
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL 509
++++ +S M++L H N++ L +LV EYV G L D + D S NL
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNL 184
Query: 510 T-WNAR--VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL--SDCGLAA- 563
T + ++ + ++H++ ++H + K NIL + + D GLA
Sbjct: 185 TELDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR 238
Query: 564 LTPNTERQVITGT 576
P + +V GT
Sbjct: 239 YKPREKLKVNFGT 251
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 35/131 (26%), Positives = 56/131 (42%), Gaps = 6/131 (4%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
S + + ++ +P LP + T L+L+ N ++ L+ LN+ R LT+
Sbjct: 11 SHLEVNCDKRNL-TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK 69
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-L 225
+ G L L TLDLS N LP +L ++ L + N++T L GL L
Sbjct: 70 L--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126
Query: 226 TTLNVANNHFS 236
L + N
Sbjct: 127 QELYLKGNELK 137
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 34/149 (22%), Positives = 53/149 (35%), Gaps = 15/149 (10%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNV 160
L L DLS N + ++P P LT L+++ N + +LP + L L +
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNV 219
N L + L L L+ NN + L N+ +L LQ N +
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGF 191
Query: 220 FSGLPLTTLNVANN---------HFSGWI 239
F L + N +F W+
Sbjct: 192 FGSHLLPFAFLHGNPWLCNCEILYFRRWL 220
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 35/163 (21%), Positives = 63/163 (38%), Gaps = 15/163 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L + L+ D+ NS+ +P LPP+L + +N LP + ++ L+ +
Sbjct: 149 LQNSSFLKIIDVDNNSLK-KLP-DLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADN 204
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
NSL + L ++ N +L ++++Y NN + +
Sbjct: 205 NSLK----KLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK---TLPDL 255
Query: 223 LP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPP 264
P L LNV +N+ + +P S+ N F PP
Sbjct: 256 PPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 35/165 (21%), Positives = 67/165 (40%), Gaps = 25/165 (15%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
+ +L+ + ++P +LPP+L SL + N+ + LP S+ SL N + +L
Sbjct: 70 DRQAHELELNNLGLS-SLP-ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 166 TQ-------------SIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
+ + + N + L +D+ N+ LP+ ++ + N
Sbjct: 127 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPD---LPPSLEFIAAGN 182
Query: 211 NQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
NQ+ L LP LT + NN +P +S+ + + N
Sbjct: 183 NQLE-ELPELQNLPFLTAIYADNNSLKK-LPDLPLSLESIVAGNN 225
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 35/167 (20%), Positives = 56/167 (33%), Gaps = 27/167 (16%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L +L L N + T+P LPP+L +LN+ N + +LP S+ L
Sbjct: 233 LQNLPFLTTIYADNNLLK-TLP-DLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIF 289
Query: 163 NSLTQSIG-------------DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQ 209
+ L++ + L L++S N +LP + L
Sbjct: 290 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIAS 345
Query: 210 NNQVTGSLNVFSGLP--LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
N L LP L L+V N P S+ + +
Sbjct: 346 FNH----LAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSH 387
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 37/153 (24%), Positives = 55/153 (35%), Gaps = 19/153 (12%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
LSL N + + Q P LT++ +N LP SL LNV N L
Sbjct: 214 PLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYL 269
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP- 224
T + ++ +L L + F+ S N+ L +N+ + LP
Sbjct: 270 T-DLPELPQSLTFLDVSENIFSGLSE-------LPPNLYYLNASSNE----IRSLCDLPP 317
Query: 225 -LTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
L LNV+NN +P + I N
Sbjct: 318 SLEELNVSNNKLIE-LPALPPRLERLIASFNHL 349
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 26/152 (17%), Positives = 52/152 (34%), Gaps = 27/152 (17%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L SL + ++S N + +P LPP L L + N+ + +P +L L+V
Sbjct: 312 LCDLPPSLEELNVSNNKL-IELP-ALPPRLERLIASFNHLA-EVPELPQ---NLKQLHVE 365
Query: 162 RNSLTQ---------------SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
N L + + ++ L L + N + P+ ++ L
Sbjct: 366 YNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD---IPESVEDL 421
Query: 207 YLQNNQVTGSLNV-FSGLPLTTLNV-ANNHFS 236
+ + +V +V ++H
Sbjct: 422 RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 27/183 (14%), Positives = 53/183 (28%), Gaps = 39/183 (21%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMV---------- 153
L++ +++ +P + + T A + + N P
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 154 ---SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
L ++ L+ + L +L S N+ + +LP SL ++
Sbjct: 69 LDRQAHELELNNLGLS----SLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 211 NQVTG----------SLNVFSGLP-------LTTLNVANNHFSGWIPRELISIRTFIYDG 253
++ S N LP L ++V NN +P S+
Sbjct: 124 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGN 182
Query: 254 NSF 256
N
Sbjct: 183 NQL 185
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 19/131 (14%), Positives = 43/131 (32%), Gaps = 13/131 (9%)
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
+ S L ++LT + N+ +++ + + P ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 205 SLYLQNNQVTG------SLNVFSGLP-----LTTLNVANNHFSGWIPRELISIRTFIYDG 253
L++ + S LP L +L + N + +P S+++ + D
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTE-LPELPQSLKSLLVDN 120
Query: 254 NSFDNGPAPPP 264
N+ PP
Sbjct: 121 NNLKALSDLPP 131
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 37/151 (24%), Positives = 65/151 (43%), Gaps = 18/151 (11%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-----VSNMSRLRHPNIV 471
+GEGS G V + G+I+A+KK ++D ++ + + +LRH N+V
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKF-----LESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L C + + LV+E+V H +L + L + + + + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+++HR+ K NIL+ L D G A
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 42/174 (24%), Positives = 71/174 (40%), Gaps = 23/174 (13%)
Query: 409 TNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS 463
+ FS + +G+G+ V R G A K I+ LS ++
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 464 RLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVAL 519
+L+HPNIV L E LV++ V G L + + +++ + + ++ L
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQIL 115
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH---LSDCGLAALTPNTER 570
++ Y H +VHRN K N+LL + L+D GLA ++E
Sbjct: 116 E---SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 34/159 (21%), Positives = 63/159 (39%), Gaps = 20/159 (12%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHP 468
SF + ++G G+ G + + + +AVK+I S E V + HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE------VQLLRESDEHP 78
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N++ + + + E L + + D + L + + T L +L
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHL 134
Query: 529 HEVCLPSVVHRNFKSANILL-----DDELNPHLSDCGLA 562
H + ++VHR+ K NIL+ ++ +SD GL
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 39/164 (23%), Positives = 62/164 (37%), Gaps = 9/164 (5%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G+ G V+ E ++G +K I+ + E E + + L HPNI+ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE-IEVLKSLDHPNIIKIFEV 88
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
++ +V E G L + + A K L+ + AL Y H V
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 537 VHRNFKSANILL---DDELNPHLSDCGLAA-LTPNTERQVITGT 576
VH++ K NIL + D GLA + GT
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 40/173 (23%), Positives = 65/173 (37%), Gaps = 25/173 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + E + G A K I E + + ++ H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L +++ + + ++ L + YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAA-LTPNTERQVITGT 576
H + H + K NI+L D+ P L D GLA + E + I GT
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 1e-15
Identities = 36/134 (26%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++L S+ + + + I Q PN+T L L N + ++ + ++ +L +L +
Sbjct: 39 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDE 96
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N + D+ +L L +L L N S D+ + L + SLYL NN++T + V
Sbjct: 97 NKIK----DLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVL 149
Query: 221 SGLP-LTTLNVANN 233
S L L TL++ +N
Sbjct: 150 SRLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 5e-14
Identities = 31/134 (23%), Positives = 57/134 (42%), Gaps = 12/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
K +L S+ D + ++ + +++ ++ I + +++ L ++
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N LT DI NL L L L N DL + L + SL L++N ++ +N
Sbjct: 75 NKLT----DIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DINGL 127
Query: 221 SGLP-LTTLNVANN 233
LP L +L + NN
Sbjct: 128 VHLPQLESLYLGNN 141
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 27/156 (17%), Positives = 48/156 (30%), Gaps = 8/156 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L L L N I D L +L+L N S ++ +A + L L +S+
Sbjct: 127 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK 184
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N ++ D+ L L L+L N +L +++ + + +
Sbjct: 185 NHIS----DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
Query: 221 SGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
NV + I +
Sbjct: 241 DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 6e-11
Identities = 23/129 (17%), Positives = 49/129 (37%), Gaps = 8/129 (6%)
Query: 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
+ + I P NL + + + + S+ + + + + S
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-S 57
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTT 227
+ I L + L L+ N + D+ +L N+ L+L N++ L+ L L +
Sbjct: 58 VQGI-QYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSSLKDLKKLKS 113
Query: 228 LNVANNHFS 236
L++ +N S
Sbjct: 114 LSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 34/196 (17%), Positives = 63/196 (32%), Gaps = 3/196 (1%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
LS L L L N I D +P L +L L+ N+ S +L ++A + +L L +
Sbjct: 149 LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 206
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
+ NL T+ + + S ++ + T ++ F
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS-FIF 265
Query: 223 LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHR 282
T+ A F G + + L + T YD + P + +
Sbjct: 266 YQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFK 325
Query: 283 QGSHSPSGSQSSSSDK 298
+G + +
Sbjct: 326 GWYTEKNGGHEWNFNT 341
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 29/136 (21%), Positives = 52/136 (38%), Gaps = 9/136 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
S L L+K +S N + IP LP +L L + N + + +++ + +
Sbjct: 98 FSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156
Query: 163 NSLTQSI--GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNV 219
N L S F L L L +S +G + ++ L+L +N++ L
Sbjct: 157 NPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPKDLP---ETLNELHLDHNKIQAIELED 212
Query: 220 FSGLP-LTTLNVANNH 234
L L + +N
Sbjct: 213 LLRYSKLYRLGLGHNQ 228
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 34/160 (21%), Positives = 60/160 (37%), Gaps = 26/160 (16%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
LR S + +P ++ P+ T L+L +N+ S + L L + N +++
Sbjct: 34 HLRVVQCSDLGL-KAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 168 SIGDIFGNLAGLATLDLSFNN--------FSG----DL---------PNSFISLSNISSL 206
F L L L +S N+ S + F L N++ +
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 207 YLQNNQVTGSL---NVFSGLPLTTLNVANNHFSGWIPREL 243
+ N + S F GL L L ++ +G IP++L
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL 191
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 30/161 (18%), Positives = 49/161 (30%), Gaps = 36/161 (22%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNF-------------------SGNLPY 147
L L +S + IP LP L L+L N N
Sbjct: 172 LKLNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230
Query: 148 SI-----ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF----- 197
I + + +L L++ N L+ + +L L + L NN + N F
Sbjct: 231 MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF 289
Query: 198 -ISLSNISSLYLQNNQVTGSL---NVFSGLP-LTTLNVANN 233
+ + + + L NN V F + + N
Sbjct: 290 GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 24/143 (16%), Positives = 53/143 (37%), Gaps = 13/143 (9%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVS 154
+ S L ++ ++ GN + ++ P L L ++ + +P + +
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSG---FEPGAFDGLKLNYLRISEAKLT-GIPKDLPE--T 194
Query: 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214
L+ L++ N + + + L L L N S L + L+L NN+++
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
Query: 215 GSLNVFSGLP-LTTLNVANNHFS 236
L L + + N+ +
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 22/123 (17%), Positives = 44/123 (35%), Gaps = 13/123 (10%)
Query: 101 YLLSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSY 157
L L + L N I + LP L L+L +N S +P + + L
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLP-TLRELHLDNNKLS-RVPAGLPDLKLLQV 268
Query: 158 LNVSRNSLTQSIGDIFGNLAG------LATLDLSFNNFSGDL--PNSFISLSNISSLYLQ 209
+ + N++T+ + F + + L N P +F +++ ++
Sbjct: 269 VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
Query: 210 NNQ 212
N +
Sbjct: 329 NYK 331
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 42/173 (24%), Positives = 66/173 (38%), Gaps = 25/173 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + E + G A K I E + + ++ HPNI+T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L +++ + + ++ L + YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAA-LTPNTERQVITGT 576
H + H + K NI+L D+ P L D GLA + E + I GT
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 20/169 (11%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNI 470
+G G + VY AE +A+K I + +E++ L E + S+L H NI
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIF---IPPREKEETLKRFEREVHN-SSQLSHQNI 73
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V++ E LV EY+ L + + S L+ + + +++ H+
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA---ALTPNTERQVITGT 576
+ +VHR+ K NIL+D + D G+A + T T+ + GT
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 31/161 (19%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLRHPNIV 471
+G G+ G+V E G +AVK ++ + + + + N+ RHP+I+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHPHII 74
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR-------- 523
L + +V EYV G L D + RV AR
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYI------------CKHGRVEEMEARRLFQQILS 122
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
A++Y H VVHR+ K N+LLD +N ++D GL+ +
Sbjct: 123 AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM 160
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 32/239 (13%)
Query: 345 PVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVAS 404
+ + + R + A + L P++ + AK + + K ++
Sbjct: 20 RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79
Query: 405 -----LQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED- 453
A F Q++ +IG G V R A G AVK ++ A L E
Sbjct: 80 EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139
Query: 454 -NFLEAVSN----MSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFAD 503
EA + ++ HP+I+TL LV++ + G L D L ++
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 504 DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++++ +R L A+ +LH ++VHR+ K NILLDD + LSD G +
Sbjct: 200 KETRSI-----MRSLLE---AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS 247
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 45/173 (26%), Positives = 67/173 (38%), Gaps = 25/173 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + + GK A K I LS E + + +RHPNI+T
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L +D + ++ L + YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYL 124
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAA-LTPNTERQVITGT 576
H + H + K NI+L D+ P+ L D G+A + E + I GT
Sbjct: 125 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 34/132 (25%), Positives = 61/132 (46%), Gaps = 8/132 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++ L S++ DL+ I D P NL L L N + N+ +A + +L YL++
Sbjct: 103 IAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGN 160
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
++ NL+ L TL N S D+ SL N+ ++L+NNQ++ ++ +
Sbjct: 161 AQVSDLTP--LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSPLAN 215
Query: 223 LP-LTTLNVANN 233
L + + N
Sbjct: 216 TSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 34/133 (25%), Positives = 57/133 (42%), Gaps = 8/133 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+DL + G + Q NL L L N + +L + ++ ++ L +S
Sbjct: 37 QADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSG 94
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N L L + TLDL+ + D+ LSN+ LYL NQ+T +++ +G
Sbjct: 95 NPLKNVSA--IAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT-NISPLAG 149
Query: 223 LP-LTTLNVANNH 234
L L L++ N
Sbjct: 150 LTNLQYLSIGNAQ 162
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 28/134 (20%), Positives = 55/134 (41%), Gaps = 12/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L + K +++ DT+ +T+L+ + + + + +L L +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N +T D+ NL + L+LS N ++ L +I +L L + Q+T +
Sbjct: 73 NQIT----DLAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT-DVTPL 125
Query: 221 SGLP-LTTLNVANN 233
+GL L L + N
Sbjct: 126 AGLSNLQVLYLDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 25/128 (19%), Positives = 53/128 (41%), Gaps = 8/128 (6%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
+I+ P N + +N + + A + ++ L+ +T +I +
Sbjct: 4 TQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGV 59
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
L L L+L N + DL +L+ I+ L L N + +++ +GL + TL++ +
Sbjct: 60 QYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTS 116
Query: 233 NHFSGWIP 240
+ P
Sbjct: 117 TQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 25/131 (19%), Positives = 51/131 (38%), Gaps = 15/131 (11%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L+ + + D P LT+L N S ++ +AS+ +L +++
Sbjct: 147 LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKN 204
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ N + L + L+ ++N Y N V + SG
Sbjct: 205 NQISDVSP--LANTSNLFIVTLTNQT-----------ITNQPVFYNNNLVVPNVVKGPSG 251
Query: 223 LPLTTLNVANN 233
P+ +++N
Sbjct: 252 APIAPATISDN 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 35/179 (19%), Positives = 65/179 (36%), Gaps = 22/179 (12%)
Query: 79 ACEGSAVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
AC + +++ GL+ L L + + N++ ++P LPP L +L ++
Sbjct: 36 ACLNNGNAVLNVGESGLT----TLPDCLPAHITTLVIPDNNL-TSLP-ALPPELRTLEVS 89
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
N + +LP ++ LS + L GL L + N + LP
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPV-- 138
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
+ L + +NQ+ + S L L NN + +P ++ N
Sbjct: 139 -LPPGLQELSVSDNQLASLPALPSE--LCKLWAYNNQLTS-LPMLPSGLQELSVSDNQL 193
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 12/130 (9%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+ L K N + ++P LP L L + S N +LP + L L VS N
Sbjct: 198 TLPSELYKLWAYNNRLT-SLP-ALPSGLKELIV-SGNRLTSLPVLPSE---LKELMVSGN 251
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL 223
LT + +GL +L + N + LP S I LS+ +++ L+ N ++ + +
Sbjct: 252 RLTS----LPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR 305
Query: 224 PLTTLNVANN 233
+T+ +
Sbjct: 306 EITSAPGYSG 315
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 37/150 (24%), Positives = 57/150 (38%), Gaps = 23/150 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L K N + ++P LP L L+++ N + +LP + + L N
Sbjct: 156 LPALPSELCKLWAYNNQLT-SLP-MLPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNR 212
Query: 162 RNSLTQSIG-----DIFGN--------LAGLATLDLSFNNFSGDLPNSFISLSNISSLYL 208
SL + GN + L L +S N + LP S + SL +
Sbjct: 213 LTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPM---LPSGLLSLSV 268
Query: 209 QNNQVTGSL-NVFSGLP-LTTLNVANNHFS 236
NQ+T L L TT+N+ N S
Sbjct: 269 YRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 28/123 (22%), Positives = 53/123 (43%), Gaps = 10/123 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L++ +SGN + ++P LP L L ++ N + +LP + L L+V
Sbjct: 216 LPALPSGLKELIVSGNRLT-SLP-VLPSELKELMVSGNRLT-SLPMLPSG---LLSLSVY 269
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
RN LT + + +L+ T++L N S + + I+S + + +
Sbjct: 270 RNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQAL--REITSAPGYSGPIIRFDMAGA 325
Query: 222 GLP 224
P
Sbjct: 326 SAP 328
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 22/108 (20%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
L++ +SGN + ++P LP L SL++ N + LP S+ + S + +N+ N L++
Sbjct: 242 ELKELMVSGNRL-TSLP-MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 298
Query: 168 SIGDIFGNLAGLATLD---LSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ + F+ P +L ++ +L +
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 37/165 (22%), Positives = 74/165 (44%), Gaps = 11/165 (6%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDN---FLEAVSNMSRLRHPNIVTL 473
+G G+ G V + +G+IMAVK+I ++ ++ ++ +M + P VT
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G G + E + +L D + + + ++A+ +ALE+LH
Sbjct: 72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL- 129
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVITGTS 577
SV+HR+ K +N+L++ + D G++ L + + + G
Sbjct: 130 -SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCK 173
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 23/197 (11%)
Query: 386 GSLKKIKSPITATSYTVASLQTATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVK 440
G + + A+ FS + +G+G+ V R G A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 441 KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML- 499
I+ LS ++ +L+HPNIV L E LV++ V G L + +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 500 ---HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH- 555
+++ + + ++ L ++ Y H +VHRN K N+LL +
Sbjct: 121 AREFYSEADASHC-----IQQILE---SIAYCHSN---GIVHRNLKPENLLLASKAKGAA 169
Query: 556 --LSDCGLAALTPNTER 570
L+D GLA ++E
Sbjct: 170 VKLADFGLAIEVNDSEA 186
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 35/175 (20%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS--------RLRHP 468
+GEG VY+A + +I+A+KKI L + ++ + L HP
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI-----KLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALEY 527
NI+ L LV++++ D+ D+S LT + ++ + T + LEY
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFM----ETDLEVIIKDNSLVLT-PSHIKAYMLMTLQGLEY 127
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--------ALTPNTERQVIT 574
LH+ ++HR+ K N+LLD+ L+D GLA A T QV+T
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH----QVVT 175
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 36/158 (22%), Positives = 70/158 (44%), Gaps = 28/158 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNI 470
+GEG+ G VY+A + + +A+K+I ++ EE+ + VS + L+H NI
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEH------EEEGVPGTAIREVSLLKELQHRNI 95
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALEYLH 529
+ L + + L++EY +D+ + D + +++ ++ L + + H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAE----NDLKKYM-DKNPDVS-MRVIKSFLYQLINGVNFCH 149
Query: 530 EVCLPSVVHRNFKSANILLDDELNPH-----LSDCGLA 562
+HR+ K N+LL + D GLA
Sbjct: 150 S---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 36/163 (22%), Positives = 56/163 (34%), Gaps = 17/163 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSI-------HDTIPYQLPPNLTSLNLASN 139
+ I+ + +L DLS N P + P L L L +
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP-TLQVLALRNA 211
Query: 140 NF---SGNLPYSIASMVSLSYLNVSRNSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPN 195
SG A+ V L L++S NSL + G + L +L+LSF
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKG 271
Query: 196 SFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSG 237
+ +S L L N++ LP + L++ N F
Sbjct: 272 LP---AKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 37/192 (19%), Positives = 66/192 (34%), Gaps = 20/192 (10%)
Query: 82 GSAVVSIDISGLGLSGTMGYLLS----DLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLN 135
G + +++ + + +L L+ ++ + Q+ P L++L+
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 136 LASNNFSGNLPYSIA----SMVSLSYLNVSRNSLTQ---SIGDIFGNLAGLATLDLSFNN 188
L+ N G A +L L + + + L LDLS N+
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 189 FSGDLPN-SFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVANNHFSGW-IPRELI 244
S S ++SL L + V GLP L+ L+++ N P EL
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPAKLSVLDLSYNRLDRNPSPDELP 296
Query: 245 SIRTFIYDGNSF 256
+ GN F
Sbjct: 297 QVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 28/151 (18%), Positives = 49/151 (32%), Gaps = 17/151 (11%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASNNFSGNLPYSIASMV--SL 155
+ LSL++ + I I + L L L + +G P + L
Sbjct: 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123
Query: 156 SYLNVSRNSLT---QSIGDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ LN+ S + ++ L GL L ++ + +S+L L +N
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183
Query: 212 QVTGSLNVFSGLP------LTTLNVANNHFS 236
G + S L L L + N
Sbjct: 184 PELGERGLISALCPLKFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 33/174 (18%), Positives = 60/174 (34%), Gaps = 19/174 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL----PPNLTSLNLASNNFS 142
+ I L G + L + L++ L + T P L P+L LNL + +++
Sbjct: 77 AARIPSRILFGALRVL--GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 143 GNLPY----SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-- 196
+ L L++++ + L+TLDLS N G+
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 197 --FISLSNISSLYLQNNQVTGSLNVFSGL-----PLTTLNVANNHFSGWIPREL 243
+ + L L+N + V S L L L++++N
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 15/61 (24%), Positives = 25/61 (40%), Gaps = 3/61 (4%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
L +LS + +P LP L+ L+L+ N P S + + L++ N
Sbjct: 254 QLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
Query: 168 S 168
S
Sbjct: 311 S 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 22/134 (16%), Positives = 44/134 (32%), Gaps = 12/134 (8%)
Query: 130 NLTSLNLASNNFSGNLPYS-IASMVSLSYLNVSRNSLTQSIGDI---FGNLAGLATLDLS 185
+L L + + ++ I +SL L V + I ++GL L L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103
Query: 186 FNNFSGDLPNSFISLS--NISSLYLQNNQVTGSLNVFSGLP------LTTLNVANNHFSG 237
+G P + + +++ L L+N + L L L++A H
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 238 WIPRELISIRTFIY 251
+ ++
Sbjct: 164 FSCEQVRVFPALST 177
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 43/165 (26%), Positives = 63/165 (38%), Gaps = 31/165 (18%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQE--EDNFLEAVSNMSRLRHPNIVTL 473
L+GEGS G+V AVK + L E N + + + RLRH N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 474 AGY---CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR------ 523
E Q++ +V EY G + +ML R + A
Sbjct: 72 --VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV----------PEKRFPVCQAHGYFCQL 118
Query: 524 --ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
LEYLH +VH++ K N+LL +S G+A
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 9/150 (6%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDN---FLEAVSNMSRLRHPNIVTL 473
IG G+ G V + +G+IMAVK+I ++ E++ ++ M P IV
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G G + E + + + ++ L T +AL +L E
Sbjct: 87 YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL- 145
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAA 563
++HR+ K +NILLD N L D G++
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISG 174
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 42/173 (24%), Positives = 65/173 (37%), Gaps = 32/173 (18%)
Query: 417 LIGEGSLGRVYRAE--FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPN 469
I G LG +Y A NG+ + +K L + E ++ + HP+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLK-----GLVHSGDAEAQAMAMAERQF-LAEVVHPS 140
Query: 470 IVTLAGYCAEHGQRL------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
IV + + EH R +V EYVG +L + L + L
Sbjct: 141 IVQIFNF-VEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILP 193
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
AL YLH + +V+ + K NI+L +E L D G + + GT
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGYLYGT 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 28/172 (16%)
Query: 408 ATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNM 462
+T+ F + + ++G G V R K AVK ID + E
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 463 SR----LR----HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLT 510
+ LR HPNI+ L + LV++ + G L D L ++ ++ +
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI- 129
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+R L + LH++ ++VHR+ K NILLDD++N L+D G +
Sbjct: 130 ----MRALLE---VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 25/191 (13%), Positives = 56/191 (29%), Gaps = 36/191 (18%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKID--------------------------NAALSL 449
++G+ A + G+ V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLLVYEYVG--NGNLHDMLHFADDS 505
+ F+ + + ++ + + R +Y + ++L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 506 SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565
K+L +AR+++ L R L LH +VH + +I+LD L+
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL--V 254
Query: 566 PNTERQVITGT 576
+ R V + +
Sbjct: 255 RDGARVVSSVS 265
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNIV 471
+GEG+ G VY+A+ + G+I+A+K+I D E++ + +S + L HPNIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDA------EDEGIPSTAIREISLLKELHHPNIV 82
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+L LV+E++ D+ D++ L + R + + H+
Sbjct: 83 SLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++HR+ K N+L++ + L+D GLA
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 42/169 (24%), Positives = 67/169 (39%), Gaps = 20/169 (11%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNI 470
L+G G +G VY AE +I+A+K + +L + F EA + RL+ P++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMS---ETLSSDPVFRTRMQREART-AGRLQEPHV 96
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V + + GQ + + +L ML L V + AL+ H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA---ALTPNTERQVITGT 576
HR+ K NIL+ + +L D G+A T+ GT
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGT 198
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 39/167 (23%), Positives = 57/167 (34%), Gaps = 15/167 (8%)
Query: 104 SDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
L L L+GN S+ L +L L N + + I + +L LNV
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 161 SRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN----ISSLYLQNNQVTG 215
+ N + + + F NL L LDLS N L SL L N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 216 -SLNVFSGLPLTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
F + L L + N +P L S++ N +D
Sbjct: 192 IQPGAFKEIRLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 28/137 (20%), Positives = 47/137 (34%), Gaps = 17/137 (12%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
S + DLS N + L L L+L+ + S+ LS L
Sbjct: 29 STKNLDLSFNPLR-----HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSL 217
++ N + F L+ L L N + L + L + +N +
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 218 NVFSGLP-LTTLNVANN 233
FS L L L++++N
Sbjct: 143 EYFSNLTNLEHLDLSSN 159
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 33/117 (28%), Positives = 50/117 (42%), Gaps = 4/117 (3%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL 182
IP LP + +L+L+ N YS S L L++SR + + +L+ L+TL
Sbjct: 22 IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL 81
Query: 183 DLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
L+ N +F LS++ L + SL L L LNVA+N
Sbjct: 82 ILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 35/135 (25%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 104 SDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
L+ DLS +I D L +L++L L N +L + + SL L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLS-HLSTLILTGNPIQ-SLALGAFSGLSSLQKLV 106
Query: 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNF-SGDLPNSFISLSNISSLYLQNNQVTGSL 217
+L S+ G+L L L+++ N S LP F +L+N+ L L +N++ S+
Sbjct: 107 AVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SI 164
Query: 218 --NVFSGLP-LTTLN 229
L + LN
Sbjct: 165 YCTDLRVLHQMPLLN 179
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 47/186 (25%), Positives = 84/186 (45%), Gaps = 25/186 (13%)
Query: 405 LQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEE-DNFLEA 458
+Q +T FS + ++G+GS G V + G+ AVK I + + + ++ L
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 459 VSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNAR 514
V + +L HPNI+ L + + G LV E G L D + F++ + +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI----- 131
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTER- 570
+R L + Y+H+ +VHR+ K N+LL + N + D GL+ +++
Sbjct: 132 IRQVLS---GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 571 QVITGT 576
+ GT
Sbjct: 186 KDKIGT 191
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 28/160 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNI 470
IG+G+ G V++A G+ +A+KK+ +N E++ F L + + L+H N+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMEN------EKEGFPITALREIKILQLLKHENV 78
Query: 471 VTLAGYCAEHGQRL--------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
V L C LV+++ HD+ + T + RV
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L Y+H ++HR+ K+AN+L+ + L+D GLA
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 31/165 (18%), Positives = 64/165 (38%), Gaps = 11/165 (6%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAG 475
+G G V + + G+ A K + L ++ + + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +L+ EY G + + + ++ ++ N +R+ + YLH+ +
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRLIKQILEGVYYLHQN---N 151
Query: 536 VVHRNFKSANILLDDELNPH---LSDCGLAA-LTPNTERQVITGT 576
+VH + K NILL + D G++ + E + I GT
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGT 196
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 40/173 (23%), Positives = 64/173 (36%), Gaps = 25/173 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + E + G A K I E + + ++HPN++T
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L ++ + ++ L + YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GVYYL 130
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAA-LTPNTERQVITGT 576
H + + H + K NI+L D P + D GLA + E + I GT
Sbjct: 131 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 16/165 (9%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G+ G V++ +G +MA K I L+ + + + P IV
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIH-----LEIKPAIRNQIIRELQVLHECNSPYIVG 95
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G G+ + E++ G+L +L A + +V++ + L YL E
Sbjct: 96 FYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
++HR+ K +NIL++ L D G++ ++ GT
Sbjct: 152 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 194
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 31/161 (19%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLRHPNIV 471
+G G+ G+V + G +AVK ++ + + + + N+ RHP+I+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKI---RSLDVVGKIRREIQNLKLFRHPHII 79
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR-------- 523
L + +V EYV G L D + R+ +R
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRRLFQQILS 127
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
++Y H VVHR+ K N+LLD +N ++D GL+ +
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 165
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 12/163 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G+ G V+R E A G++ K I+ ++ +S M++L HP ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ + +L+ E++ G L D + ++ + L+++HE S+
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SI 170
Query: 537 VHRNFKSANILLDDELNPHL--SDCGLAA-LTPNTERQVITGT 576
VH + K NI+ + + + D GLA L P+ +V T T
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 32/161 (19%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLRHPNIV 471
+GEGS G+V A + + +A+K I L + + V S + LRHP+I+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLK---KSDMHMRVEREISYLKLLRHPHII 72
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR-------- 523
L ++V EY G G L D + + R+ R
Sbjct: 73 KLYDVITTPTDIVMVIEYAG-GELFDYI------------VEKKRMTEDEGRRFFQQIIC 119
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
A+EY H +VHR+ K N+LLDD LN ++D GL+ +
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI 157
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 19/151 (12%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNIV 471
IGEG+ G VY+A+ G+ A+KKI + E++ + +S + L+H NIV
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEK------EDEGIPSTTIREISILKELKHSNIV 63
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L + +LV+E++ D+ D L L + Y H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V+HR+ K N+L++ E ++D GLA
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLA 147
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 46/214 (21%), Positives = 83/214 (38%), Gaps = 16/214 (7%)
Query: 371 PPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGE----GSLGRV 426
+ ++ S Y ++ + + I E G+ G V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 427 YRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485
+R E A G A K + +++ + + MS LRHP +V L + + ++
Sbjct: 174 HRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231
Query: 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545
+YE++ G L + + D ++ + V + L ++HE + VH + K N
Sbjct: 232 IYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPEN 285
Query: 546 ILLDDELNPHL--SDCGLAA-LTPNTERQVITGT 576
I+ + + L D GL A L P +V TGT
Sbjct: 286 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 319
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+GS G V + + + AVK I+ A+ ++ L V + +L HPNI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ +V E G L D + F++ + + ++ + Y+H+
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS---GITYMHKH- 140
Query: 533 LPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTER 570
++VHR+ K NILL + + + + D GL+ +
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++L S+ + + + I Q PN+T L L N + ++ +A++ +L +L +
Sbjct: 42 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDE 99
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N + +L L +L L N S D+ + L + SLYL NN++T + V S
Sbjct: 100 NKVKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVLSR 154
Query: 223 LP-LTTLNVANN 233
L L TL++ +N
Sbjct: 155 LTKLDTLSLEDN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 31/135 (22%), Positives = 57/135 (42%), Gaps = 12/135 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
K +L S+ D + ++ + +++ ++ I + +++ L ++
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 77
Query: 163 NSLTQSIGDIFG--NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N LT DI NL L L L N DL + L + SL L++N ++ +N
Sbjct: 78 NKLT----DIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DINGL 130
Query: 221 SGLP-LTTLNVANNH 234
LP L +L + NN
Sbjct: 131 VHLPQLESLYLGNNK 145
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 37/143 (25%), Positives = 57/143 (39%), Gaps = 7/143 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L DL L+ L N I D P L SL L +N + ++ ++ + L L++
Sbjct: 108 LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLED 165
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ I L L L LS N+ S DL L N+ L L + + + +
Sbjct: 166 NQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECL-NKPINHQ 220
Query: 223 LPLTTLNVANNHFSGWIPRELIS 245
L N N + E+IS
Sbjct: 221 SNLVVPNTVKNTDGSLVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 23/124 (18%), Positives = 46/124 (37%), Gaps = 8/124 (6%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
I NL + + + + S+ + + + + S+ I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGI- 64
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
L + L L+ N + D+ +L N+ L+L N+V L+ L L +L++ +
Sbjct: 65 QYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEH 121
Query: 233 NHFS 236
N S
Sbjct: 122 NGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 31/142 (21%), Positives = 49/142 (34%), Gaps = 17/142 (11%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
LS L L L N I D +P L +L L+ N+ S +L ++A + +L L +
Sbjct: 152 LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY-LQNNQVTGSLNVFS 221
+ NL T+ + S ++ IS + V L F+
Sbjct: 210 QECLNKPINHQSNLVVPNTVK--------NTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 261
Query: 222 GLP------LTTLNVANNHFSG 237
T+ A F G
Sbjct: 262 NEVSFIFYQPVTIGKAKARFHG 283
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 38/168 (22%), Positives = 73/168 (43%), Gaps = 21/168 (12%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G+ V+ + GK+ A+K I + + + ++ + +++H NIVTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLED 73
Query: 476 YCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEV 531
LV + V G L D + + + + + ++ L A++YLHE
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS---AVKYLHEN 125
Query: 532 CLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVITGT 576
+VHR+ K N+L ++ ++D GL+ + N GT
Sbjct: 126 ---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGT 170
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 38/164 (23%), Positives = 61/164 (37%), Gaps = 33/164 (20%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDN-------FLEAVSNMSRLRHPN 469
+G G+ G V+ A K + VK I + LE ++ +SR+ H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE-IAILSRVEHAN 90
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGN-LHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
I+ + G LV E G+G L + + R+ A
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFI------------DRHPRLDEPLASYIFRQ 138
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
A+ YL ++HR+ K NI++ ++ L D G AA
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 36/152 (23%), Positives = 67/152 (44%), Gaps = 20/152 (13%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNI 470
IGEG+ G V++A +I+A+K++ D+ +++ L + + L+H NI
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHKNI 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L + LV+E+ D+ + D + +L + L + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V+HR+ K N+L++ L++ GLA
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 8/134 (5%)
Query: 108 SLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164
++ DLS + ++ ++ +L L LA N + + + L LN+S+N
Sbjct: 276 GVKTCDLSKSKIFALLKSVFSHFT-DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNF 334
Query: 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSG 222
L +F NL L LDLS+N+ SF+ L N+ L L NQ+ S+ +F
Sbjct: 335 LGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDR 393
Query: 223 LP-LTTLNVANNHF 235
L L + + N +
Sbjct: 394 LTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 28/113 (24%), Positives = 52/113 (46%), Gaps = 5/113 (4%)
Query: 127 LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG-DIFGNLAGLATLDLS 185
LP ++ ++L+ N+ + S + + L +L V + + I + F L+ L L L
Sbjct: 28 LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87
Query: 186 FNNFSGDLPNSFISLSNISSLYLQNNQVTGSL---NVFSGLP-LTTLNVANNH 234
+N F +F L+N+ L L + G++ N F L L L + +N+
Sbjct: 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 36/165 (21%), Positives = 58/165 (35%), Gaps = 14/165 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
S L L+ + + I L +L L L N F L + +L
Sbjct: 50 FSRLQDLQFLKVEQQTPGLVIRNNTFRGL-SSLIILKLDYNQFL-QLETGAFNGLANLEV 107
Query: 158 LNVSRNSLTQSI--GDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVT 214
L +++ +L ++ G+ F L L L L NN P S F+++ L L N+V
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
Query: 215 ----GSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNS 255
L F G T L +++ L + N+
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 30/138 (21%), Positives = 49/138 (35%), Gaps = 10/138 (7%)
Query: 108 SLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNS 164
+ DLS NSI + +L L + + + + SL L + N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 165 LTQSIGDIFGNLAGLATLDLSFNNF-SGDLP-NSFISLSNISSLYLQNNQVTGSLN---V 219
Q F LA L L L+ N L N F L+++ L L++N + +
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASF 149
Query: 220 FSGLP-LTTLNVANNHFS 236
F + L++ N
Sbjct: 150 FLNMRRFHVLDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 31/168 (18%), Positives = 62/168 (36%), Gaps = 21/168 (12%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLAS---------- 138
D++ L S+ DLSGN +++ + + + S
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 139 -----NNFSG--NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG 191
NF N + + ++S++ + + +F + L L L+ N +
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK 313
Query: 192 DLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
N+F L+++ L L N + S+ +F L L L+++ NH
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 24/147 (16%), Positives = 48/147 (32%), Gaps = 23/147 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMV 153
+ L +L L+ ++ + L +L L L NN P S +M
Sbjct: 98 AFNGLANLEVLTLTQCNLDGAV---LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR 154
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLA----------TLDLSFNNFSGDLPNSFISLSNI 203
L+++ N + + N G D++ + + ++I
Sbjct: 155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI 214
Query: 204 SSLYLQNNQVTGSL--NVFSGLPLTTL 228
++L L N S+ F + T +
Sbjct: 215 TTLDLSGNGFKESMAKRFFDAIAGTKI 241
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 32/165 (19%), Positives = 54/165 (32%), Gaps = 30/165 (18%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFS----------GNLPYS 148
L SL L N+I P + L+L N ++
Sbjct: 124 FFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183
Query: 149 IASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF---ISLSNISS 205
+ + S++ +++ L + TLDLS N F + F I+ + I S
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 206 LYLQNNQVTGSL-----------NVFSGLP---LTTLNVANNHFS 236
L L N+ GS F GL + T +++ +
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 27/168 (16%), Positives = 65/168 (38%), Gaps = 23/168 (13%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G V+R E ++ K K + ++ + +S ++ RH NI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHES 69
Query: 477 CAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ ++++E++ ++ + + + + V AL++LH
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCE---ALQFLHSH 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHL--SDCGLAA-LTPNTERQVITGT 576
++ H + + NI+ + + + G A L P +++
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 21/153 (13%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNI 470
IGEG+ G VY+A G+++A+KKI D E + + +S + L HPNI
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDT------ETEGVPSTAIREISLLKELNHPNI 64
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALEYLH 529
V L + LV+E++ D+ F D S+ ++ L + L + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFL----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V+HR+ K N+L++ E L+D GLA
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 37/155 (23%), Positives = 65/155 (41%), Gaps = 22/155 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+G G+ VY+ G +A+K++ L E+ + +S M L+H NIV
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIREISLMKELKHENIVR 67
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWN----ARVRVALG-TARALEY 527
L + LV+E++ +D+ + D + T V+ + L +
Sbjct: 68 LYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
HE ++HR+ K N+L++ L D GLA
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G+ V R + G+ A I+ LS ++ L+HPNIV L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+E G L+++ V G L + + ++++ + + ++ L A+ + H++
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILE---AVLHCHQM- 129
Query: 533 LPSVVHRNFKSANILLDDELNPH---LSDCGLA 562
VVHRN K N+LL +L L+D GLA
Sbjct: 130 --GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 37/129 (28%), Positives = 54/129 (41%), Gaps = 8/129 (6%)
Query: 122 TIPYQLPPNLTSLNLASNNFSGNLP--YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
+P LP L+L+ NN S L ++ + +L L +S N L + F + L
Sbjct: 32 NVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNL 90
Query: 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
LDLS N+ F L + L L NN + + N F + L L ++ N S
Sbjct: 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 237 GWIPRELIS 245
P ELI
Sbjct: 150 -RFPVELIK 157
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 34/139 (24%), Positives = 61/139 (43%), Gaps = 12/139 (8%)
Query: 108 SLRKFDLSGNSIH----DTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSR 162
DLS N++ + P +L NL SL L+ N+ + + + +L YL++S
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLT-NLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFS 221
N L +F +L L L L N+ N+F ++ + LYL NQ++ + +
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIK 157
Query: 222 GLP----LTTLNVANNHFS 236
L L++++N
Sbjct: 158 DGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 32/148 (21%), Positives = 56/148 (37%), Gaps = 15/148 (10%)
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVS 154
+ + L +L LS N ++ I + PNL L+L+SN+ L + + + +
Sbjct: 57 EWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV-PNLRYLDLSSNHLH-TLDEFLFSDLQA 113
Query: 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL---YLQNN 211
L L + N + + F ++A L L LS N S + + L L +N
Sbjct: 114 LEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSN 173
Query: 212 QVT----GSLNVFSGLPLTTLNVANNHF 235
++ L L + NN
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 32/158 (20%), Positives = 48/158 (30%), Gaps = 7/158 (4%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S N + +P L T LN++ N S I S+ L L +S N + +
Sbjct: 6 DRSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLN 229
F L LDLS N + N+ L L N F + L L
Sbjct: 65 FKFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPS 267
++ H + + + P
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG 159
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 40/231 (17%), Positives = 89/231 (38%), Gaps = 7/231 (3%)
Query: 11 LPFSTSRLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDP 70
+ S L LTL+ ++ T +S V +T++ S+ + D
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265
Query: 71 CGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPN 130
+ G + + ++ + G + Y + ++++ F +SG + +
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325
Query: 131 LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT--QSIGDIFGNLAGLATLDLSFNN 188
L+ ++N + + + + L L + N L I ++ + L LD+S N+
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385
Query: 189 FSGDLP-NSFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVANNHFS 236
S D ++ SL + +N +T + +F LP + L++ +N
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDT--IFRCLPPRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 31/139 (22%), Positives = 54/139 (38%), Gaps = 14/139 (10%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQ-----LPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
L L L N + + +L L+++ N+ S + + SL LN
Sbjct: 347 LTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-- 217
+S N LT +I + LDL N +P + L + L + +NQ+ S+
Sbjct: 406 MSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD 461
Query: 218 NVFSGLP-LTTLNVANNHF 235
+F L L + + N +
Sbjct: 462 GIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 31/173 (17%), Positives = 60/173 (34%), Gaps = 17/173 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L R FD SG S+ L+ + S+ F Y +++ N +
Sbjct: 259 LQGQLDFRDFDYSGTSLK---------ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ---VTGSLNV 219
+ ++ LD S N + + + L+ + +L LQ NQ ++ +
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM 369
Query: 220 FSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDNGPAPPPPPS 267
+ + L L+++ N S + S+ + N + PP
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR 422
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 26/138 (18%), Positives = 47/138 (34%), Gaps = 10/138 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L LR +S N I + ++ L L+L+ N + V+L +L+
Sbjct: 41 ILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLD 96
Query: 160 VSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GS 216
+S N+ I FGN++ L L LS + L+ L +
Sbjct: 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED 156
Query: 217 LNVFSGLPLTTLNVANNH 234
+L++
Sbjct: 157 PEGLQDFNTESLHIVFPT 174
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 21/141 (14%), Positives = 48/141 (34%), Gaps = 10/141 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI---ASMVSLSYLN 159
LS++ + + + + Q P L++L L + + N I ++ Y +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 160 VSRNSLT-----QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214
+S L + +L L+ + + F + SN++ +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 215 G-SLNVFSGLP-LTTLNVANN 233
+ S + L+ +NN
Sbjct: 314 MVHMLCPSKISPFLHLDFSNN 334
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 5e-14
Identities = 50/185 (27%), Positives = 74/185 (40%), Gaps = 38/185 (20%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-------SLQEEDNFLEAVSN 461
N FS +IG G G VY GK+ A+K +D + E L VS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVR 516
P IV ++ Y +L + + + G+LH L F++ +R
Sbjct: 249 G---DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---------DMR 295
Query: 517 -----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571
+ L LE++H VV+R+ K ANILLD+ + +SD GLA +
Sbjct: 296 FYAAEIIL----GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 572 VITGT 576
GT
Sbjct: 349 ASVGT 353
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 44/168 (26%), Positives = 64/168 (38%), Gaps = 22/168 (13%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG GS G V A A KKI + + E + M L HPNI+ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQE-IEIMKSLDHPNIIRLYET 74
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
++ LV E G L + + F + + + ++ L A+ Y H++
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLS---AVAYCHKL- 125
Query: 533 LPSVVHRNFKSANILL---DDELNPHLSDCGLAA-LTPNTERQVITGT 576
+V HR+ K N L + L D GLAA P + GT
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGT 171
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 14/165 (8%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDN---FLEAVSNMSRLRHPNIVTL 473
+G G+ G+V++ F G ++AVK++ S +E+N ++ + P IV
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + + E +G + ++ + +AL YL E
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEK-- 143
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVITGTS 577
V+HR+ K +NILLD+ L D G++ L + + G +
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCA 188
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 45/168 (26%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-------SLQEEDNFLEAVSN 461
+ F ++G G G V+ + A GK+ A KK++ L E L V
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWN-ARVR--- 516
IV+LA Y E L LV + G++ H + N + R
Sbjct: 244 -----SRFIVSLA-YAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYT 295
Query: 517 --VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ LE+LH+ ++++R+ K N+LLDD+ N +SD GLA
Sbjct: 296 AQIVS----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 27/201 (13%)
Query: 383 AKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKI 442
K L I + + + +++ +IG GS G V++A+ +A+KK+
Sbjct: 13 VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV 72
Query: 443 DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL------LVYEYVGNGNLH 496
LQ++ + M ++HPN+V L + +G + LV EYV ++
Sbjct: 73 ------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 497 DMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCLPSVVHRNFKSANILLD---DEL 552
+ + +++ + R+L Y+H + + HR+ K N+LLD L
Sbjct: 126 RASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVL 181
Query: 553 NPHLSDCGLA----ALTPNTE 569
L D G A A PN
Sbjct: 182 K--LIDFGSAKILIAGEPNVS 200
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 37/165 (22%), Positives = 67/165 (40%), Gaps = 30/165 (18%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAG 475
++G GS G V G+ +AVK++ + D L + ++ HPN++
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDHPNVIRY-- 74
Query: 476 YCAEHGQRL--LVYEYVGNGNLHDML---HFADDSSKNLTWNARVRVALGTARALEYLHE 530
YC+E R + E NL D++ + +D++ K + + A + +LH
Sbjct: 75 YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 531 VCLPSVVHRNFKSANILLDDELNPH-------------LSDCGLA 562
+ ++HR+ K NIL+ +SD GL
Sbjct: 134 L---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 24/191 (12%), Positives = 51/191 (26%), Gaps = 35/191 (18%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKID--------------------------NAALSL 449
++G+ A G+ V
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLLVYEYVG--NGNLHDMLHFADDS 505
+ F+ + + ++ + + R +Y + ++L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 506 SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565
K+L +AR+++ L R L LH +VH + +I+LD L+
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 260
Query: 566 PNTERQVITGT 576
G
Sbjct: 261 DGASAVSPIGR 271
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 41/187 (21%), Positives = 70/187 (37%), Gaps = 24/187 (12%)
Query: 392 KSPITATSYTVASLQTATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAA 446
I+ + + F + +IG+G V R G+ AVK +D A
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 447 LSLQEEDNFLEAVSN----MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA 502
+ E + L+HP+IV L + G +V+E++ +L +
Sbjct: 62 FT-SSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 503 DDSSKNLTWNARVRVALGTAR----ALEYLHEVCLPSVVHRNFKSANILLDDELNPH--- 555
D+ + VA R AL Y H+ +++HR+ K +LL + N
Sbjct: 121 ADAGFVYS----EAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVK 173
Query: 556 LSDCGLA 562
L G+A
Sbjct: 174 LGGFGVA 180
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 29/134 (21%), Positives = 58/134 (43%), Gaps = 13/134 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L + K +L S+ D + + + + N ++N +L + +L L++S
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSH 72
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N ++ D+ +L L L ++ N +L I + +S L+L NN++ +
Sbjct: 73 NQIS----DLSPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELR-DTDSL 124
Query: 221 SGLP-LTTLNVANN 233
L L L++ NN
Sbjct: 125 IHLKNLEILSIRNN 138
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 35/134 (26%), Positives = 61/134 (45%), Gaps = 11/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+L ++ F+ ++I Q NL L+L+ N S +L + + L L+V+R
Sbjct: 37 QKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNR 94
Query: 163 NSLTQSIGDIFG-NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N L ++ G A L+ L L N D + I L N+ L ++NN++ S+ +
Sbjct: 95 NRLK----NLNGIPSACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SIVMLG 147
Query: 222 GLP-LTTLNVANNH 234
L L L++ N
Sbjct: 148 FLSKLEVLDLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 24/120 (20%), Positives = 43/120 (35%), Gaps = 7/120 (5%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
I+ P N NL + + + + + N +++ S+ +
Sbjct: 4 QRPTPINQVFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGM- 59
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANN 233
L L LS N S DL L+ + L + N++ +LN L+ L + NN
Sbjct: 60 QFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNN 116
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 47/171 (27%), Positives = 65/171 (38%), Gaps = 23/171 (13%)
Query: 402 VASLQTATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL 456
V L + F+ + IG GS R A AVK ID + EE
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---- 65
Query: 457 EAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV 515
+ + R +HPNI+TL + +V E + G L D + K +
Sbjct: 66 --IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREAS 119
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLA 562
V + +EYLH VVHR+ K +NIL DE + D G A
Sbjct: 120 AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 27/172 (15%), Positives = 59/172 (34%), Gaps = 17/172 (9%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L S L L+ + I + L L + +++ P S+ S+ ++S+L
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHL 203
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLS--------FNNFSGDLPNSFISLSNISSLYLQN 210
+ + + + L+L F+ S NS I ++ + +
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 211 NQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
+ + + + + L L + N +P L S++ N +D
Sbjct: 264 ESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 4/132 (3%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
S S+ ++IP L + SL+L++N + + V+L L ++ N + D
Sbjct: 37 KGSSGSL-NSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS 95
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLN 229
F +L L LDLS+N S + F LS+++ L L N G ++FS L L L
Sbjct: 96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 230 VANNHFSGWIPR 241
V N I R
Sbjct: 156 VGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 21/149 (14%), Positives = 46/149 (30%), Gaps = 14/149 (9%)
Query: 102 LLSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
L SL +L GN ++ +T + L L + + + + A + L
Sbjct: 119 WFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-- 215
L + + L ++ ++ L L L S++ L L++ +
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238
Query: 216 ----SLNVFSGLP----LTTLNVANNHFS 236
S + L + + +
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF 267
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 39/171 (22%), Positives = 70/171 (40%), Gaps = 22/171 (12%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNI 470
++G G + V+ A + + +AVK + L + +F EA + + L HP I
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLR---ADLARDPSFYLRFRREAQN-AAALNHPAI 74
Query: 471 VTLAGYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
V + +V EYV L D++H + +T + V +AL
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALN 130
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVITGT 576
+ H+ ++HR+ K ANI++ + D G+A A+ + T
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 30/163 (18%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVS-----------NMSRL 465
IG G+ G VY+A + +G +A+K + + + +
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV-----RVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 466 RHPNIVTL----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
HPN+V L A + ++ LV+E+V D+ + D + ++ +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 521 -TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
R L++LH C +VHR+ K NIL+ L+D GLA
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA 167
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 48/167 (28%), Positives = 66/167 (39%), Gaps = 31/167 (18%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSN 461
N+F Q ++G+G G V + A GK+ A KK+ E LE V+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN- 242
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR---- 516
+V+LA Y E L LV + G+L H AR
Sbjct: 243 -----SRFVVSLA-YAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFP-EARAVFYAA 293
Query: 517 -VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ LE LH +V+R+ K NILLDD + +SD GLA
Sbjct: 294 EICC----GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 37/124 (29%), Positives = 51/124 (41%), Gaps = 5/124 (4%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S IP +P + L+L SN S + + L L ++ N L I
Sbjct: 22 DCSSKK-LTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI 80
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLN 229
F L L TL ++ N F L N++ L L NQ+ SL VF L LT L+
Sbjct: 81 FKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS 139
Query: 230 VANN 233
+ N
Sbjct: 140 LGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 37/137 (27%), Positives = 58/137 (42%), Gaps = 10/137 (7%)
Query: 104 SDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
+L +L ++ N + +P + NL L L N +LP + S+ L+YL+
Sbjct: 82 KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS 139
Query: 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ N L QS+ +F L L L L N +F L+ + +L L NNQ+
Sbjct: 140 LGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE 198
Query: 218 NVFSGLP-LTTLNVANN 233
F L L L + N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-13
Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 11/144 (7%)
Query: 122 TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181
IP LP +T + L N P + + L +++S N +++ D F L L +
Sbjct: 25 EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84
Query: 182 LDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFSG 237
L L N + +LP S F L ++ L L N++ L + F L L L++ +N
Sbjct: 85 LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQT 142
Query: 238 WIPRE----LISIRTFIYDGNSFD 257
I + L +I+T N F
Sbjct: 143 -IAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 33/146 (22%), Positives = 62/146 (42%), Gaps = 25/146 (17%)
Query: 113 DLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNS 164
L N+I +PP L ++L++N S L + SL+ L + N
Sbjct: 38 RLEQNTIK-----VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGL 223
+T+ +F L L L L+ N + ++F L N++ L L +N++ + FS L
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 224 P-LTTLNVANN---------HFSGWI 239
+ T+++A N + ++
Sbjct: 152 RAIQTMHLAQNPFICDCHLKWLADYL 177
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 33/114 (28%), Positives = 47/114 (41%), Gaps = 8/114 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
S LR+ DLS N I + L +L SL L N + LP S+ + SL
Sbjct: 52 FSPYKKLRRIDLSNNQIS-ELAPDAFQGLR-SLNSLVLYGNKIT-ELPKSLFEGLFSLQL 108
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
L ++ N + D F +L L L L N +F L I +++L N
Sbjct: 109 LLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 34/159 (21%), Positives = 66/159 (41%), Gaps = 26/159 (16%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQE--EDNFLEAVSN----MSRLRHPNI 470
+G G+ G V A E K +A++ I ++ E + V + +L HP I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALE 526
+ + + + +V E + G L D + + + K + A++
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ--------MLLAVQ 253
Query: 527 YLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLA 562
YLHE ++HR+ K N+LL +++ ++D G +
Sbjct: 254 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 38/159 (23%), Positives = 57/159 (35%), Gaps = 29/159 (18%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG G+ G +++AVK I+ A ++N + N LRHPNIV
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKE 83
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALEY 527
++ EY G L++ + R + AR + Y
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI------------CNAGRFSEDEARFFFQQLLSGVSY 131
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHL--SDCGLAAL 564
H + + HR+ K N LLD P L D G +
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 9e-13
Identities = 47/204 (23%), Positives = 78/204 (38%), Gaps = 36/204 (17%)
Query: 385 SGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKID 443
+GSL+ + P F ++GEGS V A E A + A+K ++
Sbjct: 12 AGSLQHAQPPPQPRKKRP-------EDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 444 NAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDML-- 499
+ + MSRL HP V L + + ++L Y NG L +
Sbjct: 65 KRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRK 123
Query: 500 --HFADDSSKNLTWNARVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552
F + R + ALEYLH ++HR+ K NILL++++
Sbjct: 124 IGSFDET---------CTRFYTAEIVS----ALEYLHGK---GIIHRDLKPENILLNEDM 167
Query: 553 NPHLSDCGLAALTPNTERQVITGT 576
+ ++D G A + +Q +
Sbjct: 168 HIQITDFGTAKVLSPESKQARANS 191
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 22/156 (14%), Positives = 51/156 (32%), Gaps = 13/156 (8%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
G + ++A A + +A+ +D L L +SR+ P + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
L+V E++ G+L ++ + + +R A A + H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
V + + + + + L+ A + +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAY--PATMPDANPQ 182
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 30/162 (18%)
Query: 418 IGEGSLGRVYRA--EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVS---NMSRLR 466
IGEG+ G+V++A G+ +A+K++ E+ + V+ ++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT------GEEGMPLSTIREVAVLRHLETFE 72
Query: 467 HPNIVTL----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG- 520
HPN+V L + +L LV+E+V D+ + D + ++ +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
R L++LH VVHR+ K NIL+ L+D GLA
Sbjct: 129 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 41/210 (19%), Positives = 74/210 (35%), Gaps = 36/210 (17%)
Query: 384 KSGSLKKIKSPITATSYTVASLQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMA 438
SG I ++ + + +G G+ G V + A
Sbjct: 8 SSGRENLYFQGIAINPGMY--VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKA 65
Query: 439 VKKIDNAALS-----------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487
+K I + + + +S + L HPNI+ L + LV
Sbjct: 66 IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVT 125
Query: 488 EYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543
E+ G L + + F + + N+ ++ L + YLH+ ++VHR+ K
Sbjct: 126 EFYEGGELFEQIINRHKFDECDAANI-----MKQILS---GICYLHKH---NIVHRDIKP 174
Query: 544 ANILL---DDELNPHLSDCGLAALTPNTER 570
NILL + LN + D GL++ +
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 39/172 (22%), Positives = 68/172 (39%), Gaps = 12/172 (6%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142
+ + S+D ++ G + L L K + N+I T+ NLT L SN +
Sbjct: 42 ATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNI-TTLDLSQNTNLTYLACDSNKLT 98
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
NL + + L+YLN N LT+ L L+ + N + ++ S +
Sbjct: 99 -NLD--VTPLTKLTYLNCDTNKLTK---LDVSQNPLLTYLNCARNTLT-EIDVS--HNTQ 149
Query: 203 ISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGN 254
++ L N+ L+V LTTL+ + N + + + D N
Sbjct: 150 LTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTN 201
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 30/135 (22%), Positives = 53/135 (39%), Gaps = 12/135 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++ L L + N + + P LT LN A N + + ++ L+ L+
Sbjct: 102 VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHL 157
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N + L TLD SFN + +L S ++ L N +T L+ +
Sbjct: 158 NKKITKLD--VTPQTQLTTLDCSFNKIT-ELDVS--QNKLLNRLNCDTNNIT-KLD-LNQ 210
Query: 223 LP-LTTLNVANNHFS 236
LT L+ ++N +
Sbjct: 211 NIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 34/150 (22%), Positives = 53/150 (35%), Gaps = 10/150 (6%)
Query: 91 SGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
+ + T L +L D +SI D + LT L SNN + L ++
Sbjct: 26 AAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT-TLD--LS 82
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
+L+YL N LT L L L+ N + L S ++ L
Sbjct: 83 QNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLNCAR 136
Query: 211 NQVTGSLNVFSGLPLTTLNVANNHFSGWIP 240
N +T ++V LT L+ N +
Sbjct: 137 NTLT-EIDVSHNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 28/153 (18%), Positives = 54/153 (35%), Gaps = 12/153 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+S L + + N++ I LT L+ N L + L+ L+ S
Sbjct: 123 VSQNPLLTYLNCARNTL-TEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T+ L L+ NN + L + ++ L +N++T ++ +
Sbjct: 180 NKITELD---VSQNKLLNRLNCDTNNIT-KLDLN--QNIQLTFLDCSSNKLT-EID-VTP 231
Query: 223 LP-LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
L LT + + N + L + T
Sbjct: 232 LTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 23/134 (17%), Positives = 49/134 (36%), Gaps = 10/134 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+S L + + N+I + LT L+ +SN + + + + L+Y + S
Sbjct: 187 VSQNKLLNRLNCDTNNI-TKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSV 242
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N LT + L+ L TL + ++ + + + + + L+V
Sbjct: 243 NPLT-EL--DVSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKIKELDVTHN 296
Query: 223 LPLTTLNVANNHFS 236
L L+ +
Sbjct: 297 TQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 19/135 (14%), Positives = 41/135 (30%), Gaps = 10/135 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L F G + L L+ + + L ++ L YL ++
Sbjct: 271 LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNN 327
Query: 163 NSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
LT ++ + L +L + D S + +++ + Q
Sbjct: 328 TELT----ELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETL 381
Query: 222 GLPLTTLNVANNHFS 236
T+ V+ +
Sbjct: 382 TNNSLTIAVSPDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 32/140 (22%), Positives = 55/140 (39%), Gaps = 11/140 (7%)
Query: 117 NSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176
S +D P N S A+ S + +L+ L+ +S+T G L
Sbjct: 9 QSFNDWFP---DDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKL 63
Query: 177 AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHF 235
GL L + NN + L S +N++ L +N++T +L+ + L LT LN N
Sbjct: 64 TGLTKLICTSNNIT-TLDLS--QNTNLTYLACDSNKLT-NLD-VTPLTKLTYLNCDTNKL 118
Query: 236 SGWIPRELISIRTFIYDGNS 255
+ + + N+
Sbjct: 119 TKLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 15/122 (12%), Positives = 39/122 (31%), Gaps = 8/122 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++ L D I + + P L L L + + L ++ L L+
Sbjct: 293 VTHNTQLYLLDCQAAGITE-LDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVN 348
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
+ G + L + +P ++ +++ ++ + + + N +
Sbjct: 349 AHIQ-DF-SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLDQFGNPMNI 404
Query: 223 LP 224
P
Sbjct: 405 EP 406
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 40/169 (23%), Positives = 67/169 (39%), Gaps = 23/169 (13%)
Query: 408 ATNSFSQEF---------LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLE 457
+T+SFS F ++GEG+ RV + AVK I+ F E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFRE 60
Query: 458 AVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
V + + + H N++ L + E + LV+E + G++ +H ++
Sbjct: 61 -VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASV 115
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH---LSDCGLA 562
V A AL++LH + HR+ K NIL + + D L
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 28/176 (15%)
Query: 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
S++ +IG GS G VY+A+ +G+++A+KK+ LQ++ + M +L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDH 106
Query: 468 PNIVTLAGYCAEHGQRL------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-G 520
NIV L + G++ LV +YV ++ + + + L V++ +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQ 164
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLA-ALT---PNTE 569
R+L Y+H + HR+ K N+LLD L L D G A L PN
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLK--LCDFGSAKQLVRGEPNVS 215
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 33/145 (22%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 122 TIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA 180
IP +P L L +N F+ I + L +N S N +T F +G+
Sbjct: 25 KIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84
Query: 181 TLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
+ L+ N ++ + F L ++ +L L++N++T + + F GL + L++ +N +
Sbjct: 85 EILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 237 GWIPRE----LISIRTFIYDGNSFD 257
+ L S+ T N F+
Sbjct: 143 T-VAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 34/143 (23%), Positives = 60/143 (41%), Gaps = 18/143 (12%)
Query: 113 DLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQS 168
L+ N ++ P L +N ++N + ++ ++ + ++ N L
Sbjct: 38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENV 96
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-L 225
+F L L TL L N + +SFI LS++ L L +NQ+T ++ F L L
Sbjct: 97 QHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSL 155
Query: 226 TTLNVANNHF---------SGWI 239
+TLN+ N F W+
Sbjct: 156 STLNLLANPFNCNCYLAWLGEWL 178
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 29/159 (18%), Positives = 43/159 (27%), Gaps = 31/159 (19%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
S R F + + IP LP N L + + L + +S+N + +
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 168 SIG--------------------------DIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
I + F NL L L +S I
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 202 NISSLYLQ-NNQVTG-SLNVFSGLP--LTTLNVANNHFS 236
L +Q N + N F GL L + N
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 31/207 (14%), Positives = 58/207 (28%), Gaps = 14/207 (6%)
Query: 101 YLLSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS 156
L D+ N +I L L L N + S + L
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLD 180
Query: 157 YLNVSR-NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
LN+S N+L + D+F +G LD+S +L + + N +
Sbjct: 181 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK--- 237
Query: 216 SLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGR 274
L L L ++ + R I + + N +
Sbjct: 238 KLPTLEKLVALMEASLTYP----SHCCAFANWRRQISELHPICNKSILRQEVDYMTQARG 293
Query: 275 SHNNRSHRQGSHSPSGSQSSSSDKELP 301
++ + S G + ++ +
Sbjct: 294 QRSSLAEDNESSYSRGFDMTYTEFDYD 320
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 24/141 (17%), Positives = 44/141 (31%), Gaps = 9/141 (6%)
Query: 104 SDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
S+L L + + I+ LP NL L +++ + L+
Sbjct: 76 SNLPKLHEIRIEKANNLLYINPEAFQNLP-NLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 160 VSRNSLTQSIGD-IFGNLAG-LATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
+ N +I F L+ L L+ N ++F NN +
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 217 LNVFSGLP-LTTLNVANNHFS 236
+VF G L+++
Sbjct: 195 NDVFHGASGPVILDISRTRIH 215
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 35/159 (22%), Positives = 65/159 (40%), Gaps = 26/159 (16%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
+G G+ G V A E K +A+K I ++ A + + +L HP I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALE 526
+ + + + +V E + G L D + + + K L A++
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQ 128
Query: 527 YLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLA 562
YLHE ++HR+ K N+LL +++ ++D G +
Sbjct: 129 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 35/169 (20%), Positives = 61/169 (36%), Gaps = 32/169 (18%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLRH--PN 469
L+G G G VY ++ +A+K ++ +S E V + ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 470 IVTLAGYCAEHGQRLLVYEYV-GNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
++ L + +L+ E +L D + R + AR
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT------------ERGALQEELARSFFWQ 157
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNT 568
A+ + H V+HR+ K NIL+D + L D G AL +T
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 35/185 (18%), Positives = 66/185 (35%), Gaps = 55/185 (29%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKID--------------------NAALSLQEEDNF 455
IG+GS G V A + A+K + A +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 456 LEAV----SNMSRLRHPNIVTLAGY----CAEHGQRLLVYEYVGNGNLHDMLHFADDSSK 507
+E V + + +L HPN+V L +V+E V G + ++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVP-------- 129
Query: 508 NLTWNARVRVALGTAR--------ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559
++ AR +EYLH ++HR+ K +N+L+ ++ + ++D
Sbjct: 130 -----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 560 GLAAL 564
G++
Sbjct: 182 GVSNE 186
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 36/187 (19%), Positives = 71/187 (37%), Gaps = 26/187 (13%)
Query: 404 SLQTATNSFSQEF-----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLE 457
+ + + ++ ++G G G+V G+ A+K + ++ + QE
Sbjct: 18 GPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE------ 71
Query: 458 AVSNMSRL-RHPNIVTLAGYC--AEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWN 512
V + + P+IV + HG+R L++ E + G L + + T
Sbjct: 72 -VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTER 128
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTE 569
+ A+++LH ++ HR+ K N+L + + L+D G A T
Sbjct: 129 EAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
Query: 570 RQVITGT 576
Q T
Sbjct: 186 LQTPCYT 192
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 34/158 (21%), Positives = 57/158 (36%), Gaps = 24/158 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
+ N + L + L L N S +LP ++ ++ L ++
Sbjct: 32 AWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEIT 88
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
+N+L S+ ++ + L LD N S LP SL + L + NNQ +
Sbjct: 89 QNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKH---LDVDNNQ-------LT 133
Query: 222 GLP-----LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
LP L +N NN + +P S+ N
Sbjct: 134 MLPELPALLEYINADNNQLTM-LPELPTSLEVLSVRNN 170
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 24/146 (16%), Positives = 48/146 (32%), Gaps = 8/146 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS----Y 157
L SL + N + +P +LP +L +L++++N +LP +
Sbjct: 155 LPELPTSLEVLSVRNNQLT-FLP-ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIF 211
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
N +T I + +L T+ L N S + S + + + S
Sbjct: 212 FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSD 270
Query: 218 NVFSGLPLTTLNVANNHFSGWIPREL 243
+ L + F ++
Sbjct: 271 GQQNTLHRPLADAVTAWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 19/131 (14%), Positives = 44/131 (33%), Gaps = 12/131 (9%)
Query: 103 LSDLL-SLRKFDLSGNSIHDTIP------YQLPPNLTSLNLASNNFSGNLPYSIASMVSL 155
L +L SL D+S N + ++P + N + ++P +I S+
Sbjct: 175 LPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPT 232
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATL---DLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ + N L+ I + + F+ G L++ + + N+
Sbjct: 233 CTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENK 292
Query: 213 VTGSLNVFSGL 223
+ ++
Sbjct: 293 QSDVSQIWHAF 303
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 43/194 (22%), Positives = 62/194 (31%), Gaps = 45/194 (23%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG+GS G V A E I A+K ++ + + ++ + V M +L HPNI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR---------- 523
+ LV E G+L D L+ D S V+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 524 --------------------------ALEYLHEVCLPSVVHRNFKSANILL--DDELNPH 555
AL YLH + HR+ K N L +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 556 LSDCGLAALTPNTE 569
L D GL+
Sbjct: 211 LVDFGLSKEFYKLN 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 26/148 (17%), Positives = 55/148 (37%), Gaps = 10/148 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
S+L ++ + +S + + Y L +T + + + + + L +
Sbjct: 51 FSNLPNISRIYVSIDVTLQQLESHSFYNLS-KVTHIEIRNTRNLTYIDPDALKELPLLKF 109
Query: 158 LNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNIS-SLYLQNNQVT 214
L + L + L+++ N + +P N+F L N + +L L NN T
Sbjct: 110 LGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
Query: 215 G-SLNVFSGLPLTTLNVANNHFSGWIPR 241
F+G L + + N + I +
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDK 197
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 26/145 (17%), Positives = 52/145 (35%), Gaps = 15/145 (10%)
Query: 104 SDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLP--YSIASMVSLSY 157
+L + ++ I +LP L L + + P + S
Sbjct: 77 YNLSKVTHIEIRNTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFI 134
Query: 158 LNVSRNSLTQSI-GDIFGNLAG-LATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
L ++ N SI + F L TL L N F+ + + + + ++YL N+
Sbjct: 135 LEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT 193
Query: 216 SL--NVFSGLP--LTTLNVANNHFS 236
+ + F G+ + L+V+ +
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 26/133 (19%), Positives = 48/133 (36%), Gaps = 30/133 (22%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
F ++ I IP LPP+ +L L + +I S
Sbjct: 12 QEEDFRVTCKDIQ-RIP-SLPPSTQTLKLIETHLR-----TIPS---------------- 48
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSL--NVFSGLP 224
F NL ++ + +S + L +SF +LS ++ + ++N + + + LP
Sbjct: 49 ---HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP 105
Query: 225 -LTTLNVANNHFS 236
L L + N
Sbjct: 106 LLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 23/115 (20%), Positives = 47/115 (40%), Gaps = 10/115 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQ----LPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
+ +++ N +IP L +L L +N F+ ++ + L +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 159 NVSRNSLTQSI-GDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+++N I D FG + G + LD+S + + LP+ L ++ L +N
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 33/170 (19%), Positives = 60/170 (35%), Gaps = 32/170 (18%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLR----H 467
L+G+G G V+ + +A+K I + + + + ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR---- 523
P ++ L + +LV E D+ + + + G +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQ--DLFDYIT---------EKGPLGEGPSRCFFG 146
Query: 524 ----ALEYLHEVCLPSVVHRNFKSANILLDDELNP-HLSDCGLAALTPNT 568
A+++ H VVHR+ K NIL+D L D G AL +
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 30/180 (16%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH 467
+ F IG+GS G+V + K+ A+K ++ + E N + + M L H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 468 PNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVR-----V 517
P +V L Y + + + +V + + G+L L HF ++ V+ +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---------TVKLFICEL 124
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVITGT 576
+ AL+YL ++HR+ K NILLD+ + H++D +AA L T+ + GT
Sbjct: 125 VM----ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGT 177
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 43/156 (27%), Positives = 64/156 (41%), Gaps = 23/156 (14%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
+ LS NSI +L L L L+ N +L + + L YL+
Sbjct: 53 RTKALSLSQNSIS-----ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLD 106
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS--FISLSNISSLYLQNNQVT-GS 216
VS N L Q+I +A L LDLSFN+F LP F +L+ ++ L L +
Sbjct: 107 VSHNRL-QNIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 217 LNVFSGLPLTT--LNVANNHFSGWIPRELISIRTFI 250
L + L L+ L++ + H G L T +
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV 198
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 30/124 (24%), Positives = 50/124 (40%), Gaps = 7/124 (5%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S ++ +P LPP +L+L+ N+ S I+ + L L +S N + +
Sbjct: 37 DYSNRNLT-HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHV 95
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ--VTGSLNVFSGLP-LTTLN 229
F L LD+S N + ++++ L L N V F L LT L
Sbjct: 96 FLFNQDLEYLDVSHNRLQN-IS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152
Query: 230 VANN 233
++
Sbjct: 153 LSAA 156
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 29/167 (17%), Positives = 57/167 (34%), Gaps = 12/167 (7%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGN-----LPYSIASMVSLSYLNVS 161
++L+ + + + P + LN+ + + YS ++ SL +V
Sbjct: 254 VTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-LNVF 220
S ++ A + LS ++ S S+ + L N T S
Sbjct: 314 NQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGC 373
Query: 221 SGLP-LTTLNVANNHFSGW-----IPRELISIRTFIYDGNSFDNGPA 261
S L L TL + N + + + + S+ T NS ++
Sbjct: 374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 1/94 (1%)
Query: 96 SGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSL 155
S + S+ +LS N + ++ LPP + L+L +N ++P + + +L
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQAL 475
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189
LNV+ N L +F L L + L N +
Sbjct: 476 QELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 33/141 (23%), Positives = 54/141 (38%), Gaps = 18/141 (12%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQ--LPPNLTSLNLASNNFSGNLPYSIASMV-----SLSYL 158
L L+ L N + + N++SL + +L S+ L
Sbjct: 376 LKRLQTLILQRNGLK-NFFKVALMTKNMSSLET-LDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 159 NVSRNSLTQSIGDIFGNL-AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
N+S N LT S+ F L + LDL N +P L + L + +NQ+ S+
Sbjct: 434 NLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SV 488
Query: 218 --NVFSGLP-LTTLNVANNHF 235
VF L L + + +N +
Sbjct: 489 PDGVFDRLTSLQYIWLHDNPW 509
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 27/170 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEGS + + + AVK I + Q+E L+ HPNIV L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG-----HPNIVKLHE 73
Query: 476 YCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ LV E + G L + + HF++ + + +R + A+ ++H+V
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVS---AVSHMHDV 125
Query: 532 CLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVIT--GT 576
VVHR+ K N+L +D L + D G A L P + + T T
Sbjct: 126 ---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 6e-11
Identities = 25/107 (23%), Positives = 42/107 (39%), Gaps = 6/107 (5%)
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
R L+ + + +T L+L+ N LP ++A++ L L S N+L ++
Sbjct: 444 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPN--SFISLSNISSLYLQNNQVT 214
+ NL L L L N +S + L LQ N +
Sbjct: 502 DGV-ANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 28/144 (19%), Positives = 51/144 (35%), Gaps = 10/144 (6%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQL-----PPNLTSLNLASNNFSGNLPYSIASMVSL 155
LL+ +L +R D + P L+ + F +
Sbjct: 384 CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV 443
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
L+++ LT + + L + LDLS N LP + +L + L +N +
Sbjct: 444 RVLHLAHKDLT-VLCHL-EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499
Query: 216 SLNVFSGLP-LTTLNVANNHFSGW 238
+++ + LP L L + NN
Sbjct: 500 NVDGVANLPRLQELLLCNNRLQQS 523
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 46/228 (20%), Positives = 84/228 (36%), Gaps = 34/228 (14%)
Query: 355 MHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQ 414
MH S E L + ++ + + Y + + ++ S
Sbjct: 1 MHHHHHHSSGV-----DLGTENLYFQSMSSVTASAAPGTASLVPDYWI--DGSNRDALSD 53
Query: 415 EF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
F +G G+ VYR + K A+K + ++ + + RL HPN
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPN 109
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARAL 525
I+ L + LV E V G L D + ++++ + + V+ L A+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILE---AV 161
Query: 526 EYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTER 570
YLHE +VHR+ K N+L + ++D GL+ + +
Sbjct: 162 AYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 33/120 (27%), Positives = 52/120 (43%), Gaps = 4/120 (3%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
D++P +P + L+L S + + + L++LN+ N L +F +L L
Sbjct: 26 LDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGL-PLTTLNVANNHFS 236
TL L+ N + F L+ + LYL NQ+ SL VF L L L + N
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 53/197 (26%), Positives = 77/197 (39%), Gaps = 31/197 (15%)
Query: 71 CGESWKGVACEGSAVVSI------DISGLGLSGTMGYLLSD-----LLSLRKFDLSGNSI 119
C E K V C+G ++ S+ D L L T LSD L L +L N +
Sbjct: 12 CNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL 71
Query: 120 HDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQSIGDIFGN 175
T+ + L +L LA+N + +LP + + L L + N L +F
Sbjct: 72 -QTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDR 129
Query: 176 LAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVAN 232
L L L L+ N +P F L+N+ +L L NQ+ F L L T+ +
Sbjct: 130 LTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188
Query: 233 NHF----------SGWI 239
N F S WI
Sbjct: 189 NQFDCSRCEILYLSQWI 205
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 24/177 (13%)
Query: 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKI-DNAALSLQEEDNFLEAVSNMSRLR 466
+ F E + G+G+ G V + G +A+KK+ + +E L+ + +++ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQDLAVLH 77
Query: 467 HPNIVTLAGYCAEHGQR-------LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
HPNIV L Y G+R +V EYV + LH ++V L
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PILIKVFL 135
Query: 520 -GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC--GLA----ALTPNTE 569
R++ LH + +V HR+ K N+L+++ + L C G A PN
Sbjct: 136 FQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPSEPNVA 190
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 49/236 (20%)
Query: 350 NMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTAT 409
+ E E+R + A+ + ++ E +SGS T
Sbjct: 87 TFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVT 146
Query: 410 -NSFSQEFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEA 458
N F E+L +G+G+ G+V + A G+ A+K + + E+ L+
Sbjct: 147 MNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 459 VSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTW 511
RHP + L Y + RL V EY G L H F++D
Sbjct: 205 S------RHPFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSED------- 248
Query: 512 NARVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
R R + AL+YLH +VV+R+ K N++LD + + ++D GL
Sbjct: 249 --RARFYGAEIVS----ALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 57/217 (26%), Positives = 85/217 (39%), Gaps = 49/217 (22%)
Query: 368 DLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFL--IGEGSLGR 425
D P E L + SG +++ K + AS F + L IG GS +
Sbjct: 11 DYDIPTTENLYFQGAMGSG-IEEEKEAMNTRESGKASSSLGLQDF--DLLRVIGRGSYAK 67
Query: 426 VYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
V +I A++ + D +Q E + E SN HP +V L C
Sbjct: 68 VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-----HPFLVGLH-SC 121
Query: 478 AEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR-----VALGTARAL 525
+ RL V EYV G+L M H ++ R ++L AL
Sbjct: 122 FQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEE---------HARFYSAEISL----AL 166
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
YLHE +++R+ K N+LLD E + L+D G+
Sbjct: 167 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 48/170 (28%), Positives = 70/170 (41%), Gaps = 46/170 (27%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
+ L IG GS +V +I A+K + D +Q E + E SN
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN--- 68
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP +V L C + RL V EYV G+L M H ++ R
Sbjct: 69 --HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEE---------HARF 114
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++L AL YLHE +++R+ K N+LLD E + L+D G+
Sbjct: 115 YSAEISL----ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 40/231 (17%), Positives = 77/231 (33%), Gaps = 28/231 (12%)
Query: 355 MHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQ 414
+ + +S PP + + + LQ N+
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 415 EF-----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RH 467
++ ++G G G+V + + A+K + + + +E V R +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-------VELHWRASQC 114
Query: 468 PNIVTLAGYCAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
P+IV + L+V E + G L D + T +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIGE 172
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTER 570
A++YLH + ++ HR+ K N+L + P+ L+D G A T +
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNS 219
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 28/126 (22%), Positives = 46/126 (36%), Gaps = 10/126 (7%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFS--GNLPYSIASMVSLSYLNVSRNSLTQSIG 170
L+ I Y L+L NL A++ ++ S N + +
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLG---ATLDQFDAIDFSDNEIR-KLD 58
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTT 227
F L L TL ++ N +L +++ L L NN + G L+ + L LT
Sbjct: 59 G-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117
Query: 228 LNVANN 233
L + N
Sbjct: 118 LCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-10
Identities = 26/118 (22%), Positives = 47/118 (39%), Gaps = 12/118 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDT--IPYQLPPNLTSLNLASNNFS--GNLPYSIASMVSLSYL 158
++ + R+ DL G I + L +++ + N P + L L
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGATL-DQFDAIDFSDNEIRKLDGFP----LLRRLKTL 69
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLPNSFISLSNISSLYLQNNQVT 214
V+ N + + + L L L L+ N+ GDL + SL +++ L + N VT
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L D S N I + L L +L + +N ++ L+ L ++
Sbjct: 37 LGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96
Query: 162 RNSLTQSIGDI--FGNLAGLATLDLSFN 187
NSL +GD+ +L L L + N
Sbjct: 97 NNSLV-ELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 21/105 (20%), Positives = 38/105 (36%), Gaps = 8/105 (7%)
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
+ ++ + Q+ + N LDL + N +L ++ +N++ L
Sbjct: 2 VKLTAELIEQAAQ--YTNAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 218 NVFSGLP-LTTLNVANNHFS---GWIPRELISIRTFIYDGNSFDN 258
+ F L L TL V NN + + L + I NS
Sbjct: 58 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 3e-10
Identities = 18/100 (18%), Positives = 36/100 (36%), Gaps = 2/100 (2%)
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNS 196
+ + + + + + +L+ L + Q + L L L + + P++
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 197 FISLSNISSLYLQNNQVTG-SLNVFSGLPLTTLNVANNHF 235
F +S L L N + S GL L L ++ N
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 8e-04
Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 7/68 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L LR + + + + + P L+ LNL+ N +L + +SL L
Sbjct: 52 LRGLGELRNLTIVKSGL-RFVAPDAFHFTP-RLSRLNLSFNALE-SLSWKTVQGLSLQEL 108
Query: 159 NVSRNSLT 166
+S N L
Sbjct: 109 VLSGNPLH 116
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-10
Identities = 30/119 (25%), Positives = 49/119 (41%), Gaps = 6/119 (5%)
Query: 119 IHDTIPYQLPPNLTSLNL-ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
IH + + P + L L + G + A V+L +L++ L S+ L
Sbjct: 14 IHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLP 71
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLNVANN 233
L L+LS N G L L N++ L L N++ +L L L +L++ N
Sbjct: 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L ++ ++L L + P L L L+ N G L + +L++LN+S
Sbjct: 44 LTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103
Query: 162 RNSLTQSIGDI--FGNLAGLATLDLSFN 187
N L + I + L L +LDL
Sbjct: 104 GNKL-KDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 32/109 (29%), Positives = 43/109 (39%), Gaps = 14/109 (12%)
Query: 129 PNLTSLNLASNNFS--GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF 186
NL L+L + NLP + L L +S N + + + L L L+LS
Sbjct: 49 VNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSG 104
Query: 187 NNFS--GDLPNSFISLSNISSLYLQNNQVTGSLN----VFSGLP-LTTL 228
N L L + SL L N +VT + VF LP LT L
Sbjct: 105 NKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-10
Identities = 30/119 (25%), Positives = 49/119 (41%), Gaps = 6/119 (5%)
Query: 119 IHDTIPYQLPPNLTSLNLASNNFS-GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
IH + + P ++ L L ++ + G L L +L+ LT SI L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLN 64
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLNVANN 233
L L+LS N SG L N++ L L N++ ++ L L +L++ N
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-07
Identities = 20/88 (22%), Positives = 31/88 (35%), Gaps = 3/88 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L + L L L+ N SG L +L++LN+S
Sbjct: 37 LTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96
Query: 162 RNSLTQSIGDI--FGNLAGLATLDLSFN 187
N + + + I L L +LDL
Sbjct: 97 GNKI-KDLSTIEPLKKLENLKSLDLFNC 123
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 418 IGEGSLGRVYRAE-----FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIV 471
+G G+ G+V A+ K+ + E + + + + H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 472 TLAGYCAEHGQRLLV-YEYVGNGNLHDMLH 500
L G C + G L+V E+ GNL L
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 35/173 (20%), Positives = 64/173 (36%), Gaps = 26/173 (15%)
Query: 404 SLQTATNSFSQEF-----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLE 457
LQ N+ ++ ++G G G+V + + A+K + + + +E
Sbjct: 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE------ 60
Query: 458 AVSNMSRL-RHPNIVTLAGYCAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWN 512
V R + P+IV + L+V E + G L + D + T
Sbjct: 61 -VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTER 117
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLA 562
+ A++YLH + ++ HR+ K N+L L+D G A
Sbjct: 118 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 37/157 (23%), Positives = 62/157 (39%), Gaps = 28/157 (17%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ G V + K+ A+K + + + F E M+ P +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------AL 525
Y + + L +V EY+ G+L + + V AR AL
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLAL 181
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ +H + +HR+ K N+LLD + L+D G
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 43/170 (25%), Positives = 67/170 (39%), Gaps = 47/170 (27%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
++L +G+G+ G+V A G+ A+K + + E L+
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT----- 62
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
RHP + L Y + RL V EY G L H F ++ R R
Sbjct: 63 -RHPFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEE---------RARF 109
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ ALEYLH VV+R+ K N++LD + + ++D GL
Sbjct: 110 YGAEIVS----ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 46/170 (27%), Positives = 69/170 (40%), Gaps = 46/170 (27%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
EF+ +G+GS G+V A G + AVK + D+ E L N
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--- 82
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP + L C + RL V E+V G+L M H F + R R
Sbjct: 83 --HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA---------RARF 128
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ AL +LH+ +++R+ K N+LLD E + L+D G+
Sbjct: 129 YAAEIIS----ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 43/213 (20%), Positives = 77/213 (36%), Gaps = 62/213 (29%)
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKI-DNAALSLQEEDNFLEAVSNM 462
L+T++ +S +G GS G V + +GK A+KK+ + +E + M
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE-------LDIM 54
Query: 463 SRLRHPNIVTLAGYCAEHGQRL-------------------------------------- 484
L H NI+ L Y G
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCLPSVVHRNFKS 543
++ EYV + LH +L S +++ + + + RA+ ++H + + HR+ K
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIKP 169
Query: 544 ANILLD---DELNPHLSDCGLA----ALTPNTE 569
N+L++ + L L D G A P+
Sbjct: 170 QNLLVNSKDNTLK--LCDFGSAKKLIPSEPSVA 200
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 46/170 (27%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
+G+GS G+V+ AEF + A+K + D+ E L
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--- 76
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP + + + + L V EY+ G+L M H F R
Sbjct: 77 --HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLS---------RATF 122
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ L L++LH +V+R+ K NILLD + + ++D G+
Sbjct: 123 YAAEIIL----GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 34/158 (21%), Positives = 68/158 (43%), Gaps = 28/158 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
IG GS G V A + +++A+KKI ++ ++ ++ ++RL H ++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVF------EDLIDCKRILREIAILNRLNHDHV 114
Query: 471 VTL----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
V + E L +V E + + + + LT ++ L
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR----TPVYLT-ELHIKTLLYNLLVG 168
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++Y+H ++HR+ K AN L++ + + + D GLA
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 44/247 (17%), Positives = 81/247 (32%), Gaps = 48/247 (19%)
Query: 338 RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITA 397
++ + + E V + + + +K + I+
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK 328
Query: 398 TSYTVASLQTATNSFSQEFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAAL 447
+ F FL +G+GS G+V +E ++ AVK + D+
Sbjct: 329 FDNNGNRDRMKLTDF--NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE 386
Query: 448 SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------ 500
E L + P + L C + RL V EYV G+L M H
Sbjct: 387 CTMVEKRVLALPG-----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGR 438
Query: 501 FADDSSKNLTWNARVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555
F + +A+ L +L +++R+ K N++LD E +
Sbjct: 439 FKEP---------HAVFYAAEIAI----GLFFLQSK---GIIYRDLKLDNVMLDSEGHIK 482
Query: 556 LSDCGLA 562
++D G+
Sbjct: 483 IADFGMC 489
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 46/170 (27%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
FL +G+GS G+V +E ++ AVK + D+ E L
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--- 79
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
P + L C + RL V EYV G+L M H F +
Sbjct: 80 --PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEP---------HAVF 125
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+A+ L +L +++R+ K N++LD E + ++D G+
Sbjct: 126 YAAEIAI----GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 29/128 (22%), Positives = 46/128 (35%), Gaps = 6/128 (4%)
Query: 99 MGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
M LS L + + LS N+I NL L+L N + A +L L
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGS 216
+S N + S+ I L L L +S N + + + +L + L L N +
Sbjct: 99 WISYNQIA-SLSGI-EKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYND 155
Query: 217 LNVFSGLP 224
+
Sbjct: 156 YKENNATS 163
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 36/133 (27%), Positives = 57/133 (42%), Gaps = 20/133 (15%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181
IP +P + T L L N + + L L + RN LT + F + +
Sbjct: 23 IPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE 82
Query: 182 LDLSFNNFSGDLPN-SFISLSNISSLYLQNNQVT----GSLNVFSGLP-LTTLNVANN-- 233
L L N ++ N F+ L + +L L +NQ++ GS F L LT+LN+A+N
Sbjct: 83 LQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGS---FEHLNSLTSLNLASNPF 138
Query: 234 -------HFSGWI 239
F+ W+
Sbjct: 139 NCNCHLAWFAEWL 151
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 157 YLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
L ++ N L + S +FG L L L+L N +G PN+F S+I L L N++
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 216 SL--NVFSGLP-LTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFD 257
+ +F GL L TLN+ +N S + L S+ + N F+
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFN 139
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 52/221 (23%)
Query: 368 DLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFL--IGEGSLGR 425
+ A + L +K + + T + + +F E L +G G+ G+
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENF--ELLKVLGTGAYGK 69
Query: 426 VYRAEFA----NGKIMAVKKIDNAALSLQEED--------NFLEAVSNMSRLRHPNIVTL 473
V+ GK+ A+K + A + + + LE + P +VTL
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTL 124
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR-----VALGT 521
Y + +L L+ +Y+ G L H F + V+ + L
Sbjct: 125 H-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEH---------EVQIYVGEIVL-- 170
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
ALE+LH++ +++R+ K NILLD + L+D GL+
Sbjct: 171 --ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 38/165 (23%), Positives = 70/165 (42%), Gaps = 29/165 (17%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH 467
+ F + +G GS GRV + +G A+K +D + L++ ++ L + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 468 PNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVR-----V 517
P +V L + + L +V EYV G + L F++ R +
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---------HARFYAAQI 150
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L EYLH + +++R+ K N+L+D + ++D G A
Sbjct: 151 VL----TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 35/118 (29%), Positives = 50/118 (42%), Gaps = 6/118 (5%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
++P +P T L+L +N+ + SL+ L + N L +F L L
Sbjct: 19 RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 180 ATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANN 233
L+LS N LPN F L+ + L L NQ+ SL VF L L L + N
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 51/174 (29%)
Query: 415 EFL--IGEGSLGRVYRAEFANGK----IMAVKKIDNAALSLQEED--------NFLEAVS 460
E L +G+G G+V++ G I A+K + A + +D N LE V
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV- 78
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNA 513
+HP IV L Y + G +L L+ EY+ G L + F +D
Sbjct: 79 -----KHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMED--------- 121
Query: 514 RVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+++ AL +LH+ +++R+ K NI+L+ + + L+D GL
Sbjct: 122 TACFYLAEISM----ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 1e-08
Identities = 28/185 (15%), Positives = 48/185 (25%), Gaps = 43/185 (23%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI------------DNAALSLQEEDNFLEAVSNMSRL 465
IGEG G V++ A+ +A+K I + E + +S +S
Sbjct: 28 IGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 466 ---RHPNIVTL------AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDS----------- 505
R + L G + + G+ +D F D
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 506 --------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557
+K + + +L HR+ N+LL L
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLH 204
Query: 558 DCGLA 562
Sbjct: 205 YTLNG 209
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 32/129 (24%), Positives = 59/129 (45%), Gaps = 14/129 (10%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL 182
+P +P ++T L L N F+ +P +++ L+ +++S N ++ F N+ L TL
Sbjct: 25 LPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL 83
Query: 183 DLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANN------ 233
LS+N P +F L ++ L L N ++ + F+ L L+ L + N
Sbjct: 84 ILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDC 142
Query: 234 ---HFSGWI 239
S W+
Sbjct: 143 NMQWLSDWV 151
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 37/149 (24%), Positives = 60/149 (40%), Gaps = 10/149 (6%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ V + G++ A+K ++ L E F E + I L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
+ + L LV EY G+L + + + AR +A A++ +H +
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRL-- 181
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLA 562
VHR+ K NILLD + L+D G
Sbjct: 182 -GYVHRDIKPDNILLDRCGHIRLADFGSC 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 41/170 (24%), Positives = 68/170 (40%), Gaps = 47/170 (27%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQE------EDNFLEAVSNMSR 464
+ L +G GS GRV+ NG+ A+K + + L++ E L V
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV----- 63
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP I+ + + Q++ ++ +Y+ G L F + +
Sbjct: 64 -THPFIIRMW-GTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNP---------VAKF 110
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
V L ALEYLH +++R+ K NILLD + ++D G A
Sbjct: 111 YAAEVCL----ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 47/170 (27%), Positives = 67/170 (39%), Gaps = 46/170 (27%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
FL IG+GS G+V A A AVK + + E N L
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--- 97
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP +V L + + +L V +Y+ G L H F + R R
Sbjct: 98 --HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEP---------RARF 143
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+A AL YLH + ++V+R+ K NILLD + + L+D GL
Sbjct: 144 YAAEIAS----ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 38/157 (24%), Positives = 61/157 (38%), Gaps = 26/157 (16%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ G V + K+ A+K ++ L E F E + I TL
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------AL 525
Y + L LV +Y G+L + + R+ AR A+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDL--LTLLS---------KFEDRLPEEMARFYLAEMVIAI 188
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ +H++ VHR+ K NIL+D + L+D G
Sbjct: 189 DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 8/129 (6%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
K +L S+ D + ++ + +++ ++ I + ++ YL + N L
Sbjct: 20 ETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKL-H 76
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP- 224
I L L L L+ N F L+N+ L L NQ+ SL VF L
Sbjct: 77 DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTN 134
Query: 225 LTTLNVANN 233
LT LN+A+N
Sbjct: 135 LTYLNLAHN 143
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 36/131 (27%), Positives = 59/131 (45%), Gaps = 6/131 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
L S+ + + + I Q PN+ L L N ++ ++ + +L+YL ++ N L
Sbjct: 40 LNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQL 97
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGL 223
+F L L L L N F L+N++ L L +NQ+ SL VF L
Sbjct: 98 QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKL 156
Query: 224 P-LTTLNVANN 233
LT L+++ N
Sbjct: 157 TNLTELDLSYN 167
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 40/132 (30%), Positives = 57/132 (43%), Gaps = 6/132 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNS 164
L ++R L GN +HD + NLT L L N +LP + + +L L + N
Sbjct: 62 LPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ 120
Query: 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSG 222
L +F L L L+L+ N F L+N++ L L NQ+ SL VF
Sbjct: 121 LQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDK 179
Query: 223 LP-LTTLNVANN 233
L L L + N
Sbjct: 180 LTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 22/116 (18%), Positives = 39/116 (33%), Gaps = 8/116 (6%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
P NL + + + + S+ + + + + G L +
Sbjct: 10 KQIFPDDAFAETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQG--IQYLPNV 65
Query: 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANN 233
L L N D+ + L+N++ L L NQ+ VF L L L + N
Sbjct: 66 RYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN 119
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 35/112 (31%), Positives = 52/112 (46%), Gaps = 8/112 (7%)
Query: 106 LLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVS 161
L +L L+GN + ++P + NL L L N +LP + + +L+YLN++
Sbjct: 84 LTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQ 212
N L +F L L LDLS+N LP F L+ + L L NQ
Sbjct: 142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQ 192
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 33/167 (19%), Positives = 57/167 (34%), Gaps = 37/167 (22%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSN---------MSRLRHP 468
I GS G V + G +A+K++ N + + ++ ++ HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 469 NIVTL-----AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTA 522
NI+ L + LV E + +L ++H + + ++ +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH----DQRIVISPQHIQYFMYHIL 144
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLA 562
L LHE VVHR+ NILL + LA
Sbjct: 145 LGLHVLHEA---GVVHRDLHPGNILLA-------DNNDITICDFNLA 181
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 36/165 (21%), Positives = 66/165 (40%), Gaps = 42/165 (25%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
IG GS G VY A + K +A+KK++ ++ ++ ++ ++RL+ I
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMF------EDLIDCKRILREITILNRLKSDYI 87
Query: 471 VTLAG-YCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARA 524
+ L + + +V E + +L + + LT ++ L
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK----TPIFLT-EEHIKTILYNLLLG 141
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLA 562
++HE ++HR+ K AN LL+ DC GLA
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLN-------QDCSVKVCDFGLA 176
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 44/172 (25%), Positives = 80/172 (46%), Gaps = 49/172 (28%)
Query: 415 EFL--IGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQE------EDNFLEAVSNM 462
E L +G+GS G+V+ + + ++ A+K + A L +++ E + L V
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV--- 83
Query: 463 SRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARV 515
HP IV L Y + +L L+ +++ G+L F ++ V
Sbjct: 84 ---NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEE---------DV 128
Query: 516 R-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ +AL AL++LH + +++R+ K NILLD+E + L+D GL+
Sbjct: 129 KFYLAELAL----ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 30/166 (18%), Positives = 45/166 (27%), Gaps = 34/166 (20%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL------PPNLTSLNLASNNFS-------------G 143
L L LS N+ T L L L L +N
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 144 NLPYSIASMVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGD-----LP 194
+ + L + RN L + F + L T+ + N + L
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 195 NSFISLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNH 234
+ L LQ+N T GS + L L L + +
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 36/242 (14%), Positives = 68/242 (28%), Gaps = 49/242 (20%)
Query: 44 VQALQVLYTSLNSPSVLT--NWKGNE-GDPCGESWKGVACEGSA------VVSIDISG-- 92
+A + L ++ S L + G E + + A + ++ +S
Sbjct: 46 TEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105
Query: 93 LGLSG--TMGYLLSDLLSLRKFDLSGNSI---------------HDTIPYQLPPNLTSLN 135
G + + LS L L N + + P L S+
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165
Query: 136 LASNNFSGNLPYSIASMV----SLSYLNVSRNSLT-----QSIGDIFGNLAGLATLDLSF 186
N A L + + +N + + + L LDL
Sbjct: 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225
Query: 187 NNFSGD----LPNSFISLSNISSLYLQNNQVTG--------SLNVFSGLPLTTLNVANNH 234
N F+ L + S N+ L L + ++ + + + L TL + N
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285
Query: 235 FS 236
Sbjct: 286 IE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 27/132 (20%), Positives = 45/132 (34%), Gaps = 22/132 (16%)
Query: 103 LSDLLSLRKFDLSGNSIHD-----TIPYQLPPN--LTSLNLASNNFSGNLPYSIASMV-- 153
L + N I + L L L+L N F+ ++A +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 154 --SLSYLNVSRNSLT----QSIGDIFGNLA--GLATLDLSFNNFSGD----LPNSFIS-L 200
+L L ++ L+ ++ D F L GL TL L +N D L +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 302
Query: 201 SNISSLYLQNNQ 212
++ L L N+
Sbjct: 303 PDLLFLELNGNR 314
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 22/168 (13%), Positives = 42/168 (25%), Gaps = 39/168 (23%)
Query: 107 LSLRKFDLSGNSIHDT------IPYQLPPNLTSLNLASNNFSGNLPYSIASMV----SLS 156
S+ L ++I ++ + L+ N ++ + L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 157 YLNVSRNSL----------TQSIGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSN 202
S + + L T+ LS N F L + +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 203 ISSLYLQNNQVT--GSLNVFSGLP-------------LTTLNVANNHF 235
+ LYL NN + + L L ++ N
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 25/174 (14%), Positives = 49/174 (28%), Gaps = 41/174 (23%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL------PPNLTSLNLASNNFSGNLP-------YSI 149
L + S+++ LSGN+I L +L S+ F+G + +
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF-SDIFTGRVKDEIPEALRLL 86
Query: 150 ASMV----SLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFS----------- 190
+ L + +S N+ + + D L L L N
Sbjct: 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146
Query: 191 --GDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNHFS 236
+ + + S+ N++ L T+ + N
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 24/119 (20%), Positives = 40/119 (33%), Gaps = 17/119 (14%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT----IPYQLP--PNLTSLNLASNNFS 142
I G+ + L+ L+ DL N+ + L PNL L L S
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 143 GNLPYSIASMV------SLSYLNVSRNSLT----QSIGD-IFGNLAGLATLDLSFNNFS 190
++ L L + N + +++ I + L L+L+ N FS
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 32/116 (27%), Positives = 52/116 (44%), Gaps = 3/116 (2%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
H ++P +P N L L N + P S+++L L + N L +F +L L
Sbjct: 31 HASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 180 ATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANN 233
LDL N + LP++ F L ++ L++ N++T L LT L + N
Sbjct: 91 TVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN 145
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 29/115 (25%), Positives = 46/115 (40%), Gaps = 15/115 (13%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
L++L++ L N + LP LT L+L +N + LP ++ +V L
Sbjct: 63 LINLKELYLGSNQLG-----ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKE 116
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L + N L + L L L L N +F LS+++ YL N
Sbjct: 117 LFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 27/175 (15%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG GS G +Y A G+ +A+K + L E + + I T+
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQG-----GVGIPTIR 71
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
AE ++V E +G +L D+ +F S+ + + +A +EY+H
Sbjct: 72 WCGAEGDYNVMVMELLGP-SLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK--- 124
Query: 535 SVVHRNFKSANILLDDELNPH---LSDCGLAAL---------TPNTERQVITGTS 577
+ +HR+ K N L+ + + D GLA P E + +TGT+
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 25/153 (16%), Positives = 51/153 (33%), Gaps = 23/153 (15%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPP---NLTSLNLASNNFS----GNLPYSIASMVSLSYLN 159
L ++ D+ + D +L P + L + ++ ++ +L+ LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 160 VSRNSLT----QSIGDIFGNL-AGLATLDLSFNNFS----GDLPNSFISLSNISSLYLQN 210
+ N L + + L L + G L ++ +L + L+L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 211 NQVT--GSLNVFSGL-----PLTTLNVANNHFS 236
N + G + GL L L + S
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 34/183 (18%), Positives = 54/183 (29%), Gaps = 32/183 (17%)
Query: 86 VSIDISGLGLSGT------MGYLLSDLLSLRKFDLSGNSIHDT----IPYQLP--PNLTS 133
+S+DI L + LL L + L + + I L P L
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 134 LNLASNNFSGNLPYSIASMV-----SLSYLNVSRNSLT----QSIGDIFGNLAGLATLDL 184
LNL SN + + + + L++ LT + L L L L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 185 SFNNFSGDLPNSFISL-----SNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANN 233
S N + L L+ ++ + S L L V+NN
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 234 HFS 236
+
Sbjct: 181 DIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 29/161 (18%), Positives = 59/161 (36%), Gaps = 27/161 (16%)
Query: 103 LSDLLSLRKFDLSGNSIHDT-----IPYQLPPN--LTSLNLASNNFSGNLPYSIASMV-- 153
++ SLR+ L N + D P L P+ L +L + + + ++
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 154 --SLSYLNVSRNSLT----QSIGD-IFGNLAGLATLDLSFNNFSGD----LPNSFISLSN 202
SL L+++ N L + + + + L +L + +F+ +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 203 ISSLYLQNNQVT--GSLNVFSGLP-----LTTLNVANNHFS 236
+ L + NN++ G + GL L L +A+ S
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 29/162 (17%), Positives = 57/162 (35%), Gaps = 27/162 (16%)
Query: 102 LLSDLLSLRKFDLSGNSIHD----TIPYQL---PPNLTSLNLASNNFSGNLPYSIASMV- 153
L +L + +L N + D + L + L+L + +G ++S +
Sbjct: 51 ALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR 110
Query: 154 ---SLSYLNVSRNSLT----QSIGDIFG-NLAGLATLDLSFNNFS----GDLPNSFISLS 201
+L L++S N L Q + + L L L + + S L + +
Sbjct: 111 TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 170
Query: 202 NISSLYLQNNQV--TGSLNVFSGLP-----LTTLNVANNHFS 236
+ L + NN + G + GL L L + + +
Sbjct: 171 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 30/162 (18%), Positives = 58/162 (35%), Gaps = 27/162 (16%)
Query: 102 LLSDLLSLRKFDLSGNSIHDT----IPYQLPPN---LTSLNLASNNFS----GNLPYSIA 150
+L ++ +S N I++ + L + L +L L S + +L +A
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 151 SMVSLSYLNVSRNSLT----QSIGDIFGN-LAGLATLDLSFNNFSGD----LPNSFISLS 201
S SL L + N L + + + L TL + + L +
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284
Query: 202 NISSLYLQNNQVT--GSLNVFSGL-----PLTTLNVANNHFS 236
++ L L N++ G+ + L L +L V + F+
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 30/164 (18%), Positives = 48/164 (29%), Gaps = 32/164 (19%)
Query: 102 LLSDLLSLRKFDLSGNSIHDT----IPYQLP--PNLTSLNLASNNFSGNLPYSIASMV-- 153
LL LR + I + L +L L+LA N + +
Sbjct: 251 LLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE 310
Query: 154 ---SLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGD--------LPNSFI 198
L L V S T + L L +S N L
Sbjct: 311 PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP-- 368
Query: 199 SLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNHFS 236
S + L+L + V+ ++ + L L L+++NN
Sbjct: 369 -GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 34/153 (22%), Positives = 62/153 (40%), Gaps = 19/153 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
IG G+ G V A + + +A+KK+ + + M + H NI+ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
E Q + +V E + NL ++ L + R+ L +++LH
Sbjct: 93 FTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELD-HERMSYLLYQMLCGIKHLH 144
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++HR+ K +NI++ + + D GLA
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 36/164 (21%), Positives = 70/164 (42%), Gaps = 29/164 (17%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSIASMV- 153
S + DLS N+++ +L P ++TSLNL+ N+ + ++
Sbjct: 17 FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 154 ----SLSYLNVSRNSLT----QSIGDIF-GNLAGLATLDLSFNNFSGD----LPNSFISL 200
+++ LN+S N L+ + + LDL +N+FS +F +L
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 201 -SNISSLYLQNNQVT--GSLNVFSGLP-----LTTLNVANNHFS 236
++I+SL L+ N + S + L + +LN+ N+ +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 34/185 (18%), Positives = 62/185 (33%), Gaps = 35/185 (18%)
Query: 87 SIDISGLGLSGTMGYLLSDLL-----SLRKFDLSGNSIHDT-------IPYQLPPNLTSL 134
+D+ S S+ +L GN + I +P N+ SL
Sbjct: 113 VLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL 172
Query: 135 NLASNNFSGNLPYSIASMV-----SLSYLNVSRNSLT----QSIGDIF-GNLAGLATLDL 184
NL NN + +A + S++ L++S N L + IF + +L+L
Sbjct: 173 NLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNL 232
Query: 185 SFNNFSGD----LPNSFISLSNISSLYLQNNQVT-----GSLNVFSGLP----LTTLNVA 231
N G L SL ++ ++YL + V + + P + ++
Sbjct: 233 CLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKN 292
Query: 232 NNHFS 236
Sbjct: 293 GKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 24/130 (18%), Positives = 43/130 (33%), Gaps = 23/130 (17%)
Query: 108 SLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSG----NLPYSIASMVSLS 156
S+ DLS N + +L P ++ SLNL N G NL S+ L
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 157 YLNVSRNSLT-------QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL-----SNIS 204
+ + + + +++G F N+ + +D + +L
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKAD 316
Query: 205 SLYLQNNQVT 214
L N +
Sbjct: 317 VPSLLNQCLI 326
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 36/151 (23%), Positives = 61/151 (40%), Gaps = 22/151 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAG 475
+G G V+ A N + + VK + ++ + + LR PNI+TLA
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 476 --YCAEHGQRLLVYEYVGNGNLHDMLH-FADDSSKNLTWNARVRVALGTARALEYLHEVC 532
LV+E+V N + + D + + +AL+Y H +
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKALDYCHSM- 149
Query: 533 LPSVVHRNFKSANILLDDEL-NPHLSDCGLA 562
++HR+ K N+++D E L D GLA
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 34/153 (22%), Positives = 69/153 (45%), Gaps = 18/153 (11%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + G +AVKK+ S+ + + ++H N++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
E + LV +G +L++++ + LT + V+ + R L+Y+H
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGA-DLNNIVK-----CQKLT-DDHVQFLIYQILRGLKYIH 149
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++HR+ K +N+ ++++ + D GLA
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 37/159 (23%), Positives = 64/159 (40%), Gaps = 31/159 (19%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
IG G+ G V A + + +A+KK+ N A + M + H NI
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNI 123
Query: 471 VTL-----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTAR 523
++L E Q + LV E + NL ++ L + R+ L
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELD-HERMSYLLYQMLC 175
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+++LH ++HR+ K +NI++ + + D GLA
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 29/153 (18%), Positives = 64/153 (41%), Gaps = 19/153 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + +G+ +A+KK+ S + + ++H N++ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
+ LV ++ +L ++ + +++ + + L+Y+H
Sbjct: 92 FTPASSLRNFYDFYLVMPFMQT-DLQKIMG------LKFS-EEKIQYLVYQMLKGLKYIH 143
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
VVHR+ K N+ ++++ + D GLA
Sbjct: 144 SA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 31/153 (20%), Positives = 63/153 (41%), Gaps = 18/153 (11%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + G +A+KK+ S + + +RH N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
+ LV ++G +L ++ + L R++ + + L Y+H
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGT-DLGKLMK-----HEKLG-EDRIQFLVYQMLKGLRYIH 145
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++HR+ K N+ ++++ + D GLA
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 36/177 (20%), Positives = 73/177 (41%), Gaps = 29/177 (16%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IGEGS G ++ N + +A+K + A L++E + ++ I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAG-----CTGIPNVY 72
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ E +LV + +G +L D+L + + A ++ +HE
Sbjct: 73 YFGQEGLHNVLVIDLLGP-SLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK--- 125
Query: 535 SVVHRNFKSANILLDDELNP-----HLSDCGLA-----ALT----PNTERQVITGTS 577
S+V+R+ K N L+ + ++ D G+ +T P E++ ++GT+
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 30/158 (18%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPNI 470
IGEG+ G V A + N +A+KKI +L+E + + R RH NI
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-------IKILLRFRHENI 87
Query: 471 VTL-----AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
+ + A + +V + + +L+ +L +++L+ N + L R
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK-----TQHLS-NDHICYFLYQILRG 140
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
L+Y+H +V+HR+ K +N+LL+ + + D GLA
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 39/163 (23%), Positives = 78/163 (47%), Gaps = 41/163 (25%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLR-HPN 469
+G+G+ G V+++ + G+++AVKKI +A N +A + ++ L H N
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAF------QNSTDAQRTFREIMILTELSGHEN 70
Query: 470 IVTLAG-YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALE 526
IV L A++ + + LV++Y+ +LH ++ + L + + + ++
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIR-----ANILE-PVHKQYVVYQLIKVIK 123
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLA 562
YLH ++HR+ K +NILL+ ++C GL+
Sbjct: 124 YLHSG---GLLHRDMKPSNILLN-------AECHVKVADFGLS 156
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 35/165 (21%), Positives = 55/165 (33%), Gaps = 26/165 (15%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVK--------KIDNAALSLQEEDNFLEAV---------S 460
+ G +Y A + K+D L E NF +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 461 NMSRLRHPNIVTLAGYCAEHGQ-RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
+ I T G+ + R LV +G +L L+ + ++VA
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSA--LDVSPKHVLSERSVLQVAC 166
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILL--DDELNPHLSDCGLA 562
ALE+LHE VH N + NI + +D+ L+ G A
Sbjct: 167 RLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 21/102 (20%), Positives = 34/102 (33%), Gaps = 6/102 (5%)
Query: 412 FSQEF----LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR 466
+ +F +G G G V+ A+ + A+K+I L E E V +++L
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE-VKALAKLE 62
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN 508
HP IV E E + + S
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSP 104
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 23/125 (18%), Positives = 41/125 (32%), Gaps = 10/125 (8%)
Query: 448 SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH---FADD 504
S D + M N V + + + NL D ++ +D
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
+ + + A A+E+LH ++HR+ K +NI + + D GL
Sbjct: 161 REHGVCL----HIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 565 TPNTE 569
E
Sbjct: 214 MDQDE 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 35/177 (19%), Positives = 70/177 (39%), Gaps = 29/177 (16%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G+ G + + + +A+K + + A L E F + + + I +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS-----GDGIPQVY 71
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ +V E +G +L D+ + + + +A+ +EY+H
Sbjct: 72 YFGPCGKYNAMVLELLGP-SLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSK--- 124
Query: 535 SVVHRNFKSANILLDDELNP-----HLSDCGLAA--LTPNT-------ERQVITGTS 577
++++R+ K N L+ N H+ D LA + P T E + +TGT+
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 33/167 (19%), Positives = 69/167 (41%), Gaps = 28/167 (16%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVK-----KIDNA-ALSLQEEDNFL---------EAVSN 461
IG+G G +Y A+ + + + K++ + L E F +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 462 MSRLRHPNIVTLAGYCAEHGQ----RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
+L++ + G R ++ + G+ +L + + ++K + +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIY---EANAKRFSRKTVLQL 157
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLA 562
+L LEY+HE VH + K++N+LL+ + +L D GLA
Sbjct: 158 SLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 1e-05
Identities = 20/109 (18%), Positives = 36/109 (33%), Gaps = 18/109 (16%)
Query: 102 LLSDLLSLRKFDL---SGNSIHDTIPYQLP--------PNLTSLNLASNNFSGNLPYSIA 150
L SDL +L K L + D PNL L + +
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273
Query: 151 S---MVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGD 192
+ L +++S LT + + D + L +++ +N S +
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 2e-05
Identities = 24/177 (13%), Positives = 61/177 (34%), Gaps = 23/177 (12%)
Query: 61 TNWKGNEGDPCGESWKGVACEGSAV-VSIDISGLGLSGTMGYLLSDLLS--LRKFDLSGN 117
W + + SW + ++ L + GT + L+ ++
Sbjct: 144 LFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISG 203
Query: 118 SIHDTIPYQL----PPNLTSLNL--ASNNFSGNLP-------YSIASMVSLSYLNVSRNS 164
+ D++ + PNL L L ++ + +S +L +L +
Sbjct: 204 GLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263
Query: 165 LTQSIGDIFGN---LAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVT 214
+ ++F L L T+D+S + + L + + ++ + ++ N ++
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 40/165 (24%), Positives = 78/165 (47%), Gaps = 44/165 (26%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPNI 470
+GEG+ G V A G+I+A+KKI+ A +L+E + + +H NI
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE-------IKILKHFKHENI 71
Query: 471 VTLAG-YCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
+T+ + + ++ E + +LH ++ S++ L+ + ++ + T RA
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-----STQMLS-DDHIQYFIYQTLRA 124
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLA 562
++ LH +V+HR+ K +N+L++ S+C GLA
Sbjct: 125 VKVLHGS---NVIHRDLKPSNLLIN-------SNCDLKVCDFGLA 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 37/175 (21%), Positives = 66/175 (37%), Gaps = 27/175 (15%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG GS G +Y + +A+K + L E + I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG-----GTGIPNVR 69
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ E +LV + +G +L D+ + S+ L+ + +A +E++H
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLEDLF---NFCSRKLSLKTVLMLADQMINRVEFVHSK--- 122
Query: 535 SVVHRNFKSANILLDDELNPH---LSDCGLAAL---------TPNTERQVITGTS 577
S +HR+ K N L+ + + D GLA P E + +TGT+
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 9/109 (8%)
Query: 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188
+ +L+L S + V L+ + +L + I + L +L+LS N
Sbjct: 127 GSQQALDL-KGLRSDPDLVAQNIDVVLNRRSCMAATL-RIIEENIPELL---SLNLSNNR 181
Query: 189 FSG--DLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLPLTTLNVANN 233
D+ + N+ L L N++ L+ GL L L + N
Sbjct: 182 LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 230
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 25/181 (13%), Positives = 59/181 (32%), Gaps = 27/181 (14%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLL-----SLRKFDLSGNSIHDTIPYQLPP---NLTSL 134
S++ ++++G+ ++ +++ +L +L + +L+ + L P L
Sbjct: 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKL 131
Query: 135 NLASNNFSGNLPYSIASM-----VSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLS 185
L N+ + + ++ L +S N LT + + + L L
Sbjct: 132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLL 191
Query: 186 FNNFSGD----LPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNHF 235
+ L + L + N +L + L L++ N
Sbjct: 192 HTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251
Query: 236 S 236
S
Sbjct: 252 S 252
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 41/183 (22%), Positives = 72/183 (39%), Gaps = 43/183 (23%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALS---LQEEDNFLEAVSNMSRLRHPNIV 471
+G G G V+ A + K +A+KKI + L+E + + RL H NIV
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE-------IKIIRRLDHDNIV 71
Query: 472 TL-------AGYCAEHGQRL-------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
+ + L +V EY+ +L ++L L R+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLL-EEHARL 124
Query: 518 AL-GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC--GLA--ALTPNTERQV 572
+ R L+Y+H +V+HR+ K AN+ ++ E + L GLA + +
Sbjct: 125 FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTE-DLVLKIGDFGLARIMDPHYSHKGH 180
Query: 573 ITG 575
++
Sbjct: 181 LSE 183
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 36/165 (21%), Positives = 62/165 (37%), Gaps = 27/165 (16%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVK--KIDNAALS-LQEEDNFLEAVS---------NMS 463
IG G G +Y A + A K++ L E F + V+
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 464 RLRHPNIVTLAGY----CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
+L + I G R +V E +G +L + + + +++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKIS----GQNGTFKKSTVLQLGI 158
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLA 562
LEY+HE VH + K+AN+LL + +L+D GL+
Sbjct: 159 RMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 14/130 (10%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL 182
+P +P + T L L SN + L+ L++S+N + +F L L L
Sbjct: 22 VPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTIL 81
Query: 183 DLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANN------ 233
L N LPN F L+ + L L NQ+ + +F L L + + N
Sbjct: 82 YLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140
Query: 234 ----HFSGWI 239
+ S W+
Sbjct: 141 PRIDYLSRWL 150
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 30/158 (18%), Positives = 65/158 (41%), Gaps = 24/158 (15%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHP---- 468
+G G V+ A+ N +A+K + + + ++E L+ V++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 469 -NIVTL------AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALG 520
+I+ L G H ++V+E +G NL ++ + L V+ ++
Sbjct: 86 NHILKLLDHFNHKGPNGVH--VVMVFEVLGE-NLLALIKKYEHRGIPLI---YVKQISKQ 139
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
L+Y+H C ++H + K N+L++ +P
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 175
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 5e-04
Identities = 32/267 (11%), Positives = 75/267 (28%), Gaps = 84/267 (31%)
Query: 349 NNMNTEMHEQRVKSVAAVTDLTPPPAEKL-------VIERVAKSGSLKKI---KSPITAT 398
++M+ E E + + ++ + + + + + I K ++ T
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64
Query: 399 SYTVASLQTATNSFSQEFLIGEGSLGRVY-------RAE------------------FAN 433
+L + Q+F+ E L Y + E + +
Sbjct: 65 LRLFWTLLSKQEEMVQKFV--EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 434 GKIMA---------VKKIDNAALSLQEEDNF--------------LEAVSNMSRLRHP-- 468
++ A K+ A L L+ N L+ +
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDF 182
Query: 469 NI--VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL---TWNARVRVALGTAR 523
I + L C L L +L+ D + + + N ++R+ A
Sbjct: 183 KIFWLNL-KNCNSPETVLE--------MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDD 550
L + +++ ++L +
Sbjct: 234 LRRLLK--------SKPYENCLLVLLN 252
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 577 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.96 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.95 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.95 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.95 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.95 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.95 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.95 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.95 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.94 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.94 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.94 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.94 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.94 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.94 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.94 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.94 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.94 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.94 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.94 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.94 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.94 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.94 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.94 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.94 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.94 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.94 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.94 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.94 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.94 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.94 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.94 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.94 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.94 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.94 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.94 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.94 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.94 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.94 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.94 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.94 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.94 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.93 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.93 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.93 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.93 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.93 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.93 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.93 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.93 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.93 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.93 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.93 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.93 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.93 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.93 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.93 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.93 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.93 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.93 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.93 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.93 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.93 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.93 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.93 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.93 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.93 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.93 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.93 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.93 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.93 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.93 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.93 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.93 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.93 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.93 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.93 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.93 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.93 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.93 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.93 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.93 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.93 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.93 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.93 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.93 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.93 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.93 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.93 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.93 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.93 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.93 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.92 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.92 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.92 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.92 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.92 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.92 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.92 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.92 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.92 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.92 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.92 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.92 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.92 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.92 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.92 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.92 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.92 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.92 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.92 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.92 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.92 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.92 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.92 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.92 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.92 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.92 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.92 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.92 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.92 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.92 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.92 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.92 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.92 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.92 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.92 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.92 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.92 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.92 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.92 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.92 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.92 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.92 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.92 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.92 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.91 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.91 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.91 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.91 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.91 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.91 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.91 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.91 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.91 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.91 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.91 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.91 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.91 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.91 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.91 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.91 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.91 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.91 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.91 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.91 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.91 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.91 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.91 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.91 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.91 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.91 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.91 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.91 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.91 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.91 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.91 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.9 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.9 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.9 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.9 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.9 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.9 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.9 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.89 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.89 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.89 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.89 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.89 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.89 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.87 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.87 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.86 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.86 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.85 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.85 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.85 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.85 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.85 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.84 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.84 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.84 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.84 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.84 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.83 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.83 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.83 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.83 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.83 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.83 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.82 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.82 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.81 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.81 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.81 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.81 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.81 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.81 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.8 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.8 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.8 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.8 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.8 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.8 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.8 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.79 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.79 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.79 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.79 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.79 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.78 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.78 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.78 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.77 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.77 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.77 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.76 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.76 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.76 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.76 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.74 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.74 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.74 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.73 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.73 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.73 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.73 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.73 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.73 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.72 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.72 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.71 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.7 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.7 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.7 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.7 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.69 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.69 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.68 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.68 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.67 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.65 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.65 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.64 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.64 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.63 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.62 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.61 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.61 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.59 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.59 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.56 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.53 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.49 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.48 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.46 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.43 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.31 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.1 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.05 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.95 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.88 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.84 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.75 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.71 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.65 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.65 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.63 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.61 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.6 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.55 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.53 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.44 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.17 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.87 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.84 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.57 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.55 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.48 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.42 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.3 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.27 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.21 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.15 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.12 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.11 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.05 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.01 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.97 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.92 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.76 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.53 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.42 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.27 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.27 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.44 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.43 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.04 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.91 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.96 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.33 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.38 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.23 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.64 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=305.26 Aligned_cols=163 Identities=25% Similarity=0.408 Sum_probs=139.7
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||+||+|+. .+|+.||||+++.........+.|.+|+++|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5788999999999999999977 468999999997665556667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
||++|+|.++|+. .....+++.++..|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999963 2345678999999999999999999999 9999999999999999999999999999987654
Q ss_pred cc--ccccCCC
Q 008121 569 ER--QVITGTS 577 (577)
Q Consensus 569 ~~--~~~~Gt~ 577 (577)
.. ...+|||
T Consensus 179 ~~~~~~~~GT~ 189 (350)
T 4b9d_A 179 VELARACIGTP 189 (350)
T ss_dssp HHHHHHHHSCC
T ss_pred cccccccCCCc
Confidence 32 4567886
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.43 Aligned_cols=160 Identities=26% Similarity=0.441 Sum_probs=135.6
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||+||+|++.+ .||||+++....+....++|.+|+++|++++|||||+++|+|.+ +..|||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567778899999999999998753 59999997655556677889999999999999999999998865 56899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
||++|+|.++|+. ....++|.++++|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999962 345799999999999999999999999 9999999999999999999999999999976532
Q ss_pred c----cccccCCC
Q 008121 569 E----RQVITGTS 577 (577)
Q Consensus 569 ~----~~~~~Gt~ 577 (577)
. ....+||+
T Consensus 186 ~~~~~~~~~~GT~ 198 (307)
T 3omv_A 186 SGSQQVEQPTGSV 198 (307)
T ss_dssp --------CCCCT
T ss_pred CcceeecccccCC
Confidence 2 24567885
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=294.33 Aligned_cols=160 Identities=25% Similarity=0.363 Sum_probs=140.6
Q ss_pred CccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe----CCeEEEEE
Q 008121 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLVY 487 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 487 (577)
...+.||+|+||+||+|.+. +++.||+|++..........+.|.+|+++|++++|||||+++++|.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999775 58899999997666566667889999999999999999999999865 34689999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~~~~ 566 (577)
|||++|+|.++++. ...+++..+..|+.||+.||+|||++. ++||||||||+|||++ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999973 457899999999999999999999981 2399999999999998 47999999999999887
Q ss_pred CCccccccCCC
Q 008121 567 NTERQVITGTS 577 (577)
Q Consensus 567 ~~~~~~~~Gt~ 577 (577)
.......+|||
T Consensus 184 ~~~~~~~~GTp 194 (290)
T 3fpq_A 184 ASFAKAVIGTP 194 (290)
T ss_dssp TTSBEESCSSC
T ss_pred CCccCCcccCc
Confidence 77778889997
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.97 Aligned_cols=155 Identities=26% Similarity=0.473 Sum_probs=135.3
Q ss_pred cCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
++|...+.||+|+||+||+|++. +++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 45677889999999999999874 4788999999754 345677899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 008121 484 LLVYEYVGNGNLHDMLHFAD---------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 554 (577)
|+|||||++|||.++|+... .....++|.++++|+.|||+||+|||++ +||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997432 2346799999999999999999999999 99999999999999999999
Q ss_pred EEeccccCcccCCCc
Q 008121 555 HLSDCGLAALTPNTE 569 (577)
Q Consensus 555 kl~DFGla~~~~~~~ 569 (577)
||+|||+|+......
T Consensus 168 Ki~DFGla~~~~~~~ 182 (299)
T 4asz_A 168 KIGDFGMSRDVYSTD 182 (299)
T ss_dssp EECCCSCHHHHTGGG
T ss_pred EECCcccceecCCCC
Confidence 999999999765544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=297.91 Aligned_cols=155 Identities=27% Similarity=0.462 Sum_probs=130.4
Q ss_pred cCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
++|...+.||+|+||+||+|++. +++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45666788999999999999874 4789999999754 355677899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008121 484 LLVYEYVGNGNLHDMLHFADD-----------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~ 552 (577)
|+|||||++|+|.++++.... ...+++|.++++|+.|||+||+|||+. +||||||||+||||++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 999999999999999975321 235699999999999999999999998 999999999999999999
Q ss_pred CeEEeccccCcccCCCc
Q 008121 553 NPHLSDCGLAALTPNTE 569 (577)
Q Consensus 553 ~~kl~DFGla~~~~~~~ 569 (577)
.+||+|||+|+......
T Consensus 196 ~~Ki~DFGla~~~~~~~ 212 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTD 212 (329)
T ss_dssp EEEECCCC---------
T ss_pred cEEEcccccceeccCCC
Confidence 99999999999765443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=295.54 Aligned_cols=161 Identities=25% Similarity=0.355 Sum_probs=142.2
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||+||+|+. .+++.||||++.+... .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688899999999999999976 4689999999975432 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|||.++++. .+.+++.++..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999973 35799999999999999999999999 999999999999999999999999999998753
Q ss_pred Cc----cccccCCC
Q 008121 568 TE----RQVITGTS 577 (577)
Q Consensus 568 ~~----~~~~~Gt~ 577 (577)
.. ..+.+|||
T Consensus 185 ~~~~~~~~~~~GTp 198 (311)
T 4aw0_A 185 ESKQARANSFVGTA 198 (311)
T ss_dssp TTTCCCBCCCCSCG
T ss_pred CCCcccccCcccCc
Confidence 32 35678986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=294.86 Aligned_cols=154 Identities=26% Similarity=0.430 Sum_probs=132.8
Q ss_pred CCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
+...+.||+|+||+||+|.+. +++.||||+++... .....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 445678999999999999873 46889999997543 33446789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008121 486 VYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~ 553 (577)
|||||++|||.++|+.... ....++|.++++|+.|||+||+|||+. +||||||||+|||||++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999964321 124689999999999999999999999 9999999999999999999
Q ss_pred eEEeccccCcccCCCc
Q 008121 554 PHLSDCGLAALTPNTE 569 (577)
Q Consensus 554 ~kl~DFGla~~~~~~~ 569 (577)
+||+|||+|+......
T Consensus 184 ~Ki~DFGlar~~~~~~ 199 (308)
T 4gt4_A 184 VKISDLGLFREVYAAD 199 (308)
T ss_dssp EEECCSCCBCGGGGGG
T ss_pred EEECCcccceeccCCC
Confidence 9999999999765443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=296.56 Aligned_cols=158 Identities=30% Similarity=0.429 Sum_probs=140.6
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
..|+..+.||+|+||+||+|... +|+.||||+++... ....+.+.+|+++|++++|||||+++++|.+++..|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46888899999999999999874 69999999996543 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
||++|+|.++++. ..+++.++..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 152 y~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 152 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 9999999999962 4589999999999999999999999 9999999999999999999999999999987544
Q ss_pred c--cccccCCC
Q 008121 569 E--RQVITGTS 577 (577)
Q Consensus 569 ~--~~~~~Gt~ 577 (577)
. ....+|||
T Consensus 224 ~~~~~~~~GTp 234 (346)
T 4fih_A 224 VPRRKSLVGTP 234 (346)
T ss_dssp SCCBCCCCSCG
T ss_pred CCcccccccCc
Confidence 3 45678986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=294.83 Aligned_cols=161 Identities=25% Similarity=0.357 Sum_probs=134.1
Q ss_pred cCCCccceeccCccceEEEEEEc----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
++|+..+.||+|+||+||+|+.. +++.||||+++..........++.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46888999999999999999762 46899999997654444444568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||||++|||.++++. ...+++.++..|+.|++.||+|||++ +||||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999973 35799999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCc--cccccCCC
Q 008121 566 PNTE--RQVITGTS 577 (577)
Q Consensus 566 ~~~~--~~~~~Gt~ 577 (577)
.+.. ....+|||
T Consensus 177 ~~~~~~~~~~~GT~ 190 (304)
T 3ubd_A 177 IDHEKKAYSFCGTV 190 (304)
T ss_dssp ----CCCCSCCCCG
T ss_pred cCCCccccccccCc
Confidence 4433 35678986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=282.79 Aligned_cols=160 Identities=27% Similarity=0.455 Sum_probs=127.1
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|+..+.||+|+||+||+|.. .+|+.||||++++.... ......+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999976 46899999999654322 233567999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+ +|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...+
T Consensus 93 Ey~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 689999996 345799999999999999999999999 999999999999999999999999999997655
Q ss_pred Cc-cccccCCC
Q 008121 568 TE-RQVITGTS 577 (577)
Q Consensus 568 ~~-~~~~~Gt~ 577 (577)
.. ....+|||
T Consensus 165 ~~~~~~~~GT~ 175 (275)
T 3hyh_A 165 GNFLKTSCGSP 175 (275)
T ss_dssp ----------C
T ss_pred CCccCCeeECc
Confidence 44 35677886
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=298.52 Aligned_cols=159 Identities=30% Similarity=0.431 Sum_probs=141.1
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.+.|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+|++++|||||+++++|.+.+..||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 356888999999999999999874 68999999996542 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|||++|+|.++++. ..+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..
T Consensus 228 Ey~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 228 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp ECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 99999999999962 3589999999999999999999999 999999999999999999999999999998754
Q ss_pred C--ccccccCCC
Q 008121 568 T--ERQVITGTS 577 (577)
Q Consensus 568 ~--~~~~~~Gt~ 577 (577)
. .....+|||
T Consensus 300 ~~~~~~~~~GTp 311 (423)
T 4fie_A 300 EVPRRKSLVGTP 311 (423)
T ss_dssp SCCCBCCCEECT
T ss_pred CCccccccccCc
Confidence 4 345678986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=286.27 Aligned_cols=150 Identities=29% Similarity=0.399 Sum_probs=127.7
Q ss_pred CCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC----eEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QRLLV 486 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv 486 (577)
+|...+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|.+++ ..|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 466778999999999999988 58999999986432 22233445677778899999999999998654 57999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV-----CLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-----~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
||||++|+|.++|+ ...++|..+.+|+.|+++||+|||++ +.++||||||||+|||+|+++++||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999996 24689999999999999999999976 245899999999999999999999999999
Q ss_pred CcccCCCc
Q 008121 562 AALTPNTE 569 (577)
Q Consensus 562 a~~~~~~~ 569 (577)
|+......
T Consensus 155 a~~~~~~~ 162 (303)
T 3hmm_A 155 AVRHDSAT 162 (303)
T ss_dssp CEEEETTT
T ss_pred CccccCCC
Confidence 99765443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=287.59 Aligned_cols=219 Identities=26% Similarity=0.449 Sum_probs=200.4
Q ss_pred CCChHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCccEEeeC----CcEEEEEcCCCCCcc--cccccccCCCCCCE
Q 008121 38 TTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEG----SAVVSIDISGLGLSG--TMGYLLSDLLSLRK 111 (577)
Q Consensus 38 ~~~~~~~~~l~~~~~~~~~~~~l~~w~~~~~~~c~~~w~gv~C~~----~~v~~l~l~~~~l~g--~~~~~~~~l~~L~~ 111 (577)
.|.++|++||++||+++.++..+.+|.. +.|||.+.|.||.|+. ++|+.|+|++|+++| .+|..|+++++|++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~ 80 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence 4788999999999999988777889975 4688955699999985 799999999999999 99999999999999
Q ss_pred EEccC-CCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCc
Q 008121 112 FDLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (577)
Q Consensus 112 L~Ls~-N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 188 (577)
|+|++ |++.+.+|..+. ++|++|+|++|++++.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|+
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 99995 999999998776 899999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccCCC-CCCeEEccCcccccccc-cCCCCCccEEEeecCccccccCcccc---cccceeecCCcCC
Q 008121 189 FSGDLPNSFISLS-NISSLYLQNNQVTGSLN-VFSGLPLTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFD 257 (577)
Q Consensus 189 l~g~~p~~~~~l~-~L~~L~l~~N~l~~~~~-~~~~~~L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~ 257 (577)
++|.+|..++.++ +|++|+|++|++++.++ .+..++|+.|++++|++++.+|..+. +++.|++++|.+.
T Consensus 161 l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 234 (313)
T 1ogq_A 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCcee
Confidence 9999999999998 99999999999998654 56666799999999999999887665 5677889999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=289.22 Aligned_cols=154 Identities=26% Similarity=0.319 Sum_probs=132.8
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
+.|...++||+|+||+||+|++. +|+.||||+++.... +.+|+.++++++|||||++++++.+++..|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45677788999999999999874 589999999965422 2469999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~~~~ 567 (577)
||++|+|.++|+. ...+++.++..|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+.+..
T Consensus 131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999973 35699999999999999999999999 999999999999999987 699999999998754
Q ss_pred Ccc-------ccccCCC
Q 008121 568 TER-------QVITGTS 577 (577)
Q Consensus 568 ~~~-------~~~~Gt~ 577 (577)
... ..++|||
T Consensus 204 ~~~~~~~~~~~~~~GT~ 220 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTE 220 (336)
T ss_dssp ----------CCCCCCG
T ss_pred CCcccceecCCccccCc
Confidence 332 2356885
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=281.82 Aligned_cols=154 Identities=21% Similarity=0.333 Sum_probs=126.1
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-------
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------- 481 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------- 481 (577)
++|+..+.||+|+||+||+|+.. +|+.||||+++... .....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35888899999999999999874 68999999996543 3445677999999999999999999999987544
Q ss_pred -----eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 008121 482 -----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (577)
Q Consensus 482 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl 556 (577)
..|+|||||++|+|.++++.. ......++..++.|+.||++||+|||++ +||||||||+|||++.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 368999999999999999732 1223456777899999999999999999 9999999999999999999999
Q ss_pred eccccCcccCCC
Q 008121 557 SDCGLAALTPNT 568 (577)
Q Consensus 557 ~DFGla~~~~~~ 568 (577)
+|||+|+.....
T Consensus 160 ~DFGla~~~~~~ 171 (299)
T 4g31_A 160 GDFGLVTAMDQD 171 (299)
T ss_dssp CCCCCC------
T ss_pred ccCccceecCCC
Confidence 999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=284.87 Aligned_cols=161 Identities=23% Similarity=0.382 Sum_probs=137.3
Q ss_pred HHhhcCCCccceeccCccceEEEEEEcC------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCC-CceeeEeeEEE
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCA 478 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~ 478 (577)
+...++|...+.||+|+||+||+|.+.. ++.||||+++... .....++|.+|+++|++++| ||||+++|+|.
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 3445788889999999999999998643 3689999997643 34456789999999999976 89999999997
Q ss_pred eC-CeEEEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 008121 479 EH-GQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (577)
Q Consensus 479 ~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~N 545 (577)
.. +..|+|||||++|+|.++|+.... ....++|.+++.|+.|||+||+|||++ +||||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence 65 568999999999999999975321 235689999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeccccCcccCCCcc
Q 008121 546 ILLDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 546 ILl~~~~~~kl~DFGla~~~~~~~~ 570 (577)
||+++++.+||+|||+|+.+.....
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~ 240 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPD 240 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTT
T ss_pred eeeCCCCCEEECcchhhhhcccCCC
Confidence 9999999999999999997755443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=280.11 Aligned_cols=160 Identities=24% Similarity=0.375 Sum_probs=138.4
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe------CCe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE------HGQ 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~ 482 (577)
++|...+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5788999999999999999977 469999999997655455566788999999999999999999998764 357
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.|+|||||+ |+|.+++. ..+.+++.++..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 78999996 456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC------ccccccCCC
Q 008121 563 ALTPNT------ERQVITGTS 577 (577)
Q Consensus 563 ~~~~~~------~~~~~~Gt~ 577 (577)
+.+... .....+||+
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~ 226 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATR 226 (398)
T ss_dssp BCC-------CCCCCSSCCCC
T ss_pred eecccCccccccccccceeCh
Confidence 976432 234567885
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=290.29 Aligned_cols=161 Identities=30% Similarity=0.345 Sum_probs=140.9
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch-HHHH---HHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEED---NFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~---~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
++|...+.||+|+||+||+|+.. +|+.||||++++..... .... ....++.+++.++|||||+++++|.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999775 58999999996543211 1122 2334467778889999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+|||||+||+|.++|+. ...+++..+..|+.||+.||+|||++ +||||||||+|||||.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999973 35699999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCccccccCCC
Q 008121 565 TPNTERQVITGTS 577 (577)
Q Consensus 565 ~~~~~~~~~~Gt~ 577 (577)
+......+.+|||
T Consensus 342 ~~~~~~~t~~GTp 354 (689)
T 3v5w_A 342 FSKKKPHASVGTH 354 (689)
T ss_dssp CSSCCCCSCCSCG
T ss_pred cCCCCCCCccCCc
Confidence 8888888899996
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=266.86 Aligned_cols=148 Identities=23% Similarity=0.343 Sum_probs=130.9
Q ss_pred HhhcCCCccceeccCccceEEEEEEc----CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCC
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 481 (577)
...++|...+.||+|+||+||+|..+ +++.||||++.... ...++.+|+++|..+ +|||||++++++.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 34578999999999999999999753 46889999986432 345678999999988 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCG 560 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFG 560 (577)
+.|+||||+++|+|.++++ .+++.++..++.|++.||+|||++ +||||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999984 489999999999999999999999 99999999999999876 799999999
Q ss_pred cCcccCCC
Q 008121 561 LAALTPNT 568 (577)
Q Consensus 561 la~~~~~~ 568 (577)
+|+...+.
T Consensus 164 la~~~~~~ 171 (361)
T 4f9c_A 164 LAQGTHDT 171 (361)
T ss_dssp TCEECTTC
T ss_pred CCcccCCc
Confidence 99866543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=278.08 Aligned_cols=160 Identities=25% Similarity=0.417 Sum_probs=141.3
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++|+.++|||||++++++.+.+..|+|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5788999999999999999977 468999999986542 3445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC--CCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE--LNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~--~~~kl~DFGla~~~~ 566 (577)
||++|+|.++|. .....+++.++..|+.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 235 ~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999999985 2345799999999999999999999999 99999999999999854 899999999999876
Q ss_pred CCcc-ccccCCC
Q 008121 567 NTER-QVITGTS 577 (577)
Q Consensus 567 ~~~~-~~~~Gt~ 577 (577)
.... ...+||+
T Consensus 309 ~~~~~~~~~GT~ 320 (573)
T 3uto_A 309 PKQSVKVTTGTA 320 (573)
T ss_dssp TTSEEEEECSSG
T ss_pred CCCceeeeEECc
Confidence 5543 5677885
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=288.51 Aligned_cols=215 Identities=17% Similarity=0.314 Sum_probs=171.7
Q ss_pred cCCChHHHHHHHHHHHhcCCCCCCCCCCCCC----CCCCCCCC------------ccEEee-CCcEEEEEcCCCCCcccc
Q 008121 37 CTTDSSDVQALQVLYTSLNSPSVLTNWKGNE----GDPCGESW------------KGVACE-GSAVVSIDISGLGLSGTM 99 (577)
Q Consensus 37 ~~~~~~~~~~l~~~~~~~~~~~~l~~w~~~~----~~~c~~~w------------~gv~C~-~~~v~~l~l~~~~l~g~~ 99 (577)
.++..+|++||++||+++.++ +|+.++ .+||.|.| .||.|+ .++|+.|+|++++|+|.+
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE
T ss_pred cccchHHHHHHHHHHHHcCCC----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcC
Confidence 344567999999999999876 787543 47855699 999998 489999999999999999
Q ss_pred cccccCCCCCCEEEc-cCCCcCCc--------------------------------------------------------
Q 008121 100 GYLLSDLLSLRKFDL-SGNSIHDT-------------------------------------------------------- 122 (577)
Q Consensus 100 ~~~~~~l~~L~~L~L-s~N~l~~~-------------------------------------------------------- 122 (577)
|+.|++|++|++||| ++|.++|.
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 88877665
Q ss_pred --------------------CCCCCC--CCccEEEccCCcCCC-----------------cCCCCcc--CCCCccEEEec
Q 008121 123 --------------------IPYQLP--PNLTSLNLASNNFSG-----------------NLPYSIA--SMVSLSYLNVS 161 (577)
Q Consensus 123 --------------------~p~~~~--~~L~~L~l~~N~l~~-----------------~~p~~~~--~l~~L~~L~L~ 161 (577)
+|..+. ++|++|+|++|+|+| .+|..++ ++++|++|+|+
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 554444 789999999999998 3888877 89999999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCc-ccC-CCCCCccCCC-------CCCeEEccCcccccccc--cCCCCC-ccEEE
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNN-FSG-DLPNSFISLS-------NISSLYLQNNQVTGSLN--VFSGLP-LTTLN 229 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g-~~p~~~~~l~-------~L~~L~l~~N~l~~~~~--~~~~~~-L~~L~ 229 (577)
+|++.+.+|..|+++++|++|+|++|+ |+| .+|..++.++ +|++|+|++|+|+..+. .+..++ |+.|+
T Consensus 500 ~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~ 579 (876)
T 4ecn_A 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLD 579 (876)
T ss_dssp SCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEE
T ss_pred CCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEE
Confidence 999999999888899999999999887 887 7776555544 78888888888875444 455554 77777
Q ss_pred eecCccccccCcccc---cccceeecCCcCC
Q 008121 230 VANNHFSGWIPRELI---SIRTFIYDGNSFD 257 (577)
Q Consensus 230 l~~N~l~g~~p~~l~---~l~~l~~~~n~~~ 257 (577)
|++|+|+ .+| .+. +++.|.+++|.+.
T Consensus 580 Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~ 608 (876)
T 4ecn_A 580 CVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE 608 (876)
T ss_dssp CTTSCCC-BCC-CCCTTSEESEEECCSSCCS
T ss_pred CCCCCcc-cch-hhcCCCcceEEECcCCccc
Confidence 7777777 676 443 4455667777665
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=283.53 Aligned_cols=217 Identities=24% Similarity=0.327 Sum_probs=162.6
Q ss_pred ccCCChHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCccEEeeCCcEEEEEcCCCCCccc---cc------------
Q 008121 36 QCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGT---MG------------ 100 (577)
Q Consensus 36 ~~~~~~~~~~~l~~~~~~~~~~~~l~~w~~~~~~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~---~~------------ 100 (577)
+..+.++|++||++||+++.|+..+.+|+. +.||| .|.||+|+.++|+.|+|+++++.|. +|
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~~l~~W~~-~~~~C--~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKNLLPDWSS-NKNPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTTSSTTCCT-TSCGG--GSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cccCCHHHHHHHHHHHhhCCCcccccCCCC-CCCCc--CCcceEECCCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 344467899999999999988778899984 46888 8999999999999999999999987 55
Q ss_pred -----------ccccCCCCCCEEEccCCCcCCcCCC--CCC--CCccEEEccCCcCCCcCCCCc-cCCCCccEEEeccCC
Q 008121 101 -----------YLLSDLLSLRKFDLSGNSIHDTIPY--QLP--PNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNS 164 (577)
Q Consensus 101 -----------~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~--~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~L~~N~ 164 (577)
..|+.+++|++|||++|+++|.+|. .+. ++|++|+|++|.+++.+|..+ .++++|++|+|++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 4566777888888888888777776 554 778888888888877777665 677788888888888
Q ss_pred Cccccccc---ccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC
Q 008121 165 LTQSIGDI---FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 165 l~~~~p~~---~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p 240 (577)
+++..|.. +.++++|++|+|++|++++.+|. ..+++|++|+|++|++++.++.+..++ |++|++++|++++.+|
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~ 240 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFS 240 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCccc
Confidence 87777766 66777777777777777765553 567777777777777777666555554 7777777777777777
Q ss_pred cccc---cccceeecCCcCC
Q 008121 241 RELI---SIRTFIYDGNSFD 257 (577)
Q Consensus 241 ~~l~---~l~~l~~~~n~~~ 257 (577)
..+. +++.|++++|.+.
T Consensus 241 ~~l~~l~~L~~L~Ls~n~l~ 260 (768)
T 3rgz_A 241 RAISTCTELKLLNISSNQFV 260 (768)
T ss_dssp HHTTTCSSCCEEECCSSCCE
T ss_pred HHHhcCCCCCEEECCCCccc
Confidence 6544 4455666666654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=251.27 Aligned_cols=162 Identities=25% Similarity=0.383 Sum_probs=143.4
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|.+ .+|+.||||++..........+++.+|+++++.++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788899999999999999987 57999999999766555566778999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999963 35689999999999999999999999 999999999999999999999999999987654
Q ss_pred Cc-cccccCCC
Q 008121 568 TE-RQVITGTS 577 (577)
Q Consensus 568 ~~-~~~~~Gt~ 577 (577)
.. ....+||+
T Consensus 167 ~~~~~~~~gt~ 177 (328)
T 3fe3_A 167 GGKLDAFCGAP 177 (328)
T ss_dssp SCGGGTTSSSG
T ss_pred CCccccccCCc
Confidence 33 34556663
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=251.33 Aligned_cols=172 Identities=37% Similarity=0.699 Sum_probs=151.6
Q ss_pred ceeecHHHHHHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeE
Q 008121 397 ATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476 (577)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~ 476 (577)
...++..++....++|...+.||+|+||.||+|...+++.||||++..... ......|.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEE
Confidence 356788999999999999999999999999999988899999999975432 2223368999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 008121 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (577)
Q Consensus 477 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl 556 (577)
+...+..++||||+++|+|.++++........+++..+..|+.|++.||+|||+.+.++|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999865555667999999999999999999999987778999999999999999999999
Q ss_pred eccccCcccCCCc
Q 008121 557 SDCGLAALTPNTE 569 (577)
Q Consensus 557 ~DFGla~~~~~~~ 569 (577)
+|||+++......
T Consensus 176 ~Dfg~~~~~~~~~ 188 (326)
T 3uim_A 176 GDFGLAKLMDYKD 188 (326)
T ss_dssp CCCSSCEECCSSS
T ss_pred ccCccccccCccc
Confidence 9999999765433
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-29 Score=278.18 Aligned_cols=214 Identities=17% Similarity=0.300 Sum_probs=183.5
Q ss_pred CChHHHHHHHHHHHhcCCCCCC---------CCCCCCCCCCCCCCC---ccEEeeC-CcEEEEEcCCCCCcccccccccC
Q 008121 39 TDSSDVQALQVLYTSLNSPSVL---------TNWKGNEGDPCGESW---KGVACEG-SAVVSIDISGLGLSGTMGYLLSD 105 (577)
Q Consensus 39 ~~~~~~~~l~~~~~~~~~~~~l---------~~w~~~~~~~c~~~w---~gv~C~~-~~v~~l~l~~~~l~g~~~~~~~~ 105 (577)
....|++||.++|++++++.|- .+|+. +.|+| .| .||+|+. ++|+.|+|++++++|.+|+.|++
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c--~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~ 103 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELD--MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGG--GTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGG
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcc--cccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhc
Confidence 3456999999999999876432 37985 46778 89 9999975 69999999999999999999999
Q ss_pred CCCCCEEEccCCCc------------------------------------------------------------------
Q 008121 106 LLSLRKFDLSGNSI------------------------------------------------------------------ 119 (577)
Q Consensus 106 l~~L~~L~Ls~N~l------------------------------------------------------------------ 119 (577)
|++|++|||++|.+
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l 183 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred CccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence 99999999999944
Q ss_pred ------------CCcCCCCCC--CCccEEEccCCcCCCc-----------------CCCCcc--CCCCccEEEeccCCCc
Q 008121 120 ------------HDTIPYQLP--PNLTSLNLASNNFSGN-----------------LPYSIA--SMVSLSYLNVSRNSLT 166 (577)
Q Consensus 120 ------------~~~~p~~~~--~~L~~L~l~~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~ 166 (577)
+| +|..+. ++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.
T Consensus 184 ~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~ 262 (636)
T 4eco_A 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL 262 (636)
T ss_dssp CTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTC
T ss_pred hhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCC
Confidence 34 676665 8999999999999996 999999 9999999999999999
Q ss_pred ccccccccCCCCCcEEeCcCCc-ccC-CCCCCccCC------CCCCeEEccCcccccccc--cCCCCC-ccEEEeecCcc
Q 008121 167 QSIGDIFGNLAGLATLDLSFNN-FSG-DLPNSFISL------SNISSLYLQNNQVTGSLN--VFSGLP-LTTLNVANNHF 235 (577)
Q Consensus 167 ~~~p~~~~~l~~L~~L~Ls~N~-l~g-~~p~~~~~l------~~L~~L~l~~N~l~~~~~--~~~~~~-L~~L~l~~N~l 235 (577)
|.+|..|+++++|++|+|++|+ |+| .+|..++.+ ++|++|+|++|+|+..+. .+..++ |+.|++++|++
T Consensus 263 ~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l 342 (636)
T 4eco_A 263 TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL 342 (636)
T ss_dssp SSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCC
T ss_pred ccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcC
Confidence 9999999999999999999998 998 889888776 899999999999995555 566665 89999999999
Q ss_pred ccccCcccc---cccceeecCCcCC
Q 008121 236 SGWIPRELI---SIRTFIYDGNSFD 257 (577)
Q Consensus 236 ~g~~p~~l~---~l~~l~~~~n~~~ 257 (577)
+|.+| .+. +++.|++++|.+.
T Consensus 343 ~g~ip-~~~~l~~L~~L~L~~N~l~ 366 (636)
T 4eco_A 343 EGKLP-AFGSEIKLASLNLAYNQIT 366 (636)
T ss_dssp EEECC-CCEEEEEESEEECCSSEEE
T ss_pred ccchh-hhCCCCCCCEEECCCCccc
Confidence 98888 554 5566777777765
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=257.92 Aligned_cols=170 Identities=24% Similarity=0.279 Sum_probs=144.0
Q ss_pred HHHHHHhhcCCCccceeccCccceEEEEEEcC-CcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEe
Q 008121 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (577)
Q Consensus 402 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 479 (577)
+.++....++|...+.||+|+||+||+|+..+ ++.||+|++++... .......+.+|..++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44555667889999999999999999998865 78999999864321 11123348899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
.+..|+||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999962 246799999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccCCCcc---ccccCCC
Q 008121 560 GLAALTPNTER---QVITGTS 577 (577)
Q Consensus 560 Gla~~~~~~~~---~~~~Gt~ 577 (577)
|+|+....... ...+||+
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~ 240 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTP 240 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCG
T ss_pred hhhhhcccCCCcccccccCCc
Confidence 99987654433 2356774
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=241.28 Aligned_cols=151 Identities=25% Similarity=0.502 Sum_probs=135.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|.+. +++.||+|++... .....+.|.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 56778899999999999999875 5899999988543 35567789999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.++++. ....+++.++..|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999973 245699999999999999999999999 9999999999999999999999999999876443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=246.14 Aligned_cols=161 Identities=35% Similarity=0.719 Sum_probs=143.2
Q ss_pred cHHHHHHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC
Q 008121 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (577)
Q Consensus 401 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 480 (577)
...++...+++|...+.||+|+||.||+|.+.+++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3344556778999999999999999999998889999999986542 34567799999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
+..++||||+++|+|.+++.........+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999975443445699999999999999999999999 99999999999999999999999999
Q ss_pred cCcccC
Q 008121 561 LAALTP 566 (577)
Q Consensus 561 la~~~~ 566 (577)
+++...
T Consensus 185 ~~~~~~ 190 (321)
T 2qkw_B 185 ISKKGT 190 (321)
T ss_dssp TCEECS
T ss_pred cccccc
Confidence 998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=255.42 Aligned_cols=167 Identities=21% Similarity=0.291 Sum_probs=142.3
Q ss_pred HHHHHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC
Q 008121 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (577)
Q Consensus 403 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 480 (577)
.++....++|...+.||+|+||.||+|+.. +++.||+|++++... .....+.+.+|+.+++.++|||||++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 445556678999999999999999999875 588999999864321 111234578899999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
+..|+||||+++|+|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 999999999999999999962 3589999999999999999999999 99999999999999999999999999
Q ss_pred cCcccCCCcc---ccccCCC
Q 008121 561 LAALTPNTER---QVITGTS 577 (577)
Q Consensus 561 la~~~~~~~~---~~~~Gt~ 577 (577)
+|+....... ...+||+
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~ 233 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTP 233 (410)
T ss_dssp TCEECCTTSEEECCSCCSCG
T ss_pred eeEeeccCCcccccCCcCCc
Confidence 9987765432 3556774
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=245.90 Aligned_cols=161 Identities=25% Similarity=0.353 Sum_probs=138.7
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|+.. +++.||+|++++... .......+.+|+++++.++||||+++++++...+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888899999999999999875 589999999965421 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999963 35689999999999999999999999 999999999999999999999999999986432
Q ss_pred --CccccccCCC
Q 008121 568 --TERQVITGTS 577 (577)
Q Consensus 568 --~~~~~~~Gt~ 577 (577)
......+||+
T Consensus 158 ~~~~~~~~~gt~ 169 (337)
T 1o6l_A 158 DGATMKTFCGTP 169 (337)
T ss_dssp TTCCBCCCEECG
T ss_pred CCCcccccccCh
Confidence 2234455664
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=241.24 Aligned_cols=156 Identities=35% Similarity=0.549 Sum_probs=132.6
Q ss_pred hhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
..++|...+.||+|+||.||+|+. +++.||||++..........++|.+|++++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356788889999999999999987 5889999999776555666778999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||+++|+|.++++... ....+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp ECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred ecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 9999999999996211 112489999999999999999999998 7 999999999999999999999999999865
Q ss_pred CCC
Q 008121 566 PNT 568 (577)
Q Consensus 566 ~~~ 568 (577)
...
T Consensus 190 ~~~ 192 (309)
T 3p86_A 190 AST 192 (309)
T ss_dssp ---
T ss_pred ccc
Confidence 443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=253.42 Aligned_cols=171 Identities=22% Similarity=0.247 Sum_probs=145.0
Q ss_pred cHHHHHHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEE
Q 008121 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (577)
Q Consensus 401 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 478 (577)
.+.+.....++|...+.||+|+||.||+++.. +++.||+|++++... .....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556788999999999999999999875 689999999864321 1222345788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEec
Q 008121 479 EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (577)
Q Consensus 479 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~D 558 (577)
+.+..|+||||+++|+|.++++.. ...+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999632 34689999999999999999999999 999999999999999999999999
Q ss_pred cccCcccCCCcc---ccccCCC
Q 008121 559 CGLAALTPNTER---QVITGTS 577 (577)
Q Consensus 559 FGla~~~~~~~~---~~~~Gt~ 577 (577)
||+++....... ...+||+
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~ 227 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTP 227 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCG
T ss_pred chhheeccCCCccccceecccc
Confidence 999998755433 2356774
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=241.36 Aligned_cols=160 Identities=27% Similarity=0.421 Sum_probs=139.3
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+++.. +|+.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999875 689999999865422 1223566889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999973 45689999999999999999999999 999999999999999999999999999997654
Q ss_pred CccccccCCC
Q 008121 568 TERQVITGTS 577 (577)
Q Consensus 568 ~~~~~~~Gt~ 577 (577)
.....+||+
T Consensus 159 -~~~~~~gt~ 167 (318)
T 1fot_A 159 -VTYTLCGTP 167 (318)
T ss_dssp -CBCCCCSCT
T ss_pred -ccccccCCc
Confidence 344556764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=246.57 Aligned_cols=162 Identities=23% Similarity=0.332 Sum_probs=135.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 485 (577)
.++|...+.||+|+||.||+|+.. +++.||||+++.... .....+.+.+|.+++..+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467888999999999999999875 589999999975421 223355678899999988 69999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.++++. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999973 35689999999999999999999999 9999999999999999999999999999964
Q ss_pred CCC--ccccccCCC
Q 008121 566 PNT--ERQVITGTS 577 (577)
Q Consensus 566 ~~~--~~~~~~Gt~ 577 (577)
... .....+||+
T Consensus 175 ~~~~~~~~~~~gt~ 188 (353)
T 3txo_A 175 ICNGVTTATFCGTP 188 (353)
T ss_dssp CC---------CCG
T ss_pred ccCCccccccCCCc
Confidence 332 234556774
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=247.57 Aligned_cols=161 Identities=25% Similarity=0.386 Sum_probs=140.1
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||++... +++.||+|++..... .....+.+.+|+++++.++|||||++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999775 488999999864321 2233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999997 345799999999999999999999999 999999999999999999999999999997654
Q ss_pred Cc-cccccCCC
Q 008121 568 TE-RQVITGTS 577 (577)
Q Consensus 568 ~~-~~~~~Gt~ 577 (577)
.. ....+||+
T Consensus 168 ~~~~~~~~gt~ 178 (384)
T 4fr4_A 168 ETQITTMAGTK 178 (384)
T ss_dssp TCCBCCCCSCG
T ss_pred CCceeccCCCc
Confidence 33 34566764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=249.31 Aligned_cols=215 Identities=20% Similarity=0.276 Sum_probs=187.5
Q ss_pred cCCChHHHHHHHHHHHhcC-CC-CCCCCCC---CCCCCCCCCCCccEEeeC----------CcEEEEEcCCCCCcccccc
Q 008121 37 CTTDSSDVQALQVLYTSLN-SP-SVLTNWK---GNEGDPCGESWKGVACEG----------SAVVSIDISGLGLSGTMGY 101 (577)
Q Consensus 37 ~~~~~~~~~~l~~~~~~~~-~~-~~l~~w~---~~~~~~c~~~w~gv~C~~----------~~v~~l~l~~~~l~g~~~~ 101 (577)
.....+|++||+++|+++. ++ +++..|. ....++| .|.|+.|+. .+|+.|+|++|+++ .+|.
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~--~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE--TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC--CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc--ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 4456789999999999883 44 5677884 2345666 899999963 78999999999998 7888
Q ss_pred cccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccC----
Q 008121 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGN---- 175 (577)
Q Consensus 102 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---- 175 (577)
.++.+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|+++++|++|+|++|++.+.+|..+..
T Consensus 99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~ 176 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176 (328)
T ss_dssp CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-C
T ss_pred hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccch
Confidence 8999999999999999999 8898776 89999999999999 88999999999999999999999999987765
Q ss_pred -----CCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccCcccc---cc
Q 008121 176 -----LAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRELI---SI 246 (577)
Q Consensus 176 -----l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p~~l~---~l 246 (577)
+++|++|+|++|+|+ .+|..++++++|++|+|++|+|++.++.+..++ |+.|++++|++.+.+|..+. ++
T Consensus 177 ~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L 255 (328)
T 4fcg_A 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255 (328)
T ss_dssp CCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCC
T ss_pred hhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCC
Confidence 999999999999999 899999999999999999999999877776665 99999999999999998765 56
Q ss_pred cceeecCCcCC
Q 008121 247 RTFIYDGNSFD 257 (577)
Q Consensus 247 ~~l~~~~n~~~ 257 (577)
+.|++++|...
T Consensus 256 ~~L~L~~n~~~ 266 (328)
T 4fcg_A 256 KRLILKDCSNL 266 (328)
T ss_dssp CEEECTTCTTC
T ss_pred CEEECCCCCch
Confidence 67888887654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-27 Score=239.54 Aligned_cols=167 Identities=29% Similarity=0.368 Sum_probs=141.8
Q ss_pred ecHHHHHHhhcC----------CCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCC
Q 008121 400 YTVASLQTATNS----------FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468 (577)
Q Consensus 400 ~~~~~~~~~~~~----------~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~ 468 (577)
++.+++..+++. |...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCT
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCC
Confidence 455555555543 566678999999999999876 69999999986442 33456789999999999999
Q ss_pred ceeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008121 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (577)
Q Consensus 469 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl 548 (577)
||+++++++...+..++||||+++|+|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999999985 34689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeccccCcccCCCc--cccccCC
Q 008121 549 DDELNPHLSDCGLAALTPNTE--RQVITGT 576 (577)
Q Consensus 549 ~~~~~~kl~DFGla~~~~~~~--~~~~~Gt 576 (577)
+.++.+||+|||+++...... .....||
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 204 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPKRKSLVGT 204 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred CCCCcEEEeeeeeeeecccCccccccccCC
Confidence 999999999999998765432 2334455
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=239.24 Aligned_cols=152 Identities=26% Similarity=0.368 Sum_probs=133.1
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||+|...+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788899999999999999999889999999997554344445778999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|++ |+|.+.+.. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 100 FME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 997 588888862 345689999999999999999999999 999999999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-27 Score=236.82 Aligned_cols=158 Identities=27% Similarity=0.403 Sum_probs=138.2
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46789999999999999999976 568999999986443 223566899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp ECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999999962 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred Ccc--ccccCC
Q 008121 568 TER--QVITGT 576 (577)
Q Consensus 568 ~~~--~~~~Gt 576 (577)
... ....||
T Consensus 169 ~~~~~~~~~gt 179 (297)
T 3fxz_A 169 EQSKRSTMVGT 179 (297)
T ss_dssp TTCCBCCCCSC
T ss_pred cccccCCccCC
Confidence 433 334455
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=248.93 Aligned_cols=162 Identities=23% Similarity=0.340 Sum_probs=137.6
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 485 (577)
.++|...+.||+|+||.||+|+.. +++.||+|++++.... ....+.+.+|..++.++ +|||||++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457888999999999999999875 4789999999754322 22334577888888876 89999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999973 35689999999999999999999999 9999999999999999999999999999863
Q ss_pred C--CCccccccCCC
Q 008121 566 P--NTERQVITGTS 577 (577)
Q Consensus 566 ~--~~~~~~~~Gt~ 577 (577)
. .......+||+
T Consensus 204 ~~~~~~~~~~~gt~ 217 (396)
T 4dc2_A 204 LRPGDTTSTFCGTP 217 (396)
T ss_dssp CCTTCCBCCCCBCG
T ss_pred ccCCCccccccCCc
Confidence 2 33345667774
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-27 Score=244.00 Aligned_cols=156 Identities=26% Similarity=0.470 Sum_probs=136.1
Q ss_pred hcCCCccceeccCccceEEEEEEc--------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 479 (577)
.++|...+.||+|+||.||+|++. ++..||||+++... .....+++.+|+++++++ +||||++++++|..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 357888899999999999999763 35679999997543 345567899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
.+..|+||||+++|+|.++++.... ....+++.+++.++.||++||+|||+. +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999975321 124589999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccCcccCCC
Q 008121 548 LDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~~~ 568 (577)
++.++.+||+|||+++.....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~ 256 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNI 256 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCC
T ss_pred ECCCCCEEEccccCCcccCcc
Confidence 999999999999999976543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-27 Score=240.01 Aligned_cols=155 Identities=21% Similarity=0.327 Sum_probs=132.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 481 (577)
.++|...+.||+|+||.||+|... +++.||||+++... .....+.+.+|++++++++||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 356888899999999999999886 78999999986543 3345677999999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEEecCCCCHHHhhhhccCCCCCCC
Q 008121 482 ---------------------------------------------------QRLLVYEYVGNGNLHDMLHFADDSSKNLT 510 (577)
Q Consensus 482 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~ 510 (577)
..++||||+++|+|.++++... .....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence 3799999999999999997432 234457
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 511 ~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 778999999999999999999 9999999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-27 Score=240.33 Aligned_cols=153 Identities=27% Similarity=0.460 Sum_probs=135.2
Q ss_pred hcCCCccceeccCccceEEEEEEc----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.++|...+.||+|+||.||+|.+. .+..||||+++... .....+.|.+|++++++++||||+++++++.+.+..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 356788899999999999999874 35569999997543 3455678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.++++. ....+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999962 345799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
....
T Consensus 201 ~~~~ 204 (325)
T 3kul_A 201 LEDD 204 (325)
T ss_dssp CC--
T ss_pred cccC
Confidence 7544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-27 Score=242.26 Aligned_cols=161 Identities=24% Similarity=0.345 Sum_probs=138.8
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 486 (577)
++|...+.||+|+||.||+|+.. +++.||+|+++.... .....+.+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46788899999999999999875 588999999975432 234456788999999887 899999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999963 34689999999999999999999999 99999999999999999999999999998643
Q ss_pred --CCccccccCCC
Q 008121 567 --NTERQVITGTS 577 (577)
Q Consensus 567 --~~~~~~~~Gt~ 577 (577)
.......+||+
T Consensus 162 ~~~~~~~~~~gt~ 174 (345)
T 3a8x_A 162 RPGDTTSTFCGTP 174 (345)
T ss_dssp CTTCCBCCCCSCG
T ss_pred CCCCcccccCCCc
Confidence 22334556764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-27 Score=243.03 Aligned_cols=162 Identities=25% Similarity=0.382 Sum_probs=141.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467888999999999999999774 5899999999765555556678999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl~DFGla~~ 564 (577)
||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 108 e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999986 345789999999999999999999999 99999999999999865 4599999999997
Q ss_pred cCCCcc-ccccCCC
Q 008121 565 TPNTER-QVITGTS 577 (577)
Q Consensus 565 ~~~~~~-~~~~Gt~ 577 (577)
...... ...+||+
T Consensus 181 ~~~~~~~~~~~gt~ 194 (362)
T 2bdw_A 181 VNDSEAWHGFAGTP 194 (362)
T ss_dssp CTTCCSCCCSCSCT
T ss_pred ecCCcccccCCCCc
Confidence 764433 3455664
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-27 Score=242.60 Aligned_cols=162 Identities=25% Similarity=0.316 Sum_probs=139.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch----HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.+.|...+.||+|+||.||+|... +|+.||+|.++...... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 456888999999999999999875 58999999997543221 1356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEecc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDC 559 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DF 559 (577)
++||||+++|+|.+++. ....+++.++..++.||+.||+|||+. +|+||||||+|||+++++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999996 345799999999999999999999999 999999999999998877 7999999
Q ss_pred ccCcccCCCc-cccccCCC
Q 008121 560 GLAALTPNTE-RQVITGTS 577 (577)
Q Consensus 560 Gla~~~~~~~-~~~~~Gt~ 577 (577)
|+++...... ....+||+
T Consensus 164 G~a~~~~~~~~~~~~~gt~ 182 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTP 182 (361)
T ss_dssp SSCEECCTTCCCCCCCSCG
T ss_pred CCceEcCCCCccccCCCCc
Confidence 9999775543 34455764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=243.43 Aligned_cols=164 Identities=21% Similarity=0.360 Sum_probs=138.9
Q ss_pred HhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeE
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 483 (577)
...++|...+.||+|+||.||+|+.. +++.||||+++.... .....+.+..|.+++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578889999999999999999875 589999999965421 122345677888888876 999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
|+||||+++|+|.++++. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999973 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccC--CCccccccCCC
Q 008121 564 LTP--NTERQVITGTS 577 (577)
Q Consensus 564 ~~~--~~~~~~~~Gt~ 577 (577)
... .......+||+
T Consensus 167 ~~~~~~~~~~~~~gt~ 182 (345)
T 1xjd_A 167 ENMLGDAKTNTFCGTP 182 (345)
T ss_dssp CCCCTTCCBCCCCSCG
T ss_pred hcccCCCcccCCCCCc
Confidence 653 23345566774
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=233.94 Aligned_cols=150 Identities=27% Similarity=0.481 Sum_probs=135.6
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|...+.||+|+||.||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 56778899999999999999998899999999975432 345689999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+++|+|.++++. ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999962 345689999999999999999999999 9999999999999999999999999999876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=243.43 Aligned_cols=166 Identities=23% Similarity=0.298 Sum_probs=139.3
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc---hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.+.|...+.||+|+||.||+|... +++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356888899999999999999774 6899999998643211 113567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---eEEecccc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGL 561 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~---~kl~DFGl 561 (577)
+||||+++|+|.+.+.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988865444455689999999999999999999999 9999999999999986654 99999999
Q ss_pred CcccCCCcc--ccccCCC
Q 008121 562 AALTPNTER--QVITGTS 577 (577)
Q Consensus 562 a~~~~~~~~--~~~~Gt~ 577 (577)
++....... ...+||+
T Consensus 180 a~~~~~~~~~~~~~~gt~ 197 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTP 197 (351)
T ss_dssp CEECCTTSCBCCCCCSCG
T ss_pred eeEecCCCeeecCCcCCc
Confidence 998765432 3345653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-27 Score=236.76 Aligned_cols=160 Identities=16% Similarity=0.235 Sum_probs=138.7
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 357888999999999999999775 5889999998643 344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--ELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~--~~~~kl~DFGla~~~ 565 (577)
||+++|+|.+++. .....+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 81 EFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999995 2345689999999999999999999999 9999999999999987 789999999999987
Q ss_pred CCCcc-ccccCCC
Q 008121 566 PNTER-QVITGTS 577 (577)
Q Consensus 566 ~~~~~-~~~~Gt~ 577 (577)
..... ....||+
T Consensus 155 ~~~~~~~~~~gt~ 167 (321)
T 1tki_A 155 KPGDNFRLLFTAP 167 (321)
T ss_dssp CTTCEEEEEESCG
T ss_pred CCCCccccccCCh
Confidence 55433 3344553
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=244.77 Aligned_cols=153 Identities=27% Similarity=0.471 Sum_probs=129.5
Q ss_pred hcCCCccceeccCccceEEEEEEc----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.++|...+.||+|+||.||+|.+. ++..||||+++... .....++|.+|+.++++++||||+++++++...+..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 357888999999999999999765 57789999997543 3455678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.++++. ....+++.+++.|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999962 345799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
....
T Consensus 197 ~~~~ 200 (373)
T 2qol_A 197 LEDD 200 (373)
T ss_dssp ----
T ss_pred cccC
Confidence 6543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=235.52 Aligned_cols=153 Identities=25% Similarity=0.330 Sum_probs=134.6
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ......+.|.+|+.++++++||||+++++++...+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999764 68899999985432 2234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999963 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CC
Q 008121 567 NT 568 (577)
Q Consensus 567 ~~ 568 (577)
..
T Consensus 163 ~~ 164 (294)
T 4eqm_A 163 ET 164 (294)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=243.08 Aligned_cols=160 Identities=23% Similarity=0.366 Sum_probs=139.0
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||++... +|+.||+|+++.... .....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888899999999999999875 689999999865421 1233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999973 34689999999999999999999999 999999999999999999999999999997654
Q ss_pred CccccccCCC
Q 008121 568 TERQVITGTS 577 (577)
Q Consensus 568 ~~~~~~~Gt~ 577 (577)
. ....+||+
T Consensus 194 ~-~~~~~gt~ 202 (350)
T 1rdq_E 194 R-TWTLCGTP 202 (350)
T ss_dssp C-BCCCEECG
T ss_pred C-cccccCCc
Confidence 3 33455653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=240.82 Aligned_cols=150 Identities=27% Similarity=0.377 Sum_probs=131.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 357888999999999999999875 689999999864322 233466889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.++++ ....+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 9999999999986 445799999999999999999999999 99999999999999999999999999998654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=244.41 Aligned_cols=151 Identities=20% Similarity=0.280 Sum_probs=130.5
Q ss_pred hhcCCCccceeccCccceEEEEE------EcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC---CCceeeEeeEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAE------FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAGYCA 478 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~ 478 (577)
..++|...+.||+|+||.||+|. ..+++.||||+++.. ...++.+|++++..++ |+||+++++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 34678888999999999999993 456889999998643 2345777777777776 999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-------
Q 008121 479 EHGQRLLVYEYVGNGNLHDMLHFADD-SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD------- 550 (577)
Q Consensus 479 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~------- 550 (577)
..+..|+||||+++|+|.++++.... ....+++.+++.|+.|+++||+|||+. +||||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999975433 356799999999999999999999999 9999999999999998
Q ss_pred ----CCCeEEeccccCcccC
Q 008121 551 ----ELNPHLSDCGLAALTP 566 (577)
Q Consensus 551 ----~~~~kl~DFGla~~~~ 566 (577)
++.+||+|||+|+.+.
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp ----CTTEEECCCTTCEEGG
T ss_pred cccccCCEEEeeCchhhhhh
Confidence 8999999999997543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=248.66 Aligned_cols=163 Identities=25% Similarity=0.335 Sum_probs=140.2
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
..++|...+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 346788899999999999999976 4689999999976655555677899999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeccccCc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAA 563 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DFGla~ 563 (577)
|||+++|+|.+.+.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+|+
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999863 45689999999999999999999999 999999999999998 46789999999998
Q ss_pred ccCCCcc--ccccCCC
Q 008121 564 LTPNTER--QVITGTS 577 (577)
Q Consensus 564 ~~~~~~~--~~~~Gt~ 577 (577)
....... ....||+
T Consensus 162 ~~~~~~~~~~~~~gt~ 177 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTP 177 (444)
T ss_dssp CCCTTCCBCCCSCSCG
T ss_pred EecCCCceeecccCCc
Confidence 7755433 2345663
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=233.06 Aligned_cols=151 Identities=23% Similarity=0.345 Sum_probs=133.8
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||||++............+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999875 58999999997655445556788999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9975 66666642 346799999999999999999999999 999999999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=232.17 Aligned_cols=154 Identities=24% Similarity=0.429 Sum_probs=137.8
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||+|++.++..||+|+++.... ..+++.+|++++.+++||||+++++++...+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 457888899999999999999999888999999975432 34568999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.++++.. ...+++.++..|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999632 34689999999999999999999999 9999999999999999999999999999977655
Q ss_pred ccc
Q 008121 569 ERQ 571 (577)
Q Consensus 569 ~~~ 571 (577)
...
T Consensus 158 ~~~ 160 (268)
T 3sxs_A 158 QYV 160 (268)
T ss_dssp CEE
T ss_pred hhh
Confidence 443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=239.99 Aligned_cols=162 Identities=23% Similarity=0.363 Sum_probs=128.9
Q ss_pred hcCCCccceeccCccceEEEEEE----cCCcEEEEEEcccccc--chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
.++|...+.||+|+||.||+++. .+++.||+|+++.... .......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35688889999999999999987 4689999999975432 12234567889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999963 34688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCc--cccccCCC
Q 008121 563 ALTPNTE--RQVITGTS 577 (577)
Q Consensus 563 ~~~~~~~--~~~~~Gt~ 577 (577)
+...... ....+||+
T Consensus 169 ~~~~~~~~~~~~~~gt~ 185 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTI 185 (327)
T ss_dssp ----------CTTSSCC
T ss_pred cccccCCccccccCCCc
Confidence 8643322 23445653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=242.26 Aligned_cols=163 Identities=20% Similarity=0.287 Sum_probs=139.0
Q ss_pred hhcCCCccceeccCccceEEEEEEcC-CcEEEEEEcccccc-chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 484 (577)
..++|...+.||+|+||.||+|+... ++.||+|+++.... .....+.+..|.+++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34678889999999999999998864 78999999865422 122356678899999888 8999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999973 34689999999999999999999999 999999999999999999999999999996
Q ss_pred cCC--CccccccCCC
Q 008121 565 TPN--TERQVITGTS 577 (577)
Q Consensus 565 ~~~--~~~~~~~Gt~ 577 (577)
... ......+||+
T Consensus 171 ~~~~~~~~~~~~gt~ 185 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTP 185 (353)
T ss_dssp CCCTTCCBCCCCSCG
T ss_pred cccCCcccccccCCc
Confidence 432 2345566774
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=246.75 Aligned_cols=153 Identities=23% Similarity=0.417 Sum_probs=135.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|.+. +++.||||+++... .....++|.+|++++++++||||+++++++...+..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 356778899999999999999886 68999999987542 3445567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999732 34589999999999999999999999 999999999999999999999999999987544
Q ss_pred C
Q 008121 568 T 568 (577)
Q Consensus 568 ~ 568 (577)
.
T Consensus 266 ~ 266 (377)
T 3cbl_A 266 G 266 (377)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=240.54 Aligned_cols=160 Identities=29% Similarity=0.425 Sum_probs=137.7
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999987 56899999998643221 112356889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+ +|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 89 E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 7899999863 35689999999999999999999999 999999999999999999999999999997655
Q ss_pred Ccc-ccccCCC
Q 008121 568 TER-QVITGTS 577 (577)
Q Consensus 568 ~~~-~~~~Gt~ 577 (577)
... ...+||+
T Consensus 161 ~~~~~~~~gt~ 171 (336)
T 3h4j_B 161 GNFLKTSCGSP 171 (336)
T ss_dssp SBTTCCCTTST
T ss_pred CcccccccCCc
Confidence 432 4455664
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=234.95 Aligned_cols=150 Identities=27% Similarity=0.387 Sum_probs=133.8
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|...+.||+|+||.||+|...+++.||+|++..........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46788899999999999999988899999999975543333346788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+++ +|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 975 99998863 345689999999999999999999999 99999999999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-27 Score=248.56 Aligned_cols=161 Identities=25% Similarity=0.451 Sum_probs=140.3
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|... +|+.||||++...... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46788899999999999999875 6899999999654221 123567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999996 346799999999999999999999999 999999999999999999999999999998755
Q ss_pred Cc-cccccCCC
Q 008121 568 TE-RQVITGTS 577 (577)
Q Consensus 568 ~~-~~~~~Gt~ 577 (577)
.. ....+||+
T Consensus 169 ~~~~~~~~gt~ 179 (476)
T 2y94_A 169 GEFLRTSCGSP 179 (476)
T ss_dssp TCCBCCCCSCS
T ss_pred cccccccCCCc
Confidence 43 24556664
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=236.15 Aligned_cols=161 Identities=24% Similarity=0.336 Sum_probs=138.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch----HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
+.|...+.||+|+||.||+|... +++.||+|.++...... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45788899999999999999875 58999999986543211 13567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEeccc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDCG 560 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DFG 560 (577)
+||||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999996 345799999999999999999999999 999999999999999887 89999999
Q ss_pred cCcccCCCc-cccccCCC
Q 008121 561 LAALTPNTE-RQVITGTS 577 (577)
Q Consensus 561 la~~~~~~~-~~~~~Gt~ 577 (577)
+++...... .....||+
T Consensus 164 ~a~~~~~~~~~~~~~gt~ 181 (326)
T 2y0a_A 164 LAHKIDFGNEFKNIFGTP 181 (326)
T ss_dssp TCEECCTTSCCCCCCSCT
T ss_pred CCeECCCCCccccccCCc
Confidence 999775332 33445664
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-27 Score=234.13 Aligned_cols=152 Identities=22% Similarity=0.360 Sum_probs=128.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch------------------------HHHHHHHHHHHHhh
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL------------------------QEEDNFLEAVSNMS 463 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~ 463 (577)
.++|...+.||+|+||.||+|... +++.||||++....... ...+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357888999999999999999764 58899999986542111 12356889999999
Q ss_pred cCCCCceeeEeeEEEe--CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 008121 464 RLRHPNIVTLAGYCAE--HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF 541 (577)
Q Consensus 464 ~l~H~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 541 (577)
+++||||+++++++.+ .+..++||||+++|+|.+++. ...+++.++..++.|+++||+|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 568899999999999988663 45799999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 542 KSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 542 k~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
||+|||++.++.+||+|||+++.....
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CHHHEEECCCCCEEEecCCCccccccc
Confidence 999999999999999999999876544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=242.37 Aligned_cols=162 Identities=28% Similarity=0.382 Sum_probs=130.3
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHH-hhcCCCCceeeEeeEEEeCCeEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSN-MSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
.++|...+.||+|+||.||+|+.. +++.||+|++++.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356888999999999999999875 4789999999755332 2334556677776 577899999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999973 35688999999999999999999999 9999999999999999999999999999864
Q ss_pred C--CCccccccCCC
Q 008121 566 P--NTERQVITGTS 577 (577)
Q Consensus 566 ~--~~~~~~~~Gt~ 577 (577)
. .......+||+
T Consensus 190 ~~~~~~~~~~~gt~ 203 (373)
T 2r5t_A 190 IEHNSTTSTFCGTP 203 (373)
T ss_dssp BCCCCCCCSBSCCC
T ss_pred ccCCCccccccCCc
Confidence 3 23345567775
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=250.80 Aligned_cols=166 Identities=23% Similarity=0.334 Sum_probs=143.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|+.. +|+.||+|++...... ....+.+.+|++++++++||||+++++++...+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999875 5899999999654321 12356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999975444456799999999999999999999999 99999999999999999999999999999875
Q ss_pred CCcc--ccccCCC
Q 008121 567 NTER--QVITGTS 577 (577)
Q Consensus 567 ~~~~--~~~~Gt~ 577 (577)
.... ...+||+
T Consensus 341 ~~~~~~~~~~GT~ 353 (543)
T 3c4z_A 341 AGQTKTKGYAGTP 353 (543)
T ss_dssp TTCCCBCCCCSCT
T ss_pred CCCcccccccCCc
Confidence 5443 3457775
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=233.09 Aligned_cols=151 Identities=25% Similarity=0.416 Sum_probs=133.2
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||+|.+.++..||+|+++.... ..+++.+|++++.+++||||+++++++...+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 456788899999999999999999899999999975432 34568999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.++++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999963 235689999999999999999999999 9999999999999999999999999999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=231.31 Aligned_cols=157 Identities=25% Similarity=0.362 Sum_probs=138.0
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|... +++.||||+++..........++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467888999999999999999875 689999999976544455677889999999999 999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----------------
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---------------- 550 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---------------- 550 (577)
|||+++|+|.+++.........+++.++..|+.|++.||+|||+. +|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999975433346789999999999999999999999 9999999999999984
Q ss_pred ---CCCeEEeccccCcccCCC
Q 008121 551 ---ELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 551 ---~~~~kl~DFGla~~~~~~ 568 (577)
...+||+|||+++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~ 187 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP 187 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS
T ss_pred cCCceEEEEcccccccccCCc
Confidence 447999999999976544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-26 Score=230.25 Aligned_cols=166 Identities=34% Similarity=0.602 Sum_probs=146.3
Q ss_pred ceeecHHHHHHhhcCCCcc------ceeccCccceEEEEEEcCCcEEEEEEccccc--cchHHHHHHHHHHHHhhcCCCC
Q 008121 397 ATSYTVASLQTATNSFSQE------FLIGEGSLGRVYRAEFANGKIMAVKKIDNAA--LSLQEEDNFLEAVSNMSRLRHP 468 (577)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~------~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~H~ 468 (577)
...|+..++..++++|... +.||+|+||.||+|.. +++.||||++.... ......+.|.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3568889999999998877 8999999999999986 58899999986432 1233467799999999999999
Q ss_pred ceeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008121 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (577)
Q Consensus 469 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl 548 (577)
||+++++++...+..++||||+++|+|.+++.... ....+++..+..|+.|++.||+|||+. +|+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999999996432 245689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeccccCcccCC
Q 008121 549 DDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 549 ~~~~~~kl~DFGla~~~~~ 567 (577)
++++.+||+|||+++....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEK 185 (307)
T ss_dssp CTTCCEEECCCTTCEECCS
T ss_pred cCCCcEEEeeccccccccc
Confidence 9999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=251.67 Aligned_cols=165 Identities=27% Similarity=0.348 Sum_probs=141.9
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
..++|...+.||+|+||.||+|... +|+.||+|++..... .......+.+|++++++++|||||++++++.+.+..|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467888999999999999999875 689999999865422 12235668899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+..
T Consensus 262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999999632 234589999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCcc-ccccCCC
Q 008121 566 PNTER-QVITGTS 577 (577)
Q Consensus 566 ~~~~~-~~~~Gt~ 577 (577)
..... ...+||+
T Consensus 337 ~~~~~~~~~~GT~ 349 (576)
T 2acx_A 337 PEGQTIKGRVGTV 349 (576)
T ss_dssp CTTCCEECCCSCG
T ss_pred ccCccccccCCCc
Confidence 65443 4456774
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.38 Aligned_cols=151 Identities=26% Similarity=0.394 Sum_probs=130.7
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC----eEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~ 484 (577)
.++|...+.||+|+||.||+|++. ++.||||+++.. ......+.+|+.++++++||||+++++++.... ..+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 467888999999999999999876 799999998643 234455677999999999999999999998754 479
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------CCCeeecCCCCCCeeeCCCCCeEEe
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-------LPSVVHRNFKSANILLDDELNPHLS 557 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-------~~~ivHrDlk~~NILl~~~~~~kl~ 557 (577)
+||||+++|+|.++++. ..+++..+..|+.|+++||+|||+.+ .++|+||||||+|||++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999963 35899999999999999999999861 2379999999999999999999999
Q ss_pred ccccCcccCCC
Q 008121 558 DCGLAALTPNT 568 (577)
Q Consensus 558 DFGla~~~~~~ 568 (577)
|||+++.....
T Consensus 174 DFg~a~~~~~~ 184 (322)
T 3soc_A 174 DFGLALKFEAG 184 (322)
T ss_dssp CCTTCEEECTT
T ss_pred cCCcccccccc
Confidence 99999876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=251.76 Aligned_cols=153 Identities=25% Similarity=0.471 Sum_probs=136.7
Q ss_pred hcCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
..+|...+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+++|++++|||||+++++|...+..++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 3567778899999999999998865 8899999997543 23567999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++.. ....+++..++.|+.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 296 E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 296 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 999999999999742 345689999999999999999999999 999999999999999999999999999998755
Q ss_pred Cc
Q 008121 568 TE 569 (577)
Q Consensus 568 ~~ 569 (577)
..
T Consensus 371 ~~ 372 (495)
T 1opk_A 371 DT 372 (495)
T ss_dssp CC
T ss_pred Cc
Confidence 43
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-27 Score=236.00 Aligned_cols=160 Identities=26% Similarity=0.287 Sum_probs=132.8
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||+||+|... +++.||||++...........++..|+..+.++ +||||++++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999876 689999999865544444555566666666555 8999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+ +|+|.+++... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 67999988643 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred Ccc-ccccCC
Q 008121 568 TER-QVITGT 576 (577)
Q Consensus 568 ~~~-~~~~Gt 576 (577)
... ....||
T Consensus 210 ~~~~~~~~gt 219 (311)
T 3p1a_A 210 AGAGEVQEGD 219 (311)
T ss_dssp -----CCCCC
T ss_pred CCCCcccCCC
Confidence 433 233355
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=238.16 Aligned_cols=157 Identities=28% Similarity=0.452 Sum_probs=137.8
Q ss_pred HHhhcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 479 (577)
....++|...+.||+|+||.||+|... +++.||||+++... .....+.|.+|++++++++||||+++++++..
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 345678999999999999999999875 34889999997543 34456789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADDS--------------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHR 539 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHr 539 (577)
.+..++||||+++|+|.++++..... ...+++.+++.|+.|+++||+|||+. +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 99999999999999999999753211 25789999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 540 NFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 540 Dlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||||+|||++.++.+||+|||+++...
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 225 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIY 225 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccc
Confidence 999999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=248.02 Aligned_cols=149 Identities=23% Similarity=0.378 Sum_probs=124.4
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC-----CeE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 483 (577)
++|...+.||+|+||.||+|... +++.||||++..........+++.+|++++++++|||||++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57888999999999999999764 689999999976544555677899999999999999999999998543 568
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
|+||||+ +|+|.++++ ....+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+
T Consensus 133 ~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 579999986 446799999999999999999999999 99999999999999999999999999999
Q ss_pred ccC
Q 008121 564 LTP 566 (577)
Q Consensus 564 ~~~ 566 (577)
...
T Consensus 205 ~~~ 207 (458)
T 3rp9_A 205 TVD 207 (458)
T ss_dssp CTT
T ss_pred hcc
Confidence 765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=240.17 Aligned_cols=152 Identities=22% Similarity=0.293 Sum_probs=137.5
Q ss_pred hcCCCccceeccC--ccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 409 TNSFSQEFLIGEG--SLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
.++|...+.||+| +||.||+|... +++.||||+++.........+.+.+|+++++.++|||||++++++...+..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4568889999999 99999999875 68999999997665555667788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.+++... ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999732 335689999999999999999999999 9999999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=250.03 Aligned_cols=152 Identities=22% Similarity=0.415 Sum_probs=134.4
Q ss_pred hhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
..++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++|||||++++++. .+..++||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 345677889999999999999999889999999997543 23567999999999999999999999986 56789999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 262 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred eecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999999732 123578999999999999999999999 999999999999999999999999999997654
Q ss_pred C
Q 008121 568 T 568 (577)
Q Consensus 568 ~ 568 (577)
.
T Consensus 337 ~ 337 (454)
T 1qcf_A 337 N 337 (454)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=232.05 Aligned_cols=151 Identities=26% Similarity=0.403 Sum_probs=135.7
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888899999999999999875 48999999987655445556778999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++++|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999998886 345689999999999999999999999 999999999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=233.07 Aligned_cols=163 Identities=25% Similarity=0.382 Sum_probs=137.3
Q ss_pred hcCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC--eEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~l 485 (577)
.++|...+.||+|+||.||+|.... ++.||||+++.... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3568888999999999999998754 89999999975432 233567889999999999999999999998765 7899
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCeEEecccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCGL 561 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl----~~~~~~kl~DFGl 561 (577)
||||+++|+|.++++... ....+++.++..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999997432 233489999999999999999999999 99999999999999 7888899999999
Q ss_pred CcccCCCcc-ccccCC
Q 008121 562 AALTPNTER-QVITGT 576 (577)
Q Consensus 562 a~~~~~~~~-~~~~Gt 576 (577)
++....... ....||
T Consensus 163 a~~~~~~~~~~~~~gt 178 (319)
T 4euu_A 163 ARELEDDEQFVSLYGT 178 (319)
T ss_dssp CEECCTTCCBCCCCSC
T ss_pred ceecCCCCceeecccC
Confidence 997655443 234455
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=239.71 Aligned_cols=155 Identities=26% Similarity=0.449 Sum_probs=135.8
Q ss_pred hcCCCccceeccCccceEEEEEEc--------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 479 (577)
.++|...+.||+|+||.||+|+.. ++..||||+++... ......++.+|+++++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 457888899999999999999763 23579999997543 345567899999999999 99999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
.+..++||||+++|+|.+++..... ....+++.++..|+.|++.||+|||+. +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999975321 124689999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccCcccCC
Q 008121 548 LDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~~ 567 (577)
+++++.+||+|||+++....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~ 243 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHH 243 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSC
T ss_pred EcCCCcEEEcccCccccccc
Confidence 99999999999999997654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-27 Score=240.65 Aligned_cols=163 Identities=23% Similarity=0.398 Sum_probs=137.8
Q ss_pred HHHHHHhhcCCCccceeccCccceEEEEEE------cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEe
Q 008121 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLA 474 (577)
Q Consensus 402 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~ 474 (577)
........++|...+.||+|+||.||+|++ .+++.||||+++... .....+.+.+|++++.++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 344455678899999999999999999974 245789999997543 344567799999999999 799999999
Q ss_pred eEEEeCC-eEEEEEEecCCCCHHHhhhhccCC------------------------------------------------
Q 008121 475 GYCAEHG-QRLLVYEYVGNGNLHDMLHFADDS------------------------------------------------ 505 (577)
Q Consensus 475 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------ 505 (577)
+++...+ ..++||||+++|+|.++++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998765 489999999999999999743221
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 506 --------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 506 --------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 12289999999999999999999999 9999999999999999999999999999876443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=228.88 Aligned_cols=160 Identities=24% Similarity=0.349 Sum_probs=139.0
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe----CCeEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLL 485 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~l 485 (577)
.|...+.||+|+||.||+|... ++..||+|++..........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3566778999999999999774 57889999997666566677889999999999999999999999865 346899
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeC-CCCCeEEeccccC
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLD-DELNPHLSDCGLA 562 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NILl~-~~~~~kl~DFGla 562 (577)
||||+++|+|.+++.. ...+++..+..|+.|++.||+|||+. + |+||||||+|||++ +++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999963 35689999999999999999999998 6 99999999999998 7899999999999
Q ss_pred cccCCCccccccCCC
Q 008121 563 ALTPNTERQVITGTS 577 (577)
Q Consensus 563 ~~~~~~~~~~~~Gt~ 577 (577)
............||+
T Consensus 180 ~~~~~~~~~~~~~t~ 194 (290)
T 1t4h_A 180 TLKRASFAKAVIGTP 194 (290)
T ss_dssp GGCCTTSBEESCSSC
T ss_pred ccccccccccccCCc
Confidence 877666666666663
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-28 Score=246.61 Aligned_cols=150 Identities=18% Similarity=0.225 Sum_probs=124.1
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEcccccc------chHHHHHHHHHHHHhhcCC---------CCceeeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL------SLQEEDNFLEAVSNMSRLR---------HPNIVTL 473 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------H~niv~l 473 (577)
.++|...+.||+|+||+||+|.. +|+.||||+++.... .....+.+.+|+++++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35677889999999999999987 689999999975421 1223466888888888875 7777777
Q ss_pred eeEEE-----------------e-------------CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHH
Q 008121 474 AGYCA-----------------E-------------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523 (577)
Q Consensus 474 ~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~ 523 (577)
.+.+. + .+..|+||||+++|++.+.+. ...+++.++..|+.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 66542 2 678999999999998777763 256899999999999999
Q ss_pred HHHHHh-cCCCCCeeecCCCCCCeeeCCCC--------------------CeEEeccccCcccCC
Q 008121 524 ALEYLH-EVCLPSVVHRNFKSANILLDDEL--------------------NPHLSDCGLAALTPN 567 (577)
Q Consensus 524 ~L~yLH-~~~~~~ivHrDlk~~NILl~~~~--------------------~~kl~DFGla~~~~~ 567 (577)
||+||| +. +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 999999 88 999999999999999887 899999999997654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=230.19 Aligned_cols=147 Identities=27% Similarity=0.424 Sum_probs=125.9
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhc--CCCCceeeEeeEEEeC----Ce
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAEH----GQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~~ 482 (577)
.++|...+.||+|+||.||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 46788899999999999999987 6899999998643 33445666666655 8999999999987543 45
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCCeeeCCCCCe
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH--------EVCLPSVVHRNFKSANILLDDELNP 554 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivHrDlk~~NILl~~~~~~ 554 (577)
.++||||+++|+|.++++ ...+++..+.+|+.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 899999999999999995 356999999999999999999999 76 99999999999999999999
Q ss_pred EEeccccCcccCCCc
Q 008121 555 HLSDCGLAALTPNTE 569 (577)
Q Consensus 555 kl~DFGla~~~~~~~ 569 (577)
||+|||+|+......
T Consensus 153 kl~Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 153 CIADLGLAVMHSQST 167 (301)
T ss_dssp EECCCTTCEEEETTT
T ss_pred EEeeCCCeeeccccc
Confidence 999999998654433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=249.11 Aligned_cols=162 Identities=25% Similarity=0.358 Sum_probs=129.4
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|.. .+++.||||+++.... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35788899999999999999976 4689999999865422 233456688999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+|+..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999963 3568999999999999999999998 7 8999999999999999999999999999864
Q ss_pred CCCc--cccccCCC
Q 008121 566 PNTE--RQVITGTS 577 (577)
Q Consensus 566 ~~~~--~~~~~Gt~ 577 (577)
.... ....+||+
T Consensus 300 ~~~~~~~~~~~gt~ 313 (446)
T 4ejn_A 300 IKDGATMKTFCGTP 313 (446)
T ss_dssp CC-----CCSSSCG
T ss_pred cCCCcccccccCCc
Confidence 3332 24455663
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=238.98 Aligned_cols=158 Identities=22% Similarity=0.316 Sum_probs=129.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 457888999999999999999875 68999999986532 22355889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--eEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--PHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~--~kl~DFGla~~~ 565 (577)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 96 EYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999963 34689999999999999999999999 9999999999999987765 999999999854
Q ss_pred CCCc-cccccCC
Q 008121 566 PNTE-RQVITGT 576 (577)
Q Consensus 566 ~~~~-~~~~~Gt 576 (577)
.... .....||
T Consensus 169 ~~~~~~~~~~gt 180 (361)
T 3uc3_A 169 VLHSQPKSTVGT 180 (361)
T ss_dssp ------------
T ss_pred cccCCCCCCcCC
Confidence 3222 2334455
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-26 Score=237.10 Aligned_cols=161 Identities=22% Similarity=0.350 Sum_probs=138.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 357888999999999999999775 58899999986432 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--ELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~--~~~~kl~DFGla~~~ 565 (577)
||+++|+|.+++. .....+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 128 E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 128 EFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp ECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999999999985 2345799999999999999999999999 9999999999999974 578999999999987
Q ss_pred CCCcc-ccccCCC
Q 008121 566 PNTER-QVITGTS 577 (577)
Q Consensus 566 ~~~~~-~~~~Gt~ 577 (577)
..... ...+||+
T Consensus 202 ~~~~~~~~~~gt~ 214 (387)
T 1kob_A 202 NPDEIVKVTTATA 214 (387)
T ss_dssp CTTSCEEEECSSG
T ss_pred CCCcceeeeccCC
Confidence 55433 3445653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=231.95 Aligned_cols=156 Identities=28% Similarity=0.471 Sum_probs=136.0
Q ss_pred hcCCCccceeccCccceEEEEEE------cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
.++|...+.||+|+||.||+|.. .+++.||||+++... .....+++.+|++++++++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 45688889999999999999976 235789999997543 34556789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADD--------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 542 (577)
.++||||+++|+|.+++..... ....+++.++..++.|+++||+|||+. +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999975332 123589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCCeEEeccccCcccCCC
Q 008121 543 SANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 543 ~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+||++++++.+||+|||+++.....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~ 203 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEE 203 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTT
T ss_pred hheEEEcCCCCEEEcccccccccccc
Confidence 99999999999999999999876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-27 Score=233.56 Aligned_cols=152 Identities=24% Similarity=0.455 Sum_probs=130.5
Q ss_pred hcCCCccceeccCccceEEEEEE-----cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--C
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--G 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~ 481 (577)
.++|+..+.||+|+||.||+|++ .+++.||||++... .....+.|.+|++++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 35678889999999999999985 35889999998754 345567899999999999999999999998653 4
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..++||||+++|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 689999999999999999632 34589999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCC
Q 008121 562 AALTPNT 568 (577)
Q Consensus 562 a~~~~~~ 568 (577)
++.....
T Consensus 161 ~~~~~~~ 167 (295)
T 3ugc_A 161 TKVLPQD 167 (295)
T ss_dssp CC-----
T ss_pred cccccCC
Confidence 9976543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=229.60 Aligned_cols=161 Identities=29% Similarity=0.415 Sum_probs=134.5
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 457888999999999999999775 4778999998643221 12256788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999963 34689999999999999999999999 99999999999999999999999999998766
Q ss_pred CCccccccCC
Q 008121 567 NTERQVITGT 576 (577)
Q Consensus 567 ~~~~~~~~Gt 576 (577)
........||
T Consensus 161 ~~~~~~~~~~ 170 (279)
T 3fdn_A 161 SSRRTDLCGT 170 (279)
T ss_dssp -------CCC
T ss_pred cccccccCCC
Confidence 5555555555
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=243.16 Aligned_cols=152 Identities=24% Similarity=0.372 Sum_probs=133.7
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC-----Ce
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 482 (577)
.++|...+.||+|+||.||+|... +++.||||++..........+++.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 357888999999999999999774 588999999976544455677899999999999999999999999766 57
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.|+||||++ |+|.++++ ....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 69999996 346799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC
Q 008121 563 ALTPNT 568 (577)
Q Consensus 563 ~~~~~~ 568 (577)
+.....
T Consensus 177 ~~~~~~ 182 (432)
T 3n9x_A 177 RTINSE 182 (432)
T ss_dssp EEC---
T ss_pred cccccc
Confidence 976543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=235.86 Aligned_cols=152 Identities=23% Similarity=0.330 Sum_probs=129.9
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC----e
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----Q 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~ 482 (577)
.++|...+.||+|+||.||+|.. .+++.||||+++.... .......|.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999986 5689999999975432 2334567899999999999999999999987654 3
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.|+||||+++|+|.++++. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999973 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCC
Q 008121 563 ALTPN 567 (577)
Q Consensus 563 ~~~~~ 567 (577)
+....
T Consensus 164 ~~~~~ 168 (311)
T 3ork_A 164 RAIAD 168 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 87654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=230.06 Aligned_cols=156 Identities=25% Similarity=0.334 Sum_probs=133.7
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||++... +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46778899999999999999774 58899999986543 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeccccCccc
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALT 565 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~~~ 565 (577)
|+++|+|.+++.........+++..+..|+.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999865433456799999999999999999999999 99999999999999 45688999999999876
Q ss_pred CCCc
Q 008121 566 PNTE 569 (577)
Q Consensus 566 ~~~~ 569 (577)
....
T Consensus 178 ~~~~ 181 (285)
T 3is5_A 178 KSDE 181 (285)
T ss_dssp ----
T ss_pred CCcc
Confidence 5433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=240.87 Aligned_cols=153 Identities=25% Similarity=0.359 Sum_probs=133.1
Q ss_pred hcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
.++|...+.||+|+||.||+|.+. +++.||||+++... ......++.+|+.++++++||||+++++++...+.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 356788899999999999999853 46789999996532 34556679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEE
Q 008121 483 RLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHL 556 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl 556 (577)
.++||||+++|+|.++++.... ....+++.+++.|+.|+++||+|||+. +|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999975432 234689999999999999999999999 999999999999999554 5999
Q ss_pred eccccCccc
Q 008121 557 SDCGLAALT 565 (577)
Q Consensus 557 ~DFGla~~~ 565 (577)
+|||+|+..
T Consensus 226 ~DFG~a~~~ 234 (367)
T 3l9p_A 226 GDFGMARDI 234 (367)
T ss_dssp CCCHHHHHH
T ss_pred CCCcccccc
Confidence 999999854
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=231.76 Aligned_cols=153 Identities=24% Similarity=0.378 Sum_probs=120.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||+|+++... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 457888999999999999999764 58999999986443 2223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||++ |+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 69999986432 2234689999999999999999999999 9999999999999999999999999999876
Q ss_pred C
Q 008121 566 P 566 (577)
Q Consensus 566 ~ 566 (577)
.
T Consensus 159 ~ 159 (317)
T 2pmi_A 159 G 159 (317)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=233.63 Aligned_cols=158 Identities=22% Similarity=0.449 Sum_probs=123.8
Q ss_pred HhhcCCCccceeccCccceEEEEEEcCC----cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
...++|...+.||+|+||.||+|.+... ..||||+++.........++|.+|++++++++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3456788999999999999999976543 279999997654445567889999999999999999999999987765
Q ss_pred E------EEEEEecCCCCHHHhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 008121 483 R------LLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (577)
Q Consensus 483 ~------~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 554 (577)
. ++||||+++|+|.+++.... .....+++.++..|+.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 99999999999999996433 2233689999999999999999999999 99999999999999999999
Q ss_pred EEeccccCcccCC
Q 008121 555 HLSDCGLAALTPN 567 (577)
Q Consensus 555 kl~DFGla~~~~~ 567 (577)
||+|||+++....
T Consensus 177 kl~Dfg~a~~~~~ 189 (323)
T 3qup_A 177 CVADFGLSRKIYS 189 (323)
T ss_dssp EECCCCC------
T ss_pred EEeeccccccccc
Confidence 9999999987644
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-26 Score=226.35 Aligned_cols=161 Identities=25% Similarity=0.378 Sum_probs=140.0
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888999999999999999775 5899999999766555666778999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---eEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~---~kl~DFGla~~ 564 (577)
||+++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998863 35689999999999999999999999 9999999999999986655 99999999987
Q ss_pred cCCCcc-ccccCC
Q 008121 565 TPNTER-QVITGT 576 (577)
Q Consensus 565 ~~~~~~-~~~~Gt 576 (577)
...... ....||
T Consensus 158 ~~~~~~~~~~~~~ 170 (284)
T 3kk8_A 158 VNDSEAWHGFAGT 170 (284)
T ss_dssp CCSSCBCCCSCSC
T ss_pred cccCccccCCCCC
Confidence 655443 233454
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=237.25 Aligned_cols=157 Identities=28% Similarity=0.402 Sum_probs=129.9
Q ss_pred CccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecC
Q 008121 413 SQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 491 (577)
...+.||+|+||.||+|.. .+|+.||+|+++... ....++|.+|++++++++||||+++++++...+..++||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3356899999999999977 468999999987542 3456779999999999999999999999999999999999999
Q ss_pred CCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee--CCCCCeEEeccccCcccCCCc
Q 008121 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL--DDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 492 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl--~~~~~~kl~DFGla~~~~~~~ 569 (577)
+|+|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||+ +.++.+||+|||+++......
T Consensus 170 ~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 170 GGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp TCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999998863 234689999999999999999999999 99999999999999 667899999999999875543
Q ss_pred c-ccccCCC
Q 008121 570 R-QVITGTS 577 (577)
Q Consensus 570 ~-~~~~Gt~ 577 (577)
. ....||+
T Consensus 244 ~~~~~~gt~ 252 (373)
T 2x4f_A 244 KLKVNFGTP 252 (373)
T ss_dssp BCCCCCSSC
T ss_pred ccccccCCC
Confidence 3 3344653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=235.81 Aligned_cols=162 Identities=23% Similarity=0.321 Sum_probs=138.6
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccch------HHHHHHHHHHHHhhcCCCCceeeEeeEEEeC
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL------QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 480 (577)
..++|...+.||+|+||.||+|.. .+++.||||+++...... .....+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356788999999999999999976 568899999986543211 1334577899999999999999999999999
Q ss_pred CeEEEEEEecCCC-CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 481 GQRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 481 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
+..++||||+.+| +|.+++. ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999877 9999996 345699999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccCCCcc-ccccCC
Q 008121 560 GLAALTPNTER-QVITGT 576 (577)
Q Consensus 560 Gla~~~~~~~~-~~~~Gt 576 (577)
|+++....... ...+||
T Consensus 175 g~a~~~~~~~~~~~~~gt 192 (335)
T 3dls_A 175 GSAAYLERGKLFYTFCGT 192 (335)
T ss_dssp TTCEECCTTCCBCEECSC
T ss_pred ccceECCCCCceeccCCC
Confidence 99997755433 344565
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=235.63 Aligned_cols=152 Identities=22% Similarity=0.287 Sum_probs=133.5
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCC--CceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||++...+++.||||++..........+.+.+|++++.+++| |||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35688889999999999999998889999999997655556667889999999999987 9999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|| +.+|+|.+++.. ...+++.++..|+.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 568899999973 45789999999999999999999999 999999999999997 5789999999999775
Q ss_pred CCc
Q 008121 567 NTE 569 (577)
Q Consensus 567 ~~~ 569 (577)
...
T Consensus 159 ~~~ 161 (343)
T 3dbq_A 159 PDT 161 (343)
T ss_dssp ---
T ss_pred ccc
Confidence 443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=243.01 Aligned_cols=148 Identities=31% Similarity=0.485 Sum_probs=131.6
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-eEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-QRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~ 487 (577)
.++|...+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+++|++++||||+++++++...+ ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 456778899999999999999886 7899999997542 3567999999999999999999999987765 799999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.++++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999743 234579999999999999999999999 99999999999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=224.56 Aligned_cols=150 Identities=19% Similarity=0.383 Sum_probs=134.3
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 487 (577)
++|...+.||+|+||.||+|.+. ++.||||+++.........+.|.+|+.++++++||||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888899999999999999985 88999999987655566677899999999999999999999999877 7889999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||+++|+|.++++. .....+++.++..|+.|++.||+|||+. + |+||||||+||+++.++.+||+|||++...
T Consensus 89 e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999973 2334689999999999999999999998 6 999999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=235.20 Aligned_cols=158 Identities=25% Similarity=0.381 Sum_probs=122.5
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
..++|...+.||+|+||.||+|... +++.||||+++.. ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3467888999999999999999886 4789999998643 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeccccCc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGLAA 563 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFGla~ 563 (577)
|||+++|+|.+++. ....+++.++..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 127 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 127 LELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp ECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999999999996 345689999999999999999999999 9999999999999975 8899999999999
Q ss_pred ccCCCcc-ccccCC
Q 008121 564 LTPNTER-QVITGT 576 (577)
Q Consensus 564 ~~~~~~~-~~~~Gt 576 (577)
....... ...+||
T Consensus 200 ~~~~~~~~~~~~gt 213 (349)
T 2w4o_A 200 IVEHQVLMKTVCGT 213 (349)
T ss_dssp -------------C
T ss_pred ccCcccccccccCC
Confidence 7654332 334454
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=247.17 Aligned_cols=151 Identities=28% Similarity=0.494 Sum_probs=131.0
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++++||||+++++++.. +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 456778889999999999999998888999999975432 34679999999999999999999999876 67899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.++++.. ....+++.++..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 259 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999632 234689999999999999999999999 9999999999999999999999999999976543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=226.48 Aligned_cols=162 Identities=31% Similarity=0.477 Sum_probs=124.8
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccc--hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS--LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|.+. ++.||||+++..... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 356788899999999999999875 889999998654221 12346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--------CCCeEEec
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--------ELNPHLSD 558 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~--------~~~~kl~D 558 (577)
|||+++|+|.++++ ...+++..+..++.|++.||+|||+....+|+||||||+|||++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999984 457899999999999999999999993223999999999999986 67899999
Q ss_pred cccCcccCCCccccccCC
Q 008121 559 CGLAALTPNTERQVITGT 576 (577)
Q Consensus 559 FGla~~~~~~~~~~~~Gt 576 (577)
||+++...........||
T Consensus 160 fg~~~~~~~~~~~~~~~~ 177 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGA 177 (271)
T ss_dssp CCC-------------CC
T ss_pred CCcccccccccccCCCCc
Confidence 999997765555455555
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=230.22 Aligned_cols=158 Identities=28% Similarity=0.430 Sum_probs=137.0
Q ss_pred hcCCCccceeccCccceEEEEEE------cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 481 (577)
.++|...+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 45788889999999999999975 346789999997543 334567899999999999 9999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADD--------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
..++||||+++|+|.+++..... ....+++.++..++.|+++||+|||+. +|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999975321 123589999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccCcccCCCcc
Q 008121 548 LDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~~~~~ 570 (577)
++.++.+||+|||+++.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~ 200 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSN 200 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT
T ss_pred EcCCCCEEEcccccccccccccc
Confidence 99999999999999997765443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=225.00 Aligned_cols=159 Identities=28% Similarity=0.365 Sum_probs=137.6
Q ss_pred hcCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|.... +..||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 4568888999999999999998754 7789999986543 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~~ 564 (577)
||+++++|.+++.. ...+++.++..|+.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999999863 35689999999999999999999999 99999999999999 7889999999999987
Q ss_pred cCCCcc-ccccCC
Q 008121 565 TPNTER-QVITGT 576 (577)
Q Consensus 565 ~~~~~~-~~~~Gt 576 (577)
...... ....||
T Consensus 159 ~~~~~~~~~~~~t 171 (277)
T 3f3z_A 159 FKPGKMMRTKVGT 171 (277)
T ss_dssp CCTTSCBCCCCSC
T ss_pred ccCccchhccCCC
Confidence 654433 334455
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=234.19 Aligned_cols=151 Identities=32% Similarity=0.463 Sum_probs=132.9
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
+.|...+.||+|+||.||+|.. .+++.||||++..... .....+++.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999986 5689999999864322 2334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||++ |+|.+++.. ....+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 688888853 245789999999999999999999999 999999999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=226.62 Aligned_cols=160 Identities=28% Similarity=0.420 Sum_probs=138.7
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999875 5788999998643221 122467899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999973 34689999999999999999999999 999999999999999999999999999987766
Q ss_pred CccccccCC
Q 008121 568 TERQVITGT 576 (577)
Q Consensus 568 ~~~~~~~Gt 576 (577)
.......||
T Consensus 167 ~~~~~~~~~ 175 (284)
T 2vgo_A 167 LRRRTMCGT 175 (284)
T ss_dssp SCBCCCCSC
T ss_pred cccccccCC
Confidence 555555555
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=227.59 Aligned_cols=157 Identities=29% Similarity=0.452 Sum_probs=136.1
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCeEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~l 485 (577)
.++|...+.||+|+||.||++... +++.||+|++..........+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 356888899999999999999875 68999999997655455667789999999999999999999998854 568999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCCeeeCCCCCeEEeccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS-----VVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~-----ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
||||+++|+|.+++.........+++..+..|+.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976544556799999999999999999999998 6 9999999999999999999999999
Q ss_pred cCcccCCC
Q 008121 561 LAALTPNT 568 (577)
Q Consensus 561 la~~~~~~ 568 (577)
+++.....
T Consensus 162 ~~~~~~~~ 169 (279)
T 2w5a_A 162 LARILNHD 169 (279)
T ss_dssp HHHHC---
T ss_pred hheeeccc
Confidence 99876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-26 Score=231.29 Aligned_cols=149 Identities=18% Similarity=0.245 Sum_probs=131.3
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 5688899999999999999986 568999999986432 223578899999999 9999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-----eEEeccccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-----PHLSDCGLA 562 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~-----~kl~DFGla 562 (577)
||+ +|+|.+++... ...+++.++..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 99999999742 45799999999999999999999999 9999999999999998887 999999999
Q ss_pred cccCCCc
Q 008121 563 ALTPNTE 569 (577)
Q Consensus 563 ~~~~~~~ 569 (577)
+......
T Consensus 158 ~~~~~~~ 164 (330)
T 2izr_A 158 KEYIDPE 164 (330)
T ss_dssp EESBCTT
T ss_pred eeeecCC
Confidence 9765443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=245.31 Aligned_cols=162 Identities=25% Similarity=0.383 Sum_probs=134.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++|||||+++++|...+..|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888999999999999999875 6889999999765443444667899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFGla~~ 564 (577)
||+++|+|.+.+.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998863 35689999999999999999999999 9999999999999976 45699999999998
Q ss_pred cCCCcc-ccccCCC
Q 008121 565 TPNTER-QVITGTS 577 (577)
Q Consensus 565 ~~~~~~-~~~~Gt~ 577 (577)
...... ...+||+
T Consensus 189 ~~~~~~~~~~~gt~ 202 (494)
T 3lij_A 189 FENQKKMKERLGTA 202 (494)
T ss_dssp CBTTBCBCCCCSCT
T ss_pred CCCCccccccCCCc
Confidence 765433 3455664
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=230.70 Aligned_cols=151 Identities=25% Similarity=0.408 Sum_probs=132.7
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888899999999999999875 48999999986655445556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999988765 345699999999999999999999999 999999999999999999999999999986543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=225.14 Aligned_cols=151 Identities=21% Similarity=0.350 Sum_probs=134.7
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356778899999999999999875 478899999865432 234567789999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998863 35689999999999999999999999 99999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=224.98 Aligned_cols=149 Identities=28% Similarity=0.468 Sum_probs=134.9
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|...+.||+|+||.||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 56778899999999999999998899999999975432 245789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 85 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999963 235689999999999999999999999 999999999999999999999999999987644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=237.17 Aligned_cols=150 Identities=23% Similarity=0.290 Sum_probs=132.2
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC--CCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 487 (577)
.+|...+.||+|+||.||+|...+++.||||++..........+.+.+|++++.+++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999999765545566788999999999997 599999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
| +.+|+|.+++.. ...+++.++..|+.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 568899999973 34789999999999999999999999 999999999999996 57999999999997754
Q ss_pred C
Q 008121 568 T 568 (577)
Q Consensus 568 ~ 568 (577)
.
T Consensus 207 ~ 207 (390)
T 2zmd_A 207 D 207 (390)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=236.16 Aligned_cols=161 Identities=22% Similarity=0.353 Sum_probs=137.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 356888899999999999999875 68999999986542 3455678999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++. ...+++..+..|+.|++.||+|||+.. +|+||||||+|||++.++.+||+|||+++....
T Consensus 111 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999973 346899999999999999999999842 799999999999999999999999999986544
Q ss_pred CccccccCC
Q 008121 568 TERQVITGT 576 (577)
Q Consensus 568 ~~~~~~~Gt 576 (577)
.......||
T Consensus 185 ~~~~~~~gt 193 (360)
T 3eqc_A 185 SMANSFVGT 193 (360)
T ss_dssp HC----CCC
T ss_pred ccccCCCCC
Confidence 444444454
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=230.14 Aligned_cols=151 Identities=21% Similarity=0.350 Sum_probs=135.1
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 456888899999999999999875 478999999865432 234567789999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++++|.+++.. ...+++.++..|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999863 35689999999999999999999999 99999999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=237.26 Aligned_cols=164 Identities=25% Similarity=0.380 Sum_probs=137.7
Q ss_pred hcCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC--eEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLL 485 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~l 485 (577)
.++|...+.||+|+||.||+|.+.. ++.||||+++.... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3568888999999999999998754 89999999975432 233567889999999999999999999998765 7899
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCeEEecccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCGL 561 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl----~~~~~~kl~DFGl 561 (577)
||||+++|+|.++++... ....+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999996432 223489999999999999999999999 99999999999999 7788899999999
Q ss_pred CcccCCCcc-ccccCCC
Q 008121 562 AALTPNTER-QVITGTS 577 (577)
Q Consensus 562 a~~~~~~~~-~~~~Gt~ 577 (577)
++....... ....||+
T Consensus 163 a~~~~~~~~~~~~~gt~ 179 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTE 179 (396)
T ss_dssp CEECCCGGGSSCSSSCC
T ss_pred ceEccCCCccccccCCc
Confidence 997755443 2344553
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=224.15 Aligned_cols=152 Identities=29% Similarity=0.428 Sum_probs=134.2
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688889999999999999987 56899999998643211 122467899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999962 346789999999999999999999999 999999999999999999999999999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=233.75 Aligned_cols=157 Identities=27% Similarity=0.424 Sum_probs=132.2
Q ss_pred hhcCCCccceeccCccceEEEEEE------cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 480 (577)
..++|...+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 346788899999999999999986 245689999997542 233456799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDS-------------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF 541 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 541 (577)
+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 9999999999999999999743211 13489999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 542 KSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 542 k~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
||+|||++.++.+||+|||+++.....
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~ 225 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSD 225 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccC
Confidence 999999999999999999999876443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=238.11 Aligned_cols=152 Identities=24% Similarity=0.336 Sum_probs=133.1
Q ss_pred hcCCCccceeccCccceEEEEEE----cCCcEEEEEEcccccc--chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 481 (577)
.++|...+.||+|+||.||+++. .+++.||||+++.... .....+.+.+|++++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788899999999999999987 3689999999875422 112344577899999999 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..++||||+++|+|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999973 34689999999999999999999999 999999999999999999999999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
++....
T Consensus 206 a~~~~~ 211 (355)
T 1vzo_A 206 SKEFVA 211 (355)
T ss_dssp EEECCG
T ss_pred Ceeccc
Confidence 987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=226.81 Aligned_cols=154 Identities=25% Similarity=0.461 Sum_probs=137.4
Q ss_pred hhcCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
..++|...+.||+|+||.||+|.+.. ++.||+|++... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 34668888999999999999998764 889999998653 33567799999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999742 346689999999999999999999999 99999999999999999999999999999765
Q ss_pred CCc
Q 008121 567 NTE 569 (577)
Q Consensus 567 ~~~ 569 (577)
...
T Consensus 163 ~~~ 165 (288)
T 3kfa_A 163 GDT 165 (288)
T ss_dssp SSS
T ss_pred CCc
Confidence 443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=252.73 Aligned_cols=163 Identities=20% Similarity=0.296 Sum_probs=139.0
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 484 (577)
..++|...+.||+|+||.||+|+.. +++.||||+++.... .....+.+..|.+++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467889999999999999999875 578999999875321 123345678899999887 7999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.++++. ...+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999973 34689999999999999999999999 999999999999999999999999999996
Q ss_pred cC--CCccccccCCC
Q 008121 565 TP--NTERQVITGTS 577 (577)
Q Consensus 565 ~~--~~~~~~~~Gt~ 577 (577)
.. .......+||+
T Consensus 492 ~~~~~~~~~~~~GT~ 506 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTP 506 (674)
T ss_dssp CCCTTCCBCCCCSCS
T ss_pred cccCCcccccccCCC
Confidence 43 33345567875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=229.07 Aligned_cols=156 Identities=26% Similarity=0.473 Sum_probs=134.5
Q ss_pred hcCCCccceeccCccceEEEEEEc--------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 479 (577)
.++|...+.||+|+||.||+|.+. +++.||||+++... .....+++.+|+++++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 467888899999999999999863 46789999997543 345567799999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
.+..++||||+++|+|.+++..... ....+++.+++.++.|+++||+|||+. +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999974321 123589999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccCcccCCC
Q 008121 548 LDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~~~ 568 (577)
++.++.+||+|||+++.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTT
T ss_pred EcCCCCEEEcccccccccccc
Confidence 999999999999999876543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=245.11 Aligned_cols=161 Identities=25% Similarity=0.410 Sum_probs=137.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||||++............+.+|++++++++||||+++++++...+..|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356888899999999999999875 6899999998654433345677899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DFGla~~ 564 (577)
||+++|+|.+.+.. ...+++..+..|+.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999998863 35689999999999999999999999 999999999999995 566899999999987
Q ss_pred cCCCcc-ccccCC
Q 008121 565 TPNTER-QVITGT 576 (577)
Q Consensus 565 ~~~~~~-~~~~Gt 576 (577)
...... ....||
T Consensus 174 ~~~~~~~~~~~gt 186 (486)
T 3mwu_A 174 FQQNTKMKDRIGT 186 (486)
T ss_dssp BCCC----CCTTG
T ss_pred CCCCCccCCCcCC
Confidence 654332 344455
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=234.83 Aligned_cols=150 Identities=25% Similarity=0.404 Sum_probs=124.8
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCC--eE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG--QR 483 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~ 483 (577)
..++|...+.||+|+||.||+|.. .+++.||||++...........++.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 356788999999999999999976 46899999999765444556777889999999997 999999999997554 78
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
|+||||++ |+|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 699999862 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccC
Q 008121 564 LTP 566 (577)
Q Consensus 564 ~~~ 566 (577)
...
T Consensus 158 ~~~ 160 (388)
T 3oz6_A 158 SFV 160 (388)
T ss_dssp ESS
T ss_pred ccc
Confidence 764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=251.03 Aligned_cols=151 Identities=28% Similarity=0.494 Sum_probs=133.8
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 456778889999999999999998888999999975432 34679999999999999999999999876 67899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.++++.. ....+++.+++.|+.||++||+|||++ +||||||||+|||+++++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999999632 234589999999999999999999999 9999999999999999999999999999976543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-26 Score=226.49 Aligned_cols=158 Identities=23% Similarity=0.356 Sum_probs=126.0
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|.. .+++.||||+++.........+.+.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788899999999999999987 56899999999765433344445556666688899999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||++ |+|.++++........+++..+..|+.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 5998888654445678999999999999999999999853 799999999999999999999999999987654
Q ss_pred Cc
Q 008121 568 TE 569 (577)
Q Consensus 568 ~~ 569 (577)
..
T Consensus 163 ~~ 164 (290)
T 3fme_A 163 DV 164 (290)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=237.55 Aligned_cols=163 Identities=22% Similarity=0.340 Sum_probs=129.5
Q ss_pred HhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc------hHHHHHHHHHHHHhhcCCCCceeeEeeEEEe
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 479 (577)
...++|...+.||+|+||.||+|... +++.||||++...... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999764 5799999998654321 112235789999999999999999999975
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCeEE
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHL 556 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl 556 (577)
.+..++||||+++|+|.+++. ....+++.++..|+.|++.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 456899999999999999885 456799999999999999999999999 99999999999999754 45999
Q ss_pred eccccCcccCCCcc-ccccCCC
Q 008121 557 SDCGLAALTPNTER-QVITGTS 577 (577)
Q Consensus 557 ~DFGla~~~~~~~~-~~~~Gt~ 577 (577)
+|||+|+....... ...+||+
T Consensus 284 ~DFG~a~~~~~~~~~~~~~gt~ 305 (419)
T 3i6u_A 284 TDFGHSKILGETSLMRTLCGTP 305 (419)
T ss_dssp CCSSTTTSCC-----------C
T ss_pred eecccceecCCCccccccCCCC
Confidence 99999998654432 3445553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=228.68 Aligned_cols=142 Identities=27% Similarity=0.416 Sum_probs=125.3
Q ss_pred cceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 415 EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
.+.||+|+||.||+|... +++.||||++... ....+.+|+.++..+. ||||+++++++.+.+..|+||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 478999999999999875 5899999998532 3456788999999997 99999999999999999999999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEEeccccCcccCCC
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHLSDCGLAALTPNT 568 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kl~DFGla~~~~~~ 568 (577)
|+|.++++. ...+++.++..|+.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 91 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 91 GELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999999973 45799999999999999999999999 999999999999997665 8999999999876543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=226.08 Aligned_cols=155 Identities=24% Similarity=0.384 Sum_probs=130.3
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|.. .+++.||||+++... .......++.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688889999999999999976 568999999987532 23445677999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.........+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999975444566789999999999999999999999 999999999999999999999999999987644
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=234.60 Aligned_cols=160 Identities=26% Similarity=0.295 Sum_probs=134.5
Q ss_pred HHHHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc---chHHHHHHHHHHHHhhcCCCCceeeEeeEEEe
Q 008121 404 SLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (577)
Q Consensus 404 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 479 (577)
++....++|...+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3456678899999999999999999977 4588999999864321 23456789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccC------------------------------------CCCCCCHHHHHHHHHHHHH
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADD------------------------------------SSKNLTWNARVRVALGTAR 523 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~i~~ 523 (577)
.+..++||||+++|+|.+++..... ....+++..+..|+.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999852110 0223467778899999999
Q ss_pred HHHHHhcCCCCCeeecCCCCCCeeeCCCC--CeEEeccccCcccC
Q 008121 524 ALEYLHEVCLPSVVHRNFKSANILLDDEL--NPHLSDCGLAALTP 566 (577)
Q Consensus 524 ~L~yLH~~~~~~ivHrDlk~~NILl~~~~--~~kl~DFGla~~~~ 566 (577)
||+|||+. +|+||||||+|||++.++ .+||+|||+++...
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~ 221 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY 221 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGG
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeecccccccc
Confidence 99999999 999999999999998776 89999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=228.72 Aligned_cols=161 Identities=24% Similarity=0.311 Sum_probs=138.0
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch----HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.++|...+.||+|+||.||+|... +++.||+|.++...... ...+++.+|+.++++++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888899999999999999875 58999999986543221 1356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEecc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDC 559 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DF 559 (577)
++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999996 345789999999999999999999999 999999999999999887 7999999
Q ss_pred ccCcccCCCcc-ccccCC
Q 008121 560 GLAALTPNTER-QVITGT 576 (577)
Q Consensus 560 Gla~~~~~~~~-~~~~Gt 576 (577)
|+++....... ....||
T Consensus 164 g~~~~~~~~~~~~~~~gt 181 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGT 181 (321)
T ss_dssp TTCEECCTTCCCCCCCSC
T ss_pred ccceecCccccccccCCC
Confidence 99987654432 233454
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=234.08 Aligned_cols=162 Identities=20% Similarity=0.352 Sum_probs=139.3
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchH---------------HHHHHHHHHHHhhcCCCCceeeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ---------------EEDNFLEAVSNMSRLRHPNIVTL 473 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~H~niv~l 473 (577)
.++|...+.||+|+||.||+|.. +++.||||++........ ..+.|.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45788899999999999999988 899999999864322111 11779999999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCCHHHh------hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCe
Q 008121 474 AGYCAEHGQRLLVYEYVGNGNLHDM------LHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANI 546 (577)
Q Consensus 474 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NI 546 (577)
++++...+..++||||+++|+|.++ +. ......+++..+..++.|++.||+|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLD--KNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSC--SSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhh--hccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 53 2225679999999999999999999999 7 999999999999
Q ss_pred eeCCCCCeEEeccccCcccCCCccccccCC
Q 008121 547 LLDDELNPHLSDCGLAALTPNTERQVITGT 576 (577)
Q Consensus 547 Ll~~~~~~kl~DFGla~~~~~~~~~~~~Gt 576 (577)
+++.++.+||+|||+++...........||
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 213 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKKIKGSRGT 213 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTEECSSCSC
T ss_pred EEcCCCcEEEeccccccccccccccCCCCC
Confidence 999999999999999998655544444444
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=222.58 Aligned_cols=150 Identities=27% Similarity=0.382 Sum_probs=134.7
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 356888899999999999999875 68999999986443 2344677899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 9999999999985 345789999999999999999999999 99999999999999999999999999998653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=222.45 Aligned_cols=151 Identities=29% Similarity=0.481 Sum_probs=129.1
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHH-----HHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQE-----EDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
.++|...+.||+|+||.||+|.+ .+++.||+|++......... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35678889999999999999987 46899999998644322111 167899999999999999999999987665
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCC-----eE
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELN-----PH 555 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NILl~~~~~-----~k 555 (577)
++||||+++|+|.+.+. .....+++..+..++.|++.||+|||+. + |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 69999999999999885 2445799999999999999999999998 7 999999999999988776 99
Q ss_pred EeccccCcccCC
Q 008121 556 LSDCGLAALTPN 567 (577)
Q Consensus 556 l~DFGla~~~~~ 567 (577)
|+|||+++....
T Consensus 170 l~Dfg~~~~~~~ 181 (287)
T 4f0f_A 170 VADFGLSQQSVH 181 (287)
T ss_dssp ECCCTTCBCCSS
T ss_pred eCCCCccccccc
Confidence 999999986543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=225.62 Aligned_cols=152 Identities=28% Similarity=0.475 Sum_probs=133.3
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||+|...+++.||||+++... ...+.|.+|++++++++||||+++++++.. +..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 45678889999999999999999888899999987543 235678999999999999999999999864 56899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999622 123689999999999999999999999 9999999999999999999999999999977554
Q ss_pred c
Q 008121 569 E 569 (577)
Q Consensus 569 ~ 569 (577)
.
T Consensus 163 ~ 163 (279)
T 1qpc_A 163 E 163 (279)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=240.43 Aligned_cols=159 Identities=21% Similarity=0.265 Sum_probs=130.0
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC------C
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------G 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 481 (577)
.++|...+.||+|+||.||+|... +++.||||++..........+++.+|+.+++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999764 589999999976544555677899999999999999999999999654 3
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999975 5777764 2489999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCcc-ccccCCC
Q 008121 562 AALTPNTER-QVITGTS 577 (577)
Q Consensus 562 a~~~~~~~~-~~~~Gt~ 577 (577)
|+....... ...+||+
T Consensus 211 a~~~~~~~~~~~~~gt~ 227 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTR 227 (464)
T ss_dssp C-----CCCC----CCC
T ss_pred eeecCCCcccCCCcccc
Confidence 997655432 3345653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=227.10 Aligned_cols=158 Identities=24% Similarity=0.468 Sum_probs=129.5
Q ss_pred HhhcCCCccceeccCccceEEEEEEc----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC-
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG- 481 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~- 481 (577)
...++|...+.||+|+||.||+|.+. +++.||+|+++.........+.+.+|+.++++++||||+++++++...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888899999999999999764 3458999999765555566778999999999999999999999997755
Q ss_pred ----eEEEEEEecCCCCHHHhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeE
Q 008121 482 ----QRLLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (577)
Q Consensus 482 ----~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 555 (577)
..++||||+++|+|.+++.... .....+++..++.|+.|+++||.|||+. +|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 3599999999999999985332 3456799999999999999999999999 999999999999999999999
Q ss_pred EeccccCcccCC
Q 008121 556 LSDCGLAALTPN 567 (577)
Q Consensus 556 l~DFGla~~~~~ 567 (577)
|+|||+++....
T Consensus 188 l~Dfg~~~~~~~ 199 (313)
T 3brb_A 188 VADFGLSKKIYS 199 (313)
T ss_dssp ECSCSCC-----
T ss_pred EeecCcceeccc
Confidence 999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=7.3e-26 Score=229.92 Aligned_cols=158 Identities=22% Similarity=0.366 Sum_probs=137.3
Q ss_pred HHhhcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 479 (577)
....++|...+.||+|+||.||+|.+. +++.||||++.... ......+|.+|++++++++||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 345677888999999999999999764 36789999997543 34456679999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFAD------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~ 553 (577)
.+..++||||+++|+|.++++... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCe
Confidence 999999999999999999997422 1225678999999999999999999999 9999999999999999999
Q ss_pred eEEeccccCcccCC
Q 008121 554 PHLSDCGLAALTPN 567 (577)
Q Consensus 554 ~kl~DFGla~~~~~ 567 (577)
+||+|||+++....
T Consensus 177 ~kl~Dfg~~~~~~~ 190 (322)
T 1p4o_A 177 VKIGDFGMTRDIYE 190 (322)
T ss_dssp EEECCTTCCCGGGG
T ss_pred EEECcCcccccccc
Confidence 99999999986543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.2e-26 Score=226.94 Aligned_cols=153 Identities=22% Similarity=0.430 Sum_probs=131.3
Q ss_pred cCCCccceeccCccceEEEEEE-----cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--Ce
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQ 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~ 482 (577)
+.|...+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4577789999999999999984 358899999997543 233456789999999999999999999999876 66
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++||||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999953 235689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCc
Q 008121 563 ALTPNTE 569 (577)
Q Consensus 563 ~~~~~~~ 569 (577)
+......
T Consensus 174 ~~~~~~~ 180 (302)
T 4e5w_A 174 KAIETDK 180 (302)
T ss_dssp EECCTTC
T ss_pred ccccCCC
Confidence 9775543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=242.36 Aligned_cols=162 Identities=23% Similarity=0.349 Sum_probs=135.8
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch-----------HHHHHHHHHHHHhhcCCCCceeeEeeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-----------QEEDNFLEAVSNMSRLRHPNIVTLAGY 476 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~H~niv~l~~~ 476 (577)
.++|...+.||+|+||.||+|... +++.||||++....... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888999999999999999875 57899999986543221 235678999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---C
Q 008121 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---N 553 (577)
Q Consensus 477 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~---~ 553 (577)
+.+.+..|+||||+++|+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999863 35689999999999999999999999 999999999999998775 6
Q ss_pred eEEeccccCcccCCCcc-ccccCCC
Q 008121 554 PHLSDCGLAALTPNTER-QVITGTS 577 (577)
Q Consensus 554 ~kl~DFGla~~~~~~~~-~~~~Gt~ 577 (577)
+||+|||+++....... ....||+
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~ 212 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTA 212 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCT
T ss_pred EEEEECCCCEEcCCCCccccccCCc
Confidence 99999999997755432 4455664
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-26 Score=225.15 Aligned_cols=152 Identities=25% Similarity=0.395 Sum_probs=124.6
Q ss_pred hcCCCccceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.++|...+.||+|+||.||+|.+.. +..||+|+++... .....+.|.+|+.++++++||||+++++++. ++..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 4578888999999999999997743 4579999986532 3445677999999999999999999999984 55789
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 99999999999999963 234689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
....
T Consensus 166 ~~~~ 169 (281)
T 1mp8_A 166 MEDS 169 (281)
T ss_dssp ----
T ss_pred cCcc
Confidence 6543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=232.00 Aligned_cols=165 Identities=24% Similarity=0.306 Sum_probs=138.7
Q ss_pred HHHHHHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-----CCceeeEee
Q 008121 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----HPNIVTLAG 475 (577)
Q Consensus 402 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~~ 475 (577)
..+.....++|...+.||+|+||.||+|.. .+++.||||+++.. ....+.+..|++++..++ ||||+++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 333444567899999999999999999987 46889999998642 344566788999999886 999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----
Q 008121 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD----- 550 (577)
Q Consensus 476 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~----- 550 (577)
++...+..++||||+ +++|.+++... ....+++.++..|+.|++.||+|||+. +|+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 999999999999999 99999999732 334689999999999999999999999 9999999999999986
Q ss_pred --------------------CCCeEEeccccCcccCCCccccccCC
Q 008121 551 --------------------ELNPHLSDCGLAALTPNTERQVITGT 576 (577)
Q Consensus 551 --------------------~~~~kl~DFGla~~~~~~~~~~~~Gt 576 (577)
++.+||+|||+|+..... .....||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-~~~~~gt 222 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-HGSIINT 222 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-CCSCCSC
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-CcCccCc
Confidence 789999999999875433 2334454
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=225.11 Aligned_cols=164 Identities=29% Similarity=0.378 Sum_probs=130.1
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc---hHHHHHHHHHHHHhhcC---CCCceeeEeeEEEeC
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRL---RHPNIVTLAGYCAEH 480 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~ 480 (577)
..++|...+.||+|+||.||+|.. .+++.||||++...... ......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999986 56899999998643211 11123456666666655 599999999999876
Q ss_pred C-----eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeE
Q 008121 481 G-----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (577)
Q Consensus 481 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 555 (577)
. ..++||||++ |+|.+++... ....+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 5799999997 6999999732 334599999999999999999999999 999999999999999999999
Q ss_pred EeccccCcccCCCcc-ccccCCC
Q 008121 556 LSDCGLAALTPNTER-QVITGTS 577 (577)
Q Consensus 556 l~DFGla~~~~~~~~-~~~~Gt~ 577 (577)
|+|||+++....... ....||+
T Consensus 161 l~Dfg~a~~~~~~~~~~~~~gt~ 183 (308)
T 3g33_A 161 LADFGLARIYSYQMALTPVVVTL 183 (308)
T ss_dssp ECSCSCTTTSTTCCCSGGGGCCC
T ss_pred EeeCccccccCCCcccCCccccc
Confidence 999999987654433 3345553
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=8.4e-26 Score=234.05 Aligned_cols=150 Identities=19% Similarity=0.324 Sum_probs=126.8
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 481 (577)
.++|...+.||+|+||.||+|.. .+|+.||||++..........+++.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35788899999999999999987 46899999999655444555678899999999999999999999997653
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..|+||||+ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899999862 4689999999999999999999999 999999999999999999999999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
++....
T Consensus 175 a~~~~~ 180 (367)
T 1cm8_A 175 ARQADS 180 (367)
T ss_dssp CEECCS
T ss_pred cccccc
Confidence 997644
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-26 Score=225.61 Aligned_cols=149 Identities=30% Similarity=0.480 Sum_probs=125.9
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||+|.+. ..||||+++.........+.|.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 457888999999999999999764 3599999976655566678899999999999999999999965 4556899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|+++++|.++++. ....+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 100 WCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp CCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred ecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999952 346789999999999999999999999 99999999999999999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-26 Score=231.36 Aligned_cols=152 Identities=22% Similarity=0.350 Sum_probs=127.7
Q ss_pred HhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
...++|...+.||+|+||.||+|.. .+++.||||+++.........+.+.+|++++++++||||+++++++...+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3456789999999999999999976 468999999997654444445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-----CCCCCeEEeccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL-----DDELNPHLSDCG 560 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl-----~~~~~~kl~DFG 560 (577)
||||++ |+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 111 v~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 999997 599999963 34689999999999999999999999 99999999999999 455569999999
Q ss_pred cCcccC
Q 008121 561 LAALTP 566 (577)
Q Consensus 561 la~~~~ 566 (577)
+++...
T Consensus 183 ~a~~~~ 188 (329)
T 3gbz_A 183 LARAFG 188 (329)
T ss_dssp HHHHHC
T ss_pred CccccC
Confidence 998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=226.91 Aligned_cols=153 Identities=27% Similarity=0.397 Sum_probs=133.8
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe----CCe
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQ 482 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~ 482 (577)
..++|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 346788899999999999999987 56899999998643 34556789999999999999999999999863 347
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++||||+++|+|.+++.........+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999999976555567899999999999999999999999 9999999999999999999999999998
Q ss_pred ccc
Q 008121 563 ALT 565 (577)
Q Consensus 563 ~~~ 565 (577)
+..
T Consensus 182 ~~~ 184 (317)
T 2buj_A 182 NQA 184 (317)
T ss_dssp EES
T ss_pred hhc
Confidence 764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=229.93 Aligned_cols=150 Identities=26% Similarity=0.421 Sum_probs=130.6
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--------C
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--------H 480 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~ 480 (577)
++|...+.||+|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999987 568999999986554444445678899999999999999999999977 4
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
+..++||||+++ +|.+.+. .....+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999975 8888775 2345699999999999999999999999 99999999999999999999999999
Q ss_pred cCcccC
Q 008121 561 LAALTP 566 (577)
Q Consensus 561 la~~~~ 566 (577)
+|+...
T Consensus 170 ~a~~~~ 175 (351)
T 3mi9_A 170 LARAFS 175 (351)
T ss_dssp TCEECC
T ss_pred hccccc
Confidence 998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=228.62 Aligned_cols=153 Identities=25% Similarity=0.406 Sum_probs=134.2
Q ss_pred hcCCCccceeccCccceEEEEEE-----cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEE--eCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA--EHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~ 481 (577)
.++|...+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 35678889999999999999984 35889999999754 3445677999999999999999999999987 455
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..++||||+++|+|.+++... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred eEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 789999999999999999642 24589999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCc
Q 008121 562 AALTPNTE 569 (577)
Q Consensus 562 a~~~~~~~ 569 (577)
++......
T Consensus 174 ~~~~~~~~ 181 (327)
T 3lxl_A 174 AKLLPLDK 181 (327)
T ss_dssp CEECCTTC
T ss_pred ceecccCC
Confidence 99775443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=224.66 Aligned_cols=148 Identities=27% Similarity=0.461 Sum_probs=131.6
Q ss_pred CCccceeccCccceEEEEEEc-----CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC--CeEE
Q 008121 412 FSQEFLIGEGSLGRVYRAEFA-----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 484 (577)
|...+.||+|+||.||++.+. +++.||||+++... .....+.|.+|++++++++||||+++++++... ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 477889999999999998653 58899999997543 345567899999999999999999999999874 5789
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999962 3489999999999999999999999 999999999999999999999999999998
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
....
T Consensus 184 ~~~~ 187 (318)
T 3lxp_A 184 VPEG 187 (318)
T ss_dssp CCTT
T ss_pred cccc
Confidence 7554
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.3e-26 Score=225.43 Aligned_cols=151 Identities=27% Similarity=0.394 Sum_probs=132.0
Q ss_pred hcCCCccceeccCccceEEEEEEcC-C-------cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-G-------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 480 (577)
.++|...+.||+|+||.||+|.... + ..||+|++.... ....+.|.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3567888999999999999997643 3 479999986542 34567799999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-------
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN------- 553 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~------- 553 (577)
+..++||||+++|+|.++++. ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999999973 234489999999999999999999999 9999999999999998887
Q ss_pred -eEEeccccCcccCC
Q 008121 554 -PHLSDCGLAALTPN 567 (577)
Q Consensus 554 -~kl~DFGla~~~~~ 567 (577)
+||+|||+++....
T Consensus 159 ~~kl~Dfg~~~~~~~ 173 (289)
T 4fvq_A 159 FIKLSDPGISITVLP 173 (289)
T ss_dssp EEEECCCCSCTTTSC
T ss_pred eeeeccCcccccccC
Confidence 99999999976543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=226.60 Aligned_cols=159 Identities=25% Similarity=0.399 Sum_probs=135.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||++... +++.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 356888899999999999999875 68999999987532 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~~ 564 (577)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 86 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999863 34689999999999999999999999 99999999999999 7889999999999987
Q ss_pred cCCCccccccCC
Q 008121 565 TPNTERQVITGT 576 (577)
Q Consensus 565 ~~~~~~~~~~Gt 576 (577)
..........||
T Consensus 159 ~~~~~~~~~~~~ 170 (304)
T 2jam_A 159 EQNGIMSTACGT 170 (304)
T ss_dssp CCCBTTHHHHSC
T ss_pred cCCCccccccCC
Confidence 655444444454
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-26 Score=242.71 Aligned_cols=161 Identities=27% Similarity=0.446 Sum_probs=138.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|... +++.||||++...... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888899999999999999875 6899999998644322 33467799999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeccccCc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAA 563 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~ 563 (577)
|||+++|+|.+++. ....+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999986 345799999999999999999999999 99999999999999 567899999999998
Q ss_pred ccCCCcc-ccccCC
Q 008121 564 LTPNTER-QVITGT 576 (577)
Q Consensus 564 ~~~~~~~-~~~~Gt 576 (577)
....... ...+||
T Consensus 178 ~~~~~~~~~~~~gt 191 (484)
T 3nyv_A 178 HFEASKKMKDKIGT 191 (484)
T ss_dssp HBCCCCSHHHHTTG
T ss_pred EcccccccccCCCC
Confidence 7655433 334455
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.1e-26 Score=249.65 Aligned_cols=146 Identities=27% Similarity=0.422 Sum_probs=128.6
Q ss_pred ceeccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||.||+|.+. .++.||||+++.........++|.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999663 46789999998665445557789999999999999999999999964 568899999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
|+|.++++ ....+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 99999996 345689999999999999999999999 99999999999999999999999999999775443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-26 Score=230.43 Aligned_cols=152 Identities=23% Similarity=0.435 Sum_probs=126.8
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCc----EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.++|...+.||+|+||.||+|.+. +++ +||+|.++... .....++|.+|+.++++++||||++++++|.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 356788899999999999999864 344 46888875432 2344677999999999999999999999998764 7
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++|+||+++|+|.++++. ....+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 92 ~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 899999999999999973 345689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC
Q 008121 564 LTPNT 568 (577)
Q Consensus 564 ~~~~~ 568 (577)
.....
T Consensus 166 ~~~~~ 170 (327)
T 3poz_A 166 LLGAE 170 (327)
T ss_dssp HHTTT
T ss_pred EccCC
Confidence 76543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=227.03 Aligned_cols=153 Identities=27% Similarity=0.381 Sum_probs=127.1
Q ss_pred HHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhc--CCCCceeeEeeEEEeC---
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAEH--- 480 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~--- 480 (577)
....++|...+.||+|+||.||+|++. ++.||||++... ....+.+|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 344578999999999999999999876 899999998532 22334445555444 5999999999999877
Q ss_pred -CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeeeCCCCCe
Q 008121 481 -GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-----LPSVVHRNFKSANILLDDELNP 554 (577)
Q Consensus 481 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivHrDlk~~NILl~~~~~~ 554 (577)
...++||||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 789999999999999999962 36899999999999999999999762 3479999999999999999999
Q ss_pred EEeccccCcccCCCc
Q 008121 555 HLSDCGLAALTPNTE 569 (577)
Q Consensus 555 kl~DFGla~~~~~~~ 569 (577)
||+|||+++......
T Consensus 182 kl~Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 182 CIADLGLAVKFISDT 196 (337)
T ss_dssp EECCCTTCEECC---
T ss_pred EEEeCCCceeecccc
Confidence 999999998764433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=233.52 Aligned_cols=150 Identities=27% Similarity=0.510 Sum_probs=123.4
Q ss_pred CCCccceeccCccceEEEEEEc--CC--cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe-CCeEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA--NG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLL 485 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~l 485 (577)
.|...+.||+|+||.||+|.+. ++ ..||||.++... .....++|.+|+.++++++||||+++++++.. ++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 3556788999999999999764 22 468999986532 34566789999999999999999999998754 457899
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.++++ .....+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 999999999999996 2345688999999999999999999999 9999999999999999999999999999866
Q ss_pred CC
Q 008121 566 PN 567 (577)
Q Consensus 566 ~~ 567 (577)
..
T Consensus 243 ~~ 244 (373)
T 3c1x_A 243 YD 244 (373)
T ss_dssp --
T ss_pred cc
Confidence 44
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=223.85 Aligned_cols=152 Identities=27% Similarity=0.412 Sum_probs=130.2
Q ss_pred cCCCccc-eeccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEF-LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
++|...+ .||+|+||.||+|.+. +++.||||+++.........+++.+|+++++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 8999999999999653 368899999976544444567899999999999999999999999 5667899
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 95 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999973 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCc
Q 008121 566 PNTE 569 (577)
Q Consensus 566 ~~~~ 569 (577)
....
T Consensus 168 ~~~~ 171 (291)
T 1xbb_A 168 RADE 171 (291)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 5443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=229.76 Aligned_cols=166 Identities=26% Similarity=0.382 Sum_probs=141.0
Q ss_pred HHHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc--c----hHHHHHHHHHHHHhhcC-CCCceeeEeeE
Q 008121 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL--S----LQEEDNFLEAVSNMSRL-RHPNIVTLAGY 476 (577)
Q Consensus 405 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~ 476 (577)
.....++|...+.||+|+||.||+|.+. +|+.||||+++.... . ....+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445567999999999999999999885 699999999864321 1 12245688999999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 008121 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (577)
Q Consensus 477 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl 556 (577)
+...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999963 35689999999999999999999999 9999999999999999999999
Q ss_pred eccccCcccCCCcc-ccccCCC
Q 008121 557 SDCGLAALTPNTER-QVITGTS 577 (577)
Q Consensus 557 ~DFGla~~~~~~~~-~~~~Gt~ 577 (577)
+|||+++....... ...+||+
T Consensus 242 ~DfG~~~~~~~~~~~~~~~gt~ 263 (365)
T 2y7j_A 242 SDFGFSCHLEPGEKLRELCGTP 263 (365)
T ss_dssp CCCTTCEECCTTCCBCCCCSCG
T ss_pred EecCcccccCCCcccccCCCCC
Confidence 99999987654432 3455653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=222.21 Aligned_cols=151 Identities=26% Similarity=0.376 Sum_probs=133.4
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch----HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
++|...+.||+|+||.||+|... +++.||+|.++...... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888899999999999999876 58999999986543221 13567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEeccc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDCG 560 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DFG 560 (577)
+||||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999963 35689999999999999999999999 999999999999999877 89999999
Q ss_pred cCcccCC
Q 008121 561 LAALTPN 567 (577)
Q Consensus 561 la~~~~~ 567 (577)
+++....
T Consensus 158 ~~~~~~~ 164 (283)
T 3bhy_A 158 IAHKIEA 164 (283)
T ss_dssp TCEECC-
T ss_pred cceeccC
Confidence 9987644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=222.09 Aligned_cols=152 Identities=27% Similarity=0.446 Sum_probs=134.4
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|... +++.||||++..... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888899999999999999875 689999999864321 1223567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999963 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred C
Q 008121 568 T 568 (577)
Q Consensus 568 ~ 568 (577)
.
T Consensus 164 ~ 164 (276)
T 2h6d_A 164 G 164 (276)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=227.96 Aligned_cols=151 Identities=25% Similarity=0.453 Sum_probs=129.2
Q ss_pred cCCCccceeccCccceEEEEEEcC-----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.+|...+.||+|+||.||+|.+.. +..||||+++... ......+|.+|++++++++||||+++++++...+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 456778899999999999997643 2469999997543 3445667999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.+++.. ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999963 345789999999999999999999999 999999999999999999999999999987
Q ss_pred cCC
Q 008121 565 TPN 567 (577)
Q Consensus 565 ~~~ 567 (577)
...
T Consensus 197 ~~~ 199 (333)
T 1mqb_A 197 LED 199 (333)
T ss_dssp ---
T ss_pred hcc
Confidence 654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=223.69 Aligned_cols=149 Identities=28% Similarity=0.454 Sum_probs=131.8
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-------- 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-------- 479 (577)
.++|...+.||+|+||.||+|... +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 456888999999999999999874 6899999998542 3456779999999999999999999998865
Q ss_pred -----CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 008121 480 -----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (577)
Q Consensus 480 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 554 (577)
.+..++||||+++|+|.++++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence 3568999999999999999963 235678899999999999999999999 99999999999999999999
Q ss_pred EEeccccCcccC
Q 008121 555 HLSDCGLAALTP 566 (577)
Q Consensus 555 kl~DFGla~~~~ 566 (577)
||+|||+++...
T Consensus 156 kl~dfg~~~~~~ 167 (303)
T 1zy4_A 156 KIGDFGLAKNVH 167 (303)
T ss_dssp EECCCCCCSCTT
T ss_pred EEeeCcchhhcc
Confidence 999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=223.53 Aligned_cols=152 Identities=27% Similarity=0.486 Sum_probs=130.8
Q ss_pred cCCCccceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEE-eCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA-EHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~ 484 (577)
.+|...+.||+|+||.||+|.+.+ ...||+|.+.... .....+.+.+|++++++++||||+++++++. .++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 457778899999999999997643 2368999987532 3455678999999999999999999999865 456789
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.++++ .....+++.++..|+.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999996 2356689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
....
T Consensus 178 ~~~~ 181 (298)
T 3f66_A 178 MYDK 181 (298)
T ss_dssp CSCG
T ss_pred cccc
Confidence 6543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-26 Score=230.33 Aligned_cols=152 Identities=25% Similarity=0.418 Sum_probs=128.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcE----EEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKI----MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
++|...+.||+|+||.||+|.+. +++. ||+|.+.... .......+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 46778899999999999999864 3443 7888775432 1223345778999999999999999999986 45789
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.+++.. ....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999962 235789999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCc
Q 008121 565 TPNTE 569 (577)
Q Consensus 565 ~~~~~ 569 (577)
.....
T Consensus 165 ~~~~~ 169 (325)
T 3kex_A 165 LPPDD 169 (325)
T ss_dssp SCCCT
T ss_pred cCccc
Confidence 75443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=231.49 Aligned_cols=160 Identities=24% Similarity=0.327 Sum_probs=134.6
Q ss_pred cHHHHHHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEcccccc---------chHHHHHHHHHHHHhhcCCCCcee
Q 008121 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL---------SLQEEDNFLEAVSNMSRLRHPNIV 471 (577)
Q Consensus 401 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~e~~~l~~l~H~niv 471 (577)
.+.++....++|...+.||+|+||.||+|...+++.||||++..... .....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35677788899999999999999999999888899999999864321 122347799999999999999999
Q ss_pred eEeeEEEeC-----CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 008121 472 TLAGYCAEH-----GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (577)
Q Consensus 472 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NI 546 (577)
++++++... ...|+||||++ |+|.+.+. .....+++..+..|+.|++.||.|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998542 36899999997 68988886 2345799999999999999999999999 999999999999
Q ss_pred eeCCCCCeEEeccccCcccCC
Q 008121 547 LLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 547 Ll~~~~~~kl~DFGla~~~~~ 567 (577)
|++.++.+||+|||+++....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTA 186 (362)
T ss_dssp EECTTCCEEECCTTC------
T ss_pred EEcCCCCEEEEecCccccccc
Confidence 999999999999999986443
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=223.38 Aligned_cols=151 Identities=26% Similarity=0.410 Sum_probs=129.8
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||||+++.........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 46888899999999999999875 68999999986543333334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|++ |+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~-~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 154 (299)
T 2r3i_A 83 FLH-QDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154 (299)
T ss_dssp CCS-EEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred ccc-CCHHHHHHhh--hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcchhhhhcc
Confidence 997 6999998743 335689999999999999999999999 99999999999999999999999999998654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=222.81 Aligned_cols=150 Identities=27% Similarity=0.462 Sum_probs=129.7
Q ss_pred CCCccceeccCccceEEEEEEcC-C---cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE-EE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFAN-G---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR-LL 485 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~l 485 (577)
.|...+.||+|+||.||+|.+.+ + ..||+|++.... .....+.|.+|++++++++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 34556889999999999997643 2 379999987532 345567899999999999999999999999876655 99
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+.+|+|.++++. ....+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999962 356789999999999999999999999 9999999999999999999999999999865
Q ss_pred CC
Q 008121 566 PN 567 (577)
Q Consensus 566 ~~ 567 (577)
..
T Consensus 175 ~~ 176 (298)
T 3pls_A 175 LD 176 (298)
T ss_dssp TT
T ss_pred cC
Confidence 44
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=227.78 Aligned_cols=156 Identities=28% Similarity=0.342 Sum_probs=131.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|... +++.||||+++.... .+.+|++++.++ +||||+++++++.+.+..|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 456888899999999999999875 588999999965422 234678888777 799999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC----CCeEEeccccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE----LNPHLSDCGLA 562 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~----~~~kl~DFGla 562 (577)
|||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||+.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 99999999999996 345799999999999999999999999 99999999999998543 35999999999
Q ss_pred cccCCCc--cccccCCC
Q 008121 563 ALTPNTE--RQVITGTS 577 (577)
Q Consensus 563 ~~~~~~~--~~~~~Gt~ 577 (577)
+...... ....+||+
T Consensus 168 ~~~~~~~~~~~~~~gt~ 184 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTA 184 (342)
T ss_dssp EECBCTTCCBCCSSCCS
T ss_pred ccCcCCCCceeccCCCc
Confidence 9765443 23445653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=221.29 Aligned_cols=151 Identities=26% Similarity=0.426 Sum_probs=134.9
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.+.|...+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 34678889999999999999976 4688999999865432 334677999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 100 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 100 EYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp ECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999985 35689999999999999999999999 999999999999999999999999999987654
Q ss_pred C
Q 008121 568 T 568 (577)
Q Consensus 568 ~ 568 (577)
.
T Consensus 172 ~ 172 (303)
T 3a7i_A 172 T 172 (303)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=227.54 Aligned_cols=167 Identities=19% Similarity=0.295 Sum_probs=137.0
Q ss_pred HHHhhcCCCcc-ceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCC
Q 008121 405 LQTATNSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG 481 (577)
Q Consensus 405 ~~~~~~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~ 481 (577)
.....+.|... +.||+|+||.||+|... +++.||+|+++..........++.+|+.++.+++ ||||+++++++...+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445566666 88999999999999775 5899999999765444445677899999999995 699999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEec
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSD 558 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~D 558 (577)
..++||||+++|+|.+++.. .....+++.++..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+|
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred eEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence 99999999999999999852 2346799999999999999999999999 9999999999999998 78999999
Q ss_pred cccCcccCCCcc-ccccCC
Q 008121 559 CGLAALTPNTER-QVITGT 576 (577)
Q Consensus 559 FGla~~~~~~~~-~~~~Gt 576 (577)
||+++....... ....||
T Consensus 178 fg~a~~~~~~~~~~~~~gt 196 (327)
T 3lm5_A 178 FGMSRKIGHACELREIMGT 196 (327)
T ss_dssp GGGCEEC---------CCC
T ss_pred CccccccCCccccccccCC
Confidence 999997654432 233454
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=222.27 Aligned_cols=149 Identities=23% Similarity=0.417 Sum_probs=130.7
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-------- 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-------- 479 (577)
.++|...+.||+|+||.||+|... +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 456888999999999999999885 68999999986432 246789999999999999999998854
Q ss_pred --------CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 480 --------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 480 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
....++||||+++|+|.++++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 34579999999999999999743 235689999999999999999999999 99999999999999999
Q ss_pred CCeEEeccccCcccCCC
Q 008121 552 LNPHLSDCGLAALTPNT 568 (577)
Q Consensus 552 ~~~kl~DFGla~~~~~~ 568 (577)
+.+||+|||+++.....
T Consensus 159 ~~~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKND 175 (284)
T ss_dssp TEEEECCCTTCEESSCC
T ss_pred CCEEECcchhheecccc
Confidence 99999999999876554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=219.77 Aligned_cols=150 Identities=23% Similarity=0.403 Sum_probs=130.8
Q ss_pred CCCccc-eeccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 411 SFSQEF-LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 411 ~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
+|...+ .||+|+||.||+|.+. +++.||||+++... .....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 444444 8999999999999763 57889999997642 345567899999999999999999999999 55678999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.+++. .....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999995 2345699999999999999999999999 99999999999999999999999999999765
Q ss_pred CC
Q 008121 567 NT 568 (577)
Q Consensus 567 ~~ 568 (577)
..
T Consensus 162 ~~ 163 (287)
T 1u59_A 162 AD 163 (287)
T ss_dssp TC
T ss_pred cC
Confidence 43
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=226.59 Aligned_cols=161 Identities=24% Similarity=0.400 Sum_probs=136.2
Q ss_pred HHHHhhcCCCccceeccCccceEEEEEE------cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeE
Q 008121 404 SLQTATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGY 476 (577)
Q Consensus 404 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~ 476 (577)
......++|...+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+.++.++ +||||++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 3444567899999999999999999975 346889999997543 344566799999999999 79999999999
Q ss_pred EEeCC-eEEEEEEecCCCCHHHhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 008121 477 CAEHG-QRLLVYEYVGNGNLHDMLHFADDS------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543 (577)
Q Consensus 477 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~ 543 (577)
+...+ ..++||||+++|+|.+++...... ...+++..+..++.|+++||.|||+. +|+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCcc
Confidence 87755 589999999999999999743221 22388999999999999999999999 999999999
Q ss_pred CCeeeCCCCCeEEeccccCcccCCC
Q 008121 544 ANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 544 ~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+||+++.++.+||+|||+++.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~ 201 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKD 201 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTC
T ss_pred ceEEECCCCCEEECCCccccccccC
Confidence 9999999999999999999876443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=232.22 Aligned_cols=154 Identities=26% Similarity=0.341 Sum_probs=127.7
Q ss_pred HHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC----
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH---- 480 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~---- 480 (577)
....++|...+.||+|+||.||+|.. .+|+.||||++.... ....+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34567899999999999999999976 568999999986432 1234689999999999999999998443
Q ss_pred ----------------------------------CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 008121 481 ----------------------------------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526 (577)
Q Consensus 481 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~ 526 (577)
...++||||++ |+|.+.++........+++..+..++.|+++||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34889999998 5888888654345678999999999999999999
Q ss_pred HHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeccccCcccCCCc
Q 008121 527 YLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 527 yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~~~~~~~ 569 (577)
|||+. +|+||||||+|||++ +++.+||+|||+|+......
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 99999 999999999999998 68899999999999764443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=223.73 Aligned_cols=153 Identities=24% Similarity=0.344 Sum_probs=131.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367888999999999999999875 6889999998754322 33457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++++|.++++. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999973 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CC
Q 008121 567 NT 568 (577)
Q Consensus 567 ~~ 568 (577)
..
T Consensus 186 ~~ 187 (309)
T 2h34_A 186 DE 187 (309)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=232.74 Aligned_cols=155 Identities=20% Similarity=0.292 Sum_probs=121.7
Q ss_pred CCCcc-ceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHh-hcCCCCceeeEeeEEEe----CCeE
Q 008121 411 SFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNM-SRLRHPNIVTLAGYCAE----HGQR 483 (577)
Q Consensus 411 ~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~ 483 (577)
+|... +.||+|+||.||+|... +++.||||+++.. ..+.+|++++ +..+||||+++++++.. .+..
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 44444 68999999999999775 5889999998532 2356788776 44589999999999865 5578
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeccc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCG 560 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DFG 560 (577)
|+||||+++|+|.++++. .....+++.++..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999973 2235699999999999999999999999 9999999999999997 7899999999
Q ss_pred cCcccCCCcc-ccccCCC
Q 008121 561 LAALTPNTER-QVITGTS 577 (577)
Q Consensus 561 la~~~~~~~~-~~~~Gt~ 577 (577)
+++....... ...+||+
T Consensus 210 ~a~~~~~~~~~~~~~gt~ 227 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTP 227 (400)
T ss_dssp TCEECC-----------C
T ss_pred cccccCCCCccccCCCCC
Confidence 9997654332 3444553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=220.07 Aligned_cols=145 Identities=13% Similarity=0.125 Sum_probs=128.1
Q ss_pred cCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|.... ++.||||++...... ....+.|.+|+..+++++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 568888999999999999998754 899999999765332 344578999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
||+++++|.++++. . ....++.+|+.|++.||+|||+. +|+||||||+|||+++++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp ECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccccC
Confidence 99999999999951 2 35567899999999999999999 99999999999999999999999887654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=224.01 Aligned_cols=148 Identities=23% Similarity=0.340 Sum_probs=128.0
Q ss_pred cCCCc-cceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEE
Q 008121 410 NSFSQ-EFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 410 ~~~~~-~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 486 (577)
+.|.+ .+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45666 47899999999999976 468999999986542 23456789999999885 799999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---eEEeccccCc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGLAA 563 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~---~kl~DFGla~ 563 (577)
|||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999973 35689999999999999999999999 9999999999999998776 9999999998
Q ss_pred ccC
Q 008121 564 LTP 566 (577)
Q Consensus 564 ~~~ 566 (577)
...
T Consensus 163 ~~~ 165 (316)
T 2ac3_A 163 GIK 165 (316)
T ss_dssp ---
T ss_pred ccc
Confidence 654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=228.84 Aligned_cols=153 Identities=29% Similarity=0.420 Sum_probs=126.9
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch---HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL---QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
..++|...+.||+|+||.||+|... +|+.||||++....... ...+.+.+|++++++++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3567999999999999999999875 58999999996532211 1124688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++||||+++ +|.+++. .....+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999985 8988885 2345688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCC
Q 008121 564 LTPN 567 (577)
Q Consensus 564 ~~~~ 567 (577)
....
T Consensus 161 ~~~~ 164 (346)
T 1ua2_A 161 SFGS 164 (346)
T ss_dssp TTTS
T ss_pred eccC
Confidence 7643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=245.42 Aligned_cols=144 Identities=25% Similarity=0.421 Sum_probs=126.9
Q ss_pred eeccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 417 LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 417 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
.||+|+||.||+|.+. ++..||||+++... .....++|.+|+++|++++|||||+++++|.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 7999999999999774 45679999997542 33456789999999999999999999999976 5689999999999
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+|.++++. ....+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.....
T Consensus 421 ~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 421 PLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp BHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred cHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999962 355799999999999999999999999 9999999999999999999999999999976543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=232.00 Aligned_cols=153 Identities=22% Similarity=0.318 Sum_probs=126.2
Q ss_pred hhcCCCccceeccCccceEEEEEEcC------CcEEEEEEccccccchHHH---------HHHHHHHHHhhcCCCCceee
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEE---------DNFLEAVSNMSRLRHPNIVT 472 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~H~niv~ 472 (577)
..++|...+.||+|+||.||+|.+.. ++.||||++.........+ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578889999999999999998765 4789999986442111111 23445667788899999999
Q ss_pred EeeEEEeC----CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008121 473 LAGYCAEH----GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (577)
Q Consensus 473 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl 548 (577)
+++++... ...++||||+ +|+|.++++. ....+++.+++.|+.|++.||+|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4589999999 9999999963 346799999999999999999999999 99999999999999
Q ss_pred C--CCCCeEEeccccCcccCC
Q 008121 549 D--DELNPHLSDCGLAALTPN 567 (577)
Q Consensus 549 ~--~~~~~kl~DFGla~~~~~ 567 (577)
+ .++.+||+|||+|+.+..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~ 206 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCP 206 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSG
T ss_pred ecCCCCeEEEEECCcceeccc
Confidence 9 889999999999987643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-26 Score=236.91 Aligned_cols=154 Identities=16% Similarity=0.216 Sum_probs=126.4
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccc-cchHHHHHHHHHH---HHhhcCCCCceeeEe-------eE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAV---SNMSRLRHPNIVTLA-------GY 476 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~ 476 (577)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.|.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999986 568999999986432 2234567789999 556667899999998 66
Q ss_pred EEeCC-----------------eEEEEEEecCCCCHHHhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 008121 477 CAEHG-----------------QRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSV 536 (577)
Q Consensus 477 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i 536 (577)
+...+ ..|+||||+ +|+|.++++.... ....+++..+..|+.|+++||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 65543 278999999 6899999974321 123455688999999999999999999 99
Q ss_pred eecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 537 VHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 537 vHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
+||||||+|||++.++.+||+|||+|+...
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999999999643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=225.49 Aligned_cols=152 Identities=30% Similarity=0.544 Sum_probs=129.9
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcE--EEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKI--MAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 485 (577)
++|...+.||+|+||.||+|... ++.. ||+|.++... .....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 56888899999999999999764 4654 4999886432 334456789999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHhhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008121 486 VYEYVGNGNLHDMLHFAD------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~ 553 (577)
||||+++|+|.+++.... .....+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997432 2235799999999999999999999999 9999999999999999999
Q ss_pred eEEeccccCccc
Q 008121 554 PHLSDCGLAALT 565 (577)
Q Consensus 554 ~kl~DFGla~~~ 565 (577)
+||+|||+++..
T Consensus 181 ~kL~Dfg~~~~~ 192 (327)
T 1fvr_A 181 AKIADFGLSRGQ 192 (327)
T ss_dssp EEECCTTCEESS
T ss_pred EEEcccCcCccc
Confidence 999999999854
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=230.05 Aligned_cols=156 Identities=26% Similarity=0.405 Sum_probs=134.7
Q ss_pred hcCCCccceeccCccceEEEEEEcC------CcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 481 (577)
.++|...+.||+|+||.||+|.... .+.||+|.+.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4678888999999999999998643 2479999987543 344567799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADD----------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 99999999999999999974321 134689999999999999999999999 99999999999999999
Q ss_pred CCeEEeccccCcccCCC
Q 008121 552 LNPHLSDCGLAALTPNT 568 (577)
Q Consensus 552 ~~~kl~DFGla~~~~~~ 568 (577)
+.+||+|||+++.....
T Consensus 201 ~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMND 217 (333)
T ss_dssp GEEEBCCCGGGCCGGGC
T ss_pred CeEEECccccccccccc
Confidence 99999999999865443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-25 Score=224.57 Aligned_cols=150 Identities=30% Similarity=0.452 Sum_probs=131.8
Q ss_pred HHHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhc--CCCCceeeEeeEEEeCC-
Q 008121 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAEHG- 481 (577)
Q Consensus 405 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~- 481 (577)
.....++|...+.||+|+||.||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++...+
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 345567899999999999999999987 4899999998643 34567788888877 79999999999998776
Q ss_pred ---eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCCeeeCC
Q 008121 482 ---QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH--------EVCLPSVVHRNFKSANILLDD 550 (577)
Q Consensus 482 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivHrDlk~~NILl~~ 550 (577)
..++||||+++|+|.++++. ..+++.+++.++.|++.||+||| +. +|+||||||+|||++.
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred ccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 78999999999999999962 36899999999999999999999 66 9999999999999999
Q ss_pred CCCeEEeccccCcccCCC
Q 008121 551 ELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 551 ~~~~kl~DFGla~~~~~~ 568 (577)
++.+||+|||+++.....
T Consensus 183 ~~~~kL~Dfg~~~~~~~~ 200 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSA 200 (342)
T ss_dssp TSCEEECCCTTCEEEETT
T ss_pred CCCEEEEECCCceecccc
Confidence 999999999999876543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=220.52 Aligned_cols=153 Identities=26% Similarity=0.386 Sum_probs=134.5
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-------chHHHHHHHHHHHHhhcCC-CCceeeEeeEEEe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-------SLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAE 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~ 479 (577)
.++|...+.||+|+||.||+|... +++.||||+++.... .....+.+.+|++++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999875 589999999864321 1123467889999999996 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecc
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DF 559 (577)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999973 35689999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccCCC
Q 008121 560 GLAALTPNT 568 (577)
Q Consensus 560 Gla~~~~~~ 568 (577)
|+++.....
T Consensus 169 g~~~~~~~~ 177 (298)
T 1phk_A 169 GFSCQLDPG 177 (298)
T ss_dssp TTCEECCTT
T ss_pred cchhhcCCC
Confidence 999876543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=225.17 Aligned_cols=152 Identities=23% Similarity=0.350 Sum_probs=127.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc------hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 481 (577)
.++|...+.||+|+||.||+|... +++.||||++...... ......+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457888999999999999999775 5889999998654221 122345889999999999999999999987654
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---eEEec
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSD 558 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~---~kl~D 558 (577)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 899999999999999986 346789999999999999999999999 9999999999999987654 99999
Q ss_pred cccCcccCCC
Q 008121 559 CGLAALTPNT 568 (577)
Q Consensus 559 FGla~~~~~~ 568 (577)
||+++.....
T Consensus 161 fg~~~~~~~~ 170 (322)
T 2ycf_A 161 FGHSKILGET 170 (322)
T ss_dssp CTTCEECCCC
T ss_pred Cccceecccc
Confidence 9999976544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=224.67 Aligned_cols=153 Identities=25% Similarity=0.472 Sum_probs=133.1
Q ss_pred hcCCCccceeccCccceEEEEEE-----cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC--
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-- 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-- 481 (577)
.++|...+.||+|+||.||+|.+ .+++.||||++... .....+.|.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 35677889999999999999984 35889999998754 3445678999999999999999999999987654
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..++||||+++|+|.+++.. ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 67999999999999999963 235689999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCc
Q 008121 562 AALTPNTE 569 (577)
Q Consensus 562 a~~~~~~~ 569 (577)
++......
T Consensus 192 ~~~~~~~~ 199 (326)
T 2w1i_A 192 TKVLPQDK 199 (326)
T ss_dssp CEECCSSC
T ss_pred hhhccccc
Confidence 99875543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.8e-26 Score=229.49 Aligned_cols=149 Identities=26% Similarity=0.386 Sum_probs=127.9
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 46888899999999999999875 68999999986432 11222245679999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|++ |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 81 YLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 997 599998863 345689999999999999999999999 99999999999999999999999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-25 Score=228.36 Aligned_cols=150 Identities=21% Similarity=0.292 Sum_probs=127.3
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 481 (577)
.++|...+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357888999999999999999764 5889999999755444556678899999999999999999999997654
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..|+||||++ |+|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999997 57888885 3488999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCC
Q 008121 562 AALTPNT 568 (577)
Q Consensus 562 a~~~~~~ 568 (577)
++.....
T Consensus 174 a~~~~~~ 180 (371)
T 2xrw_A 174 ARTAGTS 180 (371)
T ss_dssp -------
T ss_pred ccccccc
Confidence 9876543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=230.54 Aligned_cols=150 Identities=21% Similarity=0.368 Sum_probs=118.0
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC------C
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------G 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 481 (577)
.++|...+.||+|+||.||+|.. .+|+.||||++..........+++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788899999999999999976 5689999999976544455667889999999999999999999998654 5
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
..|+|+||+ +++|.++++ ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 789999885 25699999999999999999999999 999999999999999999999999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
++....
T Consensus 179 a~~~~~ 184 (367)
T 2fst_X 179 ARHTAD 184 (367)
T ss_dssp ------
T ss_pred cccccc
Confidence 987543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.3e-25 Score=219.81 Aligned_cols=149 Identities=19% Similarity=0.270 Sum_probs=131.0
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|++++.++ +|+|++++++++......++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 35688899999999999999986 568999999986432 234578899999999 799999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-----eEEecccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-----PHLSDCGL 561 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~-----~kl~DFGl 561 (577)
|||+ +|+|.++++.. ...+++.++..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 99999999732 34699999999999999999999999 9999999999999987776 99999999
Q ss_pred CcccCCC
Q 008121 562 AALTPNT 568 (577)
Q Consensus 562 a~~~~~~ 568 (577)
++.....
T Consensus 158 ~~~~~~~ 164 (298)
T 1csn_A 158 VKFYRDP 164 (298)
T ss_dssp CEESBCT
T ss_pred ccccccc
Confidence 9976554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-25 Score=223.13 Aligned_cols=150 Identities=30% Similarity=0.488 Sum_probs=123.4
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|...+.||+|+||.||+|.+. ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 46777899999999999999875 788999998643 345679999999999999999999998763 47899999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-eEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-PHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~-~kl~DFGla~~~~~ 567 (577)
+++|+|.++++... ....+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999997321 2235788999999999999999999932228999999999999998886 79999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=227.65 Aligned_cols=156 Identities=27% Similarity=0.469 Sum_probs=133.3
Q ss_pred HHHHhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEe--
Q 008121 404 SLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE-- 479 (577)
Q Consensus 404 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-- 479 (577)
++....++|...+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3445567889999999999999999987 468999999986432 2346688999999998 79999999999976
Q ss_pred ----CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeE
Q 008121 480 ----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (577)
Q Consensus 480 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 555 (577)
.+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 46789999999999999999743 235689999999999999999999999 999999999999999999999
Q ss_pred EeccccCcccCC
Q 008121 556 LSDCGLAALTPN 567 (577)
Q Consensus 556 l~DFGla~~~~~ 567 (577)
|+|||+++....
T Consensus 170 l~Dfg~~~~~~~ 181 (326)
T 2x7f_A 170 LVDFGVSAQLDR 181 (326)
T ss_dssp ECCCTTTC----
T ss_pred EeeCcCceecCc
Confidence 999999987643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=223.60 Aligned_cols=155 Identities=25% Similarity=0.380 Sum_probs=120.9
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
..++|...+.||+|+||.||+|.. .+++.||||++..... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 456788999999999999999976 4688999999865421 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 487 YEYVGNGNLHDMLHFAD----DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
|||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 99999999999986421 1345689999999999999999999999 9999999999999999999999999999
Q ss_pred cccC
Q 008121 563 ALTP 566 (577)
Q Consensus 563 ~~~~ 566 (577)
+...
T Consensus 169 ~~~~ 172 (303)
T 2vwi_A 169 AFLA 172 (303)
T ss_dssp HHCC
T ss_pred heec
Confidence 8654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=216.11 Aligned_cols=151 Identities=24% Similarity=0.316 Sum_probs=130.2
Q ss_pred CCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
+|.....||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 455566899999999999986 458899999986542 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeccccCcccCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTPN 567 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DFGla~~~~~ 567 (577)
+++|+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 101 VPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999742 1234567889999999999999999999 9999999999999987 89999999999987654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=243.43 Aligned_cols=149 Identities=15% Similarity=0.143 Sum_probs=114.4
Q ss_pred eccCccceEEEE-EEcCCcEEEEEEcccccc--------chHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEE
Q 008121 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAAL--------SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 418 lg~G~fg~Vy~~-~~~~~~~vavK~~~~~~~--------~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.+.|++|.+..+ +..-|+.+|||.+..... .....++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 556666666655 334589999999864321 123356799999999999 6999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||++||+|.++|+ ...+++.. +|+.||+.||+|+|++ +||||||||+|||+++++.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999997 34556654 5899999999999999 999999999999999999999999999997754
Q ss_pred Ccc--ccccCC
Q 008121 568 TER--QVITGT 576 (577)
Q Consensus 568 ~~~--~~~~Gt 576 (577)
... ...+||
T Consensus 392 ~~~~~~t~vGT 402 (569)
T 4azs_A 392 DCSWPTNLVQS 402 (569)
T ss_dssp --CCSHHHHHH
T ss_pred CCccccCceec
Confidence 432 334455
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=223.79 Aligned_cols=153 Identities=25% Similarity=0.361 Sum_probs=130.1
Q ss_pred hcCCCccceeccCccceEEEEEE------cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
.++|...+.||+|+||.||+|.+ .+++.||||++.... ......++.+|+.++++++||||+++++++...+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 46788899999999999999974 347789999996432 34556789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEE
Q 008121 483 RLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHL 556 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl 556 (577)
.++||||+++|+|.+++..... ....+++.+++.++.|++.||.|||+. +|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999975432 124589999999999999999999999 9999999999999984 456999
Q ss_pred eccccCccc
Q 008121 557 SDCGLAALT 565 (577)
Q Consensus 557 ~DFGla~~~ 565 (577)
+|||+++..
T Consensus 185 ~Dfg~~~~~ 193 (327)
T 2yfx_A 185 GDFGMARDI 193 (327)
T ss_dssp CCCHHHHHH
T ss_pred Ccccccccc
Confidence 999999854
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.2e-25 Score=217.76 Aligned_cols=152 Identities=27% Similarity=0.434 Sum_probs=130.2
Q ss_pred hcCCCccceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.++|...+.||+|+||.||+|.+.+ +..||+|.+.... .....+.|.+|++++++++||||+++++++.+. ..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 4568888999999999999997643 3469999987543 344567899999999999999999999998654 568
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.++++. ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999963 235689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
....
T Consensus 163 ~~~~ 166 (281)
T 3cc6_A 163 IEDE 166 (281)
T ss_dssp C---
T ss_pred cccc
Confidence 6543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-25 Score=224.04 Aligned_cols=148 Identities=29% Similarity=0.472 Sum_probs=121.8
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHH--HHHHHhhcCCCCceeeEeeEEEe-----CC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL--EAVSNMSRLRHPNIVTLAGYCAE-----HG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~--~e~~~l~~l~H~niv~l~~~~~~-----~~ 481 (577)
.++|...+.||+|+||.||+|+. +++.||||++... ....+. .|+..+..++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 35788889999999999999976 6899999998643 223333 34444566899999999986542 23
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeeecCCCCCCeeeCCCCCeE
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC------LPSVVHRNFKSANILLDDELNPH 555 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------~~~ivHrDlk~~NILl~~~~~~k 555 (577)
..++||||+++|+|.++++. ...++..+.+|+.|+++||+|||+.+ .++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 57899999999999999962 34589999999999999999999873 33899999999999999999999
Q ss_pred EeccccCcccCC
Q 008121 556 LSDCGLAALTPN 567 (577)
Q Consensus 556 l~DFGla~~~~~ 567 (577)
|+|||+++....
T Consensus 161 L~DFG~a~~~~~ 172 (336)
T 3g2f_A 161 ISDFGLSMRLTG 172 (336)
T ss_dssp ECCCTTCEECSS
T ss_pred Eeeccceeeccc
Confidence 999999987653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=217.60 Aligned_cols=152 Identities=27% Similarity=0.343 Sum_probs=129.5
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc--hHHHHHHHHHHHHhhcCCCCceeeEeeEEE--eCCeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS--LQEEDNFLEAVSNMSRLRHPNIVTLAGYCA--EHGQR 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~ 483 (577)
.++|...+.||+|+||.||++... +++.||+|+++..... ....+.+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367899999999999999999874 5889999999754321 234577999999999999999999999984 44578
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++||||+++| |.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 77777632 346789999999999999999999999 99999999999999999999999999998
Q ss_pred ccC
Q 008121 564 LTP 566 (577)
Q Consensus 564 ~~~ 566 (577)
...
T Consensus 158 ~~~ 160 (305)
T 2wtk_C 158 ALH 160 (305)
T ss_dssp ECC
T ss_pred ccC
Confidence 764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=220.38 Aligned_cols=144 Identities=26% Similarity=0.403 Sum_probs=128.5
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEe--CCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAE--HGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~l 485 (577)
++|...+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 5788899999999999999976 56899999998643 2456889999999997 9999999999987 667899
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeccccCcc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAAL 564 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~ 564 (577)
||||+++++|.++++ .+++.++..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 111 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 999999999999884 378999999999999999999999 999999999999999776 899999999987
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
....
T Consensus 181 ~~~~ 184 (330)
T 3nsz_A 181 YHPG 184 (330)
T ss_dssp CCTT
T ss_pred cCCC
Confidence 6543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.2e-25 Score=244.84 Aligned_cols=155 Identities=24% Similarity=0.378 Sum_probs=131.8
Q ss_pred cCCCccceeccCccceEEEEEEc--CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe-----
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ----- 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 482 (577)
++|.+.+.||+|+||.||+|.+. +++.||||++.... .......|.+|++++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 67888999999999999999875 58999999986532 34456678999999999999999999999987665
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.|+||||+++++|.+++. ..+++.+++.|+.||++||+|||+. +||||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 799999999999998774 2689999999999999999999999 99999999999999986 8999999999
Q ss_pred cccCCCccccccCCC
Q 008121 563 ALTPNTERQVITGTS 577 (577)
Q Consensus 563 ~~~~~~~~~~~~Gt~ 577 (577)
+..... ....||+
T Consensus 229 ~~~~~~--~~~~gt~ 241 (681)
T 2pzi_A 229 SRINSF--GYLYGTP 241 (681)
T ss_dssp EETTCC--SCCCCCT
T ss_pred hhcccC--CccCCCc
Confidence 976544 3444553
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=220.30 Aligned_cols=151 Identities=30% Similarity=0.516 Sum_probs=129.2
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
..++|...+.||+|+||.||+|... +|+.||+|.+.... ..+++.+|+.++.+++||||+++++++...+..++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 4567888999999999999999875 48999999986432 245688999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999863 245689999999999999999999999 99999999999999999999999999998765
Q ss_pred CC
Q 008121 567 NT 568 (577)
Q Consensus 567 ~~ 568 (577)
..
T Consensus 177 ~~ 178 (314)
T 3com_A 177 DT 178 (314)
T ss_dssp TT
T ss_pred hh
Confidence 43
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=225.00 Aligned_cols=150 Identities=25% Similarity=0.367 Sum_probs=131.2
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC-----Ce
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 482 (577)
.++|...+.||+|+||.||+|... +++.||||++.... .....+.+.+|++++.+++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 357888999999999999999764 68899999997432 344457789999999999999999999999755 36
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.|+||||++ |+|.++++ ...+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999997 59999986 24589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC
Q 008121 563 ALTPNT 568 (577)
Q Consensus 563 ~~~~~~ 568 (577)
+.....
T Consensus 176 ~~~~~~ 181 (364)
T 3qyz_A 176 RVADPD 181 (364)
T ss_dssp EECCGG
T ss_pred EecCCC
Confidence 976543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-25 Score=222.97 Aligned_cols=154 Identities=27% Similarity=0.415 Sum_probs=128.4
Q ss_pred hhcCCCccceeccCccceEEEEEE--cCCcEEEEEEccccccchHHHHHHHHHHHHhhcC---CCCceeeEeeEEE----
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF--ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVTLAGYCA---- 478 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~---- 478 (577)
..++|...+.||+|+||.||+|.. .+++.||+|+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456888999999999999999987 4688999999865432222223456676666555 8999999999987
Q ss_pred -eCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 008121 479 -EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (577)
Q Consensus 479 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~ 557 (577)
.....++||||++ |+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 6999999743 334589999999999999999999999 99999999999999999999999
Q ss_pred ccccCcccCC
Q 008121 558 DCGLAALTPN 567 (577)
Q Consensus 558 DFGla~~~~~ 567 (577)
|||+++....
T Consensus 163 Dfg~~~~~~~ 172 (326)
T 1blx_A 163 DFGLARIYSF 172 (326)
T ss_dssp SCCSCCCCCG
T ss_pred cCcccccccC
Confidence 9999987653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=226.23 Aligned_cols=149 Identities=19% Similarity=0.333 Sum_probs=128.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE----
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR---- 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~---- 483 (577)
.++|...+.||+|+||.||+|... +|+.||||++..........+++.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 457888999999999999999764 589999999976554555677899999999999999999999999876654
Q ss_pred --EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 484 --LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 484 --~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
++||||++ |+|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68888773 3489999999999999999999999 999999999999999999999999999
Q ss_pred CcccCC
Q 008121 562 AALTPN 567 (577)
Q Consensus 562 a~~~~~ 567 (577)
++....
T Consensus 191 a~~~~~ 196 (371)
T 4exu_A 191 ARHADA 196 (371)
T ss_dssp C-----
T ss_pred cccccc
Confidence 986543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=217.41 Aligned_cols=152 Identities=25% Similarity=0.413 Sum_probs=134.8
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 457888999999999999999875 6899999998765444445677999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~---~~~kl~DFGla~~ 564 (577)
||+++++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||+++.
T Consensus 101 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999998863 34689999999999999999999999 99999999999999754 4799999999987
Q ss_pred cCC
Q 008121 565 TPN 567 (577)
Q Consensus 565 ~~~ 567 (577)
...
T Consensus 174 ~~~ 176 (287)
T 2wei_A 174 FQQ 176 (287)
T ss_dssp BCC
T ss_pred ecC
Confidence 644
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.8e-25 Score=220.13 Aligned_cols=149 Identities=25% Similarity=0.431 Sum_probs=130.5
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
..++|...+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3467888999999999999999885 48899999986542 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
|||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 95 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp EECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred EEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999988632 35689999999999999999999999 999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-25 Score=223.58 Aligned_cols=152 Identities=23% Similarity=0.435 Sum_probs=125.9
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCc----EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.++|...+.||+|+||.||+|.+. +++ +||+|.+.... .....+++.+|+.++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 356888999999999999999864 344 35777775432 2345677999999999999999999999998764 7
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++|+||+++|+|.+++.. ....+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred eEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 899999999999999963 245689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC
Q 008121 564 LTPNT 568 (577)
Q Consensus 564 ~~~~~ 568 (577)
.....
T Consensus 166 ~~~~~ 170 (327)
T 3lzb_A 166 LLGAE 170 (327)
T ss_dssp -----
T ss_pred EccCc
Confidence 76443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=207.02 Aligned_cols=175 Identities=21% Similarity=0.253 Sum_probs=152.6
Q ss_pred CCCCCCCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEE
Q 008121 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135 (577)
Q Consensus 69 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~ 135 (577)
+.|.|.|.+|.|+. .+++.|+|++|++++..+..|+.+++|++|+|++|+|++..+..+. ++|++|+
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 56778999999975 2588999999999988777899999999999999999965444443 8999999
Q ss_pred ccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccc
Q 008121 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (577)
Q Consensus 136 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (577)
|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.+
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 99999998877888999999999999999998888889999999999999999997666678999999999999998876
Q ss_pred ccccCCCCCccEEEeecCccccccCcccccccc
Q 008121 216 SLNVFSGLPLTTLNVANNHFSGWIPRELISIRT 248 (577)
Q Consensus 216 ~~~~~~~~~L~~L~l~~N~l~g~~p~~l~~l~~ 248 (577)
..+ .|+.|+++.|+++|.+|++++++..
T Consensus 163 ~~~-----~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 TCP-----GIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CTT-----TTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred CCC-----CHHHHHHHHHhCCceeeccCccccC
Confidence 432 3788999999999999998876643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.1e-25 Score=224.34 Aligned_cols=150 Identities=22% Similarity=0.237 Sum_probs=122.4
Q ss_pred hcCCCccceeccCccceEEEEEEc----CCcEEEEEEccccccchH---------HHHHHHHHHHHhhcCCCCceeeEee
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQ---------EEDNFLEAVSNMSRLRHPNIVTLAG 475 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~ 475 (577)
.++|...+.||+|+||.||+|... ++..||||++........ ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356888899999999999999875 578899999865421111 1234677889999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 008121 476 YCAE----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (577)
Q Consensus 476 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~ 551 (577)
++.. ....|+||||+ +|+|.+++.. ...+++.++..|+.|++.||+|||+. +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9987 67899999999 9999999963 23799999999999999999999999 99999999999999987
Q ss_pred C--CeEEeccccCcccC
Q 008121 552 L--NPHLSDCGLAALTP 566 (577)
Q Consensus 552 ~--~~kl~DFGla~~~~ 566 (577)
+ .+||+|||+++.+.
T Consensus 188 ~~~~~kL~Dfg~a~~~~ 204 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYC 204 (345)
T ss_dssp STTSEEECCCTTCEESS
T ss_pred CCCcEEEEeCCCceecc
Confidence 7 99999999998764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=230.00 Aligned_cols=157 Identities=26% Similarity=0.346 Sum_probs=126.9
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC----C--e
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH----G--Q 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----~--~ 482 (577)
.+|...+.||+|+||.||+|.+. +++.||||++.... ..+.+|++++++++|||||++++++... + .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 35778899999999999999885 58999999985432 1234699999999999999999998542 1 3
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEecccc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGL 561 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-~~~kl~DFGl 561 (577)
.++||||+++ +|.+.++........+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 6799999975 77777654334567799999999999999999999999 99999999999999965 6789999999
Q ss_pred CcccCCCcc-ccccCC
Q 008121 562 AALTPNTER-QVITGT 576 (577)
Q Consensus 562 a~~~~~~~~-~~~~Gt 576 (577)
|+....... ....||
T Consensus 204 a~~~~~~~~~~~~~~t 219 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICS 219 (420)
T ss_dssp CEECCTTCCCCSCCSC
T ss_pred hhhcccCCCceeeeeC
Confidence 997644332 234455
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-25 Score=219.01 Aligned_cols=149 Identities=32% Similarity=0.501 Sum_probs=125.0
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC-CeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-GQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~ 487 (577)
.++|...+.||+|+||.||+++.. ++.||||+++... ..+.|.+|++++++++||||+++++++... +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 456888899999999999999875 8899999987532 456789999999999999999999997654 4789999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 95 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999632 123478999999999999999999999 999999999999999999999999999986543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9e-25 Score=247.99 Aligned_cols=109 Identities=28% Similarity=0.413 Sum_probs=65.0
Q ss_pred CCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEE
Q 008121 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLN 229 (577)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~ 229 (577)
+++|+.|||++|+|+|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+| .+..++ |+.||
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 3455566666666666666666666666666666666666666666666666666666666666554 244443 66666
Q ss_pred eecCccccccCc--ccccccceeecCCcCCCCC
Q 008121 230 VANNHFSGWIPR--ELISIRTFIYDGNSFDNGP 260 (577)
Q Consensus 230 l~~N~l~g~~p~--~l~~l~~l~~~~n~~~~~~ 260 (577)
+++|+|+|.||. .+.++....+.||+..||+
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 666666666664 2444555556666655554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=218.29 Aligned_cols=147 Identities=27% Similarity=0.385 Sum_probs=123.5
Q ss_pred hcCCCccceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEE---------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA--------- 478 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--------- 478 (577)
.++|...+.||+|+||.||+|.... ++.||+|++... .....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 3578889999999999999998764 899999998643 3455678999999999999999999999873
Q ss_pred -----eCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCC
Q 008121 479 -----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DEL 552 (577)
Q Consensus 479 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-~~~ 552 (577)
..+..++||||++ |+|.++++ ...+++..+..++.|+++||+|||+. +|+||||||+||+++ +++
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred cccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 3467899999997 69999985 35689999999999999999999999 999999999999997 567
Q ss_pred CeEEeccccCcccC
Q 008121 553 NPHLSDCGLAALTP 566 (577)
Q Consensus 553 ~~kl~DFGla~~~~ 566 (577)
.+||+|||+++...
T Consensus 159 ~~kl~Dfg~~~~~~ 172 (320)
T 2i6l_A 159 VLKIGDFGLARIMD 172 (320)
T ss_dssp EEEECCCTTCBCC-
T ss_pred eEEEccCccccccC
Confidence 99999999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=222.43 Aligned_cols=149 Identities=26% Similarity=0.409 Sum_probs=130.7
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC-----Ce
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 482 (577)
.++|...+.||+|+||.||+|... +|+.||||++.... ......++.+|++++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 457888999999999999999875 68999999996432 344566788999999999999999999998654 67
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 699999862 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCC
Q 008121 563 ALTPN 567 (577)
Q Consensus 563 ~~~~~ 567 (577)
+....
T Consensus 160 ~~~~~ 164 (353)
T 2b9h_A 160 RIIDE 164 (353)
T ss_dssp EECC-
T ss_pred ccccc
Confidence 97653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=221.23 Aligned_cols=152 Identities=25% Similarity=0.415 Sum_probs=130.6
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEE--------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCA-------- 478 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~-------- 478 (577)
..+|...+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++.++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 457888999999999999999874 6899999998543 3445667899999999996 999999999984
Q ss_pred eCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCeEE
Q 008121 479 EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELNPHL 556 (577)
Q Consensus 479 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NILl~~~~~~kl 556 (577)
.....++||||++ |+|.++++... ....+++.++..|+.|++.||+|||+. + |+||||||+|||++.++.+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 3345799999995 79999986432 245699999999999999999999998 7 999999999999999999999
Q ss_pred eccccCcccCC
Q 008121 557 SDCGLAALTPN 567 (577)
Q Consensus 557 ~DFGla~~~~~ 567 (577)
+|||+++....
T Consensus 180 ~Dfg~~~~~~~ 190 (337)
T 3ll6_A 180 CDFGSATTISH 190 (337)
T ss_dssp CCCTTCBCCSS
T ss_pred ecCccceeccc
Confidence 99999987654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-25 Score=224.21 Aligned_cols=163 Identities=22% Similarity=0.271 Sum_probs=130.4
Q ss_pred HhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccch----HHHHHHHHHHHHhhcC----CCCceeeEeeEE
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRL----RHPNIVTLAGYC 477 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~H~niv~l~~~~ 477 (577)
...++|...+.||+|+||.||+|.. .+++.||||+++...... .....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 4457899999999999999999976 468899999996543211 1233456788888888 899999999999
Q ss_pred EeCCeEEEEEEe-cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeE
Q 008121 478 AEHGQRLLVYEY-VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPH 555 (577)
Q Consensus 478 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-~~~~~k 555 (577)
...+..++|||| +++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++ +++.+|
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 998999999999 789999999973 34689999999999999999999999 999999999999999 889999
Q ss_pred EeccccCcccCCCccccccCC
Q 008121 556 LSDCGLAALTPNTERQVITGT 576 (577)
Q Consensus 556 l~DFGla~~~~~~~~~~~~Gt 576 (577)
|+|||+++...........||
T Consensus 181 l~dfg~~~~~~~~~~~~~~~~ 201 (312)
T 2iwi_A 181 LIDFGSGALLHDEPYTDFDGT 201 (312)
T ss_dssp ECCCSSCEECCSSCBCCCCSC
T ss_pred EEEcchhhhcccCcccccCCc
Confidence 999999998776655555565
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=223.33 Aligned_cols=148 Identities=20% Similarity=0.331 Sum_probs=129.0
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe------
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ------ 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------ 482 (577)
++|...+.||+|+||.||+|... +|+.||||++..........+++.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999874 68999999997654445556788999999999999999999999987653
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++||||++ |+|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 68888773 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCC
Q 008121 563 ALTPN 567 (577)
Q Consensus 563 ~~~~~ 567 (577)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-24 Score=209.11 Aligned_cols=175 Identities=23% Similarity=0.309 Sum_probs=126.1
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCC-C--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL-P--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
.++.|+|++|++++..+..|.++++|++|+|++|+|+. +|... . ++|++|+|++|++++..+..|..+++|++|+|
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC-CCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe-eChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 46777777787777666677788888888888888774 44332 2 67888888888887766667777888888888
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-ccEEEeecCccccc
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP-LTTLNVANNHFSGW 238 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~L~l~~N~l~g~ 238 (577)
++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++.++. +..++ |+.|+|++|+|++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRV 196 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcC
Confidence 88888877777777788888888888888765555577778888888888887776553 54444 78888888888754
Q ss_pred cCccc---ccccceeecCCcCCCC
Q 008121 239 IPREL---ISIRTFIYDGNSFDNG 259 (577)
Q Consensus 239 ~p~~l---~~l~~l~~~~n~~~~~ 259 (577)
.+..+ .+++.+++.+|++.|.
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 197 PEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CHHHhccccCCCEEEecCCCeeCC
Confidence 44333 3556677777777653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-25 Score=222.82 Aligned_cols=154 Identities=23% Similarity=0.284 Sum_probs=134.2
Q ss_pred HHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC--CCceeeEeeEEEeCCeE
Q 008121 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 406 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~ 483 (577)
....++|...+.||+|+||.||++...+++.||||++..........+.+.+|++++.+++ ||||+++++++...+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3445678889999999999999999888999999999765545566788999999999997 59999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++||| +.+|+|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+|||+++ +.+||+|||+++
T Consensus 104 ~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 568899999973 35789999999999999999999999 9999999999999975 899999999998
Q ss_pred ccCCC
Q 008121 564 LTPNT 568 (577)
Q Consensus 564 ~~~~~ 568 (577)
.....
T Consensus 175 ~~~~~ 179 (313)
T 3cek_A 175 QMQPD 179 (313)
T ss_dssp C----
T ss_pred cccCc
Confidence 76543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=226.18 Aligned_cols=158 Identities=18% Similarity=0.240 Sum_probs=132.1
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcC------CCCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL------RHPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~ 481 (577)
..+|...+.||+|+||.||+|... +++.||||+++.. .....++.+|++++..+ +|+||+++++++...+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 356888999999999999999765 5899999999653 33445677777777766 6779999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--eEEecc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--PHLSDC 559 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~--~kl~DF 559 (577)
..++||||++ |+|.+++... ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999996 6999998742 334589999999999999999999999 9999999999999999887 999999
Q ss_pred ccCcccCCCccccccCC
Q 008121 560 GLAALTPNTERQVITGT 576 (577)
Q Consensus 560 Gla~~~~~~~~~~~~Gt 576 (577)
|+|+..... ....+||
T Consensus 247 G~a~~~~~~-~~~~~gt 262 (429)
T 3kvw_A 247 GSSCYEHQR-VYTYIQS 262 (429)
T ss_dssp TTCEETTCC-CCSSCSC
T ss_pred ccceecCCc-ccccCCC
Confidence 999865432 3334555
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=227.22 Aligned_cols=150 Identities=25% Similarity=0.348 Sum_probs=124.0
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC------eE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------QR 483 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~ 483 (577)
.+|...+.||+|+||.||+|....+..||+|++..... ...+|+++++.++||||+++++++...+ ..
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 46888899999999999999998777799998854321 1236899999999999999999986543 37
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeccccC
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLA 562 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla 562 (577)
++||||++++ +.+.+.........+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||+|
T Consensus 114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 8999999864 4444433223456799999999999999999999999 999999999999999 7999999999999
Q ss_pred cccCCCc
Q 008121 563 ALTPNTE 569 (577)
Q Consensus 563 ~~~~~~~ 569 (577)
+......
T Consensus 190 ~~~~~~~ 196 (394)
T 4e7w_A 190 KILIAGE 196 (394)
T ss_dssp EECCTTC
T ss_pred ccccCCC
Confidence 9764433
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=226.34 Aligned_cols=151 Identities=15% Similarity=0.083 Sum_probs=113.2
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHH---HHhhcCCCCceeeEe-------eEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAV---SNMSRLRHPNIVTLA-------GYC 477 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~~ 477 (577)
..|...+.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+ ..++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45778899999999999999875 689999999976543 234456677784 45555 799988754 444
Q ss_pred EeC-----------------CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCC
Q 008121 478 AEH-----------------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR------VRVALGTARALEYLHEVCLP 534 (577)
Q Consensus 478 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~L~yLH~~~~~ 534 (577)
... ...|+||||++ |+|.++++.. ...+++..+ ..++.|+++||+|||+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 332 33799999998 8999999743 223455555 78889999999999999
Q ss_pred CeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 535 ~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence 9999999999999999999999999999976543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-25 Score=227.04 Aligned_cols=145 Identities=22% Similarity=0.276 Sum_probs=126.1
Q ss_pred cCCCccceeccCccceEEEEEEcC---------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceee--------
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN---------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT-------- 472 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-------- 472 (577)
++|...+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 578889999999999999998763 789999998643 35788999999999999987
Q ss_pred -------EeeEEEe-CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 008121 473 -------LAGYCAE-HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (577)
Q Consensus 473 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~ 544 (577)
+++++.. .+..++||||+ +|+|.+++... ....+++.++..|+.|++.||+|||+. +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 6777776 67889999999 99999999732 236799999999999999999999999 9999999999
Q ss_pred CeeeCCCC--CeEEeccccCcccCC
Q 008121 545 NILLDDEL--NPHLSDCGLAALTPN 567 (577)
Q Consensus 545 NILl~~~~--~~kl~DFGla~~~~~ 567 (577)
|||++.++ .+||+|||+++....
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~ 213 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCP 213 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSG
T ss_pred HEEEcCCCCceEEEecCcceeeccC
Confidence 99999998 999999999987654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=7.6e-25 Score=222.51 Aligned_cols=163 Identities=21% Similarity=0.290 Sum_probs=138.2
Q ss_pred HhhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccch----HHHHHHHHHHHHhhcCC--CCceeeEeeEEEe
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLR--HPNIVTLAGYCAE 479 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~ 479 (577)
...++|...+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3456788899999999999999976 568999999986543221 12345678899999996 5999999999999
Q ss_pred CCeEEEEEEecCC-CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEe
Q 008121 480 HGQRLLVYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLS 557 (577)
Q Consensus 480 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~ 557 (577)
.+..++||||+.+ ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999976 899999963 35689999999999999999999999 999999999999999 78999999
Q ss_pred ccccCcccCCCccccccCC
Q 008121 558 DCGLAALTPNTERQVITGT 576 (577)
Q Consensus 558 DFGla~~~~~~~~~~~~Gt 576 (577)
|||+++...........||
T Consensus 193 Dfg~~~~~~~~~~~~~~gt 211 (320)
T 3a99_A 193 DFGSGALLKDTVYTDFDGT 211 (320)
T ss_dssp CCTTCEECCSSCBCCCCSC
T ss_pred eCccccccccccccCCCCC
Confidence 9999998776655555565
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=215.52 Aligned_cols=147 Identities=20% Similarity=0.319 Sum_probs=125.7
Q ss_pred cCCCcc-ceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHh-hcCCCCceeeEeeEEEe----CCe
Q 008121 410 NSFSQE-FLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNM-SRLRHPNIVTLAGYCAE----HGQ 482 (577)
Q Consensus 410 ~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~ 482 (577)
++|... +.||+|+||.||++.. .+++.||+|+++.. ..+.+|++++ +..+||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 345554 7799999999999977 56899999998532 2466788877 66699999999999876 667
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEecc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDC 559 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DF 559 (577)
.++||||+++|+|.+++... ....+++..+..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 89999999999999999742 345799999999999999999999999 9999999999999998 789999999
Q ss_pred ccCcccCCC
Q 008121 560 GLAALTPNT 568 (577)
Q Consensus 560 Gla~~~~~~ 568 (577)
|+++.....
T Consensus 165 g~a~~~~~~ 173 (299)
T 3m2w_A 165 GFAKETTGE 173 (299)
T ss_dssp TTCEECTTC
T ss_pred ccccccccc
Confidence 999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=222.24 Aligned_cols=166 Identities=25% Similarity=0.331 Sum_probs=124.0
Q ss_pred HHHHhhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 404 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
......++|...+.||+|+||.||+|... +++.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 34566788999999999999999999874 58999999885432 223346778888899999999999999976443
Q ss_pred -------EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeeecCCCCCCeeeCC-CC
Q 008121 483 -------RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH--EVCLPSVVHRNFKSANILLDD-EL 552 (577)
Q Consensus 483 -------~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--~~~~~~ivHrDlk~~NILl~~-~~ 552 (577)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999976 666555433345667899999999999999999999 77 9999999999999996 89
Q ss_pred CeEEeccccCcccCCCccc-cccCC
Q 008121 553 NPHLSDCGLAALTPNTERQ-VITGT 576 (577)
Q Consensus 553 ~~kl~DFGla~~~~~~~~~-~~~Gt 576 (577)
.+||+|||+++........ ...||
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~gt 194 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEPNVAYICS 194 (360)
T ss_dssp EEEECCCTTCBCCCTTSCCCSTTSC
T ss_pred cEEEeeCCCceecCCCCCcccccCC
Confidence 9999999999977554432 33454
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-25 Score=224.92 Aligned_cols=150 Identities=22% Similarity=0.371 Sum_probs=128.8
Q ss_pred HhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 407 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
...++|...+.||+|+||.||+|.+.+ .||+|+++.........+.|.+|+.++++++||||+++++++...+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345678889999999999999998754 599999875443333445678899999999999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++..
T Consensus 108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred eecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999962 345789999999999999999999999 999999999999998 679999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=226.94 Aligned_cols=145 Identities=24% Similarity=0.440 Sum_probs=114.7
Q ss_pred cceeccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCeEEEEEEe
Q 008121 415 EFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLVYEY 489 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 489 (577)
.++||+|+||.||+|.+. +++.||||++..... ...+.+|++++++++||||+++++++.. ....++||||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~ 101 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence 458999999999999875 478999999975432 2357899999999999999999999954 6689999999
Q ss_pred cCCCCHHHhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCeEEeccc
Q 008121 490 VGNGNLHDMLHFAD-----DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCG 560 (577)
Q Consensus 490 ~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl----~~~~~~kl~DFG 560 (577)
++ |+|.+++.... .....+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 102 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 102 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp CS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred CC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 96 58888876322 1233589999999999999999999999 99999999999999 778999999999
Q ss_pred cCcccCC
Q 008121 561 LAALTPN 567 (577)
Q Consensus 561 la~~~~~ 567 (577)
+|+....
T Consensus 178 ~a~~~~~ 184 (405)
T 3rgf_A 178 FARLFNS 184 (405)
T ss_dssp CCC----
T ss_pred CceecCC
Confidence 9987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=218.67 Aligned_cols=157 Identities=20% Similarity=0.297 Sum_probs=120.0
Q ss_pred hcCCCcc-ceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe----CCe
Q 008121 409 TNSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQ 482 (577)
Q Consensus 409 ~~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~ 482 (577)
.++|... +.||+|+||.||+|... +++.||||++... .... .+....+..++||||+++++++.. ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 4567664 46999999999999876 6899999998543 1222 222334567799999999999876 445
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEecc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDC 559 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DF 559 (577)
.++||||+++|+|.+++... ....+++.++..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 89999999999999999732 335799999999999999999999999 9999999999999976 456999999
Q ss_pred ccCcccCCCccccccCC
Q 008121 560 GLAALTPNTERQVITGT 576 (577)
Q Consensus 560 Gla~~~~~~~~~~~~Gt 576 (577)
|+++...........||
T Consensus 176 g~~~~~~~~~~~~~~~t 192 (336)
T 3fhr_A 176 GFAKETTQNALQTPCYT 192 (336)
T ss_dssp TTCEEC-----------
T ss_pred ccceeccccccccCCCC
Confidence 99997766555555555
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=216.34 Aligned_cols=154 Identities=27% Similarity=0.400 Sum_probs=124.5
Q ss_pred hcCCCccceeccCccceEEEEEEc--CCc--EEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA--NGK--IMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.++|...+.||+|+||.||+|.+. +++ .||||+++.... .....+++.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356888899999999999999763 233 689999865432 2345678999999999999999999999998765 8
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999642 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCc
Q 008121 564 LTPNTE 569 (577)
Q Consensus 564 ~~~~~~ 569 (577)
......
T Consensus 170 ~~~~~~ 175 (291)
T 1u46_A 170 ALPQND 175 (291)
T ss_dssp ECCC-C
T ss_pred cccccc
Confidence 775443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=237.66 Aligned_cols=153 Identities=25% Similarity=0.391 Sum_probs=132.7
Q ss_pred hhcCCCccceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
..++|...+.||+|+||.||+|.+.. +..||||+++... .....+.|.+|+.++++++||||+++++++. ++..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34678888999999999999998743 4679999986532 3445678999999999999999999999985 4568
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~ 563 (577)
|+||||+++|+|.++++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 466 ~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence 999999999999999963 234689999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCC
Q 008121 564 LTPNT 568 (577)
Q Consensus 564 ~~~~~ 568 (577)
.....
T Consensus 540 ~~~~~ 544 (656)
T 2j0j_A 540 YMEDS 544 (656)
T ss_dssp SCCC-
T ss_pred ecCCC
Confidence 77544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-24 Score=216.79 Aligned_cols=158 Identities=19% Similarity=0.310 Sum_probs=133.1
Q ss_pred hcCCCccceeccCccceEEEEEE--cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCc------eeeEeeEEEeC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF--ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN------IVTLAGYCAEH 480 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~ 480 (577)
.++|...+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 35788899999999999999976 35889999998643 344567888999998887664 99999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----------
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---------- 550 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---------- 550 (577)
+..++||||+ +++|.+++... ....+++.++..++.|+++||+|||+. +|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999 88999999732 334689999999999999999999999 9999999999999987
Q ss_pred ---------CCCeEEeccccCcccCCCccccccCC
Q 008121 551 ---------ELNPHLSDCGLAALTPNTERQVITGT 576 (577)
Q Consensus 551 ---------~~~~kl~DFGla~~~~~~~~~~~~Gt 576 (577)
++.+||+|||+++..... .....||
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt 197 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH-HSTLVST 197 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC-CCSSCSC
T ss_pred cccccccccCCCceEeeCcccccCccc-cccccCC
Confidence 678999999999875433 2334454
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-24 Score=213.16 Aligned_cols=150 Identities=22% Similarity=0.325 Sum_probs=125.1
Q ss_pred hhcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEE-EeCCeEEE
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC-AEHGQRLL 485 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~l 485 (577)
..++|...+.||+|+||.||+|.. .+++.||||++.... ..+++.+|++++..++|++++..++++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 356899999999999999999986 568999999865432 223578899999999988877666655 66778899
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeccccC
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLA 562 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla 562 (577)
||||+ +|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||++
T Consensus 83 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 99999 9999999963 245699999999999999999999999 99999999999999 78899999999999
Q ss_pred cccCCC
Q 008121 563 ALTPNT 568 (577)
Q Consensus 563 ~~~~~~ 568 (577)
+.....
T Consensus 156 ~~~~~~ 161 (296)
T 4hgt_A 156 KKYRDA 161 (296)
T ss_dssp EECBCT
T ss_pred eeccCc
Confidence 976544
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-24 Score=216.95 Aligned_cols=156 Identities=25% Similarity=0.375 Sum_probs=127.6
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHH-HhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVS-NMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|... +++.||||+++... ......++..|+. +++.++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 357788899999999999999874 68999999997543 2334445556655 77888999999999999999999999
Q ss_pred EEecCCCCHHHhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 487 YEYVGNGNLHDMLHFAD-DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999975 8888775321 23567899999999999999999999852 7999999999999999999999999999876
Q ss_pred CCC
Q 008121 566 PNT 568 (577)
Q Consensus 566 ~~~ 568 (577)
...
T Consensus 177 ~~~ 179 (327)
T 3aln_A 177 VDS 179 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=205.07 Aligned_cols=182 Identities=23% Similarity=0.285 Sum_probs=152.4
Q ss_pred CCccEEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccC
Q 008121 74 SWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIAS 151 (577)
Q Consensus 74 ~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~ 151 (577)
.|.|..|.. ..+.+++++++++ .+|..+. ++|+.|+|++|+|++..|..+. ++|++|+|++|+|++..|..|..
T Consensus 6 ~~~gC~C~~-~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 81 (251)
T 3m19_A 6 TVTGCTCNE-GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81 (251)
T ss_dssp HHHSSEEEG-GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred CCCceEcCC-CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhcc
Confidence 788999963 3446899999998 4555554 6899999999999987776665 89999999999999988888999
Q ss_pred CCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEE
Q 008121 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLN 229 (577)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~ 229 (577)
+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++.++ .+..++ |+.|+
T Consensus 82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 161 (251)
T 3m19_A 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS 161 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence 9999999999999998888889999999999999999997666678899999999999999998776 466655 99999
Q ss_pred eecCccccccCccc---ccccceeecCCcCCCC
Q 008121 230 VANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (577)
Q Consensus 230 l~~N~l~g~~p~~l---~~l~~l~~~~n~~~~~ 259 (577)
|++|+|++..|..+ .+++.+++++|++.|.
T Consensus 162 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 162 LSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999997766554 4567888999988653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=224.67 Aligned_cols=150 Identities=23% Similarity=0.332 Sum_probs=128.2
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCC-CceeeEeeEEEeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|.. .+++.||||++..... ..++.+|++++..++| ++|..+..++...+..++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 35788899999999999999986 5689999998754322 2347889999999987 4566667777888899999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeccccCc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAA 563 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~ 563 (577)
|||+ +|+|.++++.. ...+++.+++.|+.||+.||+|||+. +||||||||+|||+ +.++.+||+|||+++
T Consensus 82 me~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999 99999999632 45699999999999999999999999 99999999999999 688999999999999
Q ss_pred ccCCCc
Q 008121 564 LTPNTE 569 (577)
Q Consensus 564 ~~~~~~ 569 (577)
.+....
T Consensus 155 ~~~~~~ 160 (483)
T 3sv0_A 155 KYRDTS 160 (483)
T ss_dssp ECBCTT
T ss_pred eccCCc
Confidence 775543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=211.02 Aligned_cols=150 Identities=22% Similarity=0.326 Sum_probs=128.2
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEE-EeCCeEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC-AEHGQRLLV 486 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv 486 (577)
.++|...+.||+|+||.||+|.. .+++.||||++.... ..+++.+|+.++..++|++++..+.++ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46788899999999999999986 678999999986432 223588999999999998877665555 667788999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeccccCc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAA 563 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl---~~~~~~kl~DFGla~ 563 (577)
|||+ +|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 84 MELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 9999 9999999963 245699999999999999999999999 99999999999999 488999999999999
Q ss_pred ccCCCc
Q 008121 564 LTPNTE 569 (577)
Q Consensus 564 ~~~~~~ 569 (577)
......
T Consensus 157 ~~~~~~ 162 (296)
T 3uzp_A 157 KYRDAR 162 (296)
T ss_dssp ECBCTT
T ss_pred cccccc
Confidence 765543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.7e-24 Score=221.20 Aligned_cols=136 Identities=19% Similarity=0.293 Sum_probs=114.8
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC--------CCceeeEeeEEE-
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--------HPNIVTLAGYCA- 478 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~- 478 (577)
.++|...+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 46788999999999999999976 45889999999643 344667889999999885 788999999987
Q ss_pred ---eCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 008121 479 ---EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (577)
Q Consensus 479 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~ 552 (577)
.....++||||+ +|+|.+.+.. .....+++..+..|+.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence 455789999999 6677777653 23356999999999999999999999864 799999999999999775
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=216.78 Aligned_cols=134 Identities=25% Similarity=0.430 Sum_probs=106.4
Q ss_pred CcEEEEEcCC-CCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 83 SAVVSIDISG-LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 83 ~~v~~l~l~~-~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
..++.|+|++ |.+.+.+|..|+++++|++|+|++|+|++.+|..+. ++|++|+|++|++++.+|..|..+++|++|+
T Consensus 76 ~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 155 (313)
T 1ogq_A 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEE
Confidence 5688888985 888888888888888888888888888888887665 7888888888888888888888888888888
Q ss_pred eccCCCcccccccccCCC-CCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccc
Q 008121 160 VSRNSLTQSIGDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217 (577)
Q Consensus 160 L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (577)
|++|++++.+|..+.+++ +|++|+|++|++++.+|..+..++ |++|+|++|.+++.+
T Consensus 156 L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~ 213 (313)
T 1ogq_A 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDA 213 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECC
T ss_pred CcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcC
Confidence 888888888888888887 788888888877777776666554 666666666655533
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=213.47 Aligned_cols=152 Identities=21% Similarity=0.331 Sum_probs=118.4
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||.||+|... +++.||||++..........+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356788899999999999999875 6899999999755433333444555666788899999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
||+ ++.+..+... ....+++..+..++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5555555432 24568999999999999999999998 5 89999999999999999999999999998654
Q ss_pred C
Q 008121 567 N 567 (577)
Q Consensus 567 ~ 567 (577)
.
T Consensus 177 ~ 177 (318)
T 2dyl_A 177 D 177 (318)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.7e-24 Score=225.28 Aligned_cols=149 Identities=23% Similarity=0.271 Sum_probs=119.8
Q ss_pred CCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEEEe
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+.+..|+||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 34456789999999998877778999999998542 234578899999876 899999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-------------CC
Q 008121 490 VGNGNLHDMLHFADDSSKN---LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-------------LN 553 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~-------------~~ 553 (577)
++ |+|.+++......... .++..++.|+.||+.||+|||+. +|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 6999999743222111 13345678999999999999999 99999999999999754 48
Q ss_pred eEEeccccCcccCCC
Q 008121 554 PHLSDCGLAALTPNT 568 (577)
Q Consensus 554 ~kl~DFGla~~~~~~ 568 (577)
+||+|||+++.....
T Consensus 167 ~kL~DFG~a~~~~~~ 181 (434)
T 2rio_A 167 ILISDFGLCKKLDSG 181 (434)
T ss_dssp EEECCCTTCEECCC-
T ss_pred EEEcccccceecCCC
Confidence 999999999987654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=221.22 Aligned_cols=148 Identities=20% Similarity=0.275 Sum_probs=121.0
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 487 (577)
..+|...+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+.+..|+||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 346778899999999997766667899999999864322 2256789999998 7999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCCeEEeccccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-----ELNPHLSDCGLA 562 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-----~~~~kl~DFGla 562 (577)
||++ |+|.+++... .....+..+..|+.|+++||+|||+. +|+||||||+|||++. ...+||+|||+|
T Consensus 98 E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9996 6999999632 23345556778999999999999999 9999999999999943 346889999999
Q ss_pred cccCCC
Q 008121 563 ALTPNT 568 (577)
Q Consensus 563 ~~~~~~ 568 (577)
+.....
T Consensus 171 ~~~~~~ 176 (432)
T 3p23_A 171 KKLAVG 176 (432)
T ss_dssp ECC---
T ss_pred eeccCC
Confidence 876543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=212.35 Aligned_cols=158 Identities=20% Similarity=0.315 Sum_probs=131.7
Q ss_pred hcCCCccceeccCccceEEEEEEc-CC-cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCc------eeeEeeEEEeC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NG-KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN------IVTLAGYCAEH 480 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~ 480 (577)
.++|...+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 467888999999999999999874 34 68999998643 344567888999999987766 99999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee------------
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL------------ 548 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl------------ 548 (577)
+..++||||+ +|++.+.+... ....+++.++..|+.|++.||+|||+. +|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 9999999999 67788877632 335689999999999999999999999 99999999999999
Q ss_pred -------CCCCCeEEeccccCcccCCCccccccCC
Q 008121 549 -------DDELNPHLSDCGLAALTPNTERQVITGT 576 (577)
Q Consensus 549 -------~~~~~~kl~DFGla~~~~~~~~~~~~Gt 576 (577)
+.++.+||+|||+++..... .....||
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt 202 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH-HTTIVAT 202 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC-CCSSCSC
T ss_pred ccccccccCCCcEEEeecCcccccccc-ccCCcCC
Confidence 56789999999999875433 2334454
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.8e-23 Score=214.55 Aligned_cols=161 Identities=24% Similarity=0.246 Sum_probs=130.9
Q ss_pred hhcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CC-----ceeeEeeEEEeC
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HP-----NIVTLAGYCAEH 480 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~ 480 (577)
..++|...+.||+|+||.||+|... +++.||||+++.. .....++..|++++..++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 3568889999999999999999765 5889999999643 334556777888887775 44 499999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCCeEEec
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSD 558 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~--~~~~~kl~D 558 (577)
+..++||||++ |+|.+++... ....+++..+..++.|++.||.|||++ ..+||||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999996 5999999743 235689999999999999999999953 12899999999999994 578899999
Q ss_pred cccCcccCCCccccccCC
Q 008121 559 CGLAALTPNTERQVITGT 576 (577)
Q Consensus 559 FGla~~~~~~~~~~~~Gt 576 (577)
||+|+..... .....||
T Consensus 205 FG~a~~~~~~-~~~~~~t 221 (382)
T 2vx3_A 205 FGSSCQLGQR-IYQYIQS 221 (382)
T ss_dssp CTTCEETTCC-CCSSCSC
T ss_pred ccCceecccc-cccccCC
Confidence 9999876443 2334454
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-22 Score=201.37 Aligned_cols=176 Identities=22% Similarity=0.251 Sum_probs=157.4
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCc-CCCcCCCCccCCCCccEEE
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN-FSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~ 159 (577)
..++.|+|++|++++..+..|..+++|++|+|++|+|++..|..+. ++|++|+|++|+ +....|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 3689999999999998888999999999999999999987777665 899999999997 8877789999999999999
Q ss_pred eccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-ccEEEeecCcccc
Q 008121 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP-LTTLNVANNHFSG 237 (577)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~L~l~~N~l~g 237 (577)
|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++.++. +..++ |+.|++++|.+++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 999999999999999999999999999999977777799999999999999999987763 66655 9999999999999
Q ss_pred ccCcccc---cccceeecCCcCCC
Q 008121 238 WIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 238 ~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
..|..+. +++.|++++|.+..
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~ 215 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSA 215 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSC
T ss_pred cCHhHccCcccccEeeCCCCcCCc
Confidence 8887765 56778899998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=230.19 Aligned_cols=155 Identities=26% Similarity=0.387 Sum_probs=131.9
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe------CCe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE------HGQ 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~ 482 (577)
++|...+.||+|+||.||+|.. .+|+.||||+++.. ......+.|.+|++++++++||||+++++++.. .+.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 5789999999999999999976 45899999998754 245567789999999999999999999998755 667
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---eEEecc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDC 559 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~---~kl~DF 559 (577)
.++||||+++|+|.+++.... ....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999997432 234689999999999999999999999 9999999999999997665 999999
Q ss_pred ccCcccCCCc
Q 008121 560 GLAALTPNTE 569 (577)
Q Consensus 560 Gla~~~~~~~ 569 (577)
|+++......
T Consensus 169 G~a~~~~~~~ 178 (676)
T 3qa8_A 169 GYAKELDQGE 178 (676)
T ss_dssp CCCCBTTSCC
T ss_pred cccccccccc
Confidence 9999765443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-22 Score=197.82 Aligned_cols=165 Identities=24% Similarity=0.315 Sum_probs=149.3
Q ss_pred CCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCc
Q 008121 74 SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (577)
Q Consensus 74 ~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~ 140 (577)
.|..|.|.. ..++.|+|++|++++..+..|.++++|++|+|++|+|++..|..+. ++|++|+|++|+
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 94 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence 577788864 3688999999999999999999999999999999999987776554 899999999999
Q ss_pred CCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-c
Q 008121 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-V 219 (577)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~ 219 (577)
|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++.++ .
T Consensus 95 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 174 (251)
T 3m19_A 95 LASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGA 174 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHH
Confidence 998888899999999999999999998888889999999999999999997777789999999999999999998776 4
Q ss_pred CCCCC-ccEEEeecCccccc
Q 008121 220 FSGLP-LTTLNVANNHFSGW 238 (577)
Q Consensus 220 ~~~~~-L~~L~l~~N~l~g~ 238 (577)
+..++ |+.|+|++|.+++.
T Consensus 175 ~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 175 FDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTCTTCCEEECCSCCBCTT
T ss_pred HhCCCCCCEEEeeCCceeCC
Confidence 66655 99999999999976
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=227.49 Aligned_cols=139 Identities=15% Similarity=0.249 Sum_probs=110.0
Q ss_pred CccceeccCccceEEEEEEcCCcEEEEEEccccccc------hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEE
Q 008121 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 486 (577)
...+.||+|+||.||+|.. .++.+++|+....... ....++|.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 4778888876433221 11245689999999999999999777777777788999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.++++. +..|+.|+++||+|||++ +|+||||||+|||+++ .+||+|||+|+...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999962 568999999999999999 9999999999999999 99999999999886
Q ss_pred CCc
Q 008121 567 NTE 569 (577)
Q Consensus 567 ~~~ 569 (577)
..+
T Consensus 481 ~~~ 483 (540)
T 3en9_A 481 LDE 483 (540)
T ss_dssp CHH
T ss_pred Ccc
Confidence 643
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-22 Score=200.20 Aligned_cols=175 Identities=23% Similarity=0.223 Sum_probs=155.5
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|+|++|.+++..+..|..+++|++|+|++|+|++..+....++|++|+|++|+|+ .+|..+..+++|++|+|++
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~ 109 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCC
Confidence 468999999999999999999999999999999999996555444589999999999998 7888999999999999999
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-ccEEEeecCccccccC
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~L~l~~N~l~g~~p 240 (577)
|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++.++. +..++ |+.|+|++|+|+ .+|
T Consensus 110 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip 188 (290)
T 1p9a_G 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (290)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred CcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccC
Confidence 999998889999999999999999999977777789999999999999999987764 45555 999999999999 777
Q ss_pred cccc---cccceeecCCcCCCC
Q 008121 241 RELI---SIRTFIYDGNSFDNG 259 (577)
Q Consensus 241 ~~l~---~l~~l~~~~n~~~~~ 259 (577)
..+. +++.+.+.+|+|.|.
T Consensus 189 ~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 189 KGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp TTTTTTCCCSEEECCSCCBCCS
T ss_pred hhhcccccCCeEEeCCCCccCc
Confidence 7654 467788999999763
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-22 Score=200.08 Aligned_cols=190 Identities=21% Similarity=0.255 Sum_probs=155.4
Q ss_pred CCCCCCCc--cEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccE
Q 008121 69 DPCGESWK--GVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTS 133 (577)
Q Consensus 69 ~~c~~~w~--gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~ 133 (577)
|||.+.+. .|.|.+ ..++.|+|++|++++..+..|.++++|++|+|++|++++..+..+. ++|++
T Consensus 1 ~~C~~~~~~~~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 80 (276)
T 2z62_A 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80 (276)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceeccCCceEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCE
Confidence 56755444 477753 2589999999999988888999999999999999999976665554 89999
Q ss_pred EEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCC-CCCCccCCCCCCeEEccCcc
Q 008121 134 LNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD-LPNSFISLSNISSLYLQNNQ 212 (577)
Q Consensus 134 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~ 212 (577)
|+|++|++++..|..|.++++|++|+|++|++++..+..+.++++|++|+|++|++++. +|..|..+++|++|+|++|+
T Consensus 81 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~ 160 (276)
T 2z62_A 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (276)
T ss_dssp EECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred EECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCC
Confidence 99999999998889999999999999999999998888899999999999999999863 68999999999999999999
Q ss_pred cccccc-cCCCCC-cc----EEEeecCccccccCcccc--cccceeecCCcCCC
Q 008121 213 VTGSLN-VFSGLP-LT----TLNVANNHFSGWIPRELI--SIRTFIYDGNSFDN 258 (577)
Q Consensus 213 l~~~~~-~~~~~~-L~----~L~l~~N~l~g~~p~~l~--~l~~l~~~~n~~~~ 258 (577)
|++.++ .+..+. |+ .|++++|.+++..+..+. +++.|++++|.+..
T Consensus 161 l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~ 214 (276)
T 2z62_A 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKS 214 (276)
T ss_dssp CCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSC
T ss_pred CCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceee
Confidence 988653 232221 33 788888888765554433 56777778777653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=204.25 Aligned_cols=191 Identities=23% Similarity=0.329 Sum_probs=156.1
Q ss_pred CCCCCCCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCc---------------
Q 008121 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT--------------- 122 (577)
Q Consensus 69 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~--------------- 122 (577)
++|.|.|.+|.|+. ..++.|+|++|+++...+..|.++++|++|+|++|+++..
T Consensus 3 ~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 56778999999975 3688999999999866556688999999999999988732
Q ss_pred ----------CCCCC--CCCccEEEccCCcCCCcCC-CCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcc
Q 008121 123 ----------IPYQL--PPNLTSLNLASNNFSGNLP-YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (577)
Q Consensus 123 ----------~p~~~--~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 189 (577)
+|..+ .++|++|+|++|++++..+ ..+..+++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 83 L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 162 (306)
T 2z66_A 83 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162 (306)
T ss_dssp EECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEE
T ss_pred EECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcc
Confidence 11112 1678888888888886655 6788999999999999999999999999999999999999999
Q ss_pred cC-CCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCccc---ccccceeecCCcCCCC
Q 008121 190 SG-DLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (577)
Q Consensus 190 ~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~~l---~~l~~l~~~~n~~~~~ 259 (577)
++ .+|..+..+++|++|+|++|+|++.++ .+..++ |+.|++++|++++..+..+ .+++.|++++|.+...
T Consensus 163 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 238 (306)
T 2z66_A 163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238 (306)
T ss_dssp GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBC
T ss_pred ccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCccc
Confidence 87 578899999999999999999998754 465555 9999999999997666554 4677888999987643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-23 Score=213.80 Aligned_cols=151 Identities=17% Similarity=0.307 Sum_probs=127.9
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-----------CCceeeEeeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----------HPNIVTLAGY 476 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~ 476 (577)
.++|...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++.+++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 35788899999999999999986 56899999998643 334566888999888876 8999999999
Q ss_pred EEeCC----eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---
Q 008121 477 CAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--- 549 (577)
Q Consensus 477 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~--- 549 (577)
+...+ ..++||||+ +++|.+++... ....+++..+..|+.|++.||+|||+++ +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 87654 789999999 89999999743 3455899999999999999999999963 799999999999994
Q ss_pred ---CCCCeEEeccccCcccCC
Q 008121 550 ---DELNPHLSDCGLAALTPN 567 (577)
Q Consensus 550 ---~~~~~kl~DFGla~~~~~ 567 (577)
..+.+||+|||+++....
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB
T ss_pred CCcCcceEEEcccccccccCC
Confidence 445899999999987654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.7e-23 Score=203.98 Aligned_cols=146 Identities=14% Similarity=0.088 Sum_probs=116.5
Q ss_pred HHHHhhcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccch----------------HHHHHHHHHHHHhhcCCC
Q 008121 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL----------------QEEDNFLEAVSNMSRLRH 467 (577)
Q Consensus 404 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~H 467 (577)
.+......|...+.||+|+||.||+|.+.+|+.||+|.++...... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 3444455677779999999999999988779999999986432111 23567899999999999
Q ss_pred CceeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 468 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
| +++.+++.. +..|+||||+++|+|.+ +.. .....++.|+++||+|||+. +|+||||||+|||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 4 666665543 45699999999999988 521 12457999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccCcccCCC
Q 008121 548 LDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~~~ 568 (577)
++ ++.+||+|||+|+.....
T Consensus 226 l~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp EE-TTEEEECCCTTCEETTST
T ss_pred EE-CCcEEEEECCCCeECCCC
Confidence 99 999999999999976544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.3e-22 Score=196.98 Aligned_cols=177 Identities=23% Similarity=0.269 Sum_probs=157.2
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCC-cCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
.+++.|+|++|.+++..|..|..+++|++|+|++|+ ++...|..+. ++|++|+|++|++++..|..|.++++|++|+
T Consensus 56 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 589999999999999989999999999999999998 7755566665 8999999999999999899999999999999
Q ss_pred eccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCcccc
Q 008121 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSG 237 (577)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g 237 (577)
|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+++..+ .+..++ |+.|++++|+|++
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 215 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCc
Confidence 99999998888889999999999999999997666779999999999999999999754 566665 9999999999997
Q ss_pred ccCccc---ccccceeecCCcCCCC
Q 008121 238 WIPREL---ISIRTFIYDGNSFDNG 259 (577)
Q Consensus 238 ~~p~~l---~~l~~l~~~~n~~~~~ 259 (577)
..+..+ .+++.+++++|++.|.
T Consensus 216 ~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 216 LPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp CCHHHHTTCTTCCEEECCSSCEECS
T ss_pred CCHHHcccCcccCEEeccCCCccCC
Confidence 665544 4677889999998753
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.87 E-value=4e-22 Score=203.09 Aligned_cols=173 Identities=19% Similarity=0.269 Sum_probs=148.8
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccC--------
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIAS-------- 151 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~-------- 151 (577)
..+++.|+|++|.++ .+|..++.+++|++|+|++|+|+ .+|..+. ++|++|+|++|++.+.+|..++.
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 457899999999999 88889999999999999999998 7787665 89999999999999999988765
Q ss_pred -CCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEE
Q 008121 152 -MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTL 228 (577)
Q Consensus 152 -l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L 228 (577)
+++|++|+|++|+|+ .+|..++++++|++|+|++|++++ +|..+..+++|++|+|++|++.+.++ .+..++ |+.|
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L 258 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEE
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEE
Confidence 999999999999998 788889999999999999999995 77789999999999999999888765 455555 9999
Q ss_pred EeecCccccccCcccc---cccceeecCCcCCC
Q 008121 229 NVANNHFSGWIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 229 ~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
+|++|++.+.+|..+. +++.|++++|++..
T Consensus 259 ~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp ECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred ECCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 9999999999997665 45677888887654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.9e-21 Score=204.71 Aligned_cols=188 Identities=19% Similarity=0.201 Sum_probs=153.0
Q ss_pred CCCC--CCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEE
Q 008121 70 PCGE--SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSL 134 (577)
Q Consensus 70 ~c~~--~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L 134 (577)
.|.| .|..|.|.. ..++.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+. ++|++|
T Consensus 49 ~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 128 (452)
T 3zyi_A 49 VCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTL 128 (452)
T ss_dssp TSEECSSSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCEECCCCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEE
Confidence 4544 367899974 3689999999999999999999999999999999999987776665 899999
Q ss_pred EccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcC-CcccCCCCCCccCCCCCCeEEccCccc
Q 008121 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF-NNFSGDLPNSFISLSNISSLYLQNNQV 213 (577)
Q Consensus 135 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~l~~N~l 213 (577)
+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++ |.+....+..|.++++|++|+|++|+|
T Consensus 129 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 208 (452)
T 3zyi_A 129 ELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208 (452)
T ss_dssp ECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred ECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcc
Confidence 9999999988888899999999999999999988887888899999999988 455533334688888888888888888
Q ss_pred ccccccCCCC-CccEEEeecCccccccCcccc---cccceeecCCcCCC
Q 008121 214 TGSLNVFSGL-PLTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 214 ~~~~~~~~~~-~L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
++.+ .+..+ .|+.|+|++|+|++..|..+. +++.|.+++|.+..
T Consensus 209 ~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 256 (452)
T 3zyi_A 209 KDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256 (452)
T ss_dssp SSCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCE
T ss_pred cccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCce
Confidence 8764 34443 388888888888877776554 45667777776653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.6e-22 Score=210.09 Aligned_cols=155 Identities=18% Similarity=0.208 Sum_probs=115.8
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccc-cchHHHHHHHHHHHHhhcCCC-Ccee--------------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH-PNIV-------------- 471 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H-~niv-------------- 471 (577)
...|...+.||+|+||.||+|.+ .+|+.||||+++... ......+.|.+|+.++..++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577788999999999999985 568999999987322 122335679999999999987 2211
Q ss_pred -e------EeeEEEe-----CCeEEEEEEecCCCCHHHhhhhc---cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 008121 472 -T------LAGYCAE-----HGQRLLVYEYVGNGNLHDMLHFA---DDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536 (577)
Q Consensus 472 -~------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i 536 (577)
. +..++.. ....+++|+++ +|+|.++++.. ......+++..++.|+.|+++||+|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1 1111111 12356667655 68999998532 23355688999999999999999999999 99
Q ss_pred eecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 537 VHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 537 vHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|||||||+|||++.++.+||+|||+++....
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC
Confidence 9999999999999999999999999987543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=185.23 Aligned_cols=156 Identities=26% Similarity=0.335 Sum_probs=123.4
Q ss_pred CCCCCCCccEEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCC
Q 008121 69 DPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146 (577)
Q Consensus 69 ~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p 146 (577)
..|.|.|..|.|. +++++ .+|..+. ++|+.|+|++|+|++..|..+. ++|++|+|++|+|++..|
T Consensus 7 ~~C~C~~~~v~c~----------~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~ 73 (220)
T 2v9t_B 7 AACTCSNNIVDCR----------GKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAP 73 (220)
T ss_dssp TTSEEETTEEECT----------TSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECT
T ss_pred CCCEECCCEEEcC----------CCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCH
Confidence 4576677766665 45555 3454443 6788899999998865554554 788999999999988888
Q ss_pred CCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-
Q 008121 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP- 224 (577)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~- 224 (577)
..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++.++. +..++
T Consensus 74 ~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 153 (220)
T 2v9t_B 74 DAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153 (220)
T ss_dssp TTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred HHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCC
Confidence 8888899999999999999877777788889999999999999887788888888999999999998887653 55554
Q ss_pred ccEEEeecCcccc
Q 008121 225 LTTLNVANNHFSG 237 (577)
Q Consensus 225 L~~L~l~~N~l~g 237 (577)
|+.|+|++|.+..
T Consensus 154 L~~L~L~~N~~~c 166 (220)
T 2v9t_B 154 IQTMHLAQNPFIC 166 (220)
T ss_dssp CCEEECCSSCEEC
T ss_pred CCEEEeCCCCcCC
Confidence 8899999998874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-20 Score=187.06 Aligned_cols=174 Identities=22% Similarity=0.270 Sum_probs=104.5
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|++++|.++.. +.+..+++|++|+|++|++++.-...-.++|++|+|++|++++..+..|+.+++|++|+|++
T Consensus 41 ~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 118 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118 (272)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCCGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred cceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCchhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCC
Confidence 4566666666666532 24666666666666666666421111125666666666666666666666666666666666
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-ccEEEeecCccccccC
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~L~l~~N~l~g~~p 240 (577)
|++++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++.++. +..++ |+.|++++|+|++..|
T Consensus 119 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (272)
T 3rfs_A 119 NQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPD 198 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCH
Confidence 666666666666666666666666666655555556666666666666666665443 33333 6666666666666555
Q ss_pred ccc---ccccceeecCCcCCC
Q 008121 241 REL---ISIRTFIYDGNSFDN 258 (577)
Q Consensus 241 ~~l---~~l~~l~~~~n~~~~ 258 (577)
..+ .+++.|++++|++.|
T Consensus 199 ~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 199 GVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp TTTTTCTTCCEEECCSSCBCC
T ss_pred HHHhCCcCCCEEEccCCCccc
Confidence 433 345556666666543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-21 Score=185.45 Aligned_cols=151 Identities=24% Similarity=0.268 Sum_probs=127.8
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCC---CCCccEEEccCCcCCCcCCCCccCCCCccEEEeccC
Q 008121 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (577)
Q Consensus 87 ~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (577)
.+++++|+++. +|..+. ..++.|+|++|+|++..|... .++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 45666777764 565554 356899999999997666443 289999999999999888889999999999999999
Q ss_pred CCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccC
Q 008121 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p 240 (577)
+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++.++ .+..++ |+.|+|++|.+++..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999988889999999999999999998889999999999999999999999754 566665 9999999999987655
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.1e-21 Score=218.73 Aligned_cols=178 Identities=19% Similarity=0.206 Sum_probs=126.1
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
.+++.|+|++|++++..|..|..+++|++|+|++|+|++..|..+. ++|++|+|++|++++..+..|..+++|++|+|
T Consensus 290 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 369 (844)
T 3j0a_A 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369 (844)
T ss_dssp CCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEE
T ss_pred CCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEEC
Confidence 3566667777777666666667777777777777776655554443 56666666666666555555555555555555
Q ss_pred ccCCCccc------------------------------------------------------------------------
Q 008121 161 SRNSLTQS------------------------------------------------------------------------ 168 (577)
Q Consensus 161 ~~N~l~~~------------------------------------------------------------------------ 168 (577)
++|.+++.
T Consensus 370 s~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 449 (844)
T 3j0a_A 370 RDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449 (844)
T ss_dssp ETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCS
T ss_pred CCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccccccc
Confidence 55554321
Q ss_pred ----------------------ccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCCcc
Q 008121 169 ----------------------IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLT 226 (577)
Q Consensus 169 ----------------------~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~ 226 (577)
.|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++.++......|+
T Consensus 450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~ 529 (844)
T 3j0a_A 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLE 529 (844)
T ss_dssp CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCC
T ss_pred CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhcccc
Confidence 1123555677777777777777777777888888999999999988876654445699
Q ss_pred EEEeecCccccccCcccccccceeecCCcCCCCC
Q 008121 227 TLNVANNHFSGWIPRELISIRTFIYDGNSFDNGP 260 (577)
Q Consensus 227 ~L~l~~N~l~g~~p~~l~~l~~l~~~~n~~~~~~ 260 (577)
.|+|++|+|++.+|..+.++..+++++|++.|..
T Consensus 530 ~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 530 ILDISRNQLLAPNPDVFVSLSVLDITHNKFICEC 563 (844)
T ss_dssp EEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSS
T ss_pred EEECCCCcCCCCChhHhCCcCEEEecCCCccccc
Confidence 9999999999999999999999999999998854
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=187.62 Aligned_cols=188 Identities=16% Similarity=0.224 Sum_probs=156.3
Q ss_pred CCCCCCC-cc--EEeeC--------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCC-cCCcCCCCCC--CCccEE
Q 008121 69 DPCGESW-KG--VACEG--------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IHDTIPYQLP--PNLTSL 134 (577)
Q Consensus 69 ~~c~~~w-~g--v~C~~--------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~--~~L~~L 134 (577)
+.|.|.+ .+ |.|.. ..++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..+. ++|++|
T Consensus 6 ~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L 85 (239)
T 2xwt_C 6 PPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHI 85 (239)
T ss_dssp SSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEE
T ss_pred CCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEE
Confidence 4565543 54 55864 579999999999998888899999999999999997 8754444443 899999
Q ss_pred EccC-CcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCc---EEeCcCC-cccCCCCCCccCCCCCC-eEEc
Q 008121 135 NLAS-NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA---TLDLSFN-NFSGDLPNSFISLSNIS-SLYL 208 (577)
Q Consensus 135 ~l~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~g~~p~~~~~l~~L~-~L~l 208 (577)
+|++ |++++..+..|.++++|++|+|++|++++ +|. |..+++|+ +|+|++| ++++..+..|.++++|+ +|++
T Consensus 86 ~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp EEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEEC
T ss_pred ECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEc
Confidence 9999 99998888899999999999999999997 666 88999998 9999999 99977777799999999 9999
Q ss_pred cCccccccccc-CCCCCccEEEeecCc-cccccCccc----ccccceeecCCcCCC
Q 008121 209 QNNQVTGSLNV-FSGLPLTTLNVANNH-FSGWIPREL----ISIRTFIYDGNSFDN 258 (577)
Q Consensus 209 ~~N~l~~~~~~-~~~~~L~~L~l~~N~-l~g~~p~~l----~~l~~l~~~~n~~~~ 258 (577)
++|+|+..++. +....|+.|++++|+ +++..+..+ .+++.|++++|.+..
T Consensus 164 ~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~ 219 (239)
T 2xwt_C 164 YNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219 (239)
T ss_dssp CSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC
T ss_pred CCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc
Confidence 99999965543 444459999999995 986555544 467788899998764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-20 Score=192.22 Aligned_cols=195 Identities=18% Similarity=0.239 Sum_probs=156.6
Q ss_pred CCCCCCCCCCCCCCCCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC
Q 008121 60 LTNWKGNEGDPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP 128 (577)
Q Consensus 60 l~~w~~~~~~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 128 (577)
...|...-...|.|+|+.+.|+. ..++.|+|++|++++..+..|+++++|++|+|++|++++..|..+.
T Consensus 18 i~~~~~~cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (330)
T 1xku_A 18 IEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 97 (330)
T ss_dssp ----CCCCCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred cccccCCCCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhc
Confidence 34555433456777999999974 3688999999999998888999999999999999999987787776
Q ss_pred --CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCccc--CCCCCCccCCCCCC
Q 008121 129 --PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLPNSFISLSNIS 204 (577)
Q Consensus 129 --~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--g~~p~~~~~l~~L~ 204 (577)
++|++|+|++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++ +..+..+.++++|+
T Consensus 98 ~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~ 174 (330)
T 1xku_A 98 PLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174 (330)
T ss_dssp TCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred CCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcC
Confidence 89999999999998 5666654 78999999999999888888999999999999999985 36778888899999
Q ss_pred eEEccCcccccccccCCCCCccEEEeecCccccccCcccc---cccceeecCCcCCC
Q 008121 205 SLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 205 ~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
+|++++|.++..+..+. ..|+.|++++|++++..|..+. +++.|++++|.+..
T Consensus 175 ~L~l~~n~l~~l~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 230 (330)
T 1xku_A 175 YIRIADTNITTIPQGLP-PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230 (330)
T ss_dssp EEECCSSCCCSCCSSCC-TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred EEECCCCccccCCcccc-ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence 99999999887554333 4588888888888877776554 55667788877643
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.6e-21 Score=204.86 Aligned_cols=187 Identities=17% Similarity=0.219 Sum_probs=160.7
Q ss_pred CCCC--CCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEE
Q 008121 70 PCGE--SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSL 134 (577)
Q Consensus 70 ~c~~--~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L 134 (577)
.|.| .|..|.|.. ..++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..+. ++|++|
T Consensus 6 ~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 85 (477)
T 2id5_A 6 RCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTL 85 (477)
T ss_dssp TCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEE
Confidence 4544 578899974 3678999999999999999999999999999999999987787775 899999
Q ss_pred EccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccc
Q 008121 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (577)
Q Consensus 135 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (577)
+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++
T Consensus 86 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 86 GLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp ECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred ECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 99999999877778999999999999999999999999999999999999999999888889999999999999999999
Q ss_pred cccc-cCCCCC-ccEEEeecCccccccCcccc---cccceeecCCcC
Q 008121 215 GSLN-VFSGLP-LTTLNVANNHFSGWIPRELI---SIRTFIYDGNSF 256 (577)
Q Consensus 215 ~~~~-~~~~~~-L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~ 256 (577)
+.++ .+..++ |+.|++++|.+++..+..+. +++.|++++|+.
T Consensus 166 ~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~ 212 (477)
T 2id5_A 166 SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212 (477)
T ss_dssp SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTT
T ss_pred ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcc
Confidence 8664 355554 88999999988876665444 456666776654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-20 Score=192.95 Aligned_cols=186 Identities=19% Similarity=0.266 Sum_probs=112.1
Q ss_pred CCCCCCCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEE
Q 008121 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135 (577)
Q Consensus 69 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~ 135 (577)
..|.|+|..+.|+. ..++.|+|++|.+++..|..|.++++|++|+|++|+|++..|..+. ++|++|+
T Consensus 29 ~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 29 FGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp SSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred CCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 45667899999974 2578888888888877777788888888888888887766565443 5666666
Q ss_pred ccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCccc--CCCCCCccCC-------------
Q 008121 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLPNSFISL------------- 200 (577)
Q Consensus 136 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--g~~p~~~~~l------------- 200 (577)
|++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.++ +..|..+..+
T Consensus 109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185 (332)
T ss_dssp CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCS
T ss_pred CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCC
Confidence 6666666 3444333 45555555555555544444555555555555555553 2333333322
Q ss_pred -------CCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCcccc---cccceeecCCcCC
Q 008121 201 -------SNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFD 257 (577)
Q Consensus 201 -------~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~ 257 (577)
++|++|+|++|.+++..+ .+..++ |+.|++++|++++..|..+. +++.|++++|.+.
T Consensus 186 ~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 186 GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp SCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred ccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence 345555555555555442 344443 66666777766665554333 4455666666654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.7e-21 Score=182.90 Aligned_cols=157 Identities=24% Similarity=0.289 Sum_probs=128.7
Q ss_pred CCCCCCCCccEEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcC
Q 008121 68 GDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNL 145 (577)
Q Consensus 68 ~~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~ 145 (577)
.+.| +|++|.|+..+ +. .+|..+. ++|++|+|++|+|++..|..+. ++|++|+|++|+|++..
T Consensus 16 ~~~C--s~~~v~c~~~~----------l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 80 (229)
T 3e6j_A 16 QCSC--SGTTVDCRSKR----------HA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP 80 (229)
T ss_dssp TCEE--ETTEEECTTSC----------CS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCEE--eCCEeEccCCC----------cC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcC
Confidence 4566 89999997543 33 4454443 7899999999999987776664 88999999999998776
Q ss_pred CCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC
Q 008121 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP 224 (577)
Q Consensus 146 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~ 224 (577)
+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++.++ .+..++
T Consensus 81 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 159 (229)
T 3e6j_A 81 VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159 (229)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCC
Confidence 777889999999999999999888888889999999999999998 788889999999999999999998765 355554
Q ss_pred -ccEEEeecCccccccC
Q 008121 225 -LTTLNVANNHFSGWIP 240 (577)
Q Consensus 225 -L~~L~l~~N~l~g~~p 240 (577)
|+.|+|++|.+++..+
T Consensus 160 ~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 160 SLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TCCEEECTTSCBCTTBG
T ss_pred CCCEEEeeCCCccCCcc
Confidence 8999999999987654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=200.15 Aligned_cols=183 Identities=20% Similarity=0.202 Sum_probs=145.8
Q ss_pred CCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCc
Q 008121 74 SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (577)
Q Consensus 74 ~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~ 140 (577)
.|..|.|.. ..++.|+|++|++++..+..|.++++|++|+|++|+|++..|..+. ++|++|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 467899975 3578899999999999889999999999999999999976655554 899999999999
Q ss_pred CCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCC-cccCCCCCCccCCCCCCeEEccCccccccccc
Q 008121 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFN-NFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219 (577)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 219 (577)
|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++| .++...+..|.++++|++|+|++|+|+..+.
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~- 202 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPN- 202 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCC-
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccccc-
Confidence 99877788999999999999999999888778888888888888884 4443334467888888888888888876543
Q ss_pred CCCC-CccEEEeecCccccccCcccc---cccceeecCCcCC
Q 008121 220 FSGL-PLTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFD 257 (577)
Q Consensus 220 ~~~~-~L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~ 257 (577)
+..+ .|+.|+|++|+|++..|..+. +++.|.+++|.+.
T Consensus 203 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 244 (440)
T 3zyj_A 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244 (440)
T ss_dssp CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCcee
Confidence 4333 388888888888877676554 4556667777654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=197.15 Aligned_cols=174 Identities=18% Similarity=0.166 Sum_probs=109.3
Q ss_pred CcEEEEEcCCCCCcccccccc--cCCCCCCEEEccCCCcCCcCCCCC-------CCCccEEEccCCcCCCcCCCCccCCC
Q 008121 83 SAVVSIDISGLGLSGTMGYLL--SDLLSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSIASMV 153 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~--~~l~~L~~L~Ls~N~l~~~~p~~~-------~~~L~~L~l~~N~l~~~~p~~~~~l~ 153 (577)
.+++.|+|++|++++.+|..+ +.+++|++|+|++|+|++. |..+ .++|++|+|++|++++..|..|+.++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 356667777777777666655 6677777777777777654 4322 15677777777777766666777777
Q ss_pred CccEEEeccCCCccc--ccccc--cCCCCCcEEeCcCCcccC--CCC-CCccCCCCCCeEEccCcccccccc--cCCCC-
Q 008121 154 SLSYLNVSRNSLTQS--IGDIF--GNLAGLATLDLSFNNFSG--DLP-NSFISLSNISSLYLQNNQVTGSLN--VFSGL- 223 (577)
Q Consensus 154 ~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~g--~~p-~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~- 223 (577)
+|++|+|++|++.+. +|..+ .++++|++|+|++|+|++ .++ ..+..+++|++|+|++|+|++.++ .+..+
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 777777777776654 23333 666777777777777762 122 223456677777777777776542 23333
Q ss_pred CccEEEeecCccccccCcccc-cccceeecCCcCCC
Q 008121 224 PLTTLNVANNHFSGWIPRELI-SIRTFIYDGNSFDN 258 (577)
Q Consensus 224 ~L~~L~l~~N~l~g~~p~~l~-~l~~l~~~~n~~~~ 258 (577)
.|+.|+|++|+|+ .+|..+. +++.|++++|.+..
T Consensus 254 ~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N~l~~ 288 (312)
T 1wwl_A 254 QLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDR 288 (312)
T ss_dssp TCCEEECTTSCCS-SCCSSCCSEEEEEECCSSCCCS
T ss_pred CCCEEECCCCccC-hhhhhccCCceEEECCCCCCCC
Confidence 3777777777776 6665554 56666777776643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.84 E-value=2.9e-21 Score=180.96 Aligned_cols=169 Identities=20% Similarity=0.250 Sum_probs=120.9
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCC-CC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccC
Q 008121 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-LP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (577)
Q Consensus 87 ~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (577)
.|++++|+|+ .+|..+.. +|+.|+|++|+|++..|.. +. ++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4556677774 56665544 8899999999998655543 32 88999999999999888888999999999999999
Q ss_pred CCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccCcc
Q 008121 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE 242 (577)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p~~ 242 (577)
+|++..|..|.++++|++|+|++|+|++.+|..|..+++|++|+|++|.+++..+...... ++...+..+......|..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~ 168 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChH
Confidence 9998888888889999999999999998888888888999999999998887543111000 222223334444444555
Q ss_pred cccccceeecCCcCCC
Q 008121 243 LISIRTFIYDGNSFDN 258 (577)
Q Consensus 243 l~~l~~l~~~~n~~~~ 258 (577)
+....-.++..+.+.|
T Consensus 169 l~~~~l~~l~~~~~~C 184 (192)
T 1w8a_A 169 VRDVQIKDLPHSEFKC 184 (192)
T ss_dssp TTTSBGGGSCTTTCCC
T ss_pred HcCCChhhCcHhhcCc
Confidence 5544444444444443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.3e-21 Score=202.53 Aligned_cols=171 Identities=19% Similarity=0.187 Sum_probs=142.7
Q ss_pred CCCCCCCccEEeeC----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCC-CCC--CCccEEE
Q 008121 69 DPCGESWKGVACEG----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-QLP--PNLTSLN 135 (577)
Q Consensus 69 ~~c~~~w~gv~C~~----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~--~~L~~L~ 135 (577)
+.|.|.+..|.|+. .+++.|+|++|.+++..|..|+++++|++|+|++|.+.+.+|. .+. ++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 34533444599975 3589999999999999999999999999999999999877754 343 8999999
Q ss_pred ccCCcCCCcCCCCccCCCCccEEEeccCCCccccccc--ccCCCCCcEEeCcCCcccCCCCCC-ccCCCCCCeEEccCcc
Q 008121 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQ 212 (577)
Q Consensus 136 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~l~~N~ 212 (577)
|++|++++..|..|+++++|++|+|++|++++.+|.. |.++++|++|+|++|++++..|.. +.++++|++|+|++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999999999999999999999999999876665 999999999999999999887876 8899999999999999
Q ss_pred ccccccc-CCC---CCccEEEeecCcccccc
Q 008121 213 VTGSLNV-FSG---LPLTTLNVANNHFSGWI 239 (577)
Q Consensus 213 l~~~~~~-~~~---~~L~~L~l~~N~l~g~~ 239 (577)
+++..+. +.. ..++.|++++|.+++..
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~ 196 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMN 196 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCS
T ss_pred ccccChhhhhccccccccccccccCcccccc
Confidence 9986542 322 23566666666666433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=4e-21 Score=197.75 Aligned_cols=185 Identities=18% Similarity=0.245 Sum_probs=155.9
Q ss_pred CCCCccEEeeC-------------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEc
Q 008121 72 GESWKGVACEG-------------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNL 136 (577)
Q Consensus 72 ~~~w~gv~C~~-------------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l 136 (577)
.|.|.|+ |+. .+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..+. ++|++|+|
T Consensus 29 ~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 29 SCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp EECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 3389887 752 3689999999999988777999999999999999999987776665 89999999
Q ss_pred cCCcCCCcCCCCccCCCCccEEEeccCCCccccc-ccccCCCCCcEEeCcCC-cccCCCCCCccCCCCCCeEEccCcccc
Q 008121 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG-DIFGNLAGLATLDLSFN-NFSGDLPNSFISLSNISSLYLQNNQVT 214 (577)
Q Consensus 137 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (577)
++|++++..+..|+++++|++|+|++|++++..+ ..|.++++|++|+|++| .+++..|..|.++++|++|++++|+++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence 9999997666668999999999999999996555 57899999999999999 577666788999999999999999999
Q ss_pred cccc-cCCCCC-ccEEEeecCccccccCcc----cccccceeecCCcCCC
Q 008121 215 GSLN-VFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDN 258 (577)
Q Consensus 215 ~~~~-~~~~~~-L~~L~l~~N~l~g~~p~~----l~~l~~l~~~~n~~~~ 258 (577)
+..+ .+..++ |+.|++++|+++ .+|.. +.+++.|++++|.+..
T Consensus 188 ~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~ 236 (353)
T 2z80_A 188 SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT 236 (353)
T ss_dssp EECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTT
T ss_pred ccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCcccc
Confidence 8754 566665 999999999996 45542 4578889999998764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.9e-20 Score=184.16 Aligned_cols=170 Identities=25% Similarity=0.300 Sum_probs=147.6
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
...++.|+|++|.+++. +.++.+++|++|+|++|+|++..|..+. ++|++|+|++|++++..+..|+.+++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 46899999999999874 4899999999999999999976665443 8999999999999988888899999999999
Q ss_pred eccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-ccEEEeecCcccc
Q 008121 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP-LTTLNVANNHFSG 237 (577)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~L~l~~N~l~g 237 (577)
|++|++++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++.++. +..++ |+.|++++|.+.+
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 999999998888899999999999999999987777789999999999999999997764 55555 9999999999998
Q ss_pred ccCcccccccceeecCCcCC
Q 008121 238 WIPRELISIRTFIYDGNSFD 257 (577)
Q Consensus 238 ~~p~~l~~l~~l~~~~n~~~ 257 (577)
..| ++..+.+..|.+.
T Consensus 220 ~~~----~l~~l~~~~n~~~ 235 (272)
T 3rfs_A 220 TCP----GIRYLSEWINKHS 235 (272)
T ss_dssp CTT----TTHHHHHHHHHTG
T ss_pred cCc----HHHHHHHHHHhCC
Confidence 776 3445555555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=8.9e-21 Score=195.77 Aligned_cols=170 Identities=23% Similarity=0.244 Sum_probs=137.7
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCC---CCCccEEEccCCcCCCcCCCCccCCCCccEEEeccC
Q 008121 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (577)
Q Consensus 87 ~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (577)
.+++++++|+. +|..+. ..|+.|+|++|+|++..+..+ .++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 45667777774 555544 358899999999997655544 288999999999999888888999999999999999
Q ss_pred CCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-C---CCCC-ccEEEeecCccccc
Q 008121 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-F---SGLP-LTTLNVANNHFSGW 238 (577)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~---~~~~-L~~L~l~~N~l~g~ 238 (577)
+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++.+.. + ..++ |+.|+|++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 99988888899999999999999999988888999999999999999999987654 3 2343 99999999999954
Q ss_pred cCcccccc-----cceeecCCcCCCC
Q 008121 239 IPRELISI-----RTFIYDGNSFDNG 259 (577)
Q Consensus 239 ~p~~l~~l-----~~l~~~~n~~~~~ 259 (577)
.+..+..+ ..|.+.+|++.|.
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred CHHHhhhccHhhcceEEecCCCccCC
Confidence 44555544 5688999998864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=207.89 Aligned_cols=132 Identities=20% Similarity=0.251 Sum_probs=99.0
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
.++.|++++|.+....+..|..+++|++|+|++|.|++..|..+. ++|++|+|++|.|++..|..|+++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 456677777777766666677778888888888887766655554 678888888888877777777778888888888
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccc
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (577)
+|.|++..+..|+++++|++|+|++|+|++..|..|+.+++|++|+|++|.|++
T Consensus 132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 888876666667777888888888888877777777777777777777777765
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.2e-20 Score=197.51 Aligned_cols=106 Identities=19% Similarity=0.339 Sum_probs=79.7
Q ss_pred CCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEe
Q 008121 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNV 230 (577)
Q Consensus 153 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l 230 (577)
++|++|+|++|++++.+|..|.++++|++|+|++|++++..|..|..+++|++|+|++|.|++.++ .+..++ |+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 356666666667777778888888888888888888887777788888888888888888877654 455554 888888
Q ss_pred ecCccccccCcccc---cccceeecCCcCCC
Q 008121 231 ANNHFSGWIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 231 ~~N~l~g~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
++|++++..|..+. +++.|++++|.+..
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCcccccChhhccccccccEEECCCCcccc
Confidence 88888877776554 55667788887754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.1e-20 Score=175.83 Aligned_cols=149 Identities=21% Similarity=0.254 Sum_probs=126.1
Q ss_pred CCCCCCCccEEeeCC-----------cEEEEEcCCCCCccccc-ccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEE
Q 008121 69 DPCGESWKGVACEGS-----------AVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSL 134 (577)
Q Consensus 69 ~~c~~~w~gv~C~~~-----------~v~~l~l~~~~l~g~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L 134 (577)
..|.|.|..+.|+.. .++.|+|++|+|++..+ ..|..+++|++|+|++|+|++..|..+. ++|++|
T Consensus 7 ~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 7 EKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86 (220)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence 567778888998642 46788999999988765 4588899999999999999876665554 889999
Q ss_pred EccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccc
Q 008121 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (577)
Q Consensus 135 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (577)
+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 99999999888888889999999999999999888888999999999999999999888888999999999999999888
Q ss_pred ccc
Q 008121 215 GSL 217 (577)
Q Consensus 215 ~~~ 217 (577)
+..
T Consensus 167 c~c 169 (220)
T 2v70_A 167 CNC 169 (220)
T ss_dssp CSG
T ss_pred CCC
Confidence 643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=208.36 Aligned_cols=190 Identities=23% Similarity=0.218 Sum_probs=160.9
Q ss_pred CCCCCCC--CccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCcc
Q 008121 68 GDPCGES--WKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLT 132 (577)
Q Consensus 68 ~~~c~~~--w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~ 132 (577)
.+||.+. -..|.|.. .+++.|+|++|++++..+..|+++++|++|+|++|+|++..|..+. ++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 3567432 23588864 4689999999999999999999999999999999999987777665 8999
Q ss_pred EEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccC-CCCCCccCCCCCCeEEccCc
Q 008121 133 SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNN 211 (577)
Q Consensus 133 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N 211 (577)
+|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999999999999999999999999999999999888899999999999999999986 67999999999999999999
Q ss_pred cccccccc-CCCCC-----ccEEEeecCccccccCcccc--cccceeecCCcCC
Q 008121 212 QVTGSLNV-FSGLP-----LTTLNVANNHFSGWIPRELI--SIRTFIYDGNSFD 257 (577)
Q Consensus 212 ~l~~~~~~-~~~~~-----L~~L~l~~N~l~g~~p~~l~--~l~~l~~~~n~~~ 257 (577)
++++.++. +..+. +..|++++|.+++..+..+. +++.+++++|.+.
T Consensus 164 ~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~ 217 (606)
T 3vq2_A 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNS 217 (606)
T ss_dssp CCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSC
T ss_pred cceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccc
Confidence 99986543 33322 55899999999866555443 5677888888653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-20 Score=208.23 Aligned_cols=175 Identities=23% Similarity=0.295 Sum_probs=152.8
Q ss_pred CCCCCCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEc
Q 008121 70 PCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNL 136 (577)
Q Consensus 70 ~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l 136 (577)
+|.|.+..|.|.. .+++.|+|++|++++..+..|+++++|++|+|++|++++..|..+. ++|++|+|
T Consensus 1 ~C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 80 (680)
T 1ziw_A 1 KCTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNL 80 (680)
T ss_dssp ---CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEEC
T ss_pred CceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEEC
Confidence 3655677788863 4799999999999998888999999999999999999987776654 89999999
Q ss_pred cCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccc
Q 008121 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (577)
Q Consensus 137 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (577)
++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|.+++.
T Consensus 81 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 81 QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred CCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence 99999977677899999999999999999998889999999999999999999999999999999999999999999987
Q ss_pred ccc-C---CCCCccEEEeecCccccccCcccc
Q 008121 217 LNV-F---SGLPLTTLNVANNHFSGWIPRELI 244 (577)
Q Consensus 217 ~~~-~---~~~~L~~L~l~~N~l~g~~p~~l~ 244 (577)
++. + ....|+.|++++|++++..|..+.
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~ 192 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCCBCTTGGG
T ss_pred CHHHhhccccccccEEECCCCcccccChhhhh
Confidence 653 2 223499999999999988886554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.8e-21 Score=192.14 Aligned_cols=174 Identities=20% Similarity=0.249 Sum_probs=145.9
Q ss_pred eCCcEEEEEcCCCCCcccccccccCC-----CCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCc--CCCCc--
Q 008121 81 EGSAVVSIDISGLGLSGTMGYLLSDL-----LSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN--LPYSI-- 149 (577)
Q Consensus 81 ~~~~v~~l~l~~~~l~g~~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~--~p~~~-- 149 (577)
....++.|+|++|++++. |..++.+ ++|++|+|++|+|++..|..+. ++|++|+|++|++.+. +|..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 456899999999999988 8888887 9999999999999987777775 8999999999999876 34444
Q ss_pred cCCCCccEEEeccCCCcc---cccccccCCCCCcEEeCcCCcccCCCC-CCccCCCCCCeEEccCcccccccccCCCCCc
Q 008121 150 ASMVSLSYLNVSRNSLTQ---SIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLNVFSGLPL 225 (577)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L 225 (577)
+.+++|++|+|++|+|++ .....+.++++|++|+|++|+|++.+| ..+..+++|++|+|++|+|+..+..+. ..|
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~-~~L 276 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP-AKL 276 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC-SEE
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc-CCc
Confidence 899999999999999994 223456789999999999999998776 456778999999999999996555554 559
Q ss_pred cEEEeecCccccccCc--ccccccceeecCCcCC
Q 008121 226 TTLNVANNHFSGWIPR--ELISIRTFIYDGNSFD 257 (577)
Q Consensus 226 ~~L~l~~N~l~g~~p~--~l~~l~~l~~~~n~~~ 257 (577)
+.|||++|+|++. |. .+.+++.|++++|++.
T Consensus 277 ~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 277 SVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp EEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTT
T ss_pred eEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCC
Confidence 9999999999976 64 3446677889999875
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-20 Score=189.26 Aligned_cols=174 Identities=18% Similarity=0.200 Sum_probs=139.6
Q ss_pred cEEEEEcCCCCCcccccccc--cCCCCCCEEEccCCCcCCcCCC------CCCCCccEEEccCCcCCCcCCCCccCCCCc
Q 008121 84 AVVSIDISGLGLSGTMGYLL--SDLLSLRKFDLSGNSIHDTIPY------QLPPNLTSLNLASNNFSGNLPYSIASMVSL 155 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~--~~l~~L~~L~Ls~N~l~~~~p~------~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L 155 (577)
+++.|+|++|.+++..|..+ +.+++|++|+|++|++++..|. ...++|++|+|++|++++..|..|+.+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 58999999999999999888 8999999999999999976551 123899999999999998888999999999
Q ss_pred cEEEeccCCCccc--cc--ccccCCCCCcEEeCcCCcccCCCCC----CccCCCCCCeEEccCccccccc-ccCCCC---
Q 008121 156 SYLNVSRNSLTQS--IG--DIFGNLAGLATLDLSFNNFSGDLPN----SFISLSNISSLYLQNNQVTGSL-NVFSGL--- 223 (577)
Q Consensus 156 ~~L~L~~N~l~~~--~p--~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~~~~-~~~~~~--- 223 (577)
++|+|++|++.+. ++ ..+..+++|++|+|++|+|+ .+|. .+..+++|++|+|++|+|++.. +.+...
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 9999999998763 22 33478889999999999887 3443 2467788999999999998873 333333
Q ss_pred -CccEEEeecCccccccCccc-ccccceeecCCcCCCC
Q 008121 224 -PLTTLNVANNHFSGWIPREL-ISIRTFIYDGNSFDNG 259 (577)
Q Consensus 224 -~L~~L~l~~N~l~g~~p~~l-~~l~~l~~~~n~~~~~ 259 (577)
.|+.|+|++|+|+ .+|..+ .+++.|++++|.+..-
T Consensus 251 ~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~~ 287 (310)
T 4glp_A 251 SALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNRA 287 (310)
T ss_dssp TTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCSC
T ss_pred CcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCCC
Confidence 4889999999998 667654 4778888888887643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=205.90 Aligned_cols=183 Identities=20% Similarity=0.256 Sum_probs=153.9
Q ss_pred CCccEEeeC-------------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccC
Q 008121 74 SWKGVACEG-------------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLAS 138 (577)
Q Consensus 74 ~w~gv~C~~-------------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~ 138 (577)
.|.|+ |+. ..++.|+|++|++++..|..|+++++|++|+|++|+|++..|..+. ++|++|+|++
T Consensus 5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 83 (549)
T 2z81_A 5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83 (549)
T ss_dssp CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence 89998 874 2689999999999998889999999999999999999987776665 8999999999
Q ss_pred CcCCCcCCCCccCCCCccEEEeccCCCcc-cccccccCCCCCcEEeCcCCcccCCCC-CCccCCCCCCeEEccCcccccc
Q 008121 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGS 216 (577)
Q Consensus 139 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~ 216 (577)
|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|+|++|++.+.+| ..|.++++|++|++++|++++.
T Consensus 84 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 163 (549)
T 2z81_A 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163 (549)
T ss_dssp SCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccccc
Confidence 99998888889999999999999999997 467789999999999999998555565 6799999999999999999986
Q ss_pred cc-cCCCCC-ccEEEeecCccccccCcc----cccccceeecCCcCCC
Q 008121 217 LN-VFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDN 258 (577)
Q Consensus 217 ~~-~~~~~~-L~~L~l~~N~l~g~~p~~----l~~l~~l~~~~n~~~~ 258 (577)
++ .+..++ |+.|++++|.+. .+|.. +.+++.|++++|.+..
T Consensus 164 ~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~ 210 (549)
T 2z81_A 164 QSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLAR 210 (549)
T ss_dssp CTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTT
T ss_pred ChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCcccc
Confidence 54 455555 888888888876 44433 4577888888888764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-20 Score=193.94 Aligned_cols=134 Identities=20% Similarity=0.247 Sum_probs=108.9
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
..++.|+++++.++...+..|..+++|++|+|++|++++..|..+. ++|++|+|++|++++..|..|+++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 3567788888888766656678888888889988888866555554 78888888888888888888888888888888
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccc
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (577)
++|+++...+..|.++++|++|+|++|++++..|..|..+++|++|++++|++++.
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 88888866666678888888888888888877777788888888888888888753
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.1e-20 Score=202.98 Aligned_cols=161 Identities=24% Similarity=0.376 Sum_probs=112.2
Q ss_pred CCCCCCCCCCCCCC---CCccE-EeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEE
Q 008121 60 LTNWKGNEGDPCGE---SWKGV-ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLN 135 (577)
Q Consensus 60 l~~w~~~~~~~c~~---~w~gv-~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~ 135 (577)
+.+|.. +.+||.. .|.|+ .|...+++.|+|++|+|++ +|..+. ++|+.|+|++|+|+ .+| .+.++|++|+
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip-~~l~~L~~L~ 106 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP-ELPASLEYLD 106 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC-CCCTTCCEEE
T ss_pred HHHHhc-cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc-cccCCCCEEE
Confidence 345764 4678854 59999 8988899999999999987 666553 78888888888888 677 6668888888
Q ss_pred ccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccc
Q 008121 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (577)
Q Consensus 136 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (577)
|++|+|++ +|. |.+ +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++
T Consensus 107 Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 107 ACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp CCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred ccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC
Confidence 88888886 666 554 77777777777776 444 46667777777777664 554 35566666666666666
Q ss_pred ccccCCCCCccEEEeecCccccccCc
Q 008121 216 SLNVFSGLPLTTLNVANNHFSGWIPR 241 (577)
Q Consensus 216 ~~~~~~~~~L~~L~l~~N~l~g~~p~ 241 (577)
.+. +. ..|+.|+|++|+|+ .+|.
T Consensus 175 lp~-l~-~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 175 LPE-LP-ESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp CCC-CC-TTCCEEECCSSCCS-SCCC
T ss_pred cch-hh-CCCCEEECcCCCCC-chhh
Confidence 333 33 33555555555555 4444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=8.4e-20 Score=193.68 Aligned_cols=172 Identities=19% Similarity=0.226 Sum_probs=108.2
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+. ++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 88 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 167 (440)
T 3zyj_A 88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167 (440)
T ss_dssp SSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCC
Confidence 5788999999999988888899999999999999999854444443 78889999988888766667777777777777
Q ss_pred ccCC-CcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCcccc
Q 008121 161 SRNS-LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSG 237 (577)
Q Consensus 161 ~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g 237 (577)
++|+ ++...+..|.++++|++|+|++|+|+ .+| .+..+++|++|+|++|+|++..+ .+..++ |+.|+|++|+|++
T Consensus 168 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 245 (440)
T 3zyj_A 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245 (440)
T ss_dssp CCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred CCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE
Confidence 7643 33333335666666666666666655 344 24555555555555555555432 233332 4555555555544
Q ss_pred ccCcccc---cccceeecCCcC
Q 008121 238 WIPRELI---SIRTFIYDGNSF 256 (577)
Q Consensus 238 ~~p~~l~---~l~~l~~~~n~~ 256 (577)
..|..+. +++.|++++|.+
T Consensus 246 ~~~~~~~~l~~L~~L~L~~N~l 267 (440)
T 3zyj_A 246 IERNAFDNLQSLVEINLAHNNL 267 (440)
T ss_dssp ECTTSSTTCTTCCEEECTTSCC
T ss_pred EChhhhcCCCCCCEEECCCCCC
Confidence 4443322 333444444443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.8e-21 Score=211.95 Aligned_cols=174 Identities=16% Similarity=0.316 Sum_probs=158.0
Q ss_pred eCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCC-cCC-cCCCCCC--------CCccEEEccCCcCCCcCCC--C
Q 008121 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IHD-TIPYQLP--------PNLTSLNLASNNFSGNLPY--S 148 (577)
Q Consensus 81 ~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~--------~~L~~L~l~~N~l~~~~p~--~ 148 (577)
...+++.|+|++|++.|.+|..|+++++|++|+|++|+ |+| .+|..+. ++|++|+|++|+++ .+|. .
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~ 325 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETS 325 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHH
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhh
Confidence 34689999999999999999999999999999999999 998 8886653 79999999999999 8998 9
Q ss_pred ccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCC-CCeEEccCcccccccccCCCC---C
Q 008121 149 IASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN-ISSLYLQNNQVTGSLNVFSGL---P 224 (577)
Q Consensus 149 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~---~ 224 (577)
|+++++|++|+|++|+++|.+| .|+++++|++|+|++|+++ .+|..+..+++ |++|+|++|+|+..+..+... .
T Consensus 326 l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~ 403 (636)
T 4eco_A 326 LQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSV 403 (636)
T ss_dssp HTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSC
T ss_pred hccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchhhhhcccCc
Confidence 9999999999999999999999 8999999999999999999 89999999999 999999999999665555544 4
Q ss_pred ccEEEeecCccccccCcccc----------cccceeecCCcCC
Q 008121 225 LTTLNVANNHFSGWIPRELI----------SIRTFIYDGNSFD 257 (577)
Q Consensus 225 L~~L~l~~N~l~g~~p~~l~----------~l~~l~~~~n~~~ 257 (577)
|+.|++++|++++.+|..+. +++.|++++|.+.
T Consensus 404 L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~ 446 (636)
T 4eco_A 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446 (636)
T ss_dssp EEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC
T ss_pred cCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC
Confidence 99999999999999998776 6778889999876
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.9e-19 Score=172.42 Aligned_cols=149 Identities=23% Similarity=0.297 Sum_probs=129.7
Q ss_pred CEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcc
Q 008121 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (577)
Q Consensus 110 ~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 189 (577)
+.+++++|+++ .+|..++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp TEEECTTSCCS-SCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred CEEEcCCCCcC-cCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 57899999998 68888889999999999999988888999999999999999999999999999999999999999999
Q ss_pred cCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCcccc---cccceeecCCcCCCC
Q 008121 190 SGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFDNG 259 (577)
Q Consensus 190 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~~~ 259 (577)
+...+..|..+++|++|+|++|+|++..+ .+..++ |+.|+|++|+|++..+..+. +++.+++++|++.|.
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 96555567889999999999999998765 466665 99999999999977766554 567788999999763
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.9e-20 Score=203.50 Aligned_cols=174 Identities=25% Similarity=0.265 Sum_probs=100.0
Q ss_pred CcEEEEEcCCCCCccc--ccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCC-CCccCCCCccE
Q 008121 83 SAVVSIDISGLGLSGT--MGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP-YSIASMVSLSY 157 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~--~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~ 157 (577)
..++.|+|++|.+++. +|..+..+++|++|+|++|.+++ +|..+. ++|++|+|++|++++..| ..|..+++|++
T Consensus 350 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 4566777777776655 25566666666666666666653 443333 556666666666665555 45556666666
Q ss_pred EEeccCCCcccccccccCCCCCcEEeCcCCcccC-CCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCc
Q 008121 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNH 234 (577)
Q Consensus 158 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~ 234 (577)
|+|++|++++.+|..+.++++|++|+|++|++++ .+|..|..+++|++|+|++|++++.++ .+..++ |+.|++++|+
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 508 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCc
Confidence 6666666666555556666666666666666655 245555566666666666666655443 243333 5666666666
Q ss_pred cccccCcccc---cccceeecCCcCC
Q 008121 235 FSGWIPRELI---SIRTFIYDGNSFD 257 (577)
Q Consensus 235 l~g~~p~~l~---~l~~l~~~~n~~~ 257 (577)
+++.+|..+. +++.|++++|.+.
T Consensus 509 l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 509 LLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp CSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CCCcCHHHccCCCcCCEEECCCCcCc
Confidence 6655555443 3445555555543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-19 Score=193.56 Aligned_cols=173 Identities=20% Similarity=0.210 Sum_probs=116.5
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+. ++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 99 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 178 (452)
T 3zyi_A 99 HHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDL 178 (452)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeC
Confidence 5789999999999998889999999999999999999965544443 88999999999998776667777777777777
Q ss_pred ccC-CCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCcccc
Q 008121 161 SRN-SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSG 237 (577)
Q Consensus 161 ~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g 237 (577)
++| .+....+..|.++++|++|+|++|+|++ +| .+..+++|++|+|++|+|++..+ .+..++ |+.|+|++|+|++
T Consensus 179 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 256 (452)
T 3zyi_A 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256 (452)
T ss_dssp CCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCE
T ss_pred CCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCce
Confidence 773 3333333456666666666666666663 34 35556666666666666665433 344333 5555555555555
Q ss_pred ccCcccc---cccceeecCCcCC
Q 008121 238 WIPRELI---SIRTFIYDGNSFD 257 (577)
Q Consensus 238 ~~p~~l~---~l~~l~~~~n~~~ 257 (577)
..|..+. +++.|++++|.+.
T Consensus 257 ~~~~~~~~l~~L~~L~L~~N~l~ 279 (452)
T 3zyi_A 257 IERNAFDGLASLVELNLAHNNLS 279 (452)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCS
T ss_pred ECHHHhcCCCCCCEEECCCCcCC
Confidence 5444332 3444555555543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=184.83 Aligned_cols=141 Identities=20% Similarity=0.175 Sum_probs=108.5
Q ss_pred CCccceeccCccceEEEEEE-cCCcE--EEEEEccccccc----------------------hHHHHHHHHHHHHhhcCC
Q 008121 412 FSQEFLIGEGSLGRVYRAEF-ANGKI--MAVKKIDNAALS----------------------LQEEDNFLEAVSNMSRLR 466 (577)
Q Consensus 412 ~~~~~~lg~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~ 466 (577)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ......+.+|++.+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999987 78988 999987543111 012246889999999998
Q ss_pred CCce--eeEeeEEEeCCeEEEEEEecCC-C----CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeee
Q 008121 467 HPNI--VTLAGYCAEHGQRLLVYEYVGN-G----NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-EVCLPSVVH 538 (577)
Q Consensus 467 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~~ivH 538 (577)
|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 334432 246899999942 4 66665431 234567889999999999999 88 9999
Q ss_pred cCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 539 RNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 539 rDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|||||+|||+++ .++|+|||+|......
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 999999999998 9999999999876544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.4e-19 Score=177.27 Aligned_cols=158 Identities=22% Similarity=0.267 Sum_probs=140.6
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
.+++.|+|++|.++...+..|..+++|++|+|++|+|++..+..+. ++|++|+|++|++++..|..|..+++|++|+|
T Consensus 61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 140 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence 5799999999999977777789999999999999999965544443 89999999999999998899999999999999
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-ccEEEeecCccccc
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP-LTTLNVANNHFSGW 238 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~L~l~~N~l~g~ 238 (577)
++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++.++. +..++ |+.|+|++|.+...
T Consensus 141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 99999988888899999999999999999987777799999999999999999987664 55554 99999999999765
Q ss_pred cC
Q 008121 239 IP 240 (577)
Q Consensus 239 ~p 240 (577)
.+
T Consensus 221 c~ 222 (270)
T 2o6q_A 221 CN 222 (270)
T ss_dssp SS
T ss_pred Cc
Confidence 43
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.9e-20 Score=199.53 Aligned_cols=167 Identities=20% Similarity=0.172 Sum_probs=117.2
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccC
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (577)
.++.|+|++|.+++..| |+.+++|++|+|++|.|++..+. ++|++|+|++|+|++..+. .+++|+.|+|++|
T Consensus 59 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~---~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N 130 (487)
T 3oja_A 59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG---PSIETLHAANNNISRVSCS---RGQGKKNIYLANN 130 (487)
T ss_dssp TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC---TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSS
T ss_pred CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC---CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCC
Confidence 44455555555544433 44555555555555554432211 4555666666666655443 3578899999999
Q ss_pred CCcccccccccCCCCCcEEeCcCCcccCCCCCCcc-CCCCCCeEEccCcccccccccCCCCCccEEEeecCccccccCc-
Q 008121 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR- 241 (577)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~- 241 (577)
+|++..|..|+++++|++|+|++|+|++.+|..+. .+++|++|+|++|.|++.++......|+.|+|++|.|++..|.
T Consensus 131 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 210 (487)
T 3oja_A 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEF 210 (487)
T ss_dssp CCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGGG
T ss_pred CCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCCCHhH
Confidence 99998888899999999999999999988888876 7899999999999999875544434499999999999975553
Q ss_pred -ccccccceeecCCcCCC
Q 008121 242 -ELISIRTFIYDGNSFDN 258 (577)
Q Consensus 242 -~l~~l~~l~~~~n~~~~ 258 (577)
.+.++..|++++|.+..
T Consensus 211 ~~l~~L~~L~Ls~N~l~~ 228 (487)
T 3oja_A 211 QSAAGVTWISLRNNKLVL 228 (487)
T ss_dssp GGGTTCSEEECTTSCCCE
T ss_pred cCCCCccEEEecCCcCcc
Confidence 23467788889988764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.1e-19 Score=173.26 Aligned_cols=150 Identities=23% Similarity=0.265 Sum_probs=132.7
Q ss_pred CCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCc
Q 008121 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (577)
Q Consensus 109 L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 188 (577)
.+.+++++|+++ .+|..++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCEeEccCCCcC-ccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 357889999998 7899899999999999999999999999999999999999999998888889999999999999999
Q ss_pred ccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccCccc---ccccceeecCCcCCCC
Q 008121 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (577)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p~~l---~~l~~l~~~~n~~~~~ 259 (577)
|++..+..|..+++|++|+|++|+|+..+..+..++ |+.|+|++|+|++..+..+ .+++.+.+.+|++.|.
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 997777778999999999999999997766665555 9999999999997665544 4677888999998753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.1e-20 Score=199.39 Aligned_cols=169 Identities=17% Similarity=0.192 Sum_probs=147.2
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
...++.|+|++|.|++..+ .++|++|+|++|+|++..+.. .++|+.|+|++|+|++..|..|+.+++|++|+|+
T Consensus 79 l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (487)
T 3oja_A 79 LSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCSR-GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (487)
T ss_dssp CTTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEECC-CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECT
T ss_pred CCCCCEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCccc-cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECC
Confidence 3589999999999987553 389999999999999766654 4899999999999999999999999999999999
Q ss_pred cCCCccccccccc-CCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCcccccc
Q 008121 162 RNSLTQSIGDIFG-NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWI 239 (577)
Q Consensus 162 ~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~ 239 (577)
+|+|++.+|..+. ++++|++|+|++|.|++. |. +..+++|++|+|++|.|++.++.+..++ |+.|+|++|.|++ +
T Consensus 153 ~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-l 229 (487)
T 3oja_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-I 229 (487)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-E
T ss_pred CCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-c
Confidence 9999999998886 799999999999999976 33 4468999999999999999888776665 9999999999996 7
Q ss_pred Ccccc---cccceeecCCcCCCC
Q 008121 240 PRELI---SIRTFIYDGNSFDNG 259 (577)
Q Consensus 240 p~~l~---~l~~l~~~~n~~~~~ 259 (577)
|..+. ++..+++++|++.|+
T Consensus 230 p~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 230 EKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CTTCCCCTTCCEEECTTCCBCHH
T ss_pred chhhccCCCCCEEEcCCCCCcCc
Confidence 76654 567888999998754
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=199.96 Aligned_cols=174 Identities=24% Similarity=0.224 Sum_probs=94.0
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCC-CC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-LP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
+++.|+|++|.+.+..|..|..+++|+.|+|++|++++..|.. +. ++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 377 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 456 (606)
T 3t6q_A 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456 (606)
T ss_dssp TCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEEC
Confidence 4555555555555555555555555555555555555444432 21 55555555555555555555555555556666
Q ss_pred ccCCCccc---ccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCcc
Q 008121 161 SRNSLTQS---IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHF 235 (577)
Q Consensus 161 ~~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l 235 (577)
++|++++. .+..+..+++|++|+|++|++++..|..|..+++|++|+|++|+|++.++ .+..++ | .|++++|++
T Consensus 457 ~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l 535 (606)
T 3t6q_A 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535 (606)
T ss_dssp TTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCC
T ss_pred CCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcc
Confidence 55555542 12345555556666666666555555555555566666666665555433 344333 4 556666666
Q ss_pred ccccCccc---ccccceeecCCcCCC
Q 008121 236 SGWIPREL---ISIRTFIYDGNSFDN 258 (577)
Q Consensus 236 ~g~~p~~l---~~l~~l~~~~n~~~~ 258 (577)
++..|..+ .+++.+++++|++.|
T Consensus 536 ~~~~~~~~~~l~~L~~L~l~~N~~~c 561 (606)
T 3t6q_A 536 SIILPSLLPILSQQRTINLRQNPLDC 561 (606)
T ss_dssp CCCCGGGHHHHHTSSEEECTTCCEEC
T ss_pred cccCHhhcccCCCCCEEeCCCCCccc
Confidence 55544433 244555556665543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-20 Score=210.56 Aligned_cols=156 Identities=19% Similarity=0.299 Sum_probs=141.4
Q ss_pred ccccccCCCCCCEEEccCCCcCC-----------------cCCCCCC----CCccEEEccCCcCCCcCCCCccCCCCccE
Q 008121 99 MGYLLSDLLSLRKFDLSGNSIHD-----------------TIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSY 157 (577)
Q Consensus 99 ~~~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 157 (577)
+|..|++|++|+.|+|++|+|+| .+|..+. ++|++|+|++|++.+.+|..|+++++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 88899999999999999999998 3888774 89999999999999999999999999999
Q ss_pred EEeccCC-Ccc-cccccccCCC-------CCcEEeCcCCcccCCCCC--CccCCCCCCeEEccCcccccccccCCCCC-c
Q 008121 158 LNVSRNS-LTQ-SIGDIFGNLA-------GLATLDLSFNNFSGDLPN--SFISLSNISSLYLQNNQVTGSLNVFSGLP-L 225 (577)
Q Consensus 158 L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L 225 (577)
|+|++|+ |+| .+|..+++++ +|+.|+|++|+|+ .+|. .|+++++|++|+|++|+|+ .++.+..++ |
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L 597 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKL 597 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEE
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcc
Confidence 9999998 999 8998776665 9999999999999 8998 8999999999999999999 555777766 9
Q ss_pred cEEEeecCccccccCcccc---c-ccceeecCCcCC
Q 008121 226 TTLNVANNHFSGWIPRELI---S-IRTFIYDGNSFD 257 (577)
Q Consensus 226 ~~L~l~~N~l~g~~p~~l~---~-l~~l~~~~n~~~ 257 (577)
+.|+|++|+|+ .+|..+. + ++.|++++|.+.
T Consensus 598 ~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~ 632 (876)
T 4ecn_A 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK 632 (876)
T ss_dssp SEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC
T ss_pred eEEECcCCccc-cchHHHhhccccCCEEECcCCCCC
Confidence 99999999999 8997665 4 777899999876
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=200.78 Aligned_cols=187 Identities=20% Similarity=0.167 Sum_probs=159.3
Q ss_pred CCCCCC--CccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccE
Q 008121 69 DPCGES--WKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTS 133 (577)
Q Consensus 69 ~~c~~~--w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~ 133 (577)
..|.|. +..|.|.. ..++.|+|++|.|++..|..|+++++|++|+|++|++++..|..+. ++|++
T Consensus 6 ~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 85 (606)
T 3t6q_A 6 QKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDT 85 (606)
T ss_dssp CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCe
Confidence 345433 56788964 3689999999999999999999999999999999999988887775 89999
Q ss_pred EEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccc
Q 008121 134 LNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQV 213 (577)
Q Consensus 134 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l 213 (577)
|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|+|++|.+
T Consensus 86 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 165 (606)
T 3t6q_A 86 LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165 (606)
T ss_dssp EECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCC
T ss_pred eeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcc
Confidence 99999999999999999999999999999999998888999999999999999999974434555699999999999999
Q ss_pred ccccc-cCCCCC-cc--EEEeecCccccccCcccc--cccceeecCCc
Q 008121 214 TGSLN-VFSGLP-LT--TLNVANNHFSGWIPRELI--SIRTFIYDGNS 255 (577)
Q Consensus 214 ~~~~~-~~~~~~-L~--~L~l~~N~l~g~~p~~l~--~l~~l~~~~n~ 255 (577)
++..+ .+..++ |+ .|++++|.+++..|..+. +++.+++.+|.
T Consensus 166 ~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~ 213 (606)
T 3t6q_A 166 HYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213 (606)
T ss_dssp CEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCS
T ss_pred cccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCch
Confidence 98754 344444 66 899999999998887654 45666676664
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=7.1e-20 Score=184.41 Aligned_cols=178 Identities=23% Similarity=0.253 Sum_probs=157.8
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCC-CCCC--CCccEEEccCCcCCCcCCCCccCCCCccEE
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 158 (577)
...++.|+|++|.+++ +|..+..+++|++|+|++|++++..+ ..+. ++|++|+|++|++++..|..|..+++|++|
T Consensus 77 ~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 155 (306)
T 2z66_A 77 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155 (306)
T ss_dssp CSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence 3689999999999984 67789999999999999999996554 2333 899999999999999999999999999999
Q ss_pred EeccCCCcc-cccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCcc
Q 008121 159 NVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHF 235 (577)
Q Consensus 159 ~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l 235 (577)
+|++|.+++ .+|..+..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+ .+..++ |+.|++++|++
T Consensus 156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 235 (306)
T 2z66_A 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235 (306)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCC
Confidence 999999997 689999999999999999999998889999999999999999999998765 455554 99999999999
Q ss_pred ccccCcccc----cccceeecCCcCCCCC
Q 008121 236 SGWIPRELI----SIRTFIYDGNSFDNGP 260 (577)
Q Consensus 236 ~g~~p~~l~----~l~~l~~~~n~~~~~~ 260 (577)
++..|..+. +++.|++++|++.|..
T Consensus 236 ~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 236 MTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred cccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 998887654 5678999999998753
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.6e-19 Score=181.31 Aligned_cols=172 Identities=17% Similarity=0.262 Sum_probs=150.5
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+++.|+|++|.+++..|..|+.+++|++|+|++|+|+ .+|..+.++|++|++++|++++..+..|.++++|++|+|+
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 153 (330)
T 1xku_A 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153 (330)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECC
T ss_pred CCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhcccccEEECCCCcccccCHhHhcCCccccEEECC
Confidence 368999999999999999999999999999999999999 6888888999999999999998888889999999999999
Q ss_pred cCCCc--ccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCcccc
Q 008121 162 RNSLT--QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSG 237 (577)
Q Consensus 162 ~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g 237 (577)
+|+++ +..+..+.++++|++|++++|+++ .+|..+. ++|++|+|++|++++..+ .+..++ |+.|++++|.+++
T Consensus 154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 230 (330)
T 1xku_A 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230 (330)
T ss_dssp SSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred CCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence 99996 477888999999999999999998 5776664 789999999999988754 466655 9999999999998
Q ss_pred ccCcccc---cccceeecCCcCC
Q 008121 238 WIPRELI---SIRTFIYDGNSFD 257 (577)
Q Consensus 238 ~~p~~l~---~l~~l~~~~n~~~ 257 (577)
..|..+. +++.|++++|.+.
T Consensus 231 ~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 231 VDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp ECTTTGGGSTTCCEEECCSSCCS
T ss_pred eChhhccCCCCCCEEECCCCcCc
Confidence 7775554 6677888888876
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.6e-19 Score=168.77 Aligned_cols=170 Identities=24% Similarity=0.280 Sum_probs=141.0
Q ss_pred EEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCc
Q 008121 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSL 155 (577)
Q Consensus 78 v~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L 155 (577)
-.|.. +.+++++++++.. |..+ .++|++|+|++|+|++..+..+. ++|++|+|++|++++..+..|..+++|
T Consensus 5 C~C~~---~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 78 (208)
T 2o6s_A 5 CSCSG---TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78 (208)
T ss_dssp CEEET---TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEECC---CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCc
Confidence 45643 4688999998844 4333 46899999999999965554443 899999999999998877788999999
Q ss_pred cEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-ccEEEeecC
Q 008121 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP-LTTLNVANN 233 (577)
Q Consensus 156 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~L~l~~N 233 (577)
++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++.++. +..++ |+.|++++|
T Consensus 79 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 158 (208)
T 2o6s_A 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158 (208)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSC
T ss_pred CEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCC
Confidence 9999999999988888899999999999999999977777789999999999999999987764 55554 999999999
Q ss_pred ccccccCcccccccceeecCCcCC
Q 008121 234 HFSGWIPRELISIRTFIYDGNSFD 257 (577)
Q Consensus 234 ~l~g~~p~~l~~l~~l~~~~n~~~ 257 (577)
.+.+..| +++.|....|.+.
T Consensus 159 ~~~~~~~----~l~~L~~~~n~~~ 178 (208)
T 2o6s_A 159 PWDCTCP----GIRYLSEWINKHS 178 (208)
T ss_dssp CBCCCTT----TTHHHHHHHHHCT
T ss_pred CeecCCC----CHHHHHHHHHhCC
Confidence 9997765 4556666666654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=207.55 Aligned_cols=185 Identities=20% Similarity=0.161 Sum_probs=158.7
Q ss_pred CCCccEEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcC-CCCCC--CCccEEEccCCcCCCcCCCCc
Q 008121 73 ESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTI-PYQLP--PNLTSLNLASNNFSGNLPYSI 149 (577)
Q Consensus 73 ~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~--~~L~~L~l~~N~l~~~~p~~~ 149 (577)
+.|..|.+-..+++.|+|++|.|++..|..|.++++|++|||++|.+.+.+ |..+. ++|++|+|++|++++..|..|
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 467777774468999999999999999999999999999999999887777 55554 899999999999999999999
Q ss_pred cCCCCccEEEeccCCCccccccc--ccCCCCCcEEeCcCCcccCCCC-CCccCCCCCCeEEccCcccccccc-cCCC---
Q 008121 150 ASMVSLSYLNVSRNSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLN-VFSG--- 222 (577)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~-~~~~--- 222 (577)
+++++|++|+|++|.+++.+|.. |.++++|++|+|++|++++..| ..|+++++|++|+|++|.+++..+ .+..
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~ 173 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHH
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccC
Confidence 99999999999999999977765 9999999999999999997765 579999999999999999988654 3333
Q ss_pred CCccEEEeecCccccccCccccc---------ccceeecCCcCC
Q 008121 223 LPLTTLNVANNHFSGWIPRELIS---------IRTFIYDGNSFD 257 (577)
Q Consensus 223 ~~L~~L~l~~N~l~g~~p~~l~~---------l~~l~~~~n~~~ 257 (577)
..|+.|++++|.+++.+|..+.. ++.|++++|.+.
T Consensus 174 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 217 (844)
T 3j0a_A 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT 217 (844)
T ss_dssp CSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSS
T ss_pred CccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCc
Confidence 34889999999999888765443 677888888654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.80 E-value=5.2e-19 Score=176.76 Aligned_cols=153 Identities=21% Similarity=0.213 Sum_probs=136.3
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
..+++.|+|++|.|++..+. +.+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+
T Consensus 54 l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~ 130 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (290)
T ss_dssp CTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence 36899999999999976543 89999999999999998 6776654 8999999999999988889999999999999
Q ss_pred eccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCC-CccEEEeecCcccc
Q 008121 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL-PLTTLNVANNHFSG 237 (577)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~l~~N~l~g 237 (577)
|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+..+..+... .|+.|+|++|.+..
T Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccC
Confidence 9999999988888999999999999999999655566788999999999999999877655444 49999999999974
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=199.63 Aligned_cols=175 Identities=22% Similarity=0.253 Sum_probs=142.7
Q ss_pred CCCCCC--CccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccE
Q 008121 69 DPCGES--WKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTS 133 (577)
Q Consensus 69 ~~c~~~--w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~ 133 (577)
+||.+. -..|.|.. ..++.|||++|+|++..+.+|.++++|++|||++|+|++..|..|. ++|++
T Consensus 25 ~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~ 104 (635)
T 4g8a_A 25 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 104 (635)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCE
Confidence 466432 23577863 3689999999999988888999999999999999999965565554 89999
Q ss_pred EEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccC-CCCCCccCCCCCCeEEccCcc
Q 008121 134 LNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQ 212 (577)
Q Consensus 134 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~ 212 (577)
|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|+|++ .+|..++.+++|++|+|++|+
T Consensus 105 L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 184 (635)
T 4g8a_A 105 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 184 (635)
T ss_dssp EECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred EEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc
Confidence 9999999998888889999999999999999998888889999999999999999975 467888999999999999999
Q ss_pred cccccc-cCCC---CC--ccEEEeecCccccccCccc
Q 008121 213 VTGSLN-VFSG---LP--LTTLNVANNHFSGWIPREL 243 (577)
Q Consensus 213 l~~~~~-~~~~---~~--L~~L~l~~N~l~g~~p~~l 243 (577)
|++..+ .+.. .. ...++++.|.++...|..+
T Consensus 185 l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~ 221 (635)
T 4g8a_A 185 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 221 (635)
T ss_dssp CCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT
T ss_pred ccccccccccchhhhhhhhhhhhcccCcccccCcccc
Confidence 988654 2222 22 4578888888886555443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.9e-19 Score=195.89 Aligned_cols=174 Identities=20% Similarity=0.234 Sum_probs=123.8
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
..++.|+|++|.|++..|..|+.+++|++|+|++|.|++..|..+. ++|++|+|++|+|++..+..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 4688888988888888888888888888888888888876665544 78888888888888666666788888888888
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCC-----------------------------------------------
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL----------------------------------------------- 193 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~----------------------------------------------- 193 (577)
++|.|++..|..|+++++|++|+|++|+|++..
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L 234 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVEL 234 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCC
Confidence 888888877777777777777777777776421
Q ss_pred ------------CCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCcc---cccccceeecCCcC
Q 008121 194 ------------PNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPRE---LISIRTFIYDGNSF 256 (577)
Q Consensus 194 ------------p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~~---l~~l~~l~~~~n~~ 256 (577)
+..+..+++|++|+|++|.|++.++ .+..++ |+.|+|++|.|++ +|.. +.++..|++++|.+
T Consensus 235 ~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l 313 (597)
T 3oja_B 235 TILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 313 (597)
T ss_dssp CEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCC
T ss_pred CEEECCCCCCCCChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCC
Confidence 1124455667777777777776543 344444 6777777777765 2322 34555666666665
Q ss_pred C
Q 008121 257 D 257 (577)
Q Consensus 257 ~ 257 (577)
.
T Consensus 314 ~ 314 (597)
T 3oja_B 314 L 314 (597)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.8e-19 Score=190.54 Aligned_cols=174 Identities=18% Similarity=0.231 Sum_probs=134.0
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
.+++.|+|++|.+++..|..|+++++|++|+|++|+|++..+..+. ++|++|+|++|++++..|..|..+++|++|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 5789999999999998899999999999999999999854433343 88999999999999888889999999999999
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccc
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGW 238 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~ 238 (577)
++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+.+..+ .+..++ |+.|++++|.+.+.
T Consensus 136 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~ 215 (477)
T 2id5_A 136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215 (477)
T ss_dssp CCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCE
T ss_pred CCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccc
Confidence 9999998888889999999999999999986555668888888888888888877554 344333 56666665555554
Q ss_pred cCcccc---cccceeecCCcC
Q 008121 239 IPRELI---SIRTFIYDGNSF 256 (577)
Q Consensus 239 ~p~~l~---~l~~l~~~~n~~ 256 (577)
+|.... +++.|++++|.+
T Consensus 216 ~~~~~~~~~~L~~L~l~~n~l 236 (477)
T 2id5_A 216 MTPNCLYGLNLTSLSITHCNL 236 (477)
T ss_dssp ECTTTTTTCCCSEEEEESSCC
T ss_pred cCcccccCccccEEECcCCcc
Confidence 443222 344444444433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.79 E-value=7.6e-20 Score=185.31 Aligned_cols=169 Identities=20% Similarity=0.163 Sum_probs=121.1
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+++.|+|++|.+++..+ +..+++|++|+|++|+|++..+. ++|++|++++|++++..+.. +++|++|+|+
T Consensus 57 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~---~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~ 128 (317)
T 3o53_A 57 FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG---PSIETLHAANNNISRVSCSR---GQGKKNIYLA 128 (317)
T ss_dssp CTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEEC---TTCCEEECCSSCCSEEEECC---CSSCEEEECC
T ss_pred CCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCC---CCcCEEECCCCccCCcCccc---cCCCCEEECC
Confidence 4578888888888887665 88888888888888888753222 67777777777777655443 5678888888
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCcc-CCCCCCeEEccCcccccccccCCCCCccEEEeecCccccccC
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP 240 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p 240 (577)
+|++++..|..+..+++|++|+|++|++++..|..+. .+++|++|+|++|.|++.........|+.|++++|+|++..|
T Consensus 129 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~l~~ 208 (317)
T 3o53_A 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGP 208 (317)
T ss_dssp SSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECG
T ss_pred CCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCcchh
Confidence 8888877777788888888888888888876666653 677888888888888776443333348888888888875433
Q ss_pred c--ccccccceeecCCcCCC
Q 008121 241 R--ELISIRTFIYDGNSFDN 258 (577)
Q Consensus 241 ~--~l~~l~~l~~~~n~~~~ 258 (577)
. .+.+++.|++++|.+..
T Consensus 209 ~~~~l~~L~~L~L~~N~l~~ 228 (317)
T 3o53_A 209 EFQSAAGVTWISLRNNKLVL 228 (317)
T ss_dssp GGGGGTTCSEEECTTSCCCE
T ss_pred hhcccCcccEEECcCCcccc
Confidence 2 23356677778877653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-19 Score=195.01 Aligned_cols=174 Identities=21% Similarity=0.302 Sum_probs=125.9
Q ss_pred cEEEEEcCCCCCcccccccc-----cCCC--------------------------CCCEEEccCCCcCCcCCCCCCCCcc
Q 008121 84 AVVSIDISGLGLSGTMGYLL-----SDLL--------------------------SLRKFDLSGNSIHDTIPYQLPPNLT 132 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~-----~~l~--------------------------~L~~L~Ls~N~l~~~~p~~~~~~L~ 132 (577)
.++.|++++|.++|.+|..+ ..++ +|+.|++++|.+.........++|+
T Consensus 277 ~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~ 356 (562)
T 3a79_B 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356 (562)
T ss_dssp SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCC
T ss_pred cccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCce
Confidence 78899999999998888766 3333 3566666666654222112337888
Q ss_pred EEEccCCcCCCcCCCCccCCCCccEEEeccCCCcc--cccccccCCCCCcEEeCcCCcccCCCCC-CccCCCCCCeEEcc
Q 008121 133 SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ--SIGDIFGNLAGLATLDLSFNNFSGDLPN-SFISLSNISSLYLQ 209 (577)
Q Consensus 133 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~l~ 209 (577)
+|+|++|++++.+|..++++++|++|+|++|++++ .+|..|.++++|++|+|++|++++.+|. .+..+++|++|+|+
T Consensus 357 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~ 436 (562)
T 3a79_B 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436 (562)
T ss_dssp EEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECC
T ss_pred EEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECC
Confidence 88888888888888888888888888888888886 4456788888888888888888875665 47778888888888
Q ss_pred CcccccccccCCCCCccEEEeecCccccccCcccc---cccceeecCCcCCC
Q 008121 210 NNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 210 ~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
+|+|++.++......|+.|++++|+|+ .+|..+. +++.|++++|.+..
T Consensus 437 ~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~ 487 (562)
T 3a79_B 437 SNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS 487 (562)
T ss_dssp SSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC
T ss_pred CCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC
Confidence 888877554322235888888888887 6776543 55667788887763
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.5e-21 Score=214.00 Aligned_cols=199 Identities=21% Similarity=0.174 Sum_probs=83.2
Q ss_pred CChHHHHHHHHHHHhcCCCC--CCCCCCCCCCCCCCCCCccEEeeCCcEEEEEcCCCCCccc------------------
Q 008121 39 TDSSDVQALQVLYTSLNSPS--VLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGT------------------ 98 (577)
Q Consensus 39 ~~~~~~~~l~~~~~~~~~~~--~l~~w~~~~~~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~------------------ 98 (577)
....+.++|+.++..+.... .-..|......++ .|.++.++.++++.|+|.+|++...
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~ 206 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSG--TATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDED 206 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccc--cCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCc
Confidence 34567789999988875432 2335653333333 6999999888888887776665542
Q ss_pred ---------ccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcc
Q 008121 99 ---------MGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167 (577)
Q Consensus 99 ---------~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 167 (577)
.+..+..++.|+.|+|++|+|. .+|..+. ++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+
T Consensus 207 ~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 207 DDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 1334455555555555555555 3443332 55555555555555 55555555555555555555555
Q ss_pred cccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC--ccEEEeecCccccccCccc
Q 008121 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP--LTTLNVANNHFSGWIPREL 243 (577)
Q Consensus 168 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~--L~~L~l~~N~l~g~~p~~l 243 (577)
.+|..|++|++|++|+|++|.|+ .+|..|+.|++|++|+|++|.|++.++. +.... +..|+|++|.++|.+|..+
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l 361 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER 361 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc
Confidence 44555555555555555555554 4555555555555555555555554432 11111 2234555555555555544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=7.7e-19 Score=196.61 Aligned_cols=178 Identities=20% Similarity=0.195 Sum_probs=121.6
Q ss_pred CcEEEEEcCCCCCccccc-ccccCCCCCCEEEccCCCcCCc--------------------------CCCCCC--CCccE
Q 008121 83 SAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDT--------------------------IPYQLP--PNLTS 133 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~-~~~~~l~~L~~L~Ls~N~l~~~--------------------------~p~~~~--~~L~~ 133 (577)
.+++.|+|++|.+++.+| ..+..+++|+.|+|++|++++. +|..+. ++|++
T Consensus 405 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~ 484 (680)
T 1ziw_A 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484 (680)
T ss_dssp TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCE
T ss_pred CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCE
Confidence 467888888888877665 5677777777777777776543 333333 56777
Q ss_pred EEccCCcCCCcCCCCccCCCCccEEEeccCCCccccc--------ccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCe
Q 008121 134 LNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG--------DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205 (577)
Q Consensus 134 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 205 (577)
|+|++|++++..|..|.++++|++|+|++|++++..+ ..|.++++|++|+|++|+|+...+..|.++++|++
T Consensus 485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 564 (680)
T 1ziw_A 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcce
Confidence 7777777776666667777777777777777765422 23566777777777777777333345777777888
Q ss_pred EEccCccccccccc-CCCCC-ccEEEeecCccccccCc----ccccccceeecCCcCCCCC
Q 008121 206 LYLQNNQVTGSLNV-FSGLP-LTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFDNGP 260 (577)
Q Consensus 206 L~l~~N~l~~~~~~-~~~~~-L~~L~l~~N~l~g~~p~----~l~~l~~l~~~~n~~~~~~ 260 (577)
|+|++|+|++.++. +..++ |+.|+|++|+|++..|. .+.+++.+++++|+|.|..
T Consensus 565 L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred eECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 88888877776553 44444 78888888888766654 3456777788888887653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.79 E-value=9e-19 Score=182.65 Aligned_cols=173 Identities=20% Similarity=0.240 Sum_probs=97.6
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
+++.|+|++|.+++..+..|+.+++|++|+|++|++++..|..+. ++|++|+|++|+++...+..|.++++|++|+|+
T Consensus 70 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 149 (390)
T 3o6n_A 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 149 (390)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECC
Confidence 456666666666655555666666666666666666654444333 556666666666654333344556666666666
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCC------------------------------------------------
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL------------------------------------------------ 193 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~------------------------------------------------ 193 (577)
+|++++..|..|.++++|++|+|++|++++..
T Consensus 150 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~ 229 (390)
T 3o6n_A 150 NNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELT 229 (390)
T ss_dssp SSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCC
T ss_pred CCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeecccccccccc
Confidence 66666555555555555555555555554211
Q ss_pred -----------CCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCc---ccccccceeecCCcCC
Q 008121 194 -----------PNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPR---ELISIRTFIYDGNSFD 257 (577)
Q Consensus 194 -----------p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~---~l~~l~~l~~~~n~~~ 257 (577)
+..+..+++|++|+|++|.+++.++ .+..++ |+.|++++|++++ +|. .+.+++.|++++|.+.
T Consensus 230 ~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~ 308 (390)
T 3o6n_A 230 ILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 308 (390)
T ss_dssp EEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC
T ss_pred EEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce
Confidence 0123445666677777777666533 344444 6777777777764 232 2345566666666554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.5e-19 Score=173.76 Aligned_cols=170 Identities=18% Similarity=0.240 Sum_probs=145.0
Q ss_pred CCcEEEEEcCCCC-CcccccccccCCCCCCEEEccC-CCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCcc-
Q 008121 82 GSAVVSIDISGLG-LSGTMGYLLSDLLSLRKFDLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLS- 156 (577)
Q Consensus 82 ~~~v~~l~l~~~~-l~g~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~- 156 (577)
..+++.|+|++|. +++..+..|.++++|++|+|++ |+|++..+..+. ++|++|+|++|++++ +|. |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 3589999999997 8877777999999999999999 999965444443 899999999999997 676 88899998
Q ss_pred --EEEeccC-CCcccccccccCCCCCc-EEeCcCCcccCCCCCCccCCCCCCeEEccCcc-cccccc-cCCCC--CccEE
Q 008121 157 --YLNVSRN-SLTQSIGDIFGNLAGLA-TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ-VTGSLN-VFSGL--PLTTL 228 (577)
Q Consensus 157 --~L~L~~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~-~~~~~--~L~~L 228 (577)
+|+|++| ++++..+..|.++++|+ +|+|++|+++ .+|......++|++|+|++|+ |++.++ .+..+ .|+.|
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L 210 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEE
Confidence 9999999 99988888899999999 9999999999 666654445899999999995 998754 46666 49999
Q ss_pred EeecCccccccCcccccccceeecCC
Q 008121 229 NVANNHFSGWIPRELISIRTFIYDGN 254 (577)
Q Consensus 229 ~l~~N~l~g~~p~~l~~l~~l~~~~n 254 (577)
++++|+|++..+..+.+++.|.+.++
T Consensus 211 ~l~~N~l~~l~~~~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 211 DVSQTSVTALPSKGLEHLKELIARNT 236 (239)
T ss_dssp ECTTCCCCCCCCTTCTTCSEEECTTC
T ss_pred ECCCCccccCChhHhccCceeeccCc
Confidence 99999999655566888888887765
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-19 Score=167.05 Aligned_cols=151 Identities=17% Similarity=0.299 Sum_probs=127.0
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+++.|+|++|+++ .+| .+..+++|++|+|++|.++..-+..-.++|++|+|++|++++..|..|+.+++|++|+|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 357889999999998 555 699999999999999988743222233899999999999999889999999999999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCc-ccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCcccc
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNN-FSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSG 237 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g 237 (577)
+|++++..|..+..+++|++|+|++|+ ++ .+| .+..+++|++|++++|++++.. .+..++ |+.|++++|++.+
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC----
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcccCC
Confidence 999999889999999999999999998 65 676 6899999999999999999855 444444 9999999999864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.1e-19 Score=194.71 Aligned_cols=172 Identities=18% Similarity=0.264 Sum_probs=140.2
Q ss_pred cEEEEEcCCCCCcccccccc-----cCCCCCCEEEccCCCcCCcCC----------------------------CCCCCC
Q 008121 84 AVVSIDISGLGLSGTMGYLL-----SDLLSLRKFDLSGNSIHDTIP----------------------------YQLPPN 130 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~-----~~l~~L~~L~Ls~N~l~~~~p----------------------------~~~~~~ 130 (577)
.++.|+|++|.++|.+|..+ +.+++|+.+++++|.+ .+| ..-.++
T Consensus 248 ~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~ 325 (520)
T 2z7x_B 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325 (520)
T ss_dssp SCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCC
T ss_pred cccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCc
Confidence 67788888888888888777 6666666666666555 233 123389
Q ss_pred ccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcc--cccccccCCCCCcEEeCcCCcccCCCCCC-ccCCCCCCeEE
Q 008121 131 LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ--SIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLY 207 (577)
Q Consensus 131 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~ 207 (577)
|++|+|++|++++.+|..++.+++|++|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +..+++|++|+
T Consensus 326 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~ 405 (520)
T 2z7x_B 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405 (520)
T ss_dssp CCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEE
T ss_pred ccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEE
Confidence 9999999999999999999999999999999999997 67788999999999999999999867764 88899999999
Q ss_pred ccCcccccccccCCCCCccEEEeecCccccccCcccc---cccceeecCCcCCC
Q 008121 208 LQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 208 l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
|++|++++..+......|+.|++++|+|+ .+|..+. +++.|++++|.+..
T Consensus 406 Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~ 458 (520)
T 2z7x_B 406 MSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS 458 (520)
T ss_dssp CCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred CcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc
Confidence 99999988665433345999999999999 7887554 56778899998764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=7.6e-19 Score=177.16 Aligned_cols=168 Identities=18% Similarity=0.302 Sum_probs=129.1
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+++.|+|++|.+++..+ +..+++|++|+|++|+|++.....-.++|++|+|++|++++. |. +..+++|++|+|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~ 137 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLD 137 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECC
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCchhhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECC
Confidence 4678888999888887655 888888999999999888532222237889999999988864 33 8888889999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCC-CccEEEeecCccccccC
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL-PLTTLNVANNHFSGWIP 240 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~l~~N~l~g~~p 240 (577)
+|++++..+ +..+++|++|+|++|++++ ++. +..+++|+.|+|++|++++..+ +..+ .|+.|++++|++++..|
T Consensus 138 ~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~ 212 (308)
T 1h6u_A 138 LNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP 212 (308)
T ss_dssp SSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG
T ss_pred CCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcccc
Confidence 998887655 7888889999999998885 444 8888889999999998887655 3334 38889999998886554
Q ss_pred -cccccccceeecCCcCCC
Q 008121 241 -RELISIRTFIYDGNSFDN 258 (577)
Q Consensus 241 -~~l~~l~~l~~~~n~~~~ 258 (577)
..+.+++.|++++|++.+
T Consensus 213 l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 213 LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp GTTCTTCCEEEEEEEEEEC
T ss_pred ccCCCCCCEEEccCCeeec
Confidence 234466778888888754
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.8e-19 Score=161.35 Aligned_cols=135 Identities=21% Similarity=0.295 Sum_probs=82.3
Q ss_pred CCCCCCCccEEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCC
Q 008121 69 DPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146 (577)
Q Consensus 69 ~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p 146 (577)
+.|.|+|.+|.|+.. +++ .+|..+ .++|+.|+|++|+|++..+..+. ++|++|+|++|+|++..+
T Consensus 3 ~~C~C~~~~l~~~~~----------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSK----------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD 69 (177)
T ss_dssp TTCEEETTEEECCSS----------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CCCEeCCCEEEecCC----------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence 567778888877643 333 223222 25667777777777644333332 566666666666665555
Q ss_pred CCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccc
Q 008121 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (577)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (577)
..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|++|.+.+.
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 5566666666666666666666666666666666666666666644444455666666666666665543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-18 Score=162.53 Aligned_cols=130 Identities=26% Similarity=0.351 Sum_probs=119.9
Q ss_pred CEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCC-CccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCc
Q 008121 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY-SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (577)
Q Consensus 110 ~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 188 (577)
+.|++++|+|+ .+|..++.+|++|+|++|+|++..+. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 89 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred CEEEcCCCCcC-cCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence 78999999996 79988889999999999999987775 58999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccC
Q 008121 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p 240 (577)
|++..|..|..+++|++|+|++|+|++.++ .+..++ |+.|+|++|.+++..+
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999888889999999999999999999765 466665 9999999999998776
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-18 Score=177.88 Aligned_cols=168 Identities=24% Similarity=0.289 Sum_probs=104.6
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCC--CcCCCCccCCCCccEE
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS--GNLPYSIASMVSLSYL 158 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L 158 (577)
.+++.|+|++|.++ .+|..+. ++|++|+|++|+|++..+..+. ++|++|+|++|.++ +..|..+..+ +|++|
T Consensus 102 ~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L 177 (332)
T 2ft3_A 102 RKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYL 177 (332)
T ss_dssp TTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCC
T ss_pred CCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEE
Confidence 46777888888777 4444444 6777777777777743332232 67777777777775 3566666666 66777
Q ss_pred EeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccc
Q 008121 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFS 236 (577)
Q Consensus 159 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~ 236 (577)
++++|++++ +|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|++.++ .+..++ |+.|++++|+|+
T Consensus 178 ~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 178 RISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp BCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred ECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence 777776665 343332 566666666666666555666666666666666666666544 343333 666666666666
Q ss_pred cccCcccc---cccceeecCCcCCC
Q 008121 237 GWIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 237 g~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
.+|..+. +++.|++++|.+..
T Consensus 255 -~lp~~l~~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 255 -RVPAGLPDLKLLQVVYLHTNNITK 278 (332)
T ss_dssp -BCCTTGGGCTTCCEEECCSSCCCB
T ss_pred -ecChhhhcCccCCEEECCCCCCCc
Confidence 5555443 34556666666543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-19 Score=193.27 Aligned_cols=176 Identities=25% Similarity=0.294 Sum_probs=139.8
Q ss_pred CcEEEEEcCCCCCcccc--cccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCC-CCccCCCCccE
Q 008121 83 SAVVSIDISGLGLSGTM--GYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP-YSIASMVSLSY 157 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~ 157 (577)
..++.|+|++|.+++.. |..+..+++|++|+|++|++++..+. +. ++|++|++++|++++..| ..+.++++|++
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 425 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence 56778888888887654 67788888888888888888754332 32 788888888888887766 56788888899
Q ss_pred EEeccCCCcccccccccCCCCCcEEeCcCCccc-CCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCc
Q 008121 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS-GDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNH 234 (577)
Q Consensus 158 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~ 234 (577)
|+|++|++++.+|..|.++++|++|+|++|+++ +.+|..+..+++|++|+|++|++++.++ .+..++ |+.|++++|+
T Consensus 426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 505 (570)
T 2z63_A 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505 (570)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence 999999888888888888888999999998887 5788888888889999999988888744 565555 8889999998
Q ss_pred cccccCcccc---cccceeecCCcCCCC
Q 008121 235 FSGWIPRELI---SIRTFIYDGNSFDNG 259 (577)
Q Consensus 235 l~g~~p~~l~---~l~~l~~~~n~~~~~ 259 (577)
+++..|..+. +++.+++++|++.|.
T Consensus 506 l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 506 LKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 8877766554 566778888887654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.1e-18 Score=171.02 Aligned_cols=169 Identities=20% Similarity=0.200 Sum_probs=143.5
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCC
Q 008121 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (577)
Q Consensus 87 ~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (577)
.++..+.++. .+|..+. ++|++|+|++|+|++..+..+. ++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4677887776 4555543 5799999999999976665554 899999999999998888899999999999999999
Q ss_pred CcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccc--cccCCCCC-ccEEEeecCccccccCc
Q 008121 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS--LNVFSGLP-LTTLNVANNHFSGWIPR 241 (577)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~-L~~L~l~~N~l~g~~p~ 241 (577)
+++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++. +..+..++ |+.|++++|++++..+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 9999999999999999999999999987777899999999999999999873 44566655 99999999999987776
Q ss_pred cccc---cc----ceeecCCcCCC
Q 008121 242 ELIS---IR----TFIYDGNSFDN 258 (577)
Q Consensus 242 ~l~~---l~----~l~~~~n~~~~ 258 (577)
.+.. ++ .+++++|.+..
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~ 191 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNF 191 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCE
T ss_pred HhhhhhhccccceeeecCCCcccc
Confidence 6654 33 67788888753
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.6e-19 Score=182.31 Aligned_cols=168 Identities=24% Similarity=0.246 Sum_probs=145.1
Q ss_pred CCCCCCCccEEeeC-----------CcEEEEEcCCCCCccccccccc-CCCCCCEEEccCCCcCCcCCCCCC--CCccEE
Q 008121 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLS-DLLSLRKFDLSGNSIHDTIPYQLP--PNLTSL 134 (577)
Q Consensus 69 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L 134 (577)
..|.|.+..|.|.. ..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..+. ++|++|
T Consensus 14 ~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 93 (361)
T 2xot_A 14 ANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYL 93 (361)
T ss_dssp TTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEE
Confidence 45777899999975 2478999999999998888888 999999999999999976665565 899999
Q ss_pred EccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCC-c---cCCCCCCeEEccC
Q 008121 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-F---ISLSNISSLYLQN 210 (577)
Q Consensus 135 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~---~~l~~L~~L~l~~ 210 (577)
+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++ +|.. | ..+++|+.|+|++
T Consensus 94 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~ 172 (361)
T 2xot_A 94 DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSS 172 (361)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CTTCCEEECCS
T ss_pred ECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCC
Confidence 999999998888899999999999999999999999999999999999999999995 5554 4 5799999999999
Q ss_pred cccccccc-cCCCCC---ccEEEeecCcccc
Q 008121 211 NQVTGSLN-VFSGLP---LTTLNVANNHFSG 237 (577)
Q Consensus 211 N~l~~~~~-~~~~~~---L~~L~l~~N~l~g 237 (577)
|+|++.+. .+..++ ++.|+|++|.+..
T Consensus 173 N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp SCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 99998653 344444 5889999999974
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=192.45 Aligned_cols=180 Identities=21% Similarity=0.223 Sum_probs=141.2
Q ss_pred CCCCCCCCCCCCCCCCCccEEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEc
Q 008121 59 VLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNL 136 (577)
Q Consensus 59 ~l~~w~~~~~~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l 136 (577)
.+..|.. .-|. .|..-.|..... +.+.++.+|+ .+|..+. +++++|||++|+|++..|..|. ++|++|||
T Consensus 12 ~~~~~~~--~~p~--~~~~c~~~~~~~-~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~L 83 (635)
T 4g8a_A 12 KLAAANS--SIPE--SWEPCVEVVPNI-TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 83 (635)
T ss_dssp -----------------CCSEEEETTT-EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred hhhcccC--CCCC--CCCCccccCCCC-EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEEC
Confidence 4666763 3455 587655554433 4689999998 4565443 4799999999999966566665 89999999
Q ss_pred cCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccc
Q 008121 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (577)
Q Consensus 137 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (577)
++|+|++..|++|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|.|++.
T Consensus 84 s~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~ 163 (635)
T 4g8a_A 84 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 163 (635)
T ss_dssp TTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC
T ss_pred CCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccC
Confidence 99999998889999999999999999999998889999999999999999999987777899999999999999999874
Q ss_pred -c-ccCCCCC-ccEEEeecCccccccCcccccc
Q 008121 217 -L-NVFSGLP-LTTLNVANNHFSGWIPRELISI 246 (577)
Q Consensus 217 -~-~~~~~~~-L~~L~l~~N~l~g~~p~~l~~l 246 (577)
+ ..+..++ |+.|++++|+|++..|..+..+
T Consensus 164 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L 196 (635)
T 4g8a_A 164 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 196 (635)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred CCchhhccchhhhhhcccCccccccccccccch
Confidence 3 3455554 9999999999998888776644
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=190.43 Aligned_cols=173 Identities=20% Similarity=0.218 Sum_probs=151.3
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
..++.|+|++|++++..+..|.++++|++|||++|++++..|..+. ++|++|+|++|++++..|..|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 4689999999999999999999999999999999999976666565 89999999999999988899999999999999
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccC-CCCCCccCCCCCCeEEccCcccccccc-cCCCCC-c----cEEEeecC
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-L----TTLNVANN 233 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L----~~L~l~~N 233 (577)
++|++++..+..|+++++|++|+|++|++++ .+|..|+++++|++|++++|++++.++ .+..+. | ..|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999998877789999999999999999997 479999999999999999999998654 233222 4 78999999
Q ss_pred ccccccCcccc--cccceeecCCc
Q 008121 234 HFSGWIPRELI--SIRTFIYDGNS 255 (577)
Q Consensus 234 ~l~g~~p~~l~--~l~~l~~~~n~ 255 (577)
.+++..|..+. +++.+++.+|.
T Consensus 188 ~l~~~~~~~~~~~~L~~L~l~~n~ 211 (570)
T 2z63_A 188 PMNFIQPGAFKEIRLHKLTLRNNF 211 (570)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCC
T ss_pred CceecCHHHhccCcceeEeccccc
Confidence 99988777665 46677777763
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.9e-18 Score=175.37 Aligned_cols=176 Identities=26% Similarity=0.313 Sum_probs=148.3
Q ss_pred ccEEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCC
Q 008121 76 KGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMV 153 (577)
Q Consensus 76 ~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~ 153 (577)
....|....+ .++++++++ .+|..+. ++|++|+|++|+|++..+..+. ++|++|+|++|++++..|..|++++
T Consensus 26 ~~~~C~~~~~--c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 100 (353)
T 2z80_A 26 ASLSCDRNGI--CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG 100 (353)
T ss_dssp -CCEECTTSE--EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred cCCCCCCCeE--eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCC
Confidence 4578887666 899999998 4565554 4899999999999965554554 8999999999999998899999999
Q ss_pred CccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCC--CccCCCCCCeEEccCcc-cccccc-cCCCCC-ccEE
Q 008121 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN--SFISLSNISSLYLQNNQ-VTGSLN-VFSGLP-LTTL 228 (577)
Q Consensus 154 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~-l~~~~~-~~~~~~-L~~L 228 (577)
+|++|+|++|++++..+..|.++++|++|+|++|++++ +|. .|..+++|++|++++|+ +.+..+ .+..++ |+.|
T Consensus 101 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L 179 (353)
T 2z80_A 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179 (353)
T ss_dssp TCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred CCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEE
Confidence 99999999999998777779999999999999999995 555 78999999999999995 666544 466665 9999
Q ss_pred EeecCccccccCccccc---ccceeecCCcCC
Q 008121 229 NVANNHFSGWIPRELIS---IRTFIYDGNSFD 257 (577)
Q Consensus 229 ~l~~N~l~g~~p~~l~~---l~~l~~~~n~~~ 257 (577)
++++|++++..|..+.+ ++.|++++|.+.
T Consensus 180 ~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp EEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred ECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 99999999988887764 566778888753
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.4e-18 Score=184.71 Aligned_cols=155 Identities=21% Similarity=0.336 Sum_probs=130.8
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
.+++.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +..+|++|+|++|+|++ +|. .+++|+.|+|++
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 149 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPASLKHLDVDNNQLTM-LPE---LPALLEYINADN 149 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhcCCCEEECCCCcCCC-CCC---cCccccEEeCCC
Confidence 57999999999999 566 568999999999999997 887 77799999999999997 676 689999999999
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCCc-------cEEEeecCcc
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPL-------TTLNVANNHF 235 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L-------~~L~l~~N~l 235 (577)
|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+..+. +.. .| +.|+|++|+|
T Consensus 150 N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~-~L~~~~~~L~~L~Ls~N~l 219 (571)
T 3cvr_A 150 NQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV-RNHHSEETEIFFRCRENRI 219 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC---------CCEEEECCSSCC
T ss_pred CccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH-hhhcccccceEEecCCCcc
Confidence 99997 565 67899999999999996 787 66 899999999999996655 444 56 9999999999
Q ss_pred ccccCcccc---cccceeecCCcCCC
Q 008121 236 SGWIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 236 ~g~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
+ .+|..+. ++..|++++|++.+
T Consensus 220 ~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 220 T-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp C-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred e-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 9 6887655 55678899998864
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.7e-18 Score=170.69 Aligned_cols=166 Identities=22% Similarity=0.298 Sum_probs=127.8
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
.+++.|++++|.++.. +.+..+++|++|+|++|+|++..|..-.++|++|+|++|++++ +| .+..+++|++|+|++
T Consensus 46 ~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~ 121 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH 121 (291)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred CcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcccccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCC
Confidence 4678888888888755 3488888889999999888875553333888889999888886 33 388888889999999
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccCc
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPR 241 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p~ 241 (577)
|++++. +.+..+++|+.|+|++|++++. ..+..+++|++|+|++|+|++..+ +..++ |+.|++++|.|++ +|.
T Consensus 122 n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~-l~~ 195 (291)
T 1h6t_A 122 NGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LRA 195 (291)
T ss_dssp SCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CGG
T ss_pred CcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCC-Chh
Confidence 988874 4577888889999999888854 568888888999999888888766 54444 8888999888885 342
Q ss_pred --ccccccceeecCCcCCC
Q 008121 242 --ELISIRTFIYDGNSFDN 258 (577)
Q Consensus 242 --~l~~l~~l~~~~n~~~~ 258 (577)
.+.+++.|++++|++..
T Consensus 196 l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 196 LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GTTCTTCSEEEEEEEEEEC
T ss_pred hccCCCCCEEECcCCcccC
Confidence 34466777888887654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.3e-18 Score=185.52 Aligned_cols=174 Identities=25% Similarity=0.305 Sum_probs=150.5
Q ss_pred EEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCc
Q 008121 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSL 155 (577)
Q Consensus 78 v~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L 155 (577)
..|....+ .++++++++ .+|..+. ++|++|+|++|+|++..|..+. ++|++|+|++|++++..|..|+++++|
T Consensus 2 ~~C~~~~~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 76 (549)
T 2z81_A 2 LSCDASGV--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76 (549)
T ss_dssp CEECTTSE--EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ccCCCCce--EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccC
Confidence 36877776 799999998 5565554 7999999999999987777765 899999999999999999999999999
Q ss_pred cEEEeccCCCcccccccccCCCCCcEEeCcCCcccC-CCCCCccCCCCCCeEEccCcccccccc--cCCCCC-ccEEEee
Q 008121 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLN--VFSGLP-LTTLNVA 231 (577)
Q Consensus 156 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~-L~~L~l~ 231 (577)
++|+|++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|++++|.+.+.++ .+..++ |+.|+++
T Consensus 77 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~ 156 (549)
T 2z81_A 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156 (549)
T ss_dssp CEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred CEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeecc
Confidence 999999999999999889999999999999999996 367889999999999999999554443 566666 9999999
Q ss_pred cCccccccCccccc---ccceeecCCcC
Q 008121 232 NNHFSGWIPRELIS---IRTFIYDGNSF 256 (577)
Q Consensus 232 ~N~l~g~~p~~l~~---l~~l~~~~n~~ 256 (577)
+|.+++.+|..+.. ++.|.+.+|..
T Consensus 157 ~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 157 ALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp ETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred CCcccccChhhhhccccCceEecccCcc
Confidence 99999999987765 45677777764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=5e-18 Score=183.83 Aligned_cols=149 Identities=21% Similarity=0.263 Sum_probs=117.8
Q ss_pred CCCEEEccCCCcCCcCCCCC-----C--CCccEEEccCCcC--------------------------CCcCCCCccCCCC
Q 008121 108 SLRKFDLSGNSIHDTIPYQL-----P--PNLTSLNLASNNF--------------------------SGNLPYSIASMVS 154 (577)
Q Consensus 108 ~L~~L~Ls~N~l~~~~p~~~-----~--~~L~~L~l~~N~l--------------------------~~~~p~~~~~l~~ 154 (577)
+|++|+|++|+++|.+|..+ . ++|+.|++++|.+ .+.. .+..+++
T Consensus 248 ~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~ 325 (520)
T 2z7x_B 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISP 325 (520)
T ss_dssp SCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCC
T ss_pred cccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcccccc--chhhCCc
Confidence 56677777777777777655 2 3333444444333 2111 0167899
Q ss_pred ccEEEeccCCCcccccccccCCCCCcEEeCcCCcccC--CCCCCccCCCCCCeEEccCcccccccc--cCCCCC-ccEEE
Q 008121 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG--DLPNSFISLSNISSLYLQNNQVTGSLN--VFSGLP-LTTLN 229 (577)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~-L~~L~ 229 (577)
|++|+|++|++++.+|..+.++++|++|+|++|++++ .+|..+..+++|++|+|++|.+++.++ .+..++ |+.|+
T Consensus 326 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~ 405 (520)
T 2z7x_B 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405 (520)
T ss_dssp CCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEE
T ss_pred ccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEE
Confidence 9999999999999999999999999999999999996 566789999999999999999998443 355554 99999
Q ss_pred eecCccccccCccc-ccccceeecCCcCCC
Q 008121 230 VANNHFSGWIPREL-ISIRTFIYDGNSFDN 258 (577)
Q Consensus 230 l~~N~l~g~~p~~l-~~l~~l~~~~n~~~~ 258 (577)
+++|++++.+|..+ .+++.|++++|.+..
T Consensus 406 Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~ 435 (520)
T 2z7x_B 406 MSSNILTDTIFRCLPPRIKVLDLHSNKIKS 435 (520)
T ss_dssp CCSSCCCGGGGGSCCTTCCEEECCSSCCCC
T ss_pred CcCCCCCcchhhhhcccCCEEECCCCcccc
Confidence 99999999999888 589999999998863
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.75 E-value=8.6e-18 Score=169.44 Aligned_cols=169 Identities=23% Similarity=0.335 Sum_probs=142.7
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+++.|++++|+++. ++ .+..+++|++|+|++|++++..+..-.++|++|+|++|++++. | .+..+++|++|+|+
T Consensus 40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLT 115 (308)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECT
T ss_pred cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChhHccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECC
Confidence 3578999999999986 44 6899999999999999999755533338999999999999964 4 68999999999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p 240 (577)
+|++++..+ +..+++|++|+|++|++++. +. +..+++|++|+|++|++++..+ +..++ |+.|++++|++++..+
T Consensus 116 ~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~ 190 (308)
T 1h6u_A 116 STQITDVTP--LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP 190 (308)
T ss_dssp TSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG
T ss_pred CCCCCCchh--hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcChh
Confidence 999997543 89999999999999999964 43 8899999999999999998666 55554 9999999999997554
Q ss_pred -cccccccceeecCCcCCCC
Q 008121 241 -RELISIRTFIYDGNSFDNG 259 (577)
Q Consensus 241 -~~l~~l~~l~~~~n~~~~~ 259 (577)
..+.+++.|++++|.+...
T Consensus 191 l~~l~~L~~L~L~~N~l~~~ 210 (308)
T 1h6u_A 191 LASLPNLIEVHLKNNQISDV 210 (308)
T ss_dssp GGGCTTCCEEECTTSCCCBC
T ss_pred hcCCCCCCEEEccCCccCcc
Confidence 3455788899999987643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.7e-18 Score=158.57 Aligned_cols=113 Identities=27% Similarity=0.456 Sum_probs=54.2
Q ss_pred CCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCC
Q 008121 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202 (577)
Q Consensus 123 ~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 202 (577)
+|..++++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++
T Consensus 25 ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~ 103 (193)
T 2wfh_A 25 LPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKS 103 (193)
T ss_dssp CCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTT
T ss_pred CCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCC
Confidence 33333344444444444444 34444445555555555555555444444555555555555555555444444555555
Q ss_pred CCeEEccCcccccccc-cCCCCC-ccEEEeecCccc
Q 008121 203 ISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFS 236 (577)
Q Consensus 203 L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~ 236 (577)
|++|+|++|+|++.++ .+..++ |+.|+|++|.+.
T Consensus 104 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 104 LRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 5555555555554333 233332 555555555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-17 Score=155.60 Aligned_cols=126 Identities=26% Similarity=0.277 Sum_probs=110.8
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCC
Q 008121 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (577)
Q Consensus 87 ~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (577)
.+++++|+|+ .+|..+. .+|++|+|++|+|+ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4566677777 4555543 58999999999998 6776664 899999999999999989999999999999999999
Q ss_pred CcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccc
Q 008121 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (577)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (577)
|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 9999999999999999999999999976666799999999999999998753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.74 E-value=6.4e-18 Score=173.57 Aligned_cols=190 Identities=20% Similarity=0.176 Sum_probs=151.1
Q ss_pred CCCCCCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC---CCcc-EE
Q 008121 70 PCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLT-SL 134 (577)
Q Consensus 70 ~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~L~-~L 134 (577)
.|.|+|..|.|++ ..++.|+|++|+|+...+.+|.+|++|++|+|++|++.+.+|.... ++|+ .+
T Consensus 6 ~C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 6 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp SSEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred ccEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 3778999999975 2578999999999977677899999999999999999888886542 4544 57
Q ss_pred EccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcC-CcccCCCCCCccCCC-CCCeEEccCcc
Q 008121 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF-NNFSGDLPNSFISLS-NISSLYLQNNQ 212 (577)
Q Consensus 135 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~-~L~~L~l~~N~ 212 (577)
++++|+++...|+.|..+++|++|++++|+|++..+..+....++..|++.+ |++....+..|..+. .++.|+|++|+
T Consensus 86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~ 165 (350)
T 4ay9_X 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165 (350)
T ss_dssp EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred cccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence 7888999988899999999999999999999988887777788888898865 677755555676664 58889999999
Q ss_pred ccccccc-CCCCCccEEEeecCccccccCc-c---cccccceeecCCcCCCC
Q 008121 213 VTGSLNV-FSGLPLTTLNVANNHFSGWIPR-E---LISIRTFIYDGNSFDNG 259 (577)
Q Consensus 213 l~~~~~~-~~~~~L~~L~l~~N~l~g~~p~-~---l~~l~~l~~~~n~~~~~ 259 (577)
|+...+. +...+|+.|++++|+..+.+|. . +.+++.|++++|.+..-
T Consensus 166 i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 166 IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp CCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred ccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCcc
Confidence 9886654 5555688899886444446664 2 34677888888887643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.73 E-value=8.4e-18 Score=183.92 Aligned_cols=172 Identities=23% Similarity=0.264 Sum_probs=118.6
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCC--cCCCCccCCCCccEE
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSG--NLPYSIASMVSLSYL 158 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L 158 (577)
.+++.|++++|++.... .+..+++|++|+|++|++++.+|..+. ++|++|+|++|++++ .+|..|+++++|++|
T Consensus 331 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L 408 (562)
T 3a79_B 331 MNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL 408 (562)
T ss_dssp CCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEE
T ss_pred CcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEE
Confidence 34777777777775322 126777778888888887776776654 677888888887775 334667777788888
Q ss_pred EeccCCCcccccc-cccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccc
Q 008121 159 NVSRNSLTQSIGD-IFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS 236 (577)
Q Consensus 159 ~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~ 236 (577)
+|++|++++.+|. .+..+++|++|+|++|+|++.+|..+. ++|++|+|++|+|+..++.+..++ |+.|+|++|+|+
T Consensus 409 ~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK 486 (562)
T ss_dssp ECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC
T ss_pred ECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC
Confidence 8888887774443 477777788888888877776666554 577788888887776555444444 777888888877
Q ss_pred cccCcc-cc---cccceeecCCcCCCC
Q 008121 237 GWIPRE-LI---SIRTFIYDGNSFDNG 259 (577)
Q Consensus 237 g~~p~~-l~---~l~~l~~~~n~~~~~ 259 (577)
.+|.. +. +++.+++++|++.|.
T Consensus 487 -~l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 487 -SVPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp -CCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred -CCCHHHHhcCCCCCEEEecCCCcCCC
Confidence 45543 33 455677777777653
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.73 E-value=3.4e-17 Score=173.98 Aligned_cols=161 Identities=22% Similarity=0.329 Sum_probs=120.2
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
.+++.|+|++|++++ +| .|+++++|++|+|++|++++ +|... ++|++|+|++|++++ +| .++++++|++|++++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~-~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~ 204 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP-PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN 204 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc-ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence 467777888888776 55 58888888888888888875 56543 688888888888886 55 578888888888888
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCCccEEEeecCccccccCcc
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE 242 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~ 242 (577)
|++++ +|.. .++|++|++++|+++ .+|. ++.+++|++|++++|++++.+... ..|+.|++++|++++ +|..
T Consensus 205 N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~l~~~~--~~L~~L~l~~N~l~~-l~~~ 275 (454)
T 1jl5_A 205 NSLKK-LPDL---PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTLPDLP--PSLEALNVRDNYLTD-LPEL 275 (454)
T ss_dssp SCCSS-CCCC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSCCSCC--TTCCEEECCSSCCSC-CCCC
T ss_pred CcCCc-CCCC---cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCcccccc--cccCEEECCCCcccc-cCcc
Confidence 88886 4433 257888888888887 6774 778888888888888888754322 347888888888885 6766
Q ss_pred cccccceeecCCcCCC
Q 008121 243 LISIRTFIYDGNSFDN 258 (577)
Q Consensus 243 l~~l~~l~~~~n~~~~ 258 (577)
+.+++.|++++|.+..
T Consensus 276 ~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 276 PQSLTFLDVSENIFSG 291 (454)
T ss_dssp CTTCCEEECCSSCCSE
T ss_pred cCcCCEEECcCCccCc
Confidence 6777888888887654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.5e-18 Score=173.48 Aligned_cols=177 Identities=20% Similarity=0.221 Sum_probs=148.2
Q ss_pred eeCCcEEEEEcCCCCCccccc----ccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCc--C--CCCc
Q 008121 80 CEGSAVVSIDISGLGLSGTMG----YLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN--L--PYSI 149 (577)
Q Consensus 80 C~~~~v~~l~l~~~~l~g~~~----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~--~--p~~~ 149 (577)
.....++.|+|++|.+++..+ ..+..+++|++|+|++|+|++..|..+. ++|++|+|++|++.+. + +..+
T Consensus 114 ~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 193 (310)
T 4glp_A 114 ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCP 193 (310)
T ss_dssp CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCT
T ss_pred ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhh
Confidence 345679999999999998665 4566899999999999999987776664 8999999999998763 2 2345
Q ss_pred cCCCCccEEEeccCCCccccc--c-cccCCCCCcEEeCcCCcccCCCCCCccCC---CCCCeEEccCcccccccccCCCC
Q 008121 150 ASMVSLSYLNVSRNSLTQSIG--D-IFGNLAGLATLDLSFNNFSGDLPNSFISL---SNISSLYLQNNQVTGSLNVFSGL 223 (577)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p--~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~ 223 (577)
+.+++|++|+|++|+++...+ . .+.++++|++|+|++|+|++..|..+..+ ++|++|+|++|+|+..+..+. .
T Consensus 194 ~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~-~ 272 (310)
T 4glp_A 194 HKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP-A 272 (310)
T ss_dssp TSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC-S
T ss_pred hcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc-C
Confidence 789999999999999984322 2 35789999999999999998889888877 699999999999996655443 5
Q ss_pred CccEEEeecCcccc-ccCcccccccceeecCCcCC
Q 008121 224 PLTTLNVANNHFSG-WIPRELISIRTFIYDGNSFD 257 (577)
Q Consensus 224 ~L~~L~l~~N~l~g-~~p~~l~~l~~l~~~~n~~~ 257 (577)
.|+.|+|++|+|++ +.+..+.+++.|++++|++.
T Consensus 273 ~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 273 KLRVLDLSSNRLNRAPQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CCSCEECCSCCCCSCCCTTSCCCCSCEECSSTTTS
T ss_pred CCCEEECCCCcCCCCchhhhCCCccEEECcCCCCC
Confidence 69999999999998 56778889999999999975
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.3e-17 Score=152.11 Aligned_cols=131 Identities=21% Similarity=0.298 Sum_probs=118.7
Q ss_pred CCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCc
Q 008121 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (577)
Q Consensus 109 L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 188 (577)
.+.+++++|+++ .+|..+.++|++|+|++|++++..+..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCEEEecCCCCc-cCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 578999999998 6888888999999999999998888889999999999999999998888889999999999999999
Q ss_pred ccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-ccEEEeecCccccccC
Q 008121 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~L~l~~N~l~g~~p 240 (577)
|++..+..|..+++|++|+|++|+|++.++. +..++ |+.|++++|.+++..|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9987777789999999999999999987764 45554 9999999999998766
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.2e-18 Score=173.31 Aligned_cols=169 Identities=17% Similarity=0.201 Sum_probs=142.6
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
...++.|+|++|.+++.. .+++|++|+|++|+|++..+.. .++|++|+|++|++++..|..++.+++|++|+|+
T Consensus 79 l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~-~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (317)
T 3o53_A 79 LSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR-GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (317)
T ss_dssp CTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC-CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECT
T ss_pred cCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc-cCCCCEEECCCCCCCCccchhhhccCCCCEEECC
Confidence 468999999999998654 3489999999999999655544 4889999999999999888899999999999999
Q ss_pred cCCCcccccccc-cCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCcccccc
Q 008121 162 RNSLTQSIGDIF-GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWI 239 (577)
Q Consensus 162 ~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~ 239 (577)
+|++++..|..+ ..+++|++|+|++|+|++. |. ...+++|++|+|++|+|++.++.+..++ |+.|++++|+|+ .+
T Consensus 153 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l 229 (317)
T 3o53_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LI 229 (317)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EE
T ss_pred CCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-ch
Confidence 999999888777 4799999999999999954 43 3358999999999999999877666655 999999999999 56
Q ss_pred Cccc---ccccceeecCCcCCCC
Q 008121 240 PREL---ISIRTFIYDGNSFDNG 259 (577)
Q Consensus 240 p~~l---~~l~~l~~~~n~~~~~ 259 (577)
|..+ .+++.+++++|++.|.
T Consensus 230 ~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 230 EKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CTTCCCCTTCCEEECTTCCCBHH
T ss_pred hhHhhcCCCCCEEEccCCCccCc
Confidence 7655 4677889999998743
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.3e-17 Score=176.17 Aligned_cols=165 Identities=28% Similarity=0.426 Sum_probs=80.5
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCC
Q 008121 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (577)
Q Consensus 85 v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (577)
++.|+|++|.+++. +.+..+++|+.|+|++|++++..|..-.++|++|+|++|++++..+ +..+++|+.|+|++|+
T Consensus 223 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~ 298 (466)
T 1o6v_A 223 LDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298 (466)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred CCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchhhhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCc
Confidence 34444444444332 2344444555555555555443332222455555555555554333 4555555555555555
Q ss_pred CcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC-cc
Q 008121 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP-RE 242 (577)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p-~~ 242 (577)
+++..| +..+++|+.|+|++|++++..| +..+++|++|++++|++++. +.+..++ |+.|++++|++++..| ..
T Consensus 299 l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~~ 373 (466)
T 1o6v_A 299 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLTPLAN 373 (466)
T ss_dssp CSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCBCGGGTT
T ss_pred ccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccCccchhhc
Confidence 554433 4455555555555555554433 44555555555555555554 2233332 5566666666655554 22
Q ss_pred cccccceeecCCcCCC
Q 008121 243 LISIRTFIYDGNSFDN 258 (577)
Q Consensus 243 l~~l~~l~~~~n~~~~ 258 (577)
+.+++.|.+++|++..
T Consensus 374 l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 374 LTRITQLGLNDQAWTN 389 (466)
T ss_dssp CTTCCEEECCCEEEEC
T ss_pred CCCCCEEeccCCcccC
Confidence 3344455555555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.2e-17 Score=165.06 Aligned_cols=147 Identities=24% Similarity=0.336 Sum_probs=128.2
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+++.|+|++|++++..+ ++.+++|+.|+|++|+|++..+..-.++|++|+|++|++++. ..+..+++|+.|+|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~ 142 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLG 142 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECC
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEcc
Confidence 4689999999999998765 999999999999999999633322238999999999999974 468999999999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCcccc
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSG 237 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g 237 (577)
+|++++. ..+..+++|++|+|++|++++..| +..+++|++|+|++|.|++... +..++ |+.|++++|+++.
T Consensus 143 ~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~~-l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 143 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRA-LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp SSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGG-GTTCTTCSEEEEEEEEEEC
T ss_pred CCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCChh-hccCCCCCEEECcCCcccC
Confidence 9999986 578999999999999999997554 8999999999999999998644 55554 9999999999985
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.72 E-value=8.1e-18 Score=153.69 Aligned_cols=132 Identities=22% Similarity=0.258 Sum_probs=80.7
Q ss_pred CcEEEEEcCCCCCc-ccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 83 SAVVSIDISGLGLS-GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 83 ~~v~~l~l~~~~l~-g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
.+++.|+|++|+++ +.+|..+..+++|+.|+|++|+|++. ..+. ++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 35666677777766 56666666666777777777766644 2222 5666666666666665565555566666666
Q ss_pred eccCCCcccc-cccccCCCCCcEEeCcCCcccCCCC---CCccCCCCCCeEEccCcccccc
Q 008121 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLP---NSFISLSNISSLYLQNNQVTGS 216 (577)
Q Consensus 160 L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~~p---~~~~~l~~L~~L~l~~N~l~~~ 216 (577)
|++|+|++.. +..+..+++|++|+|++|.+++..+ ..+..+++|++|++++|.+...
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 6666666542 2556666666666666666664333 2556666666666666665543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2e-17 Score=181.36 Aligned_cols=147 Identities=25% Similarity=0.351 Sum_probs=121.1
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCC-CCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
..+++.|+|++|.|++..| +..+++|+.|+|++|+|++ +| ..-.++|+.|+|++|+|++. ..+..+++|+.|+|
T Consensus 64 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYL 138 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CTTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEEC
T ss_pred CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-ChhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEEC
Confidence 4688999999999987665 8899999999999999985 33 22238899999999999863 45888999999999
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccc
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGW 238 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~ 238 (577)
++|+|++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++. +.+..++ |+.|+|++|.|++.
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECC
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCC
Confidence 99999876 568889999999999999987656 88899999999999999886 4455554 99999999999864
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=152.03 Aligned_cols=134 Identities=24% Similarity=0.222 Sum_probs=114.1
Q ss_pred CCCCCCEEEccCCCcC-CcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcE
Q 008121 105 DLLSLRKFDLSGNSIH-DTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181 (577)
Q Consensus 105 ~l~~L~~L~Ls~N~l~-~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 181 (577)
..++|+.|+|++|+|+ +.+|..+. ++|++|+|++|++++. ..+..+++|++|+|++|++++.+|..+.++++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 4578999999999998 78887754 8899999999999976 78899999999999999999888888888999999
Q ss_pred EeCcCCcccCCC-CCCccCCCCCCeEEccCcccccccc----cCCCCC-ccEEEeecCccccccCc
Q 008121 182 LDLSFNNFSGDL-PNSFISLSNISSLYLQNNQVTGSLN----VFSGLP-LTTLNVANNHFSGWIPR 241 (577)
Q Consensus 182 L~Ls~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~-L~~L~l~~N~l~g~~p~ 241 (577)
|+|++|+|++.. +..+..+++|++|++++|.+++.++ .+..++ |+.|++++|.+. .+|+
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 999999998532 2678899999999999999998776 566665 999999999887 4554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=156.14 Aligned_cols=151 Identities=16% Similarity=0.239 Sum_probs=127.0
Q ss_pred cccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCC
Q 008121 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (577)
Q Consensus 102 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (577)
..+.+++|+.|+|++|+|+ .+| .+. ++|++|++++|.++. +..+..+++|++|+|++|++++..|..++.+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3477899999999999999 556 343 899999999997763 3478999999999999999999899999999999
Q ss_pred cEEeCcCCcccCCCCCCccCCCCCCeEEccCcc-cccccccCCCCC-ccEEEeecCccccccC-cccccccceeecCCcC
Q 008121 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ-VTGSLNVFSGLP-LTTLNVANNHFSGWIP-RELISIRTFIYDGNSF 256 (577)
Q Consensus 180 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~-L~~L~l~~N~l~g~~p-~~l~~l~~l~~~~n~~ 256 (577)
++|+|++|++++..|..+..+++|++|+|++|. ++.. +.+..++ |+.|++++|++++..+ ..+.+++.|++++|++
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-GGGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC--
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-HhhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCccc
Confidence 999999999998888899999999999999998 5554 4555555 9999999999997432 3456788899999986
Q ss_pred C
Q 008121 257 D 257 (577)
Q Consensus 257 ~ 257 (577)
.
T Consensus 194 ~ 194 (197)
T 4ezg_A 194 G 194 (197)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-16 Score=169.30 Aligned_cols=163 Identities=21% Similarity=0.251 Sum_probs=78.6
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
.+++.|+|++|++++. | .++.+++|++|+|++|+|++ +|..-.++|++|+|++|+|++. | ++++++|++|+|++
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~ 115 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LDLSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDT 115 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CCCTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCS
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-EccccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCC
Confidence 3455555555555543 2 45555555555555555553 2322224555555555555542 2 44555555555555
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccC---------------------CCCCCccCCCCCCeEEccCcccccccccCC
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSG---------------------DLPNSFISLSNISSLYLQNNQVTGSLNVFS 221 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g---------------------~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 221 (577)
|++++. | ++++++|++|+|++|+|++ .+ .+..+++|++|++++|+|++.+ +.
T Consensus 116 N~l~~l-~--~~~l~~L~~L~l~~N~l~~l~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~--l~ 188 (457)
T 3bz5_A 116 NKLTKL-D--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD--VS 188 (457)
T ss_dssp SCCSCC-C--CTTCTTCCEEECTTSCCSCCCCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC--CT
T ss_pred CcCCee-c--CCCCCcCCEEECCCCccceeccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec--cc
Confidence 555542 2 4455555555555555553 33 2444455555555555555432 22
Q ss_pred CCC-ccEEEeecCccccccCcccccccceeecCCcCCC
Q 008121 222 GLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDN 258 (577)
Q Consensus 222 ~~~-L~~L~l~~N~l~g~~p~~l~~l~~l~~~~n~~~~ 258 (577)
.++ |+.|++++|+|++.--..+.+++.|++++|.+..
T Consensus 189 ~l~~L~~L~l~~N~l~~~~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 189 QNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp TCTTCCEEECCSSCCSCCCCTTCTTCSEEECCSSCCSC
T ss_pred cCCCCCEEECcCCcCCeeccccCCCCCEEECcCCcccc
Confidence 222 5555555555554321233345555566665543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.3e-17 Score=166.96 Aligned_cols=167 Identities=21% Similarity=0.325 Sum_probs=127.3
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|++++|.+.+..+ +..+++|+.|+|++|++.+..+....++|+.|++++|++++..+ +..+++|++|+|++
T Consensus 155 ~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~ 230 (347)
T 4fmz_A 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN 230 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCS
T ss_pred CCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccccccccCCCccceeecccCCCCCCch--hhcCCcCCEEEccC
Confidence 578888999988886654 88888999999999988864443333788888888888886554 77888888888888
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccCc
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPR 241 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p~ 241 (577)
|++++..+ +..+++|++|+|++|++++ + ..+..+++|++|++++|++++. +.+..++ |+.|++++|++++..|.
T Consensus 231 n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 231 NKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred CccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChh
Confidence 88886655 7788888888888888885 3 3577888888888888888875 3344443 88888888888877776
Q ss_pred cc---ccccceeecCCcCCC
Q 008121 242 EL---ISIRTFIYDGNSFDN 258 (577)
Q Consensus 242 ~l---~~l~~l~~~~n~~~~ 258 (577)
.+ .+++.|++++|++..
T Consensus 306 ~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 306 VIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp HHHTCTTCSEEECCSSSCCC
T ss_pred HhhccccCCEEEccCCcccc
Confidence 54 356677788887654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-16 Score=169.22 Aligned_cols=162 Identities=20% Similarity=0.230 Sum_probs=125.6
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+++.|+|++|.+++. + ++.+++|++|+|++|+|++ +|..-.++|++|++++|+|++. + ++.+++|++|+++
T Consensus 84 l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~ 156 (457)
T 3bz5_A 84 NTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LDVSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCH 156 (457)
T ss_dssp CTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CCCTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECT
T ss_pred CCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ecCCCCCcCCEEECCCCcccee-c--cccCCcCCEEECC
Confidence 35789999999999985 3 8999999999999999996 5644448999999999999974 3 7888888888888
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p 240 (577)
+|+..+.+ .+..+++|++|+|++|+|++ +| +..+++|+.|++++|+|++. .+..++ |+.|++++|+|++ +|
T Consensus 157 ~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 157 LNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp TCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC
T ss_pred CCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC
Confidence 88766666 37788888888888888885 55 77788888888888888775 244443 7888888888886 45
Q ss_pred -cccccccceeecCCcCCC
Q 008121 241 -RELISIRTFIYDGNSFDN 258 (577)
Q Consensus 241 -~~l~~l~~l~~~~n~~~~ 258 (577)
..+.+++.|++++|.+..
T Consensus 229 ~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 229 VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp CTTCTTCSEEECCSSCCSC
T ss_pred ccccCCCCEEEeeCCcCCC
Confidence 334466777777777654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.70 E-value=7.1e-17 Score=176.95 Aligned_cols=168 Identities=22% Similarity=0.280 Sum_probs=142.4
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
...++.|+|++|.|... + .|..|++|+.|+|++|+|++..|..-.++|+.|+|++|+|++ +| .|..+++|+.|+|+
T Consensus 42 L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls 117 (605)
T 1m9s_A 42 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLE 117 (605)
T ss_dssp HTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECT
T ss_pred CCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChhhccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEec
Confidence 35788899999999864 3 699999999999999999976663334899999999999996 34 79999999999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p 240 (577)
+|+|++. +.+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.|++.++ +..++ |+.|+|++|+|++. |
T Consensus 118 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l-~ 191 (605)
T 1m9s_A 118 HNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL-R 191 (605)
T ss_dssp TSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC-G
T ss_pred CCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCC-h
Confidence 9999974 4588999999999999999964 678999999999999999999877 55555 99999999999974 4
Q ss_pred c--ccccccceeecCCcCCCC
Q 008121 241 R--ELISIRTFIYDGNSFDNG 259 (577)
Q Consensus 241 ~--~l~~l~~l~~~~n~~~~~ 259 (577)
. .+.+|..|++++|++...
T Consensus 192 ~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 192 ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GGTTCTTCSEEECCSEEEECC
T ss_pred HHccCCCCCEEEccCCcCcCC
Confidence 2 345678888999987654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=8.5e-17 Score=158.25 Aligned_cols=147 Identities=20% Similarity=0.248 Sum_probs=119.7
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+++.|+|++|+++. ++ .+..+++|+.|+|++|+|++..|..-.++|++|+|++|++++ +|.. .. ++|++|+|+
T Consensus 40 l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~ 114 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLD 114 (263)
T ss_dssp HTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECC
T ss_pred cCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChhhccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEcc
Confidence 4678899999999885 44 788999999999999999976553333889999999999986 4433 33 899999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccc
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGW 238 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~ 238 (577)
+|++++. + .+.++++|++|+|++|+|++ +| .+..+++|++|+|++|+|++. ..+..++ |+.|++++|.+++.
T Consensus 115 ~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 115 NNELRDT-D-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp SSCCSBS-G-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCccCCC-h-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 9999974 3 58899999999999999985 45 688899999999999999887 5555554 99999999999855
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-17 Score=149.73 Aligned_cols=126 Identities=22% Similarity=0.232 Sum_probs=93.1
Q ss_pred CcEEEEEcCCCCCc-ccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 83 SAVVSIDISGLGLS-GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 83 ~~v~~l~l~~~~l~-g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
.+++.|+|++|+++ +.+|..+..+++|+.|+|++|+|++. ..+. ++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 46777888888887 77777778888888888888888755 2332 6788888888888777777777778888888
Q ss_pred eccCCCccc-ccccccCCCCCcEEeCcCCcccCCCC---CCccCCCCCCeEEccC
Q 008121 160 VSRNSLTQS-IGDIFGNLAGLATLDLSFNNFSGDLP---NSFISLSNISSLYLQN 210 (577)
Q Consensus 160 L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p---~~~~~l~~L~~L~l~~ 210 (577)
|++|++++. .+..+..+++|++|+|++|++++..+ ..+..+++|++|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888888764 34677778888888888888875444 3577777777777653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-16 Score=169.97 Aligned_cols=167 Identities=26% Similarity=0.374 Sum_probs=128.9
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|+|++|.+++. +.+..+++|++|+|++|++++..|....++|++|++++|++++. ..+..+++|++|+|++
T Consensus 177 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~ 252 (466)
T 1o6v_A 177 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN 252 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccccccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCC
Confidence 4678888888888764 34788888888888888888776655558888888888888854 3577888888888888
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC-
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP- 240 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p- 240 (577)
|++++..| +..+++|++|+|++|++++..| +..+++|++|+|++|++++.++ +..++ |+.|++++|++++..|
T Consensus 253 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~~ 327 (466)
T 1o6v_A 253 NQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISPV 327 (466)
T ss_dssp SCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGGG
T ss_pred Cccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchhh
Confidence 88887765 7888888888888888886443 7788888888888888887655 33333 8888888888887666
Q ss_pred cccccccceeecCCcCCC
Q 008121 241 RELISIRTFIYDGNSFDN 258 (577)
Q Consensus 241 ~~l~~l~~l~~~~n~~~~ 258 (577)
..+.+++.|++++|.+..
T Consensus 328 ~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 328 SSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp GGCTTCCEEECCSSCCCC
T ss_pred ccCccCCEeECCCCccCC
Confidence 345567778888887654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.69 E-value=7.5e-17 Score=177.08 Aligned_cols=136 Identities=24% Similarity=0.396 Sum_probs=86.2
Q ss_pred CCCCCCCCCCCCCCCCccEE--------eeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCc
Q 008121 60 LTNWKGNEGDPCGESWKGVA--------CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNL 131 (577)
Q Consensus 60 l~~w~~~~~~~c~~~w~gv~--------C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L 131 (577)
+..|.. ..+|| .|+|.. |....++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|. ..++|
T Consensus 12 w~~W~~-~~~~~--~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~-~l~~L 83 (622)
T 3g06_A 12 WSAWRR-AAPAE--ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA-LPPEL 83 (622)
T ss_dssp HHHHHH-TCCGG--GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC-CCTTC
T ss_pred HHHHHh-cCCcc--hhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC-cCCCC
Confidence 345653 23455 676543 33346888888888887 6666555 68888888888887 4665 44788
Q ss_pred cEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCc
Q 008121 132 TSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211 (577)
Q Consensus 132 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N 211 (577)
++|+|++|+|++ +|. .+++|++|+|++|+|++.. . .+++|+.|+|++|+|++ +|.. +++|++|+|++|
T Consensus 84 ~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l~-~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N 151 (622)
T 3g06_A 84 RTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTHLP-A---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDN 151 (622)
T ss_dssp CEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCCCC-C---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred CEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCCCC-C---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCC
Confidence 888888888873 554 5677777777777777533 2 34555566666665553 4432 245555555555
Q ss_pred cccc
Q 008121 212 QVTG 215 (577)
Q Consensus 212 ~l~~ 215 (577)
+|++
T Consensus 152 ~l~~ 155 (622)
T 3g06_A 152 QLAS 155 (622)
T ss_dssp CCSC
T ss_pred cCCC
Confidence 5554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.7e-17 Score=159.51 Aligned_cols=164 Identities=22% Similarity=0.313 Sum_probs=134.3
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
.++.++|+++.+++.. .+..+++|+.|+|++|+|+ .+| .+. ++|++|+|++|+|++..| +..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 3556678888888654 6889999999999999998 455 333 899999999999997655 9999999999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p 240 (577)
+|++++. |. +.. ++|++|+|++|+|++ +| .+..+++|++|+|++|+|++.. .+..++ |+.|++++|+|++.-.
T Consensus 94 ~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~~~~~ 167 (263)
T 1xeu_A 94 RNRLKNL-NG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNTGG 167 (263)
T ss_dssp SSCCSCC-TT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCCBCTT
T ss_pred CCccCCc-Cc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCcchHH
Confidence 9999974 43 233 999999999999996 44 5899999999999999999874 454444 9999999999997611
Q ss_pred -cccccccceeecCCcCCCC
Q 008121 241 -RELISIRTFIYDGNSFDNG 259 (577)
Q Consensus 241 -~~l~~l~~l~~~~n~~~~~ 259 (577)
..+.+++.|++++|++.+.
T Consensus 168 l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 168 LTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp STTCCCCCEEEEEEEEEECC
T ss_pred hccCCCCCEEeCCCCcccCC
Confidence 2345677889999987643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.9e-16 Score=165.86 Aligned_cols=160 Identities=24% Similarity=0.351 Sum_probs=116.9
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+++.|+|++|.+++ +|.. +++|++|+|++|++++ +|. +.++|++|+|++|++++ +| .|+++++|++|+++
T Consensus 90 ~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~-~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 90 PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSD-LPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVD 161 (454)
T ss_dssp CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCS-CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccC-CCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECC
Confidence 3578889999999987 5543 4788888999998885 443 33788999999999886 67 58888899999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCCccEEEeecCccccccCc
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR 241 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~ 241 (577)
+|++++ +|..+ .+|++|+|++|++++ +| .++++++|++|++++|++++.+... ..|+.|++++|.++ .+|.
T Consensus 162 ~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~--~~L~~L~l~~n~l~-~lp~ 232 (454)
T 1jl5_A 162 NNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLP--LSLESIVAGNNILE-ELPE 232 (454)
T ss_dssp SSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCC--TTCCEEECCSSCCS-SCCC
T ss_pred CCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCc--CcccEEECcCCcCC-cccc
Confidence 998886 55443 588888888888885 66 5888888888888888887743322 24677777777776 5553
Q ss_pred --ccccccceeecCCcCCC
Q 008121 242 --ELISIRTFIYDGNSFDN 258 (577)
Q Consensus 242 --~l~~l~~l~~~~n~~~~ 258 (577)
.+.+++.|++++|.+..
T Consensus 233 ~~~l~~L~~L~l~~N~l~~ 251 (454)
T 1jl5_A 233 LQNLPFLTTIYADNNLLKT 251 (454)
T ss_dssp CTTCTTCCEEECCSSCCSS
T ss_pred cCCCCCCCEEECCCCcCCc
Confidence 22345566666666543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=5.4e-17 Score=165.94 Aligned_cols=142 Identities=14% Similarity=0.134 Sum_probs=102.0
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccc---------------hHH-----HHHHHHHHHHhhcCCCCc
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS---------------LQE-----EDNFLEAVSNMSRLRHPN 469 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~-----~~~~~~e~~~l~~l~H~n 469 (577)
.-|.+.+.||+|+||.||+|...+|+.||||+++....+ ... .....+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348889999999999999999999999999987532111 000 111234666666665544
Q ss_pred eeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 008121 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (577)
Q Consensus 470 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~ 549 (577)
+....-+... ..+|||||++++.|.++.. . .....++.|++.+|.|||+. +||||||||.|||++
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 4322222222 2379999999988876542 1 12356889999999999998 999999999999998
Q ss_pred CCCC----------eEEeccccCcccC
Q 008121 550 DELN----------PHLSDCGLAALTP 566 (577)
Q Consensus 550 ~~~~----------~kl~DFGla~~~~ 566 (577)
+++. +.|+||+-+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 8763 8999999776543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.1e-16 Score=161.87 Aligned_cols=166 Identities=23% Similarity=0.370 Sum_probs=121.2
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|++++|.....++ .+..+++|++|++++|.+.+..+..-.++|++|++++|++.+..+ +..+++|+.|++++
T Consensus 132 ~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~ 208 (347)
T 4fmz_A 132 TKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYV 208 (347)
T ss_dssp TTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred CceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchhhccCCCCCEEEccCCccccccc--ccCCCccceeeccc
Confidence 467888888886655544 378888888888888888765543333788888888888875443 77788888888888
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC-
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP- 240 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p- 240 (577)
|.+++..+ +..+++|++|+|++|++++ +|. +..+++|++|++++|.+++. +.+..++ |+.|++++|++++. |
T Consensus 209 n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~-~~ 282 (347)
T 4fmz_A 209 NQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISDI-SV 282 (347)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCCC-GG
T ss_pred CCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCCC-hh
Confidence 88886655 7778888888888888885 343 77888888888888888775 3444444 88888888888754 3
Q ss_pred -cccccccceeecCCcCC
Q 008121 241 -RELISIRTFIYDGNSFD 257 (577)
Q Consensus 241 -~~l~~l~~l~~~~n~~~ 257 (577)
..+.+++.|++++|.+.
T Consensus 283 ~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 283 LNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp GGGCTTCSEEECCSSCCC
T ss_pred hcCCCCCCEEECcCCcCC
Confidence 23456777788888764
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-18 Score=180.30 Aligned_cols=176 Identities=19% Similarity=0.249 Sum_probs=137.0
Q ss_pred CCcEEEEEcCCCCCcc----cccccccCCCCCCEEEccCCCcCCcCCCCCC---------------CCccEEEccCCcCC
Q 008121 82 GSAVVSIDISGLGLSG----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---------------PNLTSLNLASNNFS 142 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---------------~~L~~L~l~~N~l~ 142 (577)
..+++.|+|++|.+++ .+|..+..+++|++|+|++|.|++..+..+. ++|++|+|++|+++
T Consensus 93 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~ 172 (386)
T 2ca6_A 93 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172 (386)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred CCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence 4678889999999887 5777888899999999999988744332222 68999999999987
Q ss_pred -CcCC---CCccCCCCccEEEeccCCCc--c---cccccccCCCCCcEEeCcCCccc----CCCCCCccCCCCCCeEEcc
Q 008121 143 -GNLP---YSIASMVSLSYLNVSRNSLT--Q---SIGDIFGNLAGLATLDLSFNNFS----GDLPNSFISLSNISSLYLQ 209 (577)
Q Consensus 143 -~~~p---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----g~~p~~~~~l~~L~~L~l~ 209 (577)
+.+| ..+..+++|++|+|++|+|+ | .+|..+..+++|+.|+|++|+|+ +.+|..+..+++|++|+|+
T Consensus 173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~ 252 (386)
T 2ca6_A 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252 (386)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence 4455 46778889999999999988 3 45557888899999999999986 5678888888999999999
Q ss_pred Ccccccc----c-ccC--C-CCCccEEEeecCcccc----ccCccc----ccccceeecCCcCC
Q 008121 210 NNQVTGS----L-NVF--S-GLPLTTLNVANNHFSG----WIPREL----ISIRTFIYDGNSFD 257 (577)
Q Consensus 210 ~N~l~~~----~-~~~--~-~~~L~~L~l~~N~l~g----~~p~~l----~~l~~l~~~~n~~~ 257 (577)
+|.|++. + ..+ . ...|+.|+|++|.|++ .+|..+ .+++.|++++|++.
T Consensus 253 ~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 253 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 9998864 2 233 2 2348999999999987 477654 56788888888764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2e-18 Score=188.07 Aligned_cols=151 Identities=19% Similarity=0.213 Sum_probs=114.6
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCC-------------cCCcCCCCCC----------------------
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-------------IHDTIPYQLP---------------------- 128 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~---------------------- 128 (577)
.++.|+|++|+|+ .+|..+++|++|+.|++++|. +.+.+|..+.
T Consensus 350 ~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l 428 (567)
T 1dce_A 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSK 428 (567)
T ss_dssp TSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHH
T ss_pred cceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhh
Confidence 4557788888886 778889999999999987764 3443332110
Q ss_pred ------------CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCC
Q 008121 129 ------------PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196 (577)
Q Consensus 129 ------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 196 (577)
..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .
T Consensus 429 ~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~ 503 (567)
T 1dce_A 429 FLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-G 503 (567)
T ss_dssp HHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-G
T ss_pred hhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-c
Confidence 257788888888886 565 888888888888888888 677788888888888888888885 66 7
Q ss_pred ccCCCCCCeEEccCcccccc--cccCCCCC-ccEEEeecCccccccC
Q 008121 197 FISLSNISSLYLQNNQVTGS--LNVFSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 197 ~~~l~~L~~L~l~~N~l~~~--~~~~~~~~-L~~L~l~~N~l~g~~p 240 (577)
|+.+++|++|+|++|+|++. +..+..++ |+.|+|++|+|++..|
T Consensus 504 l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 504 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred cCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 88888888888888888887 45566655 8888888888886655
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.7e-17 Score=146.15 Aligned_cols=125 Identities=22% Similarity=0.215 Sum_probs=97.3
Q ss_pred CCCCCCEEEccCCCcC-CcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcE
Q 008121 105 DLLSLRKFDLSGNSIH-DTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181 (577)
Q Consensus 105 ~l~~L~~L~Ls~N~l~-~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 181 (577)
..++|+.|+|++|+++ +.+|..+. ++|++|+|++|++++. ..++.+++|++|+|++|++++.+|..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3467888888888888 77776554 7888888888888866 67888888888888888888878888878888888
Q ss_pred EeCcCCcccCC-CCCCccCCCCCCeEEccCcccccccc----cCCCCC-ccEEEee
Q 008121 182 LDLSFNNFSGD-LPNSFISLSNISSLYLQNNQVTGSLN----VFSGLP-LTTLNVA 231 (577)
Q Consensus 182 L~Ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~-L~~L~l~ 231 (577)
|+|++|++++. .|..+..+++|++|++++|.+++.++ .+..++ |+.||++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 88888888853 34678888888888888888887654 344333 7777665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.67 E-value=2.6e-16 Score=144.06 Aligned_cols=107 Identities=24% Similarity=0.356 Sum_probs=92.3
Q ss_pred CEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcc
Q 008121 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (577)
Q Consensus 110 ~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 189 (577)
+.|++++|+|+ .+|..++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CEEEeCCCCcC-ccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 45666777776 47777778899999999999988899999999999999999999988888889999999999999999
Q ss_pred cCCCCCCccCCCCCCeEEccCccccccc
Q 008121 190 SGDLPNSFISLSNISSLYLQNNQVTGSL 217 (577)
Q Consensus 190 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (577)
++..+..|..+++|++|+|++|.++...
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9766667899999999999999887653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.8e-16 Score=142.27 Aligned_cols=107 Identities=23% Similarity=0.317 Sum_probs=92.1
Q ss_pred CEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcc
Q 008121 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (577)
Q Consensus 110 ~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 189 (577)
+.+++++|+|+ .+|..++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l 93 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL 93 (174)
T ss_dssp SEEECCSSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cEEEeCCCCCC-ccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence 46677777775 67777778899999999999988899999999999999999999988777789999999999999999
Q ss_pred cCCCCCCccCCCCCCeEEccCccccccc
Q 008121 190 SGDLPNSFISLSNISSLYLQNNQVTGSL 217 (577)
Q Consensus 190 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (577)
++..+..|..+++|++|+|++|.+....
T Consensus 94 ~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 94 KSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ceeCHHHhccccCCCEEEeCCCCccccc
Confidence 9655556889999999999999887654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.65 E-value=4.8e-18 Score=173.21 Aligned_cols=172 Identities=16% Similarity=0.226 Sum_probs=117.2
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCc-CCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT-IPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
..++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+. ++|++|+|++|++++..|..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5677777777777776554 55677888888888877754 553332 7788888888887777777777778888888
Q ss_pred eccC-CCcc-cccccccCCCCCcEEeCcCC-cccCC-CCCCccCCC-CCCeEEccCc--ccc-c-ccccCCCC-CccEEE
Q 008121 160 VSRN-SLTQ-SIGDIFGNLAGLATLDLSFN-NFSGD-LPNSFISLS-NISSLYLQNN--QVT-G-SLNVFSGL-PLTTLN 229 (577)
Q Consensus 160 L~~N-~l~~-~~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~~l~-~L~~L~l~~N--~l~-~-~~~~~~~~-~L~~L~ 229 (577)
|++| .+++ .++..+.++++|++|+|++| ++++. ++..+..++ +|++|+|++| .++ + .+..+..+ .|+.|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 8887 6765 36666777788888888888 77753 566667777 7888888887 344 2 22223233 378888
Q ss_pred eecCc-cccccCcccc---cccceeecCCc
Q 008121 230 VANNH-FSGWIPRELI---SIRTFIYDGNS 255 (577)
Q Consensus 230 l~~N~-l~g~~p~~l~---~l~~l~~~~n~ 255 (577)
+++|. +++..+..+. +++.|++++|.
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 88887 6666555443 45566666664
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.3e-17 Score=185.19 Aligned_cols=145 Identities=23% Similarity=0.317 Sum_probs=120.2
Q ss_pred eCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEE
Q 008121 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158 (577)
Q Consensus 81 ~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 158 (577)
....++.|+|++|.+. .+|..++.+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|++|++|++|
T Consensus 222 ~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 222 DDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred cCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 3468999999999998 78888889999999999999999 8887775 89999999999999 789999999999999
Q ss_pred EeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCC-CCeEEccCcccccccccCCCCCccEEEeecC
Q 008121 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN-ISSLYLQNNQVTGSLNVFSGLPLTTLNVANN 233 (577)
Q Consensus 159 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N 233 (577)
+|++|.|+ .+|..|++|++|++|+|++|.|+|.+|..+..+.. +..|+|++|.+++.++. .|..|++++|
T Consensus 299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~----~l~~l~l~~n 369 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH----ERRFIEINTD 369 (727)
T ss_dssp ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC----C---------
T ss_pred ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc----ccceeEeecc
Confidence 99999998 77888999999999999999999999988765432 23578999999987653 2667777777
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.4e-15 Score=165.05 Aligned_cols=54 Identities=20% Similarity=0.368 Sum_probs=29.3
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCC
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~ 142 (577)
..++.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. ..++|+.|+|++|+|+
T Consensus 81 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~-~l~~L~~L~L~~N~l~ 134 (622)
T 3g06_A 81 PELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA-LPSGLCKLWIFGNQLT 134 (622)
T ss_dssp TTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC-CCTTCCEEECCSSCCS
T ss_pred CCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC-CCCCcCEEECCCCCCC
Confidence 467777777777764 333 55666666666666653 333 2234444444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.63 E-value=2.1e-16 Score=145.53 Aligned_cols=131 Identities=19% Similarity=0.243 Sum_probs=81.5
Q ss_pred cccCCCCCCEEEccCCCcCCcCCCCC--CCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCC
Q 008121 102 LLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (577)
Q Consensus 102 ~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (577)
.+.++.+|+.|+|++|+|+. +|... .++|++|+|++|+|++. ..|+.+++|++|+|++|+|++..|..|..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 45556666777777776663 33211 13677777777777654 456667777777777777775554555667777
Q ss_pred cEEeCcCCcccCCCCC--CccCCCCCCeEEccCccccccccc----CCCCC-ccEEEeecCccc
Q 008121 180 ATLDLSFNNFSGDLPN--SFISLSNISSLYLQNNQVTGSLNV----FSGLP-LTTLNVANNHFS 236 (577)
Q Consensus 180 ~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~-L~~L~l~~N~l~ 236 (577)
++|+|++|+|+ .+|. .+..+++|++|++++|.++..+.. +..++ |+.||+++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 77777777775 4554 566667777777777776654432 33333 667777666654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=2.5e-17 Score=171.43 Aligned_cols=86 Identities=24% Similarity=0.289 Sum_probs=39.8
Q ss_pred CCccEEEeccCCCc-cccc---ccccCCCCCcEEeCcCCccc--C---CCCCCccCCCCCCeEEccCcccc----ccc-c
Q 008121 153 VSLSYLNVSRNSLT-QSIG---DIFGNLAGLATLDLSFNNFS--G---DLPNSFISLSNISSLYLQNNQVT----GSL-N 218 (577)
Q Consensus 153 ~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--g---~~p~~~~~l~~L~~L~l~~N~l~----~~~-~ 218 (577)
++|++|+|++|+|+ +.+| ..+..+++|++|+|++|+|+ | .+|..+..+++|++|+|++|.|+ +.+ .
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 45555555555554 2333 23444555555555555554 2 23334445555555555555553 111 1
Q ss_pred cCCCCC-ccEEEeecCccccc
Q 008121 219 VFSGLP-LTTLNVANNHFSGW 238 (577)
Q Consensus 219 ~~~~~~-L~~L~l~~N~l~g~ 238 (577)
.+..++ |+.|+|++|.|++.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHH
T ss_pred HHccCCCcCEEECCCCCCchh
Confidence 222222 55555555555543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.61 E-value=5.2e-17 Score=167.57 Aligned_cols=154 Identities=24% Similarity=0.320 Sum_probs=75.5
Q ss_pred cEEEEEcCCCCCccccc----ccccCCC-CCCEEEccCCCcCCcCCCCC-------CCCccEEEccCCcCCCcCCCCccC
Q 008121 84 AVVSIDISGLGLSGTMG----YLLSDLL-SLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSIAS 151 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~-------~~~L~~L~l~~N~l~~~~p~~~~~ 151 (577)
.++.|+|++|.+++..+ ..|..++ +|++|+|++|+|++..+..+ .++|++|+|++|++++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 35555666655555444 4455555 55566666665554333211 145556666666555544443332
Q ss_pred C-----CCccEEEeccCCCccccccccc----C-CCCCcEEeCcCCcccCCCC----CCccCCC-CCCeEEccCcccccc
Q 008121 152 M-----VSLSYLNVSRNSLTQSIGDIFG----N-LAGLATLDLSFNNFSGDLP----NSFISLS-NISSLYLQNNQVTGS 216 (577)
Q Consensus 152 l-----~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~~L~Ls~N~l~g~~p----~~~~~l~-~L~~L~l~~N~l~~~ 216 (577)
. ++|++|+|++|+|++..+..+. . .++|++|+|++|+|++..+ ..+..++ +|++|+|++|+|++.
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~ 182 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchh
Confidence 2 5556666666655554443322 2 2455566666665553222 2223333 555666666655543
Q ss_pred cc-----cCCC--CCccEEEeecCcccc
Q 008121 217 LN-----VFSG--LPLTTLNVANNHFSG 237 (577)
Q Consensus 217 ~~-----~~~~--~~L~~L~l~~N~l~g 237 (577)
.+ .+.. ..|+.|||++|.|++
T Consensus 183 ~~~~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 183 NCAELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp CHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred hHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence 32 1111 135556666665554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.4e-17 Score=167.97 Aligned_cols=180 Identities=16% Similarity=0.193 Sum_probs=151.8
Q ss_pred CCccEEeeCCcEEEEEcCCCCCcccccccccCC--CCCCEEEccCCCcCCcCCCCCC-CCccEEEccCCcCCCc-CCCCc
Q 008121 74 SWKGVACEGSAVVSIDISGLGLSGTMGYLLSDL--LSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGN-LPYSI 149 (577)
Q Consensus 74 ~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~l~~N~l~~~-~p~~~ 149 (577)
.|.++.|+...++.|+++++.+. +..+..+ ++|+.|++++|.+++..|..+. ++|++|+|++|++++. +|..+
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~ 114 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGIL 114 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHH
T ss_pred HHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHH
Confidence 68888887777889999999887 5667777 8999999999999987765443 8999999999999976 88889
Q ss_pred cCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCC-cccCC-CCCCccCCCCCCeEEccCc-ccccc--cccCCCC-
Q 008121 150 ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFN-NFSGD-LPNSFISLSNISSLYLQNN-QVTGS--LNVFSGL- 223 (577)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~~l~~L~~L~l~~N-~l~~~--~~~~~~~- 223 (577)
..+++|++|+|++|++++..|..++.+++|++|+|++| .+++. +|..+.++++|++|++++| .+++. ...+..+
T Consensus 115 ~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~ 194 (336)
T 2ast_B 115 SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS 194 (336)
T ss_dssp TTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSC
T ss_pred hhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcc
Confidence 99999999999999999999999999999999999999 78863 6777889999999999999 99863 2323333
Q ss_pred -CccEEEeecC--ccc-cccCcc---cccccceeecCCcC
Q 008121 224 -PLTTLNVANN--HFS-GWIPRE---LISIRTFIYDGNSF 256 (577)
Q Consensus 224 -~L~~L~l~~N--~l~-g~~p~~---l~~l~~l~~~~n~~ 256 (577)
.|+.|++++| .++ +.+|.. +.+++.|++++|..
T Consensus 195 ~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 195 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred cCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 5999999999 566 455643 45788899999873
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.2e-17 Score=169.17 Aligned_cols=174 Identities=24% Similarity=0.293 Sum_probs=131.4
Q ss_pred cEEEEEcCCCCCcccccccccCC-----CCCCEEEccCCCcCCcCCCCC-------CCCccEEEccCCcCCCcCCCCccC
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDL-----LSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSIAS 151 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-------~~~L~~L~l~~N~l~~~~p~~~~~ 151 (577)
+++.|+|++|.+++..+..++.+ ++|++|+|++|+|++..+..+ .++|++|+|++|+|++..+..+..
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 78999999999998877777775 899999999999986555322 268999999999998776655443
Q ss_pred -----CCCccEEEeccCCCccc----ccccccCCC-CCcEEeCcCCcccCCCCCCcc----CC-CCCCeEEccCccccc-
Q 008121 152 -----MVSLSYLNVSRNSLTQS----IGDIFGNLA-GLATLDLSFNNFSGDLPNSFI----SL-SNISSLYLQNNQVTG- 215 (577)
Q Consensus 152 -----l~~L~~L~L~~N~l~~~----~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~----~l-~~L~~L~l~~N~l~~- 215 (577)
.++|++|+|++|+|++. ++..+..++ +|++|+|++|+|++..+..+. .+ ++|++|+|++|.|++
T Consensus 132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~ 211 (362)
T 3goz_A 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLK 211 (362)
T ss_dssp HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChh
Confidence 25899999999999853 444556665 899999999999876665444 34 589999999999887
Q ss_pred ----ccccCCC--CCccEEEeecCccccccC-------cccccccceeecCCcCC
Q 008121 216 ----SLNVFSG--LPLTTLNVANNHFSGWIP-------RELISIRTFIYDGNSFD 257 (577)
Q Consensus 216 ----~~~~~~~--~~L~~L~l~~N~l~g~~p-------~~l~~l~~l~~~~n~~~ 257 (577)
....+.. ..|+.|+|++|.|++..+ ..+.+++.|++++|.+.
T Consensus 212 ~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~ 266 (362)
T 3goz_A 212 SYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266 (362)
T ss_dssp CHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHT
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCcc
Confidence 2233322 259999999999987544 33456788888888743
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=4.7e-18 Score=159.84 Aligned_cols=130 Identities=25% Similarity=0.288 Sum_probs=90.5
Q ss_pred CcEEEEEcCCCCCcccccc------cccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCC
Q 008121 83 SAVVSIDISGLGLSGTMGY------LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVS 154 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~ 154 (577)
..++.++|+.+.++|.+|. .++.+++|++|+|++|+|++ +| .+. ++|++|+|++|+++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3455566666666666665 77778888888888888875 55 443 77777888777777 56666666777
Q ss_pred ccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCC-CCccCCCCCCeEEccCccccccc
Q 008121 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSL 217 (577)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~ 217 (577)
|++|+|++|++++ +| .+.++++|++|+|++|++++..+ ..+..+++|++|++++|.+++.+
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 7777777777776 34 46777777777777777774221 35667777777777777776654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=1.5e-15 Score=139.79 Aligned_cols=129 Identities=19% Similarity=0.232 Sum_probs=110.0
Q ss_pred CCcEEEEEcCCCCCcccccccccCCC-CCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEE
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 158 (577)
...++.|+|++|+++.. | .+..+. +|+.|+|++|+|++. ..+. ++|++|+|++|+|++..|..|..+++|++|
T Consensus 18 ~~~L~~L~l~~n~l~~i-~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPVI-E-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCCSC-C-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCchh-H-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 35789999999999954 4 455555 999999999999975 3343 899999999999997665666999999999
Q ss_pred EeccCCCcccccc--cccCCCCCcEEeCcCCcccCCCCCC----ccCCCCCCeEEccCcccccc
Q 008121 159 NVSRNSLTQSIGD--IFGNLAGLATLDLSFNNFSGDLPNS----FISLSNISSLYLQNNQVTGS 216 (577)
Q Consensus 159 ~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~g~~p~~----~~~l~~L~~L~l~~N~l~~~ 216 (577)
+|++|+|+. +|. .+..+++|+.|+|++|.++ .+|.. +..+++|+.|++++|.+...
T Consensus 94 ~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~~ 155 (176)
T 1a9n_A 94 ILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKER 155 (176)
T ss_dssp ECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred ECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence 999999964 555 7899999999999999998 57775 88999999999999988653
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-15 Score=136.99 Aligned_cols=103 Identities=22% Similarity=0.246 Sum_probs=91.0
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCC
Q 008121 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (577)
Q Consensus 87 ~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (577)
.|++++|+|+. +|..+. ++|+.|+|++|+|++..|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 45667788875 565553 8999999999999987787665 899999999999998888889999999999999999
Q ss_pred CcccccccccCCCCCcEEeCcCCcccCC
Q 008121 165 LTQSIGDIFGNLAGLATLDLSFNNFSGD 192 (577)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 192 (577)
|++..+..|.++++|++|+|++|.++..
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 9998888899999999999999999854
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=7.9e-15 Score=159.71 Aligned_cols=118 Identities=24% Similarity=0.321 Sum_probs=103.7
Q ss_pred CCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCc
Q 008121 108 SLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLS 185 (577)
Q Consensus 108 ~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 185 (577)
.|+.|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|+++++|++|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47789999999996 675 54 89999999999999 889999999999999999999998 66 89999999999999
Q ss_pred CCcccCCC-CCCccCCCCCCeEEccCcccccccccCCC----CC-ccEEEe
Q 008121 186 FNNFSGDL-PNSFISLSNISSLYLQNNQVTGSLNVFSG----LP-LTTLNV 230 (577)
Q Consensus 186 ~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~----~~-L~~L~l 230 (577)
+|+|++.. |..|+.+++|+.|+|++|+|++.++.... ++ |+.|++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999876 99999999999999999999998764432 23 777653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.1e-14 Score=129.87 Aligned_cols=108 Identities=19% Similarity=0.209 Sum_probs=94.2
Q ss_pred EEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccC
Q 008121 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (577)
Q Consensus 86 ~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (577)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57888999996 6676664 8999999999999987787665 89999999999999877777899999999999999
Q ss_pred CCcccccccccCCCCCcEEeCcCCcccCCCCCCc
Q 008121 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197 (577)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 197 (577)
+|++..+..|.++++|++|+|++|.+.. .+..+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c-~~~~~ 124 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC-ECRDI 124 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT-TBGGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc-ccccH
Confidence 9998888789999999999999999984 44433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.2e-14 Score=147.14 Aligned_cols=173 Identities=17% Similarity=0.171 Sum_probs=139.5
Q ss_pred CCcEEEEEcCCCCCcccccc-cccCCCCCCE-EEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccE
Q 008121 82 GSAVVSIDISGLGLSGTMGY-LLSDLLSLRK-FDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSY 157 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~-~~~~l~~L~~-L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 157 (577)
..+++.|+|++|.+.+.+|. .|.+|++|+. +++++|+|+...|..+. ++|++|++++|++++..+..+....++..
T Consensus 53 l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~ 132 (350)
T 4ay9_X 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132 (350)
T ss_dssp CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEE
T ss_pred CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhh
Confidence 36899999999999887764 6889998775 77788999966666554 89999999999999888888888889999
Q ss_pred EEecc-CCCcccccccccCCC-CCcEEeCcCCcccCCCCCCccCCCCCCeEEccC-cccccccc-cCCCCC-ccEEEeec
Q 008121 158 LNVSR-NSLTQSIGDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQN-NQVTGSLN-VFSGLP-LTTLNVAN 232 (577)
Q Consensus 158 L~L~~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~~-~~~~~~-L~~L~l~~ 232 (577)
|++++ |++....+..|..+. .|+.|+|++|+|+ .+|.......+|++|++.+ |.++..++ .|..++ |+.|||++
T Consensus 133 l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~ 211 (350)
T 4ay9_X 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 211 (350)
T ss_dssp EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTT
T ss_pred hhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCC
Confidence 99976 677777677787775 6899999999999 5666666677899999985 66766654 466665 99999999
Q ss_pred CccccccCcccccccceeecCCc
Q 008121 233 NHFSGWIPRELISIRTFIYDGNS 255 (577)
Q Consensus 233 N~l~g~~p~~l~~l~~l~~~~n~ 255 (577)
|+|+...+..+.+++.|...++.
T Consensus 212 N~l~~lp~~~~~~L~~L~~l~~~ 234 (350)
T 4ay9_X 212 TRIHSLPSYGLENLKKLRARSTY 234 (350)
T ss_dssp SCCCCCCSSSCTTCCEEECTTCT
T ss_pred CCcCccChhhhccchHhhhccCC
Confidence 99995444568888888876653
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=3.8e-17 Score=153.56 Aligned_cols=134 Identities=25% Similarity=0.334 Sum_probs=117.0
Q ss_pred ccCCCCCCEEEccCCCcCCcCCC------CCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCccccccccc
Q 008121 103 LSDLLSLRKFDLSGNSIHDTIPY------QLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFG 174 (577)
Q Consensus 103 ~~~l~~L~~L~Ls~N~l~~~~p~------~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 174 (577)
+.....++.++|+.|.++|.+|. .+. ++|++|+|++|++++ +| .+..+++|++|+|++|+|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 56678899999999999998885 343 899999999999997 67 8999999999999999999 6788888
Q ss_pred CCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc--cCCCCC-ccEEEeecCccccccCc
Q 008121 175 NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN--VFSGLP-LTTLNVANNHFSGWIPR 241 (577)
Q Consensus 175 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~-L~~L~l~~N~l~g~~p~ 241 (577)
.+++|++|+|++|+|++ +| .+..+++|++|+|++|+|++... .+..++ |+.|++++|.+++.+|.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 88999999999999996 66 68899999999999999997543 555555 99999999999988765
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.49 E-value=1e-15 Score=162.82 Aligned_cols=174 Identities=20% Similarity=0.209 Sum_probs=139.0
Q ss_pred cEEEEEcCCCCCcc----cccccccCCCCCCEEEccCCCcCCcCCCCC-------CCCccEEEccCCcCCCc----CCCC
Q 008121 84 AVVSIDISGLGLSG----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGN----LPYS 148 (577)
Q Consensus 84 ~v~~l~l~~~~l~g----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-------~~~L~~L~l~~N~l~~~----~p~~ 148 (577)
+++.|+|++|+++. .++..+..+++|++|+|++|.+++..+..+ .++|++|+|++|++++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 69999999999984 678899999999999999999985433221 25799999999999974 3666
Q ss_pred ccCCCCccEEEeccCCCccccccccc-----CCCCCcEEeCcCCcccCC----CCCCccCCCCCCeEEccCccccccc--
Q 008121 149 IASMVSLSYLNVSRNSLTQSIGDIFG-----NLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL-- 217 (577)
Q Consensus 149 ~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~-- 217 (577)
+..+++|++|+|++|.+++..+..+. .+++|++|+|++|++++. ++..+..+++|++|+|++|.+++..
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 77789999999999999876555543 367999999999999864 5777888999999999999988631
Q ss_pred ---cc-CCC-CCccEEEeecCccccc----cCcc---cccccceeecCCcCC
Q 008121 218 ---NV-FSG-LPLTTLNVANNHFSGW----IPRE---LISIRTFIYDGNSFD 257 (577)
Q Consensus 218 ---~~-~~~-~~L~~L~l~~N~l~g~----~p~~---l~~l~~l~~~~n~~~ 257 (577)
+. +.. ..|+.|++++|.+++. ++.. +.+++.|++++|.+.
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 297 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence 22 222 3499999999999864 5654 456788999998764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.48 E-value=1.4e-15 Score=161.74 Aligned_cols=174 Identities=18% Similarity=0.215 Sum_probs=104.8
Q ss_pred cEEEEEcCCCCCccc----ccccccCCCCCCEEEccCCCcCCcC-----CCC--CCCCccEEEccCCcCCCc----CCCC
Q 008121 84 AVVSIDISGLGLSGT----MGYLLSDLLSLRKFDLSGNSIHDTI-----PYQ--LPPNLTSLNLASNNFSGN----LPYS 148 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~----~~~~~~~l~~L~~L~Ls~N~l~~~~-----p~~--~~~~L~~L~l~~N~l~~~----~p~~ 148 (577)
+++.|+|++|.+++. ++..+..+++|++|+|++|++++.. +.. -.++|++|+|++|++++. ++..
T Consensus 200 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 279 (461)
T 1z7x_W 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279 (461)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred CceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHH
Confidence 556666666666553 4555566666666777666665321 110 125677777777777643 4555
Q ss_pred ccCCCCccEEEeccCCCcccccccccC-----CCCCcEEeCcCCcccCC----CCCCccCCCCCCeEEccCccccccc-c
Q 008121 149 IASMVSLSYLNVSRNSLTQSIGDIFGN-----LAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL-N 218 (577)
Q Consensus 149 ~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~-~ 218 (577)
+..+++|++|+|++|.+++..+..+.. .++|++|+|++|.+++. +|..+..+++|++|+|++|.+++.. .
T Consensus 280 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence 666677777777777776544333322 25777777777777654 3455566677777777777776532 1
Q ss_pred ----cCC--CCCccEEEeecCcccc----ccCccc---ccccceeecCCcCC
Q 008121 219 ----VFS--GLPLTTLNVANNHFSG----WIPREL---ISIRTFIYDGNSFD 257 (577)
Q Consensus 219 ----~~~--~~~L~~L~l~~N~l~g----~~p~~l---~~l~~l~~~~n~~~ 257 (577)
.+. ...|+.|++++|.+++ .+|..+ .+++.|++++|++.
T Consensus 360 ~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 111 2247777777777775 566543 45666777777653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.46 E-value=8.5e-14 Score=142.45 Aligned_cols=111 Identities=20% Similarity=0.268 Sum_probs=71.3
Q ss_pred CC-CCCCccEEeeCCcEEEEEcCCC-CCcccccccccCCCCCCEEEccC-CCcCCcCCCCCCCCccEEEccCCcCCCcCC
Q 008121 70 PC-GESWKGVACEGSAVVSIDISGL-GLSGTMGYLLSDLLSLRKFDLSG-NSIHDTIPYQLPPNLTSLNLASNNFSGNLP 146 (577)
Q Consensus 70 ~c-~~~w~gv~C~~~~v~~l~l~~~-~l~g~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p 146 (577)
.| .|.|..|.|+ ++ +|++ +|. |..+++|+.|+|++ |+|++ ..|
T Consensus 4 ~c~~C~~~~v~~~----------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~----------------------~~~ 49 (347)
T 2ifg_A 4 ACCPHGSSGLRCT----------RDGALDS-LHH-LPGAENLTELYIENQQHLQH----------------------LEL 49 (347)
T ss_dssp SSCCSSSSCEECC----------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCE----------------------ECG
T ss_pred cCccccCCEEEcC----------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCC----------------------cCh
Confidence 45 5578877775 33 5654 555 77777666666664 66653 444
Q ss_pred CCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccc
Q 008121 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (577)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (577)
..|++|++|++|+|++|+|++.+|..|.+|++|+.|+|++|+|++..|..|..++ |+.|+|++|.|..
T Consensus 50 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 50 RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred hHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 5566667777777777777776666677777777777777777754444444443 7777777777664
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.43 E-value=2.4e-13 Score=139.01 Aligned_cols=104 Identities=18% Similarity=0.177 Sum_probs=93.2
Q ss_pred EEEccCC-cCCCcCCCCccCCCCccEEEecc-CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccC
Q 008121 133 SLNLASN-NFSGNLPYSIASMVSLSYLNVSR-NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210 (577)
Q Consensus 133 ~L~l~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 210 (577)
.+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4677777 777 4777 99999999999996 999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc-CCCCCccEEEeecCccccc
Q 008121 211 NQVTGSLNV-FSGLPLTTLNVANNHFSGW 238 (577)
Q Consensus 211 N~l~~~~~~-~~~~~L~~L~l~~N~l~g~ 238 (577)
|+|++.++. +..++|+.|+|++|.|...
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCC
Confidence 999997764 5666799999999999853
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=4.3e-12 Score=124.31 Aligned_cols=144 Identities=12% Similarity=0.051 Sum_probs=111.3
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 487 (577)
-..|.....++.|+.+.||++... ++.+++|+...... .....+.+|+++++.+. |..+.++++++...+..|+||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 345777778888889999999754 67899999864211 12235788999888884 677889999999888999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC----------------------------------- 532 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~----------------------------------- 532 (577)
||++|.+|.+.+. +......++.+++++|+.||+..
T Consensus 90 e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 90 SEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999887641 11123478889999999999821
Q ss_pred ---------------------CCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 533 ---------------------LPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 533 ---------------------~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
.+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998766677999998864
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.4e-14 Score=146.59 Aligned_cols=162 Identities=14% Similarity=0.157 Sum_probs=119.1
Q ss_pred CcEEEEEcCCCCCcccccccccCC-----CCCCEEEccCCCcCCcCCCCCC---CCccEEEccCCcCCCcCCCCc-----
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDL-----LSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSI----- 149 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~---~~L~~L~l~~N~l~~~~p~~~----- 149 (577)
..++.|+|++|.|+......+..+ ++|+.|||++|.|+..-...+. ++|+.|+|++|+|+..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 578999999999987554444433 7999999999999753332332 689999999999985444444
Q ss_pred cCCCCccEEEeccCCCcc----cccccccCCCCCcEEeCcCCcccCC----CCCCccCCCCCCeEEccCccccccc----
Q 008121 150 ASMVSLSYLNVSRNSLTQ----SIGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL---- 217 (577)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~---- 217 (577)
...++|++|+|++|.|+. .++..+..+++|++|+|++|+|+.. ++..+...++|++|+|++|.|+...
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 245789999999999975 3455567889999999999999742 2455667789999999999998632
Q ss_pred -ccCC-CCCccEEEeecCccccccCcccc
Q 008121 218 -NVFS-GLPLTTLNVANNHFSGWIPRELI 244 (577)
Q Consensus 218 -~~~~-~~~L~~L~l~~N~l~g~~p~~l~ 244 (577)
..+. ...|+.|||++|.|+..-...+.
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 1121 23499999999999865444443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.22 E-value=3.4e-11 Score=122.17 Aligned_cols=93 Identities=18% Similarity=0.144 Sum_probs=54.6
Q ss_pred CCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCC-eEEccCccccccc-ccCCCCC-ccEE
Q 008121 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS-SLYLQNNQVTGSL-NVFSGLP-LTTL 228 (577)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~~~~-~~~~~~~-L~~L 228 (577)
+++|+.|+|++|+++.+.+..|.++++|+.|+|.+| ++..-+..|.+|.+|+ .+++.+ +++... .+|...+ |+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 456666666666666555556666666666666666 5544445566666666 666666 444433 2455443 6666
Q ss_pred EeecCccccccCcccccc
Q 008121 229 NVANNHFSGWIPRELISI 246 (577)
Q Consensus 229 ~l~~N~l~g~~p~~l~~l 246 (577)
++++|+++..-+..|.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~ 320 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNG 320 (329)
T ss_dssp EECSSCCCEECTTTTCTT
T ss_pred EeCCCccCccchhhhcCC
Confidence 666666664333444433
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=8.9e-12 Score=121.58 Aligned_cols=130 Identities=18% Similarity=0.179 Sum_probs=97.8
Q ss_pred ccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCc--eeeEeeEEEeCCeEEEEEEecCCCCHH
Q 008121 419 GEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLAGYCAEHGQRLLVYEYVGNGNLH 496 (577)
Q Consensus 419 g~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~ 496 (577)
+.|..+.||++...+|+.+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 456669999998777888999987543 1234678888888886545 456888888878899999999998773
Q ss_pred HhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q 008121 497 DMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-------------------------------------------- 532 (577)
Q Consensus 497 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-------------------------------------------- 532 (577)
.. . .+ ...++.++++.|..||+..
T Consensus 104 --~~----~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 104 --SS----H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp --TS----C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred --cC----c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 21 0 11 2357778888888888752
Q ss_pred -----------CCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 533 -----------LPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 533 -----------~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
.+.++|+|++|.||+++++..++|+|||.+...
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 012999999999999988766789999998754
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.5e-12 Score=134.25 Aligned_cols=134 Identities=19% Similarity=0.222 Sum_probs=105.5
Q ss_pred CcEEEEEcCCCCCcccccccc-cCCCCCCEEEccCCCcCCcCCCCC-------CCCccEEEccCCcCCC----cCCCCcc
Q 008121 83 SAVVSIDISGLGLSGTMGYLL-SDLLSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSG----NLPYSIA 150 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~-------~~~L~~L~l~~N~l~~----~~p~~~~ 150 (577)
..++.|+|++|.|+..-...+ ..+++|+.|+|++|+|+......+ .++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 589999999999976544443 356789999999999984322221 2789999999999974 3455567
Q ss_pred CCCCccEEEeccCCCccc----ccccccCCCCCcEEeCcCCcccCC----CCCCccCCCCCCeEEccCcccccc
Q 008121 151 SMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGS 216 (577)
Q Consensus 151 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~ 216 (577)
.+++|++|+|++|+|++. ++..+...++|++|+|++|.|+.. ++..+...++|++|+|++|.|+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 789999999999999853 466778889999999999999853 334455678999999999999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.7e-10 Score=118.38 Aligned_cols=143 Identities=16% Similarity=0.256 Sum_probs=106.1
Q ss_pred ccceeccCccceEEEEEEcCCcEEEEEEcc--ccccchHHHHHHHHHHHHhhcCC--CCceeeEeeEEEeC---CeEEEE
Q 008121 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKID--NAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEH---GQRLLV 486 (577)
Q Consensus 414 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lv 486 (577)
..+.++.|.++.||+....+ ..+++|+.. .... ......+.+|.++++.+. +..+.++++++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 35678999999999998764 577788765 3211 122446788999998887 45578889888766 458999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC---------------------------------- 532 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~---------------------------------- 532 (577)
|||++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999987764321 234678888999999999999999731
Q ss_pred ---------------------CCCeeecCCCCCCeeeCCCCC--eEEeccccCcc
Q 008121 533 ---------------------LPSVVHRNFKSANILLDDELN--PHLSDCGLAAL 564 (577)
Q Consensus 533 ---------------------~~~ivHrDlk~~NILl~~~~~--~kl~DFGla~~ 564 (577)
.+.++|+|+++.|||+++++. +.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999874
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.3e-10 Score=115.97 Aligned_cols=145 Identities=17% Similarity=0.208 Sum_probs=120.4
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCC-------------cCCCCC---------------------
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD-------------TIPYQL--------------------- 127 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~-------------~~p~~~--------------------- 127 (577)
...++.|+|++ +++..-+.+|.++++|+.|+|++|.+.. .+|...
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 46788999999 8887777889999999999999997631 112111
Q ss_pred ----------------------------------------------CCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 128 ----------------------------------------------PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 128 ----------------------------------------------~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
.++|+.|+|++|+++...+..|.++.+|+.|+|.
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 3589999999999997777899999999999999
Q ss_pred cCCCcccccccccCCCCCc-EEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEE
Q 008121 162 RNSLTQSIGDIFGNLAGLA-TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLN 229 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~ 229 (577)
+| ++.+.+.+|.++++|+ .|+|.+ +++..-+..|.+|++|+.|++++|+++...+ +|...+ |+.++
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 98 8877788999999999 999999 7875667899999999999999999998765 576664 77775
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.05 E-value=1.6e-11 Score=134.58 Aligned_cols=127 Identities=16% Similarity=0.112 Sum_probs=82.0
Q ss_pred CcEEEEEcCCCCCcccccccccCC--CCCCEEEccCCC-cCC-cCCCC--CCCCccEEEccCCcCCCc----CCCCccCC
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDL--LSLRKFDLSGNS-IHD-TIPYQ--LPPNLTSLNLASNNFSGN----LPYSIASM 152 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l--~~L~~L~Ls~N~-l~~-~~p~~--~~~~L~~L~l~~N~l~~~----~p~~~~~l 152 (577)
..++.|+|++|.+++..+..++.+ .+|++|+|++|. ++. .++.. -.++|++|+|++|.+++. ++..+..+
T Consensus 112 ~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~ 191 (592)
T 3ogk_B 112 RQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHN 191 (592)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHC
T ss_pred CCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcC
Confidence 568888888888877666666654 447888887776 221 01100 126788888888877655 33344567
Q ss_pred CCccEEEeccCCCc----ccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccC
Q 008121 153 VSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210 (577)
Q Consensus 153 ~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 210 (577)
++|++|+|++|.++ +.++..+.++++|+.|+|++|.+.+ +|..+..+++|++|++++
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 77788888877776 3445556677777888887777764 555555666666666653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.95 E-value=1.7e-10 Score=126.46 Aligned_cols=102 Identities=12% Similarity=0.126 Sum_probs=66.2
Q ss_pred cEEEEEcCCCC-Ccc-cccccccCCCCCCEEEccCCCcCCcCCC----CC--CCCccEEEccCCcCC----CcCCCCccC
Q 008121 84 AVVSIDISGLG-LSG-TMGYLLSDLLSLRKFDLSGNSIHDTIPY----QL--PPNLTSLNLASNNFS----GNLPYSIAS 151 (577)
Q Consensus 84 ~v~~l~l~~~~-l~g-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~--~~~L~~L~l~~N~l~----~~~p~~~~~ 151 (577)
+++.|+|+++. ++. .++..+..+++|++|+|++|.+++.-+. .. .++|++|+|++|.++ +.++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 38888888775 211 1233344778888888888887654211 11 277888888888886 334445567
Q ss_pred CCCccEEEeccCCCcccccccccCCCCCcEEeCcC
Q 008121 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF 186 (577)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 186 (577)
+++|+.|+|++|.+.+ +|..+.++++|++|++++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 7888888888887775 556666666677666664
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.88 E-value=4.6e-11 Score=116.29 Aligned_cols=141 Identities=17% Similarity=0.205 Sum_probs=70.2
Q ss_pred CCCCCCccEEeeCC--cEEEEEcCC---CCCccccc-ccccCCCCCCEEEccCCCcCCcCCCC-CC--CCccE--EEccC
Q 008121 70 PCGESWKGVACEGS--AVVSIDISG---LGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQ-LP--PNLTS--LNLAS 138 (577)
Q Consensus 70 ~c~~~w~gv~C~~~--~v~~l~l~~---~~l~g~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~--~~L~~--L~l~~ 138 (577)
.| +|.|+.|+.. +|..+...+ ..+.|.+. ..+..++. .|...+|..++.++.+ +. +.|.. ++++.
T Consensus 77 l~--~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~ 152 (267)
T 3rw6_A 77 LK--AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVL 152 (267)
T ss_dssp HH--HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCT
T ss_pred HH--hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccC
Confidence 45 7999999754 665554443 22333332 22222222 2222233322222211 11 23333 45555
Q ss_pred CcCC---CcCCCCccCCCCccEEEeccCCCcc--cccccccCCCCCcEEeCcCCcccCCCCCCccCCC--CCCeEEccCc
Q 008121 139 NNFS---GNLPYSIASMVSLSYLNVSRNSLTQ--SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLS--NISSLYLQNN 211 (577)
Q Consensus 139 N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~--~L~~L~l~~N 211 (577)
|+.. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|
T Consensus 153 N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~N 230 (267)
T 3rw6_A 153 NRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGN 230 (267)
T ss_dssp TSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTS
T ss_pred CHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCC
Confidence 5322 2222222345666666666666666 3445556666666666666666643 2333333 6666677777
Q ss_pred ccccc
Q 008121 212 QVTGS 216 (577)
Q Consensus 212 ~l~~~ 216 (577)
.|.+.
T Consensus 231 pl~~~ 235 (267)
T 3rw6_A 231 SLCDT 235 (267)
T ss_dssp TTGGG
T ss_pred cCccc
Confidence 66653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.84 E-value=1.1e-10 Score=128.14 Aligned_cols=128 Identities=14% Similarity=0.141 Sum_probs=87.5
Q ss_pred CCcEEEEEcCCCCCccccccccc-CCCCCCEEEccCC-CcCCc-CCCCC--CCCccEEEccCCcCCCcCCCCcc----CC
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLS-DLLSLRKFDLSGN-SIHDT-IPYQL--PPNLTSLNLASNNFSGNLPYSIA----SM 152 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~~--~~~L~~L~l~~N~l~~~~p~~~~----~l 152 (577)
..+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. ++... .++|++|+|++|.+++..+..+. .+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 45788999999998887777775 6889999999988 55532 22211 27899999999988765544443 56
Q ss_pred CCccEEEeccCC--Ccc-cccccccCCCCCcEEeCcCC-cccCCCCCCccCCCCCCeEEccC
Q 008121 153 VSLSYLNVSRNS--LTQ-SIGDIFGNLAGLATLDLSFN-NFSGDLPNSFISLSNISSLYLQN 210 (577)
Q Consensus 153 ~~L~~L~L~~N~--l~~-~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~l~~ 210 (577)
++|+.|+|++|. ++. .++..+.++++|+.|+|++| .+++ +|..+..+++|++|+++.
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~ 244 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGG 244 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSB
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEccccc
Confidence 689999998886 331 12223345788888888887 4443 555555666666666443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.2e-10 Score=127.82 Aligned_cols=171 Identities=15% Similarity=0.080 Sum_probs=101.2
Q ss_pred CcEEEEEcCCCCCccccc-ccccCCCCCCEEEccCCCcCCcCCCCC---CCCccEEEc---------cCCcCCCcCCCCc
Q 008121 83 SAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNL---------ASNNFSGNLPYSI 149 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~~L~~L~l---------~~N~l~~~~p~~~ 149 (577)
.+++.|+|++|.+++... ..+..+++|++|+|++| ++......+ .++|++|+| +.|.+++.....+
T Consensus 289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l 367 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367 (594)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence 689999999999876533 34668899999999988 442111111 267888887 3345554322223
Q ss_pred c-CCCCccEEEeccCCCccccccccc-CCCCCcEEeCc--C----CcccCCCC------CCccCCCCCCeEEccCccccc
Q 008121 150 A-SMVSLSYLNVSRNSLTQSIGDIFG-NLAGLATLDLS--F----NNFSGDLP------NSFISLSNISSLYLQNNQVTG 215 (577)
Q Consensus 150 ~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~g~~p------~~~~~l~~L~~L~l~~N~l~~ 215 (577)
. .+++|+.|+++.|++++.....+. .+++|+.|+|+ + |++++ .| ..+..+++|++|+|++ .+++
T Consensus 368 ~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC-CchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 2 367777777777777766555554 47777777777 3 55552 22 1144566677777755 4443
Q ss_pred c-cccCC--CCCccEEEeecCccccccCc----ccccccceeecCCcC
Q 008121 216 S-LNVFS--GLPLTTLNVANNHFSGWIPR----ELISIRTFIYDGNSF 256 (577)
Q Consensus 216 ~-~~~~~--~~~L~~L~l~~N~l~g~~p~----~l~~l~~l~~~~n~~ 256 (577)
. +..+. ...|+.|+|++|.+++..+. .+.+++.|++++|++
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 2 11111 12366666666666554332 234566666666665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.65 E-value=1.4e-07 Score=97.95 Aligned_cols=125 Identities=15% Similarity=0.186 Sum_probs=78.1
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
.++.|.|.+ .++..-+.+|.++++|+.++|++|+++ .+|.... .+|+.+.|.+| ++..-...|.++++|+.++|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 466777765 666566677888888888888888887 3443322 67777777744 665556677777777777776
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccc
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (577)
+| ++..-..+|.+ .+|+.+.| .|.++..-+..|.+|++|+.+++.+|.+.
T Consensus 235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 64 44444444555 55666665 33344333445556666666666555544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.65 E-value=4e-09 Score=107.82 Aligned_cols=155 Identities=15% Similarity=0.170 Sum_probs=83.1
Q ss_pred CcEEEEEcCCCCC---------cccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCcc--C
Q 008121 83 SAVVSIDISGLGL---------SGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA--S 151 (577)
Q Consensus 83 ~~v~~l~l~~~~l---------~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~--~ 151 (577)
.+++.|.+.++.. .+.++..+..+++|+.|+|++|.-. .+|..-.++|+.|+|..|.++...-..+. .
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~~~~~~L~~L~L~~~~l~~~~l~~l~~~~ 217 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCSCBCTTCSEEEEECSBCCHHHHHHHHHSB
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eeccccCCCCcEEEEecCCCChHHHHHHHHcc
Confidence 4666676655432 1224445566677777777776311 22221136777777777766543323333 5
Q ss_pred CCCccEEEecc--CCCccc-----ccccc--cCCCCCcEEeCcCCcccCCCCCCcc---CCCCCCeEEccCccccccc--
Q 008121 152 MVSLSYLNVSR--NSLTQS-----IGDIF--GNLAGLATLDLSFNNFSGDLPNSFI---SLSNISSLYLQNNQVTGSL-- 217 (577)
Q Consensus 152 l~~L~~L~L~~--N~l~~~-----~p~~~--~~l~~L~~L~Ls~N~l~g~~p~~~~---~l~~L~~L~l~~N~l~~~~-- 217 (577)
+++|+.|+|+. |...+. +...+ ..+++|++|+|++|.+++..+..+. .+++|++|+|+.|.|.+.-
T Consensus 218 lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~ 297 (362)
T 2ra8_A 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR 297 (362)
T ss_dssp CTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHH
T ss_pred CCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHH
Confidence 67777777753 221111 11112 2467777777777776643322222 3567777777777776521
Q ss_pred --c-cCCC-CCccEEEeecCccccc
Q 008121 218 --N-VFSG-LPLTTLNVANNHFSGW 238 (577)
Q Consensus 218 --~-~~~~-~~L~~L~l~~N~l~g~ 238 (577)
. .+.. ..|+.|+|++|.|+..
T Consensus 298 ~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 298 LLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp HHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHHhhcccCCcceEEECCCCcCCHH
Confidence 1 1111 2377777777776643
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.63 E-value=2.5e-07 Score=96.12 Aligned_cols=166 Identities=12% Similarity=0.116 Sum_probs=113.9
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCC-CCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-QLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
..++.|+|++|+++......|. ..+|+.+.|.+| ++ .++. .|. ++|+.|+|..| ++..-..+|.+ .+|+.+.
T Consensus 180 ~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~ 254 (401)
T 4fdw_A 180 YNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVK 254 (401)
T ss_dssp TTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEE
T ss_pred ccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEE
Confidence 5788999999988866556666 588999998854 65 3443 332 68888888875 55455566766 6888888
Q ss_pred eccCCCcccccccccCCCCCcEEeCcCCccc-----CCCCCCccCCCCCCeEEccCccccccc-ccCCCC-CccEEEeec
Q 008121 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFS-----GDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGL-PLTTLNVAN 232 (577)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~-~L~~L~l~~ 232 (577)
| .|+++..-+..|.++++|+.+++.+|.+. ..-+..|.+|++|+.++|.+ .++... .+|... .|+.++|..
T Consensus 255 l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~ 332 (401)
T 4fdw_A 255 L-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPA 332 (401)
T ss_dssp E-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECT
T ss_pred e-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECc
Confidence 8 56677666778888888888888887765 34456788888888888884 465543 346554 488888865
Q ss_pred CccccccCcccc--cccceeecCCcC
Q 008121 233 NHFSGWIPRELI--SIRTFIYDGNSF 256 (577)
Q Consensus 233 N~l~g~~p~~l~--~l~~l~~~~n~~ 256 (577)
| ++..-+..|. +++.+.+.+|..
T Consensus 333 ~-l~~I~~~aF~~~~L~~l~l~~n~~ 357 (401)
T 4fdw_A 333 N-VTQINFSAFNNTGIKEVKVEGTTP 357 (401)
T ss_dssp T-CCEECTTSSSSSCCCEEEECCSSC
T ss_pred c-ccEEcHHhCCCCCCCEEEEcCCCC
Confidence 5 5522233332 566777777643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.61 E-value=5.6e-08 Score=97.08 Aligned_cols=137 Identities=22% Similarity=0.260 Sum_probs=98.5
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCc--eeeEeeEEEeCC---eEEEEEE
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPN--IVTLAGYCAEHG---QRLLVYE 488 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e 488 (577)
.+.++.|.+..||+.. ..+++|+... ......+.+|.++++.+. +.. +.+++.+....+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999863 5678887542 234567889999998873 333 344554443332 3489999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC------------------------------------ 532 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------------------------------------ 532 (577)
|++|..|.+... ..++..++..++.++++.++.||+..
T Consensus 97 ~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 97 KIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp CCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred ccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999987765332 23567777888888888888888611
Q ss_pred -------------------CCCeeecCCCCCCeeeCC--CCCeEEeccccCccc
Q 008121 533 -------------------LPSVVHRNFKSANILLDD--ELNPHLSDCGLAALT 565 (577)
Q Consensus 533 -------------------~~~ivHrDlk~~NILl~~--~~~~kl~DFGla~~~ 565 (577)
.+.++|+|+++.||++++ ...+.|+||+.+..-
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 145899999999999998 556889999998754
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=1.8e-09 Score=99.74 Aligned_cols=117 Identities=14% Similarity=0.144 Sum_probs=63.2
Q ss_pred cccccccCCCCCCEEEccCC-CcCCc----CCCCC--CCCccEEEccCCcCCCc----CCCCccCCCCccEEEeccCCCc
Q 008121 98 TMGYLLSDLLSLRKFDLSGN-SIHDT----IPYQL--PPNLTSLNLASNNFSGN----LPYSIASMVSLSYLNVSRNSLT 166 (577)
Q Consensus 98 ~~~~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~--~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 166 (577)
.+...+...+.|++|+|++| .|... +...+ .++|++|+|++|+|... +...+...++|++|+|++|+|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34455666777777777777 66532 11111 15566666666666531 2233344456666666666666
Q ss_pred cc----ccccccCCCCCcEEeC--cCCcccCC----CCCCccCCCCCCeEEccCcccc
Q 008121 167 QS----IGDIFGNLAGLATLDL--SFNNFSGD----LPNSFISLSNISSLYLQNNQVT 214 (577)
Q Consensus 167 ~~----~p~~~~~l~~L~~L~L--s~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 214 (577)
.. +...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 42 3444555566666666 55666532 1222333455666666655543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.55 E-value=4.2e-08 Score=100.29 Aligned_cols=171 Identities=15% Similarity=0.169 Sum_probs=113.3
Q ss_pred CcEEEEEcCCCCCcc-c-------ccccccCCCCCCEEEccCCCcCC---------cCCCCC--CCCccEEEccCCcCCC
Q 008121 83 SAVVSIDISGLGLSG-T-------MGYLLSDLLSLRKFDLSGNSIHD---------TIPYQL--PPNLTSLNLASNNFSG 143 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g-~-------~~~~~~~l~~L~~L~Ls~N~l~~---------~~p~~~--~~~L~~L~l~~N~l~~ 143 (577)
.+|+.|.+......| . +..++..+++|+.|.+..+.+.. .++..+ .++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 467888887666553 2 23446678999999998765421 111111 279999999988311
Q ss_pred cCCCCccCCCCccEEEeccCCCccccccccc--CCCCCcEEeCcC--CcccCC-----CCCCc--cCCCCCCeEEccCcc
Q 008121 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFG--NLAGLATLDLSF--NNFSGD-----LPNSF--ISLSNISSLYLQNNQ 212 (577)
Q Consensus 144 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~ 212 (577)
.++. +. +++|+.|+|..|.++...-..+. .+++|+.|+|+. |...|. +...+ ..+++|++|+|.+|.
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 2343 43 89999999999998755444444 789999999863 332222 11122 257899999999999
Q ss_pred cccccc-c---CCCC-CccEEEeecCccccc----cCc---ccccccceeecCCcC
Q 008121 213 VTGSLN-V---FSGL-PLTTLNVANNHFSGW----IPR---ELISIRTFIYDGNSF 256 (577)
Q Consensus 213 l~~~~~-~---~~~~-~L~~L~l~~N~l~g~----~p~---~l~~l~~l~~~~n~~ 256 (577)
+.+... . ...+ .|+.|+|+.|.|++. ++. .+.+++.|++++|.+
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 875321 1 1123 399999999999874 333 356788888888765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.53 E-value=1.5e-08 Score=98.58 Aligned_cols=102 Identities=22% Similarity=0.217 Sum_probs=75.3
Q ss_pred ccCCCCCCE--EEccCCCcCCcCCC------CCCCCccEEEccCCcCCC--cCCCCccCCCCccEEEeccCCCccccccc
Q 008121 103 LSDLLSLRK--FDLSGNSIHDTIPY------QLPPNLTSLNLASNNFSG--NLPYSIASMVSLSYLNVSRNSLTQSIGDI 172 (577)
Q Consensus 103 ~~~l~~L~~--L~Ls~N~l~~~~p~------~~~~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 172 (577)
|...+.|.. ++++.|+.. .++. .-.++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..
T Consensus 137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~ 213 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE 213 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence 555555665 777888544 2221 112789999999999997 5667788899999999999999976 23
Q ss_pred ccCCC--CCcEEeCcCCcccCCCCC-------CccCCCCCCeEE
Q 008121 173 FGNLA--GLATLDLSFNNFSGDLPN-------SFISLSNISSLY 207 (577)
Q Consensus 173 ~~~l~--~L~~L~Ls~N~l~g~~p~-------~~~~l~~L~~L~ 207 (577)
+..+. +|++|+|++|.+++.+|. .+..+++|+.||
T Consensus 214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 44444 899999999999987773 356788888876
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.51 E-value=1.1e-08 Score=94.39 Aligned_cols=109 Identities=21% Similarity=0.317 Sum_probs=86.6
Q ss_pred CCcEEEEEcCCC-CCccc----ccccccCCCCCCEEEccCCCcCCcC----CCCCC--CCccEEEccCCcCCCc----CC
Q 008121 82 GSAVVSIDISGL-GLSGT----MGYLLSDLLSLRKFDLSGNSIHDTI----PYQLP--PNLTSLNLASNNFSGN----LP 146 (577)
Q Consensus 82 ~~~v~~l~l~~~-~l~g~----~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~--~~L~~L~l~~N~l~~~----~p 146 (577)
...++.|+|++| .|... +...+...++|++|+|++|+|...- ...+. ++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 568999999999 88653 4556777899999999999997421 11121 6899999999999853 45
Q ss_pred CCccCCCCccEEEe--ccCCCccc----ccccccCCCCCcEEeCcCCccc
Q 008121 147 YSIASMVSLSYLNV--SRNSLTQS----IGDIFGNLAGLATLDLSFNNFS 190 (577)
Q Consensus 147 ~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 190 (577)
..+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 66777889999999 88999854 3455666799999999999986
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.1e-06 Score=87.84 Aligned_cols=137 Identities=19% Similarity=0.156 Sum_probs=94.0
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCC---ceeeEeeEEE-eCCeEEEEEEec
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP---NIVTLAGYCA-EHGQRLLVYEYV 490 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~ 490 (577)
.+.++.|....||+. +..+++|+-.. ......+.+|.++|..+.+. .+.+.+.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888888899987 56778887432 23456788999999998753 3556677764 455678999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV--------------------------------------- 531 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------------------------------------- 531 (577)
+|..+.+... ..++..++..++.++++.|+.||+.
T Consensus 96 ~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 96 QGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred CCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9987765321 1234444445555555555555532
Q ss_pred ------------------CCCCeeecCCCCCCeeeCC---CCC-eEEeccccCccc
Q 008121 532 ------------------CLPSVVHRNFKSANILLDD---ELN-PHLSDCGLAALT 565 (577)
Q Consensus 532 ------------------~~~~ivHrDlk~~NILl~~---~~~-~kl~DFGla~~~ 565 (577)
..+.++|+|+++.||++++ ++. +.|+||+.+..-
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235799999999999987 455 489999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.3e-06 Score=85.33 Aligned_cols=136 Identities=15% Similarity=0.160 Sum_probs=95.4
Q ss_pred eeccCccc-eEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 417 LIGEGSLG-RVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 417 ~lg~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
.+..|..| .||+.... ++..+++|+-.. ....++.+|...|+.+. +--+.++++++.+.+..++|||++++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45566666 68987654 456788887542 23456788888887764 333668889999999999999999998
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC----------------------------------------- 532 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~----------------------------------------- 532 (577)
++.+.... .......+..++++.|.-||...
T Consensus 106 ~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 106 TAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred cccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 87765431 11123345556666666666421
Q ss_pred --------------CCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 533 --------------LPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 533 --------------~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
.+.++|+|+.+.|||+++++.+-|+||+.+..-
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 123799999999999998877789999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=1.6e-06 Score=88.41 Aligned_cols=81 Identities=6% Similarity=-0.039 Sum_probs=53.0
Q ss_pred cee-ccCccceEEEEEEc-------CCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCC---CceeeEeeEEEeC---
Q 008121 416 FLI-GEGSLGRVYRAEFA-------NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRH---PNIVTLAGYCAEH--- 480 (577)
Q Consensus 416 ~~l-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H---~niv~l~~~~~~~--- 480 (577)
+.| +.|....+|+.... ++..+++|+...... .......+.+|..+++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88989999998764 267788887653220 00011345667777776642 3466778777655
Q ss_pred CeEEEEEEecCCCCHH
Q 008121 481 GQRLLVYEYVGNGNLH 496 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~ 496 (577)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=2.5e-05 Score=78.76 Aligned_cols=142 Identities=17% Similarity=0.268 Sum_probs=79.3
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhc-----CCCCceeeEe-e--EEEeCCeEEEEE
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-----LRHPNIVTLA-G--YCAEHGQRLLVY 487 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-----l~H~niv~l~-~--~~~~~~~~~lv~ 487 (577)
+.|+.|..+.||+....+| .+++|+.... .. ++..|.+++.. +..|.++... | +....+..+++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---HH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---HH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 4566677899999987655 4889988642 11 22233333333 2334444311 1 123466789999
Q ss_pred EecCCCCHH--------------HhhhhccC-C--C-------CCCCHHHH-----------------------------
Q 008121 488 EYVGNGNLH--------------DMLHFADD-S--S-------KNLTWNAR----------------------------- 514 (577)
Q Consensus 488 e~~~~g~L~--------------~~l~~~~~-~--~-------~~l~~~~~----------------------------- 514 (577)
||++|..+. ..+|.... . . ..-.|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 11221111 0 0 01123221
Q ss_pred --HHHHHHHHHHHHHHhc----------CCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 515 --VRVALGTARALEYLHE----------VCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 515 --~~i~~~i~~~L~yLH~----------~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
..+..++.+++++|+. ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111234456777763 0234899999999999998888999999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.87 E-value=7.2e-05 Score=74.50 Aligned_cols=140 Identities=15% Similarity=0.208 Sum_probs=91.9
Q ss_pred ccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC---CCceeeEeeEEEeCCeEEEEEEec
Q 008121 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 414 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
..+.|+.|.+..+|+... ++..+++|+.... ....|..|.+.|+.+. ...+.++++++...+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 356799999999999876 4667888876432 3556788888887773 356788888888888899999999
Q ss_pred CCCCHHH-----------hhhhccC-CC-----------------CCCCHHHHH---HHHHH----------------HH
Q 008121 491 GNGNLHD-----------MLHFADD-SS-----------------KNLTWNARV---RVALG----------------TA 522 (577)
Q Consensus 491 ~~g~L~~-----------~l~~~~~-~~-----------------~~l~~~~~~---~i~~~----------------i~ 522 (577)
++..+.. .||.... .. -.-+|.... ++..+ +.
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 9876421 2332211 00 012454321 12111 11
Q ss_pred HH-HHHHhc-CCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 523 RA-LEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 523 ~~-L~yLH~-~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
+. ...|.. ...|.+||+|+.+.|++++.++ +.|.||.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 223421 2356899999999999999887 8899984
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=4e-05 Score=79.28 Aligned_cols=77 Identities=17% Similarity=0.110 Sum_probs=48.1
Q ss_pred cceeccCccceEEEEEEc-CCcEEEEEEcccccc--ch---HHHHHHHHHHHHhhcCCC--Cc-eeeEeeEEEeCCeEEE
Q 008121 415 EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL--SL---QEEDNFLEAVSNMSRLRH--PN-IVTLAGYCAEHGQRLL 485 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~---~~~~~~~~e~~~l~~l~H--~n-iv~l~~~~~~~~~~~l 485 (577)
.+.+|.|.++.||++... +++.++||....... .. ...+++..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999754 467899997643211 00 112346678888776632 33 4456544 3445689
Q ss_pred EEEecCCC
Q 008121 486 VYEYVGNG 493 (577)
Q Consensus 486 v~e~~~~g 493 (577)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=4.1e-05 Score=65.73 Aligned_cols=56 Identities=20% Similarity=0.310 Sum_probs=42.2
Q ss_pred EEEccCCCcC-CcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCc
Q 008121 111 KFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166 (577)
Q Consensus 111 ~L~Ls~N~l~-~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 166 (577)
.+|.++++|+ ..+|..++++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666677765 4577777788888888888888666677777888888888877664
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00026 Score=73.79 Aligned_cols=75 Identities=13% Similarity=0.117 Sum_probs=44.8
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcccccc--ch-----HHHHHHHHHHHHhh-cCCCCceeeEeeEEEeCCeEEEE
Q 008121 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL--SL-----QEEDNFLEAVSNMS-RLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~-----~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv 486 (577)
.+.+|.|..+.||++.. +++.++||....... .. .....+..|+..+. ......+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999964 467889994321100 00 02223444433322 22234566777665 4567999
Q ss_pred EEec-CC
Q 008121 487 YEYV-GN 492 (577)
Q Consensus 487 ~e~~-~~ 492 (577)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00012 Score=72.01 Aligned_cols=77 Identities=22% Similarity=0.289 Sum_probs=53.3
Q ss_pred CccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCC---ceeeEeeEEEeCCeEEEEEEe
Q 008121 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP---NIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~~~~~~~lv~e~ 489 (577)
...+.+|.|..+.||+.+..||+.|++|+-..... .....|..|.+.|+.+.-. -+.+++++. ..++||||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 34567999999999999999999999998654321 1233477888888776421 244455432 23789999
Q ss_pred cCCCCH
Q 008121 490 VGNGNL 495 (577)
Q Consensus 490 ~~~g~L 495 (577)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.55 E-value=2.2e-05 Score=70.80 Aligned_cols=84 Identities=5% Similarity=0.086 Sum_probs=51.6
Q ss_pred CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCC-CcccccccccCC----CCCcEEeCcCCc-ccCCCCCCccCCCC
Q 008121 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS-LTQSIGDIFGNL----AGLATLDLSFNN-FSGDLPNSFISLSN 202 (577)
Q Consensus 129 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~g~~p~~~~~l~~ 202 (577)
-+|+.|||+++.++..--..+.++++|++|+|+++. ++..-=..++.+ ++|++|+|+++. ++..-=..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666654333445677788888888874 664333334443 368888887763 65322234566777
Q ss_pred CCeEEccCcc
Q 008121 203 ISSLYLQNNQ 212 (577)
Q Consensus 203 L~~L~l~~N~ 212 (577)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888877764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.48 E-value=5.9e-06 Score=76.00 Aligned_cols=87 Identities=17% Similarity=0.130 Sum_probs=44.5
Q ss_pred ccccCCCCCCEEEccCC-CcCCc----CCCCCC--CCccEEEccCCcCCCcCC----CCccCCCCccEEEeccCCCccc-
Q 008121 101 YLLSDLLSLRKFDLSGN-SIHDT----IPYQLP--PNLTSLNLASNNFSGNLP----YSIASMVSLSYLNVSRNSLTQS- 168 (577)
Q Consensus 101 ~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~--~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~- 168 (577)
..+.+-+.|+.|+|++| +|... +-..+. +.|+.|+|++|+|...-- +.+..-+.|++|+|++|+|+..
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34455567777777774 66521 111111 566677777776653222 2222345566666666666532
Q ss_pred ---ccccccCCCCCcEEeCcCC
Q 008121 169 ---IGDIFGNLAGLATLDLSFN 187 (577)
Q Consensus 169 ---~p~~~~~l~~L~~L~Ls~N 187 (577)
+-..+..-+.|++|+|++|
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHHhhCCceeEEECCCC
Confidence 2223333344666666543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00056 Score=70.51 Aligned_cols=130 Identities=13% Similarity=0.202 Sum_probs=73.7
Q ss_pred cccccCCCCCCEEEccCCCcCCcCCCC-C--CCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCC
Q 008121 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQ-L--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176 (577)
Q Consensus 100 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~--~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 176 (577)
..+|.++..|+.+.+.++..+ +... + .++|+.+.+. +.++..-...|.++.+|+.++|..| ++.+-..+|.++
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~--I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C 333 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS--IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGC 333 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE--ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred cceeeecccccEEecccccce--ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCC
Confidence 446777777888777655433 2221 2 2677777775 4455455567777788888887654 555555677778
Q ss_pred CCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCCccEEEeecCcc
Q 008121 177 AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHF 235 (577)
Q Consensus 177 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l 235 (577)
.+|+.+.|..+ ++..-..+|.+|++|+.+++.+|..... ..+....|+.+.+..|.+
T Consensus 334 ~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~~-~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 334 EQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQWN-AISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHHH-TCBCCCCC----------
T ss_pred CCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeehh-hhhccCCCCEEEeCCCCE
Confidence 88888877644 5533345677778888887777654321 112222366665555443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.30 E-value=4.8e-05 Score=69.91 Aligned_cols=110 Identities=19% Similarity=0.257 Sum_probs=78.8
Q ss_pred eCCcEEEEEcCCC-CCcc----cccccccCCCCCCEEEccCCCcCCcCCCCCC------CCccEEEccCCcCCCc----C
Q 008121 81 EGSAVVSIDISGL-GLSG----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP------PNLTSLNLASNNFSGN----L 145 (577)
Q Consensus 81 ~~~~v~~l~l~~~-~l~g----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------~~L~~L~l~~N~l~~~----~ 145 (577)
.+..++.|+|++| +|.. .+...+..-+.|+.|+|++|+|...--..+. +.|+.|+|++|+|... +
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 4568999999986 7753 2456677788999999999999843333332 7899999999999842 2
Q ss_pred CCCccCCCCccEEEeccC---CCccc----ccccccCCCCCcEEeCcCCccc
Q 008121 146 PYSIASMVSLSYLNVSRN---SLTQS----IGDIFGNLAGLATLDLSFNNFS 190 (577)
Q Consensus 146 p~~~~~l~~L~~L~L~~N---~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 190 (577)
-+.+..-+.|++|+|++| .+... +-..+..=+.|+.|+|+.|.+.
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 334555567999999876 34432 3344555577888888877654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00039 Score=59.58 Aligned_cols=56 Identities=23% Similarity=0.262 Sum_probs=33.0
Q ss_pred EEEeccCCCc-ccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccc
Q 008121 157 YLNVSRNSLT-QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (577)
Q Consensus 157 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (577)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555566654 23443322 35667777777776444445666777777777777654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0005 Score=68.00 Aligned_cols=31 Identities=16% Similarity=0.171 Sum_probs=25.9
Q ss_pred CCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 534 ~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
+.++|+|+.+.||+ .+++.+.++||..+..-
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 35899999999999 56667899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00051 Score=68.52 Aligned_cols=144 Identities=13% Similarity=0.113 Sum_probs=77.7
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCc--eeeEeeE------EEeCCeEEEEE
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLAGY------CAEHGQRLLVY 487 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~------~~~~~~~~lv~ 487 (577)
+.|+.|....+|+....+| .+++|...... ..+++..|..++..+.... +.+++.. ....+..+++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 4577788889999987666 57788876421 1123444555555443111 2233321 12345678999
Q ss_pred EecCCCCHHH--------------hhhhcc-CCC-------CCCCHHHHHH------------HHHHHHHHHHHHhcC--
Q 008121 488 EYVGNGNLHD--------------MLHFAD-DSS-------KNLTWNARVR------------VALGTARALEYLHEV-- 531 (577)
Q Consensus 488 e~~~~g~L~~--------------~l~~~~-~~~-------~~l~~~~~~~------------i~~~i~~~L~yLH~~-- 531 (577)
+|++|..+.. .+|... ... ....|..... +...+.+.+++++..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9999864321 122110 000 0012322111 011244455666532
Q ss_pred --CCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 532 --CLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 532 --~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
..+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 124699999999999999876668999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00071 Score=67.89 Aligned_cols=32 Identities=31% Similarity=0.314 Sum_probs=27.7
Q ss_pred CCeeecCCCCCCeeeCCC----CCeEEeccccCccc
Q 008121 534 PSVVHRNFKSANILLDDE----LNPHLSDCGLAALT 565 (577)
Q Consensus 534 ~~ivHrDlk~~NILl~~~----~~~kl~DFGla~~~ 565 (577)
+.++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999874 67899999988753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.15 E-value=8.3e-05 Score=67.02 Aligned_cols=38 Identities=16% Similarity=0.079 Sum_probs=26.4
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCC-cC
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IH 120 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~-l~ 120 (577)
-+++.|||+++.++..--..+..+++|++|+|+++. |+
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~It 99 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIE 99 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccC
Confidence 368888888887765444456677777777777774 55
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0019 Score=66.53 Aligned_cols=142 Identities=14% Similarity=0.138 Sum_probs=100.7
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCC--CCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
.++.+.+... ++..-...+..+..|+.+.+..|... .....+ ...|+.+.+..+.+. ...|..+.+|+.+.+.
T Consensus 231 ~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 231 GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLL 305 (394)
T ss_dssp CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEEC
T ss_pred CCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccc
Confidence 5666766543 44344567888999999999887654 112222 277888888776533 3567888999999997
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccc-ccCCCC-CccEEEeecC
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGL-PLTTLNVANN 233 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~-~L~~L~l~~N 233 (577)
+| ++.+-..+|.++.+|+.++|.++ ++-.-..+|.+|.+|+.+.+..| ++... .+|.+. .|+.+++..|
T Consensus 306 ~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 306 DS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred cc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 65 66566678999999999999755 66444567889999999999877 55433 356664 4899988765
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0013 Score=67.75 Aligned_cols=123 Identities=15% Similarity=0.200 Sum_probs=84.5
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCC-CC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-LP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
.++.+.+.++-. ..-...|.+++.|+.+++. +.++ .++.. |. .+|+.++|..| ++..-..+|.++.+|+.+.|
T Consensus 266 ~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 266 YLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cccEEecccccc-eecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 355566654432 2445678899999999996 4555 35433 32 79999999865 66566789999999999999
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccc
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (577)
..+ ++.+-..+|.++++|+.+++.+|.... ..+..+.+|+.+.+..|.+.
T Consensus 342 p~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 342 PSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp CTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred Ccc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 755 776667889999999999999987652 46778889999998877653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0054 Score=61.10 Aligned_cols=143 Identities=16% Similarity=0.187 Sum_probs=79.6
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCC--ceeeEeeE-----EEeCCeEEEEEE
Q 008121 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP--NIVTLAGY-----CAEHGQRLLVYE 488 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~-----~~~~~~~~lv~e 488 (577)
..++ |....||+....+|+.+++|....... ....+..|..++..+... .+++++.. ....+..+++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 788899998777787899999863322 223455566666555321 23444432 223556789999
Q ss_pred ecCCCCHH-----H---------hhhhccC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHhc
Q 008121 489 YVGNGNLH-----D---------MLHFADD-----SSKNLTWNAR----VRV---------------ALGTARALEYLHE 530 (577)
Q Consensus 489 ~~~~g~L~-----~---------~l~~~~~-----~~~~l~~~~~----~~i---------------~~~i~~~L~yLH~ 530 (577)
|++|..+. . .+|.... ....+++... ..+ ...+.+.++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875432 1 0121100 0112222211 001 1111122333322
Q ss_pred C----CCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 531 V----CLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 531 ~----~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
. ..+.++|+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 223689999999999999 4 899999988764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0026 Score=64.90 Aligned_cols=129 Identities=15% Similarity=0.187 Sum_probs=85.5
Q ss_pred cccccccCCCCCCEEEccCCCcCCcCCC-CC--CCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCccccccccc
Q 008121 98 TMGYLLSDLLSLRKFDLSGNSIHDTIPY-QL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFG 174 (577)
Q Consensus 98 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 174 (577)
.....+....+|+.+.+..+ +. .++. .+ ...|+.+.+..+ ++..-...|.++.+|+.+.+..+ +.......|.
T Consensus 208 i~~~~f~~~~~l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~ 283 (379)
T 4h09_A 208 VTAYGFSYGKNLKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCS 283 (379)
T ss_dssp ECTTTTTTCSSCSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTT
T ss_pred Eeecccccccccceeeeccc-ee-EEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccc
Confidence 33456777788888887655 22 2222 22 267888888765 55455667788888888888644 5555556788
Q ss_pred CCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccc-ccCCCC-CccEEEee
Q 008121 175 NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGL-PLTTLNVA 231 (577)
Q Consensus 175 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~-~L~~L~l~ 231 (577)
++++|+.+.+.+|.++..-...|.+|.+|+.+.|..+ ++..- .+|... .|+.+.+.
T Consensus 284 ~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 284 GCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp TCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred cccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 8888888888888887545567888888888888654 44332 245543 36666554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.007 Score=62.16 Aligned_cols=143 Identities=11% Similarity=0.044 Sum_probs=87.0
Q ss_pred ccccCCCCCCEEEccCCCcCCcCCCC---CCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCC
Q 008121 101 YLLSDLLSLRKFDLSGNSIHDTIPYQ---LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177 (577)
Q Consensus 101 ~~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 177 (577)
.......+|+.+.+..+- + .+... -...|+.+.+..+... .....|..+..|+.+.+..+.+. ...|.++.
T Consensus 224 ~~~~~~~~l~~i~ip~~~-~-~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~ 297 (394)
T 4fs7_A 224 DFALSKTGVKNIIIPDSF-T-ELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCS 297 (394)
T ss_dssp TTTTTTCCCCEEEECTTC-C-EECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCT
T ss_pred hhhcccCCCceEEECCCc-e-ecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccc
Confidence 334455677777775432 2 12211 1267888888776544 55667778888888877765432 34577788
Q ss_pred CCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccc-ccCCCC-CccEEEeecCccccccCcccc---cccceeec
Q 008121 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGL-PLTTLNVANNHFSGWIPRELI---SIRTFIYD 252 (577)
Q Consensus 178 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~-~L~~L~l~~N~l~g~~p~~l~---~l~~l~~~ 252 (577)
+|+.+.+.+| ++..-...|.++.+|+.++|.++ ++..- .+|.+. .|+.+++..| ++-.-...|. +|+.+.+.
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 8888888765 55344556888888888888654 54432 345554 4888888766 5522223343 34444443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0015 Score=68.11 Aligned_cols=72 Identities=13% Similarity=0.128 Sum_probs=47.5
Q ss_pred cceeccCccceEEEEEEcC--------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCce-eeEeeEEEeCCeEEE
Q 008121 415 EFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI-VTLAGYCAEHGQRLL 485 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~l 485 (577)
.+.|+.|....+|++...+ ++.+++|+..... ..+.+.+|..++..+...++ .++++.+.. .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4568888889999998753 4788888874311 11345578887777643333 566665532 38
Q ss_pred EEEecCCCC
Q 008121 486 VYEYVGNGN 494 (577)
Q Consensus 486 v~e~~~~g~ 494 (577)
|+||++|..
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0028 Score=64.77 Aligned_cols=142 Identities=16% Similarity=0.172 Sum_probs=81.0
Q ss_pred ceeccCccceEEEEEEcC--------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCc-eeeEeeEEEeCCeEEEE
Q 008121 416 FLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN-IVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv 486 (577)
+.+..|-...+|++...+ ++.+++|+.... ......+.+|.++++.+.-.+ ..++++++.. .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 457778888999998742 478888886321 112345568888887764222 3456665543 299
Q ss_pred EEecCCCCHHH--------------h---hhhccC-CCCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 008121 487 YEYVGNGNLHD--------------M---LHFADD-SSKNL--TWNARVRVALGTAR-------------------ALEY 527 (577)
Q Consensus 487 ~e~~~~g~L~~--------------~---l~~~~~-~~~~l--~~~~~~~i~~~i~~-------------------~L~y 527 (577)
|||++|..|.. . ||...- ..+.. -|.+..++..++.. .+++
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998754421 1 121110 11122 24444445444321 2333
Q ss_pred Hh----cC-CCCCeeecCCCCCCeeeCCC----CCeEEeccccCcc
Q 008121 528 LH----EV-CLPSVVHRNFKSANILLDDE----LNPHLSDCGLAAL 564 (577)
Q Consensus 528 LH----~~-~~~~ivHrDlk~~NILl~~~----~~~kl~DFGla~~ 564 (577)
|. .. ....++|+|+.+.|||++.+ +.+.++||..|..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 21 12368999999999999876 7899999998874
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.013 Score=59.56 Aligned_cols=131 Identities=14% Similarity=0.145 Sum_probs=85.3
Q ss_pred cccCCCCCCEEEccCCCcC-CcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCc
Q 008121 102 LLSDLLSLRKFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA 180 (577)
Q Consensus 102 ~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 180 (577)
.+.....+..+.+..+.-. +........+|+.+.+..+ +...-...|.++.+|+.+.+..+ ++..-...|.++.+|+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 189 SYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp ECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred cccccccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 4445555666655443322 1111122267888888655 44455667788888988888765 6656667788888898
Q ss_pred EEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCC-CccEEEeecCccc
Q 008121 181 TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGL-PLTTLNVANNHFS 236 (577)
Q Consensus 181 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~-~L~~L~l~~N~l~ 236 (577)
.+.+..+ ++..-...|.+|.+|+.+.+.+|.++.... +|... .|+.++|..+ ++
T Consensus 267 ~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~ 322 (379)
T 4h09_A 267 TLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK 322 (379)
T ss_dssp EEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC
T ss_pred ccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc
Confidence 8888654 553444568888899999988888776543 46554 4888888654 44
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.011 Score=61.99 Aligned_cols=74 Identities=11% Similarity=0.007 Sum_probs=45.6
Q ss_pred cceeccCccceEEEEEEcC-CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCce-eeEeeEEEeCCeEEEEEEecCC
Q 008121 415 EFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI-VTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~ 492 (577)
.+.|+.|-...+|+....+ +..+++|+........ -+-.+|..++..+...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4568888889999998865 4778888764321110 011467777777764444 46777662 2 259999987
Q ss_pred CCH
Q 008121 493 GNL 495 (577)
Q Consensus 493 g~L 495 (577)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.012 Score=59.80 Aligned_cols=72 Identities=8% Similarity=0.028 Sum_probs=40.3
Q ss_pred ceeccCccceEEEEEEcC---------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCc-eeeEeeEEEeCCeEEE
Q 008121 416 FLIGEGSLGRVYRAEFAN---------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN-IVTLAGYCAEHGQRLL 485 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~l 485 (577)
+.++.|....+|+....+ +..+++|+..... ....+...|.+++..+...+ +.++++.. . -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 457788888999998754 2678888765321 11111245666666554223 34565543 2 268
Q ss_pred EEEecCCCC
Q 008121 486 VYEYVGNGN 494 (577)
Q Consensus 486 v~e~~~~g~ 494 (577)
||||++|..
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.015 Score=58.40 Aligned_cols=31 Identities=19% Similarity=0.285 Sum_probs=27.8
Q ss_pred CCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 534 PSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 534 ~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+.++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.56 E-value=0.026 Score=36.27 Aligned_cols=31 Identities=35% Similarity=0.524 Sum_probs=20.2
Q ss_pred CCCCCceeehhHHHHHHHHHHHHHHHHHHHh
Q 008121 298 KELPAGAIVGIVLGAVFLVALALLALYFCIR 328 (577)
Q Consensus 298 ~~~~~~~iv~iv~~~~~lv~~~~~~~~~~~~ 328 (577)
+.++.+.|.+++++.++.++++..+.++++|
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~~r 36 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGILVFRSR 36 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHHHee
Confidence 3456778888888887766665555454443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.43 E-value=0.12 Score=53.33 Aligned_cols=142 Identities=12% Similarity=0.115 Sum_probs=80.4
Q ss_pred cceeccCccceEEEEEEcC--------CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCc-eeeEeeEEEeCCeEEE
Q 008121 415 EFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN-IVTLAGYCAEHGQRLL 485 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~l 485 (577)
.+.+..|-...+|+....+ ++.+++|+..... ...-+..+|.++++.+.-.+ ..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 3467778889999998763 5788888864321 11111235666666553222 34555433 2 278
Q ss_pred EEEecCCCCHHH--------------h---hhhccC---------CCCCCCHHHHHHHHHHH------------------
Q 008121 486 VYEYVGNGNLHD--------------M---LHFADD---------SSKNLTWNARVRVALGT------------------ 521 (577)
Q Consensus 486 v~e~~~~g~L~~--------------~---l~~~~~---------~~~~l~~~~~~~i~~~i------------------ 521 (577)
||||++|..|.. . +|...- ...+-.|.+..++..++
T Consensus 148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 227 (424)
T 3mes_A 148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK 227 (424)
T ss_dssp EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence 999999865321 0 111100 11111244333333222
Q ss_pred -HHHHHHHhc---------------------CCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 522 -ARALEYLHE---------------------VCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 522 -~~~L~yLH~---------------------~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
...+++|.. .....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223333321 11235899999999999 8888999999998874
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.04 E-value=0.14 Score=33.91 Aligned_cols=27 Identities=22% Similarity=0.437 Sum_probs=11.1
Q ss_pred eehhHHHHHHHHHHHHHHHHHHHhhcc
Q 008121 305 IVGIVLGAVFLVALALLALYFCIRKNR 331 (577)
Q Consensus 305 iv~iv~~~~~lv~~~~~~~~~~~~rrr 331 (577)
|++.+++.+++++++++.++++.|||+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 444444444433333333344444333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.91 E-value=0.16 Score=33.55 Aligned_cols=27 Identities=22% Similarity=0.488 Sum_probs=11.4
Q ss_pred eeehhHHHHHHHHHHHHHHHHHHHhhc
Q 008121 304 AIVGIVLGAVFLVALALLALYFCIRKN 330 (577)
Q Consensus 304 ~iv~iv~~~~~lv~~~~~~~~~~~~rr 330 (577)
.|++.+++.+++++++++.++++.|||
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhh
Confidence 344445544444333333333444433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.96 E-value=0.53 Score=48.14 Aligned_cols=29 Identities=24% Similarity=0.384 Sum_probs=25.1
Q ss_pred eeecCCCCCCeee------CCCCCeEEeccccCcc
Q 008121 536 VVHRNFKSANILL------DDELNPHLSDCGLAAL 564 (577)
Q Consensus 536 ivHrDlk~~NILl------~~~~~~kl~DFGla~~ 564 (577)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.33 E-value=0.033 Score=58.37 Aligned_cols=61 Identities=7% Similarity=0.029 Sum_probs=17.2
Q ss_pred cceeccCccceEEEEEEcC-CcEEEE------EEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEE
Q 008121 415 EFLIGEGSLGRVYRAEFAN-GKIMAV------KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 478 (577)
.+.+| ||.||+|.+.. ..+||| |+.+....+.+....|.+|..++...+|||+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 45566 99999998864 367888 777654444455567889999999999999999988764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.38 E-value=0.34 Score=32.00 Aligned_cols=11 Identities=27% Similarity=0.685 Sum_probs=6.0
Q ss_pred eeehhHHHHHH
Q 008121 304 AIVGIVLGAVF 314 (577)
Q Consensus 304 ~iv~iv~~~~~ 314 (577)
.+++.++|+++
T Consensus 13 ~Ia~~vVGvll 23 (44)
T 2jwa_A 13 SIISAVVGILL 23 (44)
T ss_dssp HHHHHHHHHHH
T ss_pred chHHHHHHHHH
Confidence 45666666443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.23 E-value=1.5 Score=40.37 Aligned_cols=91 Identities=14% Similarity=0.151 Sum_probs=65.9
Q ss_pred CCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeecCCCC
Q 008121 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE-YLHEVCLPSVVHRNFKS 543 (577)
Q Consensus 465 l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~-yLH~~~~~~ivHrDlk~ 543 (577)
-.||++ -...-.+++...+.|+.-+++-=...+ +.++..++++++..++.-.. +++.. +|--+.|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P 112 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCP 112 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeC
Confidence 368888 334446677777777765443222233 24678899999999887777 66655 7778999
Q ss_pred CCeeeCCCCCeEEeccccCcccCCCc
Q 008121 544 ANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 544 ~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
+||++|.++.+++.-.|+-..+++-+
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~lpP~e 138 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESLPPDE 138 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTBSSCS
T ss_pred ceEEEeCCCcEEEEEcCCcccCCCCC
Confidence 99999999999999999877665433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.64 E-value=1.4 Score=40.47 Aligned_cols=91 Identities=13% Similarity=0.105 Sum_probs=66.9
Q ss_pred CCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 008121 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (577)
Q Consensus 465 l~H~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~ 544 (577)
-.||+++.. .+-..++...+.|+.-+. ...+- .-+.++...+++++..|+.-..+++.. +|--+.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcc--cCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 478988876 455666666666665432 22221 123578889999999999888777765 78889999
Q ss_pred CeeeCCCCCeEEeccccCcccCCC
Q 008121 545 NILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 545 NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
||++|.++.+++.-.|+-..+++.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P~ 132 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDPL 132 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSCC
T ss_pred eEEEcCCCCEEEEEccCccCCCCC
Confidence 999999999999999986655544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 577 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-40 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-37 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-37 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-36 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-35 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-35 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-34 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-32 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-31 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-26 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-04 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-40
Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 9/160 (5%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG GS G VY+ ++ +AVK ++ A + Q+ F V + + RH NI+ GY
Sbjct: 15 RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
Q +V ++ +L+ LH + +A TA+ ++YLH S+
Sbjct: 73 S-TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
+HR+ KS NI L ++L + D GLA +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-40
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 9/160 (5%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G V+ + +AVK + + D FL + M +L+H +V L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
++ EY+ NG+L D L S LT N + +A A + ++ E +
Sbjct: 77 V-TQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
+HR+ ++ANIL+ D L+ ++D GLA L + E G
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 35/173 (20%), Positives = 73/173 (42%), Gaps = 8/173 (4%)
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS 463
++ + F + +G G+ G V++ +G +MA K I + + + + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLH 59
Query: 464 RLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
P IV G G+ + E++ G+L +L + + +V++ +
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
L YL E ++HR+ K +NIL++ L D G++ ++ GT
Sbjct: 116 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-37
Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 5/163 (3%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG GS GR + ++GKI+ K++D +++ E+ + V+ + L+HPNIV
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 476 YCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE--V 531
+ +V EY G+L ++ + L +RV AL+ H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
+V+HR+ K AN+ LD + N L D GLA + +
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (347), Expect = 3e-37
Identities = 42/191 (21%), Positives = 79/191 (41%), Gaps = 20/191 (10%)
Query: 400 YTVASLQTATNSFSQEF---------LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAA 446
+T A F++E +IG G G V +A+K + +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG- 65
Query: 447 LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSS 506
+ ++ +FL S M + HPN++ L G + +++ E++ NG+L L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QND 122
Query: 507 KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
T V + G A ++YL ++ VHR+ + NIL++ L +SD GL+
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 567 NTERQVITGTS 577
+ ++
Sbjct: 180 DDTSDPTYTSA 190
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 5e-37
Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 9/159 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +A+K I + ED F+E M L H +V L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG L + L + + A+EYL +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
HR+ + N L++D+ +SD GL+ + E G+
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (343), Expect = 1e-36
Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 9/165 (5%)
Query: 412 FSQEFLIGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPN 469
FS IG GS G VY A N +++A+KK+ + S ++ + ++ V + +LRHPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+ G LV EY + K L V G + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
+++HR+ K+ NILL + L D G A++ V T
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 174
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-36
Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 9/159 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG G G V+ + N +A+K I E++F+E M +L HP +V L G C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
E LV+E++ +G L D L + + L + YL E C V+
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
HR+ + N L+ + +SD G+ + + TGT
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-36
Identities = 36/177 (20%), Positives = 70/177 (39%), Gaps = 12/177 (6%)
Query: 405 LQTATNSFS-QEFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVS 460
L ++ + +G G+ G V + + +A+K + + + +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQ 61
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
M +L +P IV L G C + +LV E G G LH L + + + +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQ 117
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
+ ++YL E + VHR+ + N+LL + +SD GL+ + ++
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 7e-36
Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 25/180 (13%)
Query: 417 LIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPN 469
+G G+ G+V A +AVK + +A L E + + + +S L H N
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMN 88
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH--------------FADDSSKNLTWNARV 515
IV L G C G L++ EY G+L + L +D L +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITG 575
+ A+ + +L + +HR+ + NILL + D GLA N V+ G
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 8e-36
Identities = 40/158 (25%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G+ G+VY+A+ + A K ID S +E ++++ + ++ HPNIV L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
++ E+ G + ++ + + LT + V T AL YLH+ +
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
+HR+ K+ NIL + + L+D G++A T ++ +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-35
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 11/159 (6%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G G V ++ G +AVK I N FL S M++LRH N+V L G
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 477 CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
E L +V EY+ G+L D L L + ++ +L A+EYL +
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NN 123
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
VHR+ + N+L+ ++ +SD GL +T+
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-35
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 20/170 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAGY 476
IG+G G V+R ++ G+ +AVK + +E F EA + LRH NI+
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 477 CAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ Q LV +Y +G+L D L+ +T +++AL TA L +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 533 L-----PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
+ P++ HR+ KS NIL+ ++D GLA + + +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-35
Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 11/167 (6%)
Query: 414 QEFLIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
++ +G G+ G V + + K +AVK + N A +D L + M +L +P I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V + G C E +LV E G L+ L ++++ + + + ++YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
+ VHR+ + N+LL + +SD GL+ E T
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-35
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 30/186 (16%)
Query: 417 LIGEGSLGRVYRA------EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPN 469
++G G+ G+V A + +AVK + A S E + + + M++L H N
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHEN 102
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH-------------------FADDSSKNLT 510
IV L G C G L++EY G+L + L ++ LT
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
+ + A A+ +E+L S VHR+ + N+L+ + D GLA +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 571 QVITGT 576
V+ G
Sbjct: 220 YVVRGN 225
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-35
Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 9/167 (5%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
S E +G+G G V+ + +A+K + + FL+ M +LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEK 73
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V L +V EY+ G+L D L ++ K L V +A A + Y+
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
+ VHR+ ++ANIL+ + L ++D GLA L + E G
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 8e-35
Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 30/200 (15%)
Query: 403 ASLQTATNSFSQEFLIGEGSLGRVYRAE------FANGKIMAVKKIDNAALSLQEEDNFL 456
SL+ N+ IGEG+ GRV++A + ++AVK + A S + +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQ 64
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH---------------- 500
+ M+ +PNIV L G CA L++EY+ G+L++ L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 501 ----FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556
+ L+ ++ +A A + YL E VHR+ + N L+ + + +
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKI 181
Query: 557 SDCGLAALTPNTERQVITGT 576
+D GL+ + + G
Sbjct: 182 ADFGLSRNIYSADYYKADGN 201
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 1e-34
Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 9/161 (5%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G G VY + +AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLG 80
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
C ++ E++ GNL D L + + + ++ + +A + A+EYL + +
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEK---KN 135
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
+HR+ + N L+ + ++D GL+ L G
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-34
Identities = 46/162 (28%), Positives = 67/162 (41%), Gaps = 9/162 (5%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G G VY A + I+A+K + A L E V S LRHPNI+ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
GY + + L+ EY G ++ L A AL Y H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS---K 125
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
V+HR+ K N+LL ++D G + P++ R + GT
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 167
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 2e-34
Identities = 40/165 (24%), Positives = 64/165 (38%), Gaps = 11/165 (6%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG GS VY+ +A ++ + L+ E F E + L+HPNIV
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 477 CAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ +LV E + +G L L K + + L++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 533 LPSVVHRNFKSANILLDDELN-PHLSDCGLAALTPNTERQVITGT 576
P ++HR+ K NI + + D GLA L + + + GT
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT 176
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-33
Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 13/170 (7%)
Query: 412 FSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR 466
F +++ +GEG+ G V A + +AVK +D ++ +N + + L
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLN 61
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
H N+V G+ E + L EY G L D + + R +
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVV 117
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
YLH + HR+ K N+LLD+ N +SD GLA + R+ +
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 127 bits (319), Expect = 8e-33
Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 12/172 (6%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSR 464
N FS +IG G G VY GK+ A+K +D + +++ + N +S +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
P IV ++ + + + + G+LH L + A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
LE++H VV+R+ K ANILLD+ + +SD GLA + GT
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 168
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-32
Identities = 39/173 (22%), Positives = 77/173 (44%), Gaps = 12/173 (6%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANG-----KIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
+ +++ +IG G G VY+ +A+K + A + ++ +FL M +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 65
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
H NI+ L G +++ +++ EY+ NG + F + + V + G A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENG---ALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
++YL + VHR+ + NIL++ L +SD GL+ + + T +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 3e-32
Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 21/184 (11%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANG---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL- 465
N + +IGEG+ G+V +A A+K++ A S + +F + + +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLG 68
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH------------FADDSSKNLTWNA 513
HPNI+ L G C G L EY +GNL D L A+ ++ L+
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQV 572
+ A AR ++YL + +HR+ + NIL+ + ++D GL+ ++ +
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185
Query: 573 ITGT 576
Sbjct: 186 GRLP 189
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 3e-32
Identities = 41/166 (24%), Positives = 70/166 (42%), Gaps = 12/166 (7%)
Query: 417 LIGEGSLGRVYRAEFANGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+IG G G VY + AVK ++ + E FL M HPN+++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 473 LAGYCAEH-GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C G L+V Y+ +G+L + F + + N T + L A+ + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRN---FIRNETHNPTVKDLIGFGLQVAKG---MKFL 146
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
VHR+ + N +LD++ ++D GLA + E + +
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-32
Identities = 42/165 (25%), Positives = 64/165 (38%), Gaps = 12/165 (7%)
Query: 418 IGEGSLGRVYRAEF----ANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVT 472
+G+GS G V R E+ +AVK + LS E D+F+ V+ M L H N++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G +V E G+L D L + R A+ A + YL
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
+HR+ + N+LL + D GL P + +
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-32
Identities = 39/162 (24%), Positives = 64/162 (39%), Gaps = 9/162 (5%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
++GEGS V A E A + A+K ++ + + MSRL HP V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ + Y NG L + + ALEYLH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG---K 127
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
++HR+ K NILL+++++ ++D G A + +Q +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 124 bits (312), Expect = 6e-32
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 12/163 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V+R A G A K + +++ + + MS LRHP +V L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHD 90
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + +++YE++ G L + + D ++ + V + L ++HE
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN--- 144
Query: 536 VVHRNFKSANILLDDELNPH--LSDCGLAA-LTPNTERQVITG 575
VH + K NI+ + + L D GL A L P +V TG
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 187
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 122 bits (308), Expect = 2e-31
Identities = 38/164 (23%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V+R A G++ K I+ ++ +S M++L HP ++ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHD 93
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + +L+ E++ G L D + ++ + L+++HE S
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE---HS 147
Query: 536 VVHRNFKSANILLDDELNPH--LSDCGLA-ALTPNTERQVITGT 576
+VH + K NI+ + + + D GLA L P+ +V T T
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-31
Identities = 39/162 (24%), Positives = 64/162 (39%), Gaps = 12/162 (7%)
Query: 417 LIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
IGEG G V++ + + +A+K N S + FL+ M + HP+IV
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVK 72
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G E+ ++ E G L F +L + + A + AL YL
Sbjct: 73 LIGVITEN-PVWIIMELCTLGELRS---FLQVRKYSLDLASLILYAYQLSTALAYLES-- 126
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
VHR+ + N+L+ L D GL+ ++ +
Sbjct: 127 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 167
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 7e-31
Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+G+ G VY A A G+ +A+++++ +++ + + M ++PNIV
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V EY+ G+L D++ + V +ALE+LH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVITGT 576
V+HR+ KS NILL + + L+D G A ++R + GT
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 42/179 (23%), Positives = 67/179 (37%), Gaps = 22/179 (12%)
Query: 417 LIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ G+V A+ A + +AVK + A + E + H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 471 VTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------------FADDSSKNLTWNARVRV 517
V L G C + G L ++ E+ GNL L D LT +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
+ A+ +E+L +HR+ + NILL ++ + D GLA V G
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 117 bits (294), Expect = 4e-30
Identities = 39/157 (24%), Positives = 64/157 (40%), Gaps = 7/157 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IGEG+ G VY+A+ G+ A+KKI + +S + L+H NIV L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ +LV+E++ + L L + Y H+ V+
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
HR+ K N+L++ E ++D GLA R+
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-29
Identities = 37/171 (21%), Positives = 70/171 (40%), Gaps = 16/171 (9%)
Query: 418 IGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G+GS G VY +A+K ++ AA S++E FL S M ++V
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 86
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARAL 525
L G ++ L++ E + G+L L + N + + +++A A +
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
YL+ VHR+ + N ++ ++ + D G+ T+ G
Sbjct: 147 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 115 bits (288), Expect = 2e-29
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 21/179 (11%)
Query: 412 FSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL-------QEEDNFLEAV 459
F + + ++G G V R K AVK ID + + L+ V
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 460 SNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518
+ ++ HPNI+ L + LV++ + G L D L L+ ++
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIM 116
Query: 519 LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVITGT 576
+ LH++ +VHR+ K NILLDD++N L+D G + L P + + + GT
Sbjct: 117 RALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT 172
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (290), Expect = 3e-29
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G+ V AE K++A+K I AL +E + ++ + +++HPNIV L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G L+ + V G L D + T R+ A++YLH++
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLG--- 127
Query: 536 VVHRNFKSANILL---DDELNPHLSDCGLAAL-TPNTERQVITGT 576
+VHR+ K N+L D++ +SD GL+ + P + GT
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT 172
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-29
Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 11/169 (6%)
Query: 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVK---KIDNAALSLQEEDNFLEAVSNMSRLRH 467
F + ++G G+ G VY+ + G+ + + K A S + L+ M+ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
P++ L G C L+ + + G L D + + N+ + + A+ + Y
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGT 576
L + +VHR+ + N+L+ + ++D GLA L E++
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 1e-28
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 9/159 (5%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G GS GRV+ NG+ A+K + + L++ ++ + +S + HP I+ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G + Q ++ +Y+ G L +L S+ A ALEYLH
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS---K 123
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVI 573
+++R+ K NILLD + ++D G A P+ +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC 162
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 2e-28
Identities = 42/181 (23%), Positives = 76/181 (41%), Gaps = 25/181 (13%)
Query: 417 LIGEGSLGRVYRAEF--------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RH 467
+GEG+ G+V AE +AVK + + A ++ + + + M + +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKH 78
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF------------ADDSSKNLTWNARV 515
NI+ L G C + G ++ EY GNL + L + + + L+ V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITG 575
A AR +EYL +HR+ + N+L+ ++ ++D GLA + + T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 576 T 576
Sbjct: 196 N 196
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-28
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 18/169 (10%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
S++ +IG GS G VY+A+ +G+++A+KK+ E + M +L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRKLDHCN 74
Query: 470 IVTLAGYCAEHGQR------LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
IV L + G++ LV +YV H+ + + L R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFR 133
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPH-LSDCGLAALTPNTERQ 571
+L Y+H + HR+ K N+LLD + L D G A E
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-28
Identities = 40/159 (25%), Positives = 64/159 (40%), Gaps = 7/159 (4%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEG+ G VY+A G+++A+KKI + + +S + L HPNIV L
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ LV+E++ M + + + L + H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVIT 574
V+HR+ K N+L++ E L+D GLA R
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 3e-28
Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 12/165 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQE--EDNFLEAVSNMSRLRHPNIVTL 473
++G+GS G+V+ AEF + A+K + + + + E +E HP + +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
V EY+ G+L + S + A L++LH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS--- 121
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTERQVITGT 576
+V+R+ K NILLD + + ++D G+ + + + GT
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT 166
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 5e-28
Identities = 28/164 (17%), Positives = 67/164 (40%), Gaps = 12/164 (7%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G G V+R E ++ K K + + ++ + +S ++ RH NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ ++++E++ ++ + ++ S+ L V AL++LH +
Sbjct: 69 SFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 536 VVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVITGTS 577
+ H + + NI+ + + + G A + + T+
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-26
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 11/150 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED---NFLEAVSNMSRLRHPNIVT 472
+GEG VY+A +I+A+KKI S ++ L + + L HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L LV++++ D+ D+S LT + L T + LEYLH+
Sbjct: 65 LLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA 562
++HR+ K N+LLD+ L+D GLA
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLA 147
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 38/166 (22%), Positives = 68/166 (40%), Gaps = 14/166 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEG+ G V A N +A+KKI L + + R RH NI+ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 73
Query: 476 YCA----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
E + + + ++ +L+ +L +++L+ + R L+Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA 128
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
V+HR+ K +N+LL+ + + D GLA + T
Sbjct: 129 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 105 bits (262), Expect = 7e-26
Identities = 37/167 (22%), Positives = 66/167 (39%), Gaps = 13/167 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
++G G + V+ A + +AVK + + A F N + L HP IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 475 GYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+V EYV L D++H + +T + V +AL + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVITGTS 577
++HR+ K ANI++ + D G+A ++ V +
Sbjct: 130 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 33/163 (20%), Positives = 62/163 (38%), Gaps = 19/163 (11%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G G+V + + A+K + + + +E + A + P+IV +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA------SQCPHIVRIVD 72
Query: 476 YC----AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
A L+V E + G L + D + T + A++YLH +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 532 CLPSVVHRNFKSANILLDDELNP---HLSDCGLAALTPNTERQ 571
++ HR+ K N+L + L+D G A T +
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-25
Identities = 43/184 (23%), Positives = 65/184 (35%), Gaps = 26/184 (14%)
Query: 412 FSQEFL---------IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN 461
F QE + +G G V + + G A K I E +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 462 ----MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
+ ++HPN++TL +L+ E V G L D L ++LT
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEF 118
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP----HLSDCGLA-ALTPNTERQV 572
+ YLH + + H + K NI+L D P + D GLA + E +
Sbjct: 119 LKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 573 ITGT 576
I GT
Sbjct: 176 IFGT 179
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-24
Identities = 26/147 (17%), Positives = 51/147 (34%), Gaps = 4/147 (2%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V A G +A+KK+ S + + +RH N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
++ + L + + + L Y+H +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII- 143
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLA 562
HR+ K N+ ++++ + D GLA
Sbjct: 144 --HRDLKPGNLAVNEDCELKILDFGLA 168
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 36/167 (21%), Positives = 63/167 (37%), Gaps = 11/167 (6%)
Query: 418 IGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVT 472
IGEG+ G+V++A G+ +A+K++ + + V+ + L HPN+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLH--DMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
L C + ++ + + + R L++LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVITGT 576
VVHR+ K NIL+ L+D GLA + + T
Sbjct: 135 HR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 178
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 2e-24
Identities = 33/168 (19%), Positives = 56/168 (33%), Gaps = 14/168 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS----LQEEDNFLEAVSNMSRLR--HPN 469
L+G G G VY ++ +A+K ++ +S L V + ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
++ L + +L+ E L A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127
Query: 530 EVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQVITGT 576
V+HR+ K NIL+D + L D G AL +T GT
Sbjct: 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT 172
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (255), Expect = 2e-24
Identities = 34/147 (23%), Positives = 62/147 (42%), Gaps = 9/147 (6%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS GRV + +G A+K +D + L++ ++ L + + P +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
++ +V EYV G + L + A EYLH +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD--- 161
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLA 562
+++R+ K N+L+D + ++D G A
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 3e-24
Identities = 34/155 (21%), Positives = 60/155 (38%), Gaps = 8/155 (5%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEG+ G V++A+ +I+A+K++ + L + + L+H NIV L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ LV+E+ V + L+ L +V
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571
+HR+ K N+L++ L++ GLA R
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.9 bits (248), Expect = 1e-23
Identities = 42/171 (24%), Positives = 67/171 (39%), Gaps = 11/171 (6%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRH 467
N F L+G+G+ G+V A G+ A+K + ++ E + + + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
P + L H + V EY G L L + T ALEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVITGT 576
LH VV+R+ K N++LD + + ++D GL + + GT
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 168
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 4e-23
Identities = 37/154 (24%), Positives = 65/154 (42%), Gaps = 16/154 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G+ G V++A G+ +A+KK+ L + + L+H N+V L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 477 CAEH--------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
C G LV+++ + + + T + RV L Y+
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
H ++HR+ K+AN+L+ + L+D GLA
Sbjct: 134 HRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 98.0 bits (243), Expect = 5e-23
Identities = 41/166 (24%), Positives = 67/166 (40%), Gaps = 21/166 (12%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLA 474
+G G V+ A N + + VK + ++ + + LR PNI+TLA
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLA 96
Query: 475 GYCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ R LV+E+V N + + + LT +AL+Y H +
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 533 LPSVVHRNFKSANILLDDE-LNPHLSDCGLAA-LTPNTERQVITGT 576
++HR+ K N+++D E L D GLA P E V +
Sbjct: 150 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 192
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 96.8 bits (240), Expect = 7e-23
Identities = 27/160 (16%), Positives = 54/160 (33%), Gaps = 18/160 (11%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLA 474
IGEGS G ++ N + +A+K + + L I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ E +LV + +G + D + + A ++ +HE
Sbjct: 68 YFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 535 SVVHRNFKSANILLDDELNPH-----LSDCGLAALTPNTE 569
S+V+R+ K N L+ + + + D G+ +
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.9 bits (235), Expect = 4e-22
Identities = 29/151 (19%), Positives = 51/151 (33%), Gaps = 16/151 (10%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G +Y A G+ +A+K + ++ +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+C G +V E +G S+ + + +A +EY+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---K 122
Query: 535 SVVHRNFKSANIL---LDDELNPHLSDCGLA 562
+ +HR+ K N L ++ D GLA
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 1e-21
Identities = 36/153 (23%), Positives = 67/153 (43%), Gaps = 14/153 (9%)
Query: 417 LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEE--DNFLEAVSNMSRLRH-PN 469
++G G+ G+V+ GK+ A+K + A + + + ++ + +R P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+VTL + L+ +Y+ G L L + T + ALE+LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLH 146
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562
+ +++R+ K NILLD + L+D GL+
Sbjct: 147 K---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 9e-21
Identities = 29/147 (19%), Positives = 56/147 (38%), Gaps = 4/147 (2%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V A G +AVKK+ S+ + + ++H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +L + LT + + R L+Y+H +
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADII- 143
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLA 562
HR+ K +N+ ++++ + D GLA
Sbjct: 144 --HRDLKPSNLAVNEDCELKILDFGLA 168
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 1e-20
Identities = 30/161 (18%), Positives = 55/161 (34%), Gaps = 17/161 (10%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG G+ G V A + +A+KK+ + + M + H NI++L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 476 YCA------EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
E LV E + + D + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
++HR+ K +NI++ + + D GLA +
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.0 bits (199), Expect = 3e-18
Identities = 23/163 (14%), Positives = 43/163 (26%), Gaps = 19/163 (11%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE--------EDNFLEAVSNMSRLRHP 468
L+GEG V+ VK S ++ + +F +R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+ L G + Y GN M + V +
Sbjct: 67 ALQKLQGLA-------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571
+ +VH + N+L+ +E + D + +
Sbjct: 120 YHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR 158
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.6 bits (192), Expect = 1e-16
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 10/167 (5%)
Query: 40 DSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSA----VVSIDISGLGL 95
+ D QAL + L +P+ L++W D C +W GV C+ V ++D+SGL L
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 96 SGTMG--YLLSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
L++L L + G L L + N SG +P ++
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
+ +L L+ S N+L+ ++ +L L + N SG +P+S+
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.5 bits (132), Expect = 5e-09
Identities = 23/75 (30%), Positives = 29/75 (38%), Gaps = 1/75 (1%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
D L NL L+L +N G LP + + L LNVS N+L I GNL
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRF 293
Query: 180 ATLDLSFNNFSGDLP 194
+ N P
Sbjct: 294 DVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 14/57 (24%), Positives = 27/57 (47%), Gaps = 1/57 (1%)
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ L++ N + ++ L L +L++SFNN G++P +L NN+
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.5 bits (119), Expect = 2e-07
Identities = 16/59 (27%), Positives = 20/59 (33%), Gaps = 1/59 (1%)
Query: 183 DLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240
DL N G LP L + SL + N + G + L ANN P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.1 bits (92), Expect = 4e-04
Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 3/92 (3%)
Query: 62 NWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD 121
K + G + +D+ + GT+ L+ L L ++S N++
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 122 TIPY--QLPPNLTSLNLASNNFSGNLPYSIAS 151
IP L A+N P +
Sbjct: 283 EIPQGGNL-QRFDVSAYANNKCLCGSPLPACT 313
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.6 bits (187), Expect = 1e-15
Identities = 23/162 (14%), Positives = 56/162 (34%), Gaps = 19/162 (11%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G V+ A+ N +A+K + + + + + + R+ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDS 76
Query: 476 YCAEHGQRLLVYEYVGNGNL------------HDMLHFADDSSKNLTWNARVRVALGTAR 523
A H +LL + N + + + + +++
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAAL 564
L+Y+H ++H + K N+L++ + +L +A L
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 176
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.3 bits (176), Expect = 3e-14
Identities = 35/152 (23%), Positives = 62/152 (40%), Gaps = 26/152 (17%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLP---------------- 146
L+ L +L DL+ N I + P LT L L +N S P
Sbjct: 237 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296
Query: 147 ----YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
I+++ +L+YL + N+++ +L L L + N S +S +L+N
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 203 ISSLYLQNNQVTGSLNVFSGLP-LTTLNVANN 233
I+ L +NQ++ + L +T L + +
Sbjct: 353 INWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.0 bits (157), Expect = 7e-12
Identities = 36/152 (23%), Positives = 62/152 (40%), Gaps = 7/152 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
L +L + N I D P + NL L+L N ++AS+ +L+ L+++ N +
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPL 225
+ L L L L N S P L+ +++L L NQ+ + + L
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 226 TTLNVANNHFSGWIP-RELISIRTFIYDGNSF 256
T L + N+ S P L ++ + N
Sbjct: 310 TYLTLYFNNISDISPVSSLTKLQRLFFANNKV 341
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.5 bits (122), Expect = 1e-07
Identities = 16/104 (15%), Positives = 35/104 (33%), Gaps = 4/104 (3%)
Query: 60 LTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSI 119
LT E + + + + +S +S L L++ + N +
Sbjct: 284 LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV 341
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
D N+ L+ N S P +A++ ++ L ++
Sbjct: 342 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 17/86 (19%), Positives = 33/86 (38%), Gaps = 4/86 (4%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+ L K L ++ DT+ +T+L ++ + + +L+ +N S N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNN 76
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNF 189
LT NL L + ++ N
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 17/75 (22%), Positives = 29/75 (38%), Gaps = 6/75 (8%)
Query: 169 IGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-L 225
I IF LA L N + + + L +++L + S++ L L
Sbjct: 12 INQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNL 68
Query: 226 TTLNVANNHFSGWIP 240
T +N +NN + P
Sbjct: 69 TQINFSNNQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 2/61 (3%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+DL + I + NLT +N ++N + P + ++ L + ++
Sbjct: 40 QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97
Query: 163 N 163
N
Sbjct: 98 N 98
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.4 bits (145), Expect = 1e-10
Identities = 39/206 (18%), Positives = 70/206 (33%), Gaps = 23/206 (11%)
Query: 70 PCGESWKGVACEGSAVVSI-----------DISGLGLSGTMGYLLSDLLSLRKFDLSGNS 118
C + V C + + D+ ++ +L +L L N
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 119 IHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176
I P L L L+ N LP + + L V N +T+ +F L
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQ--ELRVHENEITKVRKSVFNGL 123
Query: 177 AGLATLDLSF--NNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVAN 232
+ ++L SG +F + +S + + + +T + GLP LT L++
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDG 180
Query: 233 NHFSGWIPRELISIRTFIYDGNSFDN 258
N + L + G SF++
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNS 206
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 37/154 (24%), Positives = 60/154 (38%), Gaps = 10/154 (6%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
L SG + L ++ +I TIP LPP+LT L+L N + S+ +
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGL 194
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L+ L +S NS++ N L L L+ N P I +YL NN
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNN 253
Query: 213 VTG-SLNVFSGLP-------LTTLNVANNHFSGW 238
++ N F + +++ +N W
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 28/154 (18%), Positives = 50/154 (32%), Gaps = 8/154 (5%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLT-SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
LR + + ++ L + L SG + M LSY+ ++ ++T
Sbjct: 104 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163
Query: 167 QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG----SLNVFSG 222
+ +L L L N + S L+N++ L L N ++ SL
Sbjct: 164 TIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220
Query: 223 LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
L LN + I+ N+
Sbjct: 221 LRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 7e-09
Identities = 19/105 (18%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 110 RKFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ- 167
+ DL+G ++H D L + + + L S + ++++S + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
++ I + L L L S + N+ SN+ L L
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 5e-04
Identities = 14/78 (17%), Positives = 30/78 (38%), Gaps = 4/78 (5%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNF 141
V++ + + S ++ DLS + I + + + L +L+L
Sbjct: 25 VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 142 SGNLPYSIASMVSLSYLN 159
S + ++A +L LN
Sbjct: 84 SDPIVNTLAKNSNLVRLN 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 2e-08
Identities = 13/95 (13%), Positives = 29/95 (30%), Gaps = 12/95 (12%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPP---NLTSLNLASNNFSG----NLPYSIASMVSLSYLN 159
L ++ D+ + D +L P + L + ++ ++ +L+ LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 160 VSRNSLT----QSIGDIFG-NLAGLATLDLSFNNF 189
+ N L + + L L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 3e-08
Identities = 13/86 (15%), Positives = 26/86 (30%), Gaps = 5/86 (5%)
Query: 130 NLTSLNLASNNFSGN-LPYSIASMVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDL 184
++ SL++ S + + + + LT + I LA L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 185 SFNNFSGDLPNSFISLSNISSLYLQN 210
N + + S +Q
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQK 88
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 2e-07
Identities = 20/95 (21%), Positives = 34/95 (35%), Gaps = 9/95 (9%)
Query: 115 SGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMV----SLSYLNVSRNSLTQSIG 170
+G Q L L LA + S + S+A+ + SL L++S N L +
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 171 DIFG-----NLAGLATLDLSFNNFSGDLPNSFISL 200
L L L +S ++ + +L
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 4e-07
Identities = 11/93 (11%), Positives = 31/93 (33%), Gaps = 7/93 (7%)
Query: 153 VSLSYLNVSRNSLT-QSIGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLY 207
+ + L++ L+ ++ L + L + + ++ ++ L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 208 LQNNQVT--GSLNVFSGLPLTTLNVANNHFSGW 238
L++N++ G V GL + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 5e-06
Identities = 18/86 (20%), Positives = 28/86 (32%), Gaps = 7/86 (8%)
Query: 87 SIDISGLGLSGT-MGYLLSDLLSLRKFDLSGNSIHDTIPYQLP------PNLTSLNLASN 139
S+DI LS LL L + L + + + P L LNL SN
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 140 NFSGNLPYSIASMVSLSYLNVSRNSL 165
+ + + + + SL
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 2e-05
Identities = 13/101 (12%), Positives = 28/101 (27%), Gaps = 21/101 (20%)
Query: 151 SMVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
L L ++ ++ S+ L LDLS N +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES------ 420
Query: 207 YLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIR 247
++ L L + + ++S + L ++
Sbjct: 421 -VRQPGCL----------LEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 4e-05
Identities = 11/74 (14%), Positives = 23/74 (31%), Gaps = 7/74 (9%)
Query: 179 LATLDLSFNNFS-GDLPNSFISLSNISSLYLQNNQVTGS-----LNVFSGLP-LTTLNVA 231
+ +LD+ S L + L + +T + + P L LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 232 NNHFSGWIPRELIS 245
+N ++
Sbjct: 64 SNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 2e-04
Identities = 21/103 (20%), Positives = 38/103 (36%), Gaps = 11/103 (10%)
Query: 61 TNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGT----MGYLLSDLLSLRKFDLSG 116
+ E E +G+ GS + + ++ +S + + L SLR+ DLS
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406
Query: 117 NSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSIASM 152
N + D QL L L L +S + + ++
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.7 bits (122), Expect = 8e-08
Identities = 30/218 (13%), Positives = 54/218 (24%), Gaps = 27/218 (12%)
Query: 53 SLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKF 112
S + LT + L L L
Sbjct: 51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110
Query: 113 DLSGNSIHDTIP--YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG 170
L + + P ++ L L L N + + +L++L + N ++
Sbjct: 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLS------------------------NISSL 206
F L L L L N + P++F L + L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230
Query: 207 YLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPREL 243
L +N L +++ +P+ L
Sbjct: 231 RLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 1e-05
Identities = 35/207 (16%), Positives = 62/207 (29%), Gaps = 34/207 (16%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN 139
C V+ GL + + + L GN I +P +L +
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIPAASQRI---FLHGNRIS-HVPAASFRACRNLTILWL 63
Query: 140 NFSGNL----------------------------PYSIASMVSLSYLNVSRNSLTQSIGD 171
+ + P + + L L++ R L +
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123
Query: 172 IFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLP-LTTLN 229
+F LA L L L N ++F L N++ L+L N+++ F GL L L
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSF 256
+ N + P + +
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFA 210
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 3e-04
Identities = 27/134 (20%), Positives = 46/134 (34%), Gaps = 5/134 (3%)
Query: 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188
L +L+L P + +L YL + N+L D F +L L L L N
Sbjct: 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164
Query: 189 FSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLPLTTLNVANNHFSGWI----PREL 243
S +F L ++ L L N+V + F L + + L
Sbjct: 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224
Query: 244 ISIRTFIYDGNSFD 257
+++ + N +
Sbjct: 225 RALQYLRLNDNPWV 238
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (87), Expect = 0.002
Identities = 12/68 (17%), Positives = 20/68 (29%), Gaps = 4/68 (5%)
Query: 124 PYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLD 183
L L L N + + + L S + + + LAG
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVP---CSLPQRLAGRDLKR 275
Query: 184 LSFNNFSG 191
L+ N+ G
Sbjct: 276 LAANDLQG 283
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 1e-07
Identities = 24/125 (19%), Positives = 43/125 (34%), Gaps = 9/125 (7%)
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
R L+ + + +T L+L+ N P ++A++ L L S N+L
Sbjct: 1 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 170 GDIFGNLAGLATLDLSFNNF-SGDLPNSFISLSNISSLYLQNNQVTGS----LNVFSGLP 224
G L L N +S + L LQ N + + LP
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 225 -LTTL 228
++++
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 1e-04
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 7/109 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY-SIASMVSLSYLNVS 161
L LL + DLS N + P L L + + + +A++ L L +
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPP--ALAALRCLEVLQASDNALENVDGVANLPRLQELLLC 73
Query: 162 RNSLTQSIG-DIFGNLAGLATLDLSFNNFSG--DLPNSFIS-LSNISSL 206
N L QS + L L+L N+ + L ++SS+
Sbjct: 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 4e-07
Identities = 19/86 (22%), Positives = 34/86 (39%), Gaps = 8/86 (9%)
Query: 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N S + SL LNVS N L + + L L SFN+ + ++P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPEL-- 322
Query: 199 SLSNISSLYLQNNQVTGSLNVFSGLP 224
N+ L+++ N + ++ +
Sbjct: 323 -PQNLKQLHVEYNPLREFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 6e-05
Identities = 17/97 (17%), Positives = 34/97 (35%), Gaps = 8/97 (8%)
Query: 63 WKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT 122
+ + + ++ +++S L L + L + S N +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI----ELPALPPRLERLIASFNHL-AE 318
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+P +LP NL L++ N P S+ L +N
Sbjct: 319 VP-ELPQNLKQLHVEYNPLRE-FPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 1e-04
Identities = 20/91 (21%), Positives = 31/91 (34%), Gaps = 12/91 (13%)
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N+ + I + L L++S N +LP + L N L
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNH----LAEV 319
Query: 221 SGLP--LTTLNVANNHFSGW--IPRELISIR 247
LP L L+V N + IP + +R
Sbjct: 320 PELPQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 6/60 (10%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
+ +L+ + ++P +LPP+L SL + N+ + LP SL L V N+L
Sbjct: 39 QAHELELNNLGLS-SLP-ELPPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNLKA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 8/85 (9%)
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQV 213
L ++ L+ S+ ++ +L +L S N+ + +LP ++ SL + NN +
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPE---LPQSLKSLLVDNNNL 90
Query: 214 TGSLNVFSGLPLTTLNVANNHFSGW 238
++ L ++
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPE 115
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 4e-07
Identities = 33/197 (16%), Positives = 57/197 (28%), Gaps = 3/197 (1%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
S + S + + ++ +P LP + T L+L+ N ++ L+ LN+ R
Sbjct: 7 SKVASHLEVNCDKRNL-TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL 223
+ + G L L TLDLS N + N + L GL
Sbjct: 66 E--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 224 PLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQ 283
+ +P L++ + + +N P
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 284 GSHSPSGSQSSSSDKEL 300
P G S
Sbjct: 184 LYTIPKGFFGSHLLPFA 200
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 4e-05
Identities = 17/73 (23%), Positives = 28/73 (38%), Gaps = 1/73 (1%)
Query: 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N P + L L+++ N+LT+ + L L TL L N+ +P F
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 199 SLSNISSLYLQNN 211
+ +L N
Sbjct: 193 GSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 3e-04
Identities = 35/237 (14%), Positives = 62/237 (26%), Gaps = 29/237 (12%)
Query: 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN-- 139
+ +S L L L + +L + P L +L+L+ N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQL 89
Query: 140 ---------------------NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAG 178
+ ++ + L L + N L +
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 179 LATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS- 236
L L L+ NN + L N+ +L LQ N + F G L + N +
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
Query: 237 ----GWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS 289
+ R L +Y + A ++ G P+
Sbjct: 210 NCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPT 266
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 2e-06
Identities = 27/134 (20%), Positives = 45/134 (33%), Gaps = 14/134 (10%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
S + DL G + Q LN ++ + L ++ L LN+S N L
Sbjct: 22 GSQQALDLKGLRSDPDLVAQ--NIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLY 78
Query: 167 --QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN------ 218
+ I L L+LS N + I + L+L N ++ +
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138
Query: 219 --VFSGLP-LTTLN 229
+ P L L+
Sbjct: 139 SAIRERFPKLLRLD 152
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.9 bits (99), Expect = 3e-05
Identities = 29/176 (16%), Positives = 57/176 (32%), Gaps = 27/176 (15%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVS------------- 154
D +G + IP +P + T L L N + +
Sbjct: 9 EGTTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 155 ------------LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ L + N + + +F L L TL+L N S +P SF L++
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 203 ISSLYLQNNQVTGSLNVFSGLPL-TTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
++SL L +N + ++ ++ P ++ ++ + F
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFK 183
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 6e-05
Identities = 13/79 (16%), Positives = 23/79 (29%)
Query: 134 LNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL 193
L L N + N+L + D+F +G LD+S
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 194 PNSFISLSNISSLYLQNNQ 212
+L + + N +
Sbjct: 218 SYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 3e-04
Identities = 9/45 (20%), Positives = 13/45 (28%), Gaps = 1/45 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
S R F + + IP LP N L + +
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGF 52
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 0.004
Identities = 11/46 (23%), Positives = 15/46 (32%), Gaps = 1/46 (2%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLP 146
+ D+S IH ++P NL L S LP
Sbjct: 195 DVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLP 239
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 7e-05
Identities = 16/59 (27%), Positives = 27/59 (45%), Gaps = 2/59 (3%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L++L L N I D P PNL ++L +N S P +A+ +L + ++
Sbjct: 169 LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 8/80 (10%)
Query: 164 SLTQ--SIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
S+TQ +I IF LA + +N + + + L I++L VT ++
Sbjct: 2 SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG 58
Query: 220 FSGLP-LTTLNVANNHFSGW 238
L L L + +N +
Sbjct: 59 VQYLNNLIGLELKDNQITDL 78
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 4/62 (6%)
Query: 149 IASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYL 208
+A++ L+ L N ++ +L L + L N S P + SN+ + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 209 QN 210
N
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 13/56 (23%), Positives = 25/56 (44%), Gaps = 4/56 (7%)
Query: 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLS 185
LT+L N S P +AS+ +L +++ N ++ N + L + L+
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 12/108 (11%), Positives = 29/108 (26%), Gaps = 28/108 (25%)
Query: 112 FDLSGNSIHDTIPYQLP--------PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
L+ + + L +L L N + ++ ++
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV----------- 296
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
I + L L+L+ N F + + + + S +
Sbjct: 297 --------IDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 10/70 (14%), Positives = 23/70 (32%), Gaps = 6/70 (8%)
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSN 202
+SI SL ++ +S+ + + + LS N + L + S +
Sbjct: 3 FSIEG-KSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 203 ISSLYLQNNQ 212
+ +
Sbjct: 61 LEIAEFSDIF 70
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 24/170 (14%), Positives = 47/170 (27%), Gaps = 42/170 (24%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS-----GNLPYSIASMVSLSY 157
++L S+ + + + I Q PN+T L L N + NL + +
Sbjct: 42 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK 101
Query: 158 L----------------------------------NVSRNSLTQSIGDIFGNLAGLATLD 183
+ + +
Sbjct: 102 VKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTL 161
Query: 184 LSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
+N D+ L+ + +LYL N ++ L +GL L L + +
Sbjct: 162 SLEDNQISDIVP-LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 14/74 (18%), Positives = 28/74 (37%), Gaps = 6/74 (8%)
Query: 168 SIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP- 224
I IF A +L + + + + L++I + N+ + S+ LP
Sbjct: 13 PIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQYLPN 69
Query: 225 LTTLNVANNHFSGW 238
+T L + N +
Sbjct: 70 VTKLFLNGNKLTDI 83
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 7e-04
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 8/80 (10%)
Query: 164 SLTQ--SIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
++TQ I IF LA L N + + + L +++L + S++
Sbjct: 1 TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG 57
Query: 220 FSGLP-LTTLNVANNHFSGW 238
L LT +N +NN +
Sbjct: 58 VEYLNNLTQINFSNNQLTDI 77
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 577 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.98 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.98 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.98 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.95 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.95 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.95 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.95 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.95 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.94 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.94 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.94 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.86 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.86 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.83 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.82 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.81 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.74 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.64 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.61 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.59 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.59 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.59 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.58 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.56 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.46 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.41 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.34 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.27 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.24 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.23 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.21 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.04 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.03 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.82 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.55 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.42 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.36 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.21 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.75 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.67 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.5 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.99 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.96 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.01 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=6.9e-35 Score=293.33 Aligned_cols=219 Identities=27% Similarity=0.466 Sum_probs=174.2
Q ss_pred CCChHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCccEEeeC----CcEEEEEcCCCCCcc--cccccccCCCCCCE
Q 008121 38 TTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEG----SAVVSIDISGLGLSG--TMGYLLSDLLSLRK 111 (577)
Q Consensus 38 ~~~~~~~~~l~~~~~~~~~~~~l~~w~~~~~~~c~~~w~gv~C~~----~~v~~l~l~~~~l~g--~~~~~~~~l~~L~~ 111 (577)
-|.++|++||++||+++.++..+.+|.. +.|||.+.|.||+|+. .||+.|+|++++++| .+|+.+++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 4789999999999999999888999985 5799977899999985 279999999999998 57899999999999
Q ss_pred EEccC-CCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCc
Q 008121 112 FDLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (577)
Q Consensus 112 L~Ls~-N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 188 (577)
|||++ |+++|.+|..+. ++|++|+|++|+|.+..|..+..+.+|+++++++|++.+.+|..+.+++.|+++++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 899999998876 899999999999988888777778888888888887777777777777777777777777
Q ss_pred ccCCCCCCccCCCCC-CeEEccCccccc-----------------------------------------------ccccC
Q 008121 189 FSGDLPNSFISLSNI-SSLYLQNNQVTG-----------------------------------------------SLNVF 220 (577)
Q Consensus 189 l~g~~p~~~~~l~~L-~~L~l~~N~l~~-----------------------------------------------~~~~~ 220 (577)
++|.+|..+..+.++ +.+++++|++++ .++.+
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~ 240 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 777777666555543 455555555443 22222
Q ss_pred CCCC-ccEEEeecCccccccCccccc---ccceeecCCcCC
Q 008121 221 SGLP-LTTLNVANNHFSGWIPRELIS---IRTFIYDGNSFD 257 (577)
Q Consensus 221 ~~~~-L~~L~l~~N~l~g~~p~~l~~---l~~l~~~~n~~~ 257 (577)
...+ |+.|+|++|+|+|.+|+++.+ ++.|++++|.+.
T Consensus 241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~ 281 (313)
T d1ogqa_ 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred ccccccccccCccCeecccCChHHhCCCCCCEEECcCCccc
Confidence 2222 788888888888888887654 566778888775
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=282.44 Aligned_cols=160 Identities=26% Similarity=0.370 Sum_probs=137.9
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|+..+.||+|+||+||+|.+. +|+.||||+++... .....+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46888899999999999999874 68999999986543 22344678999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.++++ ....+++.++..|+.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999996 456799999999999999999999999 9999999999999999999999999999976433
Q ss_pred c----cccccCCC
Q 008121 569 E----RQVITGTS 577 (577)
Q Consensus 569 ~----~~~~~Gt~ 577 (577)
. ....+||+
T Consensus 157 ~~~~~~~~~~GT~ 169 (271)
T d1nvra_ 157 NRERLLNKMCGTL 169 (271)
T ss_dssp TEECCBCCCCSCG
T ss_pred CccccccceeeCc
Confidence 2 23456875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-34 Score=279.14 Aligned_cols=161 Identities=29% Similarity=0.419 Sum_probs=143.6
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccc-hHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||+||+|+.. +++.||+|++...... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999875 5889999998654321 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.. ...+++.++..|+.||++||+|||++ +||||||||+|||+++++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999973 35689999999999999999999999 999999999999999999999999999998887
Q ss_pred CccccccCCC
Q 008121 568 TERQVITGTS 577 (577)
Q Consensus 568 ~~~~~~~Gt~ 577 (577)
......+||+
T Consensus 159 ~~~~~~~Gt~ 168 (263)
T d2j4za1 159 SRRTTLCGTL 168 (263)
T ss_dssp CCCEETTEEG
T ss_pred CcccccCCCC
Confidence 7777777874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-34 Score=283.06 Aligned_cols=158 Identities=24% Similarity=0.434 Sum_probs=139.6
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|...+.||+|+||+||+|.+. +++.||||+++... ...++|.+|+++|++++|||||+++++|.+.+..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 356777889999999999999875 58899999997543 23567999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++.. .....+++..++.|+.||++||+|||++ +||||||||+|||+++++.+||+|||+|+....
T Consensus 93 E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 93 EFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp ECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999963 2456799999999999999999999999 999999999999999999999999999998766
Q ss_pred Ccccccc
Q 008121 568 TERQVIT 574 (577)
Q Consensus 568 ~~~~~~~ 574 (577)
......+
T Consensus 168 ~~~~~~~ 174 (287)
T d1opja_ 168 DTYTAHA 174 (287)
T ss_dssp SSSEEET
T ss_pred CCceeec
Confidence 5544433
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-34 Score=280.52 Aligned_cols=168 Identities=27% Similarity=0.435 Sum_probs=133.1
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--CCeEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLV 486 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv 486 (577)
++|+..+.||+|+||+||+|+. .+|+.||||+++.........+.|.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 4688899999999999999977 468999999997765556667789999999999999999999999865 4568999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC--LPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
|||+++|+|.+++.........+++.++..|+.|++.||+|||+.. ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999754445678999999999999999999999862 12499999999999999999999999999998
Q ss_pred cCCCcc--ccccCCC
Q 008121 565 TPNTER--QVITGTS 577 (577)
Q Consensus 565 ~~~~~~--~~~~Gt~ 577 (577)
...... ...+|||
T Consensus 164 ~~~~~~~~~~~~gt~ 178 (269)
T d2java1 164 LNHDTSFAKAFVGTP 178 (269)
T ss_dssp C-----------CCC
T ss_pred cccCCCccccCCCCc
Confidence 755433 4566775
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-33 Score=275.97 Aligned_cols=160 Identities=25% Similarity=0.363 Sum_probs=139.4
Q ss_pred CccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe----CCeEEEEE
Q 008121 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLVY 487 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 487 (577)
+..+.||+|+||+||+|.+. +++.||+|++..........+.|.+|+++|++++|||||++++++.+ ....|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44567999999999999875 58899999997665556667789999999999999999999999865 34679999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeccccCcccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTP 566 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kl~DFGla~~~~ 566 (577)
||+++|+|.++++. ...+++.++..|+.||++||+|||++. ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999973 357899999999999999999999981 2399999999999996 57899999999999887
Q ss_pred CCccccccCCC
Q 008121 567 NTERQVITGTS 577 (577)
Q Consensus 567 ~~~~~~~~Gt~ 577 (577)
.......+|||
T Consensus 167 ~~~~~~~~GT~ 177 (270)
T d1t4ha_ 167 ASFAKAVIGTP 177 (270)
T ss_dssp TTSBEESCSSC
T ss_pred CCccCCcccCc
Confidence 77778888986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-33 Score=278.23 Aligned_cols=160 Identities=28% Similarity=0.473 Sum_probs=135.1
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||+||+|++. ..||||+++....+....++|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 457888999999999999999865 359999997665556677889999999999999999999998765 56899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.++++. ....+++.+++.|+.||++||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999962 345699999999999999999999999 9999999999999999999999999999876543
Q ss_pred cc----ccccCCC
Q 008121 569 ER----QVITGTS 577 (577)
Q Consensus 569 ~~----~~~~Gt~ 577 (577)
.. ...+||+
T Consensus 158 ~~~~~~~~~~gt~ 170 (276)
T d1uwha_ 158 SGSHQFEQLSGSI 170 (276)
T ss_dssp --------CCCCG
T ss_pred CCcccccccccCc
Confidence 32 3445664
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-34 Score=288.18 Aligned_cols=162 Identities=22% Similarity=0.352 Sum_probs=142.0
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|+..+.||+|+||+||+|.. .+|+.||+|+++... .....+++.+|+.+|++++|||||+++++|.+.++.|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56788999999999999999987 468999999986543 3445678999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.++++. ...+++..+..++.|+++||.|||+.. +|+||||||+|||+++++.+||+|||+|+...+
T Consensus 84 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999973 346899999999999999999999731 799999999999999999999999999998776
Q ss_pred CccccccCCC
Q 008121 568 TERQVITGTS 577 (577)
Q Consensus 568 ~~~~~~~Gt~ 577 (577)
......+||+
T Consensus 158 ~~~~~~~GT~ 167 (322)
T d1s9ja_ 158 SMANSFVGTR 167 (322)
T ss_dssp HTC---CCSS
T ss_pred CccccccCCc
Confidence 6667778885
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-33 Score=277.32 Aligned_cols=158 Identities=27% Similarity=0.423 Sum_probs=139.8
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|...+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4789999999999999999976 569999999986543 2235679999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.+++. ...+++.++..|+.|++.||+|||++ +||||||||+|||++.++++||+|||+|+.+...
T Consensus 98 y~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 98 YLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp CCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 999999999885 24689999999999999999999999 9999999999999999999999999999987544
Q ss_pred c--cccccCCC
Q 008121 569 E--RQVITGTS 577 (577)
Q Consensus 569 ~--~~~~~Gt~ 577 (577)
. ....+||+
T Consensus 170 ~~~~~~~~gt~ 180 (293)
T d1yhwa1 170 QSKRSTMVGTP 180 (293)
T ss_dssp TCCBCCCCSCG
T ss_pred cccccccccCC
Confidence 3 34566875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-33 Score=276.98 Aligned_cols=152 Identities=27% Similarity=0.471 Sum_probs=130.3
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|+..+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|...+..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 4577788999999999999999989999999997543 2346799999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
+++|+|.++++ .....++|..++.|+.|+|+||+|||+. +|+||||||+|||+|+++.+||+|||+|+......
T Consensus 82 ~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999999986 2456789999999999999999999999 99999999999999999999999999999775544
Q ss_pred c
Q 008121 570 R 570 (577)
Q Consensus 570 ~ 570 (577)
.
T Consensus 156 ~ 156 (263)
T d1sm2a_ 156 Y 156 (263)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-33 Score=277.50 Aligned_cols=153 Identities=28% Similarity=0.468 Sum_probs=134.5
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
.++|...+.||+|+||.||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 35677788999999999999999988999999997543 234679999999999999999999998864 56799999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.+++... ....++|.++++|+.||++||.|||+. +|+||||||+|||+++++.+||+|||+|+...+.
T Consensus 88 y~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred eCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 99999999988632 234589999999999999999999999 9999999999999999999999999999988665
Q ss_pred cc
Q 008121 569 ER 570 (577)
Q Consensus 569 ~~ 570 (577)
..
T Consensus 163 ~~ 164 (272)
T d1qpca_ 163 EY 164 (272)
T ss_dssp CE
T ss_pred cc
Confidence 44
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-33 Score=278.06 Aligned_cols=153 Identities=26% Similarity=0.490 Sum_probs=126.9
Q ss_pred cCCCccceeccCccceEEEEEEcC-C---cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-G---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
++|...+.||+|+||+||+|.+.. + ..||||++.... .....++|.+|+++|++++|||||+++|+|...+..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 456667899999999999998743 3 368999986543 34556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
|||||++|+|.++++ .....++|.++++|+.||++||+|||+. +||||||||+|||++.++.+||+|||+|+..
T Consensus 105 v~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999886 2345799999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCc
Q 008121 566 PNTE 569 (577)
Q Consensus 566 ~~~~ 569 (577)
....
T Consensus 179 ~~~~ 182 (299)
T d1jpaa_ 179 EDDT 182 (299)
T ss_dssp ----
T ss_pred cCCC
Confidence 5443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.7e-33 Score=277.31 Aligned_cols=160 Identities=26% Similarity=0.410 Sum_probs=139.3
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
+.|+..+.||+|+||+||+|+.. +++.||||+++... ....+.|.+|+++|++++|||||++++++.+++..|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 45788899999999999999874 68899999986542 3445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.+++.. ....+++.++..|+.||++||+|||++ +||||||||+|||++.++++||+|||+|+.....
T Consensus 90 y~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 90 FCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999999998763 245699999999999999999999999 9999999999999999999999999999865433
Q ss_pred c--cccccCCC
Q 008121 569 E--RQVITGTS 577 (577)
Q Consensus 569 ~--~~~~~Gt~ 577 (577)
. ....+||+
T Consensus 164 ~~~~~~~~Gt~ 174 (288)
T d2jfla1 164 IQRRDSFIGTP 174 (288)
T ss_dssp HHHHTCCCSCC
T ss_pred ccccccccccc
Confidence 2 23456764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.9e-33 Score=275.30 Aligned_cols=161 Identities=25% Similarity=0.369 Sum_probs=138.3
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|+..+.||+|+||+||+|.. .+++.||||+++.... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688899999999999999987 4689999999865432 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999986 345799999999999999999999999 999999999999999999999999999998754
Q ss_pred Ccc----ccccCCC
Q 008121 568 TER----QVITGTS 577 (577)
Q Consensus 568 ~~~----~~~~Gt~ 577 (577)
... ...+||+
T Consensus 161 ~~~~~~~~~~~GT~ 174 (288)
T d1uu3a_ 161 ESKQARANSFVGTA 174 (288)
T ss_dssp ---------CCCCG
T ss_pred CCcccccccccCCc
Confidence 332 3456874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=1.1e-32 Score=275.53 Aligned_cols=159 Identities=30% Similarity=0.407 Sum_probs=138.4
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
..|+..+.||+|+||+||+|.. .+++.||||+++.... .....+.|.+|+++|++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3578889999999999999976 4688999999865432 2334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|||++|+|..++. ....+++.++..|+.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999876664 345799999999999999999999999 999999999999999999999999999997644
Q ss_pred CccccccCCC
Q 008121 568 TERQVITGTS 577 (577)
Q Consensus 568 ~~~~~~~Gt~ 577 (577)
....+||+
T Consensus 168 --~~~~~GT~ 175 (309)
T d1u5ra_ 168 --ANSFVGTP 175 (309)
T ss_dssp --BCCCCSCG
T ss_pred --CCccccCc
Confidence 34556774
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-32 Score=266.62 Aligned_cols=152 Identities=25% Similarity=0.417 Sum_probs=137.4
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57888999999999999999999899999999975432 356799999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
+++|+|.+++.. ....+++..+.+|+.|+++||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 81 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999752 345689999999999999999999999 99999999999999999999999999998765544
Q ss_pred c
Q 008121 570 R 570 (577)
Q Consensus 570 ~ 570 (577)
.
T Consensus 155 ~ 155 (258)
T d1k2pa_ 155 Y 155 (258)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-32 Score=268.47 Aligned_cols=147 Identities=27% Similarity=0.420 Sum_probs=127.3
Q ss_pred ceeccCccceEEEEEEcC---CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 008121 416 FLIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (577)
Q Consensus 416 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 492 (577)
+.||+|+||+||+|.+.+ ++.||||+++....+....++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998753 4689999997655445556789999999999999999999999865 467899999999
Q ss_pred CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCcc
Q 008121 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 493 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 570 (577)
|+|.++++ ....+++.++++|+.||++||+|||+. +||||||||+|||++.++.+||+|||+|+.......
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999997 346799999999999999999999999 999999999999999999999999999997755443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-32 Score=276.31 Aligned_cols=161 Identities=26% Similarity=0.364 Sum_probs=141.6
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|...+.||+|+||.||+|+. .+|+.||||++++... .....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688899999999999999977 5699999999975432 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
|||++|+|.++++ ....+++..+..++.|++.||+|||++ +||||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999997 345689999999999999999999999 999999999999999999999999999997644
Q ss_pred C--ccccccCCC
Q 008121 568 T--ERQVITGTS 577 (577)
Q Consensus 568 ~--~~~~~~Gt~ 577 (577)
. .....+|||
T Consensus 158 ~~~~~~~~~GT~ 169 (337)
T d1o6la_ 158 DGATMKTFCGTP 169 (337)
T ss_dssp TTCCBCCCEECG
T ss_pred CCcccccceeCH
Confidence 3 335677885
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=7.8e-32 Score=273.94 Aligned_cols=160 Identities=25% Similarity=0.415 Sum_probs=140.7
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4788899999999999999987 468999999997543 3456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~--~~~~~kl~DFGla~~~~ 566 (577)
||++|+|.+++. .....+++.++..|+.||+.||+|||++ +||||||||+|||++ .++.+||+|||+|+...
T Consensus 104 ~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999985 2345799999999999999999999999 999999999999996 46789999999999876
Q ss_pred CCcc-ccccCCC
Q 008121 567 NTER-QVITGTS 577 (577)
Q Consensus 567 ~~~~-~~~~Gt~ 577 (577)
.... ...+||+
T Consensus 178 ~~~~~~~~~gT~ 189 (350)
T d1koaa2 178 PKQSVKVTTGTA 189 (350)
T ss_dssp TTSCEEEECSCT
T ss_pred cccccceecCcc
Confidence 5444 4567775
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6e-32 Score=267.16 Aligned_cols=152 Identities=23% Similarity=0.418 Sum_probs=131.3
Q ss_pred cCCCccce-eccCccceEEEEEEc---CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFL-IGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~-lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 485 (577)
++|...+. ||+|+||.||+|.+. ++..||||+++... .....++|.+|+++|++++|||||+++|++.. +..|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 34555564 999999999999764 35579999997543 34556789999999999999999999999865 46899
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCccc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~ 565 (577)
||||+++|+|.+++. .....+++.++.+|+.||++||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 86 vmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999985 2346799999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCc
Q 008121 566 PNTE 569 (577)
Q Consensus 566 ~~~~ 569 (577)
....
T Consensus 160 ~~~~ 163 (285)
T d1u59a_ 160 GADD 163 (285)
T ss_dssp TTCS
T ss_pred cccc
Confidence 5543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=4.2e-32 Score=272.32 Aligned_cols=160 Identities=27% Similarity=0.432 Sum_probs=141.2
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... .....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999987 4689999999965432 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999886 455688899999999999999999999 999999999999999999999999999998754
Q ss_pred CccccccCCC
Q 008121 568 TERQVITGTS 577 (577)
Q Consensus 568 ~~~~~~~Gt~ 577 (577)
. ....+||+
T Consensus 157 ~-~~~~~Gt~ 165 (316)
T d1fota_ 157 V-TYTLCGTP 165 (316)
T ss_dssp C-BCCCCSCT
T ss_pred c-cccccCcc
Confidence 3 45677885
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3.3e-32 Score=271.94 Aligned_cols=161 Identities=26% Similarity=0.435 Sum_probs=124.3
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.+.|...+.||+|+||+||+|... +++.||||++...... .....+.+|+++|++++|||||++++++.+++..|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456888999999999999999875 5899999999754332 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DFGla~~ 564 (577)
||+++|+|.+++. ....+++.++..|+.|++.||+|||+. +||||||||+|||+. +++.+||+|||+|+.
T Consensus 87 E~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 9999999999996 356799999999999999999999999 999999999999994 578999999999997
Q ss_pred cCCCcc-ccccCCC
Q 008121 565 TPNTER-QVITGTS 577 (577)
Q Consensus 565 ~~~~~~-~~~~Gt~ 577 (577)
...... ...+||+
T Consensus 160 ~~~~~~~~~~~GT~ 173 (307)
T d1a06a_ 160 EDPGSVLSTACGTP 173 (307)
T ss_dssp -------------C
T ss_pred ccCCCeeeeeeeCc
Confidence 754443 4567875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=9.8e-32 Score=273.42 Aligned_cols=160 Identities=23% Similarity=0.363 Sum_probs=140.0
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
+.|+..+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4688899999999999999977 469999999986542 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCCeEEeccccCcccC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLAALTP 566 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~--~~~~~kl~DFGla~~~~ 566 (577)
||++|+|.+++. .....+++.++..|+.||+.||+|||+. +||||||||+|||++ .++.+||+|||+|+.+.
T Consensus 107 ~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999998875 2345799999999999999999999999 999999999999998 57899999999999876
Q ss_pred CCcc-ccccCCC
Q 008121 567 NTER-QVITGTS 577 (577)
Q Consensus 567 ~~~~-~~~~Gt~ 577 (577)
.... ....||+
T Consensus 181 ~~~~~~~~~gt~ 192 (352)
T d1koba_ 181 PDEIVKVTTATA 192 (352)
T ss_dssp TTSCEEEECSSG
T ss_pred CCCceeeccCcc
Confidence 5543 4456664
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=7.2e-32 Score=265.45 Aligned_cols=161 Identities=27% Similarity=0.402 Sum_probs=140.0
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccc-------hHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeC
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEH 480 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~ 480 (577)
++|+..+.||+|+||+||+|+. .+|+.||||+++..... ....+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999977 56899999998654321 122456889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
+..|+||||+++|||.++++. ...+++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999973 35799999999999999999999999 99999999999999999999999999
Q ss_pred cCcccCCCc-cccccCCC
Q 008121 561 LAALTPNTE-RQVITGTS 577 (577)
Q Consensus 561 la~~~~~~~-~~~~~Gt~ 577 (577)
+|+...... ....+||+
T Consensus 156 ~a~~~~~~~~~~~~~gt~ 173 (277)
T d1phka_ 156 FSCQLDPGEKLREVCGTP 173 (277)
T ss_dssp TCEECCTTCCBCCCCSCG
T ss_pred heeEccCCCceeeeeccC
Confidence 999875433 34456764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.1e-32 Score=267.38 Aligned_cols=153 Identities=25% Similarity=0.449 Sum_probs=129.4
Q ss_pred cCCCccceeccCccceEEEEEEcCC-----cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANG-----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
+.|+..++||+|+||.||+|.+++. ..||||+++... ......+|.+|++++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4577789999999999999987542 479999996543 3445667999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+.+|++.+++.. ....++|.++++|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998753 346799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCc
Q 008121 565 TPNTE 569 (577)
Q Consensus 565 ~~~~~ 569 (577)
.....
T Consensus 160 ~~~~~ 164 (283)
T d1mqba_ 160 LEDDP 164 (283)
T ss_dssp -----
T ss_pred ccCCC
Confidence 75543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-32 Score=269.71 Aligned_cols=152 Identities=29% Similarity=0.486 Sum_probs=130.7
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|+..+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 5688889999999999999999988899999997543 234679999999999999999999999854 567999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
+++|+|.+++... ....++|.+++.|+.||+.||+|||+. +|+||||||+|||+|+++++||+|||+|+......
T Consensus 93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999988642 234699999999999999999999999 99999999999999999999999999999875444
Q ss_pred c
Q 008121 570 R 570 (577)
Q Consensus 570 ~ 570 (577)
.
T Consensus 168 ~ 168 (285)
T d1fmka3 168 Y 168 (285)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=266.27 Aligned_cols=162 Identities=24% Similarity=0.336 Sum_probs=140.0
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccch----HHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 483 (577)
.++|...+.||+|+||+||+|.. .+|+.||||+++...... ...+.|.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35788899999999999999987 468999999986543221 2357799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEecc
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDC 559 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kl~DF 559 (577)
|+|||||++|+|.+++.. ...+++.++..++.|++.||+|||+. +||||||||+|||++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 999999999999999973 35799999999999999999999999 999999999999998776 5999999
Q ss_pred ccCcccCCCcc-ccccCCC
Q 008121 560 GLAALTPNTER-QVITGTS 577 (577)
Q Consensus 560 Gla~~~~~~~~-~~~~Gt~ 577 (577)
|+|+....... ....||+
T Consensus 162 G~a~~~~~~~~~~~~~~t~ 180 (293)
T d1jksa_ 162 GLAHKIDFGNEFKNIFGTP 180 (293)
T ss_dssp TTCEECTTSCBCSCCCCCG
T ss_pred hhhhhcCCCccccccCCCC
Confidence 99998765433 4455663
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=1.3e-31 Score=274.03 Aligned_cols=161 Identities=29% Similarity=0.335 Sum_probs=139.5
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccch-HHHHHH---HHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNF---LEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~---~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
++|...+.||+|+||.||+|... +|+.||||++....... .....+ .+|+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57888999999999999999875 68999999986432211 112233 34477788889999999999999999999
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.+++.. ...+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999973 45688999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCccccccCCC
Q 008121 565 TPNTERQVITGTS 577 (577)
Q Consensus 565 ~~~~~~~~~~Gt~ 577 (577)
+........+||+
T Consensus 157 ~~~~~~~~~~GT~ 169 (364)
T d1omwa3 157 FSKKKPHASVGTH 169 (364)
T ss_dssp CSSSCCCSCCSCG
T ss_pred cCCCccccccccc
Confidence 8888777888885
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=9.4e-32 Score=268.50 Aligned_cols=162 Identities=28% Similarity=0.452 Sum_probs=140.1
Q ss_pred HHHhhcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEE
Q 008121 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (577)
Q Consensus 405 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 478 (577)
++...++|+..+.||+|+||+||+|++. +++.||||+++... ..+..++|.+|++++++++||||++++++|.
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 4445678999999999999999999864 35789999997543 3455678999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHhhhhcc--------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 008121 479 EHGQRLLVYEYVGNGNLHDMLHFAD--------------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVH 538 (577)
Q Consensus 479 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH 538 (577)
..+..+++|||+++|+|.++++... .....+++..+++|+.|++.||+|||+. +|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 9999999999999999999996422 1223589999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCCeEEeccccCcccCCCcc
Q 008121 539 RNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 539 rDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 570 (577)
|||||+|||+|.++.+||+|||+|+...+...
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~ 195 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADY 195 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGC
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCcc
Confidence 99999999999999999999999997655443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=270.51 Aligned_cols=158 Identities=27% Similarity=0.422 Sum_probs=131.7
Q ss_pred hcCCCccceeccCccceEEEEEEcC-C-----cEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN-G-----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 481 (577)
.++|...+.||+|+||+||+|++.. + ..||||++.... .......|.+|+.++.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3568888999999999999998743 2 369999986543 233456789999999998 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADD-------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 542 (577)
..|+||||+++|+|.++|+..+. ....+++.+++.|+.||++||+|||++ +|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence 99999999999999999974321 124589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCCeEEeccccCcccCCCcc
Q 008121 543 SANILLDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 543 ~~NILl~~~~~~kl~DFGla~~~~~~~~ 570 (577)
|+|||++.++.+||+|||+|+.......
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~ 219 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSN 219 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTT
T ss_pred hhccccccCCeEEEeeccccccccCCCc
Confidence 9999999999999999999997655443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.8e-31 Score=264.16 Aligned_cols=160 Identities=16% Similarity=0.231 Sum_probs=138.2
Q ss_pred hcCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
.++|.+.+.||+|+||+||+|... +++.||||.++.. ......+.+|+++|++++|||||++++++.+++..|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 357888999999999999999875 6889999999754 234556889999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCCeEEeccccCccc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--ELNPHLSDCGLAALT 565 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~--~~~~kl~DFGla~~~ 565 (577)
|||++|+|.++++. ....+++.++..|+.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++..
T Consensus 81 E~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 81 EFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999962 344699999999999999999999999 9999999999999985 458999999999987
Q ss_pred CCCcc-ccccCCC
Q 008121 566 PNTER-QVITGTS 577 (577)
Q Consensus 566 ~~~~~-~~~~Gt~ 577 (577)
..... ....||+
T Consensus 155 ~~~~~~~~~~~t~ 167 (321)
T d1tkia_ 155 KPGDNFRLLFTAP 167 (321)
T ss_dssp CTTCEEEEEESCG
T ss_pred ccCCccccccccc
Confidence 55443 3445553
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=2.4e-31 Score=270.47 Aligned_cols=160 Identities=23% Similarity=0.367 Sum_probs=140.7
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 487 (577)
++|++.+.||+|+||.||+|+. .+|+.||||+++.... .....+.+.+|+++|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4788899999999999999987 4699999999864322 2233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 567 (577)
||+.+|+|.+++.. ...+++.++..|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999963 34689999999999999999999999 999999999999999999999999999998754
Q ss_pred CccccccCCC
Q 008121 568 TERQVITGTS 577 (577)
Q Consensus 568 ~~~~~~~Gt~ 577 (577)
. ....+||+
T Consensus 194 ~-~~~~~Gt~ 202 (350)
T d1rdqe_ 194 R-TWTLCGTP 202 (350)
T ss_dssp C-BCCCEECG
T ss_pred c-cccccCcc
Confidence 3 44566774
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5e-31 Score=262.90 Aligned_cols=162 Identities=26% Similarity=0.369 Sum_probs=134.4
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|+..+.||+|+||+||+|.. .+|+.||||+++.........+++.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788899999999999999987 568999999997554333345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+.+ ++.+++.. .....+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9975 55555532 2456799999999999999999999999 9999999999999999999999999999976543
Q ss_pred cc--ccccCCC
Q 008121 569 ER--QVITGTS 577 (577)
Q Consensus 569 ~~--~~~~Gt~ 577 (577)
.. ....||+
T Consensus 156 ~~~~~~~~gt~ 166 (298)
T d1gz8a_ 156 VRTYTHEVVTL 166 (298)
T ss_dssp SBCTTCCBCCC
T ss_pred cccceeecccc
Confidence 32 3345654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=6.5e-31 Score=260.60 Aligned_cols=152 Identities=25% Similarity=0.319 Sum_probs=136.2
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 489 (577)
++|...+.||+|+||+||+|++.+|+.||||+++.........++|.+|+.+|++++|||||++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57888999999999999999999999999999976544444467899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
+.++.+..+.+ ..+.+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+|++|||+|......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 98877666654 457799999999999999999999999 9999999999999999999999999999876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-30 Score=260.49 Aligned_cols=161 Identities=22% Similarity=0.364 Sum_probs=135.7
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEcccccc-chHHHHHHHHHHHHhh-cCCCCceeeEeeEEEeCCeEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMS-RLRHPNIVTLAGYCAEHGQRLLV 486 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv 486 (577)
++|...+.||+|+||+||+|... +++.||||++++... .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888999999999999999774 689999999965321 1223445666666654 68999999999999999999999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccC
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~ 566 (577)
|||+++|+|.++++. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999973 45689999999999999999999999 99999999999999999999999999999654
Q ss_pred CCc--cccccCCC
Q 008121 567 NTE--RQVITGTS 577 (577)
Q Consensus 567 ~~~--~~~~~Gt~ 577 (577)
... ....+||+
T Consensus 155 ~~~~~~~~~~gt~ 167 (320)
T d1xjda_ 155 LGDAKTNTFCGTP 167 (320)
T ss_dssp CTTCCBCCCCSCG
T ss_pred cccccccccCCCC
Confidence 332 34456774
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.9e-30 Score=259.91 Aligned_cols=163 Identities=28% Similarity=0.487 Sum_probs=134.2
Q ss_pred cCCCccceeccCccceEEEEEEcC-Cc--EEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCCeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN-GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 485 (577)
++|+..+.||+|+||.||+|.+.+ +. .||||+++... .....++|.+|+++|+++ +|||||+++|+|.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 578888999999999999998754 44 47888875432 234566799999999998 79999999999999999999
Q ss_pred EEEecCCCCHHHhhhhc------------cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 008121 486 VYEYVGNGNLHDMLHFA------------DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~------------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~ 553 (577)
||||+++|+|.++|+.. ......+++.++.+++.||++||.|||+. +||||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 99999999999999642 12356799999999999999999999999 9999999999999999999
Q ss_pred eEEeccccCcccCCCccc-cccCC
Q 008121 554 PHLSDCGLAALTPNTERQ-VITGT 576 (577)
Q Consensus 554 ~kl~DFGla~~~~~~~~~-~~~Gt 576 (577)
+||+|||+|+........ ..+||
T Consensus 166 ~kl~DfG~a~~~~~~~~~~~~~gt 189 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKKTMGRLP 189 (309)
T ss_dssp EEECCTTCEESSCEECCC----CC
T ss_pred eEEccccccccccccccccceecC
Confidence 999999999876544332 33455
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-30 Score=260.22 Aligned_cols=156 Identities=29% Similarity=0.346 Sum_probs=129.9
Q ss_pred cceeccCccceEEEEEEc-CCcEEEEEEccccccchH---HHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEEec
Q 008121 415 EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ---EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 490 (577)
.++||+|+||+||+|+.. +|+.||||+++....... ..+.+.+|+.++++++|||||++++++..++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999874 589999999965432211 1346889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCcc
Q 008121 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 491 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 570 (577)
+++++..+.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9887776653 456789999999999999999999999 999999999999999999999999999987655433
Q ss_pred --ccccCCC
Q 008121 571 --QVITGTS 577 (577)
Q Consensus 571 --~~~~Gt~ 577 (577)
...+||+
T Consensus 156 ~~~~~~gt~ 164 (299)
T d1ua2a_ 156 AYTHQVVTR 164 (299)
T ss_dssp CCCCSCCCC
T ss_pred cccceecCh
Confidence 3455764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-30 Score=258.47 Aligned_cols=158 Identities=22% Similarity=0.364 Sum_probs=137.4
Q ss_pred hcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 482 (577)
.++|...+.||+|+||.||+|.+. +++.||||+++... .......|.+|++++++++|||||+++++|..++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 356777899999999999999763 35789999997543 44556779999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 008121 483 RLLVYEYVGNGNLHDMLHFAD------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl 556 (577)
.++||||+++|+|.++++..+ .....+++..+.+|+.|+++||.|||+. +|+||||||+|||+|.++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEE
Confidence 999999999999999986432 2334679999999999999999999999 9999999999999999999999
Q ss_pred eccccCcccCCCcc
Q 008121 557 SDCGLAALTPNTER 570 (577)
Q Consensus 557 ~DFGla~~~~~~~~ 570 (577)
+|||+|+.......
T Consensus 175 ~DFGla~~~~~~~~ 188 (308)
T d1p4oa_ 175 GDFGMTRDIYETDY 188 (308)
T ss_dssp CCTTCCCGGGGGGC
T ss_pred eecccceeccCCcc
Confidence 99999997755443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=255.46 Aligned_cols=152 Identities=25% Similarity=0.395 Sum_probs=124.8
Q ss_pred hcCCCccceeccCccceEEEEEEcC----CcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.++|...+.||+|+||.||+|.+.. +..||||+++... .....+.|.+|++++++++|||||++++++. ++..|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 3568888999999999999997743 3568999986543 3445678999999999999999999999986 46789
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|+|.+++.. ....+++..++.++.||++||+|||+. +||||||||+||++++++.+||+|||+|+.
T Consensus 84 iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999998753 345789999999999999999999999 999999999999999999999999999997
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
....
T Consensus 158 ~~~~ 161 (273)
T d1mp8a_ 158 MEDS 161 (273)
T ss_dssp ----
T ss_pred ccCC
Confidence 6543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.2e-30 Score=256.44 Aligned_cols=149 Identities=29% Similarity=0.397 Sum_probs=124.7
Q ss_pred CCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC----eEEEE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QRLLV 486 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv 486 (577)
+|...+.||+|+||.||+|++ +|+.||||+++... .....+..|+..+..++|||||+++++|.+.+ ..|+|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 466678899999999999987 58999999986432 22222344566667889999999999997654 58999
Q ss_pred EEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-----LPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 487 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
||||++|+|.++++. ..++|..+++++.|+|.||+|+|+.. .++||||||||+|||+|+++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999973 36899999999999999999999731 24899999999999999999999999999
Q ss_pred CcccCCC
Q 008121 562 AALTPNT 568 (577)
Q Consensus 562 a~~~~~~ 568 (577)
++.....
T Consensus 155 ~~~~~~~ 161 (303)
T d1vjya_ 155 AVRHDSA 161 (303)
T ss_dssp CEEEETT
T ss_pred cccccCC
Confidence 9976543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.9e-30 Score=255.18 Aligned_cols=148 Identities=28% Similarity=0.517 Sum_probs=129.0
Q ss_pred cceeccCccceEEEEEEcCC----cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe-CCeEEEEEEe
Q 008121 415 EFLIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLLVYEY 489 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~ 489 (577)
.++||+|+||+||+|.+.++ ..||||+++.. .+....++|.+|+++|++++|||||+++|++.. ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46799999999999987542 35899999643 245567889999999999999999999999875 4689999999
Q ss_pred cCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCCc
Q 008121 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 490 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 569 (577)
|++|+|.++++ .....+++..+++++.|+++||.|||+. +|+||||||+|||+|+++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999986 3455678999999999999999999999 99999999999999999999999999999765443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.96 E-value=4.2e-30 Score=253.43 Aligned_cols=152 Identities=23% Similarity=0.327 Sum_probs=133.4
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC----e
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----Q 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~ 482 (577)
.++|...+.||+|+||.||+|+. .+|+.||||+++.... +....+.|.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35688899999999999999976 5699999999975433 2344667999999999999999999999987654 3
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.|+||||+++|+|.+++. ..+.+++.++..|+.||+.||+|||+. +||||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999886 345799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCC
Q 008121 563 ALTPN 567 (577)
Q Consensus 563 ~~~~~ 567 (577)
+....
T Consensus 159 ~~~~~ 163 (277)
T d1o6ya_ 159 RAIAD 163 (277)
T ss_dssp EECC-
T ss_pred hhhcc
Confidence 86543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-30 Score=254.61 Aligned_cols=149 Identities=32% Similarity=0.502 Sum_probs=124.5
Q ss_pred cCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe-CCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e 488 (577)
++|+..+.||+|+||.||+|++. |+.||||+++.. ...++|.+|++++++++|||||+++|+|.+ .+..|+|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 45677889999999999999985 788999999753 234679999999999999999999999865 456899999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+++|+|.++++.. ....++|..+++|+.||+.||.|||+. +||||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999999632 233589999999999999999999999 9999999999999999999999999999976543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.7e-30 Score=258.70 Aligned_cols=153 Identities=24% Similarity=0.448 Sum_probs=129.7
Q ss_pred cCCCccceeccCccceEEEEEEc-CCc----EEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
.+|+..+.||+|+||+||+|.+. +|+ +||+|+++... +....++|.+|++++++++|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 35888999999999999999774 343 68999886432 334567899999999999999999999999865 567
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+++||+.+|+|.+.+.. ....+++..+++|+.||++||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence 88999999999998863 456799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCcc
Q 008121 565 TPNTER 570 (577)
Q Consensus 565 ~~~~~~ 570 (577)
......
T Consensus 161 ~~~~~~ 166 (317)
T d1xkka_ 161 LGAEEK 166 (317)
T ss_dssp TTTTCC
T ss_pred cccccc
Confidence 755443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-30 Score=257.11 Aligned_cols=162 Identities=21% Similarity=0.290 Sum_probs=138.7
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccch----HHHHHHHHHHHHhhcCC--CCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~ 481 (577)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++...... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35788899999999999999977 468999999986543221 12234678999999986 899999999999999
Q ss_pred eEEEEEEecCC-CCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEecc
Q 008121 482 QRLLVYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDC 559 (577)
Q Consensus 482 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kl~DF 559 (577)
..++||||+.+ +++.+++. ....+++.++..++.|+++||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 68888886 345789999999999999999999999 9999999999999985 579999999
Q ss_pred ccCcccCCCccccccCCC
Q 008121 560 GLAALTPNTERQVITGTS 577 (577)
Q Consensus 560 Gla~~~~~~~~~~~~Gt~ 577 (577)
|+|+..........+||+
T Consensus 156 G~a~~~~~~~~~~~~GT~ 173 (273)
T d1xwsa_ 156 GSGALLKDTVYTDFDGTR 173 (273)
T ss_dssp TTCEECCSSCBCCCCSCG
T ss_pred ccceecccccccccccCC
Confidence 999988777777788885
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.2e-30 Score=253.25 Aligned_cols=154 Identities=27% Similarity=0.390 Sum_probs=124.4
Q ss_pred cCCCccceeccCccceEEEEEEcC--C--cEEEEEEcccccc-chHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFAN--G--KIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 484 (577)
++|+..+.||+|+||+||+|++.. + ..||||+++.... .....++|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 457888899999999999997642 2 3689999865432 23445789999999999999999999999975 4678
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
+||||+++|++.+.+.. ....+++..+++++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998863 245699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCcc
Q 008121 565 TPNTER 570 (577)
Q Consensus 565 ~~~~~~ 570 (577)
......
T Consensus 161 ~~~~~~ 166 (273)
T d1u46a_ 161 LPQNDD 166 (273)
T ss_dssp CCC-CC
T ss_pred cccCCC
Confidence 755543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.2e-30 Score=255.12 Aligned_cols=157 Identities=24% Similarity=0.397 Sum_probs=123.2
Q ss_pred hcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeC-
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH- 480 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~- 480 (577)
.++|...+.||+|+||.||+|.+. +++.||||+++... .....+.+.+|...+.++ +|+|||.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 467888999999999999999764 24689999997543 344566788888877776 689999999998765
Q ss_pred CeEEEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl 548 (577)
+..++|||||++|+|.++++.... ....+++.+++.|+.||++||+|||++ +||||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeE
Confidence 468999999999999999974321 234689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeccccCcccCCCc
Q 008121 549 DDELNPHLSDCGLAALTPNTE 569 (577)
Q Consensus 549 ~~~~~~kl~DFGla~~~~~~~ 569 (577)
++++.+||+|||+|+......
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~ 188 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDP 188 (299)
T ss_dssp CGGGCEEECC------CCSCT
T ss_pred CCCCcEEEccCcchhhccccc
Confidence 999999999999999765443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-29 Score=256.27 Aligned_cols=156 Identities=21% Similarity=0.299 Sum_probs=130.0
Q ss_pred cCCCcc-ceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhc-CCCCceeeEeeEEEe----CCe
Q 008121 410 NSFSQE-FLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAE----HGQ 482 (577)
Q Consensus 410 ~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~----~~~ 482 (577)
++|.+. +.||+|+||.||+|.. .+++.||||+++.. ..+.+|++++.+ .+|||||+++++|.+ +..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 467665 4699999999999976 56899999998532 346778988765 489999999999865 456
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEecc
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDC 559 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~---~~~~kl~DF 559 (577)
.|+|||||++|+|.++++. .....+++.++..|+.|++.||+|||+. +|+||||||+|||+++ .+.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 8999999999999999972 2345799999999999999999999999 9999999999999985 567999999
Q ss_pred ccCcccCCCcc-ccccCCC
Q 008121 560 GLAALTPNTER-QVITGTS 577 (577)
Q Consensus 560 Gla~~~~~~~~-~~~~Gt~ 577 (577)
|+|+....... ...+||+
T Consensus 159 G~a~~~~~~~~~~~~~gt~ 177 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTP 177 (335)
T ss_dssp TTCEECCCCCCCCCCSCCC
T ss_pred ceeeeccCCCccccccCCc
Confidence 99997655443 4566775
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-29 Score=254.73 Aligned_cols=158 Identities=28% Similarity=0.426 Sum_probs=136.9
Q ss_pred hcCCCccceeccCccceEEEEEEc------CCcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEeCC
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 481 (577)
.++|...+.||+|+||.||+|++. +++.||||+++... ......+|.+|+++++++ +|||||+++++|.+.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 356777889999999999999762 45789999997543 344566799999999999 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADD--------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
..++||||+++|+|.++++.... ....+++.++.+|+.||++||+|||++ +||||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence 99999999999999999975321 234689999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccCcccCCCcc
Q 008121 548 LDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~~~~~ 570 (577)
++.++.+|++|||+++...+...
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~ 200 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSN 200 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT
T ss_pred ccccCcccccccchheeccCCCc
Confidence 99999999999999998765443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.2e-29 Score=250.83 Aligned_cols=158 Identities=26% Similarity=0.442 Sum_probs=130.7
Q ss_pred hcCCCccceeccCccceEEEEEEcC--------CcEEEEEEccccccchHHHHHHHHHHHHhhcC-CCCceeeEeeEEEe
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 479 (577)
.++|...+.||+|+||.||+|+... +..||||+++... ......++.+|...+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3567788999999999999997632 2479999997653 344567788898888888 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 008121 480 HGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (577)
Q Consensus 480 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIL 547 (577)
++..++||||+++|+|.++++.... ....+++.++++++.|++.||+|||+. +||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 9999999999999999999974321 235689999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccCcccCCCcc
Q 008121 548 LDDELNPHLSDCGLAALTPNTER 570 (577)
Q Consensus 548 l~~~~~~kl~DFGla~~~~~~~~ 570 (577)
++.++.+||+|||+++...+...
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~ 190 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDY 190 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCT
T ss_pred ecCCCCeEeccchhhcccccccc
Confidence 99999999999999997755443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.2e-29 Score=246.44 Aligned_cols=153 Identities=22% Similarity=0.302 Sum_probs=137.9
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCCeEEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 488 (577)
++|+..+.||+|+||+||+|++ .+++.||||+++..........++.+|+.+++.++|||||++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4788899999999999999987 568899999997654445567889999999999999999999999999999999999
Q ss_pred ecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcccCCC
Q 008121 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (577)
Q Consensus 489 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 568 (577)
|+.+++|..+++ ..+.+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999888775 456789999999999999999999999 9999999999999999999999999999976544
Q ss_pred c
Q 008121 569 E 569 (577)
Q Consensus 569 ~ 569 (577)
.
T Consensus 155 ~ 155 (292)
T d1unla_ 155 V 155 (292)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1e-28 Score=251.42 Aligned_cols=158 Identities=19% Similarity=0.294 Sum_probs=130.7
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC------
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 481 (577)
.++|...+.||+|+||+||+|.. .+|+.||||+++....+....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 45788899999999999999986 46999999999765555566778999999999999999999999997654
Q ss_pred eEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEecccc
Q 008121 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (577)
Q Consensus 482 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGl 561 (577)
+.|+||||+ +++|.++++ ...+++..+..++.|++.||+|||++ +||||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 579999999 568887775 34699999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCccccccCC
Q 008121 562 AALTPNTERQVITGT 576 (577)
Q Consensus 562 a~~~~~~~~~~~~Gt 576 (577)
|+..... .....||
T Consensus 168 a~~~~~~-~~~~~~t 181 (346)
T d1cm8a_ 168 ARQADSE-MTGYVVT 181 (346)
T ss_dssp CEECCSS-CCSSCSC
T ss_pred eeccCCc-ccccccc
Confidence 9986543 3344555
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.6e-28 Score=250.26 Aligned_cols=157 Identities=26% Similarity=0.330 Sum_probs=126.7
Q ss_pred CCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC------CeE
Q 008121 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------GQR 483 (577)
Q Consensus 411 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~ 483 (577)
+|...++||+|+||+||+|++. +|+.||||+++.... .+.+|+++|++++|||||+++++|... .+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 4667789999999999999875 689999999965421 234799999999999999999998543 357
Q ss_pred EEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeccccC
Q 008121 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLA 562 (577)
Q Consensus 484 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla 562 (577)
|+||||+++|. .+.+.........+++.++..|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|
T Consensus 95 ~lv~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 95 NLVLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 89999998654 444432223456799999999999999999999999 999999999999999765 8999999999
Q ss_pred cccCCCc-cccccCCC
Q 008121 563 ALTPNTE-RQVITGTS 577 (577)
Q Consensus 563 ~~~~~~~-~~~~~Gt~ 577 (577)
+...... ....+||+
T Consensus 171 ~~~~~~~~~~~~~gt~ 186 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSR 186 (350)
T ss_dssp EECCTTSCCCSCCSCT
T ss_pred hhccCCcccccccccc
Confidence 9765443 33455653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.95 E-value=2.9e-28 Score=246.16 Aligned_cols=152 Identities=25% Similarity=0.389 Sum_probs=129.9
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeC--CeEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEH--GQRLL 485 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~l 485 (577)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5788999999999999999987 56899999998643 2456889999999995 99999999998743 46899
Q ss_pred EEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeccccCcc
Q 008121 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAAL 564 (577)
Q Consensus 486 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~-~~kl~DFGla~~ 564 (577)
||||+++|+|.++. +.+++.++..++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.
T Consensus 110 v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 99999999987654 3589999999999999999999999 999999999999998655 699999999997
Q ss_pred cCCCc-cccccCC
Q 008121 565 TPNTE-RQVITGT 576 (577)
Q Consensus 565 ~~~~~-~~~~~Gt 576 (577)
..... ....+||
T Consensus 180 ~~~~~~~~~~~~t 192 (328)
T d3bqca1 180 YHPGQEYNVRVAS 192 (328)
T ss_dssp CCTTCCCCSCCSC
T ss_pred ccCCCcccccccC
Confidence 75543 3444555
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2e-28 Score=246.36 Aligned_cols=151 Identities=25% Similarity=0.364 Sum_probs=127.5
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEe--------C
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--------H 480 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~ 480 (577)
++|++.+.||+|+||+||+|.. .+|+.||||++..........+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6788899999999999999987 579999999986554444456678999999999999999999998855 3
Q ss_pred CeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccc
Q 008121 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (577)
Q Consensus 481 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFG 560 (577)
+..|+||||++++.+..... ....+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 46899999998876654443 456789999999999999999999999 99999999999999999999999999
Q ss_pred cCcccCC
Q 008121 561 LAALTPN 567 (577)
Q Consensus 561 la~~~~~ 567 (577)
+++....
T Consensus 163 ~~~~~~~ 169 (318)
T d3blha1 163 LARAFSL 169 (318)
T ss_dssp TCEECCC
T ss_pred eeeeccc
Confidence 9987653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.6e-28 Score=249.73 Aligned_cols=150 Identities=24% Similarity=0.359 Sum_probs=126.5
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeCC----eEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QRL 484 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~ 484 (577)
.+|...+.||+|+||+||+|.. .+|+.||||+++... .....+++++|+++|++++||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4688899999999999999976 579999999997543 3445667899999999999999999999997543 235
Q ss_pred EEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 485 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
++++|+.+|||.+++. ...+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 5566777999999996 24689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
....
T Consensus 159 ~~~~ 162 (345)
T d1pmea_ 159 ADPD 162 (345)
T ss_dssp CCGG
T ss_pred ccCC
Confidence 6443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.9e-28 Score=244.95 Aligned_cols=164 Identities=25% Similarity=0.347 Sum_probs=130.6
Q ss_pred hhcCCCccceeccCccceEEEEEEc-C-CcEEEEEEccccccchHHHHHHHHHHHHhhc---CCCCceeeEeeEEEe---
Q 008121 408 ATNSFSQEFLIGEGSLGRVYRAEFA-N-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSR---LRHPNIVTLAGYCAE--- 479 (577)
Q Consensus 408 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~---l~H~niv~l~~~~~~--- 479 (577)
..++|++.+.||+|+||+||+|.+. + ++.||||+++...........+.+|+.+++. ++||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3578999999999999999999873 4 6779999986543332223345566666555 489999999999853
Q ss_pred --CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 008121 480 --HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (577)
Q Consensus 480 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~ 557 (577)
....+++|||+++|++..... .....+++..+..++.|++.||+|||++ +||||||||+|||+++++.+||+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence 246799999998877654443 2456789999999999999999999999 99999999999999999999999
Q ss_pred ccccCcccCCCcc-ccccCCC
Q 008121 558 DCGLAALTPNTER-QVITGTS 577 (577)
Q Consensus 558 DFGla~~~~~~~~-~~~~Gt~ 577 (577)
|||+++....... ...+||+
T Consensus 159 dfg~~~~~~~~~~~~~~~gT~ 179 (305)
T d1blxa_ 159 DFGLARIYSFQMALTSVVVTL 179 (305)
T ss_dssp SCCSCCCCCGGGGGCCCCCCC
T ss_pred chhhhhhhcccccCCCcccCh
Confidence 9999987654333 4566775
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.1e-28 Score=248.06 Aligned_cols=152 Identities=24% Similarity=0.344 Sum_probs=132.5
Q ss_pred cCCCccceeccCccceEEEEEEc----CCcEEEEEEccccccc--hHHHHHHHHHHHHhhcCCC-CceeeEeeEEEeCCe
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALS--LQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQ 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~ 482 (577)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56888999999999999999752 4789999998754321 2234568899999999977 899999999999999
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.+++|||+.+|+|.+++.. ...+++.....++.|++.||+|||+. +||||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999973 34567888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC
Q 008121 563 ALTPNT 568 (577)
Q Consensus 563 ~~~~~~ 568 (577)
+.+...
T Consensus 177 ~~~~~~ 182 (322)
T d1vzoa_ 177 KEFVAD 182 (322)
T ss_dssp EECCGG
T ss_pred hhhccc
Confidence 876543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.4e-28 Score=244.85 Aligned_cols=150 Identities=20% Similarity=0.332 Sum_probs=129.0
Q ss_pred hcCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC-----Ce
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 482 (577)
.++|+..+.||+|+||+||+|.. .+|+.||||+++....+....+++.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45788999999999999999976 5699999999986655556677899999999999999999999998643 34
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.++++||+.+|+|.++++ .+.+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+|++|||+|
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 567788889999999985 34699999999999999999999999 9999999999999999999999999999
Q ss_pred cccC
Q 008121 563 ALTP 566 (577)
Q Consensus 563 ~~~~ 566 (577)
....
T Consensus 169 ~~~~ 172 (348)
T d2gfsa1 169 RHTD 172 (348)
T ss_dssp -CCT
T ss_pred cccC
Confidence 8654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.94 E-value=3.2e-27 Score=234.34 Aligned_cols=147 Identities=19% Similarity=0.269 Sum_probs=127.1
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCC-CceeeEeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 487 (577)
++|.+.+.||+|+||+||+|.+. +|+.||||+++... ....+.+|++.++.++| +|++.+++++......++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 57888999999999999999864 68999999875432 22346778888888875 89999999999999999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCCeEEeccccC
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-----ELNPHLSDCGLA 562 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~-----~~~~kl~DFGla 562 (577)
||+ +|+|.++++. ....+++.++..++.|++.||+|||+. +||||||||+|||++. ++.+||+|||+|
T Consensus 81 e~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 999 6899998863 345689999999999999999999999 9999999999999974 578999999999
Q ss_pred cccCC
Q 008121 563 ALTPN 567 (577)
Q Consensus 563 ~~~~~ 567 (577)
+.+.+
T Consensus 154 ~~~~~ 158 (293)
T d1csna_ 154 KFYRD 158 (293)
T ss_dssp EESBC
T ss_pred EEccc
Confidence 97654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.6e-27 Score=239.79 Aligned_cols=157 Identities=21% Similarity=0.271 Sum_probs=124.4
Q ss_pred cCCCccceeccCccceEEEEEEc-CCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceeeEeeEEEeC------Ce
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------GQ 482 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~ 482 (577)
++|.+.+.||+|+||+||+|.+. +|+.||||+++....+....+++.+|+.++++++|||||+++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57889999999999999999875 699999999976655556667899999999999999999999999643 57
Q ss_pred EEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeccccC
Q 008121 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (577)
Q Consensus 483 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl~DFGla 562 (577)
.|+||||+.+ ++.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 8999999965 4555553 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCcc-ccccCC
Q 008121 563 ALTPNTER-QVITGT 576 (577)
Q Consensus 563 ~~~~~~~~-~~~~Gt 576 (577)
+....... ...+||
T Consensus 167 ~~~~~~~~~~~~~~t 181 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVT 181 (355)
T ss_dssp --------------C
T ss_pred hcccccccccccccc
Confidence 87655443 334455
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=5.8e-26 Score=226.08 Aligned_cols=148 Identities=22% Similarity=0.293 Sum_probs=122.6
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCceee-EeeEEEeCCeEEEEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT-LAGYCAEHGQRLLVY 487 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~~~~lv~ 487 (577)
++|+..+.||+|+||.||+|.+ .+|+.||||++.... ..+++..|+++++.++|+|+|. +.+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4688899999999999999976 568999999876432 2234788999999998777554 555667788899999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeccccCcc
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAAL 564 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~---~~~~~kl~DFGla~~ 564 (577)
||+ +|++.+.+.. ....+++..+..++.|++.||+|||++ +||||||||+|||++ .+..+||+|||+|+.
T Consensus 83 e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999 5677776642 346799999999999999999999999 999999999999986 456799999999998
Q ss_pred cCCC
Q 008121 565 TPNT 568 (577)
Q Consensus 565 ~~~~ 568 (577)
+.+.
T Consensus 156 ~~~~ 159 (299)
T d1ckia_ 156 YRDA 159 (299)
T ss_dssp CBCT
T ss_pred cccc
Confidence 7544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=5.6e-23 Score=190.27 Aligned_cols=137 Identities=13% Similarity=0.094 Sum_probs=107.1
Q ss_pred CccceeccCccceEEEEEEcCCcEEEEEEccccccc----------------hHHHHHHHHHHHHhhcCCCCceeeEeeE
Q 008121 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS----------------LQEEDNFLEAVSNMSRLRHPNIVTLAGY 476 (577)
Q Consensus 413 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~H~niv~l~~~ 476 (577)
...+.||+|+||.||+|...+|+.||||+++....+ ......+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356789999999999999889999999987532110 1112345678889999999999988765
Q ss_pred EEeCCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 008121 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (577)
Q Consensus 477 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kl 556 (577)
.. .+++|||++++.+.+ +++.....++.|+++|++|||+. +|+||||||+|||+++++ ++|
T Consensus 83 ~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp ET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEE
T ss_pred cC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEE
Confidence 32 379999998765433 23334567999999999999999 999999999999999764 899
Q ss_pred eccccCcccCCC
Q 008121 557 SDCGLAALTPNT 568 (577)
Q Consensus 557 ~DFGla~~~~~~ 568 (577)
+|||+|+....+
T Consensus 144 iDFG~a~~~~~~ 155 (191)
T d1zara2 144 IDFPQSVEVGEE 155 (191)
T ss_dssp CCCTTCEETTST
T ss_pred EECCCcccCCCC
Confidence 999999876544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.3e-22 Score=196.26 Aligned_cols=175 Identities=23% Similarity=0.222 Sum_probs=154.2
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|+|++|.|++..+..|.++++|++|+|++|+|+..-+....++|++|+|++|++++ ++..+..+++|+.|++++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~ 109 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSF 109 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCS
T ss_pred cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc
Confidence 3689999999999988888999999999999999999843333445999999999999995 577899999999999999
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCccccccccc-CCCCC-ccEEEeecCccccccC
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLP-LTTLNVANNHFSGWIP 240 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~L~l~~N~l~g~~p 240 (577)
|.+.+..+..+..+.+|++|++++|.++...+..+..+++|+.|++++|+|++.++. +..++ |+.|+|++|+|+ .+|
T Consensus 110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp 188 (266)
T d1p9ag_ 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (266)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred cccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccC
Confidence 999999999999999999999999999977777788999999999999999997754 66655 999999999999 888
Q ss_pred cccc---cccceeecCCcCCCC
Q 008121 241 RELI---SIRTFIYDGNSFDNG 259 (577)
Q Consensus 241 ~~l~---~l~~l~~~~n~~~~~ 259 (577)
+.+. +++.+.++||+|.|.
T Consensus 189 ~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 189 KGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp TTTTTTCCCSEEECCSCCBCCS
T ss_pred hhHCCCCCCCEEEecCCCCCCC
Confidence 7655 567788999999874
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.86 E-value=2.8e-22 Score=185.65 Aligned_cols=178 Identities=21% Similarity=0.261 Sum_probs=146.4
Q ss_pred CCCCCCccEEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCC-C--CCccEEEccCCcCCCcCC
Q 008121 70 PCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL-P--PNLTSLNLASNNFSGNLP 146 (577)
Q Consensus 70 ~c~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~--~~L~~L~l~~N~l~~~~p 146 (577)
.|.|.|..|.| ++++|+ .+|..+. +++++|+|++|+|++.++... . ++|+.|+|++|++.+..+
T Consensus 5 ~C~C~~~~v~C----------s~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~ 71 (192)
T d1w8aa_ 5 MCHCEGTTVDC----------TGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71 (192)
T ss_dssp TSEEETTEEEC----------TTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCT
T ss_pred CCEEcCCEEEE----------eCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccc
Confidence 46556665555 566776 5566553 689999999999987665443 2 899999999999999999
Q ss_pred CCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCC-Cc
Q 008121 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL-PL 225 (577)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L 225 (577)
..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.......... .+
T Consensus 72 ~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l 151 (192)
T d1w8aa_ 72 NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWL 151 (192)
T ss_dssp TTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHH
T ss_pred cccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhh
Confidence 99999999999999999999999999999999999999999999888888999999999999999998754321111 15
Q ss_pred cEEEeecCccccccCcccccccceeecCCcCCCCC
Q 008121 226 TTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGP 260 (577)
Q Consensus 226 ~~L~l~~N~l~g~~p~~l~~l~~l~~~~n~~~~~~ 260 (577)
+.+.+..|.++...|..+.+++-++++.|.+.|.+
T Consensus 152 ~~~~l~~~~~~c~~p~~l~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 152 RKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp HHHCCSGGGCBBCSSTTTTTSBGGGSCTTTCCCCC
T ss_pred hhhcccCCCeEeCCChhhcCCEeeecCHhhCcCCC
Confidence 66678889998888988888888888888887643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.86 E-value=6.3e-22 Score=202.01 Aligned_cols=161 Identities=16% Similarity=0.173 Sum_probs=123.0
Q ss_pred cCCCccceeccCccceEEEEEE-cCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-----------CCceeeEeeEE
Q 008121 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----------HPNIVTLAGYC 477 (577)
Q Consensus 410 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~ 477 (577)
.+|.+.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3588899999999999999987 569999999997542 33456778888877765 57899999887
Q ss_pred Ee--CCeEEEEEEecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---
Q 008121 478 AE--HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL--- 552 (577)
Q Consensus 478 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NILl~~~~--- 552 (577)
.. ....+++|+++..+........ ......+++..+..++.||+.||+|||+.. +|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred eeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccc
Confidence 54 4566777777765543333221 234567889999999999999999999832 899999999999998665
Q ss_pred ---CeEEeccccCcccCCCccccccCCC
Q 008121 553 ---NPHLSDCGLAALTPNTERQVITGTS 577 (577)
Q Consensus 553 ---~~kl~DFGla~~~~~~~~~~~~Gt~ 577 (577)
.+|++|||.|+.... .....+||+
T Consensus 167 ~~~~~kl~dfg~s~~~~~-~~~~~~gt~ 193 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE-HYTNSIQTR 193 (362)
T ss_dssp TEEEEEECCCTTCEETTB-CCCSCCSCG
T ss_pred ccceeeEeeccccccccc-ccccccccc
Confidence 399999999986543 334455653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=2.7e-20 Score=183.13 Aligned_cols=184 Identities=22% Similarity=0.231 Sum_probs=116.8
Q ss_pred CccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC---------------
Q 008121 75 WKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--------------- 128 (577)
Q Consensus 75 w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--------------- 128 (577)
|.-|.|++ ..++.|+|++|+|++..+..|.++++|++||+++|+|.+..+..+.
T Consensus 13 ~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 13 KVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp SCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred CeEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 45688875 2468899999999987778899999999999999998754332221
Q ss_pred ------------CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCC
Q 008121 129 ------------PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196 (577)
Q Consensus 129 ------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 196 (577)
++|++|++++|.+....+..+..+.+|+.+++++|+|++..+..|.++++|+.|+|++|+|++..|..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence 45666666666665555555555666666666666666555555666666666666666666555555
Q ss_pred ccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCcccc---cccceeecCCcCCC
Q 008121 197 FISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPRELI---SIRTFIYDGNSFDN 258 (577)
Q Consensus 197 ~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~~l~---~l~~l~~~~n~~~~ 258 (577)
|.++++|+.+++++|++++..+ .|..++ |++||+++|++++..|..+. +++.+++++|++.|
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 5666666666666666665433 344443 66666666666654444433 34555566666544
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.82 E-value=1.6e-21 Score=194.81 Aligned_cols=178 Identities=27% Similarity=0.375 Sum_probs=142.6
Q ss_pred CcEEEEEcCC-CCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 83 SAVVSIDISG-LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 83 ~~v~~l~l~~-~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
..++.|+|++ |+++|.+|..|++|++|++|||++|+|.+..|..+. .+|+.|++++|++.+.+|..|+++++|+.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceee
Confidence 5789999997 899999999999999999999999999987775443 6788888888888888888888888888888
Q ss_pred eccCCCcccccccccC------------------------------------------------CCCCcEEeCcCCcccC
Q 008121 160 VSRNSLTQSIGDIFGN------------------------------------------------LAGLATLDLSFNNFSG 191 (577)
Q Consensus 160 L~~N~l~~~~p~~~~~------------------------------------------------l~~L~~L~Ls~N~l~g 191 (577)
+++|.++|.+|..+.. +++|+.|++++|.+++
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 8887777766654433 3455555666666665
Q ss_pred CCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCcc--cccccceeecCCcCCCCCC
Q 008121 192 DLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPRE--LISIRTFIYDGNSFDNGPA 261 (577)
Q Consensus 192 ~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~~--l~~l~~l~~~~n~~~~~~~ 261 (577)
.+| .++.+++|+.|+|++|+|+|.+| .+..++ |++|+|++|+|+|.+|.. +.+++.+.+.+|++.|+.+
T Consensus 236 ~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 236 DLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp BGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 444 46778899999999999998765 466666 999999999999999963 5677788899999887754
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.81 E-value=1.1e-19 Score=180.49 Aligned_cols=75 Identities=19% Similarity=0.244 Sum_probs=62.2
Q ss_pred CCCCCCCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEE
Q 008121 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135 (577)
Q Consensus 69 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~ 135 (577)
-.|.|.|.+|.|++ ..++.|+|++|+|+...+.+|.++++|++|++++|.+....|..+. ++|++|+
T Consensus 6 ~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~ 85 (305)
T d1xkua_ 6 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85 (305)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence 46778999999975 3578899999999977777899999999999999999976666564 7888888
Q ss_pred ccCCcCCC
Q 008121 136 LASNNFSG 143 (577)
Q Consensus 136 l~~N~l~~ 143 (577)
+++|+++.
T Consensus 86 l~~n~l~~ 93 (305)
T d1xkua_ 86 LSKNQLKE 93 (305)
T ss_dssp CCSSCCSB
T ss_pred ccCCccCc
Confidence 88888763
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=1.4e-18 Score=160.47 Aligned_cols=149 Identities=24% Similarity=0.291 Sum_probs=126.6
Q ss_pred CCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcC-CCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCC
Q 008121 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNL-PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFN 187 (577)
Q Consensus 109 L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 187 (577)
.+.++.++|+|+ .+|..+++++++|+|++|+|++.+ +..|.++++|++|+|++|++++.++..|..+++|++|+|++|
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CCEEEEeCCCcC-ccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 357999999999 799999999999999999998754 677899999999999999999999999999999999999999
Q ss_pred cccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccccCc-ccc-cccceeecCCcCCC
Q 008121 188 NFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGWIPR-ELI-SIRTFIYDGNSFDN 258 (577)
Q Consensus 188 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~~p~-~l~-~l~~l~~~~n~~~~ 258 (577)
+|++..|..|.++++|++|+|++|+|++.++ .|..++ |++|+|++|.+....+. ++. .+..+.+..|...|
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c 163 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARC 163 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBB
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEe
Confidence 9998778889999999999999999999776 466666 99999999999865442 221 23444555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.3e-17 Score=162.15 Aligned_cols=153 Identities=21% Similarity=0.211 Sum_probs=135.5
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
..+++.|+|++|+|+.. | .++.+++|++|+|++|+|++. |..+. ++|++|++++|.+.+..+..+..+.+|++|+
T Consensus 54 l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~ 130 (266)
T d1p9ag_ 54 YTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (266)
T ss_dssp CTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred ccccccccccccccccc-c-ccccccccccccccccccccc-ccccccccccccccccccccceeecccccccccccccc
Confidence 36899999999999854 3 468899999999999999854 44443 8999999999999988889999999999999
Q ss_pred eccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCC-CccEEEeecCcccc
Q 008121 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL-PLTTLNVANNHFSG 237 (577)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~l~~N~l~g 237 (577)
+++|.++...+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+..++.+..+ .|+.|+|++|.+..
T Consensus 131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCC
Confidence 9999999998899999999999999999999888888999999999999999999766655554 49999999999863
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=7.3e-18 Score=165.49 Aligned_cols=157 Identities=19% Similarity=0.213 Sum_probs=137.6
Q ss_pred cEEEEEc-CCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 84 AVVSIDI-SGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 84 ~v~~l~l-~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
.+..++. ..+.++...+..|.++++|++|+|++|.+....+..+. ++|+.+++++|+|++..+..|..+++|+.|+|
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence 4556554 46677777788999999999999999999865554443 88999999999999888889999999999999
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCCCCC-ccEEEeecCccccc
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANNHFSGW 238 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~L~l~~N~l~g~ 238 (577)
++|+|++..+..|.++++|+.|++++|++++..|..|.++++|++|++++|.+.+.++ .+...+ |+.|++++|.+.+.
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999775 455555 99999999999865
Q ss_pred cC
Q 008121 239 IP 240 (577)
Q Consensus 239 ~p 240 (577)
.+
T Consensus 241 C~ 242 (284)
T d1ozna_ 241 CR 242 (284)
T ss_dssp GG
T ss_pred cc
Confidence 44
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=5.7e-16 Score=143.37 Aligned_cols=155 Identities=25% Similarity=0.374 Sum_probs=127.4
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
.+++.|++++++++.. +.+..+++|++|+|++|+|++..|..-.++|++|++++|.+... + .++++++|+.|++++
T Consensus 40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~ 115 (199)
T d2omxa2 40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTLFN 115 (199)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEECCS
T ss_pred cCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCcccccCCcccccccccccccccc-c-ccccccccccccccc
Confidence 5788999999999853 35889999999999999999765544448999999999999853 3 488999999999999
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccCc
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPR 241 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p~ 241 (577)
|.+.... .+..+++|+.|++++|++. .+| .+..+++|++|++++|++++..+ +..++ |+.|++++|+++. +|
T Consensus 116 ~~~~~~~--~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~i~~-i~- 188 (199)
T d2omxa2 116 NQITDID--PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKVSD-IS- 188 (199)
T ss_dssp SCCCCCG--GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CG-
T ss_pred ccccccc--ccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCcc-ccCCCCCCEEECCCCCCCC-Cc-
Confidence 9998654 3788999999999999998 454 58899999999999999998654 55554 9999999999985 44
Q ss_pred ccccccc
Q 008121 242 ELISIRT 248 (577)
Q Consensus 242 ~l~~l~~ 248 (577)
.+.+++.
T Consensus 189 ~l~~L~~ 195 (199)
T d2omxa2 189 VLAKLTN 195 (199)
T ss_dssp GGGGCTT
T ss_pred cccCCCC
Confidence 3444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.64 E-value=8.1e-16 Score=143.60 Aligned_cols=160 Identities=23% Similarity=0.312 Sum_probs=127.8
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|+++++.++... .+..+++|++|+|++|+|++..|....++|++|++++|++++ +| .+..+++|+.|++++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCccccccCccccccccccccccc-cc-ccccccccccccccc
Confidence 46888999999998643 478899999999999999976555555899999999999985 44 588899999999999
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccCc
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPR 241 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p~ 241 (577)
|.+... ..+..+++|+.+++++|.+++ +..+..+++|+++++++|++++..+ +..++ |+.|+|++|+|+. +|.
T Consensus 122 ~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i~~-l~~ 195 (210)
T d1h6ta2 122 NGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LRA 195 (210)
T ss_dssp SCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CGG
T ss_pred cccccc--ccccccccccccccccccccc--ccccccccccccccccccccccccc-ccCCCCCCEEECCCCCCCC-Chh
Confidence 998743 357889999999999999984 3457789999999999999987544 55555 9999999999984 552
Q ss_pred --ccccccceeec
Q 008121 242 --ELISIRTFIYD 252 (577)
Q Consensus 242 --~l~~l~~l~~~ 252 (577)
.+.+++.|+++
T Consensus 196 l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 196 LAGLKNLDVLELF 208 (210)
T ss_dssp GTTCTTCSEEEEE
T ss_pred hcCCCCCCEEEcc
Confidence 23355555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.7e-15 Score=144.50 Aligned_cols=188 Identities=20% Similarity=0.210 Sum_probs=129.6
Q ss_pred CCCCCCCccEEeeC-----------CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCC---CCCccEE
Q 008121 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSL 134 (577)
Q Consensus 69 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~~L~~L 134 (577)
-+|.|.+..|.|.. ..+++|+|++|.|+...+..|.++++|++|+|++|.+...+|... .+.+++|
T Consensus 4 ~~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l 83 (242)
T d1xwdc1 4 RICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 83 (242)
T ss_dssp SSEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE
T ss_pred CcCCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccc
Confidence 36778899999974 258899999999997777789999999999999999987666433 2788888
Q ss_pred Ecc-CCcCCCcCCCCccCCCCccEEEeccCCCcccccc-cccCCCCCcEEeCcCCcccCCCCCCccCCC-CCCeEEccCc
Q 008121 135 NLA-SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGD-IFGNLAGLATLDLSFNNFSGDLPNSFISLS-NISSLYLQNN 211 (577)
Q Consensus 135 ~l~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~l~~N 211 (577)
++. .|++....+..|.++++|++|++++|++....+. .+..+..|..+..+++++....+..|.++. .++.|++++|
T Consensus 84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n 163 (242)
T d1xwdc1 84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 163 (242)
T ss_dssp EEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred cccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccc
Confidence 876 5788888888899999999999999999754332 233455555556666666644445555443 5666777777
Q ss_pred cccccccc-CCCCCccEE-EeecCccccccCc-c---cccccceeecCCcCC
Q 008121 212 QVTGSLNV-FSGLPLTTL-NVANNHFSGWIPR-E---LISIRTFIYDGNSFD 257 (577)
Q Consensus 212 ~l~~~~~~-~~~~~L~~L-~l~~N~l~g~~p~-~---l~~l~~l~~~~n~~~ 257 (577)
+++..... +....+..+ ++++|+|+ .+|. . +.+++.|++++|.+.
T Consensus 164 ~l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 164 GIQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp CCCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC
T ss_pred cccccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCC
Confidence 77654432 333333333 45556666 3432 2 234556666666654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.59 E-value=6.4e-15 Score=145.57 Aligned_cols=135 Identities=24% Similarity=0.340 Sum_probs=81.7
Q ss_pred cccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCC
Q 008121 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (577)
Q Consensus 100 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (577)
+..+..+++|+.+++++|+++ .+|..+.++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~-~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCC-SCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred ccccccccccCccccccCCcc-ccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccc
Confidence 344555666666666666665 4555555666666666666666666666666666666666666666666666666666
Q ss_pred cEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccc-cCC------C-CCccEEEeecCccc
Q 008121 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFS------G-LPLTTLNVANNHFS 236 (577)
Q Consensus 180 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~------~-~~L~~L~l~~N~l~ 236 (577)
++|+|++|+|+ .+|.+|..+++|++|+|++|+|+.... .|. . ..|+.|+|++|.++
T Consensus 222 ~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred eeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 66666666666 456666666666666666666665322 111 1 12556666666553
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.59 E-value=5.2e-15 Score=136.81 Aligned_cols=161 Identities=20% Similarity=0.315 Sum_probs=128.4
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcc
Q 008121 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167 (577)
Q Consensus 88 l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 167 (577)
+.++.+.+++.++ ...+.+|++|++++|+++..-..+..++|++|+|++|++++..| ++++++|++|++++|.+..
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCccccccCCCcCcCccccccccCccc--ccCCccccccccccccccc
Confidence 4566666766543 35688999999999999843222334899999999999997544 8999999999999999986
Q ss_pred cccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCC-CccEEEeecCccccccC-ccccc
Q 008121 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL-PLTTLNVANNHFSGWIP-RELIS 245 (577)
Q Consensus 168 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~l~~N~l~g~~p-~~l~~ 245 (577)
.. .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.... .+... .++.|++++|++++..| ..+.+
T Consensus 99 ~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~ 173 (199)
T d2omxa2 99 IT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTT 173 (199)
T ss_dssp CG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTT
T ss_pred cc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcccc-cccccccccccccccccccCCccccCCCC
Confidence 44 388999999999999999853 34788999999999999998754 34444 49999999999996543 34667
Q ss_pred ccceeecCCcCC
Q 008121 246 IRTFIYDGNSFD 257 (577)
Q Consensus 246 l~~l~~~~n~~~ 257 (577)
++.|++++|++.
T Consensus 174 L~~L~ls~N~i~ 185 (199)
T d2omxa2 174 LERLDISSNKVS 185 (199)
T ss_dssp CCEEECCSSCCC
T ss_pred CCEEECCCCCCC
Confidence 888999999864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.59 E-value=4.2e-15 Score=151.36 Aligned_cols=163 Identities=27% Similarity=0.406 Sum_probs=110.8
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
.+++.|++++|.++.. +.+..+++|+.|++++|++++..|....++|++|++++|++++..+ +..++.++.+++++
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCcccccccCCEeeccCcccCCCCc--cccccccccccccc
Confidence 3566667777766642 3566677777777777777765554444677777777777765432 55667777777777
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC-
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP- 240 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p- 240 (577)
|++++. ..+..+++++.|+|++|+|++. + .+..+++|++|++++|+|++.. .+..++ |++|++++|+|++..|
T Consensus 295 n~l~~~--~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~~N~l~~l~~l 369 (384)
T d2omza2 295 NQLEDI--SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHNQISDLTPL 369 (384)
T ss_dssp SCCSCC--GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCBCGGG
T ss_pred cccccc--cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECCCCcCCCChhh
Confidence 777653 2366778888888888888864 3 2777888888888888887643 344444 8888888888886655
Q ss_pred cccccccceeecCC
Q 008121 241 RELISIRTFIYDGN 254 (577)
Q Consensus 241 ~~l~~l~~l~~~~n 254 (577)
..+.+++.|++++|
T Consensus 370 ~~l~~L~~L~L~~N 383 (384)
T d2omza2 370 ANLTRITQLGLNDQ 383 (384)
T ss_dssp TTCTTCSEEECCCE
T ss_pred ccCCCCCEeeCCCC
Confidence 23446667777766
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.58 E-value=7.5e-15 Score=138.64 Aligned_cols=165 Identities=24% Similarity=0.349 Sum_probs=90.6
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|++.+|+|+.. +.+..+++|++|+|++|+|++..|..-.++|++|++++|.++. ++ .+..+++|+.|++++
T Consensus 41 ~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~ 116 (227)
T d1h6ua2 41 DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTS 116 (227)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTT
T ss_pred CCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccccccccccccccccccccccc-cc-ccccccccccccccc
Confidence 4677777777777743 3477778888888888877765554444777777777777763 33 466777777777777
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeecCccccccC-
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP- 240 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~~p- 240 (577)
|...+..+ +...+.+..+.++++.+.... .+.++++|++|++++|.+.+..+ +..++ |+.|++++|++++..+
T Consensus 117 ~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~l~~l 191 (227)
T d1h6ua2 117 TQITDVTP--LAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISPL 191 (227)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGGG
T ss_pred ccccccch--hccccchhhhhchhhhhchhh--hhccccccccccccccccccchh-hcccccceecccCCCccCCChhh
Confidence 77665433 333444444444444444211 23344444444444444443222 22222 4444444444443111
Q ss_pred cccccccceeecCCcC
Q 008121 241 RELISIRTFIYDGNSF 256 (577)
Q Consensus 241 ~~l~~l~~l~~~~n~~ 256 (577)
..+.+++.|++++|.+
T Consensus 192 ~~l~~L~~L~Ls~N~l 207 (227)
T d1h6ua2 192 ASLPNLIEVHLKNNQI 207 (227)
T ss_dssp GGCTTCCEEECTTSCC
T ss_pred cCCCCCCEEECcCCcC
Confidence 1233344444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.56 E-value=1.3e-14 Score=135.20 Aligned_cols=141 Identities=25% Similarity=0.376 Sum_probs=118.8
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCC-CCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEe
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 160 (577)
..+++.|+|++|++++.. .++.+++|+.|++++|+|++ +| ..-.++|+.|++++|.+.. + ..+..+++|+.+++
T Consensus 67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (210)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cccccccccccccccccccccc-c-cccccccccccccc
Confidence 468999999999999754 47899999999999999995 44 3333899999999999874 3 35889999999999
Q ss_pred ccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEeec
Q 008121 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232 (577)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~ 232 (577)
++|.+++. ..+..+++|+++++++|++++ ++ .+.++++|++|+|++|+|+.. +.+..++ |+.|+|++
T Consensus 142 ~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFS 209 (210)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEE
T ss_pred cccccccc--ccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCCC-hhhcCCCCCCEEEccC
Confidence 99999864 347789999999999999995 44 388999999999999999875 4566665 99999975
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.3e-15 Score=134.23 Aligned_cols=111 Identities=22% Similarity=0.260 Sum_probs=72.4
Q ss_pred cccCCCCCCEEEccCCCcCCcCCCCC--CCCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCC
Q 008121 102 LLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (577)
Q Consensus 102 ~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (577)
.+.+...|+.|||++|+|+. +|..+ .++|+.|||++|+|+. ++ .|..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 45566677777777777763 44322 1667777777777763 33 46677777777777777776555556667777
Q ss_pred cEEeCcCCcccCCCC--CCccCCCCCCeEEccCcccccc
Q 008121 180 ATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGS 216 (577)
Q Consensus 180 ~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~ 216 (577)
+.|+|++|+|+. ++ ..+..+++|++|++++|.++..
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCccccc
Confidence 777777777763 33 2456677777777777776654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=1.4e-14 Score=122.89 Aligned_cols=100 Identities=25% Similarity=0.315 Sum_probs=53.4
Q ss_pred EEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCc
Q 008121 111 KFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (577)
Q Consensus 111 ~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 188 (577)
.|||++|+|+ .+|. +. ++|++|++++|+|+ .+|+.|+.+++|+.|++++|+|++. | .+.++++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 4555555554 2221 21 45555555555554 3455556666666666666666643 2 25566666666666666
Q ss_pred ccCCCC-CCccCCCCCCeEEccCccccc
Q 008121 189 FSGDLP-NSFISLSNISSLYLQNNQVTG 215 (577)
Q Consensus 189 l~g~~p-~~~~~l~~L~~L~l~~N~l~~ 215 (577)
|+.... ..+..+++|++|++++|+++.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 653211 345556666666666666554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=7.4e-15 Score=130.84 Aligned_cols=122 Identities=19% Similarity=0.187 Sum_probs=102.3
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCC-CCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
.++..|+|++|+|+.. +..+..+++|+.|||++|+|+. ++ ....++|++|+|++|+++...+..+..+++|++|+|+
T Consensus 18 ~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp TSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-ECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-cCCcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 4688999999999865 6677889999999999999994 44 2223899999999999997666667789999999999
Q ss_pred cCCCccccc-ccccCCCCCcEEeCcCCcccCCCCC----CccCCCCCCeEE
Q 008121 162 RNSLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPN----SFISLSNISSLY 207 (577)
Q Consensus 162 ~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~L~ 207 (577)
+|+|+.... ..+..+++|++|++++|.++ ..|. .+..+++|++||
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 999986432 46889999999999999998 4564 467889999886
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.53 E-value=2.2e-14 Score=145.92 Aligned_cols=143 Identities=24% Similarity=0.348 Sum_probs=124.3
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
..++.|++++|.+++..+ ++.+++|++|++++|++++..|..-.+.++.++++.|++++. ..+..+++|+.|+|++
T Consensus 241 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~ 316 (384)
T d2omza2 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYF 316 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCS
T ss_pred cccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccc--cccchhcccCeEECCC
Confidence 478899999999997654 889999999999999999766655558999999999999863 3578899999999999
Q ss_pred CCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCC-CccEEEeecCc
Q 008121 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL-PLTTLNVANNH 234 (577)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~l~~N~ 234 (577)
|++++..| +..+++|++|+|++|+|++ +| .+.++++|++|++++|+|++.++ +..+ .|+.|+|++|.
T Consensus 317 n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 317 NNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQA 384 (384)
T ss_dssp SCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCEE
T ss_pred CCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCCc
Confidence 99998754 8899999999999999994 55 69999999999999999999776 5555 49999999983
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=1.8e-14 Score=122.11 Aligned_cols=115 Identities=23% Similarity=0.296 Sum_probs=94.0
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCC
Q 008121 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (577)
Q Consensus 87 ~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (577)
.|+|++|+|+. ++ .++.+++|++|||++|+|+ .+|..+. ++|+.|++++|+|++ +| .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 58999999984 44 5899999999999999998 5776554 899999999999995 45 48999999999999999
Q ss_pred Cccccc-ccccCCCCCcEEeCcCCcccCCC--CC-CccCCCCCCeE
Q 008121 165 LTQSIG-DIFGNLAGLATLDLSFNNFSGDL--PN-SFISLSNISSL 206 (577)
Q Consensus 165 l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~--p~-~~~~l~~L~~L 206 (577)
|+.... ..+..+++|++|+|++|.++... +. .+..+++|+.|
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 996543 56899999999999999998421 12 23345666655
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.46 E-value=2.4e-13 Score=128.00 Aligned_cols=168 Identities=19% Similarity=0.328 Sum_probs=132.1
Q ss_pred CCccEEeeCCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCC-CCCCCCccEEEccCCcCCCcCCCCccCC
Q 008121 74 SWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLPYSIASM 152 (577)
Q Consensus 74 ~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~~L~~L~l~~N~l~~~~p~~~~~l 152 (577)
.++|+ ....+++.|+|++|.+++..| +..+++|+.|++++|.++. ++ ..-.++|+.|++++|...+..+ +...
T Consensus 55 ~l~~l-~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~~~~~--~~~~ 128 (227)
T d1h6ua2 55 TIEGV-QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTP--LAGL 128 (227)
T ss_dssp CCTTG-GGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCCCGG--GTTC
T ss_pred cchhH-hcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cccccccccccccccccccccccch--hccc
Confidence 45554 245789999999999997654 8999999999999999984 44 2334899999999999886543 6677
Q ss_pred CCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEccCcccccccccCCCCC-ccEEEee
Q 008121 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVA 231 (577)
Q Consensus 153 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~ 231 (577)
+.++.++++++.+....+ +.++++|+.|++++|.+++.. .++++++|++|+|++|++++..+ +..++ |+.|+|+
T Consensus 129 ~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls 203 (227)
T d1h6ua2 129 SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLK 203 (227)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECT
T ss_pred cchhhhhchhhhhchhhh--hccccccccccccccccccch--hhcccccceecccCCCccCCChh-hcCCCCCCEEECc
Confidence 899999999999986544 678899999999999998433 38899999999999999987543 55444 9999999
Q ss_pred cCccccccC-cccccccceeec
Q 008121 232 NNHFSGWIP-RELISIRTFIYD 252 (577)
Q Consensus 232 ~N~l~g~~p-~~l~~l~~l~~~ 252 (577)
+|+|++..| ..+.+++.|+++
T Consensus 204 ~N~lt~i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 204 NNQISDVSPLANTSNLFIVTLT 225 (227)
T ss_dssp TSCCCBCGGGTTCTTCCEEEEE
T ss_pred CCcCCCCcccccCCCCCEEEee
Confidence 999995433 344555666554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=4.3e-13 Score=118.36 Aligned_cols=85 Identities=22% Similarity=0.275 Sum_probs=60.1
Q ss_pred CCccEEEccCC-cCCCcCCCCccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEE
Q 008121 129 PNLTSLNLASN-NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY 207 (577)
Q Consensus 129 ~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 207 (577)
++|++|++++| .|+...++.|.++++|+.|+|++|+|+.+.|..|..+++|++|+|++|+|+ .+|.......+|++|+
T Consensus 31 ~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~ 109 (156)
T d2ifga3 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELV 109 (156)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEE
T ss_pred cccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccc
Confidence 34444555433 345444566788888888888888888877888888888888888888888 5555544444677888
Q ss_pred ccCcccc
Q 008121 208 LQNNQVT 214 (577)
Q Consensus 208 l~~N~l~ 214 (577)
|++|.+.
T Consensus 110 L~~Np~~ 116 (156)
T d2ifga3 110 LSGNPLH 116 (156)
T ss_dssp CCSSCCC
T ss_pred cCCCccc
Confidence 7777764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.34 E-value=9.9e-12 Score=124.06 Aligned_cols=167 Identities=22% Similarity=0.269 Sum_probs=104.9
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEecc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (577)
++++.|+|++|+|+ .+|.. +.+|+.|++++|+++ .++ .+++.|++|++++|.+. .+|. ++.+++|+.|++++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~-~lp~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~ 129 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALS-DLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDN 129 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCC-SCCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCS
T ss_pred CCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhh-hhccccccccccccccc-cccc-hhhhccceeecccc
Confidence 46788888888887 55654 346778888888887 444 34567888888888887 4554 57788888888888
Q ss_pred CCCccccc------------------ccccCCCCCcEEeCcCCcccCCC------------------CCCccCCCCCCeE
Q 008121 163 NSLTQSIG------------------DIFGNLAGLATLDLSFNNFSGDL------------------PNSFISLSNISSL 206 (577)
Q Consensus 163 N~l~~~~p------------------~~~~~l~~L~~L~Ls~N~l~g~~------------------p~~~~~l~~L~~L 206 (577)
|.++...+ ..+..++.++.|++++|.+.... ...+..++.|+.+
T Consensus 130 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l 209 (353)
T d1jl5a_ 130 NSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209 (353)
T ss_dssp SCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEE
T ss_pred ccccccccccccccchhhccccccccccccccccceeccccccccccccccccccccccccccccccccccccccccccc
Confidence 87764322 12344555666666655543210 0123344555555
Q ss_pred EccCccccccc----------------------------------------cc----------------C-CCC-CccEE
Q 008121 207 YLQNNQVTGSL----------------------------------------NV----------------F-SGL-PLTTL 228 (577)
Q Consensus 207 ~l~~N~l~~~~----------------------------------------~~----------------~-~~~-~L~~L 228 (577)
++++|.....+ .. + ... .|++|
T Consensus 210 ~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L 289 (353)
T d1jl5a_ 210 YADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEEL 289 (353)
T ss_dssp ECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhcccccccCccccccccCCCCCEE
Confidence 55555432210 00 0 001 27888
Q ss_pred EeecCccccccCcccccccceeecCCcCCC
Q 008121 229 NVANNHFSGWIPRELISIRTFIYDGNSFDN 258 (577)
Q Consensus 229 ~l~~N~l~g~~p~~l~~l~~l~~~~n~~~~ 258 (577)
+|++|+|+ .+|..+.+++.|.+++|.+..
T Consensus 290 ~Ls~N~l~-~lp~~~~~L~~L~L~~N~L~~ 318 (353)
T d1jl5a_ 290 NVSNNKLI-ELPALPPRLERLIASFNHLAE 318 (353)
T ss_dssp ECCSSCCS-CCCCCCTTCCEEECCSSCCSC
T ss_pred ECCCCccC-ccccccCCCCEEECCCCcCCc
Confidence 88888888 678778888888888887653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=2.9e-12 Score=112.94 Aligned_cols=105 Identities=17% Similarity=0.151 Sum_probs=90.5
Q ss_pred ccEEEccCCcCCCcCCCCccCCCCccEEEeccC-CCcccccccccCCCCCcEEeCcCCcccCCCCCCccCCCCCCeEEcc
Q 008121 131 LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN-SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQ 209 (577)
Q Consensus 131 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~ 209 (577)
.+.++.+++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 455777777776 56777888999999999876 5888888899999999999999999998778889999999999999
Q ss_pred Cccccccccc-CCCCCccEEEeecCccc
Q 008121 210 NNQVTGSLNV-FSGLPLTTLNVANNHFS 236 (577)
Q Consensus 210 ~N~l~~~~~~-~~~~~L~~L~l~~N~l~ 236 (577)
+|+|+..++. +...+|+.|+|++|.|.
T Consensus 89 ~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCcccChhhhccccccccccCCCccc
Confidence 9999986654 55667999999999985
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.27 E-value=2.6e-14 Score=131.70 Aligned_cols=114 Identities=25% Similarity=0.290 Sum_probs=88.8
Q ss_pred cccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEEeccCCCcccccccccC
Q 008121 98 TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGN 175 (577)
Q Consensus 98 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 175 (577)
.++..++.|++|++|+|++|+|+ .++ .+. ++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.. + .+.+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~-~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-S-GIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-H-HHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-c-cccc
Confidence 34567889999999999999998 444 233 78999999999987 5566666667899999999998854 3 3777
Q ss_pred CCCCcEEeCcCCcccCCCC--CCccCCCCCCeEEccCccccccc
Q 008121 176 LAGLATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGSL 217 (577)
Q Consensus 176 l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~ 217 (577)
+++|+.|+|++|+|+. ++ ..+..+++|++|+|++|++....
T Consensus 114 l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~ 156 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp HHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred cccccccccccchhcc-ccccccccCCCccceeecCCCccccCc
Confidence 8889999999998873 44 35778888888888888877644
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.24 E-value=7e-11 Score=117.70 Aligned_cols=98 Identities=28% Similarity=0.345 Sum_probs=80.5
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCCCCccEEEccCCcCCCcCCCCccCCCCccEEEec
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (577)
..+++.|||++++|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .++|++|+|+
T Consensus 37 ~~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~-~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 37 DRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP-QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp HHTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC-TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred HcCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch-hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 356889999999998 46753 568999999999999 788654 79999999999998 34431 1469999999
Q ss_pred cCCCcccccccccCCCCCcEEeCcCCcccC
Q 008121 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSG 191 (577)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 191 (577)
+|.++. +|. ++.+++|+.|++++|.++.
T Consensus 107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~ 134 (353)
T d1jl5a_ 107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLKK 134 (353)
T ss_dssp SSCCSS-CCC-CTTCTTCCEEECCSSCCSC
T ss_pred cccccc-ccc-hhhhccceeeccccccccc
Confidence 999985 554 6889999999999999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=2.6e-11 Score=114.77 Aligned_cols=152 Identities=14% Similarity=0.088 Sum_probs=114.7
Q ss_pred EEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCC-CCC--CCccEEEccCCcCCCcC-CCCccCCCCccEEEec
Q 008121 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-QLP--PNLTSLNLASNNFSGNL-PYSIASMVSLSYLNVS 161 (577)
Q Consensus 86 ~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~--~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~L~ 161 (577)
..++.++.+++ .+|..+. +++++|||++|+|+. +|. .+. ++|++|+|++|.+...+ +..|.+++++++|++.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~-l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCE-ECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCc-cChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 36788888888 6665553 578999999999984 554 343 89999999999998755 4578899999999876
Q ss_pred -cCCCcccccccccCCCCCcEEeCcCCcccCCCCC-CccCCCCCCeEEccCccccccc-ccCCCC--CccEEEeecCccc
Q 008121 162 -RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN-SFISLSNISSLYLQNNQVTGSL-NVFSGL--PLTTLNVANNHFS 236 (577)
Q Consensus 162 -~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~~~-~~~~~~--~L~~L~l~~N~l~ 236 (577)
.|++....+..|.++++|++|++++|++....+. .+..+..+..+..+++.+.... ..+..+ .+..|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 4788888888899999999999999999843332 2345556666677777777654 345444 3788999999999
Q ss_pred cccCc
Q 008121 237 GWIPR 241 (577)
Q Consensus 237 g~~p~ 241 (577)
...+.
T Consensus 167 ~i~~~ 171 (242)
T d1xwdc1 167 EIHNC 171 (242)
T ss_dssp EECTT
T ss_pred ccccc
Confidence 54333
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.21 E-value=7.4e-14 Score=128.60 Aligned_cols=121 Identities=25% Similarity=0.239 Sum_probs=98.9
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCCcCCCcCCCCccCCCCccEEE
Q 008121 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (577)
Q Consensus 82 ~~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 159 (577)
-.+++.|+|++|+|+.. + .|..+++|+.|+|++|+|+ .+|.... ++|++|++++|+++.. + .+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-S-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-H-HHHHHHHSSEEE
T ss_pred ccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-c-cccccccccccc
Confidence 36899999999999854 4 5999999999999999998 4553322 6899999999999954 3 478899999999
Q ss_pred eccCCCccccc-ccccCCCCCcEEeCcCCcccCCCCCC----------ccCCCCCCeEE
Q 008121 160 VSRNSLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPNS----------FISLSNISSLY 207 (577)
Q Consensus 160 L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~----------~~~l~~L~~L~ 207 (577)
|++|+|+.... ..+..+++|+.|+|++|.+....+.. +..+++|+.||
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99999986533 56899999999999999998554433 45678888875
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=1.6e-11 Score=119.46 Aligned_cols=172 Identities=24% Similarity=0.243 Sum_probs=92.7
Q ss_pred CcEEEEEcCCCCCccc-ccccccCCCCCCEEEccCCCcCCcCCCCCC--CCccEEEccCC-cCCCc-CCCCccCCCCccE
Q 008121 83 SAVVSIDISGLGLSGT-MGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASN-NFSGN-LPYSIASMVSLSY 157 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~ 157 (577)
.+++.|||+++.++.. +...+..+++|++|+|++|.+++..+..+. ++|++|+|+++ .++.. +...+.++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 3677788887777644 344567778888888888877754443333 67888888774 45421 2222345677888
Q ss_pred EEeccC-CCccc-cccccc-CCCCCcEEeCcCC--cccCC-CCCCccCCCCCCeEEccCcc-ccc-ccccCCCCC-ccEE
Q 008121 158 LNVSRN-SLTQS-IGDIFG-NLAGLATLDLSFN--NFSGD-LPNSFISLSNISSLYLQNNQ-VTG-SLNVFSGLP-LTTL 228 (577)
Q Consensus 158 L~L~~N-~l~~~-~p~~~~-~l~~L~~L~Ls~N--~l~g~-~p~~~~~l~~L~~L~l~~N~-l~~-~~~~~~~~~-L~~L 228 (577)
|+|+++ .++.. +...+. ..++|+.|++++. .++.. +...+.++++|++|++++|. +++ .+..+...+ |++|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 888774 44421 222222 2356666666643 23211 12222345666666666643 443 222333333 6666
Q ss_pred Eeec-CccccccCcccc---cccceeecCC
Q 008121 229 NVAN-NHFSGWIPRELI---SIRTFIYDGN 254 (577)
Q Consensus 229 ~l~~-N~l~g~~p~~l~---~l~~l~~~~n 254 (577)
++++ +.+++.....+. +++.|++.|+
T Consensus 206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 6666 355544333332 3444455443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.03 E-value=1.3e-11 Score=123.66 Aligned_cols=175 Identities=18% Similarity=0.212 Sum_probs=126.1
Q ss_pred CcEEEEEcCCCCCccc----ccccccCCCCCCEEEccCCCcCCcCC---------------CCCCCCccEEEccCCcCCC
Q 008121 83 SAVVSIDISGLGLSGT----MGYLLSDLLSLRKFDLSGNSIHDTIP---------------YQLPPNLTSLNLASNNFSG 143 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~----~~~~~~~l~~L~~L~Ls~N~l~~~~p---------------~~~~~~L~~L~l~~N~l~~ 143 (577)
.+++.|+|++|.+... +...+...++|++|+|++|.|+..-. ....+.|+.|++++|+++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 5788999999988764 34456678899999999998752110 0112678999999998863
Q ss_pred c----CCCCccCCCCccEEEeccCCCccc-----ccccccCCCCCcEEeCcCCcccCC----CCCCccCCCCCCeEEccC
Q 008121 144 N----LPYSIASMVSLSYLNVSRNSLTQS-----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQN 210 (577)
Q Consensus 144 ~----~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~ 210 (577)
. +...+...+.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 2 233455678999999999998742 345577889999999999998632 344567889999999999
Q ss_pred ccccccc-----cc---CCCCCccEEEeecCccccc----cCc----ccccccceeecCCcCC
Q 008121 211 NQVTGSL-----NV---FSGLPLTTLNVANNHFSGW----IPR----ELISIRTFIYDGNSFD 257 (577)
Q Consensus 211 N~l~~~~-----~~---~~~~~L~~L~l~~N~l~g~----~p~----~l~~l~~l~~~~n~~~ 257 (577)
|.|++.- .. .....|+.|++++|+|+.. +.. ...+++.|++++|.+.
T Consensus 253 n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 9997631 11 2234599999999998753 222 2346788889998873
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=2.1e-10 Score=111.38 Aligned_cols=175 Identities=22% Similarity=0.290 Sum_probs=125.0
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEccCC-CcCCc-CCC--CCCCCccEEEccCC-cCCCc-CCCCccC-CCCc
Q 008121 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN-SIHDT-IPY--QLPPNLTSLNLASN-NFSGN-LPYSIAS-MVSL 155 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~--~~~~~L~~L~l~~N-~l~~~-~p~~~~~-l~~L 155 (577)
.+++.|+|+++.+++..+..++.+++|++|+|+++ .++.. +.. .-.++|++|+|+++ +++.. +...+.. .++|
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 57999999999999888889999999999999995 56631 111 11289999999985 55422 2223333 4789
Q ss_pred cEEEeccC--CCcc-cccccccCCCCCcEEeCcCC-cccCCCCCCccCCCCCCeEEccC-cccccc-cccCCCCC-ccEE
Q 008121 156 SYLNVSRN--SLTQ-SIGDIFGNLAGLATLDLSFN-NFSGDLPNSFISLSNISSLYLQN-NQVTGS-LNVFSGLP-LTTL 228 (577)
Q Consensus 156 ~~L~L~~N--~l~~-~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~-~~~~~~~~-L~~L 228 (577)
+.|++++. .++. .+...+.++++|++|+|++| .+++.....+.++++|++|+|++ +.+++. +..+...+ |+.|
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L 230 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 230 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEE
Confidence 99999964 4553 24444567899999999986 58877788899999999999999 467653 23344444 9999
Q ss_pred EeecCccccccCcccccccceeecCCcCC
Q 008121 229 NVANNHFSGWIPRELISIRTFIYDGNSFD 257 (577)
Q Consensus 229 ~l~~N~l~g~~p~~l~~l~~l~~~~n~~~ 257 (577)
+++++--.+.++.....++.+.+..+.+.
T Consensus 231 ~l~~~~~d~~l~~l~~~lp~L~i~~~~ls 259 (284)
T d2astb2 231 QVFGIVPDGTLQLLKEALPHLQINCSHFT 259 (284)
T ss_dssp ECTTSSCTTCHHHHHHHSTTSEESCCCSC
T ss_pred eeeCCCCHHHHHHHHHhCccccccCccCC
Confidence 99887222233333345777877666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.77 E-value=4.3e-10 Score=112.23 Aligned_cols=155 Identities=19% Similarity=0.161 Sum_probs=82.1
Q ss_pred CcEEEEEcCCCCCccc----------ccccccCCCCCCEEEccCCCcCCcCC----CCC--CCCccEEEccCCcCCCcCC
Q 008121 83 SAVVSIDISGLGLSGT----------MGYLLSDLLSLRKFDLSGNSIHDTIP----YQL--PPNLTSLNLASNNFSGNLP 146 (577)
Q Consensus 83 ~~v~~l~l~~~~l~g~----------~~~~~~~l~~L~~L~Ls~N~l~~~~p----~~~--~~~L~~L~l~~N~l~~~~p 146 (577)
..++.|+|+++.+... +...+...++|+.|||++|.++..-. ..+ .++|++|++++|.+...-.
T Consensus 59 ~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~ 138 (344)
T d2ca6a1 59 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 138 (344)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccc
Confidence 4556666665543211 12234455666677777666653211 111 1566677776666542100
Q ss_pred CC-------------ccCCCCccEEEeccCCCccc----ccccccCCCCCcEEeCcCCcccCC-----CCCCccCCCCCC
Q 008121 147 YS-------------IASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD-----LPNSFISLSNIS 204 (577)
Q Consensus 147 ~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~-----~p~~~~~l~~L~ 204 (577)
.. ....+.|+.|++++|+++.. +...+...+.|++|+|++|+++.. +...+..+++|+
T Consensus 139 ~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~ 218 (344)
T d2ca6a1 139 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 218 (344)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred ccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhc
Confidence 00 12345666677776666522 233345566777777777776521 233455666777
Q ss_pred eEEccCcccccc----c-ccCCCC-CccEEEeecCcccc
Q 008121 205 SLYLQNNQVTGS----L-NVFSGL-PLTTLNVANNHFSG 237 (577)
Q Consensus 205 ~L~l~~N~l~~~----~-~~~~~~-~L~~L~l~~N~l~g 237 (577)
.|+|++|.|+.. + ..+... .|+.|+|++|.|++
T Consensus 219 ~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 219 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred ccccccccccccccccccccccccccchhhhhhcCccCc
Confidence 777777776532 1 122222 37777777777764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=8.7e-10 Score=113.53 Aligned_cols=38 Identities=24% Similarity=0.239 Sum_probs=16.7
Q ss_pred CCCcEEeCcCCcccCC----CCCCccCCCCCCeEEccCcccc
Q 008121 177 AGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVT 214 (577)
Q Consensus 177 ~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 214 (577)
+.|++|+|++|+|+.. ++..+..+++|++|+|++|+|+
T Consensus 369 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred CCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 3455555555554421 2222333444555555555544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.42 E-value=2e-09 Score=94.93 Aligned_cols=42 Identities=26% Similarity=0.084 Sum_probs=17.9
Q ss_pred ccCCCCccEEEeccCCCcccccccccCCCCCcEEeCcCCccc
Q 008121 149 IASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS 190 (577)
Q Consensus 149 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 190 (577)
+..+++|+.|+|++|+|+...+-.+....+|+.|+|++|.++
T Consensus 87 ~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 334444444444444444332222222334444444444444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=1e-06 Score=83.21 Aligned_cols=144 Identities=12% Similarity=0.042 Sum_probs=92.3
Q ss_pred hcCCCccceeccCccceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCC-CCceeeEeeEEEeCCeEEEEE
Q 008121 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVY 487 (577)
Q Consensus 409 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 487 (577)
-..|...+..+.++.+.||+... +++.+++|+..... ......+.+|...+..+. +--+.+++++...++..++||
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 34454444433344568998864 45567788875432 112223566777666553 333567788888888999999
Q ss_pred EecCCCCHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 008121 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC----------------------------------- 532 (577)
Q Consensus 488 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~----------------------------------- 532 (577)
+++++..+.+.... ......++.++++.++.||+..
T Consensus 90 ~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 90 SEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred Eecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99999887654420 0112234555555666666421
Q ss_pred ---------------------CCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 533 ---------------------LPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 533 ---------------------~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
.+.++|+|+.|.|||+++++..-|.||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877677999998875
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=8e-09 Score=106.06 Aligned_cols=107 Identities=25% Similarity=0.302 Sum_probs=67.8
Q ss_pred cEEEEEcCCCCCcccc-cccccCCCCCCEEEccCCCcCCc----CCCCC--CCCccEEEccCCcCCCc----CCCCcc-C
Q 008121 84 AVVSIDISGLGLSGTM-GYLLSDLLSLRKFDLSGNSIHDT----IPYQL--PPNLTSLNLASNNFSGN----LPYSIA-S 151 (577)
Q Consensus 84 ~v~~l~l~~~~l~g~~-~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~~L~~L~l~~N~l~~~----~p~~~~-~ 151 (577)
+|+.|||++|++++.. ...+..+++|++|+|++|+|+.. ++..+ .++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5788888888887632 34566678888888888877621 12111 26677777777777521 122222 2
Q ss_pred CCCccEEEeccCCCccc----ccccccCCCCCcEEeCcCCccc
Q 008121 152 MVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFS 190 (577)
Q Consensus 152 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 190 (577)
..+|+.|+|++|++++. ++..+..+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 24677777777777643 4555666777777777777765
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=1.4e-08 Score=89.38 Aligned_cols=65 Identities=25% Similarity=0.309 Sum_probs=31.1
Q ss_pred cCCCCccEEEeccCCCccc--ccccccCCCCCcEEeCcCCcccCCCCC-CccCCCCCCeEEccCccccc
Q 008121 150 ASMVSLSYLNVSRNSLTQS--IGDIFGNLAGLATLDLSFNNFSGDLPN-SFISLSNISSLYLQNNQVTG 215 (577)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~ 215 (577)
..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+. ++. .+.+..+|+.|++++|.+..
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCc
Confidence 3455555555555555543 22334455555555555555552 222 22222345555555555443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=8.9e-06 Score=76.15 Aligned_cols=131 Identities=19% Similarity=0.186 Sum_probs=83.1
Q ss_pred eeccCcc-ceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCC--CceeeEeeEEEeCCeEEEEEEecCCC
Q 008121 417 LIGEGSL-GRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PNIVTLAGYCAEHGQRLLVYEYVGNG 493 (577)
Q Consensus 417 ~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g 493 (577)
.+..|.. +.||+....++..+++|...... ...+..|.+.++.+.. --+.+++++..+.+..++||||++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3455554 57899988888888899865432 1234556666655532 23567788888888899999999876
Q ss_pred CHHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 008121 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-------------------------------------------- 529 (577)
Q Consensus 494 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-------------------------------------------- 529 (577)
++.+.. .. ...++.++++.|+-||
T Consensus 92 ~~~~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 92 DLLSSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp ETTTSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 543210 00 0011112222222222
Q ss_pred -------cCC----CCCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 530 -------EVC----LPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 530 -------~~~----~~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
... .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 12479999999999999877778999998875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.75 E-value=3.2e-06 Score=74.09 Aligned_cols=85 Identities=15% Similarity=0.044 Sum_probs=49.7
Q ss_pred CCccEEEccCCcCCCcC----CCCccCCCCccEEEeccCCCccc----ccccccCCCCCcEEeCcCCcccCC-------C
Q 008121 129 PNLTSLNLASNNFSGNL----PYSIASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD-------L 193 (577)
Q Consensus 129 ~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~-------~ 193 (577)
+.|++|+|++|.+...- .+.+...+.|++|+|++|.|+.. +-..+..-++|++|+|++|++... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 45666666666665221 22333456777777777777642 223455667778888877765521 1
Q ss_pred CCCccCCCCCCeEEccCccc
Q 008121 194 PNSFISLSNISSLYLQNNQV 213 (577)
Q Consensus 194 p~~~~~l~~L~~L~l~~N~l 213 (577)
...+...++|+.|+++.+..
T Consensus 124 ~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCccEeeCcCCCc
Confidence 22333456777887776643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.67 E-value=2.7e-06 Score=74.57 Aligned_cols=66 Identities=12% Similarity=0.218 Sum_probs=35.9
Q ss_pred ccCCCCccEEEeccCCCccc----ccccccCCCCCcEEeCcCCcccCCC----CCCccCCCCCCeEEccCcccc
Q 008121 149 IASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGDL----PNSFISLSNISSLYLQNNQVT 214 (577)
Q Consensus 149 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~----p~~~~~l~~L~~L~l~~N~l~ 214 (577)
+...+.|+.|+|++|.+... +...+...+.|++|+|++|.|+..- -..+...++|++|+|++|.+.
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 34455666667776666532 2223444566666777766665321 112444556666666666543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.50 E-value=9.5e-05 Score=73.81 Aligned_cols=78 Identities=17% Similarity=0.059 Sum_probs=46.1
Q ss_pred cceeccCccceEEEEEEcC-CcEEEEEEcccccc----c-hHHHHHHHHHHHHhhcCC---CCceeeEeeEEEeCCeEEE
Q 008121 415 EFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL----S-LQEEDNFLEAVSNMSRLR---HPNIVTLAGYCAEHGQRLL 485 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~-~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~l 485 (577)
.+.||.|....||+....+ ++.|+||.-..... + ....++...|.+.+..+. ...+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999997654 67888886432100 0 011223445666665442 2345566654 4445689
Q ss_pred EEEecCCCC
Q 008121 486 VYEYVGNGN 494 (577)
Q Consensus 486 v~e~~~~g~ 494 (577)
||||+++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.99 E-value=1.2e-05 Score=70.11 Aligned_cols=84 Identities=13% Similarity=0.165 Sum_probs=36.2
Q ss_pred CCccEEEccCCcCCCc----CCCCccCCCCccEEEeccCCCccc----ccccccCCCCCcEEeC--cCCcccC----CCC
Q 008121 129 PNLTSLNLASNNFSGN----LPYSIASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDL--SFNNFSG----DLP 194 (577)
Q Consensus 129 ~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~g----~~p 194 (577)
++|++|+|++|.++.. +-..+...++|+.|++++|.++.. +-..+...++|+.++| ++|.+.. .+.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 4455555555555422 112223345555555555555422 1233444455554333 3444431 112
Q ss_pred CCccCCCCCCeEEccCcc
Q 008121 195 NSFISLSNISSLYLQNNQ 212 (577)
Q Consensus 195 ~~~~~l~~L~~L~l~~N~ 212 (577)
..+...++|+.|+++.|.
T Consensus 126 ~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHHCSSCCEEECCCSS
T ss_pred HHHHhCCCcCEEeCcCCC
Confidence 223344455555554443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.96 E-value=4e-05 Score=66.71 Aligned_cols=110 Identities=21% Similarity=0.340 Sum_probs=79.2
Q ss_pred eCCcEEEEEcCC-CCCccc----ccccccCCCCCCEEEccCCCcCCcCCCCC------CCCccEEEccCCcCCCc----C
Q 008121 81 EGSAVVSIDISG-LGLSGT----MGYLLSDLLSLRKFDLSGNSIHDTIPYQL------PPNLTSLNLASNNFSGN----L 145 (577)
Q Consensus 81 ~~~~v~~l~l~~-~~l~g~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~------~~~L~~L~l~~N~l~~~----~ 145 (577)
++..++.|+|++ +.++.. +-..+...++|++|+|++|.++...-..+ .+.|+.|++++|.++.. +
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 346788999997 456432 34566788999999999999874322111 27899999999999733 2
Q ss_pred CCCccCCCCccEEEe--ccCCCcc----cccccccCCCCCcEEeCcCCccc
Q 008121 146 PYSIASMVSLSYLNV--SRNSLTQ----SIGDIFGNLAGLATLDLSFNNFS 190 (577)
Q Consensus 146 p~~~~~l~~L~~L~L--~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 190 (577)
-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.|+..
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 356677888987655 5777864 34556677899999999887654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.39 E-value=0.0067 Score=58.14 Aligned_cols=136 Identities=18% Similarity=0.208 Sum_probs=75.4
Q ss_pred ceEEEEEEcCCcEEEEEEccccccchHHHHHHHHHHHHhhcCCCCce-----eeEe--eEEEeCCeEEEEEEecCCCCHH
Q 008121 424 GRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI-----VTLA--GYCAEHGQRLLVYEYVGNGNLH 496 (577)
Q Consensus 424 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-----v~l~--~~~~~~~~~~lv~e~~~~g~L~ 496 (577)
-.||+...++|+.|++|..+....+ .+++.+|...+..+....| +..- ......+..+.+++|++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 4899999999999999998654332 3445667766655532221 1111 1234566788999999763321
Q ss_pred -----Hh---------hhhc----c-CCCCCCCH-------------------HHHHHHHHHHHHHHHHHhc----CCCC
Q 008121 497 -----DM---------LHFA----D-DSSKNLTW-------------------NARVRVALGTARALEYLHE----VCLP 534 (577)
Q Consensus 497 -----~~---------l~~~----~-~~~~~l~~-------------------~~~~~i~~~i~~~L~yLH~----~~~~ 534 (577)
.+ +|.. . .....+++ ..+..+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 10 1110 0 00111111 1111122222233333322 2234
Q ss_pred CeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 535 SVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 535 ~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
++||+|+.+.|||++++ ..+.||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 68999999999999754 56899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.93 E-value=0.01 Score=58.49 Aligned_cols=73 Identities=14% Similarity=0.132 Sum_probs=45.6
Q ss_pred cceeccCccceEEEEEEcCC--------cEEEEEEccccccchHHHHHHHHHHHHhhcCCCCce-eeEeeEEEeCCeEEE
Q 008121 415 EFLIGEGSLGRVYRAEFANG--------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI-VTLAGYCAEHGQRLL 485 (577)
Q Consensus 415 ~~~lg~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~l 485 (577)
.+.|+.|-.-.+|+....++ +.|.+++... ... .....+|..+++.+.-.++ .++++++.. .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 35688888889999987543 4566665532 111 2234567777776643344 467777643 68
Q ss_pred EEEecCCCCH
Q 008121 486 VYEYVGNGNL 495 (577)
Q Consensus 486 v~e~~~~g~L 495 (577)
|+||+++..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.01 E-value=0.084 Score=49.65 Aligned_cols=31 Identities=19% Similarity=0.220 Sum_probs=27.5
Q ss_pred CCeeecCCCCCCeeeCCCCCeEEeccccCcc
Q 008121 534 PSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (577)
Q Consensus 534 ~~ivHrDlk~~NILl~~~~~~kl~DFGla~~ 564 (577)
.++||+|+.+.||+++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999887778999998863
|